The Health Advocates
A podcast that breaks down major health news of the week to help you make sense of it all.
“The Health Advocates” is hosted by Steven Newmark, Director of Policy at GHLF and Zoe Rothblatt, Patient Advocate and Community Outreach Manager at GHLF. Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
“The Health Advocates” is part of the Global Healthy Living Foundation Podcast Network and hosted by Steven Newmark and Zoe Rothblatt.
Crohn’s and Colitis Awareness Week with Keyla Caba
This Crohn’s and Colitis Awareness Week we’re joined by Keyla Caba, who lives with Crohn’s disease and ulcerative colitis, and is the founder of the nonprofit Connecting Pieces. Keyla shares her patient journey, talks about the common misconceptions people have about inflammatory bowel disease (IBD), and why awareness and community is important.
Crohn’s and Colitis Awareness Week with Keyla Caba
Narrator 00:00
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation, Podcast Network.
Steven Newmark 00:08
Welcome to “The Health Advocates: A Podcast that Breaks Down Major Health News of the Week, to Help you Make Sense of it All.” I’m Steven Newmark, Chief of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Director of Community Outreach at GHLF.
Steven Newmark 00:21
Our goal is to help you understand what’s happening in the health care world, to help you make informed decisions to live your best life.
Zoe Rothblatt 00:26
And today, we’re joined by Keyla Caba, who lives with Crohn’s disease and ulcerative colitis. She is the CEO and founder of “Connecting Pieces,” a non profit with the mission to improve the lives of those impacted by gastrointestinal disorders, gastrointestinal cancers, and ostomies. Today, we talk about her IBD journey, the importance of awareness and advocacy, and why she started connecting pieces.
Steven Newmark 00:50
Great! I’m excited to have a listen.
Zoe Rothblatt 00:52
So, Keyla, welcome to “The Health Advocates.” Can you start by introducing yourself to our audience?
Keyla Caba 00:58
Hi! My name is Keyla, I am 39 years old, and I have Crohn’s disease and ulcerative colitis. I have had the conditions for about 12 years now, which has left me with a permanent ostomy bag. I live in Boston, Massachusetts. I am a caregiver to a child, with ulcerative colitis as well, I am a non profit founder and owner, and a uterine cancer survivor, and a patient advocate as well.
Zoe Rothblatt 01:26
And can you describe what those symptoms were like in the beginning?
Keyla Caba 01:30
See, this is kind of interesting as well, because in my story, I started to have symptoms when I was a child, but I was not officially diagnosed until I was 28 years old. So, my parents kind of came from the Dominican Republic; they didn’t speak the lick of English, when they came to this country, and so I had to serve as a translator for them. And I don’t know if it was, just like, me lost in translation, or what the problem was that there was a delay in my diagnosis, but when I was growing up, I thought that rectal bleeding, which is what I was having and passing out as well with bowel movements, was normal for everyone, and it wasn’t until I worked in the health care field, and I started, actually, working with children that have IBD, and I had passed out at work one day, and one of my co-workers said, “Hey, that’s not normal. You need to get that checked.” So, I was like, “Okay, I guess so.” I ended up going to the doctors, and even then, I didn’t get my official diagnosis; I had to go for a second opinion afterwards, and that’s when they told me that I had ulcerative colitis.
Zoe Rothblatt 02:35
Thinking about your journey to diagnosis and living with this disease, what’s one thing that you wish more people knew about inflammatory bowel disease?
Keyla Caba 02:44
I feel like it’s everything, everything because there’s not enough, not even myself as a patient, like I didn’t even know enough; it’s a lifelong condition; it’s an invisible illness. I know, like on the outside, right, I look okay, but on the inside, my body is like creating all this havoc that nobody can see and nobody knows that I’m experiencing. So, it’s a roller coaster ride that I did not sign up for, but I have learned to become friends with it. So many people, and everybody’s journey is so different, and you cannot compare, like, one person’s IBD story to another. So, those are definitely, I think, the main ones for me.
Zoe Rothblatt 03:24
It’s so true that everybody’s journey is so different, which kind of leads me into my next question, which is, why do you think it’s so important to raise awareness for Crohn’s disease and ulcerative colitis?
Keyla Caba 03:35
So, I think it’s important to raise awareness, because just in having this condition for 12 years, even then, I’ve seen science and so many things change already. In the beginning, I think there was only maybe five medications available for the condition, when I was first diagnosed. Now, I believe there’s like 10 or 12. So, that’s one thing. But definitely too, if we don’t raise awareness, like, how are other people gonna know that this exists? Nobody enjoys talking about poop, first of all. No one enjoys talking about bathroom experiences, what they go through, and so some of the symptoms that you have when you’re having Crohn’s is, some people have, rectal bleeding, is one of them, or diarrhea. And no one likes to talk about having rectal bleeding or diarrhea, and these are some signs of just, it could be, like many different things. And the second thing about raising awareness is kind of going back to, previously, my other answer is the invisible illness, the lack of awareness, the lack of resources that we have. I think the more that people know about it, the more access that we’ll have to better health care, to better treatment, just to a better lifestyle in general. So, also too, I feel like it’s helped me sort of heal in my journey as well. So, sharing my story has absolutely been sort of a pillar for me in this kind of roller coaster ride, as I said.
Zoe Rothblatt 04:57
Speaking of a roller coaster ride, there’s a lot to learn when diagnosed with a condition like this. So, how did you educate yourself as a newly diagnosed patient? Can you tell us a little bit about those early days of your journey?
Keyla Caba 05:09
So, when I started my journey, how did I get to where I am now? I guess sort of the resources I found was everything and everything – I just researched like a mad woman. I made it my priority to learn as much as I could about having an ostomy, what people were doing out there, what they were wearing, just to think, just everything. And then, similar to IBD as well, like, what are natural things people are doing, what’s working for them? And so through all this research, I kind of just started one-by-one, fracking, and then finding what worked for me. And that’s where I think journaling is, like, super important as well, because I’ve come to a point where I even know, like, what foods I can and can’t have, how long if I do decide to cheat, how long I can wait in between to, you know, like I’ve mastered it so well. So, I would say tracking, community support groups, and communication. Because if you don’t communicate to your doctors or anybody, then how you gonna get anywhere?
Zoe Rothblatt 06:12
So, what’s a common misconception about Crohn’s and ostomies, that you’d like to debunk?
Keyla Caba 06:17
So, let’s go with Crohn’s first. “You have to eat better,” or, “I’m sure if you exercise or if you rest, like, you’ll be fine and it’ll get better.” Wrong. “Take your medications and you’ll be cured.” There is no cure for Crohn’s right now. There are people, who can maintain the condition, without being on medications, which is amazing for them, but there’s no cure for this disease, and having an ostomy, we could be here all day talking about this. There’s like, “Do we smell?” Just personally, like I was like, “Am I gonna be sexy? Am I gonna be attractive? Am I gonna be able to do anything?” I wear, whatever I want, as well, as I said earlier, I’m a model as well; I’ve worn wedding gowns, I’ve worn bathing suits, I have modeled in anything and everything that you could possibly think of, and I’ve still been able to make it work or conceal it as well, whichever way you are. Not everybody likes to show their bag, and some people don’t care. I remember right out of the hospital, I was like, “Can I wear my seat belt? Like, should I not let it be against my abdomen? Swimming?” I like to shower without my bag sometimes. People, who have ostomy don’t even know that. So, there’s so many things, so many things that we can touch on, but we’d be real thing.
Zoe Rothblatt 07:32
Yeah, we would be here all day. So, speaking of day, what does a good day look like to you? And how does it differ from a bad day?
Keyla Caba 07:40
So, good days versus bad days, I feel, like, they’re all interesting days. This roller coaster ride that we, and it really is, I always call it a roller coaster because of this, because one day I might wake up and I’m in pain sort of every day, right. But it’s a matter of how much am I able to tolerate, first of all. That day, I just took my medication yesterday. So, today is actually a low frequency day for me, because I’m exhausted, but you see me here, I’m smiling, I’m energetic because I went to bed so early. I’ve had to learn what kind of works for my body, give myself grace, and just kind of go with the flow as well. So, a realistic good day, okay, not one where I’m sugar coating of how I feel, I would say, consists of maybe a pain scale of like five and under. I’m constantly in pain every day, whether it be joint pain, stomach pain, or some sort of symptom I’ll be having, like nausea, something with my Crohn’s will always kind of come out. I would say a good day would be making sure I get out of bed, making sure I am able to walk. There’s been times where I haven’t been able to walk or shower myself, or I would love to go for a walk, but I’m in a hospital bed. So, I count the little things, I guess, that some people would say would be little, as like, a good day right now, and if I end up achieving more than that, then even better. Bad days for me, I would say it could just be, like, I’m either really nauseous or I’m not able to eat a lot that day, or take in a lot of, like, liquids, or it be where I am, kind of in bed, or working from my bed.
Zoe Rothblatt 09:26
Diving in a bit deeper, to what you just said, how has your relationship with food changed since being diagnosed with Crohn’s?
Keyla Caba 09:33
Oh my gosh, like you’re the first person that’s ever asked me this question. Thank you for asking this, because it’s like, what, something I’m so passionate about, actually, as well. My organization provides a virtual cooking class for this exact reason. So first, I’m not gonna lie, it was a love-hate relationship, and you start to sort of, well, at least for myself, build this fear. Because you can eat a cracker today, and that same cracker tomorrow might make you so sick. And so, you start to get this sort of trauma, I guess, and fear, and anxiety with eating food. And you have to learn that, at least for myself, I had to teach myself it’s not me, like, it’s not what I’m doing. I am doing all of the things that I know my body needs. Just right now, it’s wreaking havoc, and it’s angry, and it’ll calm down, and that cracker will be your friend tomorrow. And then I say it after. And so, I try to, like, learn, you know, when these flares come, what are my flare foods that sort of don’t upset my stomach? And so for me, it’s like, plain rice, or like chicken; very plain, sort of diet and food. And then I’ve also had to learn to navigate things now that I have an ostomy. And so that just threw in like a whole other curve ball with eating as well. Because you have to sort of learn, if you want an apple, you got to take the peel off. Maybe it might work for me; might not work for you. You know, you might not be able to have an apple at all. And so, it’s like trial and error, but also thinking outside the box, like I would never have thought of like peeling a grape. Who peels grape? Nobody ever peels grape. So, I’m actually able to tolerate them, as long as I don’t have a peel. And like, I wouldn’t have thought something like that until I wouldn’t have spoken, like, I talked to a nutritionist, I talked in support groups, I did so much research. And our cooking class is there for this exact reason, for those people that are getting discouraged, and eliminating foods left and right, and, basically, leaving themselves with, like, not many options.
Zoe Rothblatt 11:36
Well, Keyla, you’ve been smiling and laughing throughout the interview, so my question is, how do you stay positive and manage your mental health when dealing with a flare up?
Keyla Caba 11:45
I mean, I consider myself now a veteran with Crohn’s. I still, every day I’m learning something new about the condition, about myself, and about this healing journey. I would absolutely say I had to learn to become friends with it, not see it as my enemy; learn to cohabitate with the condition. Learn that it is my lifelong friends, and how are we going to support each other, right? What’s my self-care look like, whether it be journaling, whether it be meditating, whether it be a bubble bath, whether it just be laying in my bed for a couple days, because I need that. Whatever that kind of self care sort of looks like in that time frame and in my journey, I try to listen to my body absolutely a lot more, because it will definitely let me know if I don’t listen to it. Sharing my journey, too, on social media. I’m too old to consider myself an influencer, but sharing my journey online as well, knowing that there’s someone out there that can relate, and that I’m not alone has absolutely been just really great in my journey. And I have been, you know, in those dark places before like, this journey is absolutely not easy, but I find that it’s a lot harder when you’re kind of at a low frequency, let’s say, or if you’re thinking negatively. And I’ve allowed myself a certain time frame for that, and then after that, it’s like, “Let’s just keep going, because this condition is going to be here, and it stuck with me forever. So, let’s just keep on trucking.”
Zoe Rothblatt 13:16
Now, you’re also a fierce advocate. Can you tell us what led you to, you know, start speaking up about your conditions, and advocate for yourself?
Keyla Caba 13:24
It was from my personal journey and barriers that I sort of ran into, anything from insurance denying medications that I needed to be on, that my doctor had suggested that that was the one I needed to be on, that, I have so many stories for days, but all the barriers sort of that I ran into, and I was like, this, my background in health care as well working in health care, and the knowledge that I knew. A combination of all of those. And then I was like, “This has to improve. This has to get better for us.” And so I found this other organization called ‘Patients Rising.’ They are a non-profit, and they pretty much provide support and resources, and advocacy on legislative levels, state and federal, to patients and caregivers. Anyone that’s interested in advocating, they have a free master class online. You go at your own pace, which I love, and I learned everything I know from them. They’re the ones, who taught me about speaking to your insurance companies, and to the state about making sure that medications stay covered on the insurance formulary every year. I know microbes medication is about $50,000, so I definitely want to make sure that states is a covered medication there. And so knowing that as well, how much does your medication cost? Knowledge is power, and I definitely got that from ‘Patients Rising.’
Zoe Rothblatt 14:42
And can you tell us a little bit more about your advocacy work?
Keyla Caba 14:46
I really think it’s fun. I love talking to legislators and telling them like, “Hey, this is what is really going down with these insurance companies and what they’re doing. And this is not okay.” I’m actually going to be advocating later today with legislators, here in Massachusetts. I’ll be testifying and sharing my story about the lack of ostomy supplies and coverage. So, like I said, I could be here all day talking about this, but I speak on the state level, federal level, I’ve gone to Washington. I go at least every year for different awareness days or weeks, and talk about different bills from improving disability, health care, it could be speaking to insurance companies about continuing coverage for our medication specifically. So, like I said, it could be like so many different, anything to improve the lives for our community.
Zoe Rothblatt 15:32
It really is so many different things. Would you mind telling us one example of a time you advocated with legislators that made you feel like you really made a difference?
Keyla Caba 15:42
I would say, getting the proclamation for Massachusetts for Ostomy Awareness Day, that was probably, for me, like the biggest thing, even though it’s just like an awareness day, and just the acknowledgement that they acknowledged it. And then I would say, the current project: me testifying later today, we’re about to meet with this committee, who have the power to say, either ‘yes’ or ‘no’ about covering ostomy supplies for people in our state. If this gets passed, then other states can start incorporating it as well. So, for me, I would say probably today, right now.
Zoe Rothblatt 16:16
And can you tell us why having a support network is important for people living with chronic illness?
Keyla Caba 16:22
Having a strong support network is going to be life, and it’s going to look different for everyone. So, for example, my family never understood this condition, and so, they were not as supportive as I would have liked for them to be. So, people are going to show up in whatever form they’re going to show up. It’s a matter of how do you want them to show up for you? And so, I feel like it’s definitely important for you to communicate that to whoever your circle is, whether it be a stranger, someone you met online, someone in the community, could be a relative, a friend, whoever it is that you’re choosing to keep in that circle, give them grace and give yourself grace, but communication is key, and allow them to learn into your journey and what’s going on with you as well.
Zoe Rothblatt 17:08
I think that leads us into my next question so well, with talking about support. Can you tell us more about your nonprofit, ‘Connecting Pieces?’
Keyla Caba 17:16
Yes! So, my nonprofit is ‘Connecting Pieces.’ We are a 501(c)(3), registered non-profit, out of Boston, Massachusetts. We provide support for patients with gastrointestinal disorders, cancers, and ostomies, adults and children, caregivers, and we provide free ostomy supplies for anyone in need, internationally and nationally as well. We’ve provided supplies to patients in the Caribbean, Europe, Middle East, UK, and we’ve been open for about a year. We also offer virtual art expression classes, and movement classes, and we also offer virtual cooking classes with these amazing chefs, and a dietitian that we have as well.
Zoe Rothblatt 17:57
Keyla, thank you for all you do – You’re such a powerful voice for the community, and, you know, sharing your story with us. And one last question before you go, if you had one message of ‘hope’ you wanted to share with others on living with Crohn’s, what’s your message?
Keyla Caba 18:11
You are not alone! You are not alone; there’s like a whole community of us out there. And reach out to people. You have an entire community of people out there, organizations out there that have many different levels of support, bilingual support, virtual support, in-person support, for children, for adults, for caregivers. Don’t be afraid to talk to people in the community, or anybody, and just know, like, give yourself grace, and you are not alone.
Zoe Rothblatt 18:40
Keyla, thank you so much for joining us on “The Health Advocates,” and for spreading awareness this Crohn’s and Colitis Awareness Week.
Steven Newmark 18:48
Wow, Zoe, that was a really great discussion! Well, before we go, we want to encourage everyone to check out all of our podcasts at ghlf.org/listen
Zoe Rothblatt 18:57
Well, everyone, thanks for listening to “The Health Advocates: A Podcast that Breaks Down Major Health News of the Week, to Help you Make Sense of it All.” If you like this episode, give us a rating, write a review, and hit that subscribe button wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 19:10
I’m Steven Newmark. We’ll see you next time.
Narrator 19:16
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation, Podcast Network.
Turkey Day Conversations: Advocating Against Weight Stigma
In this year’s Thanksgiving special of The Health Advocates, Steven and Zoe delve into an important topic — weight bias — and how it impacts the chronic illness community. They explore the misconceptions surrounding weight and health, share strategies for fostering compassionate care, and encourage listeners to use the holiday as an opportunity to educate and advocate with loved ones. Join them for an inspiring conversation filled with practical advice, personal reflections, and gratitude for the patient advocacy community.
Turkey Day Conversations: Advocating Against Weight Stigma
Narrator 00:00
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation, Podcast Network.
Steven Newmark 00:08
Welcome to “The Health Advocates: a Podcast that Breaks Down Major Health News of the Week to Help you Make Sense of it All.” I’m Steven Newmark, Chief Policy Officer at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Director of Community Outreach at GHLF.
Steven Newmark 00:21
Our goal is to help you understand what’s happening in the health care world, to help you make informed decisions to live your best life.
Zoe Rothblatt 00:27
And today, we have our special episode, our annual ‘Turkey Day Talking Points.’ But first, Steven, I want to ask, what are you thankful for this year?
Steven Newmark 00:35
Well, I’m always thankful for our patient advocates here at GHLF. I’m so thankful for the 1000s of patients that we have, that continue to advocate for themselves, and patients around the country.
Zoe Rothblatt 00:47
It’s so true, especially coming off of the American College of Rheumatology Conference, seeing our colleagues there in the patient community really active, it just reminds you that, you know, we’re stronger together.
Steven Newmark 01:00
Absolutely, this holiday is also an important opportunity to share with loved ones, what it’s like to live with a chronic condition, and the vital advocacy you engage in, to ensure better access to treatments and care.
Zoe Rothblatt 01:11
And today, we wanted to highlight one key topic that you can bring up with your family, something that may be going around in the news, or you hear about online, and that’s weight bias. So, you know, let’s just talk about what it is, why it’s important to address it, and give some conversation tips.
Steven Newmark 01:27
Sure. So, weight bias refers to negative attitudes and beliefs about individuals based on their body weight. The bias can manifest itself in many areas of life, including health care, education, and employment, and it often leads to discrimination and stigma, which can significantly impact the person’s quality of life and health.
Zoe Rothblatt 01:42
And addressing it is really important because we want to reduce weight bias. It’s essential for building a more inclusive society, where everyone feels supported to get access to the care that they need, because weight bias can often lead to a lot of prejudice health beliefs amongst, even health care providers, but those around you, and it can make you hesitant to seek care, and we want to try to reduce that as much as possible, so people feel respected and compassion from the health care system and those around them.
Steven Newmark 02:13
So, what can we do, as advocates, to people in the community around this topic? Starting with conversations.
Zoe Rothblatt 02:20
Exactly, yeah, just like we are now. You know you could bring up these talking points, share your experiences, or stories, with loved ones about the importance of treating people who has chronic illness with respect and how chronic illness affects people’s lives.
Steven Newmark 02:35
Yeah, and you should also understand, and perhaps challenge myths, educating people about misconcessions that surround weight and health, emphasize that health is multi-dimensional and cannot be judged solely by one’s body size.
Zoe Rothblatt 02:47
And you could also take it a step further and advocate for policy change. There are bills, like, we talked about TROA [the Treat and Reduce Obesity Act] at the federal level that increases access to obesity care. You could join our 50 State Network of Advocates to learn more, and we could help you get involved there too.
Steven Newmark 03:04
Yeah, and I’ve heard people say that focusing on someone’s weight or weight bias can sometimes undermine the importance of maintaining a healthy lifestyle, or even continue to encourage unhealthy habits. But that’s not really the point. The point is that to explain that addressing weight bias doesn’t necessarily downplay one’s health. You could talk about health and weight in not, necessarily, in the same sentence, If that makes sense. You want to foster a supportive environment, that allows individuals to pursue health, without fear of stigma or discrimination is the key.
Zoe Rothblatt 03:31
Exactly. And research actually shows that compassionate, unbiased care leads to better health outcomes, which makes sense, you’re more likely to seek care when you feel comfortable and follow those recommendations from a provider that makes you feel safe, and like you’re in really good hands. So, it ultimately leads to better health outcomes to have these conversations and really, like, foster that support.
Steven Newmark 03:55
Excellent. Well so, this Thanksgiving, we encourage everyone to start meaningful conversations with your loved ones on this topic, or any topic of importance, of advocating for patients and what it’s like to live with a chronic condition.
Zoe Rothblatt 04:05
And you can share your story with us at [email protected] and we also encourage you to join our 50 State Network and get involved in advocacy with us. We’ll drop a link in the show notes to sign up.
Steven Newmark 04:17
And once again, we’re incredibly thankful for the hard work and dedication of our advocates, your passion and commitment drive change and help create a world where everyone has access to compassion and effective care.
Zoe Rothblatt 04:27
Absolutely, it is really the voice of patients that help affect change.
Steven Newmark 04:32
Before we go. Zoe, you know it is Thanksgiving. What are you looking forward to this Thanksgiving?
Zoe Rothblatt 04:37
Oh my gosh. I love the parade, the Macy’s Thanksgiving Parade, that’s here in New York.
Steven Newmark 04:42
Nice. Are you gonna go?
Zoe Rothblatt 04:43
No, I usually watch it from the comfort of my couch.
Steven Newmark 04:46
Yes, smart.
Zoe Rothblatt 04:47
With breakfast and a coffee in hand, just staying warm, cozy with the family, enjoying all of the floats. It’s really fun.
Steven Newmark 04:55
That’s a good one. That’s a good one. When I was a little kid, every year we’d watch the parade, and every year I would ask to go. And every year my parents would say, “Maybe next year, maybe next year.” I never got to go. I want to do it someday, someday.
Zoe Rothblatt 05:06
Do your kids ever ask about going?
Steven Newmark 05:08
No, I can’t even get them to watch it on TV…different generations.
Zoe Rothblatt 05:11
*laughter
Steven Newmark 05:11
Yeah, well, that’s great. I’m excited myself to just have a couple of days to relax, and watch a little football, and kind of let the brain rest a little bit.
Zoe Rothblatt 05:20
Yeah, that’s what that’s for, right? Good family time.
Steven Newmark 05:24
Definitely
Zoe Rothblatt 05:24
Also, like, to say you should be, like, thankful for yourself and like you’re saying, give yourself that time to rest and like, appreciate how far you’ve come in the last year.
Steven Newmark 05:33
Yeah. Well, Happy Thanksgiving listeners. And before we go, we want to encourage everyone to check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 05:42
Well, everyone, thanks for listening to “The Health Advocates, a Podcast that Breaks Down Major Health News of the Week to Help you Make Sense of it all.” If you like this episode, give us a rating, write a review, and hit that subscribe button wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 05:55
I’m Steven Newmark. We’ll see you next time.
Narrator 06:01
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation, Podcast Network.
Live from ACR Convergence: Key Takeaways from Rheumatologists, Researchers, and Patients
We’re reporting live from the American College of Rheumatology (ACR) Convergence 2024 in Washington, D.C., a yearly gathering for rheumatology experts worldwide. Join us as we talk to rheumatologists, researchers, and patients to discover how these advancements in research are shaping the future of health and advocacy.
Live from ACR Convergence: Key Takeaways from Rheumatologists, Researchers, and Patients
Narrator 00:00
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation, Podcast Network.
Zoe Rothblatt 00:08
Welcome to “The Health Advocates: a Podcast that Breaks Down Major Health News of the Week to Help you Make Sense of it all.” I’m Zoe Rothblatt, Director of Community Outreach at GHLF. And we’re here live reporting from ACR, the American College of Rheumatology Annual Convergence, where patients, providers and researchers all come together to learn about the latest updates in rheumatology. And today, we are interviewing providers and patients. So, let’s start with our first guest, Sharon Dowell. Sharon, welcome to “The Health Advocates.” Can you please introduce yourself to our audience?
Dr. Sharon Dowell 00:43
I am Sharon Dowell, and currently, I am the medical director of Rheumatology at NEA Baptist Hospital in Jonesboro, Arkansas, and that’s coming right after working for over 10 years at Harvard University in Washington, DC. And I have been a rheumatologist for, I guess, well, for 10 years, like time really flies.
Zoe Rothblatt 01:05
So, we’re at ACR. Which session are you most looking forward to this year?
Dr. Sharon Dowell 01:09
At ACR, the session, that I love the most from the time I was a fellow, is a thieves market, and that’s because you have those really interesting, puzzling presentations that challenge the mind, and it’s always a challenge to come to the right diagnosis. And it shows how diverse rheumatology is.
Zoe Rothblatt 01:27
And can you tell us a little bit about how attending an event, like ACR, helps you become a better health advocate?
Dr. Sharon Dowell 01:34
Attending an event, like ACR, it helps us in many different ways; It doesn’t only enrich us in terms of knowledge and updating ourselves on what is happening in the world of rheumatology, but it’s also an opportunity for networking, an opportunity to interact with your fellow rheumatologists around the globe, and to hear about different challenges that they themselves are facing. And I think that allows you to better advocate for your patients, because it gives you all these different nuances of care and the patient experience as well, some that you may not experience yourself, but it helps you to have that, sort of, really broad view of patient care.
Zoe Rothblatt 02:13
Well, thank you so much, Dr. Dowell. And now we have another clinician with us, Dr. Swami Venturapalli. Dr. Venturapalli, can you please introduce yourself to our audience?
Dr. Swami Venturapalli 02:24
Yeah, hi, my name is Dr. Swami Venturapalli. And I run a practice called Attuned Health in Los Angeles, California. I’ve been doing clinical trials for over 20 years, I have participated in over 150 clinical trials, several of them as a principal investigator, several of them in lupus, myositis, some in rheumatoid arthritis.
Zoe Rothblatt 02:42
And are there any lupus specific sessions, during ACR, that you’re looking forward to this year?
Dr. Swami Venturapalli 02:47
Yeah, the big lupus specific sessions that I’m really interested is in some of the newer therapies for lupus, particularly related to the advent of these drugs called CAR T-cells, which are really interesting. They’re the ‘New Kids on the Block,’ really, and I’m trying to learn more about them so that I can discuss them in from a knowledgeable perspective with my patients. So I think those are the sessions I’m really looking forward to. I think there’s some posters related to CAR T-cell therapies and lupus. I have a patient, currently, with lupus nephritis, and she’s tried multiple medications, and unfortunately, they’ve not been able to control the lupus, so I’m interested in learning more and taking back to her, when I get back to my practice, and letting her know what I’ve learned.
Zoe Rothblatt 03:28
Finally, why is ACR, and specifically the lupus research that comes out of it important for the patient community to learn about?
Dr. Swami Venturapalli 03:36
Well, ACR is the biggest show in rheumatology. It’s where rheumatology meets. It’s called “Convergence,” for a reason, it’s for people all over the world coming in, presenting their research. It’s the best scientific meeting for anything in rheumatology, lupus, included. Lupus is actually highlighted quite a bit in the programs throughout ACR, and it attracts a lot of lupus researchers, from all over the world, who want to present their data, their research, and what they’re doing, and what’s new and exciting. And it’s a great way for people, like me, to come in, interact with colleagues, and learn from their own experiences.
Zoe Rothblatt 04:09
Well, thank you so much for joining us on “The Health Advocates.” And listeners, we’re not done yet, we’ve also interviewed patient, dietitian, and CreakyJoints contributor, Cristina Montoya. Hi, Cristina. It’s so good to be with you. Can you start by introducing yourself to our audience?
Cristina Montoya 04:25
My name is Cristina Montoya. I’m a registered dietitian and a person living with Sjögren’s disease and rheumatoid arthritis for more than 20 years. I am excited to be here at ACR, for the very first time, and very first time that I had the opportunity to participate in a panel. I was with, Eileen Davidson, and other team members, we were discussing about the unrecognized symptoms of rheumatic diseases, so that it’s not just joint pain. So, I was very honored to share my experience as a patient, and also as a registered dietician – As every single rheumatologist gets a question about diet and arthritis.
Zoe Rothblatt 05:06
So, what has been your favorite thing at ACR, so far?
Cristina Montoya 05:10
My favorite thing at ACR. Okay, so the fact that I was a speaker. For the first time I attended ACR, being a speaker and sharing my expertise in front of over 200 people, that was pretty amazing. But there’s also something else that happened, and it happened last night. So, if you don’t know, I’ve been involved with the OMERACT Sjögren’s disease working group, that is an international group that are working on, basically, developing new domain outcomes set for clinical trials, so we can actually have more validated data in Sjögren’s disease. And I was so, so happy that my advocacy, about the gastrointestinal manifestation in Sjögren’s, are being taken into account. And I was, actually, very honored to be one of the patient partners, that have been contributing to the development of these tools. That was a highlight for me.
Zoe Rothblatt 06:11
Thank you so much, Cristina, for joining us and all the work you do for patient advocates. Finally, we have our very own, Dr. Shilpa Venkatachalam, who is the Chief Patient Centered Research and Ethical Oversight Officer at GHLF, as well as Co-principal investigator of PatientSpot. Shilpa, you’ve been meeting with a lot of health care professionals for the past few days, here at ACR, and you’ve also been to many presentations. Can you, please, tell us how this year’s ACR has been? You know what you’ve learned? Any highlights you want to share with our audience?
Dr. Shilpa Venkatachalam 06:11
Thank you, Zoe. So, attending the American College of Rheumatology Conference 2024 right here in DC, on a beautiful, sunny day was truly inspiring. For many of us, living with rheumatic conditions, like myself, this conference is more than just a meeting. It’s really a beacon of hope and progress, and this year, I was particularly moved by the numerous patient centered sessions that emphasize the importance of our voices as patients in shaping research and treatment strategies. Hearing first hand accounts, from fellow patients, and seeing our stories highlighted alongside cutting edge scientific advancements, reinforce the crucial partnership between patients and health care providers. The 2024 ACR Conference showcased some remarkable strides in rheumatology research, reflecting our shared commitment to improving patient outcomes. Breakthroughs in biologic therapies and novel treatment modalities were at the forefront: promising enhanced efficacy and reduced side effects for patients, like you and me, collaborative panels underscored the vital role of patient advocacy in guiding research priorities and ensuring that scientific developments must align with the real world needs of those affected, by these diseases. It was heartening to see such a strong synergy between researchers and the patient community driving forward innovations that hold the promise of a better quality of life for us all. The American College of Rheumatology 2024, has really reinforced our dedication to advancing rheumatology care through collaboration, innovation, and unwavering support for the patient community. We’re truly excited about the future and remain committed to bridging the gap between research and real life impact, ensuring that every breakthrough translates into meaningful improvements for those we serve. Wow, Shilpa. Thank you so much for that recap and being on the ground to, you know, break this down for patients like me, and I’m wondering, you know, how does research help patients advocate for themselves? Can you talk to us a little bit about that? So, the question really is, how does patient centered research help advocate for patients? And the main point of patient centered research is that it’s relevant research. And what we mean by relevant research is we translate the everyday lived experience of patients. So, you know, things like, how do patients living with these conditions, with chronic pain, do laundry, for example, very simple questions, what kind of hopes do they have when they think about attending their grandson’s wedding, or a graduation, and their family. And so, those are the pieces of the puzzle that you can’t see on blood work or imaging. And so, what we’re doing with patient centered research is combining those pieces of information with clinical research, data from EHR, and then building a bigger picture, a more fuller picture of the person, not just the patient. And so, when patients then come to their appointments, and talk to their doctors, they’re able to talk about how this disease affects them in everyday lives, and so that’s how they can advocate for themselves. And Shilpa, on the other end, how, as a researcher, do you advocate for patients? So, as a patient advocacy organization, that has a lot of emphasis on patient centered research, one of our commitments to the patient community and to the clinical community, and of course, to the research community, is to help advance our understanding in dramatic and musculoskeletal conditions. And one of the ways that we can do this is by bringing together different pieces of the puzzle, because this really is a jigsaw where we have to build and piece together different pieces of information, different kinds of data, anecdotal data, data that’s coming from the everyday, lived experience, and then, of course, clinical and EHR data. And when we combine them all together, we are really telling researchers and clinicians what matters to patients, to people who live with these diseases. Thanks, Shilpa, I love that metaphor about the puzzle. It really is so important to just bring together the lived experiences, and the data, to really get a full picture and help patients stay more informed on their health. You know, I also wanted to ask you, what’s one study that you’re presenting on that you think can help patients advocate for themselves, with their doctor, or with their loved ones? So, I’ll tell you that we use our patient registry, the PatientSpot platform, to collect information, to collect what we call patient reported outcome data. These are pieces of information that come directly from the patient, and then doctors, and clinicians, partner with us, so that they can share information that they’re seeing in lab works, and blood works, and imaging in their encounters with patients. Then, we combine all this information, and so, instead of just one study, think of the PatientSpot registry as the study here, that can be used for patients to advocate for themselves, to talk about how this condition really affects them, impacts them every day that they live with it, right? So, from walking your dog to getting enough sleep, to feeling fatigued, then going to work, and then coming back, meeting with your family, making sure there’s, you know, food on the plate, doing your social activities that helps you maintain your mental health. Those are the things that PatientSpot can help you advocate, because many of these diseases are invisible, and so one important thing that patients need to advocate for themselves is for us to make these diseases visible. And the way we make them visible is by collecting information from patients, directly from patients, combining it with EHR data, with clinical data, and then packaging it in a way that can then be shared with loved ones, so that the invisible becomes visible.
Zoe Rothblatt 12:52
Well, thank you, Shilpa, for joining us on “The Health Advocates,” for all your work you do on behalf of patients, you and the entire GHLF team. We’re really grateful for this research that’s, you know, being done, and that we’re able to share it with the patient community.
Dr. Shilpa Venkatachalam 13:06
Thank you, Zoe.
Zoe Rothblatt 13:09
And thank you to everyone, who joined us live from ACR, to talk about the research. You can really feel the spirit here, and we hope this helps improve patient outcomes. Well, everyone, thanks for listening to “The Health Advocates: a Podcast that Breaks Down Major Health News of the Week to Help you Make Sense of it all.” If you liked this episode, give us a rating, write a review, and hit that subscribe button wherever you listen. I’m Zoe Rothblatt, and thanks for tuning in to our special episode about ACR.
Narrator 13:40
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation, Podcast Network.
Advocating for Fair Health Care: Health Insurance Battles and Burnout with Ron Howrigon
In this episode, we’re joined by Ron Howrigon, President of Fulcrum Strategies, who specializes in guiding doctors through the complexities of insurance policies. Ron shares his unique journey from working on the insurance side to advocating for physicians and patients against unfair industry practices. We dive into the challenges of prior authorization, insurance denials, and their impact on physician burnout. Ron sheds light on the incentives driving insurance companies and the reasons behind coverage battles, while offering thoughtful solutions to improve the system for patients and health care providers alike.
Advocating for Fair Health Care: Health Insurance Battles and Burnout with Ron Howrigon
Narrator 00:00
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation, Podcast Network.
Steven Newmark 00:08
Welcome to “The Health Advocates: A Podcast that Breaks Down Major Health News of the Week, to Help you Make Sense of it All.” I’m Steven Newmark, Chief of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Director of Community Outreach at GHLF.
Steven Newmark 00:21
Our goal is to help you understand what’s happening in the health care world, to help you make informed decisions to live your best life.
Zoe Rothblatt 00:26
And today, we’re joined by Ron Howrigon, who is President and CEO of Fulcrum Strategies, with 18 years of experience in the managed care industry. As a negotiator and network manager, he has held senior management level positions with three of the largest managed care companies, in the country, and he’s also the host of “The Flatlining Podcast.”
Steven Newmark 00:45
Great. I’m excited to have a listen.
Zoe Rothblatt 00:48
Welcome to “The Health Advocates,” Ron. Why don’t you kick us off by introducing yourself?
Ron Howrigon 00:52
Great. Well, first of all, thanks for having me. My name is Ron Howrigon. I’m the president of a consulting firm, that I founded and owned, called Fulcrum Strategies. And we try to help doctors navigate, what is a very difficult insurance environment right now. And I really appreciate what you guys are doing, and glad to be here.
Zoe Rothblatt 01:07
Awesome. So, can you tell us a little bit more about that career path and what motivated you to start this consulting firm? And, you know, where you were previously with insurance companies?
Ron Howrigon 01:17
I tell people, I’m a recovering managed care executive. I feel like I need to do that. You know, I’ve been clean and sober for 20 years now. So, I started my career actually working for insurance companies. Worked for Blue Cross Plan, Kaiser, Permanente, Cigna, all over the country. And my job, simply put, was to try to purchase health care at the absolute lowest price possible. I negotiated rates and reimbursement policies against physicians and hospitals, and I started to get a little disillusioned with who I was working for, what I was doing, to the practice of medicine. And when my second child was born, I was working for Blue Cross Plan. We had reduced the reimbursement for the obstetricians across the state, about six weeks prior to that delivery, and had an emergency C section. I’m holding a beautiful baby boy, thanking everybody and everything in the room. I think I thank the surgical tray. And the doctors did what they do; They didn’t take a victory lap, they didn’t take a bow. They just sort of played it off and said, “Hey, you know, glad everything worked out.” And the obstetrician turned right before he left the OR and said, “You know, Ron, the next time you take money out of a doctor’s pocket, you remember tonight, because I’m the one who was here,” and I felt terrible. And later, I’ve heard somebody describe that feeling of being in a job that you’re not comfortable with, as friend of mine once described his job and said, “I feel like a prostitute sitting on the side of the bed, counting her money, hating what I had to do to get it.” And that really describes the feeling. So, that’s when I decided that I couldn’t do it anymore, and I started my company and switched sides and decided to devote the rest of my career to try to help physicians. That was 20 years ago now.
Zoe Rothblatt 01:20
*laughter Yeah, I mean, a little different, but I have my own patient journey; I live with arthritis and Crohn’s, and, like, that experience with the health care system definitely informed me wanting to go into public health and advocate for others. So, like, while I didn’t have that, like, I’ve been working on the other side, like, feeling that you did, I definitely understand that motivation once it hits you personally.
Ron Howrigon 03:04
Exactly. You know exactly what I’m talking about then.
Zoe Rothblatt 03:06
And then, you know, transitioning to today. So, you founded your consulting firm, and you help doctors fill in the blank for us.
Ron Howrigon 03:15
Well, the bulk of what we do is try to help doctors negotiate fair and equitable reimbursement and contractual terms with the payers. What we tell doctors is we try to help them with the business side of it, so they can focus on what they do well, which is being a doctor. Now, because all of our interactions are revolving their relationship with insurance companies, we get involved in a lot of other stuff: the frustrations over prior authorization, the frustration over denials, how can I communicate better with the insurance company explain what I’m doing, why are they doing this. So, I get a lot of interaction with physicians just dealing with their sense of burnout, their frustration, their really dim out view of the future, which is concerning for me as a potential future patient. It was a survey that came out the other day, and it was just disturbing to me that almost two thirds of all the physicians interviewed, or surveyed, said they would not recommend medicine as a profession for their children. That’s really telling when two thirds of the doctors, who are caring for our patients today, say don’t do this to their kids. And that’s something I think we need to address.
Zoe Rothblatt 04:12
And you attribute a lot of that to the burnout of battling with insurance companies?
Ron Howrigon 04:17
Yeah, it’s the financial pressures. Medicare doesn’t help that, as they keep cutting Doctor Reimbursement. But the bulk of it is the insurance companies. I had one doctor say to me, which was really telling, he said, “When I went into medicine, I thought the medicine was going to be the hard part.” And he was talking about sort of keeping up with clinical advancements, new technologies, etc. He thought that was going to be hard part. And the hard part for him was trying to figure out, ‘how can I care for my patients the way I think they need it, deserve it, and that I want to, with all these barriers and roadblocks that the insurance companies put in front of me?’ I think it’s very frustrating for them. So, to me, that’s the biggest factor to physician burnout.
Zoe Rothblatt 04:53
So aside, I mean, you mentioned prior authorization, that must come up a lot, that comes up a lot in our patient community. What are some of the other common issues that you encounter, when talking with physicians?
Ron Howrigon 05:04
So, the whole process of prior auth is big. The other part of it is the physician having the patient come back in after a retro denial. They got prior authorization, they provided a service, the service was rendered, and then, after the fact, the payer denies it and looks back and says, “Well, I don’t think it was medically necessary,” and now the physician has this awkward situation with their patient of do I as the physician, just eat that bill? What if it’s for an expensive drug or an infusion that I’ve already provided and paid for? I don’t want to bill the patient; they shouldn’t have to deal with this. And so that post payment denial stuff also gets very frustrating. A lot of physicians also get very frustrated with patients, who believe they have good insurance, and then realize that, you know, between deductibles and co insurance, etc, that they don’t have the financial resources to really pay 20% of what is a large bill, or pay the first $5,000 for the deductible. That’s very frustrating for physicians to go, “Look, I know what you need. Unfortunately, you can’t afford that. Now, how do we provide you what care you can afford?” Which is, in many cases, what they think is substandard care.
Zoe Rothblatt 06:04
Totally. I feel like I say this almost on every episode, but it’s like you’re chronically paying for chronic disease, like our community lives with, you know, different types of autoimmune diseases, and those don’t go away. You may go into a remission, but you’re still going to be taking that medication for life, which means you’re paying those co pays for life, and it’s extremely expensive.
Ron Howrigon 06:22
And those are the people who need health insurance most. The young, healthy, 25 year old that goes to the doctor once a year, it’s not that bad for them. Those chronically ill people are the ones who need the insurance the most, and they’re the ones who have the worst time of it, both through the prior off, and all of the different bills, and having a deductible reset every year. You start all over again after you paid it the last time. It can be crushing.
Zoe Rothblatt 06:42
Exactly. Okay, so you have these scenarios, where your insurance is getting in the way of the doctor patient relationship. What do you do? Like, how do you come in and help negotiate?
Ron Howrigon 06:52
So, sometimes we will help try to educate the physician about what the best avenue to try to advocate for their patient is. Sometimes it’s being a listening ear. When they say, “I’m frustrated with this,” and I say, “I understand. That’s the nature of the industry right now.” Explaining to them, how to educate their patients for their rights. Lot of patients don’t know that they have certain rights to appeal things, to complain to the Department of Insurance, to complain to their employer, and just trying to help them understand how to get that voice out there. I had a recent situation in North Carolina with rheumatology, where one of the payers, and it really wasn’t the payers fault, the reimbursement for one of the drugs they used was well below cost, and it had to do with, you know, the government hadn’t set the reimbursement correctly. And so, I helped the rheumatologist sort of draft letters to the payers to explain to them what was going on and how they could address it. They eventually did, which is great, but it’s just helping them understand how to navigate those waters.
Zoe Rothblatt 07:39
That’s great. Yeah, I think it’s like, until you do it once, you don’t really know how to draft these letters or who to send it to, and it can seem really like, big and confusing. And then it’s like, helpful to have a mentor, orsomeone like you, especially because I’m sure you know, like, some of the keywords that insurance is looking for based on your background to navigate that system, right?
Ron Howrigon 08:03
Exactly.
Zoe Rothblatt 08:03
I guess, like, on that note, is it ever like, of ‘I know exactly what they’re doing because I’ve been on the other side of this?’ Are you ever kind of smirking to yourself, like you have the answer?
Ron Howrigon 08:14
I know their motivation and I know why they’re doing things. I recently wrote an article for a sub stack area, and sort of the title was, “Don’t hate the player, hate the game.” And it sort of explained that, look, health insurance companies, especially the for profit companies, in some respects, they’re doing what they should do. They’re trying to maximize their shareholders investment. They’re trying to make as much profit as possible. When we invest in our retirement accounts, we want those things to happen. The problem is that that drive for profit, which every company does, is counter to what the patients need. So, I understand their motivations; I understand why they’re doing it; and I understand all of their tactics. It’s then trying to help those physicians, so they can help their patients counter those tactics, because there’s a real disconnect between what the payers want and what the patient needs.
Zoe Rothblatt 08:56
And do you think something like a universal health plan could help break down some of these incentives, that the insurance company has?
Ron Howrigon 09:03
It could, yeah, it depends on how it’s done. Whenever somebody talks to me, let’s say for about Medicare for all, or something like that, I say, “It’s a tool. If done well, it could do wonderful things. If done poorly, it can do horrible things.” It’s like, people talk about guns are just a tool in the hands of somebody trained to use them; can be a useful tool, but in the hands of a child, it can be very dangerous. Universal health care could get rid of the profit motivation of insurance companies, which is one of the things that creates real harm. It could create other problems depending on how it’s done, but you could absolutely get rid of that profit motivation.
Zoe Rothblatt 09:32
So, chronic disease is, I guess, becoming more popular for a multitude of reasons, and our community lives with chronic disease. So, I’m curious to ask you, like, how have you seen the health care landscape change over the years, when it comes to chronic disease and dealing with these insurance coverage issues?
Ron Howrigon 09:49
So, there’s a couple things that I think have really changed. One is, and this has been true for a long time, is the insurance companies understand that a very small part of their population consumes most of the cost. It’s a really bizzare kind of environment. 5% of the people in this country consume half of all the health care dollars, and the bulk of the people in that 5% are chronically ill. It’s MS, it’s RA, it’s Parkinson’s, it’s things that are chronically ill. It’s not the episodic, you know, I had an ACL repair. So, the insurance companies know that, and they don’t like those patients, because they’re never gonna make money on those patients, so they would like to attract the other 95% of the population and get rid of the 5% of chronically ill with backwards problem. The other is, and this has been a good and bad thing, some of the treatment availability for those chronically ill has been wonderful advancements. You know, when you talk about things like RA and MS, etc, some of the new therapies that we have have really helped people’s quality of life, but they’ve also increased the cost.
Zoe Rothblatt 10:43
Totally. Yeah, just to pause there and put things in perspective, I take a biologic for my diseases, and I always see the price. I think, I pay $5, between insurance and co pay assistance, but I always look at the price, and it’s about $6,000 per month. And like, who can afford that?
Ron Howrigon 11:01
And so that creates a heightened awareness to those chronically ill. And given the incentive that the insurance company doesn’t want those people, they don’t want to have to pay for that, it creates more. That’s why we’ve seen more of the step therapy, the prior auth, to try to get rid of that. Health insurance is a bizarre industry, because when you think about it, health insurance companies finance your health care, that’s why they don’t really provide health care any more than my bank built my house. They financed it, but they don’t want you to use the product. So, if youthink about it’d be similar, like if you went into a bank and said, “Hey, I want to buy a house; I need a loan.” Most time the bank is like, “That’s great. We’re happy,” because they make money when they write more in loans. When it is the insurance companies is the opposite, when you have to spend that $6,000 every month for your biologic, but the insurance company say,”We don’t want you to do that. We’d really not even like you as a customer. We’d be happy if you’d go to somebody else.” That’s where it creates that sort of perverse incentive. The bank wants to help you borrow money because that’s how they make money. The insurance company wants to keep you from using the product because that’s how they lose money. And it just creates a real problem.
Zoe Rothblatt 11:58
And I guess, talk to us about when these utilization management methods, like step therapy, started popping up.
Ron Howrigon 12:05
Well, they started popping up, and it’s been. sort of a. an increase in use over time. Okay, they’ve been around for a long time. They’re just getting heightened; they’re getting better and better, from the payer perspective. The use of computer algorithms and AI has improved that – their ability to sort of target these things. So, they’ve been going on for some time, and as the expense of some of these chronically ill goes up, you know, they just turn up the heat, because, from the payer’s perspective, there’s a massive amount of money to be made, by either reducing the care that gets received by the patients, reducing the cost of it, or frustrating you so much that you go to one of their competitors. You know, I mean, think about it: We buy computers Apple or at an Apple shop, etc, so, when I go to the Apple store with my corporate account, they’re happy – They want me to buy more computers. If Apple has a hard time with service with me and I threaten to go start buying PC, they’re going to want to keep me as a customer. I’ll take you as an example, because you’ve talked about your own biologics, etc. If you threaten your insurance company, say, “Look, if you don’t provide me better service. I’m going to leave your insurance and I’m going to go to one of your competitors.” They would thank you, because they don’t get enough premium to cover your expense. And so you’d be doing them a good thing – That’s such a bizarre thing. And so, that’s why these efforts have stepped up; It’s not just to reduce the cost; It’s to kind of frustrate. The other thing that happens, which is really weird, is you don’t want to be known as the insurance company that’s the easiest one to deal with to get these medications or biologics, because then in communities like yours, it would go, “Hey, you know, choose Cigna or choose Aetna. I can get everything I need. It’s easy. It’s all,” then people will gravitate to them, and they’ll get more of those people than they can afford. That’s called adverse selection. And so it’s this really bizarre thing, where they’re not trying to make their customers happy; They don’t want them to be happy – They actually want them to go somewhere else.
Zoe Rothblatt 13:45
Well, I guess it’s like, where do we go from here? Are we just stuck in this insurance loop of bad incentives?
Ron Howrigon 13:52
Well, I think there’s, like, a lot of problems. There’s another way to solve the problem. The first thing, it’s like anything else, it’s like admitting you have a problem. We’ve got to and you guys are doing a great job of shedding a light to here’s the problem, and at the end of this problem, there’s a real patient like yourself, who’s dealing with a lifelong condition, who’s trying to have as high a quality life as possible, whose physicians are dedicated to do that. And why should you have to fight these fights all the time? So, it’s shedding light on it, and then we can start to explore what are the best solutions. One solution is universal health care. Another solution, if that doesn’t seem to be a viable option, is to either curtail or get rid of or change the way payers can do this. One of the things I’ve advocated is, every time there is a prior auth, review, or a denial, or this isn’t medically necessary, I think that should be reviewed and signed off by a doctor. And, this is the important part, state and federal law should call that act: the act of practicing medicine. Once you do that, the game changes, because then what would happen is, if I’m a medical director for an insurance company, and I have to sign off on saying, “You can’t have that drug,” I’ve got to be practicing within my field of specialty. I can’t practice outside of my field; I have to be licensed in the state I’m working, I have to create a medical record that shows that I reviewed your personal clinical situation. And the big one is, and if I’m wrong and I’ve done damage to you, which your physician, if they prescribe the wrong medication, or whatever faces this, I should build responsible both for my license and for malpractice. Once you do that, it changes the game, because then they can’t do this just blanket denial, these blanket step therapies, or these blanket prior auth things. And so there’s a number of fixes; we got to realize we have a problem, and then start to pursue the solution.
Zoe Rothblatt 15:29
I think you nailed it right there. I hear from a lot of patients in our community that they’re just so frustrated that some, seemingly random, person in insurance gets to deny their medication and, like, they haven’t gone through med school, or seen them, or like their doctor has.
Ron Howrigon 15:44
Yeah. I mean, there was a story that ProPublica did about Cigna. These doctors were signing off on denials, and they were signing off on a denial every 1.2 seconds. Now, you would never accept that if your physician said, “Look, I’m gonna write you a prescription after reviewing your chart for a whole 1.2 seconds,” and your physician would ever do that. Then, why does a physician on the payer side get to do that? Basically, tell you can’t have something. Obviously, they’re not looking at your clinical situation or presentation. They’re just hitting a click button and somebody else is recommending it, usually a nurse, and usually that nurse hasn’t reviewed your situation very much. So, that’s frustrating for the patient – It should be. And that to me, in my opinion, just my opinion, should be illegal.
Zoe Rothblatt 16:21
My opinion too. It’s ridiculous. You know, so our advocacy network, advocates a lot for laws, you know, at the state and federal level that offers step therapy protections, or ban COVID accumulators, and non medical switching, things like that. What’s your opinion on these laws? Do you think they’re making a difference?
Ron Howrigon 16:39
I think they are. It’s one of those things where, and I see the successes in those laws, it’s not nearly fast enough or enough, but it’s helpful. We just need to speed it up and make it more universal or more sticking of, if you will. The problem is the payer lobby is enormous and powerful, and so anytime you start to pursue one of these advancements in the law at a state level or a federal level, you’re met with massive pushback by the payers. And what they say, they’ve got the spin really good is, well, if we do this, health care will become unaffordable. Well, that’s not really true, and sometimes their numbers are questionable at best, but we’ve got to play that game, we’ve got to continue to play at the efforts of your organization, and we just have to keep pushing until we get everywhere we need to be.
Zoe Rothblatt 17:20
Yeah, absolutely. And it can be frustrating at times, because policy change does take so long, right, especially at the federal level, and it’s like years and years of bringing patient groups and provider groups forward to say, exactly what you’re saying, like this is leading to a lot of burnout and suboptimal care for patients.
Ron Howrigon 17:38
That’s one of the reasons why I like this idea, of, because it’s fairly simple to explain, of, hey, if they’re going to sign off it, then make it be the reactive practice in medicine. That’s all I’m asking. Is for that doctor to have the same responsibility than the doctor, who wrote the prescription, or who offered the care. That’s fairly easy to understand and would be fundamental in the change. Now, the payers are going to hate it, because it’ll impact their profits. But the other thing we need to shine a light on is the payer profits have been enormous, just enormous. If you took $100,000 20 years ago and invested it, and I’ll just pick one, because I know the numbers on UnitedHealthcare. Today, do you know how much money you would have from that investment? $9,000,000. 20 years ago, UnitedHealthcare stock was trading at 20 some bucks a share, today, it’s about $450. And it’s split three times. So, anytime a payer talks about health care being unaffordable, if we do this or will this, I have a hard time with that message, because you guys have been making massive amounts of profit. Now, if you have that stock in your retirement account, good for you, you benefited, but that profit has come at the expense of physicians and patients, and that’s the problem I have with it.
Zoe Rothblatt 18:39
Exactly. So, maybe to leave us on a hopeful note, you can share some advice for patients and physicians, who are currently dealing with this process and feeling frustrated?
Ron Howrigon 18:49
Yeah, I guess a couple of things. First of all, I continue to be amazed at the passion and the commitment that physicians have, and I respect that immensely. We are so lucky to have these individuals in our system, and the resiliency of patients, and that’s fantastic. The hopeful note for them is there’s a lot of positive things: the advances in medicine, the science, the new medication, some of the things that are coming out. There’s new drugs coming out for Alzheimer’s that look like they may start to reverse the progression of these – that’s incredible. The advice is, “Don’t quit. Keep pushing,” both for your individual well-being, keeping the same for the doctor, as well as these policy changes, make sure you get active with your representatives. Make sure they understand. It’s much harder to say “No” to some of these advances, when you can put a face to a disease and a condition, you know, like yours, like all the people that are dealing with similar conditions. So, there’s a wonderful Winston Churchill quote that I love, that he said during the middle of the Battle of Britain, which he said, “When you’re going through hell, don’t stop.” And that’s what I told you, is, I know, I know it’s hard, but we’ve got to get to the goal line here, and so don’t stop.
Zoe Rothblatt 19:50
Thank you. I love that messaging. It was great having you on, Ron. Take care.
Ron Howrigon 19:54
Thank you, and keep up the great work.
Steven Newmark 19:57
Well, Zoe, that was a really great discussion with Ron. As Ron said there is such a huge burden on our health care providers, to submit appeals and battle with insurance companies, and it’s unfortunate that this impacts patient care.
Zoe Rothblatt 20:07
100%. It was really powerful to hear Ron’s story about what motivated him to change from working to insurance companies to, you know, helping doctors advocate against these practices.
Steven Newmark 20:18
Well, we hope that you learned something too. And before we go, we want to encourage everyone to check out all of our podcasts at ghlf.org/listen
Zoe Rothblatt 20:26
Well, everyone. Thanks for listening to “The Health Advocates: A Podcast that Breaks Down Major Health News of the Week to Help you Make Sense of it all.” If you like this episode, give us a rating, write a review, and hit that subscribe button wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 20:40
I’m Steven Newmark. We’ll see you next time.
Narrator 20:46
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation, Podcast Network.
Post-Election Recap: What Trump’s Return Means for Health Care
In this special post-election episode of The Health Advocates, Steven Newmark, Chief Policy Officer at the Global Healthy Living Foundation, provides an update on the potential impacts of Donald Trump’s second non-consecutive presidential term on health care. With changes expected in the Senate and possible shifts in the House, Steven breaks down how Trump’s administration, along with controversial figures like Robert F. Kennedy Jr., may influence public health agencies, Medicaid, Medicare, and the Affordable Care Act. Tune in for a quick, informative recap of the election’s health care implications.
Post-Election Recap: What Trump’s Return Means for Health Care
Narrator 00:00
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation, Podcast Network.
Steven Newmark 00:09
Welcome to “The Health Advocates: A Podcast That Breaks Down Major Health News of the Week, to Help you Make Sense of it all.” I’m Steven Newmark, Chief Policy Officer at the Global Healthy Living Foundation. And welcome to a special post-election episode of “The Health Advocates.” Today, we’re coming to you, right after the election, to give a quick recap on what’s going on. It’s a special episode, and we’re gonna keep it short, sweet, and snappy. And I’ll be doing it solo today. Well, the polls said the election would be close, and overall, they were right; The election was close. It’s hard to be surprised at the results of the election, when the polls were so close, but it is surprising to have our only second-president to win a non-consecutive term, as well as the oldest elected ever. Donald Trump will be 78 years old, when he takes the oath of office, in January, and he will have support in Congress too, with the Senate flipping from Democrat to Republican. As we were recording, it’s too early to know the final Senate numbers and the final numbers in the house, but if Republicans take the house, Trump will have a lot to work with. So, how did Trump win? He built a strong coalition and increased his totals, almost universally across the board: in urban, suburban, and rural areas. He increased his vote share amongst Latino and Black voters too. It’s also the first of his three elections, that he won an outright majority of the votes: 51% at the latest count, as we’re recording. So, what does this mean for healthcare, health policy, and chronically ill Americans? Trump definitely cobbled together a team with, shall we say, interesting positions, when it comes to public health. His most notable ally, in the public health sphere, is Robert Kennedy, Jr., who, if I may say, espouses some dangerous views, to say the least. Trump has indicated that he would appoint Robert F. Kennedy, a noted vaccine skeptic, conspiracy theorist, and former independent presidential candidate, to a key role in his administration in the health sphere. Kennedy has already signaled he would seek to remove fluoride from water, work to remove vaccines in certain instances, though, his actual role and plans remain vague. Trump said last week that he would let Kennedy go, quote “Wild on health, in his administration,” but has not stated what role Kennedy would be appointed to. Kennedy’s stances on vaccine, fluoride, and other health issues have been slammed by health experts and organizations for having roots in conspiracy theories. He has, repeatedly, made false claims that vaccines cause autism, and he chaired the Children’s Health Defense, an organization that says it wants to end childhood health crises, but is a source of vaccine misinformation. He compared vaccine mandates to the Holocaust, in 2022, which he apologized for, and he was previously banned by YouTube and Instagram, for spreading misinformation about the COVID-19 vaccine. Just as a reminder, Kennedy does not have any scientific or medical credentials. Prior to his political career, he was an environmental lawyer. Kennedy put together a platform called ‘Make America Healthy Again.’ So, what’s in it? Well, first off, it is a catchy slogan, ‘Make America Healthy Again.’ And there’s not a doubt, that America could be healthier. We have short lives, avoidable deaths, and less than stellar access to care. However, the first step is to accurately identify what is causing us to be unhealthy, to fix that. And we won’t make substantial progress if we choose after falsehoods, of course. But the big, [MAHA], that’s ‘Make America Healthy Again,’ talking points: organic food, pesticides, alternative medicine, and going after drug companies, often lack specificity, are riddled with falsehoods, and widen the risk perception gap; focusing on relatively minor issues, while overlooking some significant threats, that shape our public health. One of the most dangerous aspects of the campaign is mixing reasonable statements with outright falsehoods. The combination makes it difficult for the general public to distinguish fact from fiction, and determine where we can get the most bang for our buck. Some examples from the MAHA platform include, Medicaid should pay for three organic meals a day for every American; access to nutritional food is a huge issue in the United States, that part is definitely true. However, there’s no strong evidence to date that organic food is nutritionally superior, necessarily. Organic food can also be unhealthy – Just because ice cream is organic, for example, doesn’t make it a healthy food. We should definitely prioritize increasing access to nutrient dense foods, and fruits and vegetables is, of course, important, but the misdirection in talking about organic versus nutrient dense, or healthy foods, could be misleading. A second platform is embracing alternative medicine. Many alternative medicines simply don’t work, and more dangerously, may discourage people from seeking actual tested therapies. A third is prohibiting members of U.S. Department of Agriculture Advisory Committee from making money from food or drug companies. While avoiding conflicts of interest is very important, this proposal creates a false dichotomy between expertise, and industry, and excludes valuable knowledge, and expertise. A more balanced approach would involve transparent disclosure and management of potential conflict, distinguishing between conflicts of interest that are handled appropriately versus genuine corruption. Public health. Trump’s team has called for, quote, “Cleaning up public health agencies.” This sounds a little, like, trimming the fire department, even though there are more houses catching on fire. While we agree that federal agencies need to be more nimble, flexible, and responsible to the needs on the ground, we cannot overlook the existing challenges in public health infrastructure. Trump has called for the weakening of the CDC through restructuring. The Centers for Disease Control, our National Public Health entity, holds the state public health ligaments together, if you will, through data and guidance. If the CDC is weakened, the whole system itself starts to break down, adding more institutions, like proposals to split up the CDC, for example, actually adds to bureaucracy. Institutions need to be cohesive, with sufficient, stable, and efficient funding, if we want them to be more nimble. So, what about Congress? What about laws that might be passed? Well, House Speaker, Mike Johnson, said just before that the election, that the Affordable Care Act repeal is on the table. Should Trump win, we will see what they will do, and right now, we’ll see how much fight the Democrats have, and in them, should the Republicans seek to actually pursue the repeal of the Affordable Care Act. As part of the 2021 Stimulus Package, Joe Biden and the Democratic Congress adopted expanded subsidies for the Affordable Care Act’s marketplaces. If you were an individual, a small business buying private insurance, the tax credits you received to offset premiums were larger. Subsidies were no longer cut off for people making over 400% of the poverty line, and subsidies for people subsidies for people below that were made far more generous. These provisions were later extended through the end of 2025, as part of the inflation Reduction Act. It’s hard to imagine a Republican Congress voting to extend these measures past next year. We’ll see what happens…I guess. Trump has promised not to cut Medicare, much as he did in 2016, when he first got elected, but his budgets did envision spending reductions, which were mostly minor, and came from cutting provider payments rather than limiting eligibility. The last time Trump had a Republican majority, he tried extensive cuts to Medicaid and also to food stamps, I should add, but ultimately could not get those cuts passed. Trump waffled on how clear he wanted to be in calling for Medicaid cuts during this election cycle, but when he was clear, last time he was President, the proposals had three steps. The first was to repeal the Affordable Care Act’s Medicaid coverage expansion, and replace it with a block grant for states to spanning. The second was to place a per capita cap on the rest of Medicaid, meaning states would only be granted a set amount per covered person by the federal government. And the third was to impose a work requirement, specifically to require able bodied working individuals to find employment, trained for work or volunteer, in order to receive Medicaid. Whether Trump can make these plans a reality, really depends strongly on what moderate Republicans feel about them. So, as for what’s in store, from a Trump two administration. Well, we’ll wait and see. But of course, we’re going to keep a close eye on things here at the Global Healthy Living Foundation and make sure everyone is kept up to date. And as always, we’ll make sure to insert the patient voice into any policy decisions that are being made. Well, thanks for listening to “The Health Advocates: A Podcast That Breaks Down Major Health News of the Week, to Help you Make Sense of it All.” If you liked this episode, give us a rating, and write a review on Apple podcast, and hit that subscribe button, wherever you listen – It’ll help more people like you, find us. I’m Steven Newmark. We’ll see you next time.
Narrator 08:15
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation, Podcast Network.
Spooky Tales from the Health Care System: Lessons in Advocacy
In this special Halloween episode of The Health Advocates, we’re diving into some spine-chilling experiences in the health care system. Our guests open up about their scariest moments — from misdiagnoses and panic attacks in MRI machines to doctors dismissing their pain. But it’s not all fright! They share how these tough experiences helped them become stronger self-advocates, turning fear into resilience.
Spooky Tales from the Health Care System: Lessons in Advocacy
Steven Newmark 00:00
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation, Podcast Network. Welcome, listeners, to a spooky edition of “The Health Advocates.” I’m Steven Newmark, Chief Policy Officer at the Global Healthy Living Foundation.
Zoe Rothblatt 00:18
And I’m Zoe Rothblatt, Director of Community Outreach at GHLF. And that’s right. Today, we are doing something a little bit different; We are diving into the eerie – the unsettling and sometimes downright scary side of health care.
Steven Newmark 00:31
That’s right, it’s time for some health care spooky stories, because what’s spookier than a haunted house? Getting stuck in a scary health care scenario.
Zoe Rothblatt 00:39
A 100%. But also, don’t worry, we’re not here to scare you. We’re here to just share real stories about what can go wrong in the health care world, and, more importantly, how patients like you have spoken up, and advocated for themselves, and turned these scary situations into empowering outcomes.
Steven Newmark 00:56
Exactly. We all know that navigating the health care system can be a real fright, sometimes, from misdiagnoses to medication mix-ups or even getting ghosted by your doctor. There are some truly hair raising experiences out there, but today’s stories aren’t just about things going wrong – They’re about how these patients found the courage to speak up and get the care they deserved.
Zoe Rothblatt 01:14
So, Steven, I spoke to three of our colleagues, who live with different chronic illnesses, about their spooky – turned advocacy health care stories. I’m excited for you all to have a listen and maybe learn a trick or two about advocating. First up, we have Shelley: So, imagine heading out for a nice dinner with your family, only to end the night in the emergency room. The care Shelley received was just confusing, chaotic, and awful; a true health care horror story. So, let’s dive into what happened, and how Shelley had to navigate the confusion to get the right care. Hi, Shelley.
Shelley Fritz 01:48
Hi, Zoe.
Zoe Rothblatt 01:50
Welcome to our spooky episode of “The Health Advocates.” We’re excited to have you here. And why don’t you start by introducing yourself?
Shelley Fritz 01:58
Hi, I’m Shelley Fritz. I have rheumatoid arthritis, and fibromyalgia, and osteoarthritis, and I am a patient advocate, and I’m happy to share my…Well, I’m not really happy to share my spooky story. I wish I didn’t have so many to choose from to share today. So, it was April, of 2017, it was actually Easter weekend. It was April 15th, and I remember this date, and I always will, because it was a bad day. So, in the months leading up to April, I had been feeling a little bit funky. I had been feeling like my breathing was just like, a little bit shallow. I was working as a teacher, and I was working with elementary kids, and always on the go.
Zoe Rothblatt 02:38
Yeah.
Shelley Fritz 02:39
And my mother had passed a few months prior, like had passed in the fall, so I was kind of attributing some of the breathing issues to panic and just not dealing with that well. And I wasn’t really sure, but I saw an ENT, and we were doing some tests to try to figure out what was wrong, and we really couldn’t pinpoint it. So, as we’re thinking about more tests we’re gonna do, he had wanted to set me up for those. Now we’re at Saturday, April 15th, and my family decided to go rent a boat and go fishing. So, they all went out, and I stayed home. I wasn’t feeling so well, so it’s just kind of lying around, reading, and just taking it easy. But it wasn’t getting worse, you know, just kind of laying on one side, and I felt uncomfortable moving around, but I didn’t really know what was wrong. I honestly thought maybe I have, like, indigestion (*laughter), and I laugh at that, but I do have that problem sometimes. And sometimes that’s a mistake people make: To think they have indigestion, and then they don’t deal with their problems. So, first lesson learned.
Zoe Rothblatt 03:29
Well, sometimes, also, you’re like, it must be, like, the most simplest, obvious reason, right? Like, I get why your head went to indigestion. Like, sometimes you’re like, oh, it’s the simple, obvious thing; nothing major going on here.
Shelley Fritz 03:42
Exactly. And it’s so complicated when you have chronic illnesses. Especially when you have more than one, and then you’re trying to attribute, what is the cause of this? Is it the medication, I just started? You know. Is it the medication I was last on? What is going on? So, you know, these things are running through my head. But anyway, started to feel better. So much better that that night, we decided to go out to dinner, so we went to the melting pot.
Zoe Rothblatt 04:02
Oh, I love the melting pot. Yeah.
Shelley Fritz 04:06
There’s no way I’m gonna miss this.
Zoe Rothblatt 04:07
*laughter
Shelley Fritz 04:08
So, we went, and it was 45 minutes or so, away from our house, but it’s worth the drive, right?
Zoe Rothblatt 04:14
It is!
Shelley Fritz 04:15
So it’s my husband, and my son, and I. So, we went to dinner, and we’re enjoying the meal. Everything’s going great. And then I’m not feeling well. I’m starting to get that ‘maybe it’s indigestion again,’ but now it’s starting to become more pain, and the pain is in my chest, and it’s, it’s on my left side, specifically, and it’s starting to, like, move into my shoulder blade. Now, I’m getting a little worried that maybe something else is going on. So, I hide my pain pretty well, but not this night, my husband said, “We need to leave, something’s not right.” So, I think we’re going home, right? I’m like, “Oh yeah, we should probably go home and rest.” So, we pack up from the melting pot a little bit early; We don’t even get to the chocolate. *laughter We leave.
Zoe Rothblatt 04:50
Oh no…
Shelley Fritz 04:51
I know. Bummer.
Zoe Rothblatt 04:52
I’m like, is that the spooky part of the story? We didn’t get dessert?
Shelley Fritz 04:56
Didn’t get dessert, and that’s it. *laughter So, we started driving. And you know, when you’re in extreme pain, you don’t always, I don’t, I’ll speak for myself, I don’t always make the best decisions, because I can’t think straight. And so, another thing, a lesson learned is have a plan of action with your family, and you know your Emergency Contacts, for when you have an emergency, that potential emergency that could happen one day that you’re not expecting. And so, you know, we had talked about, what hospitals do we go to. We’ve had some bad experiences at different ones, but we were very far away, and my thinking was really strange this day. I said, we have to get my son home so that he can, you know, he’s in high school, he has a lot of stuff to do, we got to get him home, he can’t be with us far away at a hospital; We need to go to that community hospital close to our house. Which, I’m just gonna say without naming it, was not the best choice. So, we pass the first exit to a great hospital, and my husband goes, “Okay, I’m turning off to this hospital.” And I say, “No, no, no, no, no, no, we’re going to this one.” And he disagrees, but I say, “No, I’m adamant.” I can barely speak, mind you. It took me forever to get me in the car, I could barely breathe now. Now, I’m like, crying and I’m panicking because I can barely breathe. I don’t want to breathe, because any type of breath was like, excruciating in my chest, and it was just shooting up into my shoulder blade, and I couldn’t move. So, I was like, stiff as a board, in the back seat, crying. And then I’m just like, I just want to get someplace, to stop the car. Just stop the car. I kept saying, “Just stop the car.” And he’s like, “Well, I can stop it at this hospital.” I said, “No, no, no, you gotta go to the one close to our house.” We’re on this really bumpy road with potholes, and I’m just feel like I’m gonna die.
Zoe Rothblatt 06:31
Oh my gosh.
Shelley Fritz 06:32
I think maybe I’m having a heart attack. I really thought it was a heart attack. And spoiler alert, it wasn’t a heart attack.
Zoe Rothblatt 06:38
Spoiler alert, Shelley is still here with us.
Shelley Fritz 06:41
Yeah, it was not, but it was something potentially fatal, but it was not a heart attack. So, we get to the hospital and go in the emergency room, and anyway, they start running some tests. And one of the first tests they did was they checked to make sure I wasn’t having a heart attack, and they assure me that that wasn’t probably what was going on, because my stats looked pretty good. So, they ran blood work. The blood work came back with a really high D-dimer level. And, if you don’t know, a D-dimer level, that’s high, can indicate the possibility of blood clots.
Zoe Rothblatt 07:09
Oh my gosh.
Shelley Fritz 07:10
So, then I might get blood clots. So, the nurse says, “We’re just gonna run some more tests your D-dimer level.” I have no idea what this is at the time.
Zoe Rothblatt 07:18
Yeah, I’m learning what that is now. I don’t think that’s something most people know until they’re encountering it, unfortunately.
Shelley Fritz 07:25
Right? It wasn’t a possibility in my head, because I just didn’t think that would happen to me, right? So, it comes back high. She says, “We’re gonna send you back for some X-rays.” And so they moved me to the X-ray table, which is excruciating, and but I did learn a great tip, that I’ll share from the X-ray technician. That’s where I learned that, if you’re in a lot of pain and you cross your arms in front of you and then they pull you up, it doesn’t pull on these muscles, right here. So…
Zoe Rothblatt 07:50
Oh…
Shelley Fritz 07:50
…crossing your arms and having your caregiver. or emergency technician. pull you up is a lot more helpful. So. we got the test done and came back, and then all of a sudden there were like five people from the hospital in our little area, in a little cubby area, and they say, “Don’t move. You can’t move her. She has bilateral pulmonary embolisms. You have blood clots in both lungs.” So, I just was, “What is going on?” And then I’m like, “Oh my god, I’m gonna die.” And I just started to panic. My husband was, like, asking a bunch of questions, you know, what does this mean? They started to act weird. They’re like, “We’re just gonna move her upstairs and just, you know, try to keep her still, and we don’t wanna move her too much.” And I’m like, “I can’t move? What is going on? This is horrifying.” So, they moved me upstairs and they gave me morphine to try to stop the pain. And this is where advocacy really came in, because I had a nurse, who hadn’t read my chart, or she didn’t read it thoroughly anyway. She didn’t know that I had the blood clots. She came in, and she immediately didn’t ask me about my pain level. She came in to take my stats, and she pulled me up from a lying down position to a sitting position.
Zoe Rothblatt 08:52
Oh my gosh.
Shelley Fritz 08:52
Just grabbed me from the back and just yanked me up, and it’s like, I think a scream came out, I don’t know, because I could barely even make noises, because I couldn’t breathe well and talk. And I was like, “No!” I just stopped her. I was like, “No, you can’t do that.” She’s like, “I have to take your stats.” And I looked at my husband, so it’s important to have somebody with you, whether it’s your neighbor, just somebody with you to advocate for you. Because I couldn’t speak, I couldn’t voice what I was trying to say, but he knew in my eyes, he’s like, “Look, you can’t move her right now. She’s in so much pain, and this morphine is not working for her.” I said, “Morphine doesn’t work for me. I know from a previous experience, I need something different.” And so she thought I just wanted more medication. And so her response to me was, “Look, lady, we can’t give you more morphine.” I said, “I don’t want any more morphine.” If you don’t want it…
Zoe Rothblatt 09:37
Yeah.
Shelley Fritz 09:37
I need something different. And so nurses changed shifts, and thank goodness. When another nurse came in, I said, “Look, I need another drug classification, then morphine. This doesn’t work for me.” And she listened to me, and she went back and talked to the doctor, and it was hours later, but I finally got another medication, Dilaudid, and that helped me to be able to breathe, and they got me on a blood thinner. And you know, long story short, I’m here today, and I’m doing well, and I don’t have any more issues with that, but I had to go on a treatment for it to help the blood clots dissipate. I made some bad decisions in the moment of crisis, and it’s important to first have a plan and then tell your family, no matter what I say, stick to my plan. But also when you know that there’s a medication that you’re being given, that, you know, doesn’t work for you well, it’s important to speak up and also to have somebody there with you, who can advocate for you.
Zoe Rothblatt 10:27
Yeah, wow. Thank you for sharing that story. Shelley, and that sounds so terrifying. And I think there’s so many elements of your story that just show strength, and like changing course of action when things were going wrong, and realizing that you needed help and relying on those around you, and I’m just so happy that you got the care you need. You’re okay, and hopefully something like that has not happened since…
Shelley Fritz 10:50
No. *laughter
Zoe Rothblatt 10:51
Good.
Shelley Fritz 10:52
It’s been really calm.
Zoe Rothblatt 10:54
Yeah, that is definitely a spooky story.
Shelley Fritz 10:57
Yeah, unfortunately it is.
Zoe Rothblatt 10:59
Yeah.
Shelley Fritz 11:00
Thanks for letting me share it, though.
Zoe Rothblatt 11:01
Yeah, thanks for coming on. And I’m excited for you to hear the rest of the stories, as part of this episode.
Shelley Fritz 11:07
I’m excited to hear them too.
Steven Newmark 11:09
That is definitely a spooky story. Lots of important lessons in Shelley’s story, especially about making a plan with your family for emergencies. I’ll add too, that when choosing hospitals, something to pay attention to is your insurance coverage, and what is in your work and with your plan.
Zoe Rothblatt 11:23
That’s a really good point. And next up, I spoke to Sarah. When Sarah went to her doctor looking for answers instead of getting help, she was told something shocking. Let’s have a listen to what happened. Hey Sarah, welcome to “The Health Advocates.”
Sarah Shaw 11:37
Thank you, Zoe. I’m really excited to be back for this spooky episode. Let’s get into it.
Zoe Rothblatt 11:42
Yeah, we’re excited to have you. I know you’ve been on before, but it’s been a minute. So, why don’t you introduce yourself to our listeners?
Sarah Shaw 11:50
Well, thank you. Thank you again. I’m Sarah Shaw. I am the Associate Director of Diversity, Equity, and Inclusion at the Global Healthy Living Foundation, and I also happen to be a person living with migraine. I’ve been living with chronic migraine for almost eight years now.
Zoe Rothblatt 12:05
And you have a spooky story to tell us. I’m actually quite excited, because I don’t know what you’re gonna talk about, and we often chat on the side about all things spooky in our health care stories. So, I’m, like, locked in and ready to see which one you picked today.
Sarah Shaw 12:20
There’s so many to choose from and Zoe, it’s been fun and also validating to have on the side conversations about our chronic illness ‘Boo Boos’ through the years. My spooky story is with an old doctor of mine, and it really taught me about the strength of advocating for myself. So, I had been seeing a doctor to help treat my chronic migraine, for about, I think, four years, and it got to the point where my migraines had just been getting worse and worse, and the treatments that I was on weren’t exactly working, or I wasn’t responding to the medication the way that I should have been. And my doctor got to the point where, I think she was really frustrated at that, but she took it out on me and actually called me a problem patient. And that was a really sad and kind of horror in my chapter of dealing with chronic migraine, because not only was I in severe pain, but now my doctor had basically given up on me, and said that there was nothing else that she could do, but didn’t say those words exactly.
Zoe Rothblatt 13:19
Wait, so set the scene for us. Were you just sitting in the room at the doctor’s office on the table, and she just said that to you?
Sarah Shaw 13:27
Yeah, I had, think I had come in for a follow up appointment after trying a newer medication, and she was just going over how I’d been feeling, how I was doing, and I kind of gave her the, “Not good, not well, I’ve had X amount of migraine attacks, and the pain is at this level,” and you could just tell she was getting kind of flustered and frustrated, and just kind of exasperated out. Was just like, “Man, you’re such a problem patient.”
Zoe Rothblatt 13:51
Oh my gosh.
Sarah Shaw 13:51
That really took me, like, off guard, and I was like, it made me feel like I was doing something wrong as a patient, not responding to the medications, and I had used my knowledge as a migraine advocate, of knowing that there were other treatments out there that we could try. And I brought that up to her, even after that comment happened, and she was like, “Oh, well, we can’t try those. We’re just gonna get denied by insurance.” And at that point, I was like, “Okay, this doctor, you know, is not going to be advocating on my behalf. I’m my best advocate.” And so I went home. Well, I cried in the car first, after that happened.
Zoe Rothblatt 14:25
Sarah, we love a cry in the car. Like, I feel like we’re always messaging, ‘Yeah, just cried about my health care year; Just cried about my health care there.’
Sarah Shaw 14:33
Nothing like a good cry, to kind of set the scene and like, inspire, like, I feel like, after a good cry, I’m always more energized to like advocate on behalf of myself and like other patients. So, I went home after my cry, and I was just sitting there, and I was like, “You know what? I’m gonna go find a better doctor. I’m gonna find someone who is going to listen to my needs, who’s not going to give up on me.” And took me a while to not internalize that problem patient comment, that obviously sat with me for a while, and then I found a wonderful doctor, who listens to me. We deal with those same insurance issues that the old doctor was hesitant to work with because, you know, she was like, you’re just gonna get denied. And believe me, me and my doctor, I want to say, every four months, we’re dealing with some other step therapy or prior authorization issue with one of my migraine medications, but every step of the way, she has always reassured me that she’s going to do whatever she can, to make sure we find a treatment plan that works well for me. And you know, I recently just had another issue, and she jumped right on it. And I think, I don’t want to say the moral of the story, but really, I think back to what would have happened if I hadn’t, like spoken up, or if I hadn’t gone home and really thought about, “I deserve better care. I deserve a health care team that’s going to advocate on behalf of me and who I work well with,” and now to this day, unfortunately, the insurance denials are still coming, but I know I have a great teammate in my health care team to advocate with me.
Zoe Rothblatt 16:02
I’m so glad that you have an amazing doctor now. And yeah, I mean, I feel like I can relate to how scary it is in the moment to hear those words, especially with like, the power imbalance of a doctor and patient, you know, like they’re supposed to be the expert, and like one who’s knowledgeable, and like you’re in their hands for care. And while we know a lot as advocates, and because of the work we do, and just living with chronic illness, like you’re never gonna know as much as the doctor, right? So like, if a doctor is sitting there telling you you’re the problem, like part of you is gonna want to believe that, and, like, get really scared.
Sarah Shaw 16:33
Yeah, exactly, exactly. And I think the language that I picked up from my current doctor, which I everyone that I meet in the work that we do here at GHLF is she’s like, “You didn’t fail the medication, the treatment failed you.” And I think that’s a much better way to have a conversation with a patient when every body is literally different. Everyone reacts differently to different treatments, and sometimes it just doesn’t work out. But the onus should never be put on the patient as the problem; It should be, “You know what? It didn’t work out, but we’re gonna keep fighting, to make sure we can get you to feeling more baseline.”
Zoe Rothblatt 17:05
And just to bring it full circle, you know, when you saw your new doctor, who’s amazing. Now, what are the kind of things you said in that first appointment? To speak up and change what had happened in the past.
Sarah Shaw 17:17
Honestly, and I remember it was 2020, yeah, so everything went to telehealth, and I was sitting in the living room in front of my computer, like, sweating profusely, like, so nervous about that first appointment, because I told her exactly what happened. I said, “This is what my last doctor said. And it made me feel, like, really uncomfortable.” And I had that awkward conversation, which wasn’t really awkward, of saying, like, “I want to work with a doctor that’s going to be able to work with me, so I don’t ever fall into that situation again.” And I remember once I said that she was like, “Listen, I’m your cheerleader. We’re gonna be teammates. That situation will not happen.” I wish for every patient to be able to have that conversation and that situation that happens, if they do have bad situations happen, to find the correct providers in your health care team to advocate along with you.
Zoe Rothblatt 18:00
That’s so powerful and such good advice, because you don’t necessarily need to know the path forward of like, what’s next, but you can clearly articulate to your doctor, like, what you don’t want to happen and what happened in the past that was wrong for you. So, thanks, Sarah, for sharing your spooky story with us.
Sarah Shaw 18:17
Thanks, Zoe, for having me on this spooky episode.
Zoe Rothblatt 18:20
Yeah, Sarah, more than happy to have you on as always. Well. Steven, that was another unsettling story.
Steven Newmark 18:25
Yeah, unfortunately, this happens so often that patient pain gets dismissed, and it can lead to many years in between the onset of symptoms to diagnosis. That’s why the work we do here is so important, to help spread awareness and give people the tools to advocate for themselves, like Sarah did.
Zoe Rothblatt 18:38
It really does happen all too often, and actually, maybe it’s time for my spooky story. I can tell you about a time where things didn’t go as planned for me. I was debating what story to tell you, and Sarah’s story made me remember a time where I felt just like something wasn’t right seeing a doctor. So, are you ready to hear it?
Steven Newmark 18:57
Sure.
Zoe Rothblatt 18:58
You know, as you know, I live with arthritis and Crohn’s, and my specialist was like, “Okay, it’s time to see a dermatologist. It’s really important that you get a skin check every year, just given your diseases and the medications you’re on.” So, I was like, “Okay, that sounds easy enough.” I made the appointment, I saw the dermatologist, she was really late and coming in, and the appointment took a while, like, to actually get started, but, you know, it wasn’t the best experience, it wasn’t the worst, I just moved on. Everything was fine. I hadn’t gone back in a little bit, my rheumatologist was like, “You know, it’s really time to go back and get another skin check. You’re supposed to do these annually.” So, I just thought, “I’ll give that doctor another chance. I’ll go.” So, here’s where things took a turn. I got to the office, and I had waited around 40 minutes, and I went to the front desk and said, “Hey, I’ve been waiting here a while. Like, any idea when the doctor is gonna see me?” They were like, I could tell they were really frustrated; They were like, “Yeah, she does this all the time.” Like, “It’ll be soon.” Like, another 10 minutes go by and now I’m like, “Okay, it’s been basically an hour.” Like. I need to say something, you know…
Steven Newmark 18:58
Oh my gosh.
Zoe Rothblatt 19:02
Like my time is important too.
Steven Newmark 19:55
An hour, wow!
Zoe Rothblatt 19:57
I know. So, I go up and they’re like, “Okay, we’ll get you in a room.” And I don’t know, if you or our listeners, have ever done a skin check, but what happens is that you get completely undressed and you’re just in a gown, because they look at every inch of your body to see if there’s like, moles or, you know, spots of concern. So, they put me in a room, they get me in the gown. Another hour passes of me sitting there waiting for the doctor.
Steven Newmark 20:27
I would have stolen all the cotton balls, at least.
Zoe Rothblatt 20:47
So, the doctor comes in and is like, “Hey, what’s going on? Let’s do a skin test.” And I was like, “Really, you’re two hours late?” And she was like, “What? I am?” And I was like, “Yeah, you’re not gonna say anything?” And she was completely taken aback that I said that. And then, like, she just, like, mumbled a little sorry, like it wasn’t anything that was like meaningful. So, I was like, I’m just gonna sit here get the test done. And I can only guess what was going through her head, when she did what she did next, when trying to, like, change things around in the appointment, maybe. But so she looked at my chart, so I have these other two autoimmune diseases, and she asked me what treatments I’m on, and I take two injections, and she starts to say, “At your age, you shouldn’t be on those – There’s better treatments now.” And it’s like talking about like a newer class of medications, JAK inhibitors, which are great options for patients. But I was just so frustrated, because this isn’t the doctor that treats these conditions, she knows nothing about my plan. I’m like, sitting here…
Steven Newmark 20:55
Wow…
Zoe Rothblatt 20:55
I know. And you know, I was, like, feeling so vulnerable because I’m just, like, sitting in this little paper gown; I didn’t want to pop my head out to say, “What’s going on?” Because I’m like, I’m not dressed appropriately. So, I’m like, “What do I do? What do I do? I’ve already wasted two hours here. Like, I’m not gonna just leave.” …after two hours undressed, and she’s just telling me what treatments I should or should not be taking.
Steven Newmark 21:51
Oh, man… Yeah.
Zoe Rothblatt 21:52
Yeah. I mean, your reaction is like, how I felt in the moment, just like, “Oh man, I gotta get out of here. I feel so uncomfortable.” And you know, for the part where things turned around, there was like a bit of time where I didn’t see a dermatologist, and finally, I got the courage to go see one again. And I did a lot of research. And what went into that research was like looking at often on doctors pages, they’ll say, like, ‘What interests the doctor.’ So, you know, I was looking for someone that deals with patients with different chronic diseases. I was reading patient reviews to see if other people had similar situations to me. And I went to this dermatologist, I had a great experience. I even, similar to Sarah, when I got there, I said, “You know, I’ve had a bad experience in the past. This is what I’m here for.” And she was really thorough, and, you know, explained things every step of the way. And my learning from that was just like, 1. If things don’t feel right, trust your gut. I think after that first appointment with the dermatologist, I should have just, because nothing’s good or bad doesn’t mean you should keep going. 2. You know, just because one provider didn’t treat you right, doesn’t mean they all are.
Steven Newmark 22:50
Right.
Zoe Rothblatt 22:50
And then also, you know, if you don’t feel comfortable speaking up, that’s a problem, and it’s really important to find a doctor that will give you the space to speak up.
Steven Newmark 22:59
Yeah, well, at least on a positive note, you learn some things…to say the least, and that’s a good thing going forward. You learn from your experiences, right? As others have also spoken up about too.
Zoe Rothblatt 23:11
Yeah.
Steven Newmark 23:12
Oh, man, it’s wild. I have a relative, who goes to a primary care doctor. Elderly loves the primary care doctor, and she tells me, she waits over an hour every time. And I’m like, “How could you go back?” She said, “I love him.”
Zoe Rothblatt 23:24
Oh my gosh.
Steven Newmark 23:25
“I love him. He’s the best. When you get taken in, he spends a lot of time with you, and that’s the deal. And you know that he does that with everybody else before you, and then when it’s your turn, you get your time too.” And I said, “Well, all right, if you know that going in, you’re willing to accept that, I guess that’s okay.” I would never do that because I don’t have that kind of patience. But everyone’s different. But man, oh, man, to have gone through that without any, I can’t believe there wasn’t, like, barely an apology or something, some mumbling, but wild somehow, cool.
Zoe Rothblatt 23:51
Yeah, exactly. And the whole appointment was, like, lasted five minutes. So, unlike your relative, it was like, I didn’t get the time back in any capacity.
Steven Newmark 23:59
Yeah.
Zoe Rothblatt 24:00
To then be questioning, what my other doctor’s doing when she didn’t even ask for my opinion, like, I’m happy on my treatment.
Steven Newmark 24:07
Oh, man.
Zoe Rothblatt 24:08
That really got me.
Steven Newmark 24:09
I’ll tell you another really quick one. I know someone, who went to a doctor, had, it was for something a little more substantive, I don’t remember the full details, but it was like to inspect something with difficulties swallowing, and got to see a specialist. And you know how that can be, sometimes those super specialists, it’s hard to get an appointment, or it’s they have you waiting. And she was waiting almost two hours as well, including one hour in the room. And she got to the point where she started to leave, and she said, I would like my file. And right away they were like, “No, no, no, we’re so sorry. No, no, the doctors…” Then all of a sudden, the doctor came right in. She said, “No, I’m done. I don’t want to be here anymore. I don’t like the treatment. Been two hours, and nobody’s spoken to me, and I don’t like that. That leaves me with a bad taste in my mouth.” So, anyway, very, very scary.
Zoe Rothblatt 24:49
Yeah, I mean, just walking out, that’s so powerful to say, you know, like, my time is just as valuable. And like, with the power, I was talking about thiswith Sarah, you know, there’s such a power imbalance with, you feel, the doctor is this expert, and has all these credentials, and you should respect them, and feel like, no, you’re the patient and you’re there, like, you and your insurance are paying for this time, like you really should get out of it what you need.
Steven Newmark 25:13
Yeah, it’s a tough situation. I mean, part of it, hate to say it like this, part of it is like, you keep expectations low. Number one, I always bring reading materials with me, something like, okay…
Zoe Rothblatt 25:24
Yeah.
Steven Newmark 25:24
…I’m stuck here, at least I have a book, or work, or my laptop, or something. And also, I do try my best to find doctors that will not keep me waiting, that are notorious for being good about keeping appointments on time. I also, oh, gosh, I don’t want to give away this secret because, but whatever, I always choose the first appointment of the day, whenever I can.
Zoe Rothblatt 25:45
Oh yeah, that’s a good one. It’s kind of like flights too. Like usually, the ones in the morning take off on time, and as the day goes on, it’s delayed.
Steven Newmark 25:54
Totally. Even if the doctor’s stuck in traffic, you’re still the first one. So, how late can it be? The other one, by the way, is the first one after lunch.
Zoe Rothblatt 26:01
Oh, yeah, that’s a good one too.
Steven Newmark 26:02
Yeah, if you could figure that out, although I’ve had like, very like, dare I say nasty receptionist, who say the doctor doesn’t take lunch, she has no time for lunches. I’m like, “Yeah, I’m pretty sure she’s eating something somewhere, along the way. I can’t imagine she’s in here nine hours, but whatever.” And if that’s the case, then that’s really bad for the people coming late in the day.
Zoe Rothblatt 26:18
Well, you know, lastly, we are heading into the MRI machine, which is never a fun place to be. When JP’s scan didn’t and go as planned, she took charge, and fought for the approval she needed. Let’s hear how JP made it happen. Hey, JP, welcome to our special spooky edition of “The Health Advocates.”
JP Summers 26:37
Hi, Zoe, thank you for having me today!
Zoe Rothblatt 26:39
Well, I’m excited to hear your spooky health care story, but before we dive in, why don’t you introduce yourself to our listeners?
JP Summers 26:47
Sure! My name is JP Summers, I’m the senior patient advocate community outreach manager at the Global Healthy Living Foundation. I’m also someone, who has several chronic conditions, and I’m a caregiver to my mom and my son, who also have chronic conditions.
Zoe Rothblatt 27:00
So yeah, what I’m hearing is, you have a bunch of conditions, and you’re a caregiver. So, there must be a library of spooky stories you could have picked from.
JP Summers 27:09
Yes, definitely.
Zoe Rothblatt 27:11
Let’s hear the one you’re gonna share with us today.
JP Summers 27:13
So, you’re right, there are several stories, but the one out of all of the stories, that I feel is the scariest, and to this day, haunts me, and when I say haunts me, it still gives me a phobia, is when I went in for MRI. During the early stages of my chronic journey, which I didn’t know, I was going to get diagnosed with something, I was sent by the ENT specialist to get some scans. And I’ve had several MRIs before, so it was like, nothing new to me, I’m like, “Oh, that’s a piece of cake.” Well, at that point, I was having two months straight of head pain, nausea, dizziness; I just was not well. So, and I also wasn’t driving, so my mom had taken me to, again, just a regular MRI appointment. I went in the, radiologist just kind of familiarized myself with, okay, this is what we’re gonna do. And as I was laying down, and he was, you know, getting ready to proceed with putting my arms in position and making sure that I was comfortable, I just felt uneasy. And as the machine started up, I started to sweat, and then my heart started racy, which is very unusual, because, again, I’ve had these before. So, I was just kind of laying there, and as the machine was, the part where you lay on, was moving into the MRI machine, my whole body, like I started to shake. I started to just feel uneasy, like my skin was crawling. And I look back and I think, I don’t know if it’s because I was in pain or just simply because of the situation, again, I wasn’t getting any the answers. I was just in this mental state, that wasn’t well at all. And all of a sudden, I dug my hands, or my fingers into my hands so hard, that I left, like, fingernail marks. And I was like crying, and all of a sudden, the radiologist was like, “Are you okay?” And I was screaming, I’m like, “Get me out. Get me out!” Because I was halfway, I’m like, “Get me out of here. Get me out of here!” And so, he’s like, “It’s gonna take, like, a minute at least to pull you out,” and like, and I was hyperventilating, and I was sweating, crying; All these things. My body was just having this bad reaction. And so he got me out, and I couldn’t stop crying; I was shaking. He was trying to calm me down; Nothing was working. And he was like, “Is there anyone here with you?” And I’m like, “My mom, my mom, my mom.” So, he brought her in, and I just remembered laying there, just bawling. My heart was still racing. And she was like, kind of patting my head, like, you know, “It’s gonna be okay. It’s gonna be okay.” And I’m like, “I can’t do this. I can’t do this.” Like, I can’t go into that MRI machine. And so, after that, again, moment, he goes, “Do you have a history of panic attacks?” I’m like, “No, no, I’ve never had one before.” And he’s like, “Well, it’s safe to say, you’re having one.” And so, we were there for like, at least 30 minutes, before I could get off the table, because I was still, like, just crying and shaking. And so, my mom was, you know, there next to me, just trying to calm me down trying to, like, “It’s going to be okay.” So, in the process of that, the radiologist was like, “Give me a moment, I’m going to make some calls.” He came back to me about 10, it was like, 10 minutes later, and he’s like, “Well, I don’t know how you feel about trying an open MRI?” He’s like, “But there’s going to be a process, because your insurance company.” And I’m like, “Oh, great. Another insurance obstacle,” because already at that point, I was going through several hurdles, just trying to obtain care for myself. And so, he’s like, “Well, I’m gonna type up a report to send to the anti specialist and see if we can get one pre authorized.” And he’s like, “You may have to talk to someone with the insurance company as well.” And I’m like, “I don’t care. I just can’t do this. I can’t going through the MRI machine.” So, I did have to talk to someone. It was like, the next day, the anti specialist put in a request, and the nurse did call me. She’s like, “Okay, you know, we put in requests. We don’t know how long it’s gonna take. Chances are you’re not gonna get approved, because this is not something they tend to do often. You kind of have to, like, be you might have to speak with them.” And at that point, I hadn’t even started advocating yet as a patient. So, I said, “You know what? Whatever I need to do.” I said, “I cannot go through that MRI machine.” So, I did talk to the insurance company, and then with the note CNT specialist sent, I just said “I had a panic attack. I want to figure out what’s going on with my health. Like something’s not right; I can’t walk unassisted, I’ve gone too much through it with head pain, nausea, dizziness, all these symptoms,” and I’m like, you know, “I really do need to get this test up, because we need to figure out what’s going on with me.” It took almost three weeks. I had to make two additional phone calls, so three phone calls total, to the insurance company, just to vouch for myself, saying “I can’t do a normal MRI. So, it took three weeks to get approved for me to do an open MRI scan, which, I will say this, I did have a little bit of phobia going in, because I’ve never had an open MRI. It is a little bit different; It’s not as open as they say. Because I walked in there, I’m like, say, I looked at it, and I’m like, “I thought, open is like, open.” And it’s like, no, you still go underneath it. So, it’s like, the way it’s it looks, it looks like, it looked like a huge hamburger bun: It’s round, and they put you the middle of it. So, you still have something like this over your face, like it’s this ‘close.’ Like, if you sneeze, you’re gonna hit your head, ‘close.’
Zoe Rothblatt 32:07
Oh my gosh, yeah, that doesn’t sound open.
JP Summers 32:10
No, I had to convince myself, this is to get answers. This is to get answers. You got to do this to get answers. And I had to coach, like, myself through it, like through the process of getting that open MRI. But at the same time, I thought, I cannot believe that I had to be on the phone several times, just to get to this point. And that was something that early in my stages of getting diagnosis, I didn’t realize that this was going to be something I was going to continuously do throughout my journey. But going forward, if I was ever to need the MRI, at least, I now know the process, and that helps me to feel a little bit more comforted with knowing that, I can fight for an open MRI, if need be.
Zoe Rothblatt 32:53
Yeah, I think you’re talking about something so real, that happens a lot with chronic illness that, actually, I’m really glad you’re talking about, because I don’t see it talked about a lot, but a lot of the diagnostic tests are, like, really takes a toll on you. Like, for instance, I have Crohn’s, and I remember thinking how, like, doing the colonoscopy, you have to do a prep, or sometimes even a scan, like, what you’re talking about, there was some weird liquid to drink with it, and it was so uncomfortable, and people just made such light of it, like, “Oh, it’s easy. Just drink this and we’ll get an image.” And you’re sitting there, like, so confused. Like, “Do I just have to endure this? Is this normal?” Like, a lot of the stuff you were talking about, like, “I’m just trying to calm down, like, why can’t I do it?” And it’s like, such a real fear. And I’m really glad you’re talking about this, because, like, the more I think about the more, like, a lot of people just don’t talk about these, like diagnostic tests you have to go through that are really challenging.
JP Summers 33:43
I agree. And being someone that’s gone through several diagnostic testing, I will say that, yeah, there’s that little bit of anxiety already going in. Because, for one, you’re like thinking, “Okay, so now I’m gonna get this test done, but am I gonna be okay with getting the answers that they might have for me afterwards?” But also the prep…
Zoe Rothblatt 34:02
Yeah.
JP Summers 34:02
…the prep going into it. And that’s something, again, as someone. who’s dealt with several conditions getting diagnosed, the prep alone; it’s, it’s like, you know what’s gonna happen. But at the same time, you kind of dread it, because you’re just like, “Oh, you know, I’m gonna have to do this. I can’t eat; fasting.” That’s something, again, that some of us with certain conditions…
Zoe Rothblatt 34:24
Oh yeah. Yeah, and I think what you’re saying is so important, like, it’s okay if you’re having a harder time, and it’s okay to speak up, and ask for options. Because in your case, there was another option, but now you know that for the future. So, I’m really glad that you said, like, we need to stop something’s wrong.
JP Summers 34:25
…you can’t not eat for so long, because it could trigger a migraine attack. Or, you know, so the dehydration, you know, if you weren’t getting enough fluids the day before, and then you have to wait so much long. So, all these factors into, like, can play a role. And that’s another type of anxiety that you can get, because you’re just like thinking, “Oh my gosh, you know, I haven’t eaten in so many hours, and now I have to wait additional, this many hours, before I can even drink anything.” And so those are things, again, that play a factor in that anxiety that build up to again, getting these testing done, that people really don’t understand, or maybe they do understand, but some people just have a harder time because, again, of their conditions. I just, I’ve never had that experience before. I’ve never done that before and again, like you think that would factor into the approval, but it didn’t. So again, I was on the phone several times, and the fact that it took three weeks; three whole weeks, that’s three weeks that I had to wait that much longer to get an answer, to move forward with my, ‘What’s the next step to my treatment? What are we gonna do now?’ And that’s something as a person, not necessarily a patient, I felt was unjust, like I cannot believe that people have to go through this process. It just didn’t seem fair. But at the same time, I learned that I do have a voice, and sometimes you do have to fight for what you need. And now, I know that I’m not afraid to be on the phone, not that I want to be, but it gave me more power over my situation.
Zoe Rothblatt 36:02
Well, I think that’s a beautiful note to end this spooky story on. Thank you for sharing with us and being vulnerable, sharing this hard moment, but also the, how you became an advocate, and spoke up for yourself and others. So, thanks, JP!
JP Summers 36:17
Yes, thank you, Zoe.
Steven Newmark 36:18
Well, thank you to JP, Shelley, and Sarah, for those stories are spooky, scary, but also powerful, in that we’ve learned from them. We’ve learned to advocate; We did advocate, and some, in some of these folks did advocate in these stories. So, there’s the bright line, after October 31st comes November 1st, so.
Zoe Rothblatt 36:36
Exactly, yeah, it’s important, I think, to share these stories, because sometimes, like, when you’re in these situations, you feel so alone. You’re like, “Am I the problem?” Like, what happened to Sarah. “Am I the only one this stuff is happening to?” But unfortunately, when you live with chronic illness and you’re encountering providers, often, like, this stuff does happen. And we’re here to say, you know, you have a voice and you deserve the care that’s right for you. So, we hope you have the tools, through our 50-State Network, to be able to speak up.
Steven Newmark 37:04
Definitely, it’s sometimes about the confidence. And I just want to call out and thank all of our 50-State Network members, for having the courage to speak up, for taking the time and energy to speak up on behalf of themselves and other patients, because as you do that, you strengthen other, all patients, around the country and around the world, and we hope that you learn something about advocating for yourself; even when things don’t go as planned or they seem scary. Before we go, as always, we want to encourage everyone to check out all of our podcasts at ghlf.org/listen
Zoe Rothblatt 37:37
Well, everyone. Thanks for listening to this spooky edition of “The Health Advocates: a Podcast That Breaks Down Major Health News of the Week, to Help you Make Sense of it all.” If you liked this episode, give us a rating, write a review, hit that subscribe button, and e-mail us in your spooky stories. I’m Zoe Rothblatt.
Steven Newmark 37:53
I’m Steven Newmark. We’ll see you next time.
Narrator 38:02
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation, Podcast Network.
Get Vaccinated, Stay Protected: 2024-2025 COVID and Flu Shots
In this episode, we discuss the 2024-2025 fall vaccine lineup, covering everything you need to know to stay protected this season. We start with updates on the latest COVID and flu vaccines, and Zoe shares her personal experience getting these shots. We then dive into the recent approval of self-administered FluMist, exploring how it compares to the traditional injectable flu vaccine in terms of effectiveness and convenience. Plus, we provide a brief update on RSV.
Get Vaccinated, Stay Protected: 2024-2025 COVID and Flu Shots
Narrator 00:00
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation, Podcast Network.
Steven Newmark 00:06
Welcome to “The Health Advocates: A Podcast that Breaks Down Major Health News of the Week, to Help you Make Sense of it all.” I’m Steven Newmark, Chief of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Director of Community Outreach, at GHLF.
Steven Newmark 00:21
Our goal is to help you understand, what’s happening in the health care world, to help you make informed decisions, to live your best life.
Zoe Rothblatt 00:27
And today, we’ll talk about, you know, flu, COVID, respiratory virus season; It’s coming upon us, and so are the fall vaccines. So, let’s get into it.
Steven Newmark 00:37
Let’s get into it. Well, our favorite vaccine, perhaps, the COVID vaccine, and the CDC is recommending everyone ages six months and older, receive an updated 2024/2025, COVID-19 vaccine.
Zoe Rothblatt 00:48
And I know we always have questions from our community, who’s immunocompromised, because of chronic illness, and the questions are usually, you know, “Do I get an extra dose?” Sometimes, you may not have as much immunity as, you know, the average healthy person. So, the CDC recommends talking to your doctor. They say, you can get an additional COVID vaccine, two or more months after taking the last one. But ultimately, that should be a decision with you and your doctor.
Steven Newmark 01:13
That’s a good number to remember, two months though, after from the last recommended vaccine. The updated vaccines are available for Moderna, Pfizer, and Novavax.
Zoe Rothblatt 01:21
Yeah, and you know, the updated vaccine is really to target the new strains, right? So, we know it continues to mutate, and similar to how we address the flu every year, the experts look at what’s circulating, and they plan a vaccine that’s going to, most likely, help against the newest strain.
Steven Newmark 01:38
Yeah, that’s why these new COVID vaccines are called updated vaccines, as opposed to boosters. They’re expected to be updated annually. Boosters, by comparison, are additional doses of the same or previous formula taken to boost immunity.
Zoe Rothblatt 01:50
Exactly! And if you think, you know, “I’ve gotten the shot, I don’t really need to get another one.” I mean, the news is that you have to. It does protect against severe illness, hospitalization, and death. It also enhances immunity that you have, like memory in your body.
Steven Newmark 02:06
Right!
Zoe Rothblatt 02:06
And although COVID infections have declined, and it’s not as intense as the pandemic was, in 2020 or like the few years after, there’s still periods of upticks in hospitalizations. And from what we know about CDC data is that most of the people who were hospitalized had not received the updated vaccine.
Steven Newmark 02:25
Yeah, that’s right. In fact, in 2023, more than 900,000 people were hospitalized in the U.S., due to COVID, and more than 75,000 people died from it; And most of these people had not received the updated shot.
Zoe Rothblatt 02:35
Yeah, and also, I know a big concern in our community is long COVID, and the vaccine also reduces your chance of getting long COVID, because it reduces the severity of the virus.
Steven Newmark 02:46
Yeah, absolutely, that’s a really good point! So, let’s talk about our other favorite seasonal vaccine, I don’t know if COVID is seasonal yet, but well, the flu vaccine certainly is. The CDC recommends that everyone six months of age and older receive an updated flu vaccine.
Zoe Rothblatt 03:00
Yeah, and this one for this year is a trivalent. It’s, ugh, this is so scientific, but if you’re interested: It protects against H1N1, H3N2, and a B/Victoria lineage virus.
Steven Newmark 03:12
Very cool. Wait, so let me just ask you, are you gonna get both at the same time?
Zoe Rothblatt 03:16
I actually did. So, I got it last week.
Steven Newmark 03:19
Whoa, boom!
Zoe Rothblatt 03:20
Yeah.
Steven Newmark 03:21
Wow!
Zoe Rothblatt 03:21
Yeah, I guess I can tell you a little bit about that.
Steven Newmark 03:24
One arm or two?
Zoe Rothblatt 03:25
I did one in each arm. I wasn’t brave enough to do it in the same arm.
Steven Newmark 03:29
Wow.
Zoe Rothblatt 03:30
It went totally fine. I talked to my rheumatologist first about, you know, adjusting my treatment plan, and actually one of my medications, I didn’t have to pause, which I’ve had to pause in the past. So, it’s just good to even if you think, you know, just ask your doctor again. Because I was really excited about that.
Steven Newmark 03:46
Huh.
Zoe Rothblatt 03:46
Okay, so I actually asked the pharmacist, you know, like, are people coming in? Are people getting both? What’s the deal.
Steven Newmark 03:53
Right.
Zoe Rothblatt 03:53
Because I knew we were gonna talk about it, and she said, “Most people are getting both at the same time. Some older adults, their doctor suggested, you know, get COVID now, but come back in a few weeks for the flu.”
Steven Newmark 04:03
Ehh.
Zoe Rothblatt 04:04
And the pharmacist was kind of up in the air about if that’s totally necessary. If you’re gonna come back for the next appointment, sure, but if it’s gonna be a pain to book another appointment, then just get it done at the same time, she said.
Steven Newmark 04:16
Right, right. Interesting.
Zoe Rothblatt 04:17
Yeah. She also said Mondays and Fridays seem to be popular days. So, if you’re in New York City, you might want to book a different day.
Steven Newmark 04:24
Monday and Friday. Okay, yeah, because you do have to sort of plan ahead in that, particularly getting two, it can have the effect of wiping you out, making you tired and drowsy, and what not to mention, a little localized pain in your arm, where the shot is.
Zoe Rothblatt 04:37
And then, actually, there was a few things that were different this year for me. So, one, we’ve had the COVID vaccine card in the past, and even last year, I was still asked about it. But this year, I wasn’t asked about it at all, which was good, because I didn’t even think about finding it, but I realized once I was at the appointment. I also got, you know, when you pick up a prescription and you get those little like scripts with your pills, you know it’s like all information about it, I was handed those about the vaccine, which I’d never been handed before.
Steven Newmark 05:05
Interesting.
Zoe Rothblatt 05:06
So, I got to, like, read up on what I got. And then also, I didn’t have to wait the 10 minutes to see if I had a reaction. She said, just go ahead.
Steven Newmark 05:13
Just get out of here.
Zoe Rothblatt 05:13
Yeah, ha ha.
Steven Newmark 05:14
This is a premium in New York City, I guess. We don’t have time for a waiting area.
Zoe Rothblatt 05:18
Well, I think it’s just, you know now that the COVID vaccines been out a few years, like, we could confidently say, most people aren’t having a reaction at the time of vaccine, so they’ve eliminated that, I guess, protective preventative measure.
Steven Newmark 05:32
Wow! Well, that’s great, that’s exciting! I guess we could go behind the curtain, we’re recording this in late September, I’m planning to get both of my shots in mid-October, so I’ll be right behind you, so to speak, and good to hear that all went well for you, and I’m looking forward to it myself.
Zoe Rothblatt 05:46
Awesome, yeah!
Steven Newmark 05:46
But there are, folks, by the way, you can get vaccinated with the flu without getting a shot now.
Zoe Rothblatt 05:51
Ooh, do tell!
Steven Newmark 05:52
Well, in September, the FDA approved a FluMist, for self or caregiver administration, for prevention of the flu. FluMist, as the name implies, is a mist that is spread into the nose.
Zoe Rothblatt 06:02
Very cool. I was actually looking up on this because I was like, “Oh, is this an option for me?” But actually, it’s not recommended for people, who are immunocompromised right now.
Steven Newmark 06:11
Ehh.
Zoe Rothblatt 06:12
So, I guess this is more like informational for our community, rather than, like, ask your doctor about this.
Steven Newmark 06:18
Yeah, okay, that’s fair enough. I think I prefer the vaccine anyway, I know it’s getting in there. Whenever I use those mists, you know, my nose like, I never know how much I’m getting in and how much is blowing out anyway. I want the full stuff inside my body.
Zoe Rothblatt 06:30
That’s true, yeah.
Steven Newmark 06:31
So, I’ll stick to the injectable. I’ll let the professionals take care of that and get it in me. But still, in all seriousness, it’s good to have more folks out there, more options for the general public, is always a good thing.
Zoe Rothblatt 06:41
Yeah. Also, I saw that, you know, when you look at it compared to the injectable vaccine, there actually is not, like, a consistent answer on which is more protective. There’s obviously more data on the injectable vaccine, because that’s been around and widely used for a long time.
Steven Newmark 06:57
Right.
Zoe Rothblatt 06:57
But there is some evidence, to say that, because the FluMist goes through your nose and the flu also comes in through your nose, that it can have, like, extra protections in like, how deep the respiratory virus goes.
Steven Newmark 07:10
Woah! Okay. Well, it’s good to see now, I guess it’s something we’ll keep our eye on, maybe in five years, we’ll all be taking the mist. And it’s like I said, it’s good to have more options out there for folks, particularly an option where you don’t have to make an appointment, make it more likely that people will follow up on that.
Zoe Rothblatt 07:24
Yeah, actually, it’s available on an online pharmacy, like through the manufacturer, there’s a screening process, and then the pharmacy will prescribe and ship the FluMist. So, it’s a little bit different. You can’t just walk into your regular pharmacy right now to get it, it seems like.
Steven Newmark 07:39
Excellent! Well, in terms of timing, basically, by the time you’re hearing this recording, you should be getting it, approximately, now. The CDC says September/October, the best times for most people to get both vaccines. Obviously, talk with your doctor to get more specifics on that. If you really want to nail down the exact date, that’s quite impossible to do. The exact date would be like two weeks before some cresting of the illness is coming, but it’s impossible to predict with particularity. So, my plan is, personally, to be vaccinated at a high rate before Thanksgiving, for example.
Zoe Rothblatt 08:09
Yeah, I was gonna say that like, you’ve said this in years past, if you’re not having much plans before the holidays, and then the holidays are coming up, it’s a good idea to time it like that. I kind of was of the like, I just want to get it done, so I don’t forget about it, especially because I do have to adjust my treatment a little bit, like I wanted to take that into consideration. When I didn’t have plans, it’s okay to feel a little worse. So yeah, I really feel like it’s just up to the person.
Steven Newmark 08:33
Right, totally! And depending on how you react to vaccines, I’m someone, at least with the COVID vaccine, with the mRNA shots, I am somebody that definitely feels it, and wants to make sure that the next day I’m prepared. That day later, afterwards, as well as into the next morning, at least, I don’t have anything major going on. So, that’s a factor, too.
Zoe Rothblatt 08:50
Yeah. Actually, I only felt a little bit tired; I was surprised at how good I felt. I kind of, actually, I feel like the chronic illness community would relate to this. I feel worse like after, like, the hangover from my regular injections, then I felt from the side effects of the vaccine. It’s almost like, “Yeah, I’m used to getting shots and feeling bad.” It was totally fine.
Steven Newmark 09:11
Right! It’s like, this is so non-scientific to say, but it’s like, sometimes you go out, and you have a drink of alcohol, and you feel just disgusting after, and sometimes you have, like, multiple drinks, and you’re totally fine. There are just factors, that I’m not wise enough to understand, and who knows, but still better to plan for the worst and get lucky.
Zoe Rothblatt 09:31
Also hydrate. Oh my gosh, I drink so much water, and I think that really, really helps.
Steven Newmark 09:35
Okay, there you go. I’ll be doing that. What about the RSV vaccine? How’s that looking?
Zoe Rothblatt 09:39
Yeah, so RSV vaccines, for older adults, were new last year, and they’re recommended for anyone 75 and older, or those 60 and older, who are at high risk. Otherwise, it’s really just available for pregnant women, so you can pass along antibodies to newborns, or babies under eight months. So, for the general population for RSV, there’s no vaccine right now, and we could just think about our other protections, like masking, and hand washing, and distancing.
Steven Newmark 10:09
Yeah, and also, very important: Rapid tests! There’s another round of free rapid tests, that are available, from the federal government. So, you should definitely get your hands on those. Because it’s good to know, when you or someone in your household, is coming down with COVID, to protect yourselves.
Zoe Rothblatt 10:24
Totally! Also, you know, like, especially around the holidays, if you find yourself kind of not feeling well, maybe you can’t get an appointment to test, or things are backed up, not open, it’s good to just like, have the rapid tests, feel confident you could do it, like, get an answer within 15 minutes, and then you can go about your plans or not.
Steven Newmark 10:42
Yeah yeah yeah, my tests have been expiring because I had so many.
Zoe Rothblatt 10:45
Mine too. I just did this round of orders, so I’ll let you know when we get it.
Steven Newmark 10:50
That’s good. Yeah, I found myself like using, I had so many, and I found myself using them, even with like a sniffle, just to make sure. Because I knew that these things were not really useful anymore, or the usefulness was expiring, as well. So, it’s good to resupply.
Zoe Rothblatt 11:04
Well, yeah, just a quick plug also, before we wrap up, our “Informed Immunity” podcast is back, hosted by our colleague, Susan Jara, who’s the Director of Patient Education here. And it’s a podcast that’s just gonna explore the role of community and equity immunization, debunking vaccine myths, navigating the health care system, and latest on vaccine research. So, definitely check it out. We’ll drop a link in the episode description.
Steven Newmark 11:28
Excellent, wow! Well, you know what? I’m gonna go with that as my learning: I’m learning that I didn’t realize that we had a new season of “Informed Immunity” coming out. So, I’m looking forward to that; Looking forward to learning more on the world of vaccines.
Zoe Rothblatt 11:40
Definitely! And for me, I learned a lot about the FluMist vaccine, in preparation for this podcast, and excited to see, just like, advancements in this space.
Steven Newmark 11:50
Well, we hope that you learned something too. Before we go, we want to encourage everyone to check out all of our podcasts, such as “Informed Immunity,” and more, at ghlf.org/listen
Zoe Rothblatt 12:00
Well, everyone, thanks for listening to “The Health Advocates: A Podcast That Breaks Down Major Health News of the Week, to Help you Make Sense of it All.” If you like this episode, give us a rating, write a review, and hit that subscribe button wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 12:13
I’m Steven Newmark, and we’ll see you next time!
Narrator 12:19
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation, Podcast Network.
See the Future: Eye Health, World Sight Day, and Thyroid Eye Disease
In this special World Sight Day episode, Steven and Zoe are joined by Caroline Casey, President of the International Agency for the Prevention of Blindness (IAPB), and Seth Ginsberg, President of the Global Healthy Living Foundation (GHLF). Together, they explore the critical importance of eye health, especially for those living with chronic diseases like thyroid eye disease and diabetes. Caroline and Seth discuss global initiatives, innovative campaigns like “Love Your Eyes,” and how advocating for better eye health can transform lives.
Tune in as we raise awareness for blindness prevention, highlight the need for regular eye checkups, and share valuable insights on how chronic conditions can impact vision.
See the Future: Eye Health, World Sight Day, and Thyroid Eye Disease
Narrator 00:00
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation, Podcast Network.
Steven Newmark 00:08
Welcome to “The Health Advocates: A Podcast that Breaks Down Major Health News of the Week to Help you Make Sense of it All.” I’m Steven Newmark, Chief of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:16
And I’m Zoe Rothblatt, Director of Community Outreach at GHLF.
Steven Newmark 00:20
Our goal is to help you understand what’s happening in the health care world, to help you make informed decisions to live your best life. And today, October 10th, is World Sight Day, and happens to be a special episode of the Health Advocates, as we shine a spotlight on this important global awareness day. World Sight Day aims to bring global attention to blindness, eye health, and vision impairment. Eye health is not just a critical aspect of overall health, but especially crucial for those living with chronic conditions, many of which we work on here at GHLF, including newer work in Australia on thyroid eye disease. We’re joined today by two special guests: First, our very own Seth Ginsberg, President of the Global Healthy Living Foundation, and Caroline Casey, President of the International Agency for the Prevention of Blindness. Together, we’ll dive into the significance of World Sight Day, the innovative work being done around the world by these two organizations, and what you can do to protect your vision and advocate for better eye health. So, let’s get started.
Zoe Rothblatt 01:09
Great, I’m excited to have a listen!
Steven Newmark 01:12
Well, thank you both for joining us. Before we dive into the questions, Caroline, can you tell us a little bit about yourself?
Caroline Casey 01:17
Well, that’s a real invitation to an Irish over speaker. I am an Irish woman, I have ocular albinism, I’m registered blind, and I’m a troublemaker of positive kind, I hope. I’m a founder of the world’s biggest business partnership, of 500 CEOs and brands, to end disability exclusion through business, but I am also the very proud President of the International Agency for the Prevention of Blindness.
Steven Newmark 01:42
Excellent! And Seth, and I think most of our listeners know you very well, but to those who don’t, why don’t you tell us a little bit about yourself and the founding of GHLF?
Seth Ginsberg 01:50
Hi, sure! I’m Seth Ginsberg, I’m a co-founder of the Global Healthy Living Foundation. This October 28th will be 25 years, since we began, originally, as an online patient community, one of the first in the world for people with musculoskeletal conditions. And we realized, very early on, that chronic conditions never come alone, and it was best to look at the whole person and have a mission to improve access to care, for people with all forms of chronic illnesses. So, really glad to be doing this, and so lovely to be chatting with Caroline today.
Caroline Casey 02:22
Yeah, two, you’ve got two founders, that’s going to be trouble for you. Two founding troublemakers!
Steven Newmark 02:27
Yeah, well, thanks for that, Seth and Caroline. And great to have you both. Caroline, let’s dive right in. Would you tell us what World Sight Day is all about, and why it’s such a vital day on the Global Health calendar?
Caroline Casey 02:36
Well, World Sight Day is today, so it is the 10th of October, and it’s a great month; it’s my birthday in October, so I love it. But what’s so good about this day, is it’s one day and a moment, to really get the attention of the entire world and focus the attention on our sight, and the issue of sight, and sight loss, and eye health, and eye care, and avoidable sight loss, so everything to do with eyes, and make every person on the planet aware of their sight, and the issue of sight as a socio economic issue, as well as the health issue, as an issue about potential and education. So, we and the International Agency for the Prevention of Blindness (IAPB), so we have over 250 members, who are all working in this sector, and it’s a moment for us to galvanize, to create as much conversation, attention, so that we can deliver impact for the rest of the 364 days of the year.
Steven Newmark 03:28
Excellent! Thanks, Caroline. It sounds like World Sight Day’s mission is really aligned with a lot of the work that we do here at GHLF; to raise awareness and provide educational resources, to people living with chronic disease. Seth, can you share with our listeners why eye health is a significant concern for the chronic disease community.
03:44
Yeah, sure. You’re right, Steven. World Sight Day’s mission is aligned with the work we do here at GHLF, because it’s really about awareness and engagement in our own health and well being. At GHLF, we make sure we’re working for and with people, living with chronic conditions, and a key goal for us is to make sure that they’re more informed, and crucially, more involved in their health, in order to help them put themselves at the center of their own care. So, patient advocacy can be a scary phrase for some folks, but at the end of the day, it really means just that: putting yourself at the center of your own care and speaking up for what can help make a difference for you and, in turn, for others like you. So, eye health is a really vital aspect of overall well being, for people living with chronic diseases. So, you know, many chronic conditions, like diabetes, and rheumatoid arthritis, and thyroid disorders, and even some inflammatory diseases can have a real direct or an indirect impact on eye health, potentially leading to vision impairment or blindness. So, for instance, conditions, like thyroid eye disease and diabetic retinopathy, are common complications that can arise from underlying chronic conditions, and can have consequences related to eye health. In that regard, it’s important for organizations, like GHLF and IAPB to work together, so we can raise awareness about the connections between chronic illness and eye health, so patients can proactively manage their care. Educating the chronic disease community about the importance of regular eye checkups, understanding early symptoms, and advocating for access to innovative treatments, can help empower patients to take charge of their overall health and prevent avoidable vision loss. Addressing eye health is integral to improving overall quality of life, and ensuring that patients have the tools and the knowledge to protect their vision, while also managing and protecting their health with their chronic conditions.
Steven Newmark 05:34
Thanks, Seth. Caroline, I know that you share a lot of these sentiments, especially because you’re doing such incredible work, in promoting eye health worldwide. Can you give us an overview of some of your organization’s current initiatives and the impact that they’re having?
Caroline Casey 05:46
Well, I was just listening to Seth, and I, it’s, I love that we’re having a conversation about how so much of our work overlaps with each other, and finding these intersections or connections, whether it’s between chronic diseases, or chronic health issues and eye health, or in our case, disability, and multiple disabilities, and chronic illness. Nothing in the world is so singular. So, first of all, it’s really important, and I think one of the things, within the International Agency for the Prevention of Blindness. So, of our members, we have members from so many different areas of eye health, and eye care. And so when we’re trying to really mobilize this global connection to the topic, is we have to have very overarching initiatives. So, what we did, which we have loved, is on World Sight Day, we had this campaign, called Love Your Eyes. Now, it sounds really strange because you’re thinking, “Love Your Eyes,” but you’ve heard Seth say it, as humans, we take our sight for granted so much, and particularly if you have a chronic health condition, you’re often dealing with that issue first, right? And you’re not seeing all the other secondary issues that can happen. And so the idea is to take responsibility, or to be aware about looking after your sight. So, when we talk about “Love Your Eyes,” the whole idea is, last year, it was at “Love Your Eyes at Work,” which is trying to get our employers to get screening at your place of employment, so that we can look at the health of our eyes, to catch any diseases, or to understand where our sight is: Do we need glasses? Do we need corrective lenses? This year, it’s “Love Your Eyes for Kids,” right? Which I think is so exciting, because we do know, and for me as a child, right, and so I was diagnosed very, very young. My parents never told me about my sight loss, which is another very interesting story, but I’m very lucky, I’m Irish, I’m middle class, I’m white, I had all of the access to eye house, and you think about what my life is now, if I didn’t have access to that. So, how can we get to kids and diagnose, or get our children tested in schools, early, so we can provide solutions for them. So, that’s what’s very exciting about this year. And it’s not that we’re stopping the work around the employers, but it’s really about getting parents, teachers at school, people who are testing sight, is to get our young kids in getting their eyes tested, because the sooner we can look at diagnosing needs and correcting that need, the better chance a child has at school. And you’ve got to remember, there are 540 million children who have eye issues, that can be corrected. So, why would we have children going needlessly with sight problems, when that does not need to happen? So, there’s the tumor to the biggest, but the biggest point is, if everybody today, please make a pledge, to go and get an eye test, because we’re trying to get as many in the world. Go onto the IAPB website and get involved. And the big one, in which we love this year, is getting young kids to design glasses for the future. So, these are kids under the age of 12 to say, “Can you imagine, in 10-20 years, what glasses look like?” So, to make it fun and make it engaging. So, that’s kind of two of the key areas we’re at.
Steven Newmark 08:37
Well, I’m just curious, what are some of the examples of what our future glasses going to look like?
Caroline Casey 08:41
Have you heard of smart glasses? So, this is so important. You know, when we’re starting to see glasses, where they’ve got cameras in them, and now they have a sense to their own hearing. We have no idea what technology is going to do, but the biggest access issue is really about that we care enough to ask, to ensure that we can advocate for ourselves, to get those eye tests, so that we can get the solutions. And the big thing with the IAPB is to get affordable and accessible eye health to everyone in the world. Because believe it, or believe it or not, there are a billion people on this planet, who are needlessly blind. A billion people. Don’t we have enough issues in the world? We have a solution for this, right? And so this is why our partnership with you is so important, because we can continue to talk to each other, and see that overlap, and how we can speak to patients and humans, and so they can look after their health and be self-advocating.
08:48
Wow. Well, that’s great, Caroline. I know here at GHLF, we recently started addressing eye health head on, through our work on thyroid eye disease, starting down under, as you say, in Australia. Seth, you touched on this a little bit earlier. Could you tell us a little bit more about what thyroid eye disease is and the work that we’re doing around this disease, and how it aimed to support patients in managing their condition?
09:51
I’m really excited to have the opportunity to share a little bit more about this program, but first, to take a step back, for those listening out there, who might not know what it is. Thyroid eye disease is an autoimmune inflammatory disorder, that occurs when your immune system mistakenly attacks the tissue behind your eyes: It causes swelling, redness, and scar tissue, and then that, in turn, can lead to eye bulging, misaligned eyes, and double vision, among other changes, including blindness in rare cases. So, this is why World Sight Day is a great chance to talk about this misunderstood, frankly, condition. And so to start, GHLF introduced a dedicated online resource hub for our Australian thyroid eye disease patients; It’s full of educational insights about the condition and symptoms, how to live with TED, as it’s referred to thyroid eye disease, and resources, importantly, about getting involved as patients and the information that folks need to understand how their voices can be heard, in general, as patients with things, like governmental approval processes for new treatments that are now on the horizon for TED. So, our goal with this hub, is really for thyroid eye disease patients to advocate for themselves effectively, having now been informed and armed with more information about their options related to their conditions. So, we’re going to be working with patients directly, including walking them through the different shared decision making, tips and tricks, as well as a walk around patient advocacy, in Australia, and how treatments get approved. Because, as we know, every health care system is, like, completely different, and Australia has its own unique ins and outs, and we’re quite experienced at this point in those, so we hope to support our Australian community, through this program. But the conversation with you today, Caroline, really, truly highlights the importance of integrating chronic disease management with eye health, especially regarding vision impairment, and blindness prevention. Our TED resource hub is really an essential part of this global effort for us, but we hope it’ll provide the beginnings of support for patients navigating TED’s complex impact on vision, and overall eye health. And just finally, to come back, for a moment, to one other point Caroline was making in the “Love Your Eyes” campaign, and you know, in the youth, especially, which is an incredible way to literally help determine a person’s trajectory in life, not just by health, but in all manners of speaking. Prioritizing eye health, especially in kids, is super important, I say this as a father of young kids, a father who is most known around our house for saying, “Please move that iPad away from your face, at least to the distance of your arm.” I think if I had $1 for every time I said that…
Steven Newmark 11:11
Does that work?
Seth Ginsberg 11:12
…I could fund the whole global campaign. But yes, I think that most importantly, and very seriously, it’s so commendable and GHLF is really excited to be able to work together on raising awareness for this.
Caroline Casey 12:44
But the issue, just to your point about hold that iPad away from you, can I just say, I grew up in a family where I was told to sit away from the television; even the fact that I only have about a half a foot vision. But this issue, that we have so many devices, we, it does make our eyes more vulnerable, and therefore we absolutely need to take responsibility and to ensure that this is not something. Because traditionally, eye health is not seen as something that’s life threatening, so it has not got the priority and the importance of connecting to other issues. So, when in July, of 2021, we were able to get the UN resolution passed by all member states, to have eye health as part of primary health care in every country. Okay, so everybody agrees it needs to happen, but how are we going to make it happen now? And this conversation in itself, the fact that these are two big organizations speaking to each other, it’s about radical collaboration; It’s not about competing with each other. Of what points can we both benefit from this visibility, to ensure that a human being has seen its entirety of all the things as we go from cradle to grave in our life, about our health. So, I think this is why, it’s exciting that we’re seeing so much more collaboration and intersectionality across what our work is. And that’s where I get excited.
Caroline Casey 13:59
Yeah. Caroline, could you elaborate on some of the connections between chronic diseases and vision impairment, and what steps individuals can take to protect their eyesight?
Caroline Casey 14:08
I think, like, when you listen to Seth talking, do you know what the biggest issue for me is? So, I think diabetes, when you hear about diabetes, okay, a lot of people know that if you have diabetes too, your eyes are seriously at risk. The most important thing that we need to do is to have the confidence. This is, I know this sounds crazy, but the confidence to ask questions, to trust your own body when you know something is not right, because I think a lot of us can feel slightly gaslit. Do you know about our health, and is it okay to ask? And what do we need to do? And so this is why your work is so important, because the more information people have access to, in a way that’s understandable and not too convoluted, that means you ask questions. And the thing that I would say, as a person, who is now just coming up to 53years old, and as you get older, there’s lots of other bits and bobs that with you, that you notice aren’t right, it’s having the confidence to ask, so sometimes it’s finding those groups of people, that you know, that you can trust, that you can ask for, or why or reading into an area, for example, menopause. I know this might sound crazy, but when I first got menopause, there were so many things that were going on in my body, and I thought I, there was something wrong with me, until I started to go and talk to different groups, and starting to read up, and taking responsibility for it. But what I will say is there are so many intersections now in our health conditions, and I think that is why organizations, like you and ourselves, are working as a model, that we would love to see happen in many different organizations. But the one that has been most recently obvious is around diabetes and sight loss. Diabetes is one of the most significant reasons for the loss of sight, particularly in the Global South.
Seth Ginsberg 15:40
Totally preventable.
Caroline Casey 15:41
And totally preventable, right?
Seth Ginsberg 15:42
Yeah.
Steven Newmark 15:42
Yeah, that really makes sense. I think you make some important points that speak to how crucial it is for patients to be involved in their health care, as much as possible. Seth, we know that this is the core of what we do at GHLF, which is helping patients put themselves at the center of their care. In that regard, Seth, how do you advocate? How do you help patients advocate for themselves, in playing a role in improving outcomes, when they have chronic conditions, and how that might affect their eye health?
16:06
The big question here. Like I mentioned earlier, at GHLF, our focus is on empowering patients to become active participants in their health care journey. And advocacy is just like a key, key, key component of that empowerment. When patients advocate for themselves, especially in areas like eye health, like we’ve been talking about here, it strengthens that patient provider relationship, and it ensures that these patients unique needs are taken into account. You got to speak up. If you don’t speak up, they’re not going to know. And so, advocacy encourages patients to speak up about their symptoms, ask for best treatment options, and be involved in decisions regarding their care. This is particularly important for chronic conditions that affect eye health, where early intervention, like we’ve been talking about, can literally prevent much more severe outcomes. And speaking up can occur, in so many different venues, and environments, not just with your doctor or the nurse or the health care professional, but at home, in your family, or in your community, or circle, or at your workplace, in the right way, in the right fashion, or with government, because many of us have the opportunity to speak up to government, and raise our voice in productive ways, where we can share our experience, so that the decision makers, the people in government that regulate things, that make laws, all that, take into account what we’re going through and what it’s all about. So, by providing these tools, and educational resources, like this thyroid eye disease hub, just to give it one more plug, in Australia, we’re able to help patients understand the complexities of their conditions and how to navigate the health care system. So, moving forward, we’re committed to expanding these advocacy efforts by fostering stronger patient networks, creating more educational programs, and ensuring patients had the resources to advocate, not just for themselves, but for better system, access to innovative treatments, and to access to care, in general. So, our focus is going to be on that, especially on how patients can get involved through these different shared decision making tools, and talking with government, and things like that. So, we could ultimately help improve people’s quality life with TED, but with so many other conditions that do as a result of under treating or mismanaging, lead to serious eye vision health and impairment.
Steven Newmark 18:18
Thanks, Seth. Yeah, I think that’s very important for patients to hear, whoever is running your advocacy team over there at GHLF, doing a phenomenal job, I would say. Thankfully, there are organizations, like IAPB and GHLF, that patients can turn to for support, and advocacy, and getting involved. Before we go, I have just one final question for each of you.Caroline, looking forward, what are some of the key challenges and opportunities, you and IAPBC? In the field of blindness prevention and eye health promotion, particulary, in the context of chronic disease management.
Caroline Casey 18:47
I think the challenge is also the opportunity. Honestly, it’s like I mentioned earlier on, is that because people don’t recognize, or see eye health as more than the issue of eyes, but because it’s not life threatening, it has never got the importance, really, in the field of health, and yet it’s a socioeconomic issue. This is how we have our eyes can determine the way we live. And Seth said that, and that’s why early intervention and diagnosis is so important. And constantly managing our eyes all the way through our life, it’s really big. So, what I think the biggest opportunity we have right now is to build on what we achieved, with the resolution in the UN. Okay, so we’ve got these member states saying, “Yeah, we’ve got to ensure that eye health care is part of our primary systems.” And Seth was talking about the governments, yes, governments! We do need to make sure primary eye health is part of our primary health care. So, how do we do that? And I think one of the biggest things, that we can do over the next few years, is to have as many partners, where eye health touches across around the world, to help support our government making that possible. So, what are the policy changes they’re going to need to make? What are the interventions they’re going to need to make? How do we release the finance that is going to be able to allow that? But honestly, most importantly is that the world needs to say, “We need to see the future.” Like this is the world’s biggest blind spot, and it intersects so many issues, this is why we’re having this call today. So, for me, it’s the greatest challenge to get people to say “We have to do this.” But on the other side, it’s the greatest opportunity, because this is more than just about these two eyes that we have in our heads, right? This is really about the potential of our citizens, on this planet, to live their very best life. And if we only see eyes separated from the rest of the body, and the rest of the experience, we are making our lives more difficult. We have so many issues right now in the world, so the more that we can work together to see the human experience and the body as a whole, and to support each other, then I do believe we have some chance not to accept, that we continuously avoid dealing with these issues. And I just want to say, I really admire the work that you guys are doing, in GHLF, because as a patient, for lots of different things, and in a family, giving me the courage to ask for help, and giving me the information, and seeing other people do that. Because what we don’t speak about does not get resolved, and what your work is doing is giving people that confidence and the resources to do it, so that we can start having these cross cutting conversations. And I just, never underestimate the importance of giving people the confidence and the courage to stand up for themselves. So, yeah, I just want to say thank you for the work that you guys do. It’s really important.
Steven Newmark 21:25
Yeah, absolutely. Thank you, Caroline. And Seth, any final thoughts, any final words of wisdom, that you would give our listeners today?
21:32
I would first say, I agree, we have this amazing advocacy team at GHLF, and thank you, Caroline, those are kind and thoughtful words, that fill our cups, at GHLF. As we wake up every day, trying to find ways to help, in innovative and impactful ways, and World Sight Day presents an opportunity for us to double down our efforts, and prioritize sight, and understand its seriousness. We take it for granted so easily. I hear that message loud and clear. And you know, when you live with autoimmune diseases, and when you live with various chronic conditions, you know the notion of good days and bad days, and you can get through a bad day, knowing there’s a good day in the future, but if you don’t show up for your health, and if you aren’t empowered, and if you don’t make at least some of the right decisions, there won’t be good days, or certainly not as many as you deserve. So, we want to just say thank you for what you’re doing, and allowing GHLF to join this global effort. We are, humbly, a global organization, who definitely operate on that World Wide Web, in ways that we hope is productive and helpful to support people going through various stages of their situation. And we all have our own situation, as you pointed out. But I think my parting words here for today’s discussion is, “Take care of your sight, check your vision, talk to your doctors and others, about your sight and vision, and recognize that it’s the portal into the rest of your health, potentially, and something that we have to take very seriously today, World Sight Day, but every day.” So, I just appreciate this opportunity, and thank you for allowing us to be involved in it, and raising awareness on key topics, like youth vision, as well as things like thyroid eye disease, and other autoimmune conditions.
Caroline Casey 23:29
And also, get your eyes checked, everyone.
Seth Ginsberg 23:30
Do it.
Caroline Casey 23:31
Get your eyes checked and pledge. Put it onto the website, today, because we’re going to have to get as many commitments to make sure this is one of the biggest World Sight Days ever.
Steven Newmark 23:38
Well, thank you, Seth and Caroline, for joining us today and sharing such valuable insights. I know I’ve learned a lot, but one thing that stuck out is that eye health is deeply connected to overall health, especially for those living with chronic conditions, and it’s important for organizations, like ours and IAPB to work together to bring even more awareness to days like World Sight Day, and important issues like blindness, and visual impairment prevention, and eye health. So, thank you.
Caroline Casey 24:00
Thank you, both, so much. It was an absolute pleasure and Happy World Sight Day.
Steven Newmark 24:04
Thanks again, Steven and Zoe. Appreciate it.
Steven Newmark 24:08
Thank you, Seth and Caroline, for joining us today and sharing such valuable insight.
Zoe Rothblatt 24:11
Yeah, Steven, that was a really great listen, especially, just on the importance of something, like World Sight Day, as an opportunity to bring awareness. I really didn’t know a lot about TED; thyroid eye disease, eye health, before this. So, I’m excited to have heard from Seth and Caroline, and continue spreading awareness on this.
Steven Newmark 24:28
Yeah, same here. Eye health is so important, I know, kind of give me a kick in the pants, because my rheumatologist is always telling me to go see the ophthalmologist, and I’m always like, “yeah, yeah, yeah…yeah, yeah…” but don’t actually, so I need to start doing that more. I do know how important it is, so you know, let’s get on that for all of us, right?
Zoe Rothblatt 24:45
Absolutely. Yeah.
Steven Newmark 24:46
Well, we hope that you learned something too. And before we go, we want to encourage everyone to check out all of our podcasts at ghlf.org/listen
Zoe Rothblatt 24:53
Well, everyone. Thanks for listening to “The Health Advocates: A Podcast that Breaks Down Major Health News of the Week to Help you Make Sense of it All.”
Zoe Rothblatt 25:00
If you like this episode, give us a rating, write a review, and hit that subscribe button, wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 25:06
I’m Steven Newmark, and we’ll see you next time.
Narrator 25:12
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation, Podcast Network.
Celebrating Hispanic Heritage Month: Advocacy and Awareness in the Lupus Community
In this episode, we are joined by Estela Mata, President and CEO of Looms for Lupus, a non-profit dedicated to raising awareness and providing support for those living with lupus, and other chronic conditions. Estela shares her personal and family journey with lupus and the profound impact of advocacy. She highlights the importance of community, the need for increased awareness, and the power of sharing personal stories, especially within the Hispanic community. Estela’s message of hope and resilience is a reminder of the strength found in community and the critical role of advocacy in chronic illness management.
Celebrating Hispanic Heritage Month: Advocacy and Awareness in the Lupus Community
Narrator 00:00
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation, Podcast Network.
Steven Newmark 00:08
Welcome to “The Health Advocates: A Podcast That Breaks Down Major Health News of the Week, to Help You Make Sense of it All.” I’m Steven Newmark, Chief of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Director of Community Outreach at GHLF.
Steven Newmark 00:21
Our goal is to help you understand what’s happening in the health care world, to help you make informed decisions, to live your best life.
Zoe Rothblatt 00:26
And today, we’re joined by Estela Mata, the President and CEO of Looms for Lupus (Looms4Lupus), which is a nonprofit organization that provides lupus, fibromyalgia, mental health awareness, advocacy, and support to those living with these conditions, their loved ones, and caregivers. I really learned a lot from Estela and her family’s story, how they started Looms for Lupus and the importance of advocacy. We also had a really powerful conversation on finding hope, the impact of community, and raising awareness this Hispanic Heritage Month.
Steven Newmark 00:56
Yeah, I think Estela is fantastic. I’ve been to Washington, DC, been to Capitol Hill, with her. She’s great, and I’m excited to have a listen.
Zoe Rothblatt 01:04
Hi, Estela. Welcome to “The Health Advocates.”
Estela Mata 01:07
Hi, how are you?
Zoe Rothblatt 01:08
I’m good. How are you? Why don’t you start off by introducing yourself to our listeners?
Estela Mata 01:13
Hi, I’m Estela Mata. I am a Co-founder and President of Looms for Lupus, a nonprofit organization that provides advocacy, awareness, education and support to those living with lupus and overlapping conditions, like fibromyalgia and mental health. We support those living with these conditions, their loved ones, and caregivers. So, I’m excited to be here today.
Zoe Rothblatt 01:31
Yeah, we’re so excited to talk to you, learn more about your story, your family’s story, and the work that you do as part of Looms for Lupus. I guess maybe going back, can you talk to us about your connection to lupus, and how you started sharing your and your family’s story?
Estela Mata 01:45
So, it all started in 2009, when my sister, Juana, almost lost her life to lupus. She was not diagnosed until she was very chronically and critically ill. She was diagnosed in the emergency room, which very rarely happens. She had so many symptoms that she had been going through, dating back to 2004, where she got diagnosed with an autoimmune condition: hypothyroidism and then rheumatoid arthritis. And so when she went into the urgent care that day, in 2009, her platelets were very, very low. So, something was literally attacking her body, and now we know that it was lupus that was attacking her platelets. She was originally sent home because they told her, you know, just we’re gonna get routine labs come back tomorrow, typical kind of, like, urgent care visit. But she insisted and persisted, and she was able to have the provider listen to her and get tests done that day, and because of that, she is alive today.
Zoe Rothblatt 02:45
Yeah, it’s remarkable how much advocating, like that, is part of the chronic illness story. I live with two chronic diseases, and I remember being in a similar position of, like, really having to speak up and fight for the care that I need. I’m wondering if you can talk about how you’ve advocated alongside your sister, how you’ve seen her advocate, just like what that’s been like for you.
Estela Mata 03:09
You know, like you said, Zoe, it is very difficult to sometimes get a diagnosis. And I think learning about your symptoms, tracking your symptoms, and, most importantly, using your voice is very important. You know, gaslighting is completely real. So, I could attest to that, because my sister went through that. But about why we advocate: Lupus is a complex autoimmune disease; It could attack literally anything in your body, it could attack your kidneys, your heart, your lungs, your brain, but it also can impact your daily life, right? It could impact your mental health, your physical health, and for me, being able to learn and share our story with my sister. You know, we advocate here at the local level, at the federal level, at the state level, we want to share her story, and we want to empower others to do the same. And that’s why we started advocating, because we wanted to help others.
Zoe Rothblatt 03:57
And what’s it been like connecting with others in the community, through advocacy?
Estela Mata 04:01
Oh, my goodness, it’s been amazing. We’re all like family, and this is one of the things, that I always say, when we connect with the community, you feel heard, you feel seen, and that goes both ways. You know, for us, we want people to see us and hear us, and hear our stories, and learn from them, and then we also get to do the same. We get to listen to their stories, we get to support them, and then we get to, even though we don’t always have the answer, we don’t always have every single resource, we can at least guide them to get the resources or the support that they need.
Zoe Rothblatt 04:32
I totally agree with that! So much of the journey is just about feeling less alone and feeling in it together, and you’re doing that within your family, with your sister, but also in the wider community, with Looms for Lupus, I have so much respect for all that you do. Maybe you could tell us about how you started Looms for Lupus?
Estela Mata 04:50
With Looms for Lupus, we literally just started, exactly the way I told you. My sister was diagnosed with lupus, and it was very difficult to see the challenges that she was facing, and we knew that it wasn’t just going to impact her, right? It was impacting the whole family. And we wanted to be there for those people that were going through the same, more similar situations, like us. So, it was actually two of my sisters and I, so we co-founded the organization; it was Araceli, my younger sister, who is a detective, and Juana, who lives with lupus, and myself. And so, our parents taught us from a young age to always give back, to help others. So, that’s really what we wanted to do. It was an opportunity for us to kind of turn this condition into something positive, right? We can’t change a lot of things, but the one thing that we can change is what we do moving forward, and that was going to be supporting others, learning with others, and engaging with the community, so they can get a better understanding about what lupus is, and get an earlier diagnosis. Especially with lupus, because it does impact everyone differently, and it does impact our Hispanic, Latino community.
Zoe Rothblatt 05:56
And what kinds of things have you learned over the years from the community about, you know, like maybe some common challenges that people with lupus face? You talked about time to diagnosis, so that’s one, maybe. What are some others?
Estela Mata 06:08
So, people that live with lupus, and, you know, face so many challenges, both physical and mental. And at Looms for Lupus, we offer support groups, we offer educational symposiums. Within those symposiums, we talk about disease management, tracking your symptoms, knowing your numbers, knowing what your normal is and when to detect those flare ups. Because with lupus, you know, a lot of stress can trigger flares. We also educate and empower them on how to utilize Stress Management Techniques. So, basically everything from beginning to end, from navigating their health care, to learning about how to advocate for themselves, and learning about potential treatment options.
Zoe Rothblatt 06:47
That’s amazing! And I know Estela, we got introduced because you’re working with some of my colleagues on ‘Awareness of Clinical Trials,’ and I was hoping that we can talk a little bit more about that. Specifically, your and your family’s experience with clinical trials and your advice with kind of navigating something, that can seem so intimidating.
Estela Mata 07:07
As a patient myself and a caregiver to someone that lives with an autoimmune disease, like lupus, it is important for us to not only learn about our conditions, how to help ourselves, but also to learn about current treatments and possible treatment options. And for us, possible treatment options are clinical trials, being able to participate and being able to get that opportunity to try a potential new treatment for a disease, like lupus, to us, is something like, kind of like a instilling hope in someone and saying, “You know, there is an opportunity for you, to not only participate in something that can help you, but something that can help other and future generations.”
Zoe Rothblatt 07:46
I love that message about hope, especially because, like you mentioned, lupus impacts the whole body. So, it really is like tremendous, I guess, like hope and relief to finally find something that works. How have you felt hope in watching your sister’s journey?
Estela Mata 08:01
Actually, my mom’s name is Hope; in Spanish, Esperanza. So, we’ve been living with hope all of our lives, right? We say that.
Zoe Rothblatt 08:08
I love that.
Estela Mata 08:08
One of the things that I saw from the beginning is, my sister never lost hope. Even though lupus was impacting her, like I said, physically, but it was also impacting her emotionally. She started loom knitting. So, it’s a form of knitting, and she was using it as a coping mechanism, to kind of feel a little bit better. Getting diagnosed with lupus, a chronic autoimmune disease that was impacting her daily life, was gonna be a struggle that she was gonna face. We knew there were no FDA approved treatments back then. Now there are, but it still can impact everyone, you know, completely different. So, for me, seeing her that she had hope, even though she was dealing with all of this, gave me hope and inspiration to continue to learn about the condition, to figure out ways on how I can help her, and just be there for her.
Zoe Rothblatt 08:52
Yeah, you guys are lucky to have each other, and it’s so funny you mentioned about the looming, because actually, when I was in the hospital, getting diagnosed with Crohn’s disease, I remember like feeling so antsy and scared and just needing to do something. And I started crocheting a lot. And it’s funny how that, I guess, like doing something with your hands, something tangible that you can have control of. It’s like such a part of the journey, like, when so much is out of your control, doing something like simple and focused, like, helps bring about that hope.
Estela Mata 09:21
Yes! Oh, my goodness! I’m glad that you shared about you crocheting, because when you’re feeling so helpless, you’re feeling so overwhelmed; being focused in that little, small accomplishments, right, even if you get just one loop at a time, right? Like that’s a huge accomplishment, and you’re already focusing on something other than what you are going through and what you’re struggling with. So, you know, for us, when she started loom knitting, it was something that just kind of came in together, because my mom crochets. In Mexico, that’s something very traditional – My mom would crochet, my sister would loom knit, I cannot do either, but I tried. But, you know, just being together and being there for one another, I think has helped us tremendously. And we do have a saying, and we say that, “We’re continuing to knit a community of hope.” We never want to change the name Looms for Lupus, because that’s how we started. Even though, now we have expanded to other conditions, and advocating, and raising more awareness, just an overall, you know, equitable health care access, we still want to do it one loop at a time.
Zoe Rothblatt 10:22
Yeah, I was about to say, even if you may not physically be knitting, you totally are, through the community aspect and providing support through every step of the journey, like you mentioned. And then actually, you just mentioned about other chronic conditions, maybe you could talk to us a little bit about that, like why it’s important to support lupus along with other chronic conditions, and how you came to do that.
Estela Mata 10:44
Raising awareness, not just for lupus, but just, overall, any chronic condition, is very important. Because it impacts us all very differently. We need to be able to learn about these conditions, learn how to prevent them, learn how to navigate them, learn how to navigate, you know, health care access, learn about treatment, treatment options. So, I think that’s with any chronic condition. You know, we need to always be aware and continue to learn.
Zoe Rothblatt 11:13
And you know, you touched on this lightly before, and I’d like to go into it more now, especially because it’s Hispanic Heritage Month. But there’s, of course, an added layer of health disparity, when it comes to lupus in the Hispanic community. Can you, I guess, like talk about what messages you have for the Hispanic Latinx community about the importance of raising awareness?
Estela Mata 11:35
So, raising awareness about health conditions, that are impacting our Latino Hispanic community, is crucial. It is crucial because, you know, the more we learn, the more that we will reduce these health disparities. We will be able to, hopefully, get improved access to care, early diagnosis and just, basically, just empowering individuals to get the support, to get the knowledge that they need.
Zoe Rothblatt 11:59
Absolutely! Early diagnosis is so important. For one, like, you’re obviously uncomfortable and need answers, but two, especially with a condition, like lupus, you can have some, like, pretty permanent damage in different areas of your body, right?
Estela Mata 12:16
Yes, definitely. With lupus, lupus affects, basically, it could impact your whole body, like I said, physically and emotionally. It could impact your brain, it could impact your lungs, it could impact your kidneys, and a lot of the times, it causes irreversible damage. And in many cases, my sister has been really lucky, to be able to get preventative care, and take action with her care team, and preventing that irreversible damage. When lupus was attacking her kidneys, it could have caused her to lose her kidney function, to be in dialysis, and even potentially need an organ. So, for us, prevention has been the key, and her proactive care has been really essential, and her advocating for herself, and her being/taking charge of our health, really.
Zoe Rothblatt 13:01
And what role do you think that advocacy and raising awareness plays in addressing the needs of chronic illness? Especially, in the Hispanic community.
Estela Mata 13:10
Advocacy helps address the needs of the Hispanic communities by ensuring that we receive equitable health care. Everyone deserves to get equitable health care access. To getting culturally competent services, information in our languages; my mom only speaks Spanish, so the information that needs to get provided to her has to be in Spanish. It is also necessary for us to support everyone on how to manage their chronic conditions effectively, right? So, raising awareness, reducing stigma, all of this will empower individuals to not only advocating for themselves, but advocating for their loved ones and the community as a whole.
Zoe Rothblatt 13:47
And what’s your advice for people who, like, want to get started in advocacy and sharing their story, or just get more involved?
Estela Mata 13:54
One of the things that I always say is, “We all have a voice. We have a voice, so let’s use it. Let’s amplify our voices, let’s advocate for ourselves when we go to the provider’s office, when we go to the physicians. Let’s advocate for our communities, let’s advocate for better research, let’s advocate for better health care. Let’s use our voice.” And I think the more we utilize our voices together, the better it is amplified. And change comes with that. So, if we need something, if we want change, we need to be able to speak on it and advocate.
Zoe Rothblatt 14:25
Yeah, absolutely. There’s like nothing more powerful than just sharing a story as a patient. You know, I’ve spent some time advocating with elected officials, and their teams are really smart and can share with them the data all day long. But there’s nothing like getting a personal story to really just say we’re real people, living with chronic illness, and this is how the system, the laws, impact us. So, I would just say, like to amplify what you said, that everyone has a story. You don’t need to be an expert in health care to get started.
Estela Mata 14:55
My sister says this, and it’s so interesting that you said ‘expert.’ My sister says, that she’s an expert in her body.
Zoe Rothblatt 15:02
Yeah.
Estela Mata 15:02
And I think we all are experts. So, they may be the experts in policy making, and running and help run the country. They work for us. So, we’re the experts of our bodies, and we know what we need. What better way to do this, but then by sharing our stories, sharing our needs, and helping solve and create solutions for equitable health care access for everyone, right? So, you’re right. When we meet with the legislators, we can make an impact by sharing our personal journeys, because they’re people like us; they have families, they may be living with chronic conditions themselves, or supporting someone that is. So, you never know how impactful your story can be and how many lives it can touch.
Zoe Rothblatt 15:40
It’s true. Yeah, you never know, like, how closely people are connected. And I also think, you know, there’s something so special about when you share your story; It inspires others to do so, like, just think about how you and your two sisters sitting down, one time, deciding to start Looms for Lupus, and how much it’s grown to inspire others to share as well. It’s, like, really remarkable.
Estela Mata 16:00
Yes! And you know, one of the things for me, too, has always been about having people see us and see themselves in us. Because if there’s a little Hispanic, Latino, little girl, that looks at me and sees that I look like her, or that she looks up to me and says, “You know what, I can do, that.” Maybe they could be doing much better in the future, and they will get inspired, and that’s why we do it. We just want to make sure that everyone’s represented, that our communities are represented, and that we are heard. It’s just one thing that we were raised to do. So, we want to continue to, kind of, add that little layer of support for the community.
Zoe Rothblatt 16:37
And I think that representation and advocacy, that you’re talking about, is also such an important piece of the clinical trial discussion. To have that representation, we know there’s been such a lack of diversity in clinical trials, and for you to be speaking on it, I’m sure encourages others from your community to feel a little bit more confident in making health decisions.
Estela Mata 16:59
I think it’s scary. I mean, just even our family members, they could be hesitant about trying new things. You know, participating in clinical trials, being known as like you’re a guinea pig, or they’re just gonna use you. It’s not about that. I think, you know, education is key when it comes to, you know, participating in clinical trials; we need to learn and understand, what does it entail? The fact that it is optional, the fact that we are giving ourselves the opportunity to get a potential treatment, that we may be the first ones to get, and it could be life changing, and if it doesn’t work for us, it could help others that are dealing with the conditions that we are. So, to me, I just see it more like, it’s hopeful, but we do need more awareness, we need more education, we need to feel empowered, and the way we’re gonna do that is by getting as much information as we can.
Zoe Rothblatt 17:48
Yeah, I think you make a really good point about the intersection of hope and information. Like, we really need to be equipped with good resources, filled with information coming from experts in the field, in order to feel that hope.
Estela Mata 18:02
Yes, definitely. Through experts, and also through patients; through others, living with these conditions or going through it, right? A patient experience is so valuable, and I think it’s so much needed, because thinking about participating in a clinical trial, but I’ve never done it, it could be a little scary. It could be overwhelming to say, “Okay, I’m being committed to participating in a trial for X amount of time. I have to be going X amount of time, or whatever the clinical trial requires me to do.” It could be scary and overwhelming, but if I talk to someone that has gone through that same journey, or is going through the similar journey, they can empower me and give me hope that I can do this, that I can participate and that I can make a difference. So, yes, hope is definitely, I guess, the beacon of light that we need, right? To guide us through these dark tunnels, that we go through and that boost, that we need.
Zoe Rothblatt 18:52
Yeah, I love that! Well, I guess, I know you’ve given us so much words of hope, but maybe for the last question, just any final, just like, thoughts of hope you want to share with the community, for any listeners, struggling right now, looking for a piece of that light?
Estela Mata 19:06
One of the things, my younger sister, Araceli, created for us was a little slogan. And I guess they do this, you know, maybe when they’re in academy or something like that. But she created a slogan that says, “Never give in, never give up, never let go. Just keep fighting.” So, that’s what I want to leave everyone with, that message. So, not giving up, don’t give up. If you are diagnosed with a chronic or autoimmune condition, it does not define who you are; it is just simply a part of your life. And just keep fighting, keep fighting for better treatments, keep fighting for, just for, everything, just keep fighting for yourself. And that’s really how I want to leave it. Just “Never give in, never give up, never let go. Just keep fighting.”
Zoe Rothblatt 19:48
That’s beautiful! And yeah, I guess just know that, like, we’re also here, there’s a community here, fighting with you.
Estela Mata 19:55
Yes! You are not alone; you are not alone in this life. Dealing with a chronic condition can be difficult, but we can do this together.
Zoe Rothblatt 20:03
Absolutely! Well, Estela, thank you so much for joining us today!
Estela Mata 20:07
Thank you, Zoe!
Steven Newmark 20:10
Wow, Zoe, that was a really great discussion, with Estela. I normally ask, “What you learned?,” but I’m gonna start off by saying, that I really learned a lot about clinical trials, and it was great to hear a deeper dive on the discussion of clinical trials and how it impacts patients.
Zoe Rothblatt 20:24
Yeah! And also, on that note, just really quickly for our listeners, we’re launching a lot of resources about clinical trials, especially for lupus patients. So, if you want to sign up for the newsletter, we’ll leave a link in the show notes. And also from Estela, you know, I just love the message of hope she left us with. It’s so important to community build, and really appreciate all the work she does with Looms for Lupus.
Steven Newmark 20:46
Absolutely! Well, we hope that you learned something too, and before we go, we want to encourage everyone to check out all of our podcasts at ghlf.org/listen
Zoe Rothblatt 20:55
Well, everyone, thanks for listening to “The Health Advocates: a Podcast That Breaks Down Major Health News of the Week to Help You Make Sense of it All.” If you like this episode, give us a rating, write a review, and hit that subscribe button, wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 21:08
I’m Steven Newmark. We’ll see you next time.
Narrator 21:14
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation, Podcast Network.
Spreading Awareness This Asthma Peak Week
In this episode, we’re joined by Jessica Buckley, President and CEO of the Lung Health Foundation (LHF), and Dr. Dawn Bowdish, scientist and the Executive Director of the Firestone Institute for Respiratory Health and member of the Board of Directors of the LHF. We talk about how asthma, despite being common, can be complicated to diagnose and that many are living with uncontrolled asthma. Jessica and Dawn also share recent survey results of asthma patients’ experience, and how patients can set health goals with an asthma action plan and advocate for better air quality.
Spreading Awareness This Asthma Peak Week
Narrator 00:00
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to “The Health Advocates: A Podcast that Breaks Down Major Health News of the Week, to Help You Make Sense of it All.” I’m Steven Newmark, Chief of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Director of Community Outreach, at GHLF.
Steven Newmark 00:21
Our goal is to help you understand what’s happening in the health care world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:26
And today, we’re really lucky. We have two special guests to talk about asthma and their work with the Lung Health Foundation: Jessica Buckley and Dawn Bowdish. So, a little bit about the two of them, before we dive in. Jessica is the President and Chief Executive Officer of the Lung Health Foundation, and she’s focused on building lasting relationships across Canada with other similar organizations, governments, health care providers, researchers, and patients. So, similar what we do, to fill the Lung Health Foundation’s missions of improving lung health for all Canadians. And we’re also joined by Dr. Dawn Bowdish, who’s the Executive Director of the Firestone Institute for Respiratory Health at St. Joseph’s Healthcare Hamilton. And she’s an academic researcher; she brings more than 10 years of research into immunology and aging to discussion; and she also serves as the scientific advisor and board member for the Lung Health Foundation.
Steven Newmark 01:20
Wow! This should be exciting! Can’t wait to have a listen.
Steven Newmark 01:23
And just in time for Asthma Peak Week.
01:26
Hi Jessica and Dawn! Welcome to “the Health Advocates.”
Dr. Dawn Bowdish 01:29
Hello!
Jessica Buckley 01:30
Hi, Zoe. Thank you very much!
Zoe Rothblatt 01:32
Why don’t you both start off by introducing yourselves? Let’s start off with Dawn and then Jessica.
Dr. Dawn Bowdish 01:37
Hi, I’m Dr. Dawn Bowdish. I’m the Executive Director of the Firestone Institute for respiratory health. I’m a scientist, and I’m also a member of the Board of Directors of the Lung Health Foundation.
Zoe Rothblatt 01:47
And Jessica.
Jessica Buckley 01:48
I am Jessica Buckley, I am the President and CEO of the Lung Health Foundation in Canada.
Zoe Rothblatt 01:54
And Jessica, can you tell us a little bit more about the Lung Health Foundation?
Jessica Buckley 01:58
Yes! So, the Lung Health Foundation is a national charity, dedicated to the lung health of all Canadians. We invest in research, we do federal and provincial advocacy, we do awareness campaigns, develop clinical tools for health care professionals, and we also provide programs for people with lived experience and their caregivers.
Zoe Rothblatt 02:19
Thank you so much for the work that you do to help patients. And I know we’re going to talk a lot about asthma today, but first, I just wanted to start off, I guess, learning about each of your personal journeys and what kind of drew you each to lung health advocacy.
Jessica Buckley 02:33
Well, I’ll start. Zoe, thank you. I was very moved by the work of the Lung Health foundation, after learning about them, and realizing and connecting the dots that lung health has sprinkled throughout my family many, many times through the years. Having family that have suffered from asthma, others living with chronic obstructive pulmonary disease, also known as COPD, and having lost a few family members to lung cancer, also knowing that one in five Canadians are affected by lung disease, there’s just a huge amount of need.
Dr. Dawn Bowdish 03:06
My journey was through my research path. So, I did my Ph.D. and my postdoctoral training in respiratory infections, and when I started my own research lab at McMaster University, one of the first grants I got was for the lung health foundation trying to understand respiratory infections in older adults. And I was invited to a gala dinner to celebrate this research grant, and sat beside two people who were suffering from lung disease – young mom of three who had lung cancer, and a young woman who had lung fibrosis and had just received a lung transplant. I was so moved by their stories, and their graciousness and generosity in congratulating me for my award, even though my research was from sort of the late end of life, and they had this really immediate need.
Dr. Dawn Bowdish 03:53
And I was also really touched by stories of how having lung cancer was a really fundamentally different experience than having breast cancer, because there was so much blame attack. People are always asking about whether you smoked and this and that, and so that really was such an inspiring night for me. I bowed at that point, that I would help the Lung Health foundation raise the $50,000 that I got as a research grant. But then I couldn’t stop, because it became apparent to me that as a researcher, so underfunded compared to other conditions and diseases, despite the huge impact it has on people. And so that really ignited my passion to work with the Lung Health Foundation, to do advocacy, to increase research funding, to increase awareness. And I can’t perceive stopping doing that anytime soon, because I don’t perceive it becoming a more equal world for lung health anytime soon.
Zoe Rothblatt 04:42
That’s amazing, and I so appreciate how each of you pointed to a specific patient story: Jessica, with your family, and Dawn meeting that family at the event. Something that we always say here is like, “No active advocacy is too small, and sharing your story is just so powerful, because every patient has a unique story.” And you know, when you’re meeting with, let’s say, like legislators or trying to just like, make changes, it can be really intimidating to try and get all the facts. And we remind patients, like, “You’re the expert, your story is what’s powerful.” And I think that’s like really becoming clear in what both of you are saying, how it led you to do this work. So, you know, just thank you for highlighting the patient voice. So, let’s go back to maybe some basics. Dawn, I’ll throw this one to you: Can you tell us, like the basics of asthma, how one gets it, how to treat it, how it changes over time, stuff like that?
Dr. Dawn Bowdish 05:34
Sure! So, asthma is defined as variable airway obstruction, which basically variable means it’s not constant, so it comes and goes, and it can be triggered, and I’ll talk about that in a second, and airway obstruction, meaning that the airways can’t do their job breathing properly. We know that asthma is extremely common. As many as 10% of children may have asthma, but it’s also very unfair. So, in Canada, we know some of our indigenous communities, as an example, can be up to 30% of children can have asthma. And then in adults in Canada, it can be between six and 10%, but again, higher in some communities, as opposed to others.
Dr. Dawn Bowdish 06:08
To understand why there’s so much range in who gets asthma and who doesn’t we have to understand how it starts. So, believe it or not, predisposition to asthma starts before you’re born. So, when a woman is pregnant, if she has exposure to air pollution, tobacco smoke – then those babies might be more at risk of having asthma. We also know there’s a genetic link, so if you have a family history, you’re more likely to develop asthma, and then once you’re born, we know that asthma can be triggered by many different factors. So, one of the features of asthma is that the lungs are a little bit fundamentally different, but exposures to things like allergens, or in this world, climate change and wildfire smoke, sometimes exercise, sometimes cold, dry air can trigger, what many patients call, an asthma attack, or we often call an asthma exacerbation. And so that’s a really acute event that can lead to the airways spasming. It can lead to production of mucus and phlegm and lead to that horrible breathless feeling and that feeling of cough.
Dr. Dawn Bowdish 07:06
So, diagnosis you would think for such a common condition would be really simple, but it actually can be quite complicated. For really young children, it’s almost impossible to get them to do a breathing test. So, basically, doctors have to get a really detailed history of what that child’s asthma attacks feel like. They have to listen to hear, if they can hear wheeziness, and then they can try a treatment, and if the child gets better, it’s assumed that asthma was the cause. On the other end of life, in late life, asthma can be difficult to diagnose and treat as well, because there may be other lung conditions that are also happening at the same time. So, COPD and asthma often travel together. And so, surprisingly, like I said, it can require a really detailed investigation to get to the bottom of that. And then within asthma, there are different sort of levels; if someone whose asthma can be controlled pretty easily and they don’t really have their daily life effective, would be considered a mild asthma case. But then some people have very, very severe asthma, and they need to go a really detailed investigation from a respirologist to get the proper diagnosis and then the proper treatments that they need.
Zoe Rothblatt 08:08
Thank you for that overview, that’s really helpful. And I’m curious from both of you, and maybe we’ll start with Jessica. When you talk to people living with asthma, are there like common topics or themes that arise that you’re seeing among these like patient populations?
Jessica Buckley 08:22
Yes. So, one of the common themes that arises is really what is a lack of an asthma action plan, and that’s when people living with asthma are feeling great and they’re not taking their regular medication and inhalers, and they might be quite reliant on what we would consider our reliever inhaler and not using the maintenance program. So, the importance of having your asthma under control is something that we speak to people about a lot, and have tools on our website to help speak to your health care professional about putting an asthma action plan in place.
Zoe Rothblatt 08:57
Yeah, and can you tell us a little bit more about the action plan and like, what typically goes into that.
Jessica Buckley 09:03
So, it’s the truth is that we want all children and people living with asthma to be able to live their full lives. And often, children with asthma may be told to sit on the sidelines during gym class, or not exert themselves, or not participate in sports. And we just know that if they have an action plan in place, where they are taking the medication on a regular basis, as is prescribed by their health care professional. Any triggers that come into play, and Professor Bowdish was speaking about some of the triggers, like allergens from pets or wildfire smoke or anything that may trigger their asthma, they would have their asthma more under control and not experience those triggers in the same way. And we have a great example, currently, who is our Brand Ambassador for the Lung Health Foundation, Maggie McNeil is a world champion swimmer and competing at that high, high level, with asthma. And just incredibly inspiring to what is possible, when you have a very effective asthma action plan.
Zoe Rothblatt 10:05
Absolutely! Well, not to kind of jump ahead, but that leads me into my next question. So, I know you all had a survey done, that was of more than 2,000 Canadians, and one of the findings showed that only 24% of respondents were confident that you can have an active life if you have a lung condition. And what you just said about Maggie McNeil is like proof that you can have an active life. And I’m just wondering, Dawn like, what’s your reaction to this statistic that only 24% are confident in that?
Dr. Dawn Bowdish 10:36
Well, I think it depends on the lung issue in question, but certainly with asthma, the goal is, if your asthma is under control and you’re getting the appropriate medications, the goal is you should be able to be an athlete and have an absolutely active life. In fact, we have sort of a checklist that’s used. And if you’re up at night, because of your asthma, more than one night a week; if you have more than two days a week, you have to take your rescue medication; if you are not able to do the exercise that you would like to do, then that is definitely time to talk to your practitioner, and hopefully a respirologist.
Dr. Dawn Bowdish 11:10
Gets the appropriate medications, because asthma should be something that you can live with, but live well with. And I think a lot of the misconceptions are outdated, frankly, but they’re a real challenge, and one can’t help but to be sympathetic for people who are living with these lung conditions, because that feeling of breathlessness is terrifying, and you want to avoid it at all costs, because it is such a scary and horrible feeling. And certainly, people who’ve had such a severe asthma attack, that they’ve gone to the hospital, are really cautious about never wanting to have that experience again. So, I would say that if you’re struggling and not meeting those criteria, it’s time to have an appointment with respirologist or a pulmonologist and really make sure you’re getting the appropriate treatments and medication to live a completely full life.
Zoe Rothblatt 11:55
Absolutely! Yeah, what I’m hearing from you is that, 100% of asthma patients should feel confident that they can have some sort of active life, and if you don’t, then it’s time to talk to your doctor and reconsider the ways you’ve been treating your asthma and think about what more there is to do.
Dr. Dawn Bowdish 12:11
That’s right! And I would also add to that there is room for bigger advocacy as well. We’re moving to a point in time where wildfire smoke is going to be more common; climate change is obviously something that’s affecting that; air pollution is a problem too. Those triggers are a lot harder to avoid than things like allergens, you know you’re allergic to. And so I think there’s a lot of room for patients living with lung disease to help do the political advocacy to get those bigger problems under control rather.
Zoe Rothblatt 12:40
Yeah. Can you talk to us a little bit more about, like, navigating these changes? And you mentioned the wildfires, this episode will come out during Asthma Peak Week, like a time when there’s an increase in asthma symptoms, and I guess, like, how patients can be better equipped to navigate these changes.
Dr. Dawn Bowdish 12:58
Patients living with asthma really need to think about air quality. So, many weather reports, and weather stations, and weather apps now also include an air quality measure. And for all of us, with or without asthma, we need to think about changing our behaviors when that air quality is poor, and unfortunately, because of wildfires and climate change, we’re going to have more of those days. So, when air quality is really poor, we need to think about staying indoors, if we’re able. We need to think about exercising less outdoors. And people with asthma might have to take that to the extreme.
Dr. Dawn Bowdish 13:29
We also have to think about improving indoor air quality during those difficult times. So, air filters, if one can afford them. But again, there’s sort of a personal, but there’s also a bigger picture question here too, because, of course, people who have jobs that are outside, people who can’t afford air conditioning and air filters and those sorts of things, renters, as opposed to owners, are less empowered to make those changes to their buildings they live in. So, we have to think about ourselves, but we also have to think about our society adapting to those changes as well. Some of the easier things to avoid, if you have asthma or known triggers, for example, if you have a specific allergen you know you’re susceptible to, then you might have to make some decisions about not being exposed to that allergen, even if it means getting rid of a cherished pet or, you know, making some other lifestyle decisions. And those are changes that can be made that can really help reduce the frequency of asthma attacks.
Zoe Rothblatt 14:20
It seems like there’s a lot to learn about asthma and that it’s really unique to each person. And I wanted to highlight another one of the survey findings revealed that, “94% of respondents agreed that there needs to be more education done, to get people informed about lung health.” And Jessica, I wanted to ask you how Lung Health Foundation, you know, helps provide education to people and some of the health policies that you advocate for?
Jessica Buckley 14:48
Yes! So, I think that most definitely, lung health has been overlooked by all of us. And the truth behind that is that, historically, there has been a stigma associated with specific lung diseases. And because of that, it has been an overlooked and underfunded area of health, but so incredibly important. I mean, just being able to think about the fact that we take around 22,000 breaths per day as humans, and how important our breath is to everything that we do. So, we do a lot of national advocacy and provincial advocacy in Canada, some of the policies that we advocate for picking up on the comments from Professor Bowdish around air quality. I mean, it’s such a massive cross border, world concern, on outdoor air quality, and is going to take all levels of government worldwide to be able to improve outdoor air quality.
Jessica Buckley 15:45
We do advocate for that, of course, but we’re focused on indoor air quality and helping people be able to afford HEPA filters with certain lung conditions, etc, and advocating for patients that way. Some of the other policies we’re focused on are one of the biggest way that youth in Canada are affecting their lung health right now, is we are amongst the highest in the world on youth vaping rates. And smoking rates have declined in that population, which is fantastic to see, all the great work that’s been done to decrease smoking in that category of people, but the vaping rates are skyrocketing, unfortunately. So, the future effects of vaping on their lung health are yet to be known, but early indicators are that it’s not a good outlook, and these are some of the other policies that we’re advocating for around youth vaping rates, and decreasing access, and something called a smoke free generation, which would make it illegal for children born after a certain year to ever purchase tobacco, or nicotine, or vaping products.
Zoe Rothblatt 16:49
Yeah, I mean, thank you so much for the advocacy you do. It’s so important, especially for a youth population, which is just so vulnerable to like trends and not particularly understanding the depths of what they’re doing at such a young age. I think it’s like so important to have people like you spreading awareness and advocating at the local and national level, like you mentioned. And on that awareness, Lung Health Foundation recently launched the ‘Our Lungs Make Our Lives’ Campaign. Can you tell us about this and what you hope people will take away from it?
Jessica Buckley 17:21
Yes, we are very excited about our new brand campaign, that really just to make people think about their lungs, and the power of our lungs, and the moments that happen in your everyday life, that are powered because of your breath. And thinking about them in a way where you appreciate what they bring to your life and want to protect them. And I think messaging around lung health, in the past, has maybe been more focused on the disease, versus just thinking about your lungs and protecting them. And we really wanted to change the narrative and get people thinking about that, that our lungs make our lives.
Zoe Rothblatt 17:58
Awesome! I love that so much. I mean, it’s something so simple that you just take for granted, that you’re able to breathe nicely. And I know everyone’s had that experience when you get over a cold and you can have a clear nose and throat, and you’re like, “I’m never gonna take that for granted again.” Like new lease on life, like whatever phrase you want to say, and slowly you forget, and it just becomes something you take for granted, and it’s important to cherish, like, our health while, like, we have it. I think what you’re saying of like, just getting people to notice their health and, like, even healthy people, like, take notice of your lungs and the good that it’s doing for you. I love that messaging.
Jessica Buckley 18:35
That’s it! And people, typically, don’t think about their lungs. And to your point, until you have a short respiratory illness, and then suddenly you’re thinking about it; or someone in your family is diagnosed with respiratory disease, and then you’re focused on it. But it’s appreciating, how we need to protect them every day and at all costs, and getting that message through to our governments and others to be able to improve the world around us as it relates to our lung health.
Zoe Rothblatt 19:04
On that note, I wanted to conclude. First, I’ll ask Dawn, and then throw it to you, Jessica. What is your advice or message of hope for people living with asthma?
Dr. Dawn Bowdish 19:14
One of the things I’m really excited about is there are a slew of new treatments being developed and that are being used. So, once upon a time, people with severe asthma had very few options to help treat them, and as a consequence, they really did have the quality of their life really significantly impacted. But in the past five, seven years, suddenly there’s been a number of new treatments that target the immune parts that go wrong, and these have to be used really precisely. They have to be used just for the right patient. But when they, they work, they work beautifully. And so I’m really excited that those people who, 15 years ago would have really had their lives contracted by having asthma, now have fuller and more complete lives. And the research is ongoing, and I suspect we’ll see a number of new treatments hit the market in the next five years, as well.
Zoe Rothblatt 20:05
That’s really exciting. And I guess my add on to that is just like, ask your doctor about new treatment options, because you might not know about great options that you haven’t considered yet. And Jessica, what’s your message of hope or advice?
Jessica Buckley 20:17
So, I think there is a lot of hope. And regardless of living with asthma, our lung health can be improved. So, managing with a very effective asthma action plan and speaking with your doctor and your health care professional, being diligent about avoiding triggers, etc., there is a lot of hope. And our website is lunghealth.ca which includes the asthma action plan, there is a back to school plan, for children, specifically, as children return to school, this in the coming weeks. And there’s often a spike of asthma symptoms amongst children when they do return to school. So, getting on top of that now, as you prepare for back to school, we do have a very effective tool on our website to help.
Zoe Rothblatt 21:01
Awesome, thank you. Yeah, that was the last thing I was gonna ask you, is where everyone can find you and keep up with you. But you just mentioned the website, so, perfect. And unless Dawn, do you have another resource to add?
Dr. Dawn Bowdish 21:11
I think that website is great. I mean, patients use it all the time, and people go to it all the time because it’s clear, easy to understand, really easy to use. And I would just echo Jessica and that everyone should have an asthma action plan, because it’s been shown that if you have one, you’re less likely to have exacerbations that could end you up in the hospital or having severe outcomes. So, an action plan is essential.
Zoe Rothblatt 21:32
Awesome. Thank you both so much for joining us on “The Health Advocates.”
Jessica Buckley 21:36
Thank you very much, Zoe. Greatly appreciate it!
Dr. Dawn Bowdish 21:39
Thank you so much. It’s been a pleasure!
Steven Newmark 21:42
Well, Zoe, that was a really great discussion with Dawn and Jessica, particularly around the work the Lung Health Foundation is doing to support people with asthma and bring more public awareness to our breath.
Zoe Rothblatt 21:50
And for me, it was interesting to hear about the common themes that arise when people talk about asthma, especially the concerns around exercise and living an active life.
Steven Newmark 22:00
Yeah, absolutely! Well, we have a gold medalist, who has dealt with asthma, so you can live an active life for sure. Well, we hope that you learn something too. And before we go, we definitely want to encourage everyone to check out all of our podcasts at ghlf.org/listen
Zoe Rothblatt 22:13
Well, everyone. Thanks for listening to “The Health Advocates: A Podcast that Breaks Down Major Health News of the Week, to Help You Make Sense of it All.” If you liked this episode, give us a rating, write a review, and hit that subscribe button wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 22:26
I’m Steven Newmark. We’ll see you next time.
Narrator 22:32
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation Podcast Network.
“A Politician’s Job is to Listen” with Yvan Baker, MP
Yvan Baker, member of the House of Commons of Canada, joins us to talk about Canadians’ health care issues and needs. Mr. Baker discusses the benefits of Canada’s universal health care system for essential services and needs, but highlights gaps in the system like doctor shortages, delays in services, and how until recently dental care was not part of the system. He shares how he’s helped advocate for the expansion of dental care, for the government to consider patient outcomes, and his work with the older adult community.
"A Politician’s Job is to Listen" with Yvan Baker, MP
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Chief of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Director of Community Outreach at GHLF.
Steven Newmark 00:21
Our goal is to help you understand what’s happening in the healthcare world, to help you make informed decisions to live your best life. And today, we’re joined by Yvan Baker, member of the House of Commons of Canada. Yvan and I are going to talk a little bit about some of the issues that Canadians are dealing with in terms of healthcare, and what some of what Member Baker is doing to address Canadians’ healthcare needs.
Zoe Rothblatt 00:42
Great. Well, I’m excited to have a listen.
Steven Newmark 00:45
Well, welcome Mr. Baker. We really appreciate your being here. It’s an exciting bio that you have. You’re so young. Before we get into a discussion a little bit about Canadian healthcare and what you’re doing to improveimprove the lives of Canadian citizens vis a vis healthcare, could you just tell us a little bit about yourself, a little bit about your background and why you decided to pursue public service.
Yvan Baker 01:04
Yeah, you bet. Well, Steven, first of all, thank you very, very much for having me. It’s real honor to be on the podcast. I am the member of parliament for Etobicoke center. Etobicoke is a suburban community in the western side of the city of Toronto, and so I represent a community of about 120,000 people in Canada’s parliament. I’m with the governing Liberal Party. I’m a member of the Standing Committee on Finance, and I chair something called the Canada Ukraine Parliamentary Friendship Group. And in the last few years, that particular group of MPs and senators in Canada has played an important role in trying to support the Ukrainian people in their fight against Russia’s invasion. So I’ve taken a lead on that. Prior to this, I was a member of Provincial Parliament for the same community in Etobicoke. And prior to that, I was a management consultant. I worked for the Boston Consulting Group. I spent some of my time with BCG in Toronto, a little bit in New York as well. And I also had the chance to teach as part of the MBA program at the Schulich School of Business at York University here in Toronto.
Steven Newmark 01:56
That’s interesting, just to get into healthcare, what is your currentinterest in healthcare. And if I may ask a follow up, what led you to an interest in healthcare?
Yvan Baker 02:05
You know, I ran for office because when I was a management consultant, when I was in business, when I was in doing my university studies, I would often, as many people do, volunteer for various charities or nonprofits that try to make a difference for folks on a range of issues. And one of the things that I realized pretty quickly as a volunteer is that on so many of the issues that I cared about, it was really government that had the ability to make the greatest impact in solving those problems. And so that’s really what led me to volunteer into politics, get involved a little bit, take an interest, and then eventually run for public office, first as a provincial representative and now as a federal representative. So in terms of your question about about healthcare, first of all, my family has a philosophy that health is – there are a few things in life that are more important than health, that without health, there’s really no happiness. And in Canada, we have a universal healthcare system. So government plays a particularly important role in the quality of healthcare and therefore the quality of life that people have. And when I started running for office, when I was elected to office, I interacted with hundreds, 1000s of people in my community, and what I would hear from them consistently were concerns, views, suggestions, advocacy on the issue of healthcare, what we could do better, how we could improve the quality of healthcare in this country. So those are really the key reasons that I took an interest in healthcare. It’s something that’s really important to folks, and it’s something that the government of Canada can really impact significantly because of our universal healthcare system and that’s really why I spent a lot of my time on that issue.
Steven Newmark 03:29
There’s something you said, I’m going to butcher it, so apologies, but it’s something that we talk about a lot, something to the effect of, there’s no entity that can impact as many people’s lives as government. When government decides to put its full weight behind something, whether it’s in the field of healthcare, the environment, sanitation, whatever the case may be, there’s really no substitute for what a government can do with the right resources. And it’s so true what you said, and we talk about that all the time on our show, on our podcast, which is why it’s so important for patients to advocate to their governments for improved healthcare, to improve their lives.
Yvan Baker 03:59
Yeah, absolutely. I think that’s true in most countries around the world, and I think it’s especially true in places like Canada, where, like I said, we have a healthcare system that is universal. There are gaps in that system, but, but it is, broadly speaking, a universal healthcare system. Canadians have come to rely on the healthcare system that is provided through the single payer system that we have. And so the beauty of a universal healthcare system is that there is universal access for most essential healthcare services and needs. But the flip side of that is, is that when a patient is dissatisfied with that care, whether it’s the quality of care, the accessibility of that care, the speed of accessing that care, then the solution very rarely can they simply pay out of pocket and resolve that problem, as you might in different healthcare systems around the world. The onus is on government to address that, whether it’s a doctor shortage or a specialist shortage or the quality of care, and we can talk about that more if you’d like. So to your point, government plays an important role, but it’s a particularly important role in the context of healthcare in our country.
Steven Newmark 04:53
Yeah, you talked about the gaps. Not all basic needs, like eye care or dental care are covered completely under most universal healthcare systems. Can you talk about efforts being made to fill some of the gaps in Canada?
Yvan Baker 05:04
Yeah, absolutely. So you nailed it right? Our universal healthcare system has gaps in it, and that’s common to, I think most universal healthcare systems aroundthe world. What I would say, for the benefit of your listeners, is, I would say that in Canada, the way I think about it is essential care is covered things like hospital care, emergency care, family doctor, essential tests and screens and procedures and those sorts of things, an elective, non-essential care is not covered. But there are gaps that in some of those areas of what I would consider essential care. So there are services that aren’t covered. You talked about it, dental care, eye care, until recently have not been part of the universal system. There are also procedures that are considered important, but perhaps not as critical, not as urgent, and are sometimes depending on risk factors and other factors, cost factors may not be covered for some folks, and sometimes people face delays in getting services that are essential. So that essential service may be covered, but you may have to wait months or even years, in some cases, to receive that care if it’s not urgent. So there’s some of the gaps, I think, going back to your question in terms of what’s being done to address I mean, first and foremost, what we’re trying to do is make sure that those services, where there are those wait times, that those get shortened. In Canada, the healthcare system is actually the jurisdiction of the provinces, and the federal government provides a lot of the funding for healthcare, so it is something that the provinces own and execute, have jurisdiction over, but the federal government plays a big role in. And what our federal government has done over the last few years is, said, we want to plug more of those gaps in the healthcare system. One of them is dental care, and so that’s one of the areas that you know, I’d love to talk to you about more if you’re interested, but we’re doing a bunch of things to try to make sure that we’re also improving the quality of care. One of the things I’m proudest of as an MP is, you know, as an MP, you’re an advocate. You’re trying to get the government to do things better, and I’m not the one who makes the decisions, but I certainly try to advocate for those decisions to be made. And one of the things I’m proud of is that I was one of the MPs who fought very hard, successfully, to convince the government to tie funding that we provide to the provincial governments, that the federal government provides to the provinces to results. So instead of sort of just cutting a check every few years for healthcare and giving to the provinces and saying, off you go spend it as you see fit. Let’s tie that to certain outcomes for patients, whether it’s access doctors or certain care providers and those sorts of things. But obviously, the biggest thing that we’re doing in terms of plugging gaps is the creation of the new Canada dental care program. It’s the biggest expansion of healthcare, of the universal healthcare system in Canada since the inception of universal healthcare in this country.
Steven Newmark 07:14
Can you describe what that entails, what the current plan provides, and what you’re hoping to achieve?
Yvan Baker 07:19
Currently if we take a step back in terms of dental care, I mean, we know dental care is so important to people’s broader health, it’s not just about their oral health. But you spend a lot of time on your podcast talking about chronic illnesses, and you know, and I have to say that, you know, dental care, if I think about your listeners, who are experts, who are patients, others concerned about chronic illnesses, I’ve got to believe that for them, you know, dental care is something that they value, or can see value in as a preventative measure to prevent some of those chronic illnesses. But the plan for the Dental Care program is basically that people who have a family income under $90,000 and don’t currently have private dental insurance will qualify for the program, and virtually all essential, let’s just say, essential dental services oral care will be covered. So preventative services, like scaling, polishing, diagnostic services, restorative services, prosthodontic services, removal of dentures, deep scaling, oral surgery, the list goes on. So we’re really covering a pretty comprehensive set of services, and it’s specifically targeted at those who have family incomes under $90,000 and don’t currently have private insurance. The reason this is, is because the goal here is to prioritize those folks who currently aren’t accessing dental care because of the cost of dental care.
Steven Newmark 08:28
You said it beautifully, dental care is healthcare. What goes on in your mouth really affects your entire body. So it is important not to neglect dental care, and it really should be part of more comprehensive healthcare around the world, not just in Canada, so that’s fantastic. You’re also doing a lot of work to strengthen support for seniors. Can you share why it’s important for you to devote so much time and energy to senior citizens?
Yvan Baker 08:49
There’s a number of reasons. I mean, one is because I think that seniors play an important role in my community, play important role in our country, in communities that your listeners are in, but I also think that they have contributed a lot, and we owe it to them to provide them with the best possible quality of life that we can. And healthcare is an important part of that. I work a lot with seniors because I also appreciate the wisdom and perspective that they offer on whether it’s issues of healthcare or things that touch them or things that touch people of all ages and backgrounds. In my community, we have one of the largest percentages of proportions of seniors in Canada. So I have a lot more seniors than most of my colleagues who are members of parliament. And so seniors issues are of particular importance to me, because that’s what’s important to my constituents. But also, going back to our earlier conversation, Steven, you know, we were talking about the role of government. And again, when we think about what I hear from seniors, a lot about is issues like healthcare, like housing, like transportation, and those are things where government can really move the dial in terms of the quality of life that seniors enjoy. Pensions is another one. So these are some of the reasons why I spend a lot of time working with seniors. I hold a monthly seniors advisory group meeting where the purpose of these is really to hear from seniors about what’s important to them, answer questions, take advice on how we could improve. And you know, we were talking about dental care a moment ago, I’ve been elected for almost 10 years in public office, and you know, dental care was one of the first things I started to hear from seniors about, not just for the medical benefits that we talked about, but just from an affordability perspective. I know a lot of folks around the world, a lot of your listeners in different countries around the world are struggling with inflation, cost of living. My constituents are whether it’s housing or daily cost of living, and one of the expenses that touches seniors the most is those dental care expenses, especially when there’s unexpected need for dental care. Some have insurance through their pensions programs or through private means, but very often, the most expensive services have to be paid for by seniors out of pocket. So in all those ways, this is why I work with seniors. They deserve the support we need to support we need to support them. They’re a large percent of the population, but also, government can really impact their quality of life.
Steven Newmark 10:45
Well, first of all, it’s fantastic all the work that you’re doing on behalf of Canadians and particularly your constituents. And with that, I just want to wrap up by asking, let me just say, a lot of what we do here on the podcast at GHLF is to encourage patients to share their stories with elected officials. Can you talk to us as an elected official about what it’s like meeting with constituents and why patient voices matter?
Yvan Baker 11:05
When I first got elected, Steven, my predecessor as the representative for the community, as the member Provincial Parliament, gave me a piece of advice. She said to me, you know, a lot of people see their elected officials speaking at a speech, at an event, maybe on a podcast, and we kind of get accustomed to having to thinking that politicians are there, kind of to talk, to communicate in some form, and that’s certainly part of the job. But she said to me, the most important part of a politician’s job is to listen, because when you listen, you understand what people’s priorities are, what their concerns are, but you also hear the ideas that you need to solve these problems. No member of parliament, no congressman, no representative, has the solutions to all of the problems that people are facing. And so to your question around why it’s so important to hear patient voices, it’s kind of for those reasons, right? Like whether you live in a country with a universal healthcare system, or you pay privately, or a combination of both, the reality is, is that whoever’s responsible for that healthcare system is only going to improve that system if they know what those problems are, and if they’re motivated and held accountable to solve it. In the case of a universal healthcare system like the one we have in Canada, it’s the elected officials at the provincial and federal level who are accountable for the quality and the services that are provided, even if you’re not in that situation. I think it’s important that patients are communicating what’s working what’s not working for them, and pushing the healthcare providers to be responsible, to make sure that we improve that system, because there is no happiness without healthcare.
Steven Newmark 12:17
Wow. I want to tattoo that somewhere, not on my body. Though there is no happiness of healthcare, I love it. I love it. Well, with that, thank you so much, Mr. Baker, we’re so appreciative for all that you’re doing, and thank you for taking your time to come on the show.
Yvan Baker 12:30
Steven, thanks for having me. It’s been an honor.
Zoe Rothblatt 12:34
Well, Steven, that was a really great discussion with Yvan. It’s interesting to hear about, you know what issues crosses the borders and just a reminder that it’s always important to hear from constituents.
Steven Newmark 12:45
Yeah, absolutely, like you said, for me, it’s always instructive to talk directly with elected officials and to hear from them, and it’s fantastic when they tell us how important it is to hear directly from their constituent patients. So with that, we hope that you learned something too. And before we go, we want to encourage everyone to check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 13:05
well, everyone. Thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, give us a rating, write a review, and hit that subscribe button wherever you listen. I’m Zoe Rothblatt
Steven Newmark 13:18
I’m Steven Newmark. We’ll see you next time,
Narrator 13:24
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Voices from Capitol Hill: Advocating Together for Autoimmune Patients
We’re joined by Amanda Krzepicki, Policy Director at the Autoimmune Association. We talk about the long process of getting legislation passed, top issues the Autoimmune Association is advocating for, and how patient groups can come together to make a difference. Amanda also offers advice for if you’re feeling nervous on connecting with stakeholders.
Voices from Capitol Hill: Advocating Together for Autoimmune Patients
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Chief of Policy at the Global Healthy Living Foundation,
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Director of Community Outreach at GHLF.
Steven Newmark 00:21
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life. Today, we are joined by Amanda Krzepicki, Policy Director of the Autoimmune Association. Amanda is based in Washington, and spends much of her time on Capitol Hill, advocating for patients. The Autoimmune Association helps autoimmune patients by sponsoring research, advocating for access to healthcare, and fostering collaboration to identify and explore the common threads that link autoimmune diseases. Like the Global Healthy Living Foundation, the Autoimmune Association works around the world, not just here in the US, to help patients.
Zoe Rothblatt 00:53
Great. I’m excited to have a listen, Steven.
Steven Newmark 00:55
All right, well, let’s get into it. Welcome Amanda, thanks for coming.
Amanda Krzepicki 00:59
Thank you so much for having me, Steven. It’s great to be here.
Steven Newmark 01:01
Yeah, why don’t you start by telling our audience a little bit about yourself, how you got into patient advocacy, and we’ll go from there.
Amanda Krzepicki 01:07
Yeah, absolutely. So to give you a little bit of background about myself, I started my career working in a federally qualified health center where I worked with patients who are directly impacted by burdensome utilization management practices. I actually managed a mobile dental clinic, which went around to local elementary schools, and I saw children without their parents.
Steven Newmark 01:27
Where was this?
Amanda Krzepicki 01:28
Alexandria City in Virginia.
Steven Newmark 01:30
Excellent.
Amanda Krzepicki 01:31
So, I saw all these students without their parents on a mobile dental clinic. You can only imagine the level of screaming I had to deal with on a day to day basis.
Steven Newmark 01:31
Oh my gosh.
Amanda Krzepicki 01:32
So, working on the bus, I teamed up with the school nurses and providers to make calls on behalf of patients, to try to argue prior authorizations, and I truly felt the frustrations of the system from the ground up. It was a really eye opening experience to see children experience these inequities, and I was doing this job while concurrently getting my Master’s of Public Health degree. So this really kind of pushed me to do that in the policy space. So I had another internship where I did Medicaid insurance policy for a while, and then I got my feet wet with my first job in the private sector where I represented a few patient groups as well as nonprofits, before coming in house at Autoimmune.
Steven Newmark 02:21
Wow. So tell us a little bit about the Autoimmune Association. Many of our patients, as I’m sure you’re aware, and by extension, many of our listeners, live with an autoimmune condition. So tell us about the Autoimmune Association.
Amanda Krzepicki 02:31
Yeah, absolutely. The Autoimmune Association is the world’s leading nonprofit organization dedicated to autoimmune awareness, advocacy, education, and research. We represent over 50 million Americans, and you know, more research needs to be done to get a worldwide estimate with over 100 diseases, many of which are rare. So we’ve had a lot of resources on our website to help patients. We actually just developed a new question prompt list to help patients have more effective meetings with their doctors, and I’m currently in the process of revamping our policy page and our legislative action center to get our patients more involved in changing the healthcare system so it works better for them their families.
Steven Newmark 03:08
Wow. Well, that’s, uh, fantastic, and thank you for doing all that you do. So you’re based in Washington. Can you provide our patients some information on the basics of how legislation works, how patients can help influence legislators to come up with more patient, friendly outcomes?
Amanda Krzepicki 03:24
Yeah, absolutely. So unfortunately, I have to tell everyone, first and foremost, you have to throw away everything you learned in civics class and from School House Rock.
Steven Newmark 03:31
What? How a bill becomes a law? I can’t watch the video.
Amanda Krzepicki 03:34
Right, no. I truly wish it was as simple as that song makes it out to be. But you know, with recently, the house has kind of thrown away normal order, and it takes years for things to kind of change in the healthcare system. So initially you need an individual, more likely, an organization, group of organizations, to come up with legislation. In this case, a bill that is an idea that improves the healthcare system. That’s what we hope for that it would improve the healthcare system. So you have to take this bill to Congress and have meetings with various legislators to see if this bill aligns with their priorities. So sometimes you have to do research on what they’ve worked on in the past. It helps if you’re working with committees of jurisdiction like Health, Senate, Finance, Ways and Means in the house and Energy and Commerce to see if there are members there who care about the same issue that you care about. Once you find a member, ideally, one on each side of the aisle and one in both the House and Senate, or two. I guess in both the House and Senate, you have them introduce the bill. That is the hardest step, and can take years in itself. But after you have a bill introduced, then you need to put an effort shopping around additional sponsors or co sponsors, so more members that are engaged in this bill and wanted to move once you kind of have a majority of members or a couple committees who think it’s really important, they might take the bill up for a markup where every member on that committee has an opportunity to kind of change the text of the bill to have it as they see fit. Once you have the markup, then you have the hearing, then you have the final vote with each side, so the House and the Senate, and per chance, if those markups maybe didn’t go your way, and you’ve got two different bills on each side, then they need to conference those changes. And as you can imagine, all of this takes years, so it’s the coming up with the idea then having the members of Congress work on the issue, getting it up to a vote, getting it out of the House and Senate, and eventually getting it to the President’s desk. So, you know, it is a huge accomplishment for bills to get passed.
Steven Newmark 05:33
Yeah. First of all, that was a really good overview. I have to say, how bill becomes a law, 101, it does remind me of the cartoon. It also reminds me of Mr. Smith Goes to Washington. I hope I’m not dating myself too much, but yeah, that really is how it’s done. Obviously, there’s more to it than that.
Amanda Krzepicki 05:47
A little Yeah? I mean, we left out all the midnight conferences and the sneaky changing up the text right before the other party can see it. But you know, those are just the fun little tidbits you get working in DC, right?
Steven Newmark 05:58
Those don’t make it into the cartoon.
Amanda Krzepicki 05:59
Yeah.
Steven Newmark 05:59
But no, no, no. That’s right. That’s the basics of it. And like you said, it takes years. That’s something that we always stress. It’s you don’t just go to Washington and tell your story and expect a piece of legislation to become law a few weeks later. It takes a long time, and sometimes it’s just a matter of introducing yourself to your local legislators and continuing on over the course of many years. Do you have any good examples from your career of a great victory worth noting, worth talking about?
Amanda Krzepicki 06:25
Yeah, actually, very recently. So there’s the Medicaid drug rebate program, which recently had a proposed policy change come out. And this policy change would kind of affect how patients get their medication, because it’s a very complicated process to very quickly explain, but I like to very quickly refer to it as a shower thought. So I feel like somebody woke up one morning, had this idea where they were in the shower, thought it was a great quick fix to a problem, and then forgot to kind of think the idea all the way through, think about the unintended consequences. So there’s this specific policy in the mdrp where they wanted to stack all of the rebates that pharmaceutical manufacturers have across the system and make that the best price for Medicaid, which would bring, frankly, the price to zero. Which sounds like a really fabulous idea, you know, when you say it quickly.
Amanda Krzepicki 07:14
But what the unintended consequences would likely be like, all of these rebates that patients are getting to make their drugs affordable for them across the system would then be eliminated, so patients would no longer have access to that benefit that they like and are using to afford their medications. And it’s just a little bit scary to make that change so quickly without talking to people. So we had a letter. The Autoimmune Association has a coalition, the National Coalition of Autoimmune Patient Groups, and we had that coalition run this letter open to all patient group, all 501(c)(3) patient groups, and we got 31 other patient groups to say that they also would like HHS to take another look at this letter. We then also worked with members of Congress, because they were going to have a hearing with Secretary Becerra. And we asked them if they would ask Secretary Becerra to review this policy and make sure that those unintended consequences were not going to harm patient access to their drugs. So we had representative Robin Kelly ask during a hearing if he could follow up with her on this policy. And he said yes. So we have now on record that he has to get back to her office. And since that has occurred, and we have other support from other members of Congress as well. HHS has pulled back on this policy for this year, so we’re really excited that they’re going to be taking another look at it, working with manufacturers to kind of see the bigger scope of the rebate system in itself, and how they can work to get more affordable drugs for patients as they intend, which we are supportive of, obviously. We want patients, especially who are Medicaid dependent to have better, cheaper access to drugs, we’re always for that, but this is just like, a huge win and a huge group effort.
Steven Newmark 07:14
Right?
Steven Newmark 08:47
Yeah, no, absolutely. First of all, I should mention that the Global Healthy Living Foundation was active in that as well. And of course, we’re happy about the outcome, but it’s an interesting example, because it’s not from the legislative side, it’s on the executive side, going to the Department of Health and Human Services, which is interesting and can be even more arcane when trying to advocate.
Amanda Krzepicki 09:06
Yeah.
Steven Newmark 09:06
But we won’t get into that. That’s a little more difficult. But it is interesting that even when it’s not just the legislative side that we advocate, probably in all three branches, actually. So that’s an interesting example.
Amanda Krzepicki 09:15
Yeah, judicial advocacy is becoming a huge priority with all these different course cases that are buzzing around. It is complicated. As a patient organization, have to work with lawyers, because if you’re not a lawyer, writing amicus brief is a little bit a couple steps above, so you gotta get some support there. But yeah, it’s important to gage all three branches for sure.
Steven Newmark 09:33
Right, for sure. Do you have any funny stories about any interactions with staff members or anything of that nature?
Amanda Krzepicki 09:38
You know, it’s so funny from my grad school program, it was located in DC. I have a lot of friends that actually work on the hill, so while they were so happily meet with me, I always joke when I was either bringing in former clients in or like going with myself, that they love to tell me no. So it’s always like you think your friends are going to be the ones that are really going to be the easiest to work with. But no, that’s really not the case.
Steven Newmark 10:00
Because they could tell you no, because they’re your friends,
Amanda Krzepicki 10:01
Yeah.
Amanda Krzepicki 10:02
I know totally I guess that’s true.
Amanda Krzepicki 10:04
And when I first got started in this space, this is probably more of a funny story about me, but I was so nervous. I was, like, fresh out of grad school, just getting out there, and I was very intimidated by Hill staff, so I used to get really, like, stress going into these meetings where I was going to talk to them about the policy issues I cared about. So I frankly would look them up on social media, because once you’ve seen someone in their Halloween costume, they become significantly less intimidating.
Steven Newmark 10:28
Totally.
Amanda Krzepicki 10:28
So is something I recommend, like, if you’re going to be trying to get your feet wet out there with staff, just to kind of you know, and that maybe if your staff make your social media private, because it was alot.
Steven Newmark 10:38
Oh geez.
Amanda Krzepicki 10:39
But just seeing someone in their Halloween costume makes things like, really down to earth. They are just people at the end of the day. We all go through the same experiences, so just having genuine conversations with them kind of always turns out the best in the end.
Steven Newmark 10:52
That’s true. That’s really good advice. If there’s any like, even just seeing on their social media feed, if there’s a certain hook, like, you know you’re in Washington, if they’re a Washington Nationals fan or something, something you could bring up while you get inside.
Amanda Krzepicki 11:01
Yeah? If they’re from the district, and you’re from the district, and you have those ties, and you can talk about, maybe you both went to the same high school, or maybe you both, like, the same coffee shop, it’s always like, great to have that personal interaction. Yeah,
Steven Newmark 11:12
No, totally. That is really good advice. So what are some of the top issues that you’re working on Capitol Hill these days? Summer of 2024, what are we up to?
Amanda Krzepicki 11:20
We’re in the kind of final sprint for elections.
Steven Newmark 11:22
Yes.
Steven Newmark 11:22
Right.
Amanda Krzepicki 11:22
Right before we get into lame duck session. So one of our top priorities as an organization, and I think many patient groups feel the same way, is the Safe Step Act. So that policy makes it easier to get exemptions from step therapy policies, which is utilization management and hinders patients from getting their preferred form of treatment. So one of the main sponsors of that bill, Representative Wenstrup, is retiring this year. We are so close to 218 co sponsors in the house, which, as I mentioned before, you really want to get the majority of members on that bill. So we are constantly reaching out to different offices trying to get members in, because we really want to pass that before he retires. So that’s a huge thing. Also the help copay bill, which works with copay accumulators and maximizers, which is where, in theory, you should be getting rebates from pharmaceutical manufacturers and co pay assistance. And instead, the PBM companies will then take that money and not use it towards your out of pocket costs, which is unfortunate. But there was recently a policy change within the Department of Labor. So here the two branches of government kind of working in tandem, where they released, like a FAQ that you in theory would bring the cost of this bill. So this bill was, I think, originally scored at something like ten million it was not going to be easy to pass, costing the federal government so much money.
Amanda Krzepicki 12:36
And they, I think, have brought that cost estimate down to zero by fixing something essential health benefits like loophole with that FAQ. So we’re kind of looking to Congress now to kind of assess their FAQ and pull that into the cost there, and hopefully get that passed now that it costs significantly less money. A new bill that just came out that we’re really excited about is called the 340B Access Act, so that helps create more transparency within the 340B system. I used to work for a federally qualified health center, so 340B is really close to my heart. I know those patients benefited from that program so much, and it’s really unfortunate to kind of see hospitals taking the drugs that they’re buying for pennies on the dollar and then up charging low income patients for them. We want to see those cost savings passed on. So this bill really increases transparency and ideally access for patients. So we’re really excited about that. It’s very new, so obviously it’s not going to pass this year. I can expect that we’re going to take this on for many years to come. So excited to get other groups involved on that bill and work together to make that a priority for years to come.
Steven Newmark 13:39
Yeah, those are some great examples. Those are all bills that we’re active with, too, in some of these coalitions that you were describing. And they’re all at different phases, if you will, in terms of where they are in terms of passage, The Safe Step Act, correct me if I’m wrong, this is the third Congress or the fourth congress that’s been introduced. So the point being, it takes many, many years. I think it’s the sixth year. So I think 2018 was when it was first, if I have that right, give or take, to get it over the line, and it may not make it. We’re going to push very hard, as you said, with Congressman Wenstrup retiring, hopefully this is the year, but it takes many years, and we’ve slowly but surely been building towards that 218 majority in the House. And if we can get to that tipping point, that would be fantastic. Well, let me just ask, just to tie it all together. Final question, how important is it for all of these patient groups and patients with different backgrounds to work together to achieve these outcomes?
Amanda Krzepicki 14:28
I think it’s critical. I was just at a coalition meeting this morning, and I run a coalition of 65 autoimmune patient groups. I think it creates like an echo chamber for all of our voices. I think going to the Hill with coalitions is really impactful, because then you’re meeting with all these members, and you’re showing that whatever issue you’re advocating for has a wide breadth of patient groups behind it, that people support it, and members want to hear that there are patients in their district that care about the issue that you’re pushing for. So bringing those people in is a lot easier with coalition work, having numerous groups behind it. So that way, if there are any opponents of the bill, they can be like, you know, this one opponent, but there are 65 groups that support it. It makes their jobs easier to help us, help them. So I think it is critical to work together, and that’s why, you know, we’re on this podcast today, kind of working together. So, yeah, I just think all the the patient community is so strong, especially like those of us in DC, we see each other all the time, so we’re constantly bouncing ideas off of each other and thinking of new, creative ways to get these bills passed.
Steven Newmark 15:27
Yeah, no, I totally agree. We achieve more together as patients than we do separately, and that’s why it’s so important for us to all gather and inform elected officials and others policymakers as a team, if you will. So this has been great. Thank you again, so much for your time, and thank you for all that you do on behalf of autoimmune patients. This has been wonderful.
Amanda Krzepicki 15:46
Thanks so much for taking the time to sit down today. I really look forward to hearing this go live, and look forward to continue to working together.
Steven Newmark 15:53
Absolutely. Thank you, Amanda.
Zoe Rothblatt 15:57
Steven, that was a great interview. It was so great hearing from Amanda about the work that she does, and just reminds me of the importance of groups like us working together.
Steven Newmark 16:06
Yeah, absolutely, it’s always good to chat with other patient groups and hear what other groups are up to. Well, we hope that you learned something from today’s conversation, too. And before we go, we want to encourage everyone to check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 16:19
Well everyone, thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense at all. If you liked this episode, give us a rating, write a review on Apple podcast, and definitely hit that subscribe button wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 16:34
I’m Steven Newmark. We’ll see you next time.
Narrator 16:40
Be inspired, supported and empowered. This is the Global Healthy Living Foundation, Podcast Network.
Special Episode: The Power of Patient Stories
Welcome to our special episode of The Health Advocates hosted by our 50-State Network and the Obesity Action Coalition (OAC). This episode features advocates Jody Quinn, Judy Nagy, Yolanda Clay, and Alecia Smith, who share their personal journeys — how they began sharing their stories, the invaluable support of community, the challenges they faced, and their successes along the way. You’ll also hear their advice for others looking to make a difference.
Special Episode: The Power of Patient Stories
Narrator 00:00
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation Podcast Network.
Zoe Rothblatt 00:08
Welcome to “the Health Advocates,” a podcast that breaks down major health news of the week, to help you make sense of it all. I’m Zoe Rothblatt, Director of Community Outreach at GHLF, and we have a special episode for you today, and I’m passing the mic to my colleague Erik Stone, who’ll be hosting this episode. Hey, Erik.
Erik Stone 00:25
Thanks, Zoe! Welcome to the first episode of our Advocacy Training Series, where we explore how you can get started on your own journey with patient advocacy and learn from the stories of other experienced patient advocates. My name is Erik Stone, and I am the Global Healthy Living Foundation’s Associate Director of Learning Experience Design. I’m so excited to be co-hosting this webinar today with Kendall Griffey from the Obesity Action Coalition.
Kendall 00:45
Hi! Thank you for the introduction, Erik. I’m Kendall, Communications Manager with the Obesity Action Coalition (OAC). OAC is a national non profit organization dedicated to improving the lives of individuals, affected by the disease of obesity through education, advocacy, and support.
Erik Stone 01:02
Thanks, Kendall. Today we are joined by Jody, Alicia, Yolanda and Judy, four patient advocates from around the country, who will be sharing their stories with us today. Maybe we could start out by learning a little bit more about them. Could you please introduce yourself: where you’re from, and share a few sentences about how you got into advocacy work.
Judy 01:18
My name is Judy Nagy, and I live in Sandusky, Ohio, which is on the shores of Lake Erie, halfway between Cleveland and Toledo. And I was diagnosed with rheumatoid arthritis at the age of 25 and that was about 44 years ago. So, I started my advocacy work, about 14 years ago, with the Global Healthy Living Foundation, and I’m also a platinum ambassador with the Arthritis Foundation. I have been to Washington and to Columbus, Ohio, participating in support for legislation to help all people with chronic illnesses and many medical needs. So, I love it, and I wouldn’t trade it for the world. I’ve met a lot of nice people, and it’s really wonderful.
Erik Stone 02:12
Thanks, Judy! Jody, do you want to go next?
Jody 02:14
My name is Jody Quinn. I live in Plymouth, Massachusetts – Lifelong Massachusetts residents, originally from Cambridge. I have psoriatic disease, psoriasis, and psoriatic arthritis. Diagnosed about 20 years ago, after 15 years of misdiagnosis. About eight or ten years ago, as my disease progressed, I started looking for a community – I didn’t know anybody else who had psoriatic arthritis. So, I, you know, through online searches, found the National Psoriasis Foundation and got involved with them as a volunteer for events and fundraisers. And then one day, they said to me, “how would you like to go to Capitol Hill and speak to all the legislators and then go to the FDA for hearings?” And I said, “You are crazy. I can’t do any of that.” So, I went, and I never stopped. I’ve just been going since then, and so I’ve been advocating with them for about eight years, along with AI arthritis, and patients rising, and other organizations. Because if one is good, ten is better, and I absolutely love it.
Erik Stone 03:13
Alicia, do you want to go next?
Alicia 03:14
My name is Alicia Smith, and I’m from Lakewood, Ohio. I’m a suburb just west of Cleveland. I am a nurse, and I became a patient advocate, almost by accident. I started on a health journey as a patient with obesity, and I started researching on social media for a community, just for support and education, and came across the Obesity Action Coalition, and really resonated with me what they were doing and how they were trying to get things moving forward with health advocacy, and I just happened to reach out by email to share my story with them, not necessarily meaning to be an advocate, but they reached out to me with an advocacy opportunity, and I realized that it was a really great opportunity, and decided to take a chance, and it’s kind of snowballed from there with different chances and opportunities, and I realized it was something that I really loved and wanted to do and really grateful for.
Yolanda 04:10
I’m Yolanda, I’m from the Pacific Northwest. I was a fledgling supporter of issues, such as weight bias, campaigns, and issues concerning healthcare access to people who are experiencing the disease of chronic obesity. I jumped into the arena, because I myself experienced the disease of chronic obesity. I was afraid to jump in, because I listened to the false narrative of what I was and was not capable of achieving, and I let that keep me back, but then I did finally emerge as a patient advocate with a story to share and my voice amplified. And the reason I was able to do that, because I was able to get involved with an organization called Obesity Action Coalition. And they were the ones to help me learn how to use my voice and to share my story, in order to assist people who are experiencing the same thing that I was, the disease of chronic obesity. And with sharing my story and using my voice, I hope to change the outcome for people who are experiencing that, and advocate for them and for myself, at the same time by doing that.
Erik Stone 05:22
Thank you, Yolanda! I will pass it over to Kendall to introduce our first discussion topic today.
Kendall 05:29
Thank you, Erik. So, let’s dive right into getting started with advocacy. What first steps should someone interested in doing patient advocacy work, take to get started? Let’s start with Judy.
Judy 05:40
I believe that you reach a point in your journey with your disease, where you feel comfortable sharing stories about yourself, and meeting fellow people that are dealing with the same issue you are. When you have already been through all the tests and the medicines and those surgeries, you really have an understanding, that a lot of people don’t know about. The first step is to find an organization, that is connected to the issue that you’re dealing with, and nearly all of them are involved in the legislation issues. I have worked with two organizations, and both times, when I went to Washington and when I went to Columbus, Ohio, we were joined by 59 other organizations, who were all in support of the same issue that we were. So, it takes a village to get things done, and when we work together, we can make life easier and a little bit better. I mean, we can’t take away the pain and we can’t take away the mental stress of living with a chronic illness, but working together, we can make great things happen.
Kendall 06:57
Thank you, Judy! Now, let’s pass it to Jody.
Jody 07:00
I agree with Judy. Finding a nonprofit or a patient group – they’re out there for whether it be arthritis or obesity or Crohn’s or diabetes, MS, pretty much any medical condition. They have a nonprofit or a group, and they all have advocacy groups within them that will provide training and access. Another option is even if you ask at your doctor’s office and you say, “gee, I’d like to get involved.” But sometimes they have good suggestions. And one day, just when I was up at the State House, in Boston, waiting to speak to the member, I was talking to the staff there, and I said, “what do other people do?” And they came out with some great suggestions of things for me to do, that I never would have thought of, and even have heard of, with these other groups. So, that’s another option. Or hospitals have advocacy groups too, that you can join. There’s a lot of avenues out there for people, whether they want to jump in full time or maybe just write an article here and there. So, there’s a lot out there, that people can try.
Kendall 07:54
Thanks, Jody! Those are some great tips. Alicia, what are your thoughts?
Alicia 07:57
I have a couple suggestions: I would say the first step is just having a passion for it. I think a big part of it is just being very, just, genuine and passionate about the topic. I think people will really see and connect to that, and then using that passion. And I think social media can really be a good tool to kind of find your community and find organizations, that may be out there, that inspire you and that you connect with, that you kind of share in their mission that you’d like to join. And then you can look on their website, and usually, that organization has a advocacy page. Advocates are really needed, so usually they have an advocacy page on there with contact information, and if they don’t, you can use like, their contact form or an email on a contact page and just email. At the time, I didn’t know what an advocacy page was, so I just use an email – so really, any way, and someone will most likely get connected to you.
Kendall 08:56
Thank you, Alicia. Now, I’ll pass it to Yolanda.
Yolanda 08:59
I agree with Alicia, having a passion, and I’m a purpose driven, behind your advocacy is very important, at least it was for me, and is for me, because it carries me through when things get difficult or when the process seems daunting. So, yes, having that purpose driven by my advocacy work. Volunteering in the area where my interest lies, that’s very important. Seeking out other people, who are in that area, surrounding myself in that space, that’s important. Just seeking out those people in that area, that’s important. Researching information about what I’m interested in, that’s important too. Yeah, just finding all the information that I can about what subject that I’m interested in advocating for. Self education, like they said, go to websites. And there’s so much information out there that you can find for yourself. So, that’s what I would suggest doing.
Kendall 09:54
Yeah, thank you. Those are some really amazing tips that each of you shared. Now, how did you overcome the fear of not knowing enough, to do advocacy work. Judy, we’ll start with you.
Judy 10:04
I don’t think I ever really had any fear. Working with the Global Health Living Foundation was very easy; they provided all the materials that we needed, to prepare ourselves, for being a patient advocate, and when I joined the 50 State Network, they reached out to me and we connected in Columbus, Ohio, the first time. They actually had another person there, that was helping us to put our story together, so that we could make a presentation to the legislators. I testified before the State Senate, in Ohio, for biosimilars when I first started. They gave me the courage, because they were so supportive, and that’s why it’s important to be part of an organization, that provides you the materials you need, and the camaraderie is amazing, especially with the Global Healthy Living Foundation. They have it all together. These people are really good at what they do, and they help you prepare. They have staff that reach out to you, when you have any fear. But really, I believe you need encouragement from your fellow patients as well, and your family and friends, because we’re not alone, and I’ve come across so many people that they’re afraid to make a change, they’re afraid to take the next step, and I encourage them, and I give them suggestions, and I’ve had a lot of people that were just so appreciative. It’s just taking that first step, reaching out, talking to other people, and knowing that your courage is going to make life better for you and for everybody. Because my motto is, ‘we’re all in this together, and together, we are stronger.’
Kendall 11:59
Wow, Judy! That’s incredible, thank you for sharing. It was very beautifully said! Now, I’ll pass it to Jody. How did you overcome the fear of not knowing enough to do advocacy work?
Jody 12:09
I was definitely afraid. For me, I was actually brought in kicking and screaming, dragged in to my first advocacy event saying “there’s no way, I can’t do this. I can’t talk to these senators, and I don’t want to go.” And they’re like, “you’re going.” So, I went. It was great, you know, all this fear – Got to meet with my senator, and I think she could see I was scared, and she just put her hand on my arm and said, “you’ll be fine.” And I just told my story, you know, I realized it isn’t how much you know, it’s you, it’s your story, that’s what you have to tell! Your story is the most important thing in advocacy. And even if 20 people have the same thing as you in the room, there’s still 20 different stories to be told. So, the encouragement I received that first day, and then every meeting I go to since then, you know, before you go, everybody is like, “you got this!” to each other. You know, there’s a lot of support along the way. So, after that first meeting, I’m not going to say each time you get a little anxious, you know, before you go in, but the fear just sort of melted away. When I saw, you know, it’s not us against Goliath; it’s us for ourselves, and everything we say is important. Your story is never right around you. So, that’s how I overcame my fear.
Kendall 13:16
That’s amazing, thank you for sharing! Alicia, I’ll pass it to you.
Alicia 13:20
I definitely, initially, had a bit of a fear as well, and then I quickly realized when people were telling me that, really it’s the advocates that are making the impact in the meetings. It’s the personalization, it’s not really the facts and figures, so much. When you’re trying to make a difference, but it’s that personalization, that’s really connecting to people: when someone can really relate, and put those facts and figures, seeing how it works into an everyday life, really makes a difference, and seeing how it plays out in the every modern day situation, and how it’s affecting people’s lives, really started to make me feel comfortable and know that when I’m speaking, I’m probably actually really being heard. It’s not just someone twiddling their thumb at a PowerPoint presentation. So, that really helped make me feel comfortable, and made me feel like I was actually making a difference.
Kendall 14:12
Definitely, thank you! Yolanda, what about you?
Yolanda 14:15
I came from a place, when I first started, of imposter syndrome. I believed that my story didn’t matter, how could I make a difference, to being surrounded by advocates? My experience with advocates is that they’re the best hype people ever. They lifted me up, they supported me, they helped me, like I said, find my voice and help me, instill in me, that I mattered, my story mattered, my story could help change, and change in make a difference. So, yeah, it’s who you surround yourself with, and you’ll find your inner story is important and that you can, too, make a difference. So, that’s how I dealt with my imposter syndrome and my feelings that I didn’t matter or my story didn’t matter. So, it was a rough start, but I increased my belief in myself and things I’m doing now, or being on this panel wouldn’t be possible, if without starting my advocacy work. So, it’s a good path start and just take the baby steps. The possibilities are endless – You don’t know where you’re gonna end up, but it will be a good start and a good place, I promise.
Erik Stone 15:17
Thank you so much, everyone, for sharing your answers to that. Throughout all of the stories you’ve shared so far, I’ve noticed the common theme of community. I’m curious, if you had to describe the patient advocacy community in one word, what would it be? And let’s start with Jody.
Jody 15:32
‘Supportive.’ I think there’s a million words to describe them, but that’s what I get out of the community. I get support in every possible way that I could even eat.
Erik Stone 15:40
That’s wonderful. Yolanda, what about you?
Yolanda 15:42
I would say ‘lightworkers,’ that’s my word.
Erik Stone 15:45
I love that. Judy…
Judy 15:46
I would say, the best part about it is the ‘fellowship’ and being comfortable talking to somebody, that has experienced another chronic illness, no matter what kind of chronic illness it is, because I haven’t come across anybody that isn’t dealing with something and fellowship, makes a big difference in that. The support, the camaraderie, the sharing of stories, and it’s just so rewarding to know that you can help each other through a lot of problems, in your journey, because most of these problems that we’re living with are lifelong. You make so many good friends when you’re a patient advocate. It’s fulfilling, it’s heartwarming, and yeah, at Global Healthy Living Foundation, we call it ‘the beacons of health.’ That’s what we have.
Erik Stone 16:36
That’s fantastic! What a beautiful answer, Judy, thank you. Alicia, what about you?
Alicia 16:41
I would say, I describe it as ‘hopeful.’ Just, it’s positive, hopeful, and just how they’re working for change, just gives me a lot of hope. So, ‘hopeful,’ would be my word.
Erik Stone 16:51
These are all great words. I’m feeling very warm and fuzzy, just hearing all these words like friendship and lightworkers passed around here. I think these are all, such great words to describe the advocacy community. I’m curious, if maybe we could elaborate a little bit more on how important things like fellowship and mentorship and friendship are to being a patient advocate, especially in those first few steps of getting started. Yolanda, do you want to start us off?
Yolanda 17:15
For me, mentorship is very important. Mentors offer insight into things that I’m going through, that I need help with. And their experience is invaluable, because this is still new to me, still, and they can, like I said, offer their insight and help me through the tough situations and make the road a little less bumpy for me. And not walking the road alone is comforting, and it makes it not so lonely, and there’s power in community. Just as you saying, “there’s power in that,” I get strength in that, and it’s very important. So, I’m grateful for that. I have a little community of my advocacy, and at the OAC, there’s people that I can call and connect with, if I have questions. And I’m grateful for that. I had questions; I was offered to sit on two local boards, a Medicare and a Medicaid board. I wasn’t sure if I was able to do that. A little bit of imposter syndrome was coming in, but this was an opportunity for me to do advocacy work, at the local level, and make change for people, who are experiencing the chronic disease of obesity, and I just needed that little wisdom from a mentor, whether or not if I’m ready for this, and I was able to speak with Crystal from OAC, and she says “Every bit helps, and everyone needs a place at the table.” So, that was the little push that I needed, and I accepted the positions, and I’m glad I did. I feel like I’m making a real change. And yeah, mentorship is important, and I’m glad I have mentors, and one day, I hope to be that to someone else, so you pass it along, and it’s a chain, it’s giving, it’s natural order, I think. In this community, that’s what it’s supposed to be. So, mentorship is very important, and I hope to do it for someone else one day.
Erik Stone 18:57
Thank you for sharing, Yolanda! Judy, why don’t you go next?
Judy 19:00
So, I considered myself very fortunate, because I had a lot of mentors from the very beginning. They led me on the path to being confident, that I was going to be able to live with this disease. You have to trust your doctor. If you don’t trust your doctor, then you’re going to have a lot of trouble dealing with your illness. So, the nursing staff, everybody involved with your journey, makes a big difference, and you have to be self confident that you can do everything that they ask you to do, and be able to speak up, if you’re not comfortable with what it’s doing for you, because they’re trained to help us, and that’s your first line of defense. From there, that mentorship helped me immensely, and I went full speed at that. And I did the research, I’m signing up before my patient portals at all of my healthcare facilities, and I read all my reports before I even see the doctor for a follow up. So, you have to be prepared. That is a relationship that, that is probably even greater than a marriage. It’s, hopefully, it’s a good marriage when you’re with a good doctor.
Erik Stone 20:19
Jody, I’ll pass it to you next. How important is mentorship to your experiences with patient advocacy?
Jody 20:25
Mentorship is what kept me in advocacy. Like I said that first time I went, I was a little scared, but after that, a lot of the agencies that you work with, they do provide you training before you go into any type of a session, but it’s what happens after – you strike up this friendship, and I’m the new person, and your eyes are aglow because you’re like, “Oh, look at this person. They’re talking with such ease, and they understand,” you know, and everybody’s listening to them, and they’ve been doing it for maybe 10 years, 15 years. So, after the meeting, I would strike up friendships with these people and do it, just a wealth of information. They tell you, “You can do it!” You need their assistance, they’re the people you can call. We have this issue in Massachusetts, and I just can’t figure out how to write this letter. Well, they’ll help. They’ll read the letter for you and say, maybe you should word it this way or that way. And it’s almost like a professor or student relationship. I think it’s vital. You can never learn enough, so, no matter how many people, and even now I’m doing it, probably eight years solid of advocacy, now, I’m at the point, where if I go to a meeting, they’ll send a new person in with me. But there’s nothing greater than when I post something online, one of these people that I thought were my mentors will say, “Great job, Jody!” And I’m like, it’s like a pat on the back from the professor, you know. So, I think it’s very important to have a mentor, and it doesn’t even have to be somebody within your own part of the arthritis, psoriasis society. But when you go to this advocacy events, you’re not just with that group. You’re meeting advocates from around country, around the world, all different groups, and you learn from all of them. So, mentorship is vital to any successful advocacy program.
Erik Stone 21:58
Thanks, Jody, those are really powerful words. Alicia, I’ll turn it to you now.
Alicia 22:02
Sure, thank you. I do believe that mentorship is very important, just kind of bouncing ideas off of each other and kind of a guide, just because you know when you’re new to it, you’re not really sure, really what you’re doing. So, I’ve had several and been inspired by people, kind of learning what it’s all about, and even just someone, to be honest with you, and even if maybe you’re doing something a little wrong, or maybe not necessarily wrong, but something that could be better than just kind of showing you the ropes there too, because you’re in it to grow also. So, you know, I’m fully open to learning a new way of doing something, I’ve learned better ways of doing things too: learning better word choices for things, maybe even seeing some of my own biases and things, and learning and growing too. So, that’s been really nice, and someone who has been living that topic, in that area, for a lot longer, with more experience is the perfect person to kind of show someone the ropes, and I think the mentor is a perfect person for that. So, I’m really grateful, and I think it’s a really important part of advocacy.
Erik Stone 23:08
Wonderful! I will pass it to Kendall, for our next topic.
Kendall 23:12
Thanks, Erik. Yeah, we’ve talked a lot about that warm, fuzzy feeling, that Erik mentioned, that you get with advocacy. It’s fulfilling, it’s inspiring, but sometimes it can be a little bit challenging. So, I’m curious, how did you overcome the frustration of how slow advocacy work can be sometimes? Let’s start with Yolanda.
Yolanda 23:34
I haven’t actually overcome that yet. That’s something I work on every day, and try to enrich and improve my processes around that, but I found that again, that community, advocacy community, is the foundation of everything, and being able to refer back to people who have been doing this and how I’ve done it, and know the process, and that is so valuable and important. So, I refer back to my advocacy community, they helped me get through those times, when I think, “what is the point? Or am I really making any progress? Am I really helping?” So, sticking with that community, referring back to that, is important for me to continue this work.
Kendall 24:11
Thanks, Yolanda. That was very beautifully put. And I love the idea of reframing, rather than overcoming, you know, as a means to an end. So, let’s pass it to Alicia. Alicia, how do you overcome any frustrations that might come with advocacy work?
Alicia 24:27
I just try to focus on the positive and just look at the silver lining, and just remind myself of what went well and not get frustrated with what didn’t. And just make adjustments and shifts and just keep going. But yeah, I’m just, definitely, stay motivated, positive, and know that good things take time and patience.
Kendall 24:52
Thank you for that. Jody, what about you?
Jody 24:54
When I first started advocacy, maybe the first year or so, I was naive enough to think I was going to go in, ask for something, they’re going to say yes, and that was it, and the bill was going to be paid, and we’re done. And it started to get frustrated. And then in the Commonwealth of Massachusetts, they have this program called Citizens Legislative Seminar. And my senator, said to me, “I think you should go to this.” You have to be referred by a state senator. It’s a two day program at the State House, run by all the senators, and they explain to you what the Senate’s about, how bills are passed, and all this stuff. So, one of them was a real hearing, and we had one bill that they were working on. It had 160 amendments. And I remember to this day, I’m like, “How can you do anything else?” They’re like, “We can’t. It’s going to take us three days, just to get through this one bill.” So, from that day forward, I always had that in the back of my mind, that everything takes a long time, because it’s a process – It’s not just a one step job. And now I consider every single step along the way important. Maybe I’ll go in for a hearing, one day a meeting, and they won’t pass it, but they heard my story. The next time I go in, they remember who I am, they remember my story. So, I consider every single step along the way important. And then, of course, the end result is the best. But it may take a two years. May take one of the things, Massachusetts, six years. But along the way, we informed a lot of people, educated a lot of people, so I don’t really get upset about the length of time. As long as people are listening to us and hearing our stories, I think it’s important!
Kendall 26:17
Absolutely, thank you so much, Jody. What about you, Judy?
Judy 26:20
Once you become enveloped in the advocacy world, I do believe that you learn patience as you go. There are times when you feel frustrated and you just have to move on to the next challenge. It’s really up to the patient themselves to make a change, if you’re dealing one on one with patients. Legislations, as we all know, that takes forever, and I can tell you that when I went with the Global Healthy Living Foundation, to support the bill for biosimilars in Ohio, that was about 12 years ago, and to this day, biosimilars are still not available, in Ohio. What they had told us was, “The bill passed and it was signed by the governor,” but then months later, we heard that it was held up because the State Medical Board had to put everything together, the parameters for coding and billing and pricing. And we thought, “Okay, that’ll take a while.” So, months go by, and the next reason they had was that, “Now we have drug companies that are challenging each other over who’s going to have distribution rights in the state,” and I wanted to be one of the first to get the biosimilars, when they were available. They’re still not available. So, years and years and years can go by before something good happens. And like grandma always said, “Patience is a virtue,” yeah, and sometimes you just have to wait it out. But the rewards are so awesome!
Kendall 28:03
Absolutely! Thank you so much, Judy.
Erik Stone 28:05
To wrap up our episode today, I’d love to know to those who are listening right now, who are considering starting their own patient advocacy journeys. What’s one piece of advice that you would give them? And let’s start with Judy.
Judy 28:17
Find the organization, that is connected to your chronic illness, participate in their advocacy programs that they have available, reach out to other people, who may already be involved with organizations, and once you make that first step, you will never go back. It’s so rewarding!
Erik Stone 28:38
Perfect! Yolanda, what about you?
Yolanda 28:41
I would give the advice: you don’t need to rewrite the whole playbook. There’s people out there who’ve been doing this, who know how it works, in the best ways to approach it, not that what you’re bringing to the table is not important, because your innovations are important as well. You could bring a new spark to the whole cause, but you just don’t have to start from scratch. There are things that are being done, that have been done previously, so you don’t feel that overwhelming need to figure everything out, because there’s things in place already. So, that gives you time to focus on how you can best use your gifts and talents, to further the cause that you’re interested in advocating for.
Erik Stone 29:16
Very inspiring, Yolanda, thank you! Alicia, what about you?
Alicia 29:19
My advice would be that, if this sounds just even remotely interesting to you, I would just try it. Advocacy is really needed. It’s a really powerful tool to bring change, and I think you would most likely surprise yourself and be really happy that you did try it. I know, I was really surprised by how much confidence it gave me and how much joy it brought to my life. So, I really would encourage you to give it a try.
Jody 29:46
Just the fact that you, may be thinking about advocacy, means you already have that little spark inside of you. But don’t be afraid to start small; you don’t have to start out your first year of being on two boards and going to cabinet for four times a year, and being on steering committees. You can start out with simply joining an advocacy group and signing on to send letters to your legislators, or going to a local event that there might be, and just speaking to other patients. You can start small, and patient groups are definitely the easiest gateway to it. But as Yolanda said, you get so much out of it, that you never expected. You almost feel selfish. And you know, I was doing this for everybody else, but it just makes me feel so good inside, to do this. And I have never heard of anybody who started advocacy and said “I got nothing out of it. I’m never going back.” You always get something out of it. But don’t be afraid to start small. If that’s what’s holding you back, there’s something out there for everybody, so just give it a try. You won’t be dissapointed!
Erik Stone 30:42
That’s wonderful, Jody!
Erik Stone 30:45
Thank you all for joining us today. This has been such an inspiring discussion, and I want to thank you each individually, for sharing your stories with us today. I think we had some really great stuff.
Judy 30:56
It was nice meeting all of you. We’re all in this together and together, we are stronger.
Jody 31:02
Thank you, for this opportunity today to talk about advocacy, because I never want to stop talking about advocacy. And today’s a perfect example of the community I didn’t know these other three advocates before today and now is three more advocates, that we’re all friends. Thank you.
Alicia 31:16
Thank you, everybody. It’s really nice meeting all of you. And thank you Crystal again for inviting me to be a part of something again. I very much appreciate it. And thank you to Erik, Ben, and Kendall for helping out today. Appreciate that.
Erik Stone 31:31
And thank you to my co-host, Kendall Griffey from the Obesity Action Coalition, it’s been wonderful facilitating this discussion with you today.
Kendall 31:38
Yes, Erik, it absolutely has. And thank you to each of these advocates. It was incredible, hearing your stories and sharing your insights. So, appreciate it so much.
Erik Stone 31:48
We hope you enjoyed this special episode of “the Health Advocates,” a podcast that breaks down the major health news of the week, to help you make sense of it all. And before you go, click on the link in the description to join our 50 State Network, so you can make a difference and join our amazing team of advocates. If you liked this episode, give us a rating, write a review, and hit that subscribe button, wherever you listen. You can listen to all of our podcasts at ghlf.org/listen. Once again, I’m Erik Stone, and join us for our next episode of our Advocacy Training Series.
Narrator 32:17
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation Podcast Network.
Addressing Obesity: Kevin’s Story of Change and Advocacy
We’re joined by Kevin Stephens, a weight loss surgery patient, and an active advocate with the Obesity Action Coalition (OAC). In this episode, we learn about Kevin’s struggle with his weight since childhood and the many health issues that come along with obesity. We talk a lot about the importance of health insurance coverage and reducing barriers to accessing treatment.
Addressing Obesity: Kevin’s Story of Change and Advocacy
Zoe Rothblatt 00:00
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to “The Health Advocates,” a podcast that breaks down major health news of the week, to help you make sense of it all. I’m Steven Newmark, Chief of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
and I’m Zoe Rothblatt, Director of Community Outreach at GHLF.
Steven Newmark 00:21
Our goal is to help you understand what’s happening in the healthcare world, to help you make informed decisions to live your best life.
Zoe Rothblatt 00:27
And today, we’re joined by Kevin Stephens. I’m really excited for you all to hear from Kevin. He’s a weight loss surgery patient and an active member with the Obesity Action Coalition. He advocates for people living with obesity, and he struggled with his weight since childhood, and he’ll share today with us his journey and a lot about the importance of health insurance coverage and access to treatments.
Steven Newmark 00:50
Great. Well, I’m excited to have a listen.
Zoe Rothblatt 00:53
Hi Kevin. Welcome to “The Health Advocates!”
Kevin Stephens 00:55
Hi. Thanks for having me.
Zoe Rothblatt 00:57
Awesome. We’re so excited for you to be here. I got introduced to you through Obesity Action Coalition. But why don’t you start off by introducing yourself to our listeners.
Kevin Stephens 01:05
Hi everyone. My name is Kevin Stevens. I live and I work in Riverside County. I’m a weight loss patient and an advocate for the OAC. I manage a Human Services Office. I oversee the Medi-Cal and the CalFresh programs. CalFresh is also known as a snap in some states, it’s a food stamp program, and Medi-Cal is an insurance for low income and disabled individuals.
Zoe Rothblatt 01:28
Yeah, that’s awesome, that you do so much related to health and also have your own personal journey. So, maybe just diving into that a little bit more. How did you get involved with the OAC?
Kevin Stephens 01:38
Well, I got involved with the OAC; I go to a lot of weight loss conferences, like Obesity Health and things like that. And I discovered the OAC online, and I saw they were very like, policy driven, advocacy driven. In my tenure at Riverside County, I worked in policy for several, several years, and I used to go up to Sacramento, and we would review the bills and things like that, that was related to Medi-Cal and how it affected County. And I’ve always been curious on why we do the things we do. And I really, I saw the website of the OAC, and I really liked how it was presented, and they cover the treatment of obesity, rather than just, oh, this is a weight loss surgery conference, or this is for people who’ve had that gastric bypass and things like that. It was a different type of conference, and I, it was in Washington, D.C.. So, I took a little vacation. Whenever I go on these conferences, I turned them into like little mini vacations. And I went up to the conference for the OCA in Washington, D.C., and it was very enlightening. So, I trained and became an advocate as well, and that led me to have the great opportunity of going to Washington, D.C. again, to talk to the lawmakers about my story.
Zoe Rothblatt 02:44
I’m wondering what it was like. You know, you mentioned, you did policy in your work life, and then you also had this experience with policy. Like, what was that like? I guess, like tying in, like the personal and professional little bit and like, did you see differences in the work you do with Medi-Cal and snap versus the work you’re doing in D.C. with TROA.
Kevin Stephens 03:03
I started with Forsyth County about, it’ll be 26 years this year, and I’ve always been in Medi-Cal. I was a Medi-Cal eligibility they call it eligibility worker or technician, and we review customers cases, we approve them, and we try to get them put on Medi-Cal. So, I’ve always done Medi-Cal, and it overlaps, because sometimes you have to work with the customers. Sometimes certain customers, you have to kind of advocate for them when they’re having difficulties getting their benefits or what have you, and you have to teach them and things like that. But in the policy part of it, when I became, I was a program specialist for several years, and that job involved going up to Sacramento, once a month, for meetings, representing Riverside, and we talked about various bills, how it’s going to affect our county. So, that’s the part I was really interested in. So, when I became part of the OAC, and I was talking to some of the members, and I was telling them my background, they said you probably would really want to consider becoming an advocate, because, you know, we go not only to D.C., but we advocate locally, probably represent California and things like that.
Zoe Rothblatt 04:04
And you answering my question, I realized I, like, skipped such an important part of this. But like, what is your patient journey? When did it start? Like, how did you get to where you are today? We talked about, I guess, your advocacy journey, but what’s your patient journey been like?
Kevin Stephens 04:19
My patient journey – It started off early, I’ve always had a struggled with my weight. I’m always going to live with obesity, and I always struggled with my weight, and I started recognizing it at a very young age. I noticed every year in my school pictures, I was always getting a little bit heavier or a little bit chunkier or what have you. We don’t like to use the word that…I started noticing it. People would tell me every year, at the end of the school year, “Oh, Kevin,” oh, after the summer, you know, you lose a little you know, you’ll be a little smaller, you lose a little weight, things like that. And it really was brought to my attention when my mother took me to Weight Watchers when I was in the fourth grade. In the fourth grade, I went to Weight Watchers, and when I got there, one of my classmates was there, and we both, like, looked at each other, and we were both, like, mortified. So, I think I went back to one or two more sessions, and I never saw her there again. We never talked about it.
Zoe Rothblatt 05:06
It’s like the silent pact of, “we’re not talking about this.”
Kevin Stephens 05:10
Yes, that’s exactly what it was. I didn’t really get teased too much during school, elementary. I mean, it was some teasing here and there, and, you know, they call it bullying and stuff now. I never thought it was that extreme. I was able to physically do a lot of things for the longest time, and I didn’t really let the weight bother me until I got into my late 30s and late early 40s, I started developing a lot of health problems. I had sleep apnea; I was falling asleep in the middle of the day at work. Real close friend of mine, a co-worker, she would just, on the other side of the cubicle, she would go, “Kevin!” and I “What?” And she goes, “Oh, nothing.” I said, “Oh, okay, thanks.” And that was like our little signal, Kevin, you’re like, snoring. And I said, you know what’s going on, why am I falling asleep all the time? And then, um, I was just having, my blood pressure started going up, I was pre diabetic, and I was actually, technically, I look back at my numbers, I was diabetic for a short period of time. It just things like that. Then I was not able to do certain things that I wanted to do. I had to, for example, like for work, I would have to to go back and forth to Sacramento. I would have to fly, obviously. And after that, one day or two day trips, and I said, “Well, I don’t mind going. I would love to go, but you might have to buy another seat for me on the plane.” And my supervisor and my manager, they were awesome. They said “that’s no problem, it’s part of your job. We’ll do it.”
Zoe Rothblatt 06:22
Wow, that’s amazing. I imagine, like, that was like, a hard conversation to go into. So, to get that response, probably meant a lot.
Kevin Stephens 06:30
It meant a lot to me, and I’m close to these individuals to this day, and I think maybe a few opportunities slip by me, or I was bypassed because of my weight, a few. Because I’ve been very successful in my career, so I don’t really want to use that as a crutch or anything like that. I have no regrets, in regards to my career, and I guess I’ll fast forward to when I had my gastric bypass surgery. They basically go in and they reroute your intestines so you want to Sorb the food as fast and like the fat and all that stuff. And they also make your stomach almost the size of a little egg. Goes from being a little bit, not as big as a football, but down to a size of an egg. And obviously, you know, you’re gonna loose weight. And I did. My heaviest, I was at 417 pounds, and I got down to about, my lowest was about 198, so I lost about 220 pounds, roughly, or a little bit over that. That was in 2011 and my life really, really changed. I didn’t have to get the extra seat on the plane, my sleep apnea went away; I didn’t have to do the CPAP anymore, which I hardly ever use. Because if you’re familiar with the CPAP, that’s that machine they put on your face, and you have, like, this oxygen thing. It’s not really oxygen, it’s just air. You’re getting constant air throughout the night; It’s loud, it’s cumbersome. I hardly ever used it. But the biggest thing that changed, like, I had a situation before the surgery, where I was at a restaurant with a friend, and we were in some, it’s like a little fast food restaurant outside, and I broke the chair. I ended up falling on the ground, breaking the chair; that was very embarrassing. Yeah, so I had the surgery, and it was successful. Then later on, in about six, six years now, I had some skin removal surgery around my abdomen and my chest, because after when you lose weight that fast, I’m older, I had a lot of excess skin that was left over, so they took care of that for me. So, my life really changed. But the biggest part of it all is that when I joined OAC and started getting educated on a lot of things, I found out I was educated, and I learned that Obesity is a disease. Is a chronic disease. It can be treated, you just have to find the right treatment program, which I did. But the biggest thing that I took from it, it wasn’t my fault.
Zoe Rothblatt 08:27
Yes! Louder, for the people in the back, “Obesity is a disease, and it is not your fault.”
Kevin Stephens 08:33
It is not your fault, it’s not your fault. And it clicked, because all my life it was always, why can’t I lose this weight? Why can’t I keep it off? I try to various diets, like I said, started with Weight Watchers and all kind of thing, the Atkins, this and that, another. And Pritikin, you probably don’t even remember that, or…
Zoe Rothblatt 08:50
I have heard of it, yeah.
Kevin Stephens 08:52
Okay, I’m 55 years old, so some of the stuff you probably not don’t even know.
Zoe Rothblatt 08:56
I’m younger. But unfortunately, a lot of the toxic diet culture has just prevailed…
Kevin Stephens 09:02
Yeah.
Zoe Rothblatt 09:02
…and passed down, yeah.
Kevin Stephens 09:04
Yes. I almost tried what Oprah Winfrey tried, back early in her career. And I don’t remember when she had that episode where she came out and she was in this all black and the jeans, and she lost all this weight, and she carried out a thing of fat, and she basically, it’s a all you drink is shakes for like, six or seven weeks. And obviously, you know, when you’re not eating, you’re gonna lose weight.
Zoe Rothblatt 09:22
But, like, I can imagine how much of your life deteriorates by just drinking shakes. How can you participate in your every day?
Kevin Stephens 09:30
Yes, and she even admitted she goes, you know, the next day after I started eating again, she started, she gained like, 10 pounds almost instantly. But when I realized that obesity, because the American Medical Association says that, you know, it is a disease, and when it started to fall and it was like a big burden was lifted off me, I said, “wow,” you know, because growing up and what have you, and even up till 40, I, the doctors never did address my weight. They said “he would grow out of it, he’ll get taller, he’s gonna play sports.” Well, I didn’t get much taller, and I didn’t play sports. And it’s been a journey. You asked me about the journey – it’s been a big journey. It’s been a challenging, but it’s been exciting, and I’ve learned a lot through it.
Zoe Rothblatt 10:07
Yeah, I’m amazed by the way that you’re able to look back at your journey with such clarity, like even saying, you know, you were successful at work, but there was still challenges. And just like defining things and calling it for what it was, probably is a huge part of, like, the healing journey. And then I wanted to highlight something that you said, like, in addition to obesity being a disease, you listed so many comorbidities, like the sleep apnea, the diabetes, like, I think people underestimate, like, how many health complications come along with obesity, and it’s often dismissed, but it’s making you feel bad in everyday life.
Kevin Stephens 10:46
Yes, and I don’t think I mentioned the turning point in regards to my health. I was diagnosed, my legs kept on swelling real bad, as I got to my heaviest weight. And I was going to all these doctors, and they were all saying, “Oh, it’s because of your weight. You need to lose weight. You need to lose weight. It’s probably something with your veins, you’re carrying extra water. We’ll give you some water pills,” and all this stuff. Then finally, I found a great doctor, and he goes, “You know what, Kevin, you have what we call lymphedema.” I said, “What’s that exactly?” He said, well your lymph nodes and your legs are damaged, and once they’re damaged, they it’s permanent. It’s you can’t replace them. You can’t they won’t come back.” I said, “Wow.” So, the first thing is, in my mind, am I gonna lose my legs?
Zoe Rothblatt 11:21
No, that’s terrifying.
Kevin Stephens 11:24
Terrified thoughts, yes, I was gonna have to get my legs amputated. He said, “No, no, no, you’re not gonna lose your legs.” I said, “Well, did this? What did my weight cause this?” He said, “I’m not gonna say it did or didn’t, because I don’t know. No one will ever really know. I just know that you obviously have been to a third world country, so you didn’t catch any parasite or anything like that, and you don’t have you’re not a cancer patient, so you didn’t get it from chemo or anything like that, or from cancer treatment, obviously. So, your weight probably did contribute to it, but it’s not like you’re gonna lose your legs and you’re gonna be able to walk, but you can treat this and you can losing weight will probably not reverse it all the way,” because mine isn’t too bad. It’s really, people don’t even really notice until I, like, point out. It’s mainly, primarily, in my left leg. And he said, “losing weight will be, I do recommend you lose some weight, because it’ll help,” and that’s why I went forward with the gastric bypass, because, like I said, I tried everything and it just couldn’t. But yeah, like you said, it’s a lot of issues with your health because of obesity.
Zoe Rothblatt 12:16
And in thinking about, like, the decision to have the surgery and that turning point, and then also, you know, tying that into what we were talking about before with Troa and access and the importance of that. How, like, easy or difficult was it for you to access the needed treatments, like, once you decided, in that turning point that you were going to, you know, tackle this head on?
Kevin Stephens 12:37
Well, in 2004, I had my gallbladder removed. And the doctor, the surgeon, said, “You know what, while we’re in there, we can have you ever heard a gastric bypass?” And I said, “Yeah.” And he goes, “would you want to consider that? Because, you know you need to lose this weight.” And I said, “No.” I said, “I can’t do that.” And I talked to one of my close friends at work, and she goes, “why didn’t you do it back then?” I said, “No.” I said, “I’m not doing that.” I go, I can’t imagine my life without being able to eat a ribeye steak. That’s how, I want to say, stupid I was, but that’s the first thing that popped out of my mind was, “I won’t be able to eat I’m not gonna do this to myself.”
Zoe Rothblatt 13:11
I think it’s like important to go through all those thoughts before you make a decision, you know, like, what are the risks, benefits? How does it impact my daily living? Totally, I’m with you.
Kevin Stephens 13:22
And what I learned, I wasn’t ready to have it in 2004. So, fast forward to 2011, when I found out about the lymphedema, break the chair. Oh, it was a situation where I fell on the floor and I couldn’t get back up. My surgery, I was lucky, it was covered by my insurance. We’ll probably talk about, a little bit more about, that later. But yeah, I was covered by my insurance, so I didn’t have any issues getting surgery. I had to go through like, a three month class, and they teach you about nutrition. You have to have a psych, a behavioral therapist who will come and give and, basically, they give you five questions: they ask you, “oh, are you good spirits? Are you this? Are you that? Why are you losing the weight?” So, you’re not gonna say, “I’m losing weight because I’m gonna be in a wedding next week.” You know not to say that; a smart person knows not to say something like that. You say, “I want to lose weight because I want to be healthier and ….” So, you’re out there in five minutes, and I go, “What is this?” They could do have just done this probably over the phone. But anyways, I got approved for the weight loss surgery. So, fast forward to just last year, actually. And you know, all the GLP-1 drugs, all the new treatment programs they have for weight loss, and I’ve been to a lot of conferences, and we talk about regain because, you know, I told you, I lost 120 pounds, but throughout the last three years, and I don’t want to blame it on Covid, because I started gaining it right a little bit before Covid. I gained about 35-40 pounds. And I said, I’m having this regain, the weights not coming off as fast as it did back then, obviously. And I’m exercising. I’ve been watching what I eat, but I’m still having issues. So, then all this talk about these drugs came out. So, I went to my physician – one is prescribed when you have diabetes. So, I was basically, because of my weight gain, my A1C, that determines if you’re diabetic or not, was gradually increasing, but not, I wasn’t diabetic, they said pre diabetic. So, I said, “Well, I’m pre diabetic.” “Well, I only give it to my diabetic patients.” I said, “Well, what about the other one?” That’s the same thing, but it’s for weight loss. It’s branded for weight loss. He goes, “Well, you need to talk to your weight loss specialist about that.” And I said, “Okay,” it was very dismissive, and I was very, I don’t know, I just the minute I, the conversation turned to those drugs, it was like he started acting weird. And I really mean, it’s just like he was, wasn’t like the same doctor I’ve known all these years.
Zoe Rothblatt 15:20
Yeah, especially because he knows your history and like the struggle and how far you’ve come, and you know how much, like, regain, could impact your journey, physically, mentally, yeah, I’m so surprised. Like, yeah, you want an advocate alongside you!
Kevin Stephens 15:34
Correct. So, then he finds this something that really just, oh my goodness, I every time I tell this story, it just really has an impact on the people in the room, but we go through it a lot in the weight loss community, he told me, “Well, you already took the easy way out years ago.”
Zoe Rothblatt 15:49
Oh my gosh!
Kevin Stephens 15:49
You just need to stop eating as much and exercise a little bit more. I was so, like, devastated and disappointed in him. I didn’t even, like call him on it, which I should have, I know as an advocate, I should have called on it right then and there. But when it happens to you, people told me, Kevin, “when it happens to you, it’s easy to know what we’re gonna do, when we’re gonna do it, how we’re taught to do things, but when it happens to you, you never know how you’re gonna take it.”
Zoe Rothblatt 16:09
For sure, it’s shocking! Also, since when is a major surgery, easy? Like…
Kevin Stephens 16:14
Yes!
Zoe Rothblatt 16:15
What!?
Kevin Stephens 16:16
So, I said, “Okay.” So, I was so, like, angry, and man, I said, you know what it was like late September/October, and I said, “I’m just gonna do an open enrollment in November. I’m just gonna switch providers and get a new doctor to start all over again,” which I did. And then I got my new doctor, he’s great. He immediately prescribed it for me, the diabetic one. And then I found out the hurdles that I’ve been reading about and hearing about – It’s an insurance company. The insurance company denied it. I’m looking on my phone. My pharmacy is attached to my phone. I get the thing, oh, it’s been denied. I called it, “Oh, yeah, we deny it. You’re not diabetic, you’re pre diabetic, but you’re not diabetic. So, it’s been denied. And it’s in our, if you read our…” I forgot what they call it.
Zoe Rothblatt 16:54
“The explanation of benefits.” Maybe?
Kevin Stephens 16:57
Thank you! That’s what it is. I said, “Okay, well, I can’t really, probably do nothing about that. It says this in writing. I can’t do it, and I understand, you know, policy.” So, I said, “Okay.” So, I went back to the doctor, two weeks later, I said, “they denied it.” “They denied it?” I go, “Yeah, yeah,” “We’ll try the other one then.” Two days later, denied. And it’s for weight loss, “Yeah, we do cover it, but you have to take a nutrition class and …. for six months, and then we’ll…
Zoe Rothblatt 17:20
Wow!
Kevin Stephens 17:20
…reevaluate. I said, “Well, no, I’m still considered obese through the BMI,” which, that’s a whole another story.
Zoe Rothblatt 17:25
Yeah.
Kevin Stephens 17:25
You know, you lose all this weight, and they tell you you’re still obese, but um. And I said, “Okay, wow.” I changed insurance companies, and I’m still going through this, like, struggle, but I see the struggle is real. I always heard about it happening to others, but now it’s happening to me. And I would talk to co workers and other friends, and they said “I was able to get it,” like, I go, “Are you diabetic?, “No, I’m not diabetic. My doctor got it. My insurance company paid for it.” So, I realized that insurance has a lot to do with it.
Zoe Rothblatt 17:47
And were you able to get it in the end?
Kevin Stephens 17:49
No, I haven’t got it yet. I still, I’m in my, in August, I’ll be done with my six month program. I joined this online program, which they said I could join. It was sponsored through my insurance, and I, they put me on some type of eating plan. It’s a diet, but basically it’s similar to a Keto, almost diet. It’s low carb, high protein, and all the stuff that, I, they’re trying to teach me, I’ve been through all that before.
Zoe Rothblatt 18:11
Right. I’m thinking like, that’s so frustrating after your entire journey, you named all the diets you’ve tried, you’ve had the surgery, like, you clearly know what options work or don’t work, or what’s worth considering, and they’re making you step through…
Kevin Stephens 18:25
Yes
Zoe Rothblatt 18:25
…this program for six months, in order to try an option that you and your doctor both agreed would be beneficial for you.
Kevin Stephens 18:32
Yes, and I’m going to, like I said, in August, it will be the six months, and I might, I’m still considering, it’s just I haven’t had the time to really sit down, I have to draft it up. I might just go in and try to appeal the first denial, the denial I got a few months ago, and tell them all that I’ve been through all this. I had weight loss surgery, and then I’m suffering from regain, it’s proven that the weight loss drugs. And I just want to try it, I might not be able to stay on it. So, not everybody, like they talk about these drugs, but not everybody, they some people get severely ill, some people have a lot of, what you call it, side effects from it, but I want to have the option. That’s where I learned that the physicians, the doctors, they need to give patients options and let them decide if they want to go through that option or not, and then if that doesn’t work, try something else. But when you’re just blocked all together, it’s very difficult.
Zoe Rothblatt 19:16
Totally! All the time, I’m like, to the insurance company, let’s see, like, your medical degree, like, come on. You know, it’s like me and my doctor decided this, that’s what the specialist is saying. And you think you could come in here and just slap a denial after never, like, having met me or my doctor or gone to medical school.
Kevin Stephens 19:35
Yeah, but it’s a coverage. I, they send me a copy of it, and it says, we do cover it. However, you have to do this: your BMI has to be that, which is me, I’m fine. I meet all the criteria. You have to have some kind of illness, I have high blood pressure, still, I take medication for it, so it’s fine. So, I meet that criteria. But then all of a sudden, when you keep reading, oh, you have to join a nutrition program for six months and meet the criteria…. Because I haven’t done that yet, they wouldn’t prescribe it. But even after I do all this, it’s no guarantee they can come up with something else that I hear…
Zoe Rothblatt 20:04
Right, right.
Kevin Stephens 20:05
Ongoing – it’s like a circle forever, forever. And I guess some people are successful. They follow an appeal, and some people get it, some people don’t, and that’s where all this talk about bias comes into play. Because why are some people getting it? Some people aren’t getting it? So frustrating.
Zoe Rothblatt 20:18
Think it’s also so frustrating because, like, you’re an advocate in this space and you’re having trouble, and it just makes me think, like, so much about the people that, like, don’t even really understand what’s happening when they get these letters from their insurance, right? Like, it takes so much like, health literacy to just like, understand this.
Kevin Stephens 20:35
Yes, and that’s how I tied it to my job. People apply for, it’s Medi-Cal in California, which is Medicaid. It’s Medicaid, but it’s Medi-Cal in California. California always have to have a special name for everything, although there’s Medicaid, but we have to be Medi-Cal. But they apply for Medi-Cal, they get denied. And some people, they’ll file an appeal. “Why am I denied? Explain it to me.” Some people won’t do all that. They just like, “Oh, whatever.” And they just give up. And like you said, that’s how it is with this. Like some people, they just the insurance company won’t approve them. They’re not going to fight for. They don’t really know how to, they don’t even know where to start, and it’s sad that and they get away with not covering another person.
Zoe Rothblatt 21:08
So, what is your advice for other patients, like, either just for advocating for themselves in everyday life, or, I guess, larger scale advocacy like you do with OAC. How can people just like, I don’t know, feel like motivated to share their story like you do?
Kevin Stephens 21:22
You might want to start off by going to, if you’re a weight loss surgery patient, or you’re thinking about having the surgery, you might want to start off with, like, a local or online support group, and you start speaking there, like for me, for example, my advocacy really started, right after I had the surgery. It was like six months out when I lost a lot of weight at that time, at the very beginning, my physician that ran the support group, which also was the person who did our health maintenance classes, to prepare for the surgery, she called me, she asked me, she said, “How are you doing? It sounds like you’re doing real well.” This is another, “Would you mind coming and talk to the class?” So, I said, “Sure, I’ll come talk to the class.” You can bring bring a prop or something, like a old pair of pants or whatever. Just make it your own, make it personal. So, I brought my pants, because I used to wear a size 56 and then I was down to, like, a 34 or something at the time. And so I showed them, you know, the I could step in one of the pants legs. That’s how big I was. That makes you feel comfortable talking about your story. It makes you, I recommend that to start out small, like that. But if you really just want to jump into advocacy, go to the OAC website. They have a whole web page dedicated to advocacy and what you can do on the local level. It doesn’t mean you have to go out to Washington, D.C. and go up to Capitol Hill and talk to lawmakers. You don’t have to do all that. You can help with letters to your congressmen, things like that. And you can do things locally if you want to, for people to get involved with the advocacy.
Zoe Rothblatt 22:41
Yeah, I think it’s like, no active advocacy is too small. I love your suggestion. Just start off locally with what’s comfortable. On that note, Kevin, thank you so much for joining us today and sharing your story. I learned so much from you, and I really just want to reiterate the main point that you said that, “Obesity is a disease and it’s not your fault.” I think so many people need to hear that, and have heard opposite their whole lives, and I’m hoping a podcast like this can help reduce some of that stigma.
Kevin Stephens 23:10
I hope so too. Thanks for having me again.
Zoe Rothblatt 23:12
Yeah, and going off of that, it was a good reminder from Kevin that no act of advocacy is too small. I really appreciate that he encouraged people to just get involved locally and share their story however they can.
Steven Newmark 23:12
Well, Zoe, that was a really great discussion with Kevin. It was a reminder of how much work there is to do to reduce barriers and treatments, and advocate for a better insurance coverage, especially for the Medicaid population.
Steven Newmark 23:35
Yeah, and we hope that you learned something too. Before we go, we definitely want to encourage everyone to check out all of our podcasts at ghlf.org/listen
Zoe Rothblatt 23:43
Well, everyone. Thanks for listening to “The Health Advocates,” a podcast that breaks down major health news of the week to help you make sense of it all. If you like this episode, give us a rating, write a review, and hit that subscribe button, wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 23:56
I’m Steven Newmark. We’ll see you next time.
Narrator 24:02
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation Podcast Network.
Immunocompromised and Informed: Navigating Current Viral Risks and Heat
In this episode, we’re breaking down the current viral landscape, focusing on COVID-19, mpox, norovirus, bird flu, and pertussis. We will discuss the unique challenges these viruses pose to immunocompromised individuals and offer practical advice on how to stay protected from viruses during this hot summer. We also recap the recommendations from the recent ACIP meeting, the advisory committee to the CDC on vaccines.
Immunocompromised and Informed: Navigating Current Viral Risks and Heat
Narrator 00:00
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:06
Welcome to “The Health Advocates,” a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Chief of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Director of Community Outreach at GHLF.
Steven Newmark 00:21
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:27
And Steven, it’s been a while since we’ve done a check in on the latest and greatest with viruses roaming our nation.
Steven Newmark 00:34
Yeah.
Zoe Rothblatt 00:34
So, we thought this would be a good time for a midsummer check in to see where we’re at.
Steven Newmark 00:39
Yeah, excellent. We’ll also discuss the latest vaccine news and how you can keep safe for the rest of the summer and into fall. So, let’s get into it.
Zoe Rothblatt 00:47
Yeah, so I guess just to level set, before we dive into the specifics, it’s always helpful to say that things are better now, in Summer 2024, then each of the previous summers, especially better than Summer 2020. So, I’m grateful for that.
Steven Newmark 01:01
Absolutely. So, I feel like that’s a caveat to the entire production here today. All the negativity we were about to put into the ether. It’s better than it was.
Steven Newmark 01:10
Let’s say you’re supposed to like sandwich like bad news or feedback with two bits of good news. So, that was that was me sandwiching. Well…
Steven Newmark 01:18
There you go!
Zoe Rothblatt 01:18
the bottom half of the sandwich. Yeah.
Steven Newmark 01:20
Yeah, let’s see it!
Zoe Rothblatt 01:21
So, COVID…
Steven Newmark 01:22
COVID. All right. Well, on the downer, COVID cases are once again rising across the country. Of course, they’re rising in relation to the low levels, that we’re becoming accustomed to. Positive tests, emergency department visits, hospitalization; the mean markers that the CDC uses to gauge virus activity are all rising, especially in seniors, and especially in Western states.
Zoe Rothblatt 01:42
This is a pattern though, that we’ve seen, traditionally, in the summer in the U.S. every year, especially around July 4th travel. So, it’s not too surprising. And like you mentioned, it’s like, while case rates are rising, it’s still a low level, because it’s in relation to the low level that we’ve been seeing. So, it’s not like at a scary point.
Steven Newmark 02:01
Yeah, I just want to note that Hawaii, in particular, is showing high levels of COVID-19. So, to our friends on the islands, we ask that you stay safe.
Zoe Rothblatt 02:08
Yeah. Shout out Hawaii, stay safe out there!
Steven Newmark 02:11
And there are some new sub variants. We’ve all become mini virology experts, at this point. We know that viruses mutate, and Omicron has continued to do so itself.
Zoe Rothblatt 02:20
Yeah, well, it’s like hard to keep track of all these names, I guess, like the biggest point to make about this sub variant is just that experts are closely monitoring it so that we can tailor the vaccine to be, like, most effective towards the newest variants.
Steven Newmark 02:34
Right! You mentioned July 4th travel, that the spread is possibly also caused by the heat, it’s kind of like the reverse of what we deal with in the winter. “Ahh it’s been so Gosh, darn hot out this summer,” that many folks are hanging out inside for the air conditioning. So, of course, viruses spread more easily indoors, which is why we often see a spike in infections, as I mentioned in the winters, when folks had indoors to avoid the cold. So, they’re doing a lot of that now to avoid the heat.
Zoe Rothblatt 02:57
Right! Who wants to do a picnic outside in 92 degrees with humidity, when you can sit in the nice AC.
Steven Newmark 03:03
Totally! Who wants to go out and get the mail even? Sheesh.
Zoe Rothblatt 03:06
Yeah.
Steven Newmark 03:06
It is absurt out there.
Zoe Rothblatt 03:08
But unfortunately, that makes it hard for social distancing, or extra…
Steven Newmark 03:12
Right.
Zoe Rothblatt 03:13
…precautions that you’re afforded outside versus inside.
Steven Newmark 03:16
Totally. I mentioned Hawaii earlier; Hawaii had a small COVID wave this past winter, which likely means less immunity for its residents. And that could be a factor in why COVID has just been spreading more easily over there. Will this continue to grow? Who knows?
Zoe Rothblatt 03:28
And I’m not sure if you know this, but also is it like more challenging to get a vaccine over there just by the nature of, like, travel from some of the islands to health care places?
Steven Newmark 03:39
That’s a great question that I do not know the answer to. Let’s put a pin in that and get an answer before we get to the end of our show. Maybe if not, we’ll get an answer for our next show. I don’t know the answer to that. I mean, obviously, you know, it goes without saying that anywhere in the world, anywhere in the United States, the more remote location you’re in, the less access you have, generally, to healthcare and then healthcare facilities. So yes, that stands to reason that if you’re in certain parts, certain islands, you’re going to have less access, generally.
Zoe Rothblatt 04:05
Yeah. Which could contribute then to the less immunity. Like you said there was a smaller wave in the past winter, and then also just by nature of access to vaccines.
Steven Newmark 04:16
Yeah, absolutely. And just as a reminder, as you mentioned, I think the FDA is recommending an updated formula to target these newer mutations. And we’ll find out what’s coming, vis-à-vis, new vaccines for the fall in the coming weeks, and we’ll be sure to keep everyone updated. Hopefully, a formula targeting the current mutations will be made available soon.
Zoe Rothblatt 04:33
Yeah, that’s exciting. And I think we mentioned in a previous episode that they’re working on a combined shot flu and COVID. It won’t be available for this season. But I feel like that’s still on my mind, as like, as we hear about more vaccine news to keep learning more about that too, because that would be fun.
Steven Newmark 04:49
Yeah, that will be great. All right, well, M-pox, it’s still around. Monkeypox cases in New York City, for example, are four times higher than they were last year. However, that’s still lower than it was in 2022.
Zoe Rothblatt 05:01
And I guess the good news is that the U.S. has a less severe strain that’s dominant. So, I guess it’s just like not such an active threat, per my professional opinion as an advocate.
Steven Newmark 05:13
Yeah, exactly. Moving on, Norovirus. Cases are increasing and Norovirus, very important, can be stopped with handwashing. So, make sure you’re doing that.
Zoe Rothblatt 05:22
Yeah, this is an ugly stomach bug that can really take a toll on you and it is not fun. So, definitely, handwashing is greater than spending your night or few days in the bathroom.
Steven Newmark 05:34
Definitely! Pertussis, or whooping cough, is increasing in pockets of the country, like Kentucky and Delaware. Over in England, cases reached a record breaking level, recently of whooping cough. This is preventable with a Tdap vaccine. So, be sure to get that Tdap vaccine, every 10 years.
Zoe Rothblatt 05:49
Yeah, that’s a good public health call out reminder, like check your vaccine records. I was due for it recently and just like kind of came across that by accident, but good to stay on top of!
Steven Newmark 05:59
Yeah, you don’t want to get whooping cough. This isn’t 1800s.
Zoe Rothblatt 06:02
No, especially when you’re immunocompromised. I feel like I would feel quite lousy.
Steven Newmark 06:07
Totally. Measles has been detected in New York City. Vaccinations against measles offer a high degree of protection. Two doses of the combined measles mumps and rubella, the MMR vaccine, are 97% effective. So, just like we said, with the Tdap for whooping cough, make sure you’re up to date on your MMR vaccines as well.
Zoe Rothblatt 06:24
Yeah, I guess the bottom line with all of these is, like, there are viruses circulating like to some extent they’re circulating to a normal level, like norovirus comes I think like it has a peak season every year. Measles, like vaccines are so effective, like it shouldn’t really be spreading and we’ve seen it quiet for a long time, but it does pop up in communities. But just as a really good idea to be like talking to your doctor about what’s going around and make sure that you’re up to date on all of your vaccinations.
Steven Newmark 06:50
Absolutely! One illness that does not have a vaccination is bird flu. It doesn’t have one publicly available, is bird flu, few more poultry workers in Colorado have tested positive; all the cases are mild. Health officials continue to characterize this threat to the general public has a low and the virus, as far as, is known has not spread from person to person. It’s only spread from animal to human, not human to human.
Zoe Rothblatt 07:13
So yeah, that’s good news. And then I guess, not necessarily like a virus, but just thinking about the heat. Like what you mentioned before where I think most of the country is experiencing a heatwave, it’s really important to think about health in a time like this, because some of your medications can lead you to be more dehydrated, can cause higher sensitivity to sun; you get sunburned much easier than you would have otherwise, or just make it harder for you to stay cool, or contribute to you feeling lightheaded. So, just double check with your doctor on what medications you’re taking and how to, you know, just like stay hydrated, and cool, and healthy during this heat.
Steven Newmark 07:49
Yeah, here’s my language, “It totally sucks, this heat.” You know, in June, we’re getting emails or I was getting notifications on my phone, like “unprecedented heat. It’s June! It’s June!” I’m like, June is now part of the summer. Unfortunately, the summer is like forever now. This week, this particular week that we’re recording, this is like the fifth week in a row and I’m getting alerts on my phone, “Oh, the heat wave is going to be extended another day! The heat waves gonna be extended another two days! The heat waves gonna be…” I’m like, it’s not a heat wave, that’s the temperature! That’s the weather! It’s the summer!
Zoe Rothblatt 08:15
It’s true, yeah.
Steven Newmark 08:16
Unfortunately, we just have to deal with it. There’s no other way around it.
Zoe Rothblatt 08:19
Yeah, it’s like it’s not a wave. Speaking of all the viruses, like, makes me reminiscent of flatten the curve in two weeks, like, okay…
Steven Newmark 08:27
Oh, right!
Zoe Rothblatt 08:27
just another day. And it’s like, “Guys, this is happening. Like we have to just admit it.”
Steven Newmark 08:32
Right. First of all, it’s not just July and August. It’s June, July, August, September, for now. Someday, it’ll probably extend into May and October as well. But yeah, and it’s everywhere. I don’t know, maybe we should move to Greenland or something. But, until then we’re gonna have to stay hydrated. As you said, stay cool, stay hydrated as best you can. And definitely understand that it does cause lightheadedness, and it’s not fun to get heatstroke, it’s not fun to even just be out in the heat for extended periods of time.
Zoe Rothblatt 08:56
Yeah, I think it’s also it’s one of those that like, seems so obvious, like, “Oh, you’ve experienced a summer every year you’ve been alive. Of course, you know how to handle the heat.” But, it can really sneak up on you
Steven Newmark 09:05
Totally!
Zoe Rothblatt 09:06
Especially when you live with underlying illness.
Steven Newmark 09:08
Yeah, absolutely. It affects your decision making too. I read a study about how it affects your decision making. I’ve read another study how it actually reduces your IQ points, by being out in the heat for prolonged periods of time. So, you’re not playing with your 100% self when you’re out there for too long.
Zoe Rothblatt 09:23
Well, turning to our final bit of news, there was a recent ASIP meeting, that’s the committee for the CDC that reviews the vaccine data and makes recommendations. And like you mentioned at the top of the episode, they’re still determinations for the COVID vaccine. We don’t have the new formula yet, but they agreed that everyone six months and up should get the COVID and flu vaccines this year and that, for COVID, they should target the new variants of this JN 1 lineage.
Steven Newmark 09:53
Yeah, they also simplified recommendations for RSV, respiratory syncler…Ahh I can’t pronounce. Can you pronounce it, Zoe? Come on. Syncytial virus, well whatever, RSV!
Zoe Rothblatt 10:03
Yeah,
Steven Newmark 10:03
the RSV vaccine, they now recommend all adults, 75 years of age and older, to receive a single dose. Adults 60 to 74 should get a single dose of RSV vaccine, if they’re at increased risk of severe disease. And adults 60 to 74 are at higher risk, if they have certain chronic medical conditions, such as lung or heart disease or if they live in a nursing home or long term care facility.
Zoe Rothblatt 10:23
And the last bit of vaccine news from this meeting was that there’s a new pneumococcal vaccine recommended. So, this is a new 21 valent pneumococcal conjugate vaccine. So, the abbreviation is PCV 21. And it’s now an option for adults aged 19 and older. And basically, what that just means is that it includes some newer strains that are not contained in the current vaccine. And that it also, no longer contains certain sub variants that are like no longer circulating. So, really just an update.
Steven Newmark 10:54
Excellent. Well, so the bottom line is there are things out there that could keep you up at night, if you want. But of course, there are steps we can all take to live our best lives. Get vaccinated, wash your hands, take extra precautions as necessary when local cases spike. And stay cool and hydrated to prevent heat related illnesses.
Zoe Rothblatt 11:09
Great job packaging the positivity!
Steven Newmark 11:11
Yeah, there you go! Boom!
Zoe Rothblatt 11:12
There we go. Lots of public health measures to stay positive.
Steven Newmark 11:15
Absolutely!
Zoe Rothblatt 11:18
Well, I think you know, my next question, what did you learn today?
Steven Newmark 11:20
There’s a lot out there, but nothing that really should keep you up at night, is what I would say. That’s the learning.
Zoe Rothblatt 11:25
Yeah. And I learned from you a little bit more about what’s going on in Hawaii.
Steven Newmark 11:28
Well, we hope that you learned something too. And before we go, we want to encourage everyone to check out all of our podcasts at ghlf.org/listen
Zoe Rothblatt 11:36
Well, everyone, thanks for listening to “The Health Advocates,” a podcast that breaks down major health news of the week to help you make sense of it all. If you like this episode, give us a rating, write a review, and hit that subscribe button wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 11:49
I’m Steven Newmark. We’ll see you next time.
Narrator 11:55
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation Podcast Network.
Dr. Omole: Combating Racial Disparities in Health Care
In this episode, breast surgical oncologist and president of the Black Physicians’ Association of Ontario, Dr. Mojola Omole, joins us to talk about her advocacy work. She shares how she aims to increase the percentage of Black physicians in Ontario, reduce systemic barriers and racism in medicine, and support Black mental health. We also discuss the need for more robust data that accounts for racial differences to inform screening recommendations.
Dr. Omole: Combating Racial Disparities in Health Care
Narrator 00:00
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to “the Health Advocates,” a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Chief of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Director of Community Outreach at GHLF.
Steven Newmark 00:20
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:26
And today we’re joined by Dr. Mojola Omole, who is a Breast Surgical Oncologist and General Surgeon with the Scarborough Health Network in Toronto. She is president of the Black Physicians’ Association of Ontario (BPAO), a consultant for Anti Black Racism and Anti Black Oppression Training, Chair of Specialist Issue in the CMAJ on Anti Black Racism and Medicine and Chief Medical Officer. She also hosts a biweekly podcast with the Canadian Medical Association Journal and her podcast explores the intersection of scientific advancements and social health issues and find voices of patients, clinicians, and advocates.
Zoe Rothblatt 01:02
Welcome to the Health Advocates, Dr. Omole!
Dr. Omole 01:04
Thank you so much for having me.
Steven Newmark 01:06
Can you start by introducing yourself to our listeners, your background, and what it is that you practice beyond what we have gone over already in your bio.
Dr. Omole 01:12
So, I’m a general surgeon and a breast surgical oncologist. So, as a breast surgical oncologist, my main focus is breast cancer. I do do other cancers. But my background training and specialty is breast surgical oncologist. So, it’s involved in the care and management diagnosis of breast cancer. I also do work as a DIA consultant for medical boards and different organizations in terms of Anti Oppression and Anti Black Racism Training. And I’m also the President of the Black Physicians’ Association of Ontario (BPAO).
Zoe Rothblatt 01:13
Awesome! Well, we’re excited to have you and dive into some of your work. But before we do, I want to ask how did you choose breast cancer?
Zoe Rothblatt 01:50
That’s great!
Dr. Omole 01:50
That’s a really good question, I can’t remember. There were a lot of things I didn’t enjoy in the OR. I was like, “I don’t love lung cases,” “I don’t love this.” And so quite a few of the things that I do is because I’m like, Oh I do, but then I really enjoyed breast cancer. For me, it’s like I really like the connection of being able to do advocacy work, being able to do community outreach. And unlike other cancer domains, that’s a much longer longitudinal care that’s associated with breast cancer typically, and I really loved the multidisciplinary aspect of it. So, that was part of the reasons I chose breast.
Steven Newmark 02:23
Interesting in terms of your advocacy and work on Anti Black Racism and Anti Oppression Training, you’re a strong advocate, obviously for patients and clinicians. Well, what are your main goals, what you’re trying to achieve?
Dr. Omole 02:33
So, I would say that, especially like with my work with Black Physicians’ Association of Ontario, also, there’s like two prongs to it. One is for advocating for increase of Black physicians in Ontario, currently, we are Black Ontarians make up about 4% of the population and Black physicians only make about 2% of it. We know when there is racial and ethnic concordance, there is an increase in better care that patients receive, there’s been studies shown for maternal health. And to be frank, all of our data that we use in Canada is from the U.S. and the U.K., because in Canada, we don’t collect race based data. But we know when there’s racial concordance, pregnant people and their babies do better, we know that there’s just differing treatment. And so, part of what we advocate at the Black Physicians’ Association of Ontario is to increase the amount of Black physicians in medicine, once we have that, we also have to maintain well-being and part of that is there quite a lot of like systemic racism that people are just not aware of, and being able to advocate, to help people to understand what that looks like. I always say when I give workshops, that we are all capable of Anti Black Racism, even Black people are capable of Anti Black Racism, and part of it is being able to understand what our positionality is, and that way we can better combat Anti Black Racism. And finally, it’s just community outreach to increase health awareness around different diseases. I’m very passionate about oncology, and so breast, prostate and also maternal care. That’s another thing that we do quite a lot of advocacy work around in terms of outreach to the community, and also Black mental health. So, in terms of just having the community understand how to access resources, how to advocate for themselves, because it is quite challenging when you’re someone, whether it’s racialized, or you are of a different gender, different sexuality. There’s barriers when you try to advocate for yourself.
Zoe Rothblatt 02:49
And can you talk to us a little bit more about some of the maybe underlying reasons of why there’s such a small percentage of Black health workers in, I guess, in the workforce and some of the steps you’re taking to improve that.
Dr. Omole 04:32
I would say that one of them is that if you look at most medical training, people are legacy students. I also am a legacy student. My father was general surgeon. I have like a very different upbringing. I also grew up in like rural Ontario, but I have a very different upbringing when it comes to being able to be savvy in terms of navigating the system. That is a huge barrier. Plus we will have dreams to become doctors, but not a lot of people have the: 1. The financial means to do it, because it requires you to take your summers off to be doing unpaid work on paid research. For some people, that’s just not possible for like many people in the racialized communities to do. And also just understanding how to navigate the system to increase your G.P.A., the extracurricular that’s needed, and how to do your application properly. All of those things are barriers that when you have someone who is in medicine in your family, or even like your neighbor is a doctor, so you can go to them to ask for help, that really changes things. And for a lot of our Black, indigenous and racialized folks, and low income folks, that’s just not something that they have accessible to them. So, that’s part of the work we try to do at BPAO. I always say that I was lucky that my dad was my first mentor. So, I want to be the first mentor for other people, too.
Zoe Rothblatt 05:42
Yeah, that’s amazing that you’re doing that. And it’s so interesting, because it really mirrors the conversations that we have in the patient community of like that peer to peer support and navigating the system. And I just hadn’t thought about it so much from the provider perspective of how much you have to navigate early on.
Steven Newmark 05:58
I was going to ask, you are chairing a special issue in the Canadian Medical Association Journal on Anti Black Racism in medicine. What is this special issue going to do? And what key problems does it expose?
Dr. Omole 06:08
So, that was released last year, the special issue that we did, and that really was to bring to the forefront what Anti Black Racism and what systemic barriers look like in medicine. And so we had topics that was looking at mentorship and medicine for Black medical learners, we had topics around prostate cancer, and for example, there is in Canada, P.S.A. (Prostate-Specific Antigen) is not routinely done. But there’s an argument that measuring the prostate specific antigen in Black folks, because Black people have a higher rate of prostate cancer and more aggressive prostate cancer, that that should be included in the screening. So oftentimes, what we’re doing is that like, we don’t want race corrections for different tests, however, we need to understand that whether it’s breast, prostate, or other diseases, we just have a different biology. And that not one size fits all is what works. And so part of that was to advocate for and to talk about the differences in managing different disease processes, and also just navigating the system that Black medical learners face.
Zoe Rothblatt 07:10
And, I actually have a question on that. Can you talk to me a little bit about how you navigate the idea of maybe over screening, but also accounting for the differences among populations, like you’re mentioning?
Dr. Omole 07:22
I think that it’s important to understand and I do my work around this and breast mainly, I know just a little bit of a prostate from doing the special issue, is that I think that we miss use the word over screening, and not necessarily understand that there’s different biologies to different types of cancer, and that there is a difference in the oncological outcomes for different groups. There’s a breast surgeon named Lisa Newman, in New York, that’s all I remember, now, she’s coined this term anthropological oncology and it is that different people have different subsets of biology. And so this is looking at people from the West African region, I use the word people, not women, because just to also be inclusive of our trans and non-binary folks, because they also still get breast cancer. And that when you look at the tumor biology of breast cancer in West Africa, and it’s very similar to the biology of Black Americans and the Caribbean, because of the transatlantic slave trade, like that is the same gene pool that’s traveling, when you look at East Africans, they have a completely different human biology. And it actually mirrors what you would see in the Middle East, because East Africans that were part of the slave trade went to the Middle East and not to the colonies in the U.S. and in the Caribbean. And so that our D.N.A. is just, I’m West African, I’m Nigerian. So, our tumor biology is just different, like we present differently, and we do differently with the same medications. And so therefore, we should screen differently. So, for example, in breast cancer, the median age of presentation is 63 years of age. But when you actually look at Black people, the median age of presentation is 45. So, you have to screen those populations differently; It’s not a one size fits all. When I talk to patients, I always say every breast is different. So, if that holds true for management and treatment, that should also hold true for screening.
Zoe Rothblatt 09:06
Yeah, that makes a lot of sense. And is this something that’s taught in medical schools? Or is that part of your work now, to get people more aware of these differences?
Dr. Omole 09:14
It is not taught in medical school. Medical school is wholly lacking in having an understanding of how different populations present with diseases. Part of some of the work that the CanMED, which is kind of our, for Canada, the governing principles for medical learners, is trying to revise is that we need to put this in there. We need to be advocating that different populations present differently. For example, things that I know are mainly from doing the CMAJ podcast, like the treatment for Gout in Asian population actually can cause severe illness and death because they don’t have a gene that allows them to metabolize it. That’s not taught in medical school, that’s not even taught in residency, but these are the kinds of things that we need to start incorporating is that we need to teach students “okay, this is the things that you need to know, but in certain populations these things can be different.” But, we also have not researched them. So, like this wave of researching of making sure that we’re including ethnic variations is very new.
Zoe Rothblatt 10:10
Yeah, my background is in Public Health and I’ve just learned a lot about the lack of research on these topics. And
Dr. Omole 10:16
For sure.
Zoe Rothblatt 10:16
like how necessary it is to start teaching early on about this, we talk a lot about here in our organization about how Psoriasis and different skin conditions are often taught in medical school using images of white skin. And there’s such a lack of diagnosis, because just something as simple as images are not inclusive.
Dr. Omole 10:36
Yeah, and there’s some people in Canada who have been doing work around. There’s a dermatologist out at Memorial, his name is Boluwaji Ogunyemi. He’s been doing quite a bit of work in terms of trying to update text to include variations of skin conditions in darker skin tones.
Zoe Rothblatt 10:52
It’s amazing and such necessary work. I mean, we know the time to diagnosis is a huge challenge. And I guess I’m thinking about that you’ve done a lot of work around breast cancer screening, and I was hoping you could describe the issues around that and what you think the recommendation should be. I think there was a recommendation by the Canadian Taskforce on Preventative Healthcare. Can you talk to us about this?
Dr. Omole 11:16
So, the recommendations, they say it’s a draft recommendation, but I’m like, “you publicized it, so, not much of a draft,” but it’s open for consultation for like two weeks for people to have input into it. Their recommendation is to start screening at 50. And to do it every two to three years. This is against every other Taskforce, whether it’s the U.K. or the U.S. task force that recommends screening starting at the age of 40. And to do it yearly. In addition, the Canadian Radiologists’ Association has also said screening should start at 40 and it should be yearly. So, they’re in direct opposition to other Task Forces. I would say that probably one of the driving forces, that’s not clear there, is that this is a cost analysis and this is not necessarily of a lives being saved. So, as I said, the median age for Black women is 45. So, you want to start screening 10 years before that. So, technically, you should actually start screening at 35. And there are some U.S. groups that advocate for screening much earlier in Black women. So, Black women, Asian women, and Hispanic women all get breast cancer at least 20 years earlier than what is noted in Caucasian women. And this is documented in the data. And so they say that there’s no randomised trials in Canada. But we can’t do that, because we don’t even collect race based data. But if you look at the U.S. data, it’s quite robust and it shows that there’s a difference in there. And we know that if you actually, like “you get the most bang for your buck,” both in life saved in young women with breast cancer. So, that’s like the 40 to 50 age. But we actually like the data shows that screening at that stage saves lives, the majority of Black women do not get diagnosed by screening mammogram for breast cancer, they come in with a physical symptom. By the time you can feel a lump in your breast that is a cancer, it’s usually around two centimeters. So, that completely takes you from stage zero, stage one, to probably stage two breast cancer. So, there’s more aggressive treatment versus doing like when you have a screening mammogram when you find something at stage zero, stage one, much less intervention that’s done at that stage.
Zoe Rothblatt 13:12
And why do you think there is such a difference from what this task force recommended to you know what you’re saying, like Canada’s neighbors are doing?
Dr. Omole 13:20
I think it’s money. I think it’s about cost savings, because they even said to stop screening at 74. To me, that’s just ageism, my mom is 80. And I mean, she’s just on like two medications. And so why shouldn’t she? She’s not going to die anytime soon, God willing. So, why should she not continue to get breast screening? And they put it in there, the caveat that well, like, if people want to get screening at 40, it could be a shared decision with their family physician. The problem with that is there’s a lot of people who don’t have family physicians and the self-referral to breast screening differs across Canada, B.C. is 40. So, if you’re 40, you can go yourself at 40 and do that. But until the fall, that’s not available in Ontario, and it’s not available in Quebec and in the Eastern Provinces. So, there’s quite a variation. And so we’re allowing more people to be diagnosed at later stage breast cancer and have more treatment than having earlier stage. And so to me, it just seems like it’s a cost analysis and not so much about lives being saved.
Zoe Rothblatt 14:16
And I imagine, yeah, that makes such a difference for insurance coverage. If the recommendation is later and to cut off at a certain point, even if like you’re saying you can go to your family physician and say I want this I bet there’s a barrier then when you try to get coverage for that screening test.
Dr. Omole 14:32
For us because we’re like universal pay, there’s no issue with coverage.
Zoe Rothblatt 14:35
Oh okay.
Dr. Omole 14:36
so like you’re gonna get it free, but we don’t like there’s a lack of Family Physicians in Canada, like people don’t have primary healthcare, I think can remember the data I think up to like 20% do not have a primary healthcare physician. So, they’re using like episodic care and walk in and that’s not the right way to beginning routine screening, whether it’s your mammogram, whether it’s being sent for a colonoscopy or whether it’s like a pap smear like people just won’t go.
Zoe Rothblatt 15:00
Oh my gosh, what I’m hearing from you is we need more family physicians, we need more Black providers, and we need better guidance around screening. There’s a lot to do.
Dr. Omole 15:09
We do. Yeah.
Steven Newmark 15:10
well, it’s we have a lot of work to do, I guess, both in Canada and South of the Border as well. As we wrap up, I just want to ask what advice you might have for other providers on how they can advocate for their patients?
Dr. Omole 15:19
I would say that the main thing is to ensure that you’re up to date, that you just don’t go with what the Task Force says, but that you get to know your patient and understand their risk factors and that there might be ethnic variations with each patient and trying to learn more. I mean, part of our role as providers is lifelong learning. And this is part of it. So, staying up to date so you can inform yourself. It is very challenging, because family providers have so much that they have to deal with that it’s hard to stay on top of it. And that’s why we need better guidance from our governing bodies and from Task Forces. So, it is easier to get the information, but the onus is put back on us as physicians to be doing that right now.
Steven Newmark 15:57
Great! Well, thank you so much for your time today and for all that you’re doing on behalf of patients and the entire medical community. This has been a real learning experience for us. And we look forward to talking more about it.
Dr. Omole 16:09
Thank you so much for having me.
Zoe Rothblatt 16:10
Thank you so much for joining us. And hopefully next time we chat with you, we will have increased that 2% number.
Dr. Omole 16:16
Yeah, let’s go!
Zoe Rothblatt 16:19
Well, Steven, that was a really great conversation with Dr. Omole, what did you learn today?
Steven Newmark 16:23
Yeah, for sure. I guess a very specific learning is that I learned that 4% of the population of Ontario is Black, I did not know that. And 2% of the Doctors in Ontario are Black. So, that’s just doing my basic back of the envelope calculation. That’s half of what it probably should be to be representative of the population itself.
Zoe Rothblatt 16:41
And for me, it was really interesting our conversation about the lack of research on a lot of these disparities in Healthcare, and it’s not taught in medical school, and there also needs to be more efforts to research and learn about these differences.
Steven Newmark 16:56
Absolutely! Well, we hope that you learned something, too. And before we go, we want everyone to check out all of our podcasts at ghlf.org/listen
Zoe Rothblatt 17:04
Well, everyone thanks for listening to “the Health Advocates,” a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, give us a rating, write a review, and hit that subscribe button wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 17:18
I’m Steven Newmark. We’ll see you next time!
Narrator 17:23
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation Podcast Network.
Inclusive Care: Addressing LGBTQ+ Needs in IBD
In this episode, The Health Advocates are joined by their colleagues Kelly Gavigan, Chief Data and Analytics Officer, and Adam Kegley, Associate Director of Global Partnerships at GHLF. Together they delve into the unique challenges faced by the LGBTQ+ community in managing Inflammatory Bowel Disease (IBD). Based on the analysis of the results from a survey GHLF recently conducted, they explore how identity impacts health care experiences and treatment outcomes. This episode shines a light on the critical need for inclusive health care practices and offers valuable insights on improving patient-provider relationships. Join us as we uncover the lessons learned and steps forward for LGBTQ+ individuals living with IBD.
Inclusive Care: Addressing LGBTQ+ Needs in IBD
Narrator 00:00
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to “the Health Advocates,” a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Chief of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Director of Community Outreach at GHLF.
Steven Newmark 00:21
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:27
And today, we’re joined by our colleagues, Adam Kegley, and Kelly Gavigan, to talk about a recent survey we did on the experiences of the LGBTQ+ community and caring for their inflammatory bowel disease. In this talk, we’ll dive into the findings, what surprised us, what was confirmed to us, and also, you know, what’s next, now that we have this data, how to educate our community?
Steven Newmark 00:48
Excellent. Well, let’s dive in.
Zoe Rothblatt 00:51
So, Adam, Kelly, welcome to “the Health Advocates.” Why don’t you start by introducing yourselves? Adam, let’s start with you.
Adam Kegley 00:58
Sure. Hi, everyone. And Hi, Zoe, my name is Adam Kegley. And I’m the Associate Director of Global Partnerships at the Global Healthy Living Foundation. So, I helped lead a lot of our global facing work and partnerships with other patient organizations around the world and also helped lead this project which is near and dear to my heart on the experiences of LGBTQ+ people living with inflammatory bowel disease. So, it’s great to be here and to speak about it. Thanks for having me.
Zoe Rothblatt 01:25
Yeah. Thanks so much for coming on. And Kelly..
Kelly Gavigan 01:27
Hello, Zoe, and everyone. I’m Kelly Gavigan. I’m the Chief Data and Analytics officer at the Global Healthy Living Foundation. And I worked with others on the development of the survey that we’ll be talking about today and analyzing the data that was captured from this survey participants, many of whom are from our community. And many were also new to us and found us through the survey.
Zoe Rothblatt 01:52
Great, yeah, I’m excited to dive in. And like you guys mentioned, we’re going to talk about the experience of inflammatory bowel disease patients specifically for the LGBTQ+ community. And before we get started, I figured it’d be a good idea to just do a quick review of IBD, the shorthand, inflammatory bowel disease. I actually live with Crohn’s disease, which is one of the two main types so, I feel like I’m probably qualified to give this overview, I’ll give you guys a talking break before you dive in. So yeah, basically, inflammatory bowel disease is a chronic autoimmune disease of your digestive tract. The two main types are Crohn’s disease and ulcerative colitis. And the difference between those two is that Crohn’s can be anywhere from your mouth to your anus, ulcerative colitis is kept to the large intestine, and the common symptoms of it are diarrhea, loose and bloody stool, loss of appetite, fatigue, fevers, the list can go on, and I’m sure we’ll learn more about the symptoms today. But there’s a lot of great treatments out there to treat IBD like biologics, so you know, I’m in remission. There’s a lot of hope for people with IBD. And yeah, I’ll turn it over to you guys. Specifically, Adam. Let’s start with what challenges does the LGBTQ+ community face generally in healthcare and also with IBD? You know, like, what did we know before going into the survey?
Adam Kegley 03:14
Sure. Thanks for that. I think I would say first that LGBTQ+ people, and just to define that really quickly, for anybody who’s listening, it’s Lesbian, Gay, Bisexual, Transgender, Queer and Questioning, and others community. That’s what we mean when we say the quote unquote, “alphabet soup acronym of LGBTQ+.” So, I’d say that LGBTQ+ people’s experience in healthcare really can depend on whether they have an accepting and understanding healthcare professional or healthcare team who is informed on health care related to various non heterosexual and non cisgender sexualities and gender identities in their lives. That can really save a patient crucial time at their appointment, that can save them from having to educate their own provider about their own needs being an LGBTQ+ person or a non cisgender person about very specific health care matters that might pertain to them. It also, of course, reduces most obviously discrimination in the health care setting, either about their sexuality, gender identity, or both, which is probably I would say the main challenge LGBTQ+ people might face in healthcare settings, or they possibly can face that includes either actual or perceived or anticipated discrimination. I wanted to stress that too, because anticipated discrimination can also hinder an LGBTQ+ person from even going to see the doctor because they’re nervous that they might be discriminated against. And that’s a very real thing that does happen sometimes. It can also impact trusting your health care professionals or actually providing you with the best care or even opening up about issues that might specifically concern you as an LGBTQ+ person, maybe living with a chronic condition like IBD as well. Studies from the Health Services Research have shown that at least 16% of LGBTQ+ people face discrimination actively in healthcare settings. Even things like Intake Forms being non inclusive of LGBTQ+ identities, like sexualities and gender identities could make an LGBTQ+ person feel apprehensive about their appointment and could lead to less personalized treatment or maybe even poor outcomes for them. Our survey actually found that one in three LGBTQ+ people living with IBD did not find their doctor’s office Intake Forms inclusive. And I would say with IBD, specifically, all those things can come into play those challenges that I mentioned, like actual or perceived discrimination, and those things can obviously lead to worse and health outcomes like experiencing greater frequency of flare ups and the symptoms associated with them. And it can also more deeply impact mental health and sexual health and a lot more.
Zoe Rothblatt 05:48
Thank you for that. Yeah, it’s hard enough being a chronic illness patient. And it’s important to remember like how much your identity and just lived experience plays into that. So Kelly, turning to you, you mentioned you helped in building the survey. Can you talk to us about what the aim of the survey was?
Kelly Gavigan 06:05
Yeah, absolutely. So, we wanted to shed light on the unique challenges that the LGBTQ+ individuals with IBD face, as Adam mentioned, and the specific needs that they have. So, we really wanted to better understand certain challenges that arise along the patient journey for LGBTQ+ people with IBD, and dive into the emotional and social impacts of living with IBD as a person who is LGBTQ+.
Zoe Rothblatt 06:36
Alright, so let’s go in what were some of the main findings.
Kelly Gavigan 06:40
So, we had about 250 people complete the survey, all of the participants identified as being LGBTQ+, and nearly 70% were actually between the ages of 18 and 34, which is amazing to have such high engagement among young people. On top of that, about 44% of participants identified as a gender other than cisgender women or cisgender man. So again, we were really thrilled with the variety of representation among the survey participants. And nearly 80% of participants reported using medications as a method for managing their IBD, which is great, but that does mean that more than 20% were not on medication for their IBD. And what’s more, most participants reported seeing a gastroenterologist for the care of their IBD. Again, which is great and to be expected, but a surprising quarter of participants reported primarily seeing a primary care provider to treat their IBD. And so you know, that may not seem like a huge deal. But, we actually found that the participants who were only seeing a primary care provider were 10 times more likely to not be on medication compared to participants who are seeing a gastroenterologist and that is a big deal. And unsurprisingly, a quarter of participants reported that their IBD is not very well managed. And then half of the participants reported that their doctor was aware of their sexuality or gender. And among those participants, two thirds reported that sharing this with their doctor did not affect the care they received, and a quarter reported that it positively affected their care. Notably, two thirds of respondents reported that there are not enough resources, specifically, for LGBTQ+ people living with IBD. And we asked, you know, in order to feel more supported in managing their IBD, what did they need: main participants said that they wanted more research on LGBTQ+ IBD populations, more websites with resources, and open communication between LGBTQ+ IBD patients and their health care providers.
Zoe Rothblatt 08:59
Adam, I see you nodding a lot. And I want to turn to you and ask what surprised you in what Kelly just talked about?
Adam Kegley 09:07
Yeah, I was nodding quite a bit because Kelly and I have worked really closely on this. And it’s all been so interesting to us. I think sometimes the very similar thing surprised us and probably things that we were expecting, they were also confirmed for us, both of us and all the others on the team too. I think one of the most surprising things to me in which Kelly mentioned and that was a very positive surprise was the amount of respondents who identified as a gender other than cisgender man or woman, it was almost 45% of respondents, as Kelly said, and that’s really impressive considering that this particular population can be hard to reach and engage in surveys like this or any kind of health care related studies. And that’s in particular due to some of the challenges that I mentioned earlier and a lack of trust and an apprehension or perceived discrimination or anticipated discrimination. So, I was really pleasantly surprised by that when we discovered it, because I think it gives a real nice depth and breadth to the diversity of respondents actually talking about their experiences and relating those to us.
Zoe Rothblatt 10:11
For me, I guess I was like, positively surprised by that number. Kelly, you mentioned, I think it was 14%. That said, when they shared their gender identity or sexual preferences, that their care was like, positively impacted. I feel like so often we’re hearing negative statistics. And it was just amazing to hear that, you know, being open and honest with your doctor can lead to more positive experiences for patients.
Kelly Gavigan 10:36
Yeah, absolutely. And actually, I can even expand on that. For me, I was surprised to know that, you know, among the participants who had not disclosed their sexuality, or gender to their provider, half of them had to the other half, you know, had not. Three fourths of them did not think it would affect the care that they received. But at the same time, nearly 20% of the people who had not disclosed this thought that disclosing this information would negatively affect their care. And that’s, you know, much more than the percentage of people who reported having a negative experience after disclosing this information to their doctor. And I think that this really speaks to, what Adam was saying earlier, about the perceived, you know, effects that it might have on one’s care, and likely explains why at least that portion of people, you know, chose not to disclose this information to their doctor. And I think, like I said, there were three fourths of people who did not think it would have an effect on their care. And that is the kind of a surprising number, I think. And I think that also explains why they didn’t think it was necessary to disclose their sexuality or gender to their provider, because they didn’t view it as something that would affect their care either way.
Zoe Rothblatt 11:50
I was just gonna say, it makes me think about, you know, when it comes to advocating for yourself, it’s so helpful to hear from other advocates and patient experiences. And what you just said is a perfect demonstration on how this survey tells us, like if we share more patient stories about how it positively impacted care, it can hopefully reduce some of that perceived discrimination that we’re talking about. And people could feel more comfortable, like even taking that first step to advocate for themselves.
Adam Kegley 12:18
I couldn’t agree more. And I think to just to add on to that really quickly, is that with the people who may not have thought that disclosing their sexuality or gender identity would affect the care that they receive, and those that possibly thought that it would negatively affect the care that they receive. There’s lots of factors that go into that. But, the I think the biggest thing is that if you find a provider who’s accepting, understanding, and informed, studies have shown that definitely it can improve the care that you receive as an LGBTQ+ person, because it’s that much more personalized. So, I just wanted to throw that out there too.
Zoe Rothblatt 12:54
So, building on that a little bit, Adam, what advice do you have for patients who are nervous about being open with their doctor?
Adam Kegley 13:01
It’s such a great question. And it’s also a tricky one, because it kind of asks like, how do you tell someone to come out in a healthcare setting when they’re unsure, it’s safe to do so. And for me, and for I think many of us, including us on this recording, of course, more familiar with the intersections of health outcomes and revealing your gender and sexual identities. And it can be a really crucial conversation to have with your healthcare team, but with the right health care team. And so that’s the number one thing that I would say is most important is that it’s really important that those conversations take place with someone who makes you feel comfortable, accepted, and understood as an LGBTQ+ person. Trust, or at least the potential for trust is incredibly important in this particular case. And that’s really because all of this isn’t just about your IBD, or another chronic condition that you might live with, it’s really about your IBD within the context of the rest of your life. And I say that with really pertaining to any chronic condition, it’s about that chronic condition within the context of the rest of your life and that includes your sexual orientation and your gender identity. Your sexual practices, maybe you’re on hormone replacement therapy, and there could be potential interactions between that and some medications for IBD, for example, and there’s a lot more. So really, the most important thing is to find that right health care professional and if you live in a less populated area or areas with less options, I’d encourage exploring reviews online options for telehealth or virtual visits with someone who might better suit you. There are of course resources out there that can help you find LGBTQ+ friendly providers locally and that includes the Gay and Lesbian Medical Association’s provider directory. The National Center for Transgender Equality also has great medical and health related resources on their site. You could of course also ask your LGBTQ+ friends about their doctors and specialists, are they happy with the care that they receive? Would they recommend them? I know I personally see a doctor who’s part of the LGBTQ+ community. And while that’s not necessarily needed for everyone, it does make me feel more open and willing to speak about my health and ask questions because I do feel a bit safer and more comfortable, just a bit more at ease with a provider with whom I can identify in some very specific ways. And I say this regularly nowadays, but I’ll say it here again, is that some of your healthcare needs as an LGBTQ+ and/or non cisgender person with IBD are different from those of heterosexual and cisgender persons. And that is perfectly okay and normal. And there should be room for everyone to get the tailored personalized care that they need.
Zoe Rothblatt 15:40
Thank you for that. Thanks for sharing those tangible tips that I think will be really helpful. Especially I know, like you mentioned, if you live in an area with not so many providers, I hear that a lot from our community. So, I so appreciate you zeroing in on options for that. So, looking ahead, now that we’ve learned all this, what’s next? I’ll let Kelly go first.
Kelly Gavigan 16:01
Sure. Yeah, thanks Zoe! I think that I really would like to build off of what Adam just said, honestly, because I think that a lot of what this survey confirmed is that, you know, people want more information specific to being LGBTQ+ and having IBD. And there are multiple aspects of living with IBD lobbying a person who is LGBTQ+ that are just not being discussed. And we’re doing our part to offer resources for people who are LGBTQ+ and have IBD. But of course, I think that we want people to be able to access resources that come from their doctor, if that’s what they want. And so I think that, that requires a lot of building knowledge. And it requires building research and building trust. So, I would say those three things are what would come next.
Zoe Rothblatt 16:53
And Adam, turning to you. Yeah,
Adam Kegley 16:55
I couldn’t agree more with what Kelly said. And that’s exactly what I would say, too, is that there’s a very clear need from what we had anticipated from our research before doing the survey was that there was definitely a massive lack of not only research, but resources on this particular community in living with IBD. And I would say that was confirmed for sure by the survey as well, but what respondents said, and we’ve developed some and that we’ll continue to work on developing more based on the findings of the survey. And I think overall, just adding on to what Kelly said, because she really summed it up perfectly is that I’m just really hopeful that people will see these resources as they come out and know that we didn’t just do a survey just to do a survey, but we’re actually taking action with the results and producing the resources that are tailored specifically for this community, because there’s really a great need and a great desire for them. We heard anecdotally in the open response section, time and time again, very similar responses to what we heard in the actual survey questions themselves, kind of the multiple choice survey question themselves, why we can’t cover everything for every single person individually, I just hope that, that will be a really great start in the right direction to really start to change the conversation or even rather, to help start them in some circumstances.
Adam Kegley 17:19
Well, thank you guys both so much for coming on the show and sharing the findings. I think such an important part of doing work like this is also like the dissemination aspect and sharing the results with our community. So, I really appreciate both of your time. Thank you.
Adam Kegley 18:20
Thanks so much, Zoe, and thanks for giving us the opportunity to come out here and talk about all the findings. It’s really exciting and very important.
Kelly Gavigan 18:43
Absolutely. Thanks so much, Zoe, for having us on.
Steven Newmark 18:47
Wow, Zoe, that was a great interview. It’s always great hearing from our colleagues.
Zoe Rothblatt 18:51
Absolutely. I was just reminded how important it is to go to the source patients and ask them about their experiences. And it was interesting to learn, like what was confirmed for us what surprised us and something that surprised me was just how in a good way with and I mentioned this in episode was just how positively patients had of an experience when they were open and honest with their doctor about their gender identity and sexual preferences. How about you, what did you learn?
Steven Newmark 19:19
Yeah, no, I totally agree. That was really eye opening for me as well. I think it goes to the broader point of always being open and honest with your medical professionals, and how much that can help. But my big learning from today really is just how the resources that we have at GHLF, speaking of folks like Adam and Kelly who can provide information and put out surveys and learn things of importance and spread out into the ether how valuable that is. But clearly our number one resources are our patients and the ability that we have to go to our patients and learn from our patients is really a special thing and it was great.
Zoe Rothblatt 19:51
Absolutely.
Steven Newmark 19:52
Well, we hope that you learned something too. And before we go, we want to encourage everyone to check out all of our [email protected]/listen.
Zoe Rothblatt 20:00
Well everyone, thanks for listening to “the Health Advocates,” a podcast that breaks down major health news of the week to help you make sense of it all. If you like this episode, give us a rating and write a review and definitely hit that subscribe button wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 20:15
I’m Steven Newmark. We’ll see you next time.
Narrator 20:20
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation Podcast Network.
Public Health in Action: Tackling Bird Flu and New COVID Strains
In this episode, join The Health Advocates as they dive into the latest health news with a focus on the emerging H5N1 bird flu and its implications. They discuss the virus’s potential to affect humans, current states with detected cases, and public health strategies to mitigate its spread. The hosts also touch on recent COVID-19 variants and the development of combined COVID and flu vaccines, reflecting on public health lessons learned from past pandemics and how these insights are shaping responses to new threats.
Tune in as our hosts discuss ongoing infectious disease challenges and the proactive measures in place to protect public health.
Public Health in Action: Tackling Bird Flu and New COVID Strains
Narrator 00:00
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to the Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Chief of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Director of Community Outreach at GHLF.
Steven Newmark 00:21
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:27
And Steven, it’s been a minute since it’s been just us too. But we’re original recipe today.
Steven Newmark 00:32
Yeah, there it is. So, let’s dive in. It’s probably a lot of news to cover, right. Let’s see what’s happening out there.
Zoe Rothblatt 00:39
We have some news on infectious disease updates, vaccines, and more. So, why don’t you kick us off?
Steven Newmark 00:45
Sure. Well, speaking of infectious disease, the number one, perhaps new issue of the day is bird flu. That’s the H5N1 bird flu is sickening dairy cattle throughout the United States and state and federal authorities have detected the flu in 12 states, in cattle.
Zoe Rothblatt 01:01
And there have been a few human infections confirmed that are connected to the farms. But, researchers do agree that there’s probably an undercount given the limited testing on this flu.
Steven Newmark 01:12
Yeah, just as a total side note, going off the beautiful outline here. I actually just read an article this morning, how the count is very high in Michigan. But that is in part because Michigan has a very robust counting mechanism with their public health infrastructure up there. So, it appears as though there are perhaps more cases in certain parts of the country, but it’s also likely due to better, if dare I say better, or more robust public health outreach and counting. Anyway, H5N1 is not a new virus and, knock wood, does not seem to be a big threat right now to humans. The virus is not very good at infecting humans, passing onto someone else. But as we’ve seen with COVID, we know how quickly this can change and the opportunity to spread, if we don’t contain it. It could lead to mutations and make things really worse.
Zoe Rothblatt 01:52
Well, I guess the good news is that the U.S. does have vaccines against H5 viruses and its stockpile and last month, government officials said almost five million doses are being filled and finished so they could be ready for use, though right now, there’s no plan to give them to anyone yet, because the CDC maintains its assessment that its risk to the general public is pretty low.
Steven Newmark 02:15
Yeah. And I would just say that the best thing in public health when dealing with infectious disease is that it gets so tamped down so early on that the majority of the public never even hears about the disease or never thinks about the disease which backfires of course, when a disease like COVID starts to rage. And folks do need to pay better attention in order to respond to it because it almost get this false sense of security that things are contained almost on their own when that’s not necessarily the case. But in my career, which spans a few decades now. I’ve seen the swine flu, I’ve seen the avian flu, that came from Asia several times, I’ve seen Ebola, Zika virus, and in those instances, they were able to be tamped down so early on that it never became a pandemic the way COVID did. COVID unfortunately, it was not tamped down. It started, as we know, in China, China through various let’s say anti public health measures did not properly tamp down the virus, and it was highly contagious and it became what it became. So, hopefully this falls into the earlier category and in particular, we hope that happens because in a post COVID world, I don’t know how the general public could respond to another large scale infectious disease.
Zoe Rothblatt 03:24
Right, I was gonna ask, do you think there’s like more eyes on this or like a more fear around this because of our experience that we just had with COVID?
Steven Newmark 03:33
Perhaps a little bit, but I also think the seeing the bird flu actually jumped to human form is a pretty big deal. And also what is likely an undercount, I think is alarming to say the least. I think public health officials know that there’s not a lot of appetite to listen to public health officials in the United States at the moment. So, the best way to get this under control is to do it before we have to turn to something like our viruses or rapid tests, which the government is also working on for humans. The best way to tamp it down, as I said, is to make sure it just doesn’t happen.
Zoe Rothblatt 04:04
And I guess the best way to tamp it down right now would be to monitor the areas that are infected and for people who work with infected animals should wear protective clothing and take the precautions to avoid getting sick and spreading it.
Steven Newmark 04:18
Exactly.
Zoe Rothblatt 04:19
So, I guess, you know, for just us general folk like not much to do right now, but wait and see.
Steven Newmark 04:26
Wait and see. Exactly, exactly. Fingers crossed and hope that the public health professionals are doing what they can to monitor it and keep it under control. And we’ll go from there.
Zoe Rothblatt 04:35
Well, I mean, in other infectious news, no surprise, we have another COVID variant.
Steven Newmark 04:41
Yep.
Zoe Rothblatt 04:41
Right now, KP.3 is dominant, it’s part of the JN.1 lineage. It’s the same old, deaths and hospitalizations have declined, but emergency room visits are on the rise. It doesn’t seem more dangerous than anything in the past. So, just like
Steven Newmark 04:58
Yeah.
Zoe Rothblatt 04:58
kind of the state of COVID remains the same.
Steven Newmark 05:01
Yeah, the state of COVID is that there’s COVID. It’s like saying the state of the flu is that there’s the flu, their state of the common cold is that there’s a common cold. And that’s just the way it’s going to be forever.
Zoe Rothblatt 05:11
Yeah. Well, I guess that just does lead us into our next bit of news, though, is learning about the current strains, I guess, influences our vaccine strategy. So, recently, the FDA panel recommended that the new COVID fall vaccines are designed for this JN.1 lineage.
Steven Newmark 05:30
Yeah, well that’s good. We’re staying on top of it, we will have the proper vaccine. Hopefully, for the fall, the CDC still needs to vote on the recommendations. But the evidence was presented during meetings showing that the JN.1 vaccines offer greater protection against the dominant variants than then currently available vaccine. So hopefully, we’ll be getting newer and better improved vaccines to fight the newer and the worse, if you will, variants that are out there.
Zoe Rothblatt 05:53
And also the FDA decision to do this is in line with what’s being recommended across the world. So in April, both the World Health Organization and European Medicines Agency recommended that their countries formulate their new vaccines to target this variant as well.
Steven Newmark 06:09
Yeah, in cooler news, if you will, vaccine news, there’s a COVID and flu shot that could be in our future. Moderna announced positive late stage trial results for it’s COVID Flu combined vaccine called mRNA 1083.
Zoe Rothblatt 06:21
Yeah, so this won’t be ready for this year’s flu season. But what really caught my eye about this one is that the results showed it improved immune response compared to those who got standalone shots. And these results were also true for people who are 65 and older. And I know many in our community have questions about how many doses will they need, because we don’t always allow immune response. And the same is true for a 65 plus age group, they may not mount as strong of an immune response as the standard young and healthy person. So, it’s pretty cool that the early results from this are showing, I guess not early results. They’re called late stage trial results are showing that it does mount a stronger response.
Steven Newmark 07:01
Yeah, that’s very good news. Good news for our arms, getting less injections, less pain. So, we’ll look forward to that in the future.
Zoe Rothblatt 07:08
Totally. Yeah, just think about it from like a public health standpoint, the idea that you could get two shots in one and reduce having to go back to
Steven Newmark 07:16
Yeah!
Zoe Rothblatt 07:16
the pharmacy, it just probably increases the amount of people that will be protected.
Steven Newmark 07:21
Totally. Which is great for everyone, right? Which is great for all of us.
Zoe Rothblatt 07:24
Yeah. Because not everyone can take off from work, get an appointment, or like the kids are in school. Like who knows what barrier you’re experiencing, to getting all of the shots and just making it as simple as possible is better for our community health.
Steven Newmark 07:38
Definitely! Simple is good. Other vaccine news, the FDA has expanded RSV vaccine approval to high risk adults, ages 50 to 59. So, this is for people who are at increased risk of getting severely sick.
Zoe Rothblatt 07:50
This shot was first approved in May, 2023. For people 60 and older, and we’re just excited to see it go to a different age group that could help protect people.
Steven Newmark 08:00
Yeah, absolutely. So, yeah, like you said, it was originally approved for folks, 60 and over now, it’d be 50 and over. So, that’ll be good and be helpful for those who need it.
Zoe Rothblatt 08:08
And like we mentioned above CDC is still to come in and vote on the recommendation. So, it’s not available just yet, but we could expect it to be soon.
Steven Newmark 08:17
Yeah, that’ll be interesting to see. In other news, earlier in June, there was a congressional subcommittee held hearings regarding I guess extensively regarding the origins of COVID-19 and included top officials from the National Institutes of Health along with Dr. Anthony Fauci. There was some acknowledgement some key parts of the public health guidance that their agencies promoted during the first year of the COVID-19 pandemic, were not necessarily backed up by solid science. Let’s be honest, it was a fast moving time and people had to react, but hauled before Congress, things got a little tricky to say the least.
Zoe Rothblatt 08:48
Yeah, so let’s break it down. Like what exactly were the parts that they said were not backed up by science?
Steven Newmark 08:54
So first and foremost, this subcommittee blamed Fauci for the six foot policy and Fauci responded saying that he was unaware of study supporting the six foot social distancing guidelines. He then clarified that it wasn’t based on randomized control trials. So, just a few things to say about that. First and foremost, the six foot guideline was not decided by Fauci, it was a decision by the CDC. The second thing is, this was not a policy that was decided out of thin air. This was a policy that was developed during the George W. Bush administration. It was part of their pandemic playbook in 2007. It was based on knowledge of the flu at the time dealing with the droplets and finding that six feet was appropriate for a pandemic that would involve transmission of droplets rather than aerosols, which is what COVID-19 was. So, given that COVID-19 was a novel virus, pulling from an old pandemic playbook probably was the simplest and easiest thing to do in that particular moment. In retrospect, six feet was not the perfect distance. Again, when you’re in the middle of an emergency, you’re not going to get everything right. That’s just how it is. But and in terms of a randomized control trial, you can’t get that in the middle of an emergency. We were literally losing 1000s of people per day, I think at its heights, I don’t want to get this wrong, I think it was 3500 people were dying, you got to move quickly. And you don’t always have the optimal information at your fingertips when that’s happening. That’s why you prepare in advance as much as possible to pull out the playbook. But you can only prepare for what you can prepare for, if that makes sense. And COVID-19 was novel.
Zoe Rothblatt 10:20
Totally. And just to highlight exactly what you’re saying there, like the main goal at the time was also just keeping people out of the hospital because the hospitals were so overwhelmed. And I feel like when we think about public health, a line that stands out in my head is like the greatest good for the greatest number of people. And like at that time, that’s what we thought like the six feet pulling from the playbook would be the greatest good for the greatest number of people. And it’s important to be critical and look back at what we did, but also understanding that we did what we did with the information that we had.
Steven Newmark 10:51
Absolutely, it is 100% reasonable to look back on decisions made during critical times. Everyone does that. Right. The military does that. What did we do during wartime that we could learn from so we can prepare for the next battle? Surgeons do that after our surgery, what goes well, and what doesn’t go well? What can we do to learn from that from next time? I’m an attorney, we used to do it all the time after a trial. What did we learn from this trial that we can do better next time. And that’s that is the right way to learn and move forward. So, it is totally reasonable to ask why certain decisions were made, what conversations were had, and what was the thinking at the time. If I could just take a moment and say that vilifying, attacking, and ripping apart public servants really is unhelpful in propelling people forward. It undermines trust in the system. It attacks people who work hard to make our lives healthier and better. And many public health leaders stepped up during the time of great uncertainty to try and protect people’s lives. And they had to make incredibly difficult decisions with often incomplete information. Mistakes were made, which is always going to be the case in any emergency, but the service was there. And it was there with the right intention. And you can live with those two truths that the public service, the public health goal was there and mistakes were made at the same time, and if we don’t acknowledge that we do risk losing even future public health leaders that will be there when we need them.
Zoe Rothblatt 12:07
Yeah. Also, I was just thinking about how, I don’t know, we could look back, but it’s probably been two years since we did that episode on Public Health Trust Eroding. And it just seems like, I don’t know, we’ve either been the same or gotten worse. And I’m just thinking about, like, what could we do to bolster that, especially when the news is coming out things like this, and it’s hard for the average person to just be critical and understand, like, what you’re saying about the six feet and pulling from old stuff, you know, maybe the average person isn’t going in and doing the research on that? And like, how could we help support that and build up trust?
Steven Newmark 12:41
That’s a great question and I don’t have an answer. There’s a precedent for such an approach would be the 911 commission. As an example, you look back and you say, what mistakes were made? What could be done differently? And what did we learn moving forward? It acknowledges your mistakes, which is important for public trust, but it also acknowledges who the experts are. However, as each month passes, the likelihood of something like that coming to fruition, is dissipating quickly, to say the least. So, beyond that, I don’t know the answer other than to just maybe time is really what it is. Hope beyond hope that we don’t have another pandemic anytime in the near future, and that we’re able to sort of use that intervening period of time to rebuild the trust over the years.
Zoe Rothblatt 13:22
And I guess there’s also this element of, you know, it’s easy to forget. And there’s still a lot of advocates in the community talking about this. But I guess like in March 2020, a lot of people in our community who live with autoimmune underlying conditions, including myself, were scared, like, if you walk outside, you’re gonna die.
Steven Newmark 13:39
Totally.
Zoe Rothblatt 13:39
And I don’t know, looking back, it’s like, I don’t think any of us in our community would have been upset that we were overly cautious because we all were acting overly cautious because we were so scared and didn’t know. And there’s like a difference between trusting and public health when you already have a health condition versus just being like a regular person that isn’t really focused on their well being so much.
Steven Newmark 14:01
Yeah, there’s a sense of certainly revisionism. I don’t think it was just folks with autoimmune conditions, I mean, a lot of people were scared in March of 2020, April of 2020, May of 2020. We didn’t know what this was. We didn’t have we had no treatments. We had no vaccine. We had no guidance.
Zoe Rothblatt 14:14
And no faith that if you needed care, you are going to get it, right.
Steven Newmark 14:17
Yup.
Zoe Rothblatt 14:17
Because the systems were so overwhelmed.
Steven Newmark 14:20
Yeah.
Zoe Rothblatt 14:20
Like, even seeking out care was scary.
Steven Newmark 14:23
It was a scary time. We were alone, we were told to stay inside. So, our brains weren’t a little bit fried. It was a really difficult time. I think that there’s some forgetfulness on the parts of folks of what we were dealing with. We haven’t had proper reckoning with that four years later of what it is that we dealt with. And to be fair, we’re going on about this subcommittee hearing and its effect on U.S. public health officials. The committee also spent a lot of time focused on the origin of COVID which is important to know as well and that is something we should try to find out because there is some question as to whether this came from a lab or whether it came from the Wuhan market and came from livestock. And if it came from the lab, that is a different scenario and certainly a different way of trying to prepare moving forward and in terms of safety. So, there is validity in learning about the origins and what we could do differently moving forward.
Zoe Rothblatt 15:10
For sure. And I guess like to wrap this up nicely in a bow to bring it to the top of our episode with the bird flu. Yeah, like, let’s learn about what we did and what response was effective versus not. And all apply that in today’s scenario and hope that this bird flu doesn’t spread.
Steven Newmark 15:26
Absolutely. I know, I hate to say like, our best bet is to keep our fingers crossed.
Zoe Rothblatt 15:30
Ha ha…toes too.
Steven Newmark 15:32
Yes. And like I said, just to buy ourselves, if nothing else, buy ourselves time to help build back up the credibility of the public health sector as we move forward. And, you know, go from there. And but we know we don’t have that issue with our listeners. And we’re grateful for that.
Zoe Rothblatt 15:45
Yes, thanks, listeners. On that note, that brings us to the close of our show. Steven, what did you learn today?
Steven Newmark 15:51
I guess about the combined COVID and flu shot. That’s exciting. I’m looking forward to that. I’ll see how my left arm deals with that.
Zoe Rothblatt 15:57
And actually, you know, it’s pretty good to put in your dominant arm because you’re going to move that more and it helps reduce the effects. And that’s me assuming you’re righty.
Steven Newmark 16:05
There it is.
Zoe Rothblatt 16:06
But also, I learned just from you about where we got the six feet from and pulling from old responses to new ones.
Steven Newmark 16:14
Well, we hope that you learned something, too. And before we go, we want everyone to check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 16:21
Well, everyone thanks for listening to the Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, give us a rating, write a review, and hit that subscribe button wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 16:35
I’m Steven Newmark. We’ll see you next time.
Narrator 16:40
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation Podcast Network.
Four Transplants, One Powerful Voice: Liz Schumacher’s Advocacy Journey
After being diagnosed with a type of kidney disease called acute glomerulonephritis at the age of 10, Liz Schumacher learned how to find her voice and become her own best advocate for her treatment. Now through her work in health advocacy and health sustainability, Liz uses the lessons of resilience she learned through her diagnosis journey to inspire other patients to be their own advocates too.
Join Liz as she describes her health care journey, gives tips on strength and resilience, and shares how she advocates for other persevering patients like her.
Four Transplants, One Powerful Voice: Liz Schumacher's Advocacy Journey
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to the health advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Stephen Newmark, Chief of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Director of Community Outreach at GHLF.
Steven Newmark 00:21
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:27
And today we’re joined by Liz Schumacher. Liz is a four time kidney transplant recipient and healthcare entrepreneur with over 30 years of professional health care experience in a wide range of fields including academic medicine, large healthcare system, community health, health insurance, pharma, health startups, law, clinical research, and medical specialty associations. Liz is also the founder and CEO of affinity strategies. And we had a great conversation about advocating for yourself navigating the healthcare system, and how she combines the personal patient experience with the professionals. So I’m excited to have a listen with you, Stephen.
Steven Newmark 01:04
Well, I can’t wait. Let’s get into it.
Zoe Rothblatt 01:06
Hi, Liz. Welcome to the Health Advocates.
Liz Schumacher 01:09
Thank you. I’m really happy to be here today.
Zoe Rothblatt 01:11
Awesome. Well, why don’t you start off by introducing yourself to our listeners?
01:15
Sure. Hi, there. My name is Liz Schumacher, and I am a four time kidney transplant recipient. I’ve been a patient living with chronic illness since I was 10 years old. So forty-two years, I’ve been a patient advocate.
Zoe Rothblatt 01:29
Well, I’m excited to talk to you today about your journey, and also I guess how you’ve grown, you know, part of that health journey into a business. But maybe let’s start from the beginning. Can you talk to us about the beginning of your journey and finding out you have a chronic illness and what that was like for you?
Liz Schumacher 01:47
I was diagnosed with Acute glomerulonephritis. I was quite young and wasn’t able to play my typical sports like I normally did. I just didn’t feel well. So my parents took me to the doctor. And after lots of tests, they ultimately realized or came to the conclusion, I should say, that I had acute glomerulonephritis. So my kidneys were basically failing, and nobody could determine what caused it. It was just something idiopathic. Within a few months, I was one of the youngest patients, the University of Wisconsin Hospital that had ever had with kidney disease that appeared like mine. So I quickly got referred to an academic hospital, University of Wisconsin saw a pediatric nephrologist, they tried lots of different treatments to try to make me healthy again. And unfortunately, none of the treatments worked. There was lots of experimental therapies and a variety of things, until we eventually decided that a kidney transplant was the best avenue for me during that time. I did plasmapheresis, kidney dialysis, all kinds of different IV treatments and such. And that was kind of the genesis of how it all started my patient journey.
Zoe Rothblatt 02:53
And what were you thinking during that time, when you were trying all of this stuff, what was going through your head?
Liz Schumacher 02:58
I really hoped that I was going to get healthy from all of it. I think that I really trusted my physicians and that my care team and I knew that they were really doing the very best for me, and I did everything I was supposed to do and that they recommended. I guess what I was thinking was sometimes it was scary. But I feel like when you’re in a position where you really have no choice, but to do what the smartest people around you think could potentially help save your life. I really felt I had no choice but to do what they suggested that they were going to make me healthy again.
Zoe Rothblatt 03:30
that’s really interesting to think about it as like you having no choice because I know you’re strong advocate for yourself and others. So like how did you start advocating despite feeling like there wasn’t a lot of choice in your health?
Liz Schumacher 03:43
I always felt I was part of my medical care team. I was. I shouldn’t say I felt I was. I was always included in all the decisions. So I was very fortunate in that while I was young, my medical team was very honest and forthright with what was going on what the symptoms were, what my options were. And they would say what do you want to do, Liz? How do you want to proceed? So even though I was a child, they really treated me as an equal partner to what was going to happen with me. They didn’t look up to my parents and say, What do you want to do? They would look to me and say, here’s what we think here’s the options. Here’s what we think you could potentially consider, what do you want to do? And I would ask a lot of questions. And they would always answer very honestly. They would educate me about what the illness issues were what was happening to me at any time and what the risks were and what they recommended that I would do. And then I would usually go along with what they said. And I’d ask questions. I give critical feedback. It really was kind of a team decision. And I felt like my voice was as important as anyone elses.
Zoe Rothblatt 04:44
I admire so much that you were able to do that from such a young age. Like I feel like it took me so long to figure out how to ask the right questions and be an active participant in care. It’s certainly not easy and it’s amazing that you had the team that was giving you the space to do that.
Liz Schumacher 05:01
Absolutely. I had a physician who was my primary nephrologist as a kid who would always be really honest with me and presented it in a very skillful way to not make me afraid, but make sure that I always understood what was happening. I never felt like there weren’t choices. And I never felt like anybody was going to do something to me without me agreeing to it first and understanding what it was before anything happened.
Zoe Rothblatt 05:27
And when we had talked before this podcast, you had told me about how you felt like some of your care was disjointed. Can you talk to us a little bit about that now? Like, what are some of the other providers you saw, and how did it become disjointed?
Liz Schumacher 05:42
I think that as I got older, I’ve been a, you know, a patient for over 40 years. So I’ve been able to watch how the healthcare system has changed as a patient. A lot of my friends will say we’re all patients when we talk about patient experience, but I think I just happen to be a really experienced patient who’s been around a long time. So I’m able to give a bit of a historical viewpoint on what I’ve noticed has changed from my perspective, as somebody who’s been really kind of a lifetime consumer of health care. And I think that what I’ve noticed is healthcare has become more and more sub specialized, and healthcare systems have changed. There’s so many experts to manage so many different aspects of your care at different times. And in some ways, I think that’s excellent, because you’re getting somebody who just has expertise in dealing with kidney disease, when your kidney level hits a certain point, you’re seeing this kind of person, when your kidney is working at a different level, you’re seeing a different person, when your transplants not working, you see one person when you transplant is working, you see another person. And then there’s all of the different team members, nurse who works with you, shortly before you have your transplant nurse who works with you, after your transplant to help manage you. So there’s a lot of different people who are highly specialized with different sort of time points in your medical journey. While I think a lot of that is really excellent, and as a business owner, myself, I see the scalability of that. So you’re really building expertise in certain places and points. I also think it can sometimes leave the patient wondering like, Okay, who do I go to, for what? Because as your medical situation is changing, when do you move from one caregiver to another caregiver who has certain expertise, and that is where I think being a really strong patient advocate and educated, informed patient, it really matters so that you can be paying attention to that, and you can be raising your hand and say, “Wait a minute, what about this? I think we’re missing this.” Just those natural things that fall through the cracks. Some of that feels a little disjointed to me as an adult. And I think it’s just a reflection of medicine changing, but that continuity of care throughout the whole process, from my vantage point, I am the only person who’s really managing that continuity and knows the details intimately.
Zoe Rothblatt 07:55
And did you ever get just like tired, like, I don’t know, like being a sick kid and advocating and trying to put together all this disjointed care?
Liz Schumacher 08:05
I think as a kid, it wasn’t, it didn’t feel as disjointed, quite frankly, as it does now as an adult. Because I think as a kid, there were fewer people taking care of me. So maybe a trip back in the day when I was younger, my transplant surgeon would have more of a say in the transplant medications, I’m taking post transplant, I would still see him in clinic, things like that. As an adult now, my transplant surgeon is seeing me right before transplant, giving me the transplant or doing the surgery. After, he’s following me for a while but pretty quickly, I’m then handed off to a transplant nephrologist. So all these different people managing certain aspects of where my healthcare is, I’m certain improves my long term outcomes. But the transitions and care from one point to the next is where I think you really have to pay close attention as a patient because I feel what I have experienced as an adult is there are nuances and things that just get missed as you have more people seeing you and taking care of you that you know. Or sometimes everyone might be so focused on your numbers and where you’re at and holding steady. But you have to really advocate for yourself on your symptoms and your side effects like, “Hey, I might be on dialysis right now. And my numbers are steady and my blood pressure steady and all these things that we want to keep steady medically, but I feel terrible and I’m nauseous and the nausea medications are not working. What else can we try?” Standing up for yourself to make sure that you’re maintaining your overall health as your health continues to change in the aspects that are outside of the things that your physician or nurses might do?
Zoe Rothblatt 09:36
Yeah, I think that’s excellent advice. It’s so interesting because like typically in the chronic illness journey, I guess outside of transplant, like most people have this one specialist or maybe two specialists if they have multiple chronic diseases. But like for each specialist they see it’s like really that one and once you liked them you kind of want to stick with them for life and hang on to them tight but for you it sounds like you don’t really get the opportunity to do that, to have that like one person that you know, is really looking over your case. And it just sounds like it’s challenging enough navigating your disease with that one person. And I can’t even imagine how challenging it is, like you’re saying, to just keep getting passed around and feel like just like so lost in the system of at all.
Liz Schumacher 10:19
I’m at a point now where I’m pretty stable. So I’m at one place now in my health care where I have one transplant nephrologist who really manages me and I have that continuity. But I would say I’m also, you know, in my 50s now, so there are other medical things, menopause, general healthcare issues, there are different complexities as you get older, that you keep layering on to your disease. So managing all of those things becomes, I think, more complex, and it becomes something you as a patient have to be paying attention to, and that you need to find the right people to help you with. So you don’t just become identified as somebody who just has a kidney transplant to be managed. You also have all these other things, maybe you have blood pressure issues, maybe you have gynecological issues. And I think some of that’s the really exciting thing about medicine is people are living longer and longer with chronic illnesses, but we’re still just normal people who need our normal health care to be treated. And that sometimes is something I think you really have to stand up for. So that you weren’t sacrificing, feeling great on a normal basis, like most people would be, you’re not just about your transplant or your disease, you’re also about all the other things, the side effects of the medicines, you take the other medical complexities that happen with age, those sorts of things, I think we’re in a different place now than we used to be with that as medicine advances.
Zoe Rothblatt 11:34
And we had talked a little bit about this in our previous conversation, especially through the lens of COVID, and just being so mindful. Of course, March, 2020 hit and everyone was mindful but there was an extra layer for people with chronic illness, and you were talking about as a transplant patient, how COVID really, really changed your life. Can you talk to us about that?
Liz Schumacher 11:55
For sure. You know, when COVID started, I own my own company, and we closed the office immediately. I think some of my employees didn’t totally want to do that before people really realized how serious it was that we closed our office pretty quickly. And I was isolated pretty much until September, October of this year, I would get out in the world and do some things I want to go to Costco I was going to go to certain time of day with my n95 mask I was certainly wasn’t going to get on an airplane, I gave up a lot of holidays with my family because not only was I immunocompromised as a fourth time transplant patient, I also my third kidney transplant was also rejecting so I was very sick. So I really had no choice but to really isolate and have my small bubble. And that was a really hard time as I know, it was for a lot of other people with really vulnerable health issues.
Zoe Rothblatt 12:44
And what do you think that like people could do to just be more understanding of a situation like that, like when you have a friend and you explain to them like, “hey, I need to isolate a bit more.” And let’s say they have a little bit of like a, “well why it’s not a problem anymore?” Like how I know so many in our community are struggling with having that conversation, like do you have any tips for helping people to understand?
Liz Schumacher 13:08
I would say the kind of tips that I would have, you just kind of have to rip off the band aid, I think. And I remember when COVID started, I talked to a few of my physicians and people I trusted and pretty quickly I looked at my husband and I said, “I feel like I’m gonna be the boy in the bubble,” like the 1980s, 70s movie with John Travolta. And that’s really what it was. And I remember saying to my husband like this is going to be survival of the fittest. I’m going to be at the bottom of the food chain on this, like, I’m gonna have to be so careful. It was very hard. And I feel like it changed a lot of my friendships and relationships. There are people who just kind of disappeared during that time to come back into my life now. And I try to be gracious with people and understand where they’re coming from their experience is very different than mine. But certainly, it was heartbreaking for me because I feel like there were some people who truly just didn’t get it. And those are the moments you have to say, “how can they get it, they’ve never had somebody in their life for themselves who are going through what I’m going through.” So in those cases, I just, you know, kind of step back a little bit. And I really put my energy and efforts into those who did understand and were really my support people and the people who got it, but it was very hard, I think.
Zoe Rothblatt 14:16
Yeah, well, you also said something that stuck with me about how there were some positives that came out of it like learning not to spread yourself too thin just because you are doing less and realizing that that’s giving you more energy.
Liz Schumacher 14:29
Absolutely. I would say that I really had no choice during COVID probably much like a lot of the folks listening to this podcast about what I couldn’t could do. It was very black and white. Sort of similar to when I was a kid like, “okay, it’s black and white, I’m sick, I have no choice and say no, I don’t want this disease” Like well, I have it so I have to navigate the best I can. I feel I did that as well with COVID and just saying alright, this is my reality. I have to accept this and really rely and lean into the resilience that I’ve developed throughout my life being a patient. And realize there’s going to be an other side to all of this. So my life motto is make lemonade out of lemons. So I thought, “Okay, make lemonade out of lemons like, this is my situation.” I’m going to become a better Baker. I’m gonna become a better cook. I’m going to do other things. I’m going to talk to my dad on video every single day, who is also isolated. I’m gonna put my energy and efforts into the relationships and the things that make me happy that are within my control.
Zoe Rothblatt 15:27
It’s so true. It’s almost like you had been training your whole life for that, right? Like learning to adapt with, like the body and health that you have, and figuring out how to still enjoy life while dealing with these challenging health situations.
Liz Schumacher 15:42
Yep, 100%. Being an entrepreneur, I grew up in a family of entrepreneurs, and owning my own business during COVID was actually such a blessing because I had the ability to control my schedule and where I worked, and I had a wonderful team supported me and I supported them. That really made a difference. And I think the resilience I’ve developed from being a patient, and frankly, being an entrepreneur and starting my own business, when I had my moments where I was feeling kind of sorry for myself, I’d say I can do this, like, I could do this, I’ve been through worst. So you know, one of the things I always rely on when I have to do something I don’t want to do is remembering what it was like to have a fistula in my arm when I was younger for dialysis. You know, three times a week having somebody put two big needles in your arm to dialyze I would go through a little mental exercise whenever I started dialysis. 123 Okay, the needle goes in. I would just kind of remind myself during the hard times, okay, you could do this. 123 Now do it. 123 make the phone call. 123 go out and walk. Like do what you have to do to get through.
Zoe Rothblatt 16:41
Wait, that’s so funny. Whenever I give myself my injections, I have like myself or a friend count down from five. Its just like the 54321 do the injection. There’s something about like counting yourself in. It’s like a little moment of hype and like, you have no choice you’re doing it because it’s gonna help you get better.
Liz Schumacher 17:00
100%. You have no choice. It’s like I sometimes think about, not to be grim, but okay, at some point, it’s like when you know, you’re going to die. That’s going to happen to all this at some point. And if you know what’s going to be happening, there’s nothing you can do to control this. So at a certain point, you’ll learn how to accept and be resilient about it and find peace. And it’s the same as being diagnosed with a serious disease, accept it, make the best of it. Or anything hard in life.
Zoe Rothblatt 17:27
Yeah, finding your piece is such an important piece of the patient journey. But going back to what you said, you mentioned, you’re an entrepreneur. Can you tell us about the business that you started?
Liz Schumacher 17:37
I started a company called affinity strategies 10 years ago, and we manage a medical specialty associations and patient communities. Really medical and patient communities, who need organizational management, structure, fundraising, organization, engagement, all of that sort of thing. And I started the business because I had worked for multiple medical associations professionally. I was former legal counsel at the American Medical Association. I had been a healthcare lobbyist for many years and felt that having worked at associations for so long, I felt that I could bring a different perspective and way of doing things, so I started my own company. And it’s been very successful. And it’s a pleasure because I get to work with academic physicians and academic medical people every day, who are the people I really kind of grew up with. So they’re my people.
Zoe Rothblatt 18:25
Well, congratulations on your business. And I think you said 10 years, that’s pretty awesome to look back at a decade. How do you bring your patient experience into what you do?
Liz Schumacher 18:35
I would say that when I’m pitching clients, I don’t hide it, I talk about it. In fact, I’ve recently rebranded my business to say the patient is our purpose. We have a new website coming out that’s going to reflect a lot of that because really, the reason medical associations exist or patient coalition’s are most healthcare, any kind of health care community really, is to improve patient outcomes and patient care. At the end of the day, it’s really quite simple in my mind. So I’ve really narrowed in on what that focus is. And when I’m meeting with new potential new clients, I embrace it, and I talk about it because I think it shows that we authentically, really care about what we’re doing. And we aren’t just there to be doing a job. We’re also there to be helping the people that we work with advance medicine and advance research. So I embrace it, I talk about it. And I think it inspires some of my clients. I think it also makes them understand that I understand the world they’re coming from, and the difficult kind of things that they have to see and deal with every day, having been a patient who’s been on the other side of what they do every day in their jobs. So it builds an immediate connection, I think.
Zoe Rothblatt 19:40
Yeah, I was about to ask like, what the response is like when you start sharing. Do you find people are surprised, or it’s mostly just like you’re saying like, “Oh, it’s so nice to have someone who gets it?”
Liz Schumacher 19:51
I think that a lot of people really appreciate it. I think a lot of the academic medicine physicians I work with who are doing research and spending so much their lives trying to find cures for all different kinds of diseases. Often they’re really blown away like, “whoa, you’ve had four transplants? Oh my god, really?” Like they’re kind of sometimes in shock. I think there’s some clients who are like, “wow, that’s great, I know something else about her, but can she really execute on delivering what we need for our organization?” I’ve never been greeted with anything negative. I don’t think it’s ever really been used against me in any bad way. When I was sick, my clients were amazing. They would send me texts, notes, they were on my contact list when my husband would let people know how things were going. So they were really pretty incredible.
Zoe Rothblatt 20:36
That’s amazing to hear. Like, I’m just smiling, listening to you. Like, I feel like the patient community, and just like health community can be so welcoming and supportive. And while it can be scary to start sharing your story, I’ve noticed that like, once you do, first of all, like it gets easier every time. And people typically know someone or themselves have some sort of condition that they’re like, ready to listen and be there with you.
Liz Schumacher 21:02
100%. And I think having a medical condition, I mean, you understand, I understand. We probably subconsciously overperformed because we are so resilient. So to us things that might really get in the way of some people wanting to continue, we just keep like moving ahead. So when sometimes I think it’s a little sad, but it works in my favor that when the going gets tough, like that’s when I know how to manage crisis. I know how to manage difficult situations. I just move ahead and like, get it done. And I think that skill and coping mechanism I learned when I was young has proven to be an incredibly helpful life skill for me, that not everybody quite frankly has. And it’s just innate, when you’ve had to do it your whole life.
Zoe Rothblatt 21:43
Yeah, it’s true. It’s like you have to keep your head up and keep going. Because sometimes, like if you just slip into it and think about it all, like you’ll just slip deep down. And it’s like, we’re talking about this before, like coaching yourself through it. Like having others coach you through and like keeping your head up and keep going forward.
Liz Schumacher 22:02
100%.
Zoe Rothblatt 22:03
Well, Liz, this has been a really great discussion. And the last thing I want to ask you is what advice do you have for other patients?
Liz Schumacher 22:09
I do want to talk a little bit about healthcare sustainability. It’s one of the things that I’m really interested in at this point in my life, as I continue to pay attention to what’s going on in the world. And I would say I think all patients need to be paying attention to sustainability and what’s going on with Earth. I think some people might think that’s kind of crazy. But I think that we really do need to. If COVID didn’t teach us that crazy things can happen out of the blue, we need to start learning that. And you know, there are increasing numbers of infectious, rare infectious diseases that are popping up, all you need to do is like do a Google search, and you’ll see it every day and all different kinds of news sources. So I think patients need to be paying attention to not just their own medical condition, but also what’s happening on the horizon and how some of these new types of infectious diseases and things that are happening could potentially affect our health down the road. So I really want to make a plug for people to be thinking about sustainability and how they’re living and how they’re using and what they’re doing. So that we can also protect the Earth the best that we can just like we protect our own health. Because, if the Earth isn’t healthy, we’re going to have more diseases, we’re going to have more things that are going to be happening that affect us as vulnerable patients. So I’m really putting more time and energy into the next phase of my career on sustainable health care as well.
Zoe Rothblatt 23:28
And yeah, can you tell me a little bit more about that? Like how you specifically will be focusing on a health sustainability?
Liz Schumacher 23:35
I’m working with a team of others, physician, attorney, design thinking experts, to form a nonprofit called Greenwell, where we will be working together to improve healthcare sustainability. The nonprofit will be very focused on patients and health care providers and in improving our experiences. And there will be more information coming as we continue to grow the nonprofit, but I’m very excited about it. Because my hope is that people like us don’t have a life ahead of us of more COVIDs, and scary things that come out of the blue. I want to be as prepared, and I want patients to be as prepared and ready to advocate for themselves in their health. And regarding any advice for patients, I have so much advice for patients. I think it’s just delving into learning about your disease. I think it’s not being afraid to speak up, you know, the whole imposter syndrome thing people talk about. Your voice is the most important at any table where you’re discussing yourself. So doing research, asking questions, but making sure that you have a healthcare team who you really, really trust and are really, really smart, and listen to you and treat you as an equal so that it really is a discussion about your treatment options in your future together. And if you have any weird gut feeling like your voice is not being included, then you need to speak up or maybe you need to find another team but I think that most often it’s just speaking up and asking questions and being taken seriously and engaging because I think I’m here 40 Some years later with four kidney transplants and thriving and doing well because I have spoken up and I have demanded certain things for my medical care. And I’ve asked questions, and I’ve been comfortable taking risks. So I think just speak up, ask questions, learn, understand. Also, if you’re having symptoms or things from different conditions and treatments you’re getting, ask for help. If you have chronic headaches from a medication or GI issues, say, “Hey, I know that my health is improved my diseases improved from these medicines, but what can we do about the side effects?” Like, demand and ask for the best so that you can live as, quote, “normal life” that you can that is sufficient for you.
Zoe Rothblatt 25:35
Amen to that. It’s your body, so ask the questions, because you’re the one that’s going to be living with the symptoms or symptom free, right?
25:45
Absolutely. 100% you have to. And don’t be afraid. And if you get some kickback from somebody, just keep pushing it. That’s the time to be resilient and think in your mind, “What’s the worst thing I’ve been through medically?” Okay. Like I think about a dials to dialysis needles going in my arm. Okay. 123 Just say it, just do it. Force yourself to do it and say it.
Zoe Rothblatt 26:05
Well, thank you so much, Liz, for joining us sharing your story and about the work that you’re doing.
Liz Schumacher 26:10
Thank you for having me. I hope I didn’t say too much. But it’s a topic I’m so excited about. And I’m putting more energy and effort into this third act of my career. Helping patients is really what I think I’m meant to do. So I thank you for letting me join you today.
Steven Newmark 26:25
Wow Zoe, that was a really great interview.
Zoe Rothblatt 26:26
Yeah, it was great to talk to Liz. I just appreciate learning from her about how she blends her patient experience with her professional life and how she’s just starting to share her story more broadly. And it’s going to help so many people.
Steven Newmark 26:39
Yeah, totally. I’m gonna cut you off by just diving right into my learning. Just to hear from someone like Liz, who dealt with so much at such a young age, and how she was able to take these experiences and really turn them into to be a force for positive good is really just inspiring. Absolutely. Well, we hope that you learned something, too, and before we go, we definitely want to encourage everyone to check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 27:04
Well, everyone thanks for listening to the health advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating, write a review, and definitely hit that subscribe button wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 27:18
I’m Stephen Newmark. We’ll see you next time.
Narrator 27:24
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Fighting for Improved Access to Care for IBD Patients with Dr. Brad Pasternak
In this episode, we’re joined by gastroenterologist Dr. Brad Pasternak who talks about how his personal experience with ulcerative colitis inspired him to become a pediatric gastroenterologist. Dr. Pasternak realized he needed to advocate for policies that increase access to care after seeing his patients face denied treatments by insurance. He shares the tremendous effect that harmful policies have on the medical community, in delaying treatment for patients and getting in the way of shared decision-making. Finally, he leaves us with hope, discussing the advancements in treatment for inflammatory bowel disease.
Fighting for Improved Access to Care for IBD Patients with Dr. Brad Pasternak
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to the health advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, head of policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Director of Community Outreach at GHLF.
Steven Newmark 00:21
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life. So today, in anticipation of world IBD day, which is happening on Sunday, May 19, we’ll be interviewing a gastroenterologist in Arizona who devotes unfortunately far too much of his time to helping his patients navigate the system and make sure that they get on the proper therapies. Dr. Brad Pasternak will talk to us a little bit about some of the advocacy that he does on behalf of his patients.
Zoe Rothblatt 00:51
Great. I’m excited to listen.
Steven Newmark 00:52
Let’s get into it. All right, Dr. Pasternak, thank you so much for taking your time. It’s very much appreciated. We love all advocates here on the health advocates, but there’s something extra special that doctors are willing to take time from their busy schedules to travel to Washington DC, travel to their state houses, to help make lives better for their patients. And it’s not just travel, I know, it’s hours and hours of educating yourself on the complexities of step therapy, non medical switching, and how laws and policies can help patients. So thank you for being with us today, Dr. Pasternak.
Dr. Pasternak 01:23
Thank you for inviting me. It’s always nice to have a platform to try to reach more people about what we’re doing.
Steven Newmark 01:29
Yeah, excellent. So, let’s just start like, tell us a little bit about yourself. How did you get into gastroenterology as a specialty? How did your journey take you to Phoenix, Arizona?
Dr. Pasternak 01:37
Yeah, that’s always a great question. I’ve always known that I wanted to be a physician ever since I was young. And I’ve always loved working with kids just as a camp counselor, as a lifeguard. Just growing up my whole life, I’ve just interacted with children really well. And I got personally diagnosed with ulcerative colitis when I was in college. And so I immediately became fascinated with just autoimmune conditions, inflammatory bowel disease. More immunology and science behind it, and the fact that with all the research going on, we still don’t know what causes it, there’s no cure for it. So like I knew I wanted to do GI just based on my own personal experience. And then you know, when you think about that, it’s either dealing with no offence, old people and poop problems, or kids and poop problems. And I think there’s a big difference when you’re dealing with that.
Steven Newmark 02:31
Just to be clear, so I’m the old man with the gastro problems, right?
Dr. Pasternak 02:36
Yeah, or anyone else listening, or anyone else listening? So I clearly was heading towards the pediatric GI realm. Phoenix was completely unexpected. I did my fellowship training at Cincinnati Children’s and was at that time more geared toward research career, translational research, I was working in a really high power lab, and doing completely protected research time. It was just was one of those mornings that you wake up and question like, what am I doing? I think it was 7am. And I was literally giving a mouse an enema to give it colitis. And I just sat there saying, This is not why I went into medicine. I mean, it’s not that it’s unimportant, just from my personal interest. I love working with people and just sort of had a reevaluation at that time. And I met with my Division Chief Bill Balistreri, who’s a very well known name in the pediatric GI world. And he told me about this group that really fit my personality, and they were building a brand new large hospital and I came here in a February to visit to interview and left just snow icicles, gray skies, to 65 degrees and perfect weather, and I’ve been here ever since. You know, and they’ve given me the opportunity to build a robust IBD program and have given me a lot of support. And so yeah, really, it was just sort of very lucky and managed to find a group that was able to help mentor me and support. So here I am, 15 years.
Steven Newmark 04:08
Wow, that’s, that’s fantastic. Well, what led you to advocacy specifically?
Dr. Pasternak 04:12
That actually has been quite recent, I think more within the past five years. You know, when I think back to when I started practicing, the medical world was not the way it is today. It’s completely changed. And it’s been essentially taken over by dealing with payers and policies and prior auth and appeals, and it’s a completely different animal. And really, it’s come from wanting to do the best for my patients and fight for them. I was fortunate enough to have a patient who worked in health care policy for a large company and yeah, then I would call on her whenever there were issues or things that I just felt were wrong. I would call on her ask what her understanding was and ask for some, some help with certain situations and often gripe to her. She ultimately started to involve me in some of her projects. She involved me and I’ve written some stuff about step therapy reform here in Arizona. And we had a patient once, I remember, who I had written it was a teenager who was not growing, who was diagnosed with Crohn’s, moderate Crohn’s. Then I wrote for a biologic, which is the standard of care for that particular scenario. And they denied it stating that the patient had to fail three months of steroids before approving a biologic, which in actuality is malpractice. I mean, you’re not going to give a child corticosteroids stop their growth further and make them fail for three months. I mean, that’s just setting them up for a world of adverse effects. So she actually connected me with the CMO of that particular health plan. And then we set up a meeting and the meeting was 20 minutes, the CMO completely agreed with my concerns and not only overturned the denial, but then incorporated me in their new approval process, a new protocol for approving that particular drug. And we haven’t had an issue since. So that was my first experience of like, really making a difference, locally.
Steven Newmark 06:05
Wow!
Dr. Pasternak 06:05
And then, the stories go on and on. I’ve got multiple stories of scenarios of denials, that I just got more and more involved in advocacy, getting involved with NASPGHAN, which is our pediatric GI foundation. I’ve been working really closely with Camille Bonta, who’s our Washington advocate, and other KOLs in this space, because we’re all going through it. You know, I’ve been to Capitol Hill a couple of times. And I also started utilizing social media, which believe it or not, is quite a powerful tool in the advocacy realm, so.
Steven Newmark 06:41
Yeah, I’ve heard. Wait, I just want to take a pause for our listeners. The term KOL stands for key opinion leader, and it’s often used to, you know, correct me if I have this sort of on the right path, Dr. Pasternak. KOL sort of refers to doctors who are yeah, I guess key opinion leaders right. In this sentence, people who help influence opinions in the field?
Dr. Pasternak 07:01
Yeah, I would say they’re the experts in the field where, when you go to conferences, or you read papers, like they’re the ones that you sort of follow and listen to as far as how they approach different diseases.
Steven Newmark 07:13
Right. So, I’m very curious, can you tell us what it’s like when you’re traveling to, let’s use Washington. What is it like when you’re meeting with elected officials, or staff and policymakers in Washington or even at the local level as a doctor?
Dr. Pasternak 07:26
Yeah.
Steven Newmark 07:26
Because we talk a lot about what it’s like as patients to meet with elected officials, but what is it like as a doctor?
Dr. Pasternak 07:31
It’s interesting. So, like I said, I’ve been there twice to Capitol Hill. The first time I actually went representing an organization called the infusion access foundation.
Steven Newmark 07:42
Okay, yeah, we work with them.
Dr. Pasternak 07:44
Yeah. So Alicia Baron, who’s one of their people, used to work for the Crohn’s and Colitis Foundation, and I met her through a couple mutual contacts. I joined a group of advocates that consisted of patients, providers, infusion center administrators, and then we met with our local representative. And at that time, we were talking about prior authorization reform. What was interesting, it’s almost like how medicine is structured, where, you end up meeting with staffers, mostly.
Steven Newmark 08:13
Right, right, right, of course.
Dr. Pasternak 08:14
So, you know, I’m meeting these like, immediate post college graduates or law school graduates and, you know, very young, and they would relay the messages to the policymaker. And they, they would discuss various points of contention or support with them. And it’s a little bit, I’m not sure the right word, but you’d like ultimately, as a physician, and a person who’s, you know, I’m a professor, I’m a physician, I run a program, it’d be nice if I had a seat at the table with the policymaker, but, because I’m taking time out of my day, in my practice to come down there.
Steven Newmark 08:47
Sure.
Dr. Pasternak 08:48
I think the bottom line is, it’s a hard road.
Steven Newmark 08:51
Yeah.
Dr. Pasternak 08:51
And, especially on a federal level, once things are going through, and there’s legislation and you go and speak, it takes a lot to get through to them to convince them that you have a point. But the process also, the process takes a really long time to move the needle, which is frustrating.
Steven Newmark 09:03
Yeah, I’m really glad you said that only because it’s something that I say all the time when I’m with patients, particularly in Washington. It takes a long time.f The example I always give is the Civil Rights Act, is, did not start in 1964. When it was initially passed, it takes years, there was actually a civil rights act in 1957. And, of course, much pressure, that took a long, long time. And actually, in the realm of history, that probably was considered lightning speed on such an important topic, when it comes to the world of step therapy. And what we’re talking about, it’s much harder. The other thing, just to bounce off what you were saying, is, you meet with these staffers, or sometimes you’re lucky enough to meet with the actual elected official. And legislating policy, it’s not like, you can’t fit what you want onto a bumper sticker, it’s so easy to say lower drug prices. Boom. Like let’s do that, save, pro-patients. And then you create a legislation, and it has all these unintended consequences that weren’t thought about and people who are actually in the field like you, like patients, like me, that are just not thought about when the legislation is being drafted because it’s sometimes about, hey, it fit on a bumper sticker. It sounds great. Lower prices, whatever. Let me just, just to change tracks for a second. I know we talk all the time on the health advocates about the effects of various policies on patients. Particularly, you know, some insurance policies, and you were describing some of the steps that are put in the way and forcing a patient to be on a particular medication for three months. It’s absurd. But can you talk about the effects that these policies have on doctors? I mean, how do you even have time to deal with all this kind of stuff?
Dr. Pasternak 10:37
Yeah, I think that’s a great point. People don’t think about necessarily what it does to not even just doctors. I would lump the medical profession as a whole. As I mentioned, over the past, like 15 years, there’s been a total shift in this field. And it went from a lot more autonomy and shared decision making to literally any drug I write for my patients, with the exception of very few, requires a prior off. Which immediately leads to delay, no matter what. The second that process starts, there’s delay. And it’s, it’s nonsensical. It’s not based on evidence. So for me, you know, once that process starts, it’s the prior off, the denial, the appeal, then the repeat denial, then there’s a peer to peer. And for physicians, for instance, I have peer to peers almost on a daily basis where…
Steven Newmark 11:29
Hold on, Hold on, Hold on. Can you just explain to our audience what, what a peer to peer is?
Dr. Pasternak 11:32
It’s funny that they call it a peer to peer. That’s the biggest misnomer. I mean, peer to me implies friend, but no. So a peer to peer is a way, so if a medication is denied and there’s an appeal, it’s a way for the physician or nurse practitioner or to have a conversation with one of the medical directors of the insurance company to essentially state their case and argue why it should be approved. And it takes time. And peer to peer does not mean that if I’m writing for a Remicade for my IBD patient, that the person on the other end is a pediatric gastroenterologist, I could be talking to a geriatric gynecologist, I mean, honestly, he could be the furthest thing from my field. Where, we have this conversation so many times they say, “Well, you know, explain why you think this is worthwhile. And then your reasoning and well, you know, the literature better than I do. And I’m going to, yeah, that makes sense. I’ll approve it.” It’s a complete time suck that at the end of the day, you could look at the literature, I mean, almost 80% plus of prior auth that go through this process get overturned. If you’re someone who knows the literature and you know, that steps, you know, evidence based medicine, I mean, I never, I don’t want to say never, but I would say I’m probably batting greater than 95% in terms of my peer to peers getting things approved. So the peer to peers are scheduled. They’ll say, Oh, they’ll call you between one and three on Wednesday, with no regard to your schedule, right? And so I have patients there where I have to leave they say oh, excuse me I’ve been waiting for this call from a medical director I have to leave the room excused myself take the five second call to ultimately tell them, like they have that information, tell them what what I believe is get the the appeal overturned and then go back to my patients. Sometimes they don’t call, they’re always calling from some unknown number. And these days, our phones are getting attacked by possible spam. So you never want to answer these calls. And then, beyond that, they require, often, before even getting a peer to peer, you have to send something called a letter of medical necessity. So you have to put in writing exactly why you want to get this medication or get this study, get this test for your patient. That takes a lot of time. And then, lastly, staffing. I mean, we have staff now hired that is just dedicated to this process. They’re the ones that call, find out, you know, what’s on formulary, deal with the prior off, set up the peer to peers. We have to hire people directly to handle this backlog, to try to remove some of it from the physician. I recently did a survey nationally to ask about just medical providers and the effect that it’s having on them as far as time to approval administration time. I mean, it’s significant how much it affects everyone, and I’m sure is one of the causes of burnout, I mean, without a doubt.
Steven Newmark 14:30
Yeah. Oh my gosh, I mean, I can imagine. I mean, as a patient, I’ve dealt with insurance companies, and I’ve had my battles, and I’ve had to put things in writing. And I find it to be exhausting to do it for myself. To try and be a doctor, or I’m actually meeting, I have other, let’s just say other things going on, I can’t even imagine. So I’ll say it again, just thank you for all that you do. I know how time consuming, how tough it must be. Let me ask you something more positive. Can you tell us you know, you’ve been practicing for two decades-ish, in the two decades range, I think it’s fair to say. Can you tell us some of the differences in in patient outcomes today, versus when you first started practicing?
Dr. Pasternak 15:05
Yeah, absolutely. I mean, it’s it’s night and day, even from when I was diagnosed with ulcerative colitis, probably when you were diagnosed with Crohn’s. At that time, for me, it was steroids, anti inflammatories, and that was there for a while. Then some of these newer immune modifying drugs came out with unfortunately, lots of side effects. But now there is just this surge of newer therapies that are more effective, that are safer, and they changed the game. I mean, in the past, it was the goal was always make the child, make the patient feel better, right, let’s improve their symptoms, let’s improve their labs. But now we’ve gotten to a point where we want to actually heal the colon. I mean, we want to be able to go in and show that everything is completely normal, which we didn’t have the opportunity to do with the older drugs. And obviously, our goal is to avoid surgery. Avoid surgery and avoid steroids, I mean, that’s our ultimate goal. I look at there was a an algorithm for patients with acute severe colitis, for instance. They typically will, these kids will come into the hospital, they’ll have terrible disease, and the algorithm was published in like 2017, so not very long ago, and it called for steroids, a trial of Remicade, maybe a second trial, Remicade. And then colon comes out. I mean, it’s just sort of that’s the pathway. Where now, we’ve got newer drugs, we’ve got medications that work very quickly, and ultimately, we need to already relook at that pathway to say, I mean, I think we’ve outgrown it. And I think we have the possibility of using newer medications to prevent colectomy. So yeah, patient outcomes today are significantly better with safer medication.
Steven Newmark 16:48
Yeah, it’s a better world. One thing I always say to patients is, excuse my language, it’s sucks to be a patient. It sucks having this condition. But if there’s any time on earth to have contracted it, this is where you want to be, things are getting better each day, and newer and newer therapies are coming out, so be positive. So let me ask you, what is one takeaway that you would like to impart on other medical providers on patients and on caregivers.
Dr. Pasternak 17:09
I would say that, as we mentioned it takes a long time for things to change, and there’s no quick fix. Things are not changing tomorrow. The more people get involved, the higher the likelihood that change will happen quicker. And that, I guess from a physician perspective, the goal of a lot of these payers and these processes is to almost wear us out and give up and not necessarily put in the effort put a patient on a cheaper, less effective medication to not have to deal with going through the process. That is not the answer. I would say just I always say what if it was your child, treat every patient as if it’s your child and fight as hard as you would for your own child as you would your patient and don’t give up. From a patient perspective, I mean, I applaud you for writing letters and being involved. A lot of patients don’t know what to do, and don’t really have the guidance. As far as the approach, I always tell patients like this is going to be a two pronged attack. I will fight them on my side, you fight them on your side, and let’s see if we can get them to change their decision. So having patients really just take initiative and fight for themselves. Contacting their HR department, if it’s, you know, a plan through their employer, that’s always helpful. Contacting the state insurance commissioner, that always helps. There are people here to help us and try to disallow some of these practices. Social media, I think is great. You definitely need to be careful. Because obviously, you know, especially if you represent a company, an employer, or an institution, you know, your name gets tied to whoever you work for. And so be careful in regards to that. But at the end of the day, I would say, just keep fighting it. Even if you’re not sure, the next step, there are groups like yours, there are advocacy groups that exist all over, and they’re always looking for people to help.
Steven Newmark 19:04
Yeah, that’s fantastic. I’m just going to add one more from what you said earlier, I liked the idea that you said, that you got involved because of a patient of yours, who happen to work in health advocacy, but everyone listening to this podcast, works in health advocacy, whether they know it or not. So you’re an advocate. And that includes talking to your doctors about what you’re going through. And you could bring in more folks like Dr. Pasternak to help our causes. And that’s fantastic.
Dr. Pasternak 19:27
And just briefly, because I didn’t mention anything of what I’ve done locally, that actually moves a lot quicker than federally.
Steven Newmark 19:33
Good point.
Dr. Pasternak 19:33
So I ended up getting contacted by the Arizona Medical Association, they’ve got an advocacy division. And he reached out to me, because of, he heard about my work in all of this, step therapy, non medical switching, et cetera, and asked if I wanted to testify on a local Bill involved with something called non medical switching, which is a payer dictating a switch of a medication to a cheaper medication or a biosimilar, despite the patient doing extremely well on their current therapy. And so I actually, I got to testify at the local house. And they actually were very grateful, not only the Medical Association, but the legislators were grateful to hear my perspective. And so, I don’t think they get a lot of physicians that actually testify. I know we, we’re busy, but it can make a big difference.
Steven Newmark 20:23
Yeah, no, that’s a really great point. Let me end our discussion here by asking, can we make a promise that we can meet up someday in Washington, or perhaps even at the State House in Phoenix, work together to advocate.
Dr. Pasternak 20:33
Absolutely. I think before the podcast, we were just catching up, and my comment was that we’ve got so many people working on the same thing for whether it’s rheumatoid arthritis, or psoriasis, or I mean, whatever, all, lupus, I mean, all these chronic disease states have their own advocacy groups. And really, I think we all need to work together, because the concept, the fundamental issues are the same. And it’s preventing delay, preventing prior authorization, or having some reform there, not preventing it, but having some reform, depth therapy, it’s all the same fundamental concepts, it just in each disease state. And it’s something where a group like yours that work in multiple disease states.
Steven Newmark 21:17
Yeah!
Dr. Pasternak 21:17
That’s where this needs to go.
Steven Newmark 21:19
Yeah, no, absolutely. Well, this has been fantastic. You know, again, we’re so grateful for your time. Thank you, Dr. Pasternak. And we look forward to continuing this dialogue, as I said, perhaps in Washington or in Phoenix, we’ll link arms together.
Dr. Pasternak 21:31
Absolutely. Thank you for having me.
Steven Newmark 21:35
Thank you.
Zoe Rothblatt 21:35
Wow, Steven, that was a really great interview. And it just reminds me of like the power that doctors have to advocate for patients and really be a partner in care.
Steven Newmark 21:44
Yeah, no, absolutely. It is so unfortunate that doctors have to spend so much of their time doing advocacy and fighting for their patients and dealing with this prior authorization, all the other stuff that Dr. Pasternak was talking about. I mean, doctors really should be you know, practicing medicine, but such is the world we live in, right, Zoe?
Zoe Rothblatt 22:01
Exactly, and we’re grateful for doctors like Dr. Pasternak who work hard to fight against these egregious policies.
Steven Newmark 22:08
Absolutely. Well, I’m gonna cut you off and say that was my learning, the difficulties that are faced by doctors on their end when fighting for us and how grateful I am to have great doctors out there like Dr. Pasternak.
Zoe Rothblatt 22:17
Ditto.
Steven Newmark 22:18
Alright, well, we hope that you’ve learned something too. And before we go, we want to encourage everyone to check out all of our podcasts at ghlf.org/listen
Zoe Rothblatt 22:26
Well, everyone thanks for listening to the health advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you like this episode, give us a rating, write a review on Apple podcasts, and hit that subscribe button wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 22:41
I’m Steven Newmark. I’ll see you next time.
Zoe Rothblatt 22:43
And Happy World Diabetes Day.
Narrator 22:49
Be inspired, supported and empowered. This is the global Healthy Living Foundation Podcast Network.
Celebrating Lupus Awareness Month with New York City Council Member Shahana Hanif
In honor of Lupus Awareness Month and Lupus Day of Action in New York City, we’re joined by New York City Council Member Shahana Hanif. Council Member Hanif shares about her life as a lupus patient and how her condition informs her work as a member of the city council. She underscores the importance of accessibility within New York City and the idea of creating infrastructure to help patients with chronic conditions live and age in peace.
Celebrating Lupus Awareness Month with New York City Council Member Shahana Hanif
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Head of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Director of Community Outreach at GHLF.
Steven Newmark 00:20
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life. Today, we’re going to talk to a special guest New York City Council Member Shahana Hanif about her life as a lupus patient and how her condition informs her work as a member of the city council. But first we’ll talk about some news. And actually, I want to start by acknowledging Earth Day which took place this week. So we’re a few days late, but I had an interesting learning this week from my favorite epidemiologist, Katelyn Jetelina, and from her I learned that roughly nine percent of all plant life on Earth has been used in traditional medicine to treat and prevent disease. So, go Earth! Plants have gifted us with important medications for the treatment of cancer, pain, aspirin and morphine, for example, infection, diabetes, heart disease, and more. Thank you, Earth.
Zoe Rothblatt 01:06
That’s really cool. Thank you, Earth. We know that going outside, and like walking outside, spending time with fresh air and sun is your health. But I had no idea that so much of Earth plants were helping us in forming medications.
Steven Newmark 01:20
Yes, thank you Earth for all you do. And specifically, we’re gonna say thank you for your medicine. Okay, let’s get into it. What’s going on?
Zoe Rothblatt 01:26
So biologic therapies have a potential use in COVID-19 treatments.
Steven Newmark 01:32
I’m not surprised. They’re great medicines. So the traditionally used to biologic therapies, of course, focuses on managing autoimmune diseases. There’s ongoing research into the potential role in treating complications arising from COVID-19.
Zoe Rothblatt 01:44
And the rationale behind this is basically similar, the overactive immune response similar to what you have in an autoimmune disease that COVID in severe cases can trigger a hyper-inflammatory response. So the body’s immune system not only attacks the virus, but also healthy tissues causing like a cascade of inflammation.
Steven Newmark 02:04
Yeah.
Zoe Rothblatt 02:05
And that biologics can specifically target this inflammation.
Steven Newmark 02:08
Totally makes sense to me, sort of, I guess, I’m not a doctor or scientist, but it totally makes sense, just intuitively. So I’m happy to see that I’m happy to see even more uses for some of these great therapies. Well, now let’s get into our interview with the council member.
Zoe Rothblatt 02:23
Great. I’m excited to hear.
Steven Newmark 02:24
Well, let’s start by introducing our guest today, New York City Council member Shahana Hanif, representative of the 39th Council District in Brooklyn. Councilmember Hanif was born and raised in her district and was diagnosed with lupus at age seventeen. She’s the first Muslim woman elected to the New York City Council and the first woman to represent the 39th district. Thank you for joining us, Councilmember. We’re excited to talk to you today.
Councilmember Hanif 02:46
Thank you so much for having me. I’m super honored to be your guest.
Steven Newmark 02:50
Yeah, excellent. And we’re here in part because on May 1, we’re going to do a Lupus Awareness Day in New York City. That we’ll be co hosting, spearheaded by an event at NYU Medical Center. So we’re excited for that. And we’re excited to raise awareness for lupus here in New York.
Councilmember Hanif 03:05
Absolutely.
Steven Newmark 03:06
So let’s jump right in at the beginning of your patient journey, if you don’t mind. What was it like growing up in Brooklyn and then at age seventeen, getting a life changing diagnosis?
Councilmember Hanif 03:15
So I was born and raised in Brooklyn, in a neighborhood called Kensington, which I now proudly represent, it is home to a thriving Bangladeshi working class immigrant community, which during my tenure as council member, I’ve been able to rename as little Bangladesh. It is the largest Bangladeshi enclave in Brooklyn. And so I grew up with parents who worked very hard. We never missed a day of school and I got to see what being a daughter of immigrants means in a community that had very little access to city services. And leading up to my diagnosis, we didn’t have a routine health care center that we visited. And so leading up to my diagnosis at seventeen, I was experiencing a myriad of issues and I had debilitating migraines, toothaches, swelling in both of my feet. And I had essentially seen these as individual issues and not part of a larger pattern of what could be an illness and so I was taking off the counter medications like Tylenol and would one day feel better the next again, there was another piece of symptom that was exasperated and so it wasn’t until my mother had seen my swollen feet that she was like, we have to go to the emergency room and that was our go to anytime we were sick. We would just run to the emergency room.
Steven Newmark 03:29
Yeah.
Councilmember Hanif 03:45
And that visit changed my entire life. We were there waiting for over twelve hours. And at the time it was Ramadan. So my mom and I were both fasting, we broke our fast at the hospital. And then when I got called in blood pressure was examined, urine tested, and both protein in my urine and the blood pressure were so high that they were like we need to keep you. There’s something that we need to investigate and find out what’s causing this rupture. And I remember feeling very lost and very confused. My mother also just in a frenzy, we were both very scared and very anxious. And I had never witnessed anything like this in my life. My parents had never with me and my two other siblings experienced anything this heartbreaking and this life changing.
Steven Newmark 05:45
I’m just curious, you were so young, and you were seventeen. Had you heard of lupus before? Did you have any idea what lupus was?
Councilmember Hanif 05:52
So interestingly, I had heard of lupus. But I was surprised when when I received the diagnosis, because at that moment, I couldn’t recall where I had heard it. But I had heard it on America’s Next Top Model.
Steven Newmark 06:05
Oh.
Councilmember Hanif 06:06
One of the earlier seasons and a one of their contestants who had gotten to the final round or the top three in one season, Mercedes had a flare. She was experiencing flare, and she on live television shared that she wasn’t feeling well, she was feeling sick. And so I recall that moment of onscreen, just vulnerability. So I’ve definitely heard of it. But then it also made me think about the fact that outside of that particular moment, I had no other example of anybody with chronic illness, or anybody openly sharing that they’re not feeling well outside of it being specifically older people, that older people are sort of relegated to illness and sickness and disabilities, but then a whole community of people are sort of getting by without talking about being sick or feeling unwell, or just the sheer stigma around these conversations. So I was curious as to why that was. And I think that served for me as a catalyst to wanting to do something different, to be very open about what I was experiencing, particularly because I belong to a close knit community. And that was what served to me as a catalyst for change. And for me to be an advocate both for myself, but all others who have been alienated or abandoned by illness.
Steven Newmark 07:31
Yeah, first of all, I just want to say so much of this resonates not just with me, I know it resonates with our patient community, the idea of needing a community and being a part of a community is a really big deal. So I’m curious how you went from the emergency room, not having a regular doctor, I presume by now you do have a regular doctor that you see.
Councilmember Hanif 07:50
I do.
Steven Newmark 07:51
So how did you get connected to the right places, and what were some of the challenges that you had to deal with to find the right doctor?
Councilmember Hanif 07:57
Sure, so the hospital I first turn to the Emergency Center was not the hospital that I received my initial years of treatment. In fact, that first hospital did not have a pediatric rheumatologist. So they were very much incapable of really making sure that I was receiving adequate and efficient treatment. However, they were able to move me out to a hospital and my birth hospital actually, I received care from Maimonides and was under such tremendously compassionate, dignified care with a rheumatologist, a nephrologist, and endocrinologist. I mean, I had a whole team of pediatric.
Steven Newmark 08:38
A lot of “ologists.”
Councilmember Hanif 08:39
That’s right. But initially, it was very tough because I had not navigated health care and hospitals in this way. And coming from a household where sickness was not seen with much importance, or was seen as well this is going to pass. So let’s just keep on keeping on. This was the first time that I was forced to take a pause, forced to take a pause and navigate what is a very nebulous system to tackle and not just for our immigrant or limited English proficient communities. But even as somebody who speaks English can read and write in English, this is a tough system to navigate. And I was also on top of everything uninsured, I did not have health insurance, and it just all felt overwhelming. And so once I moved on to my Maimonides, I mean, slowly, the treatment process became a bit more open to me. However, I felt that if I did not at the same time talk about the hurdles, I would have a much harder time I wanted to be able to connect with other people. I wanted to be able to connect with other women, which is why I was writing at the same time I had a blog called Shahana with Lupus, and I was keeping a diary, a public diary of sorts to share out instances that I felt were unjust. I had applied for Access-A-Ride, our city’s paratransit service and had been rejected and it bothered me so much. It infuriated me that somebody like me who now needs to go back to school, or go to doctor’s appointments, or just hang out that everything was at stake because of this rejection by Access-A-Ride. How would I get around the city, it felt inhumane and cruel that the lack of this opportunity meant that I could not leave my house that I would have to pay hundreds of dollars in cab services to get around the city. So, I really channeled my activism and my anger into activism rather to be able to talk about this.
Steven Newmark 10:47
We love that here on The Health Advocates.
Councilmember Hanif 10:49
Yeah, that’s right. So I use writing as a tool to one get closer with my friends. Because this was also within our age group. I was as a seventeen year old, unfamiliar, unfamiliar territory. And I didn’t want this diagnosis, I didn’t want lupus to be a secret. I didn’t want this to be an issue that I deal with at home with my parents. I wanted this to be a facet of my life, and for my friends to be involved in care.
Steven Newmark 11:17
Yeah. Let me ask you, you’re an elected official. How has that come up on the political trail, if you will? How does it come up day to day when you’re in the city council itself, affecting your positions, perhaps on certain pieces of legislation, but first talk about the politics of it and like managing were on the campaign trail? What was it like?
Councilmember Hanif 11:33
So, I have been very open about lupus since age seventeen, from the onset of this public blog to my first job as a tenant organizer and fighting to be able to work from home. Lupus has impacted every part of my life. When I decided to go to Brooklyn College, I chose the school because the B11 bus took me straight to my hospital, I knew that being close to home would mean that if my parents ever needed to pick me up, they could do that within 10-15 minutes. So everything revolves around care. However, our city is not built that way. Our city is not built in a way where everyone can just choose well, because the bus is here, I should go to the school, I was fortunate to be able to maneuver my life around buses and access to care. But that’s not in totality how our city is built, people have to go out of their communities to go to the hospital of their care or of their choice, right? Or the elevators may not be connected to the transit system where your Hospital is located. There’s so many challenges. And so for my run for city council, speaking about lupus was foundational, it’s a part of my story. It’s how I’ve navigated living in the city, whether it was my fight for equitable transit system, I fought really closely with my neighbors for the Seventh Avenue F G station elevator, which is right by the Methodist Hospital. And that was a huge campaign and it just recently got built under my tenure. And so anybody coming into Seventh Avenue in Park Slope has an elevator access, which is tremendous news for us. And this was years of organizing, to language accessibility issues within our broader city agencies making sure that immigrant working class families have access and feel empowered to receive health care. So on the campaign trail, I talked about lupus, I shared the impacts of what it looks like to not have adequate health care access, and particularly I ran during the height in the wake of COVID. And so this was not unfamiliar, my speaking about lupus was not an unfamiliar or rare conversation, because everybody in the city was impacted by COVID, if not directly, they had a family member they were taking care of, or they knew that they had to take time off to take care of a family member impacted by long COVID. So this conversation was and continues to be mainstream. And I think it’s very important for us to be able to talk about illness and chronic illness and also the mental health aspects very openly and candidly. Through my time in the council, I’ve been open with my colleagues as well and may is officially Lupus Awareness Month in our city and I’m looking forward to again celebrating it this year. But the way in which I’ve looked at disability, chronic illness, mental health issues is by fighting for guaranteed housing, by fighting for education equity, by ensuring that we’re improving on remote work access, and making it so that no one feels abandoned by the city and lupus has been a launching pad and foundational to every single piece of legislation that I fight for.
Steven Newmark 14:54
I do want to ask one last question, but before I did.
Councilmember Hanif 14:56
Yeah.
Steven Newmark 14:57
I mean just last week. I mean, this is not ten years ago, I was on the phone fighting for a particular therapy and dealing with my insurer. And after a few hours on the call, I was exhausted. And when I hung up, I actually said, well, you just created another health advocate or something like that another patient advocate. And as they hung up, I realized like, wait a minute, first of all, I already am a freaking advocate.
Councilmember Hanif 15:16
Yeah.
Steven Newmark 15:17
But I was like, you know what? Now I’m even more pumped up. And the whole idea what you were talking about Access-A-Ride and when things excuse my language, but when they align to screw over patients when the system is not set up in a way to help patients, but there are impediments in the way, the one positive, the one bright shining thing is that it does create more advocates to fight. So that’s good. So last question, councilwoman, how do you use your position on the city council to raise awareness about chronic illnesses like lupus and advocate for improved patient care, you spoke about the improved patient care a little bit, but?
Councilmember Hanif 15:46
Yeah, I first and foremost, I’m very honest about my own life. I am somebody who continues to be a part of the healthcare system, I am impacted. I just had my hip replaced at the onset of my term in 2022, I had to get a revision. And so the Hospital for Special Surgery is my lifeline. I have all of my doctors and care there. And to be able to be a legislator who needed to get a full hip replacement, again, is something that was so new to my colleagues. And you know, I’m 33 years old. This is a story that requires to be told, I want to make sure that the fight for health care access and improvement is not just something that is theoretical, that our constituents get to see that we have champions in elected office who are also impacted by illness. And they have navigated the tumultuous healthcare system and are fighting for better care. I also participated in lobby days I go to DC for lupus advocacy, we need more money in research, we need more money for medication that is without side effects. And we need a city that is built for us to be able to age in place. And so the age in place piece is particularly important for me, no one should need to move away from their homes simply because they have a set of stairs, we should be able to age in place and create housing and infrastructure that allows us to get around the city without any impediments. And so every part of my fight for just budget and for improved legislation for transformative legislation is through the lens of disability justice. And that is important for me. And because I speak about it, it has certainly influenced my colleagues to think about all pieces of legislation in this way, we must, the city should be built for all of us, not just for some of us.
Zoe Rothblatt 17:43
Well, this has been great. Thank you so much, Councilmember for joining us today. And if we don’t see you in New York City, if not, perhaps we’ll see each other or we can join up in Washington the next time you’re there with some of our patient advocates as well as we continue the fight.
Councilmember Hanif 17:57
Thank you so much, Steven, this was such a wonderful conversation.
Steven Newmark 18:01
Yeah, thank you.
Zoe Rothblatt 18:04
Well, Steven, that was a really great interview. It’s fun listening to you have a conversation with the council member and just really reminded me of the importance of raising awareness about lupus and having conversations with elected officials and bringing the community together.
Steven Newmark 18:18
Totally. I learned something, something we already knew. But elected officials, there are people just like us isn’t that something isn’t that in one of the magazines? They’re just like us. Celebrities too, are just like us. They have diseases and ailments that we all have to deal with and go through their lives. And the more folks I think of public prominence, you have conditions and speak out about living life with those conditions, the better we can be as advocates, and we hope that you learn something too. And before we go, we want to encourage everyone to check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 18:46
Well, everyone thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you like this episode, give us a rating, write a review, and hit that subscribe button wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 19:04
I’m Steven Newmark. We’ll see you next time.
Narrator 19:10
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
The Balancing Act of Chronic Illness with Shonta Chambers
We’re joined by Shonta Chambers, who serves as the Executive Vice President-Health Equity Initiatives and Community Engagement for the Patient Advocate Foundation (PAF). Shonta explains how social drivers impact one’s health, including things such as housing and economic status. We dive into the case work she does with PAF to combat these challenges and connect patients to resources. She also shares about her personal journey of being a caregiver.
For more information about the Patient Advocate Foundation visit: www.patientadvocate.org
The Balancing Act of Chronic Illness with Shonta Chambers
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Director of Community Outreach at GHLF.
Steven Newmark 00:20
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:22
And today, we’re joined by Shonta Chambers with the Patient Advocate Foundation. I had a really wonderful conversation with her about the work she does at Patient Advocate Foundation to improve health equity and connecting patients with resources for all things that go into their health. We talked a lot about health disparities and how things like transportation and your housing impact your health. So Steven, I’m excited for you to listen.
Steven Newmark 00:49
Yeah, well, let’s get into it.
Zoe Rothblatt 00:51
Welcome, Shonta.
Shonta Chambers 00:52
Thank you so much, Zoe for having me. Excited for today’s conversation.
Zoe Rothblatt 00:57
Me too. Why don’t you start off by introducing yourself to our listeners?
Shonta Chambers 01:00
Hello, I am Shonta Chambers, and I’m the Executive Vice President for Health Equity and Community Engagement for Patient Advocate Foundation. I am also a mother of two amazing young men, and I’m a caregiver for my mother who is living with progressive multiple sclerosis, and my father who is actually a stroke survivor. So I get to be an advocate in my profession, and as well as being an advocate in my personal life. So. that’s a little bit about me.
Zoe Rothblatt 01:28
And can you tell us more about your work with Patient Advocate Foundation and how you advocate on behalf of patients there?
Shonta Chambers 01:35
So, Patient Advocate Foundation as an organization, we’re really at the nexus of addressing access and affordability issues for persons living with chronic and complex health conditions across all 50 states. And that is really bringing to the forefront those various social and financial drivers of health and health inequities that people are living with every day. So it was really about looking at insurance and helping those who may be uninsured, identify and enroll in a health insurance plan or for those persons who may be insured and have a course of care that has been denied, working with them to actually file an appeal against that denial. Or for those folks who are just really needing financial resources to address everyday costs of living expenses, like utilities, rent, mortgage, even groceries, and transportation, to even things such as helping folks actually apply for or social security disability. So it’s really addressing everything across the spectrum of health and across a spectrum of health care, but more so focus on those social and financial aspects and less of the actual clinical aspects.
Zoe Rothblatt 02:40
And can you tell me more about that, how those social and economic aspects impact your health? I have a background in public health in policy and management and we always talk about social determinants of health and it might surprise people to learn how much these other factors like you’re saying outside the clinical impact your health, and can you tell me about like more about that, and what you’ve seen in the patients you work with.
Shonta Chambers 03:04
So there was a study done some time ago, and it really outlined the fact that 80 percent of one’s health outcomes are actually attributed to the social drivers of health or the social drivers of health inequity. And that includes things such as where they live, their economic status, and all of these factors, like you pointed out that are all non-clinical base. And so it’s really about understanding when someone is uninsured, how that hinders their ability to access and adhere to care. If someone is underinsured, that hinders their ability to access and adhere to care. If someone lives in a food desert and let’s say that there’s a course of care that requires them to have a healthy diet, that impacts their overall quality of life. Let’s say that someone lives someplace where it’s a transportation desert, and they don’t have adequate transportation, then it also hinders their ability to be able to access care, because if someone has to travel two or three hours to get to doctor’s appointments, and back and forth, etc, how that does have an overall impact on their overall health. And also for those people who may be living in dilapidated housing or those folks who may be housing insecure. I think it’s so important for us to understand that what homelessness looked like several years ago, which was basically we always have this vision of homelessness, of people living on the street, that now we have a new definition of homelessness, we have new characteristics of homelessness. And right now what we’re seeing is a lot of people who are living in these long term care lodges or these log extended stay hotels, and these individuals are actually classified as being homeless. So these are all of those other factors that we really have to think about, because they have a significant impact. That is why it’s so critically important that we have active conversations around these things, but also make sure that we’re having these policy discussions around these things as well.
Shonta Chambers 03:07
And what sort of policies or resources do you promote as a foundation? Like if a patient calls you up and let’s use your example of transportation that they need help, can you walk us through, like how you would help that patient and what you offer?
Shonta Chambers 05:15
Absolutely. So let me start by saying that we have a cadre of amazing case managers. And they are some of the most passionate and hardworking individuals that I have ever encountered, not just our case management team, but also our team that works across our entire enterprise from our copay assistance program to our financial assistance program. And so let’s take this example, let’s say that we do have a patient that comes to us, and they’ve identified transportation as a barrier. Let me also point out that is so critically important that the patients that are coming to us never come to us because they just have one challenge. So that patient who’s coming to us may be coming to us because they have an immediate transportation barrier. But because our case managers have been in this space for so long, they know that once they began to ask more questions, they’re going to find that there are more layers to this onion. So not only does that person have a transportation problem, they may have some difficulty paying for their utilities, they also may be experiencing difficulty paying for their medication. So on that transportation situation, what that case manager is going to do is look to see if he or she can actually find resources at the community level or someplace else to really be able to respond to that transportation need that that person may have. The beauty of them doing this further exploration around the needs of a patient is, let’s say that they can’t find a viable transportation resource. But they do know that this person is also having some challenges paying for medication or actually paying for their utilities. But in those two lanes, they may be able to find a viable resource. So what they may do is find that viable resource to address that medication cost issue, or that utility issue in the hopes that that will free up some additional resources within the home that now this patient can direct towards addressing that transportation barrier. So they are really some geniuses in this space and really navigating. So it’s like if they can’t find a solution to one thing, maybe if they can find a solution to something else, then it can help work with that patient or that caregiver who may be calling us on a patient’s behalf to reallocate those resources to address the need that they may be calling us about. But that is only once they’ve exhausted all possible options. And that’s what they do every single day.
Zoe Rothblatt 07:34
And I think what you guys do is so incredible, because it’s just so exhausting being a patient. And like you’re mentioning, there’s so many aspects to focus on, and to know that someone can call you guys up and get that help. And maybe you’re asking questions that they haven’t even thought about themselves, because you’re just so overwhelmed with the chronic illness. And it’s amazing that you can take away that burden from a patient and be able to support them in a time of need.
Shonta Chambers 08:00
Absolutely, we actually just completed a survey to really look at administrative burden. And those results, of course, can be found at our Patient Insight Institute. And it was just really amazing to elevate the urgency of minimizing the administrative burden that patients encounter as well as their caregivers, because it can sometimes take weeks and months and sometimes years to bring resolution to some of the challenges that they are experiencing. And I think it’s the reality that we have to understand the urgency of now. So when patients or caregivers who are coming to us on their behalf are seeking assistance or seeking help, they’re needing it like now, not three months from now, not six months from now, and not a year from now. And if I can call out when we talk about patients who are living with rare diseases, we’re talking about that disease odyssey even being much longer. So it’s just critically important for us to also understand the enormity of the administrative burden that is also on the shoulders of patients. So they’re trying to balance the administrative requirement to get assistance for things while at the same time they’re also trying to manage their condition. And that’s a balancing act that I don’t think any of us desire.
Zoe Rothblatt 09:13
And maybe this is too personal. But do you ever feel that burnout was doing it every day in personal and professional life?
Shonta Chambers 09:21
Absolutely. I’ll use my mom for an example. So my mom is bed bound as a result of her MS and there is a program in the state where I live that allows persons who would qualify for skilled nursing care to be able to receive the care in their home. So one of our case managers told me about this program back in 2022. August of 2022 was actually when we started this process. We are now sitting in March of 2024. And I am still trying to get her the first day of in home service. And so I consider myself to be somewhat intelligent on most days, right. And so here I am trying to navigate the system, and I’m having these significant delays. And I do this, or I’m in the space with people who do this every single day. And I don’t think we sometimes realize the emotional and mental toll that this can even take on a patient or their caregiver or whomever, we’re talking about 2022. And here we are in 2024. And fortunately, I am able enough to be able to care for my mom. But what if I wasn’t? And then on the other side of that, I still have to work every single day. And so what about those folks who don’t have that type of social support system? What do they do? And oftentimes, you know, what they do they just give up. And that’s not right. That’s just completely unfair.
Zoe Rothblatt 10:45
Totally. And I think a huge part of this, too, is the health literacy. So because of your work, you know, all the right questions to ask, and you know what words to use, and you’re still confronted with the barriers and the delay. And I’m just thinking about all the people that don’t do this every day in their life, and are just so confused when they pick up the phone and really just don’t know what to do. Not by any fault of their own but just because you’re learning as you go in a lot of these healthcare scenarios.
Shonta Chambers 11:13
That’s the beauty of what I appreciate about how PAF as an organization approaches our engagement with patients. And so going back to our case managers, whenever there is a moment to do a conference call with a patient or their caregiver, when we’re trying to bring an issue to resolution, we use that as a teachable moment. So they use a lot of three way calling so that that patient or that caregiver can hear the question that they’re posing, they can also hear how they’re responding to questions that are being asked of them. And we use those as teachable moments so that if individuals ever find themselves in these situations, again, they at least can draw back to what they heard in terms of how our case manager may have posed a question or how they may have actually responded to a question. Basic literacy in our country is still a challenge and so when you add on top of that health literacy, it just becomes a greater challenge. And so being able to use these audible opportunities, as teachable moments is also a way how we try to really build self advocacy among our patient population.
Zoe Rothblatt 12:17
And what are some of the other common like challenges or lack of resources that you see in your work?
Shonta Chambers 12:23
Housing.
Zoe Rothblatt 12:24
Yeah.
Shonta Chambers 12:24
Housing has been a huge challenge in terms of affordability with everything that has been happening, housing has really risen to the top for so many individuals. And housing is critically important for a number of reasons. Imagine the anxiety associated with not know that you have safe and secure and stable housing, especially if you’re someone living with a chronic or complex health condition. So housing would be one of those things. And then again, for those who are still able to maintain their housing, everything that goes along with cost of living, so cost of living continues to be one of those major issues that we hear from our patients all the time. And I’ll round that out and say costs associated with care whether that’s direct pharmacologic costs, or costs associated with having to travel to care, co-pays that are associated with their care, those would probably be the three, like I said, housing, of course, the ability to afford cost of living related expenses, and costs of care related expenses. That is what we hear most often from the patients that we serve.
Zoe Rothblatt 13:32
Yeah, it’s so hard, because like a lot of just what you would call healthy people are dealing with these challenges. And then when you’re managing a chronic disease, which I always say is like a full time job, it really requires so much. And then when you physically don’t feel well, and you should want to like curl up in bed, but you don’t have a bed, you don’t have access to reliable comfort to take care of yourself. Like it feels like it should be a basic human right.
Shonta Chambers 13:57
Right, so if I go back to that example, when I think about the new face of homelessness, when I said people are now living in these long term care, hotels, these kind of quad living environments, and probably you’re talking about a space that has one of those little cubic refrigerators. And at that, for those of us who are fortunate enough to be able to go to college, they were in our dorm rooms, right until it was enough to maybe keep maybe some water and maybe one or two snacks. But for lets if you have someone that is on a therapy of any type that needs to be refrigerated, or someone who again needs a healthy diet to accompany their therapy, how much of a healthy diet can you store in one of those itty bitty tiny cubic size refrigerators. And then for those who have to store medication, you’re having to balance how much of that space is used to store your medication, as well as how much of that is used to store your food and things of that nature. And so when we talk about it in that context, we cannot ignore the relationship with health and housing as we think about what it looks like for people as they move forward.
Zoe Rothblatt 15:02
I never even thought about that just the attention to detail and how you move through the day. And as something as simple as the size of a refrigerator could dictate your health and how often you have to get up and go to the store. And just the privilege there to even visit the store every day and trying to maintain a job. And it’s just so layered when you really dig deep.
Shonta Chambers 15:23
And Zoe that’s making the assumption that there was a store that you can get up and go to right. If we think about so many of our communities, the major market is Pinky’s convenience store. And the closest thing to a fresh fruit and vegetable, may be that banana that’s been sitting on the counter all week. And so when you start peeling this onion back a little bit more, you say, yeah, I may be in a long term housing situation where my frequency to need to go to the grocery store is great. But guess what, I don’t even have transportation to be able to get to the store because there is not one in walking distance of where I’m having to live. So becomes this amplifying effect. And then think about really the emotional toll that that has on one. As you said, sometimes you’re so physically exhausted from trying to manage your condition, and all of those things that you just want to curl up. Well, so many people can’t curl up because they realize if they curl up that the family members that are depending upon them, they lose as well.
Zoe Rothblatt 16:25
So what can we do to help? You know, that’s such a broad question, but are there policies we can advocate for? And like the individual level, how can we support our community? What suggestions do you have?
Shonta Chambers 16:38
One of the things and I’ve taken this learning environment, this learning opportunity with this with my mom and saying how can I make this easier for the next person. So I’ve been documenting just my own experience through this with A, a plan to give back or give guidance back to my local legislator. This is my story. So I think the degree all of us have a story, whether we are a patient, or whether we’re caregiver, we have a story. And it’s important for us to tell that story to the individuals that we are electing at a local level, as well as at a state level, because they are the face of us as constituents. And so it’s critically important that they know when they’re making decisions around health care when they’re making decisions around transportation infrastructure, when they’re making decisions around housing, when they’re making decisions around the state funded safety net programs, they need to understand that there are real people at the end of these types of decisions. There are real families at the end of these types of decisions. And we can’t just say that to them one time, we can’t just say that to them in a election period or the election time of year, we need to be constantly using our voice and creating an echo chamber. Because just like we know, I know my mom and her living with her MS, I know my dad and him being a stroke survivor. But when we walk out of our door, we know other people in our community, whether there are seniors in our community that are experiencing challenges when they’re only trying to live the best quality of life possible. So we have a responsibility and an opportunity to be that echo chamber to raise these voices to raise these issues so that they don’t fade away. What tends to happen is around election time, everyone wants to talk about these things. But once the polls close and the final ballots are cast, then all of these conversations become mute, but they don’t become mute in the lives of persons living with chronic and complex health conditions. They live with this 365 days a year. There are no off days, there are no primaries, there are no final votes. This is their life every single day. And we have to make sure that these experiences don’t fade to black, that they continue to be vibrant in the forefront of how we deliver health care every single day.
Zoe Rothblatt 19:04
Well said, keep the story alive and remember that it’s real people. It’s really powerful. And sometimes I say we’re all just one chronic disease away from getting a chronic disease like you never know. It could be you. I live with two chronic diseases and it’s a turning point in your life and everybody has issues they care about and there’s a lot of issues we talked about today that I think it should resonate with most people whether it’s housing, the transportation, the healthcare, the being a patient yourself, caregiving, health literacy, regular literacy, like there’s so much here that you can have a personal connection to.
Shonta Chambers 19:41
Absolutely.
Zoe Rothblatt 19:42
Shonta, the final question I want to ask you is what advice do you have for other caregivers?
Shonta Chambers 19:47
Oh, wow. What advice do I have for other caregivers? Two things. I would say first, I would have to express my appreciation for all the fellow caregivers out there because they are such unsung heroes because no one sees their tears or hears their cry. And oftentimes it is in that space of us being with ourselves that we allow that to take place. Because we don’t want to do in front of the person that we’re caring for, because they already are dealing with the emotions of knowing that we’re having to render care for them, but at the same time is to humanity of who we are, because it does get exhausting. And if you are a caregiver who also may be living with a chronic or complex health condition yourself it’s only amplified. And so for me, my advice to caregivers is don’t forget to take those moments for yourself to just reset, reframe, and then re-engage and know that it’s okay to say that you are tired. And it’s also okay to say not today. It’s okay to say that today, I’m not going to deal with that one thing, not today, because you’re only as good as your strength. And it’s alright to take those moments to restore your own mental health. So find out what that means for you and be okay with resting in that place.
Zoe Rothblatt 21:17
That’s really beautiful. I think it’s similar to as a patient, your whole identity doesn’t have to be a patient. And I’m sensing that from what you’re saying, as a caregiver, it doesn’t have to be your whole identity. And your advice to take time for yourself helps you maintain that that you’re like a person first and a caregiver second.
Shonta Chambers 21:36
So what do we always say you can’t pour from an empty cup?
Zoe Rothblatt 21:39
Yes.
Shonta Chambers 21:40
So as a caregiver, it is so important to make sure that you have someone, or something, or some space that fills your cup so that your cup doesn’t run empty.
Zoe Rothblatt 21:52
Well, thank you so much for joining. And I guess my final final question is where can our listeners like find you, find Patient Advocate Foundation, we’ll drop some links in the show notes, but let us know.
Shonta Chambers 22:01
So of course, you can find Patient Advocate foundation at www.patientadvocate.org, or you can reach us toll free at 800-532-5274. You can find me as well as Patient Advocate on LinkedIn. Of course, I’m @ShontaChambers at LinkedIn. And there are a plethora of resources on our website, we have a phenomenal national financial resource directory on our website, which is really a catalogue of all the resources across the country that our case managers have tapped into. Because we realize sometimes it’s two in the morning when you realize you need a resource. And you can’t call someone, we wanted to make sure that there was a space that patients could go to, caregivers, or even those who are in communities that are helping to support patients. So you can find a variety of resources there on our website.
Zoe Rothblatt 22:02
Thank you so much for joining us. And for all the work you do. I’m excited to follow along your journey and keep seeing how it goes.
Shonta Chambers 22:19
Oh, well, I’m not tired yet. I keep my sleeves rolled up because this is truly a marathon and not a sprint. And so and I’m ready for it, so I stay hydrated, and stay rested. Because there’s a beauty in this work called advocacy, although I wish I didn’t have to do it. But I think we all have a purpose and I think that this is part of my purpose.
Zoe Rothblatt 23:27
Amazing. Well, thank you so so much.
Shonta Chambers 23:29
Thank you so much, Zoe.
Steven Newmark 23:32
Wow. Well, that was great, Zoe. It was so interesting to hear from Shonta.
Zoe Rothblatt 23:35
Yeah, that was really great. I really appreciated her talking about caregiver support and just the burnout there and the need to think about the other players in the healthcare field. How about you what you learn?
Steven Newmark 23:47
Yeah, speaking about learning that was a big learning for me just the idea of what caregivers go through. I’ve seen it on a personal level. How emotionally draining it can be an exhausting to be a caregiver, and our hats are off here at GHLF. We never neglect caregivers. At least I hope we don’t. So we salute them. Well, we hope that you learned something, too. And before we go, we want to encourage everyone to check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 24:13
Well, everyone thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you like this episode, give us a rating, write a review, and hit that subscribe button wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 24:26
I’m Steven Newmark. We’ll see you next time.
Narrator 24:31
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
“Advocate for Yourself and Don’t Give Up” with Cyndi Lauper and Michelle Bernstein
The Health Advocates are joined by singer, songwriter, actress, and activist Cyndi Lauper and chef and restauranteur Michelle Bernstein to talk about their journey with psoriasis and psoriatic arthritis. Recently, the two of them have joined forces to bridge the worlds of music and cuisine to deliver a powerful message of hope and empowerment for patients living with psoriatic disease. Here, they share about their personal journeys with diagnosis, the importance of connecting with other patients, and why they are spreading awareness.
For more information on the resources mentioned by Cyndi Lauper and Michelle Bernstein, you can visit: ThePSConnection.com
"Advocate for Yourself and Don't Give Up" with Cyndi Lauper and Michelle Bernstein
Steven Newmark 00:00
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, head of policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:09
And I’m Zoe Rothblatt, Director of Community Outreach at GHLF.
Steven Newmark 00:13
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:21
And today we have special guests joining us. We’re joined by singer, entertainer extraordinaire Cyndi Lauper and culinary chef Michelle Bernstein, to talk about their journey with psoriasis and psoriatic arthritis. So recently, the two of them have joined forces to bridge the worlds of music and cuisine to deliver a powerful message of hope and empowerment for patients living with psoriatic disease.
Steven Newmark 00:45
They’re using their platform to share their personal journeys and insights to the millions of individuals living with chronic autoimmune conditions.
Zoe Rothblatt 00:52
So Cyndi and Michelle, welcome to The Health Advocates. Thanks for joining us.
Cyndi Lauper 00:57
Thank you.
Chef Michelle Bernstein 00:58
Thank you so much.
Steven Newmark 00:59
Yeah, we’re big fans and we’re very excited for you to join us and share what you’re doing to help patients like yourselves around the country.
Zoe Rothblatt 01:06
Yeah, we’re really excited that you’re using your platform to you know, talk about your patient journeys and we’ll get into that today. And, you know, part of our work is, Steven and I both live with chronic illness and you know, we’re patients ourselves, and we chat with patients all the time, and we’re just looking forward to learning more from you today about your journey and spreading awareness. So yeah, thank you.
Cyndi Lauper 01:29
So you have psoriasis also?
Zoe Rothblatt 01:32
I have inflammatory arthritis and Crohn’s disease. So a little different, but I can understand aspects of the journey.
Chef Michelle Bernstein 01:40
That’s a tough one.
Steven Newmark 01:41
I have, gosh, I have it all. I have inflammatory arthritis. I have IBD. And I have psoriasis. So I’ve got the triple crown.
Chef Michelle Bernstein 01:50
Yeah, you do.
Cyndi Lauper 01:52
I’m sorry.
Steven Newmark 01:53
No, it’s okay. It’s okay. Everything, I’m actually, I consider myself to be very lucky because it’s all under control. And I know how to take care of myself. I know how to get the best therapies and work with doctors, and I live a pretty good life. So I’m actually very lucky.
Chef Michelle Bernstein 02:09
that’s wonderful. That’s wonderful. As are we.
Steven Newmark 02:13
Yeah. Well, that’s great to hear. So let’s get into it. First question for Cyndi. Can you describe the initial moments when you first noticed symptoms of psoriasis on your scalp while on tour and how did you initially react to it?
Cyndi Lauper 02:26
Well, I was on vacation.
Steven Newmark 02:28
Oh, I apologize.
Cyndi Lauper 02:29
After the tour. No, it was just after the tour, and I was in Spain. And I thought, you know, because I had a kid, I thought I had like bugs from his helmet. He played hockey. So I thought oh, you know, because they always have that, hey, hey, somebody has bugs, you know, whatever. And, and then when it didn’t go away, and I went to the doctor right away, and he said, oh, that’s not bugs, that’s psoriasis. And I said really, and he gave me some shampoo and for a while was okay and then it started to get worse. And then it got even worse. And then it was even more worse than it was. And I eventually was covered head to toe with psoriasis. I had two different forms, one plaque psoriasis, and the other the red spots on my skin and it just kind of everything kind of just blended into one. So it’s really bad. And I let it go too long and that’s why I’m here talking to you. Because I realized that a lot of people have psoriasis on their skin and don’t really do anything about it, but get some cream or live with it. And you know, I waited five years before I went to a doctor.
Steven Newmark 04:01
Yeah.
Cyndi Lauper 04:01
And there are some things that can permanently change when you don’t see a doctor right away and there are doctors that specialize just in psoriasis. It wasn’t like it wasn’t going to see a doctor, but I didn’t go and see a doctor that just did psoriasis. You know, because when you have these skin things, if if it’s not recognized it goes untreated or misdiagnosed or treated. You know, for instance, nowadays doctors are learning more and more and more about this disease. And if you find a specialist, they can help you before it’s an inflammatory thing, anautoimmune inflammatory disease and what’s on the outside you don’t know what’s going on on the inside. So you need to advocate for yourself, you need to find a doctor who actually knows about what you think you might have, and recognize it, whether you have white skin, or dark skin, or whatever color skin because now, years ago, they only recognized it on white skin. Now they recognize it because they study the disease. And, there are many options for you that you don’t have to live in pain. Like you guys, you’ve seen a doctor, and you can live your best life as opposed to not taking care of yourself, you know. And, even if you think you’re but you’re going to ignore it, it’s not going to go away, because not really a rash. It’s more than that and what happens on the outside, there’s stuff other stuff that could happen on the inside. And that’s why I’m here with Chef Michelle, because chef Michelle, you can take it from there.
Zoe Rothblatt 06:11
Yeah, so turning to you, Chef Michelle, like, you know, Cyndi’s describing that she didn’t see a doctor for some time, what was it like for you in the beginning of your journey and receiving the diagnosis of psoriatic arthritis?
Chef Michelle Bernstein 06:25
You know, something I had never heard of. And I don’t know if you know anything about the life of the chef, but it’s not an easy one. It’s extremely, you know, high in labor, and many, many hours on your feet, you have to be pretty strong, up and down to be able to do a lot of the things that chefs do. And I was noticing a few years ago that it became harder and harder to get up after a night’s sleep. To be able to walk even just from my bedroom to the bathroom. I started asking my husband for help in the morning. My joints were aching. Mainly my ankles, my feet, my metatarsals, my wrists and my shoulders. And it got to the point where I could barely hold my, you know, my pans in the kitchen. I couldn’t put things in the oven because the pain was so bad that I was dropping everything. It got to the point where I couldn’t trust myself. Now, you think that somebody would run to the doctor when this was happening? But you know, I was approaching 50, I was going through menopause. I thought maybe this was just part of getting older. I was embarrassed. I was scared. I thought my career was coming to an end. I couldn’t play with my nine year old the way I’d always played with him. I couldn’t even do you know, I couldn’t hide, I couldn’t jump around, I couldn’t do all the things that I normally. Little by little things were diminishing. Right? And so finally I spoke to my sister because I knew that she wouldn’t judge me. And she said, you know Michy, go see a rheumatologist. I remember that a few years ago, you had a little dot of psoriasis but my psoriasis was so tiny. It was like half pea size that I barely even I didn’t even remember that I had it. So, she thought that possibly I could have psoriatic arthritis. I took her advice I found the best doctor I could find in South Florida. Took me a few months to get in, finally did. Sure enough, as you know, you try different things. He led me directly to one medicine that incredibly worked for me and I was really lucky because I know it doesn’t work for everyone. Right? You know, I feel really lucky that I have this solution but you know, it is autoimmune. And I know that through recipes, through different foods, I can maybe help even further my inflammatory problems. And you know, it’s been interesting, I’ve been learning. I’ve learned to you know, definitely advocate for myself as well just like Cyndi said, and to get out there and find more information because the information is out there, you just have to look for it. And you have to look in the right places. And you know…
Cyndi Lauper 09:35
We have the PS…
Chef Michelle Bernstein 09:36
Well there’s yeah there’s a website that we that we are part of that is ThePSConnection.com and you can find so much information there. Your listeners can find it, you can find my recipes on there as well. And, you know, if you feel like you’ve got something, go find a specialist just like Cyndi was saying, you know, you have to find a special dermatologist right because not every dermatologist can find.
Cyndi Lauper 10:03
No because some dermatologist are cosmetologists. Really, you know.
Chef Michelle Bernstein 10:07
That’s true, I didn’t even think about that.
Cyndi Lauper 10:08
Listen I’m a big advocate for cosmetology, right? But right when you have psoriasis, that’s not going to help you. You need someone who deals with psoriasis, knows what it looks like, studies it on all color skins, and understands the disease.
Chef Michelle Bernstein 10:29
It’s interesting though, what you’re saying because I made the mistake of going to the wrong types of doctors at the beginning of my crisis, and I finally realized that I should go to a rheumatologist. Not that I ever thought I would ever need one or you know.
Steven Newmark 10:43
Right.
Chef Michelle Bernstein 10:44
We’re all so ignorant. Right? When all this comes about you have no idea what’s going on.
Zoe Rothblatt 10:48
Absolutely yeah.
Steven Newmark 10:49
Totally yeah.
Chef Michelle Bernstein 10:50
What I did, though, and I think I did, I think this was the smart way to go about it was that I didn’t quit until I found the best and the right rheumatologist for me.
Steven Newmark 11:02
Yeah.
Chef Michelle Bernstein 11:02
And so I was really lucky. I really was, I found a great guy.
Cyndi Lauper 11:07
You know, with all of my experience, that I’ve been working with Novartis, the one constant thing that patients have talked to me about. And the other thing is, when I started to actually talk to other patients with psoriasis, I never did. What are you going to, hey, I like to sit and talk to you about my psoriasis right now, I know you’re doing something else but you know. When you talk to other patients, you don’t feel as alone.
Steven Newmark 11:44
Absolutely.
Cyndi Lauper 11:44
That was the big thing for me. Big, big because I started to isolate and start to feel really alone. And when I even pulled away from everybody in my family, because I really felt like something horrible. And I wanted so much to run away. But when I was given this opportunity, I met other patients, and it changed my outlook. And the one thing they said constantly was, besides the fact that it’s not contagious, and they’re made to feel bad sometimes because people think it’s contagious. It’s not. But the big thing was they didn’t give up until they found something right, until they found a doctor just like Michelle saying, you can’t give up. You have to advocate for yourself.
Cyndi Lauper 11:45
And time is not on your side. So like Cyndi was talking about, you know, her skin condition was getting worse. I know that that year, I didn’t go to the right doctor, my joints are now you know, I can’t go backwards. Right. So the damage is done and I’m lucky that you know, I found something that works for me. But it did, iit was a good solid year in. So whatever damage I’ve done is done. But I can move on from there and so I think it’s essential that not only you know, self advocacy is important, but you need to get on it. And you have to get on it immediately. Yeah, because, first of all, as we all know, it’s not like it goes away. It doesn’t go poof, right.
Cyndi Lauper 13:24
It doesn’t, but it moves, my moved.
Chef Michelle Bernstein 13:26
But you can make it get better, right, you could possibly find something that will help you feel better. And that will do better for you.
Cyndi Lauper 13:34
So that you could live, you want to live.
Steven Newmark 13:38
I was gonna say it’s first of all, it’s incredible how much you use the word advocate or advocacy. Because that’s what we talk about all the time on our show is the creation of a community of patients who have similar or the same conditions and really being a self advocate for yourself. I’ll just say really quickly, the first time my doctor told me that I had psoriasis, he said, you know, it’s a chronic condition. I said what the is chronic, I never even heard that. I’m like, the only chronic I know, it’s Dr. Dre like what are you talking about chronic? I’m like what, chronic? And I’m like, holy crap, right. It’s like a lifetime thing and like you said, yeah, it only moves in one direction. And the only way, you know if you don’t take the steps to remedy it. So this is amazing advice that you guys are giving. So, thank you.
Chef Michelle Bernstein 14:26
No, thank you. I mean, what an incredible platform, you know, for the two of us to be able to share with other people so that they can jump right in, and hopefully find something that works for them. You know, no matter what it is, we just want people to know that it’s out there and to be more aware. Right. And, you know, what’s funny is when you really think about it, and I didn’t even tell my husband I was so embarrassed because we’re partners and I didn’t want him to feel like he was losing his partner. So no one can jump in your body and feel your pain. Right? So if you don’t do something about it yourself, no one else will.
Cyndi Lauper 15:08
Well, yeah, my husband kept saying to me, he was gonna take me to the hospital, it looked that bad. And I didn’t want him to see me because, you know, with the skin thing you shed, you shed, and it’s gross. And I felt gross. And I didn’t want to, I didn’t want to go out and talk to anyone. One time they said, oh, you should go in the sun, you know, a doctor who thought yeah, just go in the sun.
Chef Michelle Bernstein 15:35
That’s crazy.
Cyndi Lauper 15:36
And I did. And I have scars from the sun.
Chef Michelle Bernstein 15:41
I bet.
Cyndi Lauper 15:41
From where it was on my leg. And that stuff, it doesn’t go away. And you just feel like, okay. And I remember that year, they took a picture of me, and it was on TMZ. And they thought it was mosquito bites. They said well that’s a lot of mosquito bites, look at the mosquito bites. And I just felt like yeah, okay, you know, and what are you gonna say, you know, I don’t say anything. But I just felt like, wow, you can’t go out, you know. And so I was retreating and not doing anything. My husband kept coming and going, you have to go to the hospital. And I was like, what are they going to do? They can’t do anything. So no, finally I found a doctor.
Steven Newmark 16:25
I just want to get confirmation that not everything on TMZ is accurate.
Cyndi Lauper 16:32
I know.
Steven Newmark 16:36
All right.
Zoe Rothblatt 16:37
Thinking about that visibility. And just, you know, going back to what you were saying about the stigma, and you know, feeling unfortunate, like the grossed out feeling. So, we have a program called the HEROES program, which stands for Health Education, Reliable Outreach, Empathetic Support, and it’s dedicated to training beauty professionals starting with hair stylists about psoriasis and skin conditions to help break down some of the stigma. I was hoping maybe you could talk about, you know what that’s been like for you working with beauty professionals with psoriasis and how you feel like a program like this could be helpful, or what’s the most important thing for beauty professionals to know about living with a skin condition?
Cyndi Lauper 17:18
Well, one that you’re not contagious. That’s so important. And it was very important for the other patients. Two is, yeah, I use a lot of creams, because for me, even if I’ve found something that works for me, I find I’m always dry. My arms, your extremities are dry. So no matter what you’re getting up, you’re greasing up. It’s not grease, but you know you want to put a cream on I found myself using the creams and a doctor once said, it had some kind of it’s not just a cream, you can buy it over the counter. It has some kind of…
Zoe Rothblatt 18:12
Like a steroid cream?
Cyndi Lauper 18:14
It’s not a steroid cream. No, no, no, no, just a moisturizer. That’s all. And that you’re drinking water, enough water.
Chef Michelle Bernstein 18:23
But what would you tell let’s just say like a hairstylist, what would you tell them? Aside from the fact that it’s not contagious, is there anything they can do to be more careful?
Cyndi Lauper 18:34
No, because if they’re going to do you roots, and that’s what really killed me. They had their hands in my head. And I was like ew. One guy was very kind and he said, well I have women with psoraisis, and when I put the bleach on it just it gets rid of it and it’s gone. And that wasn’t the case for me. It didn’t go away.
Chef Michelle Bernstein 19:00
Right.
Cyndi Lauper 19:01
So it’s it’s hard if you’re not going to see a doctor for it and continue to work and try and look good. It was very difficult. Very, very difficult. I started to, I love wigs. I wear wigs I don’t care. But I was wearing a wig that was long. And I was wearing net to hide the skin to make it look like it was skin. I mean, I know but what was I supposed to do? I was on stage and then when I came off and I took my clothes off, it was like and there were my beauty professionals and as kind hearted, they were kind hearted and they were good about it but I was very grossed out. And you know it’s it’s not easy to keep covering it up. You know I even took baths with I didn’t realize how much I was detoxing. I started taking baths, I was gonna really be a genius about it. And I took a lot of baths.
Steven Newmark 20:12
Right.
Cyndi Lauper 20:12
And I detoxed and I detoxed, to a point where I was on stage once and I had global amnesia, because I was running through the arena climbing up the stairs, singing, and I got like, halfway through the set, and I had no memory of the rest of it.
Chef Michelle Bernstein 20:32
How terrifying.
Cyndi Lauper 20:33
Well, wasn’t terrifying for me. But the people around me were pretty scared. And then the doctor, when they took me to emergency room, they were like, what were you doing? And I showed them the stuff and they were like, holy cow. You’ve been detoxing twice a day for a month. So it was, you know, it was so you can’t just self do it. You have to find a specialist. It’s better that way. I’m sorry I put myself through all that and the people around me. But I was afraid and I was ashamed because I felt like I was gross.
Steven Newmark 21:19
Yeah, well, I mean, this is fantastic advice, just the idea that you can’t let it linger. You’ve got to make sure that you find the specialists that can treat you and get on treatment as soon as possible. Be an advocate for yourself. Yeah, and it’s not going away on its own. It’s not a rash. It’s not something that goes away. Yeah and with psoriatic arthritis, it’s not a little pain or ache, you know, you’ve got to deal with it. And the longer you wait to deal with it, the worse it’s going to be.
Cyndi Lauper 21:48
And there are options. You can literally find a specialist who does this and say, what are my options? And there’s a bevy of them.
Chef Michelle Bernstein 21:58
There’s a lot of them.
Cyndi Lauper 21:59
There’s a lot of them.
Steven Newmark 22:01
Right.
Cyndi Lauper 22:02
So, you always have options and yeah, you can make it a little better. Make sure you put cream on twice a day or every morning or whatever. And try not to eat inflammatory foods, you know, but if you have it bad, you should take care of yourself.
Chef Michelle Bernstein 22:22
But as far as those options go, the only way to know that you have them is to go out and find out that you have them.
Cyndi Lauper 22:24
Bingo, right.
Zoe Rothblatt 22:32
One last question for you both. Is there anything surprising that you’ve learned about psoriatic disease since starting this campaign and working together?
Chef Michelle Bernstein 22:41
Well, I’ve learned a ton.
Cyndi Lauper 22:45
I learned about it and I actually do have a little bump on my hand. That because I had let it go, it’s there and it’s not going to go away.
Chef Michelle Bernstein 22:58
I mean, what I what I think neither one of us knew was that it came in so many different forms, right? And ways and shapes and different for different people. And it’s like never ending, right. So also that there is information out there to be had, and how to find it, you know, and that’s why we’re trying to guide people to the right places.
Cyndi Lauper 23:27
And that is the web page, ThePSConnection, you can learn about psoriatic arthritis, and plaque psoriasis and get a lot of information.
Chef Michelle Bernstein 23:40
A lot of information.
Steven Newmark 23:42
The one question I didn’t get to ask. I really was hoping to get a recipe. But if we go to the website, and we’ll post it in our show notes, will there be recipes there?
Chef Michelle Bernstein 23:51
Oh, absolutely. There’s a lot of recipes there.
Chef Michelle Bernstein 23:53
And I try to add a lot of you know, anti inflammatory ingredients, cruciferous vegetables. You know, a lot of capsaicin, things that you can really play with, but that are filled with flavor. You know, don’t worry, everyone, they’re fun, they’re delicious.
Steven Newmark 23:53
Excellent.
Cyndi Lauper 24:11
She’s a great cook.
Chef Michelle Bernstein 24:12
But it happens to make you feel better, thank you Cyndi, as you’re eating it. So yeah, absolutely.
Cyndi Lauper 24:19
She’s not a cook, she’s a chef.
Chef Michelle Bernstein 24:21
I’m both.
Cyndi Lauper 24:22
She’s a great chef.
Chef Michelle Bernstein 24:22
I’m both, I’m my son’s cook.
Steven Newmark 24:26
Well, I’m definitely not a chef, but I could follow a recipe and I look forward to doing that. Because anything to make me feel better. So we really appreciate all this information. As I said, we’ll post it all to our show notes. And thank you both so much for your time and for all that you’re doing on behalf of patients.
Chef Michelle Bernstein 24:48
Thank you, Steven and Zoe. And thank you, Cyndi.
Cyndi Lauper 24:50
Have a good year.
Steven Newmark 24:53
Well, thank you again Cyndi and Chef Michelle, this has been fantastic and we greatly appreciate your time and all that you’re doing for patients.
Zoe Rothblatt 25:03
Yeah, thank you so much for joining us and sharing your hope with patients.
Steven Newmark 25:08
Well with that, Zoe, I don’t know about you, I’m going a little bit of a high that was, that was a lot of fun. It’s great to hear from people who are in the public eye about what they go through, and deal with. And, you know, it just shows these diseases that we talk about week in and week out, they affect people from all walks of life.
Zoe Rothblatt 25:30
Exactly and just like the experience of needing to advocate for yourself and find the right doctor and find your sense of community, the fact that like, you could still feel alone, even no matter what job you have, these diseases are really just, like, hard to live with. And I appreciate how honest they were about that.
Steven Newmark 25:48
Yeah, I mean, I am definitely grateful with all the conditions that I have, I’ve never been the subject of TMZ follow me around taking pictures.
Zoe Rothblatt 25:56
That’s true.
Steven Newmark 25:56
So that’s one less thing you and I have to worry about. At least until the show becomes more popular.
Zoe Rothblatt 26:04
That’s true. We’ll end up on deux moi, is what the kids follow. That’s where you get little sources of the innings and outings of the world. So we’ll see if we land on there. But I’m excited to try a recipe, we have our homework to do.
Steven Newmark 26:22
Yeah, for sure. Let’s get together. Let’s do this, let’s get together. Let’s cook and hopefully get healthier.
Zoe Rothblatt 26:28
Yes, absolutely. Healthy living with The health advocates.
Steven Newmark 26:32
Yeah. So you know, really quick, I know, we always end with a learning. And I’m just going to say, you know, I’m just gonna repeat. The learning is, you know, these diseases hit everywhere, something we already knew. But even for folks that you know, may have more means, more financial means, the disease is the disease, no matter. And what it does to you, psoriasis, psoriatic arthritis, it hurts no matter where you are in life.
Zoe Rothblatt 26:59
Yeah and I think something I wanted to highlight from both of them was just like recognizing symptoms early and you know, believing in yourself to advocate for yourself that something’s not right.
Steven Newmark 27:11
Yes, yes. Well, we hope that you’ve learned something, too. We hope that you enjoyed this episode. And before we go, you want to encourage everyone to check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 27:22
Well, everyone thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you like this episode, give us a rating, write a review, and hit that subscribe button wherever you listen. It’ll help more people like you find us. I’m Zoe Rothblatt.
Steven Newmark 27:38
I’m Steven Newmark. We’ll see you next time.
Narrator 27:44
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Beyond the Gut: Creating Change for LGBTQ+ IBD Patients with Dr. Carlton
Zoe and special co-host Adam Kegley, Associate Director of Global Partnerships at GHLF, are joined by San Diego-based gastroenterologist Carlton Thomas, MD, to learn all about LGBTQ+ health and inflammatory bowel disease (IBD). Dr. Carlton shares how not enough people are talking about sexual health and IBD, how people can have more open and honest conversations with their doctors, and the challenges faced in the LGBTQ+ community when it comes to accessing health care.
If you are an LGBTQ+ person living with IBD, make your voice heard and take the survey at https://bit.ly/lgbtq-ibd
Beyond the Gut: Creating Change for LGBTQ+ IBD Patients with Dr. Carlton
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Zoe Rothblatt 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life. I’m Zoe Rothblatt, Director of Community Outreach at Global Healthy Living Foundation. And today I have a special guest co-host, my colleague, Adam Kegley, the Associate Director of Global Partnerships at GHLF. Hey, Adam, how’s it going?
Adam Kegley 00:33
Hey Zoe, it’s great. Thank you so much for having me. It is wonderful to be here.
Zoe Rothblatt 00:38
And you’re here today to talk about a special program we have focused on the LGBTQ+ and IBD population. We’re also joined by another very special guest, Dr. Carlton Thomas, a gastroenterologist in San Diego, California. Hi, Dr. Carlton, thanks for joining us today on The Health Advocates. could you begin by introducing yourself to our audience?
Dr. Carlton 01:00
Well, hi, and thank you for having me today. I’m Dr. Carlton Thomas. I go by Dr. Carlton on Instagram and TikTok. I am known as the butt stuff and queer health guy on social media.
Zoe Rothblatt 01:11
That’s awesome. And Adam, is that how you found Dr. Carlton, on Instagram?
Adam Kegley 01:16
I did, indeed. I’ve been following him for a while now. And since we started this new program, I thought hey, one plus one equals two. So, really glad to have you.
Dr. Carlton 01:27
Thank you so much. And I’m a Mayo Clinic trained GI doctor and my subspecialty training while I was there was in inflammatory bowel diseases with Dr. William Sandborn, who’s one of the world’s leading GI experts. I was the one fellow at Mayo Clinic doing talks on our required rotational talks about gut health, about the importance of sex and gut health and gay, bi, and queer men, that nobody at Mayo would ever talk about. So I raised a lot of eyebrows even back then, um, because I thought it was important to get that information out there. I was drawn to GI in particular, because I know that so many people from very young ages to very old ages can get gastrointestinal illnesses, especially inflammatory bowel diseases strike people at such a young age and can be very frustrating. Of course, there’s quite a variability in the way it presents from very mild disease to incredibly painful, debilitating multiple hospitalizations, multiple surgeries, that kind of thing. So I just wanted to try to help people. When the pandemic hit, I kind of needed an outlet for my stress relief and anxiety. So I started a TikTok page talking initially about butt stuff, you know, because people don’t talk about butt stuff, it’s a taboo subject, and I thought, who better to talk about it than someone who professionally knows the way around a butt, but also personally, you know, so I put that together on Tik Tok, and it just instantly, almost overnight, 50,000 new followers just talking about that stuff.
Zoe Rothblatt 02:52
That’s amazing.
Dr. Carlton 02:53
Pretty incredible. And three fourths of the people who initially followed me were women. So you know, butt stuff doesn’t have a gender, doesn’t have a sexuality, doesn’t have a femme or masculine role to it. It’s everybody’s got a butt, so why not talk about it?
Zoe Rothblatt 03:07
And can you talk about you mentioned, like some of the reactions that you got at Mayo Clinic, when you started to have these conversations, did you see a similar reaction when you brought that conversation like publicly online? Or was it really different? What sort of response did you get from the community?
Dr. Carlton 03:22
Well, again, this is probably 20 years later, initially, there was that subsection of people who were like, how dare you talk about this kind of thing on an app made for children. And, you know, initially, I was almost going to delete my app, because I thought, oh, this isn’t worth it. And then I said, you know what, I’m just gonna block these people and keep going. And I’m glad I did, because a lot of people all around the world have gotten a lot of the information that they need to have a better life since that time. I branched out to the queer health side of things, because I thought it was also lacking in representation on social media. And a lot of people don’t know about queer health, and why it’s important, and what’s different about it, and how much stuff is missed because people don’t ask the right questions, or how many concerns are skipped over because their providers don’t ask the right questions. So branched out to Instagram and kind of tailored my Instagram more towards the queer health side of things.
Adam Kegley 04:16
I think that’s so incredible. And I’m just so glad to have you here with us today, Dr. Carlton to discuss these things. Of course, and I think not only because these issues, health equity in general are very important to me, but also to GHLF and I think Zoe mentioned it a bit at the top of the episode, but I really wanted to share a little bit more about the program that we’re doing that focuses on the unique challenges faced by the LGBTQ+ community, particularly those living with IBD like Crohn’s disease and ulcerative colitis. And we’ve actually launched the LGBTQ+ IBD experiences survey to better understand patients experiences to confront healthcare disparities in IBD care and just to establish better inclusivity in healthcare settings in general. And we’re really hoping to use the survey results to better inform and educate the LGBTQ plus community in general, but especially those living with IBD, as well as health care providers. And our goal is really to help ensure LGBTQ+ people with IBD receive better access to care and improve condition management. So with that in mind, and in line with what you’d previously said, I want to know what you see as some of the unique challenges faced by LGBTQ+ individuals living with IBD? You know, whether it’s something related to diagnosis, or access to care, or treatment.
Dr. Carlton 05:37
Yeah, there’s a lot that happens with the queer community and IBD and the challenges that come around that. You know, not everybody lives in a place that is easy to talk about their sexuality, even in the United States. You know, if you live in small town, Alabama, it’s probably going to be harder to talk to your primary care doctor about anal sex than it is if you live in somewhere like San Francisco or New York. Between religious discrimination and homophobia, there’s a lot of challenging stuff happening. You know, there’s a huge lack of knowledge on the provider side, there is a lack of information, and obviously, some misinformation out there, and some providers own biases that lead to it being difficult for LGBTQ patients to be honest and open and be able to really express what they really need. And if there’s anyone on Earth that you need to be absolutely honest with and be able to have a frank conversation without judgment, shame or fear is your health care provider, they need to know everything. I’ll give you another instance, I had a patient who was referred to me for refractory ulcerative proctitis. So they were diagnosed with ulcerative proctitis, because they had a colonoscopy and the rectum was inflamed. And their doctor had them on all these high strength like immunologic therapies and they weren’t responding. And he came to me for a second opinion. And the first question I asked him was, do you put anything in your butt and he goes, absolutely, I’m a bottom and I haven’t used a condom in five years. And I checked him for gonorrhea and he just had gonorrhea. He didn’t even have all sorts of proctitis. So there’s that lack of just simple questions about what you do with your sex life. Even in a gastroenterologist’s office where GI doc’s aren’t always comfortable talking about sex, and that’s gotta change.
Adam Kegley 07:15
I couldn’t agree more. That’s actually exactly was my next point is we’ve really noticed similar issues in building the program and the initial resources. You may have seen or heard the stat that only 14 percent of gastroenterologist report routinely inquiring about sexual health for any patients with IBD, which is obviously a really important issue for patients, sexual health that is. And I feel like on top of that, we know that a lot of people can feel kind of a sense of shame associated to living with IBD when it comes to something like sex. And then in regard to LGBTQ+ IBD patients, there can be that sense of internalized shame for some folks about their sexuality or their identity and sex in general. So it’s almost like a double or triply compounded issue for some LGBTQ+ IBD patients. And I was just wondering if you can talk about that challenge a little bit more?
Dr. Carlton 08:07
Well, I think the biggest point that people forget about in our community is the vast majority, probably not as much in the lesbian community, but in the gay, bi, queer, trans community, a lot of us use our GI tract for our primary sexual organs. You know, anal sex is an incredibly important part of sex in the LGBTQ+ community. It’s not the only thing we do, and not everybody who’s gay has annual sex, but it’s an important part of our lives. And if you have bloody diarrhea or diarrhea in general, or rectal pain or abdominal pain, it’s hard to proceed with having sex if that part of your system is messed up. So there’s a lot of overlooking that part of our sexuality when it comes to IBD. You know, and not just the conditions themselves, but often the treatments and the surgeries. Surgeries can dramatically affect your ability to have anal sex for the rest of your life, not just in IBD even someone who has an anal fissure surgery or a hemorrhoidectomy. If they do a stapled hemorrhoidectomy, good luck trying to bottom again. If they do too much damage to the anal sphincter, good luck, bottoming again. People with pouch surgeries, all the time, you could ihave their colons completely removed and have part of their small intestine as their new rectum. Nobody talks about sex with that. Nobody knows if it’s safe to have sex in a rectal pouch. So I get asked all the time, what the hell do I do? You know, my surgeon ever talked about this, you know, am I able to have anal sex, how do I even start to explore that part of my life again. And so I try to give people an outlet to say hey, listen, you know, first of all, when it comes to IBD if you’re in a terrible flare, shelf, the sex part until you can get some good relief or to get as close to remission as possible. Or at least do some alternate things like maybe be aside rather than having penetration, just use oral sex as a way to have fun. So there’s all these things out there that people just overlook when it comes was to queer health care and IBD health care. You don’t have to be LGBTQ to have Crohn’s or colitis affect your sex life.
Zoe Rothblatt 10:07
Yeah, totally. I mean, this conversation has me reflecting I mentioned to you before I have Crohn’s disease. I’m not a member of the LGBTQ community, but I’m thinking about how my GI has never asked me about sexual health. And I guess maybe that was just kind of, oh, the gynecologist will deal with that. And it’s like, kind of crazy that until this conversation, I didn’t even realize that I hadn’t discussed that ever. And I’m wondering what advice you have for questions that patients should bring up to their doctor, if they want to get started with this conversation, you just give such great tips for actually what you could practice at home but how would you get the conversation started?
Dr. Carlton 10:41
I think it’s important to just be like we talked about in the very beginning, it’s important to be absolutely honest and open with your provider, hey, this is me, this is what I plan on doing, this is what I’m interested in doing. I’m gonna have an honest and frank conversation about the do’s and don’ts. And if you’re not comfortable with that, can you help me get to somebody who is comfortable with that, so that I can have these frank conversations. You can say it in a nice way, it’s not always going to be comfortable, but it’s necessary.
Zoe Rothblatt 11:05
What other suggestions do you have for making it safer and more acceptable for LGBTQ+ people living with IBD to speak about their conditions? You know, whether it’s to friends or family or in the doctor’s office as well, just to like you’re saying, make sure they’re getting the best treatment possible? What are other steps we could take?
Dr. Carlton 11:23
I think finding providers that are known for being welcome and opening. Talking to other queer people who have IBD is a great way to network. There are some support groups out there, and some social chains out there through like Reddit and Instagram, other places like that, where people do talk about things like this. And you know, if your provider just shuts down and just doesn’t want to talk about it, it’s probably time to change providers, if that’s possible. I mean, it’s not always easy depending on where you are. GIs aren’t always that easy to get into anymore. But ask around, talk about it, you know, let people know how important it is. I think those are big steps.
Adam Kegley 11:58
I think you really hit the nail on the head. Actually, I remember when I was younger, when I first started college, I was still going to my family general practitioner. And I think it was the first time that sex and gut health kind of came up. And I had questions and I could tell immediately that he was really uncomfortable.
Adam Kegley 12:18
And it made me very uncomfortable. And I wasn’t totally out at that time, either. So that made me even more uncomfortable. So I decided I’ve got to do something. And I think it took me a while to start asking some friends that I had made at college to kind of find a provider that I could feel more comfortable with. And I think everything that you said just really goes a long way to helping people in general feel like they have some power over there and some agency in their decision making. And I think in that regard, you know, one of my questions is what message would you like to send to LGBTQ+ people living with IBD who might be hesitant to share their experiences? You know, maybe it’s something like through a survey, the survey that we’re doing, or, you know, something like that? Why is it important to make their voice heard through something like this or with friends and family in their lives?
Dr. Carlton 12:18
Yeah.
Dr. Carlton 13:09
Well, I think it’s really again, important to know that sex is something that society doesn’t like to talk about across the board, especially here in the US. There’s a fear of judgment and shame. No one talks about IBD and sex it seems but these tailored resources, like you guys are about to provide for people with this survey, highlight the needs of the community, make people feel like they’re not alone, and help them to open up themselves and be able to share their own experiences. And when you get that courage, you can just be open and honest and represent the community and share your struggles, your disappointments, your hopes and your dreams. I think it’s crucial to help others learn specifically about your needs and about your struggles so that people will have an understanding of what other people go through. And it really helps get action on the importance of this topic. You know, if we just sit there and just say, oh, yeah, it’s tough to talk about, let’s just not talk about it, let’s not do anything, nothing’s going to change. But these important things like you guys are doing, I think it’s going to have a huge impact on educating providers, but also empowering patients.
Zoe Rothblatt 14:10
Thanks for that, Dr. Carlton. And I mean, what you’re doing is so important to you mentioned at the top, I just wanted to highlight it again that you said that, you know, people reach out to over social media, and that’s free of charge. And I think having an outlet like that for people maybe like have a hard time affording health care or just, you know, delay doctor’s visits, because of finances to be able to provide what you do free of charge and give that support to people is tremendous. So, thank you. And Adam, you had mentioned our survey, where can our listeners find it I’m sure we’ll put a link in the show notes but if you want to let us know.
Adam Kegley 14:44
Thanks, Zoe, and thanks to Dr. Carlton too. It’s super simple, anyone looking to take our short 10 minute survey can find it at ghlf.org/lgbtq-ibd-survey and click on the take the survey button and just like you said, I know I said a mouthful so for interested, folks, this survey link is going to be in the show notes. So you can check it out much more easily and click it from there. Again, just like a huge thanks to you Zoe and to Dr. Carlton, especially for all of this incredible insight it’s really, really a privilege, so thanks.
Zoe Rothblatt 15:19
Yeah, thanks so much, Dr. Carlton. It was great learning from you. And we’ll also of course, drop a link to your social media in the show notes so our listeners can find you.
Dr. Carlton 15:27
Thank you.
Zoe Rothblatt 15:30
Well, Adam, that was a really great conversation we had with Dr. Carlton and Steven and I always like to wrap up the show by sharing learnings. I can start by sharing that I was reminded in that story that Dr. Carlton said about the misdiagnosis with the STI how important it is to talk to your doctor about your lifestyle and things going on in your life and be really clear about your symptoms because you want to get the best care that you can receive. How about you, what you learned today?
Adam Kegley 15:55
I couldn’t agree more. I think Dr. Carlson gave us so many great learnings and I think mine kind of goes along perfectly with yours. And it’s that not only is a survey like ours important to help us create resources for other LGBTQ+ people living with IBD but it’s also a for us to help all the providers out there too, so that they can get you the care and resources you need to especially in this case for the LGBTQ+ community.
Zoe Rothblatt 16:23
And listeners, we hope you learned something too. Thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, give us a rating, write a review, and hit that subscribe button wherever you listen. I’m Zoe Rothblatt.
Adam Kegley 16:39
And I’m Adam kegley.
Zoe Rothblatt 16:40
We’ll see you next time.
Narrator 16:45
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
“Obesity is a Disease” with Kristal Hartman from Obesity Action Coalition
We’re joined by Kristal Hartman who is a proud member of the Obesity Action Coalition (OAC) and is honored to serve as the Chair of the OAC National Board of Directors. In this episode, we learn about her patient journey, including her bariatric surgery in August 2014, which she describes as the hardest and best decision she ever made for herself. She shares how she now fights for access to quality, compassionate, and affordable access to care for all people living with the chronic disease of obesity.
"Obesity is a Disease" with Kristal Hartman from Obesity Action Coalition
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:22
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:27
And today, we’re joined by Kristal Hartman, who works with the Obesity Action Coalition, and she shares her story about being a patient, how the medical system failed her with some of the common misconceptions around obesity, ultimately finding the right care team, and the advocacy that she does now. So Kristal, welcome to The Health Advocates.
Steven Newmark 00:48
Welcome Kristal.
Zoe Rothblatt 00:50
All right, why don’t you start off by introducing yourself to our listeners?
Kristal Hartman 00:54
Yeah, happy to do that. So my name is Kristal Hartman and I am a person living with the chronic disease of obesity. I am a proud member of the Obesity Action Coalition. I have served in many capacities on committees and on the board. And I am currently the chair of the National Board of Directors for the OAC. I’m a mom of three boys and I live on a lovely little farm in Oregon. And I’m really excited to be able to talk to your listeners today.
Zoe Rothblatt 01:25
Yeah, I’m so excited that you’re here having conversation with me and our listeners. And we had got connected through your work with OAC, I was wondering if you could tell me a little bit more about how you got involved with them?
Kristal Hartman 01:37
Yeah, absolutely. So, I actually did my very first Advocacy Day on on Washington, DC, on Capitol Hill. And as a prep for that we had a group come speak to us about living with the disease of obesity, and how to really tell our story when we were meeting with Congress and that was two of our OAC members. And after they presented and walked off the stage, I ran out of the room and said, who are you and I want to get to know you and what kind of work you’re doing. And so it was so wonderful, because they are the ones that introduced me to the Obesity Action Coalition. And they said, actually, in a few months, we’re going to have our annual convention and that convention was in Washington, DC. And so I decided that I was just going to sign up for the convention. And I didn’t know really anybody else that was going to be there. Just the two folks Hattie and Ted that had introduced me to the OAC. And so I showed up not really sure what to expect, and was incredibly welcomed into this amazing community of people, where we really had the opportunity to connect with each other and to get great science based education about obesity, and to learn how to advocate for care for ourselves. And at the end of that weekend, it was amazing, because we wrote on a kind of like a big card, what our key takeaway was from our time together, and I remember that I wrote, I found my people, because I had felt really alone in my weight management journey. I had one person that was kind of my mentor through my bariatric surgery, but I was so far away from my surgery center, because I live in a small town and had to travel to our big city for surgery that I wasn’t able to really connect with people, because back then they were in in-person support groups, per se. And so I just felt like I had found the people who were living lives that were so similar to me, and having experiences that were so similar to me, and OAC has been and will continue to be an important part of my obesity journey.
Zoe Rothblatt 03:40
That’s amazing. I’m so glad you found them. I’m not sure if you know this, but I’m also a patient. I have arthritis and Crohn’s disease. And I agree with so much of what you’re saying that finding a community is such a turning point in the patient journey, when you’re just like, able to be around people that just get it in a way that other people don’t.
Kristal Hartman 03:58
Yeah, that’s so true. And Zoe, I’m so sorry to hear that you’re managing chronic conditions as well. But you’re right, nobody understands it, like the people who are also going through it.
Zoe Rothblatt 04:09
So taking a step back, can you tell me a little bit more about your patient journey? And you mentioned surgery, like how you came to make a decision to get surgery and like how has it helped you or how you’re feeling since? Maybe just from diagnosis to now I know it’s like a long thing, but just like, you know, highlights of the journey for you.
Kristal Hartman 04:28
Yeah, absolutely. So, I started actually my journey with obesity in my teens, and it really came about because I was having really, really painful periods, and I was put on a form of birth control that was sort of like injected, you know, with a needle and at that point in time to try to manage my cycles, they felt like this was the best option. However, very quickly and continuously I ended up gaining a lot of weight during this time. And so I left, I was on dance team, I was the girl on dance team that needed the plus size dance costume. I was always super active, I played basketball, and I was on dance team, and I did everything possible, I was in choir. And so I was just really super active kid and always had been, but my weight started rapidly increasing after this form of birth control. And so what ended up happening is that I went to college, and instead of the freshman 15, it was more like the freshman 50 for me, and I just continued to gain weight without any ability to really figure out how to lose weight. And so it was finally in my early 20s, that I saw an endocrinologist for the first time and he is the one that actually diagnosed me with polycystic ovarian syndrome. And part of that really is insulin resistance and a real difficulty managing weight. Part of that also includes issues with fertility. And so she told me at that time, I was young and newly married in my early 20s, that it was probably going to be difficult for me to have kids on top of that I was diagnosed for the first time with thyroid issues, too. So, I had kind of all of these hormonal issues that were impacting me all at the same time, and really working against any efforts that I tried to take with diet and exercise to lose weight. And so when I started my fertility journey, like she said, is a you may have problems getting pregnant, you may have problems staying pregnant. And that was true, I had a miscarriage. And then I had a successful pregnancy. But then I couldn’t get pregnant a second time. And I had to go on some hormone medications to help to get pregnant, and I had another miscarriage. And then I finally had a successful pregnancy with twins. And so during this time, I’m taking all these hormones, and I’m going back and forth, and up and down with pregnancies. And then I had a twin pregnancy where you know, I also had to obviously gain weight to protect two babies. And by the time that was all said and done, I was just at my highest weight I had ever been. That started to impact my health and by my early 30s, I found that I was so sick. My kids would say like, Mom, you’re so tired, you just come home and you like go to bed or you get on the couch, and we’ll watch a movie. I was exhausted having a hard time getting through my days. And I talked to my physician about this my primary care physician, and we had the conversation about weight pretty consistently as I was going in for all of these comorbidities of obesity. And so every time I had something new pop up, she’d add a medication. So in my early 30s, I was on 14 medications.
Zoe Rothblatt 07:48
Wow.
Kristal Hartman 07:48
For comorbidities of obesity. And yet every time we talked about it, he would say like you’re young, you’re educated, you’re in the medical field, you should be able to handle this, you should be able to do this, put your fork down, walk a little more, eat a little less, and you would be able to control your weight. And so I internalized a lot of that, you know, as people living with obesity, we deal with a lot of weight bias and weight stigma. A lot of that is external, but a lot of that is also internal. And oftentimes we say the meanest things to ourselves that we would never ever say to another human being. And so I just felt really guilty. Like, I’m so successful in all of these other areas of my life, why can I not control my weight. And so it was my endocrinologist at the time who was on the weight journey with me and we tried different diets. We tried some of the early FDA approved medications for weight loss and unfortunately, I had a bad side effect from one of those. And so at some point in my early 30s, he said, okay, we’ve literally tried everything, and I think it’s time for bariatric surgery. And I couldn’t believe that because in my mind, people who had bariatric surgery were older, you know, 50s, 60s, 70s maybe. And here I was maybe like 34-35 at this time. So I went back and talked to my primary care physician, and she completely shamed me. She said, you know what, I can’t even talk my 400 and 500 pound patients into surgery, I can’t even believe that you’re considering this. And she was saying this while filling 14 prescriptions every month for me.
Zoe Rothblatt 09:20
Oh my gosh.
Kristal Hartman 09:21
And I also had a BMI of 42. Now we used to call that morbid obesity and thank goodness we took the word morbid out of that now it’s just severe obesity or obesity is now diagnosed in different types like type 1, 2, 3, 4, etc. But back then I was in the morbid obese category for my age and height and weight. My BMI was 42. So I waited a whole year and during that time, I got even sicker and sicker. I had to be hospitalized twice for comorbidity complications. For me, it was asthma and breathing and so it just got worse. And so finally a year later, I called the bariatric surgery office and I felt like like the biggest failure, and I was crying when I called and made my first appointment. But when I went and I got through obesity care for the first time, it was such a relief to be around physician and staff that knew exactly like what to do and how to treat someone living with this disease. And so that was a game changer for me. Since then, it was about a year later that I was introduced to the Obesity Action Coalition, and then became an advocate all of these years. But also during that time, I learned that I was going to need every tool in the toolbox. So for example, I needed bariatric surgery, but I also had weight regain. And at that point in time, it was available for me to get one of the GLP-1 medications and it was covered by my insurance. But once it was no longer covered, you know, I’ve had some yo-yo weight gains and losses, because for me that hunger signal, it’s not like I got the surgery, and it was one and done. That’s not what a chronic disease does. Even with surgery, this is still a long term disease, it still manifests itself in different ways. It’s complicated, and multifactorial, and so I was still having those major hunger signals and obsessing about food and GLP-1 certainly helped me with that. And yet, they’re absolutely nearly impossible to get access to because of lack of coverage and I will address some of that a bit later. But ultimately, I needed mental health care, I needed help from a dietician nutrition to help me make sure that I was getting all of my correct nutrients and vitamins. So you know, what we really advocate for is the ability to access all of the tools in the toolbox. And here I am today and I’m still utilizing several of those tools and I know I will for the rest of my life because a chronic disease means it’s a lifelong disease.
Zoe Rothblatt 11:49
Yeah, thank you for sharing all that. It angers me so much that that one doctor just like failed you and didn’t give you any of those tools. And I’m wondering, what do you wish that that doctor had said to you or other people around you at said to you that would have been helpful instead of the harmful messaging that you did receive?
Kristal Hartman 12:10
Yeah, definitely. Well, first of all, Zoe I didn’t think that I deserved better care. And that’s really hard for me to think about now, when I look back at that time, I thought this was all my fault, this disease. And when she was saying things like that, I internalize that and was like, yeah, she’s right, this is so true, I should be able to handle this what is wrong with me, you know, and so that was really difficult time for me. After I had the surgery and lost 100 pounds and got into a normal BMI range, she suddenly became like, oh, well see, like, that worked great. And so I actually changed health care providers at that time, because I said, you know, I deserve better than this. And I now have a healthcare team that is just like my dream team. They’re amazing. And that would be one thing that I would encourage for people during that time when I was hearing those wrong kinds of messages is just to be able to say, this isn’t fair, we know that you’re working really hard on your health. And we want to be here to support you through whatever tools you may need in this journey, because there were people that were nervous that I was having a permanent surgery, right? I mean, there’s always risks with that. And so the best thing that is that my family and my friends and my other doctor were there, and my mentor to who had had bariatric surgery about a year before I did, were all there and they were that support team that I needed. And so if someone has a person or a health care provider in their life, that is saying these harmful messages and contributing to weight bias and weight stigma, I really encourage people to find the right health care provider that understands this disease and is willing to be on the journey with you and help you with all of the different tools you may need. Even Obesity Action Coalition has a physician finder where you can look for obesity medicine specialists, and a lot of them see people virtually right so it doesn’t even matter where they are in the country. But we deserve better health care than that. And we deserve non biased, non stigmatized, compassionate health care. So I really encourage people to find that health care team that supports them.
Zoe Rothblatt 12:28
That actually leads me into one of the questions I had for you. I know that in obesity Bill of Rights was recently published, and I think OAC was involved in that, right?
Kristal Hartman 14:33
Yeah, absolutely. It’s exciting because it’s honestly the weight stigma and the weight bias is actually a discrimination issue. You know, in our country, the trends are changing, we hope you know toward anti discrimination of all people for all reasons, right? That we shouldn’t judge or shame or blame or you know, have biases against people of you know, certain size, or religion, or sexual orientation, etc. And unfortunately, people living with the disease of obesity still face a lot of discrimination. And so we worked on that patient bill of rights because we believe that as people living with obesity, we deserve the same compassionate treatment, the same kinds of access to affordable obesity care. And that, you know, as a nation, we should be doing things and making decisions to help people living with the disease of obesity, just like any other chronic disease, like people living with diabetes, or high blood pressure, or heart disease. That our patient bill of rights is really about having equal access and equal rights across the board.
Zoe Rothblatt 15:41
As you should. I mean, it seems so obvious, right?
Kristal Hartman 15:45
It really does.
Zoe Rothblatt 15:46
But that’s not the reality.
Kristal Hartman 15:48
That isn’t and we’re still shown in media without most of the time, it has no head. You know, when we’re shown in media articles online or on the TV, were often shown people living with obesity are rarely shown in a positive light, right, like maybe exercising or eating a healthy meal, we’re usually found without a head so it chops our head off, it usually just shows the middle generally focusing on a big jiggly tummy, you know, oftentimes holding a you know, fast food, restaurant cup, or burger or whatever it is. And that’s just not the reality. The reality is that people living with a disease of obesity care very much about their health, and we can guarantee absolutely 1,000,000% guarantee that we have tried a million things to manage our weight. So this isn’t a disease that’s about lazy people who don’t care about their house who are unmotivated. That’s not who we are, that doesn’t define us, this disease does not define us. And in fact, we’re the exact opposite of that description. And absolutely, we all understand that there is personal responsibility, and that moving our bodies and eating healthy foods are a critical part of managing obesity. But we now have actual science backed evidence that shows that this disease is so much more. That metabolically and physiologically, our bodies do not work the same as people who do not have excess weight. And that’s where all of these new medications and treatments are coming in to try to address some of these issues that are really specific to people’s bodies who have extra weight, and that science should be supported with affordable access to these treatments and to these tools.
Zoe Rothblatt 17:37
Totally. So let’s talk about some of those treatments and tools in the advocacy that you’ve been doing around them. Obviously, these GLP-1 drugs have gotten a lot of attention in the media, like what is that been like for you?
Zoe Rothblatt 17:48
Yeah, honestly, it’s good and bad. The good part is, is that it is elevating the conversation about obesity and it is making people more aware. In fact, there was a Pew research study that just came out that talks about the fact that the majority of Americans now believe that obesity is a disease and that it should be treated as such. So that kind of trend is changing in a positive way. But it’s also been really difficult to have all of the media coverage too, because a lot of that media coverage does not focus on the science of obesity as a disease. And it’s often related to vanity use, right? So like this star lost this much weight, or do we think this star isn’t admitting that they’re using Ozempic, or whatever. And so it’s really highly sensationalized, and it makes it also sound like everyone in the country is on a GLP-1 and that’s just not true. And so when we are advocating for access to these treatments, we’re advocating for comprehensive care. So that means that you actually are connected with a physician and physician team that is helping you manage your overall obesity. It’s not just about writing the prescription for this one type of medication. It’s also making sure that maybe you’re working with a mental health care provider because you have maybe eating disorders or different issues that contributes right to your view of food, and maybe it’s a nutritionist that will help you make grocery shopping lists and put meal planning together. I mean, there’s all of these other components besides just medication and so when we advocate like we were this week on Capitol Hill for the Treat and Reduce Obesity Act, so TROA, Treat and Reduce Obesity Act, when we’re advocating for that right, there’s two parts, it’s comprehensive care. For seniors or older adults in America, we believe that on one hand that they deserve all different types of health care providers to help with obesity. Right now for Medicare, only primary care physicians can bill for obesity and even when they do bill for obesity, they have to bill it three or four down because it’s not going to be a visit that’s paid for if it’s just primarily obesity. And we also know that primary care physicians, number one, if obesity is not their specialty, and number two, they hardly have any time with patients. I mean, we’re talking 10, 15, 20 minute appointments, where they’re addressing all kinds of things and so their lack of time to truly address obesity. One part of the bill is saying, okay, there are other kinds of health care providers that can also bill for obesity, maybe it’s a cardiologist, or an endocrinologist, or a dietitian, but it opens up the ability for people to add to their health care team for treatment of obesity. The other part is access to the FDA approved medications. And right now Medicare is paying for them for diabetes, but they are desperately worried about the cost of covering these same medications at the doses that they are provided for obesity. And first of all, they don’t look past about 10 years, Congress doesn’t when they’re looking to pass a bill and look at the cost of that. But we’re really urging them to look at what happens 20, 30, 40 years down the road. So I had my bariatric surgery when I was 36. So as a 35 year old before my surgery, I was on 14 medications. Fast forward that 30 to 35 years, I would have been a Medicare patient at 65 to 70, who was incredibly expensive, because those 14 medications probably would have turned to 25 medications, I would have already had diabetes, because I had pre-diabetes, maybe I would have even had my first heart event as a woman living with obesity. And so we’re really encouraging them to look long term so that they understand that by treating obesity, now, they’re actually decreasing the incidence of the comorbidities like diabetes, heart disease, high blood pressure, etc. So those things will actually even out one day, we know that the expense is daunting, upfront. But as we treat obesity, the incidence of these other diseases will decrease.
Zoe Rothblatt 21:53
And when you meet with legislators, what sort of response do you get? Are they like more in favor of the bills? Do they have a lot of questions for you? What’s it like?
Kristal Hartman 22:01
Yeah, yeah. And they do have a lot of questions. It’s been really interesting, because I was on the Hill in December, and then again, just this week, and the news media coverage actually means that there is a lot of questions about the correct utilization of these drugs. And what we’re really asking for, which is comprehensive care, not just someone to write the prescription because you need to lose 15 pounds before your class reunion, right? That’s not what these are for this is for chronic obesity, and for people who are actually diagnosed and being treated as such. And so we have to explain that. I will say that before these drugs were even on board, we were advocating for TROA. For 11 years now, we’ve been trying to get this passed. So this was happening long before all of these pharma companies jumped in and started making obesity drugs, right. And so we were advocating for equal comprehensive care set for 11 years now and we still have yet to get this through. And I will say the one thing that we have seen a good trend in is that more and more people do believe that this is a disease, that this isn’t just an issue of personal responsibility that these people should just take care of themselves. You did this to yourself, now you need to fix this, right? Because that’s been the message that we’ve received for years and years, is that you did this to yourself, therefore, it’s on you to fix it. And the Medicare rules pretty much explicitly state that because they consider weight loss like a vanity, you know, situation and an unneeded type of coverage. So we really explain that to them. A lot more people are, in Congress are believing and admitting to the fact that this is a disease, but they have a ton of questions about cost. And we’re putting a lot of pressures even on our pharma folks to really rein in the cost of knees so that we can get these bills passed, and that people will have access to reasonable co-pays for these medications.
Zoe Rothblatt 23:54
We really have been brainwashed to think that obesity is just a personal choice and not a disease. And I’m so glad to hear you squash that and say no, it’s a disease. And we need to admit that, like say it out loud. Obesity is a disease. And it’s so important that people like you are sharing your story. And you know, I’m just so grateful for the OAC and being connected to you guys, because it really is such a misconception out there.
Kristal Hartman 24:19
It really is. And your personal story means everything and that’s what we teach all of our new advocates. You know, I had the opportunity to spend the day on Monday when we were on the hill with one of our new advocates who also lives in Oregon. And just seeing her excitement and passion for the work that we’re doing is so fantastic. And it really comes down to the personal story. When we’re talking to Congress and we’re saying we are your constituents, we live in your state, we vote for you. This is something that is critically important to people living in your state and it is time to treat this as a disease and to treat it equally to all other chronic diseases and so that’s an important part of every single one of our stories and our conversations with Congress too.
Zoe Rothblatt 25:06
For sure, and how can people get involved if they want to with obesity advocacy?
Kristal Hartman 25:10
Yeah, we would love to have more advocates and advocating doesn’t necessarily mean that we, you know, you have to fly to Washington, DC and speak to Senators and House of Representatives. If that’s your jam, great, we would love to have you join us on Capitol Hill. But there’s so many different ways to advocate, you can advocate in your own community, you can advocate at the state level, and you can advocate at the federal level. And so I really highly encourage people to go to the OAC website as obesityaction.org. And there’s actually a whole entire website called the Action Center that will give you all different sorts of ideas of how to take action, sometimes taking action is going on Instagram, or Twitter and responding to negative news stories, or people who are exhibiting obvious weight bias and weight stigma and just calling them out and say, hey, you used this picture, did you know that OAC has an image gallery of people living with obesity, and we want you to use that image gallery instead of the headless jiggling tummy that you used in your news story. And so there’s so many different ways to advocate and to get involved. And while you do, you’re actually also becoming a part of this incredible community of people where you’re going to find support and science based education at the same time, which you know, it’s a kind of a three prong approach at OAC, we really focus on support and advocacy and education. So we would love for people to join as a member of the OAC, and to advocate in any way that they feel comfortable doing so.
Zoe Rothblatt 26:44
That’s amazing. Thank you and we’ll put a link to that in the show notes so people can find you guys.
Kristal Hartman 26:49
Great.
Zoe Rothblatt 26:49
And we’re excited to work with you more on some advocacy trainings and..
Kristal Hartman 26:54
Yes, we can’t wait. Yes, I’m so happy that we that’s what Chrystal was telling me, one of our team members of our staff of the OAC. And we love that your team is so passionate about this and passionate about chronic disease in general, but that you’re really ready to jump out and help us with this cause, right help us really hit home that obesity as a disease and that we deserve equal and compassionate and non bias care and access to all of the treatments and tools in the toolbox.
Zoe Rothblatt 27:25
Exactly, yeah. Well, thank you so much Kristal for joining and sharing your story and your work with OAC. I really appreciate it.
Kristal Hartman 27:32
Absolutely, anytime, we’d love to jump on and chat. And hopefully we get to see you on the Hill one of these days too.
Zoe Rothblatt 27:38
Definitely yeah, looking forward.
Kristal Hartman 27:40
Yes, us too, thank you so much.
Steven Newmark 27:44
Well, thank you, Kristal, that was another great discussion. And Zoe you’re becoming quite the interviewer, I hope we don’t lose you to ABC News or something with your skills.
Zoe Rothblatt 27:53
I’m right here. I’m a Health Advocate at heart, you guys don’t have to worry about me, but thanks, Steven.
Steven Newmark 27:57
Excellent. Well, it was really great discussion. I definitely learned a lot. I know your next question is going to be about learnings and I’ll just say for me, you know, she talked about our patient journey and what it’s like specifically with her patient journey, is really the most that I’ve ever heard from someone specifically dealing with obesity and that patient journey. So it was quite a learning for me and the misconceptions and bias around obesity.
Zoe Rothblatt 28:19
Definitely. And I really enjoyed the part where she talked about just well rounded care.
Steven Newmark 28:23
Yeah.
Zoe Rothblatt 28:24
And supporting patients in multiple ways, in a multidisciplinary healthcare team. That was really great.
Steven Newmark 28:30
Yeah, totally. Well, we hope that you learned something too. And before we go, we want to encourage everyone to check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 28:40
And if you have any questions, comments, episode topics, just want to say hi to us, definitely email us at [email protected]. Well everyone, thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you like this episode, give us a rating, write that review, and hit that subscribe button. I’m Zoe Rothblatt.
Steven Newmark 29:01
I’m Steven Newmark. We’ll see you next time.
Narrator 29:06
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Chronic Resilience: Jae Walker’s Journey
In this episode we are joined by Jae Walker, who lives with multiple autoimmune diseases including rheumatoid arthritis, fibromyalgia, and a rare neurological disease. Jae shares their emotional journey to diagnosis, offering advice for other people living with chronic illness on advocating for yourself and not giving up.
Chronic Resilience: Jae Walker's Journey
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Zoe Rothblatt 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF. Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life. And today, I’m joined by Jae Walker, patient advocate in our CreakyJoints community. We’ve been connected for a couple of years, I’m excited to catch up with them about their diagnoses since I’ve known them, but also just hearing how their journey started with rheumatoid arthritis years ago, and ultimately, what advice they have for patients. So, Jae, welcome to The Health Advocates.
Jae Walker 00:47
Oh, thank you. I’m so excited to talk to you again. It’s been so long, too long.
Zoe Rothblatt 00:52
I know, I still have your artwork. I got two pieces from you and I still have them both hanging in my apartment. So, while we may not have talked in a while, I’m thinking about you all the time.
Jae Walker 01:01
Oh, I’m so excited and I actually just thought about you the other day, because I had another patient purchas one of my most recent pieces that I did for CreakyJoints when I did that blog called The Darkness of Pain.
Zoe Rothblatt 01:14
That’s awesome. Well, yeah, why don’t you introduce yourself to our listeners, tell us a little bit about you and your story.
Jae Walker 01:21
Okay, so my name is Jae Walker and I feel like I’m kind of like your average, everyday person. Except when I was 34, I first started showing symptoms of rheumatoid arthritis. Except for it didn’t come on slowly. For me, I felt I kind of got run over with it. I went from nothing to all of a sudden. I was working for a local grocery store, I was working in the dairy department. And I was pulling 1,000 pound dairy pallets on my knees in the dairy department, stocking the milk and the butter and doing work that a lot of the guys and stuff wouldn’t do. And I’m actually non-binary, at the time I identified as female. So, I was doing a lot of stuff that guys wouldn’t do. So, I was on my knees, and knee pads like throwing all this product and everything and then all of a sudden, I was in so much pain that I started drinking wine at night in order to even go to sleep because the pain was so bad. Which is a really big deal for me, because addiction and alcoholism runs in my family. And I was in so much pain that I would wait until the absolute last minute to go to the bathroom because squatting to sit down on the toilet was so painful. It brought tears to my eyes. I lived up on the second floor, and I had to drive 30 minutes to work. So, I would do all of this physical manual labor, and then I would get in the car. And I was so stiff and swollen by the time I got home that it took me about 10 to 15 minutes to get out of the car. And I was like huffing and puffing and talking to myself. And then I would barely make it across the parking lot and stand there at the bottom of the stairs looking up and it felt and looked like Mount Everest to me, because every time I looked up, I just wasn’t even sure how it’s gonna make it up the stairs to get up to my apartment. And once I did, and I had my days off, I just didn’t go anywhere. The breaking point for me was my feet hurt so bad because I had swelling in my hands and my feet. I had joint aches and pains. I couldn’t function. I had the brain fog, I had the fatigue, I couldn’t focus, I couldn’t concentrate. And the pain was just getting worse and worse. Anyways, I had two days off together and my feet hurt so bad that I spent two days scooting around on my butt in my apartment because I couldn’t even walk on my feet. And I was just kind of trying to like suck it up. Like you don’t go to the doctor, you just kind of handle it. And I remember, he kept trying to get me to go to the doctor and try to get me to go. And I remember turning them at one point and saying, hey, do you think this is bad? Do you think I should go to the doctor?
Zoe Rothblatt 04:25
You can’t walk and you ask the question, oh, do you think this is bad? I can’t do a basic function, maybe it’s fine.
Jae Walker 04:36
And he looked at me. So look, I’m autistic and I miss social cues, right. And sometimes I miss sarcasm and stuff like that, but I didn’t miss this. He’s stood there and stared at me. Yeah, you think? You can’t even walk, you’ve got to go to the doctor and he was so relieved because cuz I’m really, really stubborn and I really kind of don’t listen to people.
Zoe Rothblatt 05:03
But how did you think to even go to a rheumatologist? Is that where you started? I can’t imagine like you said, oh, this could be rheumatoid arthritis. You know, how did you even get to that point?
Jae Walker 05:13
Um, no, I didn’t even think that at all like that wasn’t even on my radar because like a week or so before that I had dropped a crate of eggs on my left foot. And I had been really hobbling more so than normal around and that was kind of an extra incentive to go to the doctor. So, genuinely in my head, here’s what I thought I was going to happen. I was gonna go to the doctor, he was going to look at it and say, oh, you bruised it, or whatever, maybe give me something to wrap it up, maybe something stronger than what I could get over the counter, or maybe tell my work that I had to take some time off. I don’t know, something like that, so that I could actually rest it and then I would go back to work. And or maybe he figured out something that I just didn’t know, but I’d easily get fixed and I would be okay. It still didn’t occur to me that there was genuinely something really very wrong with me. So, rheumatology and rheumatoid arthritis, were not even on my horizon. I had no idea. When I went to the doctor, I went to my PCP and he was like, on top of it, he absolutely automatically was the first thing he suspected. I presented equally on both sides. But my problem was the same problem that I’ve always had is I presented with the symptoms, but no definitive tests.
Zoe Rothblatt 06:45
Oh, like the bloodwork?
Jae Walker 06:47
Yeah.
Zoe Rothblatt 06:47
Yeah.
Jae Walker 06:48
Inflammation does not show up in my bloodwork, never has. My RA factor was borderline. It just wasn’t really there and he could look at me and touch my joints, they were like red and swollen. I presented evenly on both sides of my body. I struggled. I was stiff and swollen and it took me a while to get going when I got up in the morning. And then when I laid down at night, that pain that hits you at night.
Zoe Rothblatt 07:19
Yeah.
Jae Walker 07:19
After you stop, I mean, I had all of that. But X-rays were negative, the RA factor was negative, the inflammation levels were normal in my blood work, like none of it was there. So, he couldn’t diagnose me or do anything with it. He straight up told me I think you have rheumatoid arthritis, but I can’t diagnose you with what I have. I have to send you to a rheumatologist. So I said, okay, I still was thinking, okay, fine this is just no big deal. And still don’t know why I didn’t think it was not a big deal.
Zoe Rothblatt 07:52
So you got to the rheumatologist and then they gave you the rheumatoid arthritis diagnosis?
Jae Walker 07:58
Yeah, well, I ended up going to the doctor, and she ended up running the same tests. It was like standard procedure, I guess and so then she still didn’t get the diagnosis. So, she ended up diagnosing me with an MRI of my left foot.
Zoe Rothblatt 08:14
Wow.
Jae Walker 08:15
Yeah.
Zoe Rothblatt 08:16
And that’s where she said, that’s rheumatoid arthritis?
Jae Walker 08:20
Yeah because she took all of my symptoms and she said, okay, look, I’ve done all of these tests. I can’t definitively diagnose you with this. This is what we’re gonna do, you tell me where on your body it hurts the worst. And I did what I always did back then, because of course, it was the worst back then it was uncontrolled, I laughed.
Zoe Rothblatt 08:38
You were like circling your entire body on the page saying this whole thing, that’s what hurts.
Jae Walker 08:44
Yes. I hate when, I hate when healthcare providers asked me that, especially when your body is not controlled. Where does it hurt the worst? And it was like uncontrollable, it was always uncontrollable for me. Like, what do you mean where? But I decided on my left foot because I had dropped that crate of eggs on it. And so she did an MRI of my left foot and so she pulled up the MRI and started showing me slide by slide and said okay, we’ve got inflammation, and I had so much inflammation on my foot.
Zoe Rothblatt 09:20
And what was that like for you to see that and actually say like, wow, there is something wrong?
Jae Walker 09:25
Honestly, I think I dissociated.
Zoe Rothblatt 09:28
Yeah.
Jae Walker 09:28
Because it went from being oh, this is something that is an easy fix or short term treatment, to all of a sudden she was talking to me about steroids. And I knew this was a possible treatment and what my PCP had said he thought was wrong with me. She, when I came to her and told her that she said, we’re not going to commit to anything, I have to check you out. Well, being who I am, I analyze and prepare the hell out of myself for everything. So, I had done research. I knew what kind of medication steroids were, I knew what kind of drugs and stuff or possible as a treatment for this. And so when she told me that, it was like, the world stood still, for me, I stopped hearing everything around me. And everything inside of me kind of shattered all at once. Because this was permanent, and it was long term. And I felt broken, and that’s what it was, I just, I felt broken and I felt extremely overwhelmed.
Zoe Rothblatt 10:34
Yeah, it’s like you were feeling physically broken from all the pain. And then like the emotional gravity of it just came crashing down to, right?
Jae Walker 10:43
Yeah and that’s worse than the physical part of it, the emotional side of it. Because within a month, I had a panic attack, end up in the hospital thinking that I was having a stroke. But I was having a panic attack, because I was so absolutely overwhelmed with all of the choices I was having to make, not to go out of my way to like exercise.
Zoe Rothblatt 11:05
Oh, my God.
Jae Walker 11:06
It was pretty scary in those early years.
Zoe Rothblatt 11:08
And yeah, just thinking about, you know, from the early years to like, I guess over the next few years, you would come to find the online community and really connect with other advocates and write and use art. Can you talk to us a little bit about what that part of your journey was, like, just like meeting others with these conditions and expressing yourself through these different forms?
Jae Walker 11:28
Well, I mean, overnight, my world got flipped upside down. I was taking naps in the middle of the day, I would work first shift and second shift from being a cashier and I was going through things that no one around me understood. And I always struggled because I always look younger than what I am. I always have. And so at the time, even though I was 34, I looked like I was in my 20s. And so even if I looked like I was in my 30s, it didn’t really matter because number one, people never think that you’re really sick.
Zoe Rothblatt 12:04
Yeah.
Jae Walker 12:05
Or that you’re old enough that you should have anything be wrong with you. And so if you actually open up and tell people about what’s wrong with you, because I had times where I had to use a cane, and I had times where I was so bad, I couldn’t like step up on a curb, there was one period of time where I started doing things off of a bucket list, because I was so bad. And my functionality was getting so bad, I thought I was going to end up in a wheelchair pretty soon. So, I started doing things like going to Six Flags, and doing all of this stuff that I didn’t think that I was going to be able to do in a year, you know, and so if I haven’t opened up and talk to people and tell people about what was going on with me, I always faced several reactions. And so I had to try to gauge people which of course is hard when you’re not good at reading faces.
Zoe Rothblatt 13:06
And when you’re just learning about this disease yourself, like you’re still like you said, figuring it all out, and you know what you can and can’t do. And there’s so much to learn about these diseases and you’re like responsible for learning that all yourself. And now you’re saying you’re also responsible for sharing that with other people, it’s tremendously hard.
Jae Walker 13:25
Yeah and you can’t do it all by yourself, you know, if you’re still working, and you need help with something like you need help reaching something, or leaning over or whatever it is that you need help with, you have to open up a little bit, because otherwise somebody’s going to be like, why do you need help with that? You look able bodied, you like you should be able to do that, like what’s wrong with you. And then they’re going to just think that you’re lazy, or you’re taking advantage of the people around you, which is the last thing that you need at work, right? And so then you have to deal with people several reactions, right? Either number one, people get so comfortable, and they don’t know how to talk to or deal with you because they don’t know how to deal with your pain. And so they don’t want to talk about it or they skip over, gloss over it and like they would just rather walk away from you and not deal with you. Right? Or you have you know, I’m in the South, or you get a lot of your bless your heart, people who feel sorry for you.
Jae Walker 14:39
And as someone who has been independent, extremely independent their whole life, the last thing I have ever wanted is for somebody to feel sorry for me. You never want somebody to feel sorry for you. You don’t tell people because you want them to feel sorry for you. You just explain because hey, this is why I need your help and when you do this for me, it’s a genuine need and I really appreciate that you’re doing it for me. That’s it, A plus B equals C. That’s all there is to it and instead, you get people who feel so sorry for you. They can’t think of you in any other way, except for pity, and that’s terrible.
Zoe Rothblatt 14:39
Yeah.
Zoe Rothblatt 15:20
Yeah.
Jae Walker 15:20
They can’t treat you like a normal person.
Zoe Rothblatt 15:23
Yeah, you’re like, I’m a person first not a disease.
Jae Walker 15:27
And you don’t become anything but that disease. And then like, anytime you’re around them oh, you poor thing. How are you feeling today? Are you okay? Aw, you poor little? Like, I’ve even had people go, oh, honey, are you doing? Okay? Did you know that, in the early years oh, did you know that she has? Like, I’ve had people tell my business, yeah. Like, it’s been bad before, you know.
Zoe Rothblatt 15:51
Yeah.
Jae Walker 15:52
And every once in a while, you’ll have somebody who’s just genuine and like, you know, they’ll truly be kind. They’ve had somebody in their family who has had an autoimmune, you know, someone who genuinely is trying to learn, you have somebody who’s a good person. They’re amazing, you know, and those are few and far between.
Zoe Rothblatt 16:10
I know you’ve had a few more diagnoses in the last few years. And you know, we talked a little bit about, you know, moving from patient to a zebra, can you talk to you about like how you knew something was wrong? And it wasn’t just the rheumatoid arthritis? You know, like, what made you think there could be something else going on here? And like, how did you get to the point where you’re getting these diagnoses?
Jae Walker 16:33
Well, so I was first diagnosed with RA back in 2011. Like at the end of September, and then in January, early January 2012, I got diagnosed with fibromyalgia. That was my second diagnosis. But I don’t ever remember not hurting that way. So I really just think the diagnosis came later, I think, yeah, they were pretty much simultaneous. And, you know, of hypothyroidism like all of this stuff. Well, I’ve actually gone back and looked at my artwork because I started, I reached out to CreakyJoints back in 2015, because it was super lonely for me not having anybody around me. I started blogging for CreakyJoints and it was a huge way for me to connect with other patients. And I started blogging about my experiences, and I started noticing symptoms that I was having and my problem is anytime I have symptoms, I have doctors who say to me, oh, well, that’s just like your RA.
Jae Walker 17:37
Or, oh, that’s just this, or that’s just that, and they just chalk it up. Or my favorite one is, well, why do you want another diagnosis, the treatment is just still going to be the same as what you’re doing right now. I literally can’t tell you how many times I have been told that actually, within the last four years,
Zoe Rothblatt 17:37
Yeah.
Jae Walker 17:38
That’s crazy also, because I mean, we’re studying new treatments, there could be a new treatment down the line that you need that ticket of a diagnosis to get it.
Jae Walker 18:01
That’s right and having more than one autoimmune disease actually opens you up to complications, which is actually what I have. So, I actually have small fiber polyneuropathy. Which means, polyneuropathy means I actually have it all over my body. So my small fibers, or have been demyelinating from the inflammation in my body. I have large fiber neuropathy, as well, but it’s not as advanced and it has come from the inflammation in my body. And I actually wanted to spend time talking to you about this on the show, because of several reasons. What I have is a very high risk. Most of the time, my neurologist who I see a neuromuscular neurologist, not just a regular neurologist, it’s those who have lupus and Sjogren’s are the ones who have the highest risk of developing it, although you can develop it from rheumatoid arthritis. And I was most recently diagnosed with Sjogren’s and I had undiagnosed Sjogren’s that went on for years because doctors didn’t listen to me and didn’t believe that there was anything wrong with me. I started having nerve symptoms that nobody would believe that there was anything wrong with me. And so small fiber neuropathy has all kinds of symptoms, and it crosses over with fibromyalgia, and it is believed that up to 40 percent of the people who are diagnosed with fibromyalgia actually have small fiber neuropathy, but there’s not enough information out there and not enough doctors are trained and have enough knowledge about small fiber neuropathy. So, small fiber neuropathy is a nerve disease and they usually they call it like the sock and glove, because you’ll feel it in glove and sock formation, right? Like you’re wearing gloves and socks. It started very much so with burning in my feet and I got to the point where I now been in the dead of winter, like I can almost never wear socks. And it doesn’t matter how cold it is, because the burning pain in my feet is so bad. I can’t tolerate anything on the tops of my feet. So, any kind of shoes that I have, they have to have, like it’s open on the top, and I can only wear them for like maybe two hours at the most, and I can’t tolerate anything tight on my skin. If I do, it’ll start to cause pain flare in my skin and that’s where it is the allodynia. So, a lot of fibro patients will know about this, right? It’s the skin pain, and it’ll cause it all over my body. And so in 2014, 2015 one of my pieces of artwork that I did shows that I had it and I didn’t know that I had it, I drew this piece of artwork because I went to a job interview, I went outside, I went to step down off the stairs and I missed a step, the step down my ankle rolled and I fell and I landed with my foot underneath me, I got up I walked in and I went back to work and my ankle and leg started to swell up. Now I was concerned with breaking something, right? If you have to have surgery, you have to come up with your medication and it’s a big deal for me because my body overcomes medication like very easily. And surgery is a huge fear of mine because of having to come off the medication and stuff. And so I went to the ER to try to get an X-ray to make sure everything was okay. I was in so much pain, so much pain. Of course they treated me like a drug seeker I was really mad and I told them I don’t want your drugs. You just freaking X-ray my leg and then they calmed down. So they X-rayed it said nothing was wrong, but they gave me a boot. And it went of course from my toes all the way up my calf up to my knee and they said I needed to wear it for like four days to support my ankle and my leg to give it strength and make sure I was okay and I had to wear a tight.
Zoe Rothblatt 22:39
And that set off your symptoms, of the SFN?
Jae Walker 22:42
Yes and it’s the tightness started to squeeze and it started to set off an all over nerve flare in my body. And the longest I could tolerate it was three days. By the third day I kid you not I was swearing at my partner, I was ready to punch everybody who was near me and I had to take it off. And like he was like, you can’t take this off the nurses, the doctors, the hospital said you have to wear this for four days. And I said like through gritted teeth, and I was like you do not understand me if I keep this on. I’m going to stab you with something sharp. You have no idea how much pain this is in. And the next 24 hours, I had electrical shooting pain through my foot and all the way up my leg.
Zoe Rothblatt 23:37
Oh my gosh.
Jae Walker 23:38
And that’s the nerve pain that I was having.
Zoe Rothblatt 23:41
And it took how many years later until you actually got the diagnosis?
Jae Walker 23:46
Well, it took me seven years to get my diagnosis. The only person who believed me and pushed me and kept sending me back to my regular neurologist to get tested was my nurse practitioner at my pain management doctor. I kept telling her about my symptoms and they kept getting worse and the whole diagnosis of Raynaud is a symptom. My heart arrhythmia, I have a form of dysautonomia called IST and I have SVT. Both of those are a symptom of my small fiber polyneuropathy.
Zoe Rothblatt 24:21
It’s like all of the puzzle pieces just came together.
Jae Walker 24:25
Yeah, they did. I mean, I had to wear a Holter monitor for like a month, my heart would race and race. I have so many specialists at this point. And I would talk to other peoplem, it started with talking to other patients asking them if they were having these problems. Nobody else was having this burning pain, but mine wasn’t limited. I have these random numb spots all over my body. Like when my neurologist, when I go in to see her she will have me like turn away and not look and she’ll break like tongue depressor or like something else, where it’ll have kind of like a point on it, I’ll turn. And it’s kind of scares me sometimes because she’ll use the pointy spot to kind of press in different parts of my body, and I will be able to feel it and then two inches later on my body, I won’t feel it at all.
Zoe Rothblatt 25:19
So scary, yeah.
Jae Walker 25:20
Yeah, that part of me is totally numb.
Zoe Rothblatt 25:22
You know, I’m noticing the time, I feel like we could talk about your story for hours and hours. But, I’m wondering if maybe you could leave us with what’s your advice for other patients who you know, similar to you have symptoms that are unanswered? Like, what’s your advice now, having gone through this journey, potentially more journey to go through, what would you tell other patients?
Jae Walker 25:44
Okay, yeah, so I have several things. Number one, get a physical copy of your medical records. Keep that on hand with you. Number two, keep a physical record of your symptoms, okay? Don’t try to remember it. Because you won’t, right? We have good and bad days. So don’t put that onus on yourself. Just don’t stress yourself out like that, keep that record on you. Okay, try to keep like dates, and all that kind of stuff. But even if you can’t keep that just write down your symptoms and keep a running tally of your symptom, okay? That really, really helps. And number three, find that one good friend, who is always going to bolster you up when you get discouraged, and who’s going to always have your back and who’s going to support you and say, I believe you. And there’s nothing wrong with you saying these things because you know your own body. Just because a test says there’s nothing wrong doesn’t mean there’s nothing wrong with you. We are our own best advocates, and we have to live with our bodies. It’s us and the doctors don’t live with this, we do. So, don’t give up, just don’t give up.
Zoe Rothblatt 27:01
I just got the chills. It’s so true. It’s like having the mental courage to keep seeking answers is so hard and having just one person believe in you can make such a difference.
Jae Walker 27:13
Yeah.
Zoe Rothblatt 27:14
Thank you so much for joining and sharing your story. Yeah, I really appreciate it and all the wisdom for our audience Thank you, Jae.
Jae Walker 27:21
No, of course it’s my pleasure.
Zoe Rothblatt 27:24
Well, everyone thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating write a review and hit that subscribe button wherever you listen, I’m Zoe Rothblatt. We’ll see you next time.
Narrator 27:42
Be inspired and supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Measles Outbreak: A Look at Florida’s Response
Measles has been reported in about a dozen states across the U.S. this year. In this episode, we’re discussing Florida’s response to this recent outbreak, and why it’s not in the best interest of protecting public health. In the news recap, we give an update on our advocacy related to Prescription Drug Affordability Boards (PDABs), discuss how nonprofits profited from COVID misinformation, explore lessons from a new report on vaccines, and talk about the rise in norovirus cases.
Measles Outbreak: A Look at Florida’s Response
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:21
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:27
And today we’ll continue our discussion from a few episodes ago on recent measles outbreaks, focused on Florida’s response. But as always, we have a few news updates first.
Steven Newmark 00:38
Yeah, so the first thing I think we should discuss is Prescription Drug Advisory Boards, which is something that we had spoken about in the past, we did a special episode dedicated to it and its impact on patients. And in the last few weeks, we’ve had the opportunity to speak directly to some of these boards are one in Colorado and another in Oregon. And we essentially inserted the patient voice on these boards. And we’ll talk more about this in the coming weeks as we continue to speak out on what these boards are doing and their potential impact for patients.
Zoe Rothblatt 01:07
Yeah and these are new, like we talked about them a few episodes ago did a deeper dive on exactly everything you need to know about and what we know so far. So, we’re still I guess, learning as we advocate, but the important thing is that we’re getting the patient voice in front of these advisory boards.
Steven Newmark 01:22
Absolutely and I’ll just say anecdotally, without taking a deep dive on it, on the subject right now. I had the opportunity to speak to the Colorado Board and I was very dismayed that the discussion amongst the board members for about an hour and a half before I had a chance to speak did not discuss much of the patient impact and certainly did not discuss affordability as it concerns patients themselves. I had prepared remarks ready to go and I essentially when it was my turn to speak, I said, I’m not even going to use my prepared remarks. I want to address what you guys are talking about, how you just have ignored patients in all these discussions and deliberations, you’ve created straw individuals who are not actual patients. And the idea of pulling a stable patient off of medication has real world impacts that are not being taken into account and was somewhat depressing, but also exhilarating, as we sometimes say it is good to advocate. If for nothing else, there’s a mental health boost to being able to speak up for yourself and for patients like you.
Zoe Rothblatt 02:18
For sure. I’m glad you were there and able to bring in the patient voice that’s kind of scary that they were ignoring all those things at first when talking about medications that are for patients. It’s so frustrating, right?
Steven Newmark 02:29
Yeah, totally frustrating. Totally frustrating.
Zoe Rothblatt 02:31
Well, we do have a few more news items. So, you had sent me this earlier this week and it really surprised me. But, the Washington Post recently reported how tax records are revealing that four major nonprofits capitalized on COVID misinformation and profited off of it, which is like terrifying.
Steven Newmark 02:48
Yeah, it’s amazing that there was an expose in The Washington Post that uncovered that there were four nonprofits, two of whom were really raking in the 10s of millions of dollars, between 2020 and 2022, 10s of millions of dollars with high salaries to their executives, and so forth, all of a tax deductible. And you know, so essentially, with the, if you will, the endorsement of the US government to be a nonprofit and spread misinformation about COVID. You know, this is 2020-2021, these are crucial times during the pandemic and to spread dangerous information is hurtful if nothing else, but to also be able to consider themselves a nonprofit, not pay taxes on their income is just horrific to say the least.
Zoe Rothblatt 03:31
Yeah, when you think about this misinformation is putting people’s lives at risk and damaging public health.
Steven Newmark 03:36
Totally.
Zoe Rothblatt 03:37
And you’re like profiting off of putting people’s lives at risk. It’s beyond terrifying.
Steven Newmark 03:42
Terrifying, terrifying. Maybe we’ll do a deeper dive on that as well. In the coming weeks. There’s a lot more coming to light about some of these nonprofits and what they were spreading. So maybe we’ll put a pin on it there and maybe revisit it.
Zoe Rothblatt 03:53
Sure. Our next bit of news, our colleague, Robert authored a report with IQVIA. And they were looking at flu vaccines among Medicaid fee for service patients and the link between pharmacy reimbursement and the goal was better to understand you know, what our vaccine rates compared to how pharmacists are compensated for giving vaccines and they found that basically, so, to quote one of the researchers a $13 increase in pharmacy reimbursement for adult flu vaccination was associated with a nearly 6% point surge in the state vaccination rate for Medicaid fee for service covered adults. So, basically what that saying is that as pharmacists are reimbursed at a higher rate, the vaccination rate for Medicaid goes up, which obviously we want because we want people to get vaccinated.
Steven Newmark 04:42
Interesting. That’s some interesting findings.
Zoe Rothblatt 04:44
So currently, pharmacy reimbursement averages around $12 for this group, which is considerably lower than Medicare’s $30. So, it’s interesting to see this stuff and how it could inform policy to help expand pharmacist ability to vaccinate and get compensated for it.
Steven Newmark 05:02
Yeah, in other news, norovirus cases are surging in the United States, especially in the northeast and western states.
Zoe Rothblatt 05:08
Yeah, I mean, this is nothing new. It’s something that we’ve seen before and peaks during winter months. It is very contagious, so be careful out there. It’s like a stomach flu that causes severe diarrhea and vomiting. There’s no medication you could take for it as far as I know. So it’s really just taking care of yourself and hydrating.
Steven Newmark 05:27
All right, well, I’ll wash my hands. Oh wait, I already do wash my hands.
Zoe Rothblatt 05:30
Sanitize those surfaces.
Steven Newmark 05:32
Oh my gosh. Well, speaking of viruses and surges our south eastern most state Florida is seeing measles and apparently not exactly mobilizing the most robust response to tamp down. Let’s get into that.
Zoe Rothblatt 05:45
Yeah, we talked about this a few episodes ago, the rise in measles and just the history of it, like how it was eliminated from the US why we’re seeing cases now. Along with Florida, measles has been reported in 11 other states this year, which is kind of scary, you know, we’re both vaccinated, so we’re good. But when you hear of a disease that’s been eliminated is now floating around, you have to wonder why.
Steven Newmark 06:09
Right, right. Well, the answer why is simple because you said, we’re vaccinated, but not everyone is.
Zoe Rothblatt 06:16
Yeah.
Steven Newmark 06:16
So you know, let’s talk about the response in Florida and why it may not be the most prudent according to some public health experts. So, the Florida Surgeon General Joseph Ladapo, sent parents a letter granting them permission to send unvaccinated children to school amid the outbreak. Now, obviously, if your unvaccinated do not have the vaccine for measles, when there’s a measles outbreak currently transpiring in your county, it’s probably wise to stay home.
Zoe Rothblatt 06:42
Yeah and this completely contradicts guidance from CDC and just like well established public health guidance that says if you’re unvaccinated stay home because of how contagious the measles is. So, why are we seeing a response that says, oh, it’s up to the parents to say whether the kids can go to school?
Steven Newmark 06:58
Right and, you know, the vaccine itself, by the way, is extremely safe. It’s been around for a while. Listen to the stat from Kaiser Family Foundation, a person is four times as likely to die, four times as likely to die from being struck by lightning during their lifetime in the United States, as they have a potentially life threatening allergic reaction to the measles, mumps and rubella vaccine.
Zoe Rothblatt 07:16
Okay, we should almost have a video portion for this because jaws are dropped like your four times as likely to die being struck by lightning than have a life threatening reaction to the vaccine. That’s like beyond shocking and just proves how safe it is.
Steven Newmark 07:32
Yeah. Anyway, the CDC reported that child immunization rates have hit a 10 year low. Last year record number of parents across the United States filed for exemptions from school vaccine requirements on religious or philosophical grounds.
Zoe Rothblatt 07:43
Let’s just pause for a second. I’m so curious to ask you as a parent, what would you do if this was happening in your kids school? And you got a letter saying it’s up to the parents to decide if the kids go in, like, how would you feel if you were in this situation?
Steven Newmark 07:57
I don’t know. You put me on the spot.
Zoe Rothblatt 07:58
I know.
Steven Newmark 07:59
I mean, my kids are vaccinated, so I feel comofrted. It’s a strong vaccine. You know, we talked about the COVID and flu vaccines, like oh, they prevent hospitalizations, and they tamp down the effects of the virus. The measles vaccine actually prevents the virus very strongly. I don’t have the numbers in front of me, but it’s a strong vaccine. I don’t know the answer off the top of my head, I think I would do the basic things call my pediatrician. What do you think? Call the principal like what the hell? Can we take a week off at least and see, you know, see what’s what. And ultimately I probably would strongly considering pulling my kids for a week just to see how it goes to see if it spreads more or to see if it’s tamp down. But I don’t know that’s off the top of my head. I don’t know.
Zoe Rothblatt 08:38
Isn’t it also typically the local county health department or, you know, more local public health figures that respond to these crises, not like the Surgeon General of the State?
Steven Newmark 08:48
I don’t think it’s unusual for it to come from the state health department to be honest. But yeah, that’s a good point. All right. We googled, it turns out that the Surgeon General or Florida as the title given to the head of the Florida State Health Department, most states use the moniker Commissioner, I don’t know why they use a different moniker. That being said, that being said, it is positioned when you head the health department you’re entrusted with public health, and you’re doing something that seems to be an opposite of that mission by giving a permission structure for parents to send unvaccinated children into a place where measles may be present.
Zoe Rothblatt 09:19
So, let’s take a look at what are like the vaccine rates for measles in Florida like what are we even talking about here?
Steven Newmark 09:27
Okay.
Zoe Rothblatt 09:27
So only about a quarter of Florida’s counties had reached the 95 percent threshold which communities are considered well protected against measles, according to most recent data from the Florida Health Department in 2022. And in Broward County, where six cases of measles have been reported over the past week, about 92 percent of children in kindergarten had received routine immunizations, and that remaining 8 percent is more than 1,500 kids who had vaccine exemptions. I know it sounds like a high number 92 percent but it’s like a huge drop totally to go like below that threshold.
Steven Newmark 10:05
Right, that’s a difference that allows for the spread, essentially.
Zoe Rothblatt 10:08
Yeah. And we’re seeing that.
Steven Newmark 10:09
Right, exactly. We’re seeing that, and we’re seeing it in the absence of any effort to curtail that spread, as best as I can tell, doesn’t seem to be an effort to say, hey, there’s X amount of cases. Let’s stop it there. Let’s not go beyond this. Right?
Zoe Rothblatt 10:22
For sure. I mean, like, the reason we have public health guidance is so that in times like this, we can follow it. Like I don’t know why we’re reinventing the rules and going against the science.
Steven Newmark 10:32
Everything’s political.
Zoe Rothblatt 10:33
And it’s almost like we forgot the trauma of the pandemic we just went through, like we just went through COVID and quarantine and everything and it’s like so quickly, people forget how you know, like precious our health is and how we really do need to stick to public health guidance in the face of these viruses.
Steven Newmark 10:51
Right, no, it’s unfortunate to say the least. I mean, vaccine mandates have been used for measles. In 1991, Philadelphia’s Deputy Health Commissioner ordered children to get vaccinated against their parents wishes during an outbreak. In 2019, there was a large measles outbreak among Orthodox Jewish communities in Brooklyn. And the New York City Health Commissioner mandated that anyone who lived, work, or went to school in these neighborhoods get vaccinated or face a fine of $1,000.
Zoe Rothblatt 11:15
And these are both for measles, but you know, I mean, this is like a classic public health 101. I remember the first public health class we’re talking about Jacobson V. Massachusetts, which was about smallpox, and the Court upheld the state’s authority to impose the vaccine because it put public health at risk and public health was more important than individual rights in this case.
Steven Newmark 11:36
I was just gonna go back to the standard moniker that we’ve spoken about before, you know, everyone has individual rights to do what they want, but you don’t have a right to trample on my rights or other’s rights and causing a public health scare tramples on my rights. You have a right to drink as much as you want alcohol to your own body, but you don’t have a right to get into a car and drive and put my life at danger due to that. So, there are, you know, public health laws exist for a reason it’s to protect the public health, if you will.
Zoe Rothblatt 12:03
Especially, our community who is immunocompromised may not have gotten all their shots because of their health, or you know, you have a weakened immune system so the shot may not be as robust of a response in your body as it is for a classic healthy person. And that’s why we get vaccinated to protect each other.
Steven Newmark 12:21
Exactly, you have a right to do whatever you want. But there are public health like you know, your right to drive a car, you don’t have a right to speed because you don’t want to kill somebody or get into an accident with somebody else who’s riding on that road. You know, laws exist for the betterment of society and enable us all to live our best lives, if you will.
Zoe Rothblatt 12:37
And I guess one last note to leave this on, there are laws that we advocate for that reduce the ability for people to do these like philosophical and religious exemptions.
Steven Newmark 12:48
right.
Zoe Rothblatt 12:48
Just obviously, like a medical exemption is a different story. But we do advocate at the state level, many states have passed laws like this that help ensure that our communities are vaccinated. Right.
Steven Newmark 12:59
Like, for example, you shouldn’t really be able to say I don’t want to get vaccinated because of the microchips that Bill Gates is putting into vaccines and tracking me as a reason. Just an example.
Zoe Rothblatt 13:09
Just a minor example there.
Steven Newmark 13:11
That’s my favorite of the conspiracies, by the way, because if you ever look at a vial of a vaccine before you get the shot…
Zoe Rothblatt 13:17
Well look at the needle. How would you… Like the needle is so tiny.
Steven Newmark 13:22
Somehow, somehow, Bill Gates has invented a microchip that is smaller and can fit inside incredible.
Steven Newmark 13:30
All right. Well, let’s talk about our learnings today. You know, I guess I’ve learned that the more things change, the more they stay the same when it comes to vaccine hesitancy and here we are 2024, Florida, measles, and you Zoe?
Zoe Rothblatt 13:42
And my learning is just from the top of the episode about the Prescription Drug Advisory Boards, how important is that we’re showing up and sharing the patient voice there.
Steven Newmark 13:51
Yes, absolutely. We hope that you learn something too. And before we go, we want to encourage everyone to check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 14:00
And if you have any questions, comments, episode topics, email us at [email protected] Well, everyone thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, give us that rating, write a review, and hit that subscribe button. I’m Zoe Rothblatt.
Steven Newmark 14:19
I’m Steven Newmark. We’ll see you next time.
Narrator 14:25
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
New COVID Isolation Guidance? What Immunocompromised Need to Know
The Washington Post released a story that the CDC is considering replacing the COVID five-day isolation period guidance with staying home until 24 hours fever free and improving symptoms. In this episode, we’re breaking down all we do and don’t know so far about COVID, its impact, and this potential change in recommendation from the CDC.
In the news highlights, we discuss how unfortunately two million Texans have lost Medicaid coverage, and we also share the latest results on our quick poll on the patient experience with clinical trials.
New COVID Isolation Guidance? What Immunocompromised Need to Know
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:21
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:27
And today we’ll talk about the recent rumblings and rumors about new CDC guidance about COVID isolation. But as usual, we have a few news updates.
Steven Newmark 00:37
Let’s get into it.
Zoe Rothblatt 00:39
So first, we have that more than two million people have been dropped from Medicaid in Texas. That’s a lot of people.
Steven Newmark 00:46
That is quite a lot of people. Yeah. So that’s unfortunate folks who had Medicaid and able to obtain medications able to visit doctors as a result of being on Medicaid. We’ve talked about this in the past, there were a pandemic policies that expanded Medicaid coverage, and many of those were lifted at the end of the emergency. So people are getting dropped from the Medicaid rolls.
Zoe Rothblatt 01:06
And the two million in Texas is actually the most out of any state losing coverage in a year. And just to put things in perspective, Houston’s population is 2.3 million. So that’s basically like an entire city losing coverage.
Steven Newmark 01:20
Yeah, well, you know, in Texas, they go big.
Zoe Rothblatt 01:22
Yeah.
Steven Newmark 01:23
That’s how they roll down in Texas. So, not surprised that it’s the most of any state losing coverage. It’s a large state. But yeah, it’s quite a number. And, you know, hopefully, the folks who have lost coverage are able to find some affordable plans through the exchanges or other means.
Zoe Rothblatt 01:37
And just something really unfortunate in all of this, like over half of the people that were disenrolled was because of procedural issues, like failing to return paperwork, it wasn’t always necessarily because they were ineligible. Like some people, like you said lost it because of the end of the emergency but others like…
Steven Newmark 01:54
Right.
Zoe Rothblatt 01:54
They didn’t get the notification. And it’s such a shame to lose coverage over something like that.
Steven Newmark 01:59
Oh, my gosh, so over a million people in the state of Texas have lost health care coverage due to procedural issues. And now a million people no longer have health insurance.
Zoe Rothblatt 02:09
Especially in a digital age, like 2024, how are we not making it simpler for people to renew their Medicaid?
Steven Newmark 02:15
Totally, totally. We got to look into that more. Let’s go down to Texas and figure out what’s going on. That’s not right. That’s all I can say. I wish I had more.
Zoe Rothblatt 02:22
Same I wish I had more to but I do have more news, we have a quick poll. So we did a quick poll on clinical trials. And you know, just a little bit of background on clinical trials. They help researchers study the safety of new medical, test devices, and treatments, and their effects on people. You know, clinical trials, of course, you can opt into them, you can decide to join, and there’s different roles for each one. But, we really wanted to know like what our chronic illness community is thinking about clinical trials. So we did a quick poll with our Patient Support Program. And are you ready for the results?
Steven Newmark 02:56
I’m ready.
Zoe Rothblatt 02:57
So a little over 2,000 people responded, and 68 percent said that they had not participated in a clinical trial.
Steven Newmark 03:04
Wow, I’m actually surprised how many have, so just by the reverse of that 32 percent have participated. So, almost a third. Interesting.
Zoe Rothblatt 03:12
I know that surprised me, too. Have you ever like talked to your doctor about clinical trials?
Steven Newmark 03:16
No.
Zoe Rothblatt 03:17
Or been offered one?
Steven Newmark 03:17
No, no, no, no, I frankly, I don’t know anyone personally, who has ever done a clinical trial or been asked about it.
Zoe Rothblatt 03:22
Same for me. So in the poll, we ask what are the most common reasons that people have not participated and like us, 55 percent said they never received information, 28 percent said they were never eligible, and 20 percent worried about a medical issue or side effects from a new medication or treatment with the trial.
Steven Newmark 03:41
Wow, what would help make people feel more interested, for example?
Zoe Rothblatt 03:45
So, yeah, we asked that too. And people were able to select all that apply some of the most common answers: 70 percent said knowing the risks of the side effects or medical issues, 68 percent said knowing more about the medication or treatment, 63 percent said knowing how the trial will affect my current treatment plan, 55 percent said knowing that my doctor supports it, and another popular one, 53 percent said knowing the time commitment.
Steven Newmark 04:12
Wow. Again, I’m surprised 55 percent knowing the doctor supports it. For me, I feel like just on a personal level, my doctor says something I’m like, yeah, okay, as long as she’s behind it, or he’s behind it.
Zoe Rothblatt 04:13
I know, like 100 perent I want to know my doctors supporting.
Steven Newmark 04:26
Yeah.
Zoe Rothblatt 04:27
Yeah.
Steven Newmark 04:28
I’m like, alright, if the doc’s in, im in.
Zoe Rothblatt 04:29
Yeah.
Steven Newmark 04:30
Let’s do it.
Zoe Rothblatt 04:31
I know. I’m like, I don’t want to do it unless my doctor’s involved in it.
Steven Newmark 04:34
Totally, and supports it, and supports it. If the doctor is like, well, I don’t know about this. I’m like, alright, that’s it. I’m done.
Zoe Rothblatt 04:40
But yeah, these are some good things to think about, like questions to ask your doctor. You know, if you’re thinking about a clinical trial, just like I thought those were great points, like…
Steven Newmark 04:49
Totally.
Zoe Rothblatt 04:50
How is it gonna affect your current treatment plan? What does your doctor think? What’s the time commitment? Like all great questions about clinical trials.
Steven Newmark 04:57
Yeah, absolutely. Thanks to our team for putting the together. All right, well, let’s talk about this new potential, shall we say CDC isolation guidance. Last week, the Washington Post released a story that the CDC is considering replacing the COVID five day isolation period guidance with, quote, “staying home until 24 hours fever free and improving symptoms” end quote, as the isolation guidance.
Zoe Rothblatt 05:20
So, this has not come out yet, which is so confusing. I’ve seen so many articles on this and for a minute, I thought the guidance was changed, but…
Steven Newmark 05:28
Right, right, right.
Zoe Rothblatt 05:29
This is just a leak. And we don’t really know what the CDC is thinking about. They haven’t made any comment, right?
Steven Newmark 05:34
No, they have not commented, you really have to get to the second paragraph in these articles to even know that it was a leak, not an official statement from the CDC. But yeah, someone leaked this to the Washington Post. So, you know, let’s talk about things that we know about COVID. So first and foremost, you know, if you’re contagious, you’re contagious, that’s not changing. And certainly the CDC knows that if you’re infected, you still spread COVID-19 to others for as long as 12 days even. So, regardless of whether there’s a change in protocol or not, it’s important to be safe. And also to protect others. If you have COVID and find yourself going out there, make sure you mask up to protect others.
Zoe Rothblatt 06:09
And just thinking about getting COVID testing, like testing is not what it used to be like…
Steven Newmark 06:14
Right, right.
Zoe Rothblatt 06:14
I don’t think we’ve got in a free set of tests since the summer, maybe. I can’t even remember. So, that just says how long ago it was. And it’s kind of expensive, like, yeah, they cost like $30. Like, if you’re worried, it’s not just easy to be like, let me just do a test to do a test like it adds up.
Steven Newmark 06:31
Right, there was a time when it was so easy to hoard tests. You know, anytime you had a sniffle, or scratchy throat, you could just start swabbing yourself. And then if you did eventually test positive, you’re like, alright, now I know and I could stay home. With the cost of tests rising and their accessibility and not quite as prevalent, it’s highly likely I don’t have any facts to back this up, I’m sure it is the case that many fewer Americans have home tests and those that do have fewer sets of home tests available. So, they’re more valuable, and they’re less likely to use them as quite as often. So, as a result, you’re more likely to get people perhaps experiencing early symptoms such as a feel that it’s a cold or something not to be worried about when in fact it is COVID are still going out there.
Zoe Rothblatt 07:09
Also, this is just a little aside but I wanted to take a test recently, and it was so confusing to find the expiration date on the box, like I couldn’t understand when it was shipped out or if that was the expiration, the timing wasn’t adding up. It wasn’t so clear. And I just think we need clear labeling on these boxes, too.
Steven Newmark 07:29
Yeah, that’s a great point.
Zoe Rothblatt 07:30
And I was like, ugh, do I just throw this out and buy a new one. And it’s so expensive. But obviously, like we know the importance of testing and making sure you’re not contagious. So…
Zoe Rothblatt 07:38
Yeah.
Zoe Rothblatt 07:39
Like I guess I’ll be safe and get the new test.
Steven Newmark 07:41
Another factor, the number of paid sick days for Americans is abysmal. Only 23 percent of Americans have zero, zero paid sick leave and among those who do have it, the average American has only 10 days of paid sick.
Zoe Rothblatt 07:52
Yeah, this is terrible. You could use like the 10 sick days in one go, like from one illness.
Steven Newmark 07:58
Absolutely. With COVID. Yeah, for sure. Especially if you have a preexisting condition, such as an autoimmune condition.
Zoe Rothblatt 08:04
For sure. I mean, also just like sick days, you know, you may have to take them for your kids, you may not be sick, your kid may be sick, or let’s say run through your family like your kid is sick, then you’re sick. Ten days is just simply not enough. Aside from like the personal impact of how challenging it is to work when you’re sick, like we talk about it all the time, it’s just really not cool to go out knowing that you’re sick and contagious and spreading it to people.
Steven Newmark 08:26
It’s totally not cool, yeah. And you know, you may think ah, this doesn’t affect me, I don’t know, I work from home, or I don’t really care. But the truth is, it affects everyone, like you may think it doesn’t affect you until you know your waiter at your fancy steakhouse that you go to shows up with flu symptoms, and he’s spreading his germs to you and your and your loved one over there. It affects us all when people go to work that they’re ill.
Zoe Rothblatt 08:46
Yeah, well, let’s talk about I don’t know, it’s like the state of COVID generally. Like we’re not in this emergency, we’re not really calling it a pandemic anymore, but it still feels like more of a threat than the flu, to me.
Steven Newmark 08:58
For sure.
Zoe Rothblatt 08:58
Maybe that’s like a little bit of the trauma that we’ve lived the past few years.
Steven Newmark 09:03
Yeah, we don’t know, we still you know, we still don’t know the long term effects. There’s still long COVID which is a whole separate discussion on that we don’t need to get into this virus has only been around for five years now. You know, four and a half years.
Zoe Rothblatt 09:13
So let’s look at the numbers a little bit like hospitalizations are going down, which is good. According to the CDC, emergency department visits were down 11 percent In the most recent week, and hospitalizations were down 10 percent, deaths down six percent. All that’s like really great to see, especially during this winter time. But on the flip side, like vaccine rates are also really lagging only 17 percent of the total US population receive the updated booster and this is compared to the 69 percent of the total US population had finished their primary series. So, it’s like there’s a huge group of people that got the first vaccine and now just aren’t getting the boosters.
Steven Newmark 09:52
Yeah, I know we need Travis Kelce to do another commercial for that one because those numbers are I was gonna say abysmal. I already use that word today but those numbers is a pretty poor.
Zoe Rothblatt 10:00
Maybe we need him and Taylor together getting their boosters.
Steven Newmark 10:05
That’s like too much firepower. Let’s hold back on that for next time we need to go inside, she’ll she’ll be the one to tell us. She’s the only one Americans will listen to. And like I said I mentioned long COVID but there’s still a lot to learn. The Biden administration has dedicated an additional $515 million to a major initiative to study long COVID, which is a dice increase. The NIH that have the funding would be used to test additional treatments in clinical trials to study the effects on each part of the body. So hopefully we’ll learn more about long COVID, but right now, it’s still like, uh huh, we still don’t know like you said it, COVID is still should be scary. Not freak out scary, but I think it’s definitely higher plane of scariness than the flu. Right?
Zoe Rothblatt 10:44
I think so. Yeah, and I mean, our community who lives with chronic illness definitely, like feels the seriousness of all of it, like COVID, flu, RSV, but I think there’s something like unique about COVID in that, like, exactly what we’re saying, we don’t have a lot of the answers. There’s a lot we don’t know. And the guidance has been changing a lot. Whereas something like the flu, like we’ve had guidance in place that we’re accustomed to.
Steven Newmark 11:07
Right.
Zoe Rothblatt 11:08
And whenever we hear a new thing for COVID, it’s a little bit of like, wait, what? And then…
Steven Newmark 11:12
Yeah.
Zoe Rothblatt 11:13
Now the CDC hasn’t in recent months given guidance specific to immunocompromised people. So, it’s also a little challenging when general guidance comes out and people who are immunocompromised because of their condition, or the medications they take don’t really know how applicable it is to them.
Steven Newmark 11:29
Yeah, no, absolutely, absolutely. And not to compare flu and COVID again, but flu has been around for 100 years, that’s very different, and flu seasonal. So, you kind of know, you know, when to expect it, when to ramp up your personal safety procedures, if nothing else. But getting back to the guidance. So, some of the things about the guidance, the leak guidance, if you will, that we don’t know, is number one masks, if they’re gonna change the guidance, or, you know, make it less restrictive, if you will, is there gonna be new masking guidance to go along with that? I mean, if folks are going to return to action, while still contagious with this, you know, is the CDC also going to recommend that they at least mask for that period?
Zoe Rothblatt 12:02
Yeah, I just don’t know what the likelihood of people masking is honestly.
Steven Newmark 12:06
Right. I guess it’s not going to happen. And then the the other thing you mentioned the immunocompromised and also elderly folks, is there anything special for these folks? How are you gonna protect immunocompromised individuals if more folks are walking around while contagious?
Zoe Rothblatt 12:18
I also saw rumblings that I don’t know if this is true or not. But there is a meeting on February 28, where the CDC is expected to talk about COVID shots, so maybe we’ll get information then. But I saw rumblings that the CDC is considering another updated COVID vaccine like this 2023-2024 shot to recommend another shot of that for people who are immunocompromised this spring.
Steven Newmark 12:41
Wow, and then of course, the big issues. Does any of this actually matter? How many people look to the CDC guidance and say, okay, that’s what I’m gonna follow. You know, so is this going to really impact transmission rates?
Zoe Rothblatt 12:52
I have this feeling that no, like, I feel like the general public has just moved on. Like, we talked about that a lot. And…
Zoe Rothblatt 12:59
Like they’ve moved on, and they make decisions like based on how they feel. And then our community what we just said, like, doesn’t feel so included in the guidance. So, while we want to look to the CDC and follow like, it also feels like it’s missing a little bit.
Steven Newmark 12:59
Yeah.
Steven Newmark 13:12
Yeah, no, absolutely. Anecdotally, I find that people use the CDC as a way to get back to work or send their kids back to school quicker. They’ll say, oh, we had our five daysm that’s what the CDC says, so, we’re good to get back to work. So, if the CDC shortens that I get the sense that some of these folks who rely, quote unquote, rely on the CDC for allowing them to get back into the world, if anything, use this. And I know this is a small subset of people who actually pay attention to this stuff, but it’ll be used as their excuse to get back even sooner. Like oh, no, there’s no five days anymore, I’m fine. So, I’m okay to get back, that’s what the CDC said.
Zoe Rothblatt 13:44
Kinda crazy. I know people that I just remembered this. I can’t believe I didn’t think about it earlier when we’re talking about the sick leave, but I know people that have said to their work, oh, I have COVID and they’re like, okay, so just throw in a mask and come in.
Steven Newmark 13:56
Wow.
Zoe Rothblatt 13:56
Which is just crazy to be that careless with it. I just can’t believe that.
Steven Newmark 14:01
Wow. Wow. I don’t know what to say.
Zoe Rothblatt 14:03
By the way, also, we’re talking about with immunocompromised, it’s like we’re at risk for more severe illness like many people who are immunocompromised, but a lot of people also forget that when you’re sick, you often have to delay your regular medications.
Steven Newmark 14:17
Right. Good point. Very good point. Very, very, very good point. Yeah.
Zoe Rothblatt 14:21
So like, that’s what makes me the most upset.
Steven Newmark 14:23
Totally.
Zoe Rothblatt 14:23
Because I always check in with my doctor and she says, yes, skip this dose or continue when you feel better.
Steven Newmark 14:29
Right.
Zoe Rothblatt 14:29
And then it’s like, not only am I sick, but now my arthritis and Crohn’s is acting up and it’s everything.
Steven Newmark 14:35
Totally. That’s a good point.
Zoe Rothblatt 14:37
Once again, our episode is turned into a giant vent session, but like sometimes it’s so needed.
Steven Newmark 14:40
That’s okay. Anyway, let’s see what the CDC says and I suppose the only thing you can do, I shouldn’t say the only thing you can do that sounds depressing, but always advocate on behalf of yourself. Talk to your employer about your condition, and see what kind of accommodations can be made. If you’re going into an office setting, hopefully there have been upgrades in the HVAC systems You can always mask yourself but of course, living in the real world, not everybody works in an office number one. Number two, living in the real world, there are people who may have bosses who might be judgmental about folks who are wearing masks. Unfortunately, that’s the real world, you know. So, tread carefully, I suppose is the best we can do.
Zoe Rothblatt 15:18
Yeah.
Steven Newmark 15:18
But advocate, advocate for sure.
Steven Newmark 15:20
Yeah, I know it can be scary and intimidating when it seems like everyone’s moved on. And…
Steven Newmark 15:25
Yeah.
Zoe Rothblatt 15:25
But like it’s your health and like, try to do what makes you feel most comfortable. All right, Steven, what did you learn today?
Steven Newmark 15:33
I learned a lot about the quick poll regarding clinical trials. I thought that was really interesting. How many folks have not been approached, I think that you and I anecdotally said, we’ve not been approached either. And I think that certainly shows that there’s a large cadre of patients out there who could be approached, I certainly would be interested, if there’s a new therapy on the horizon that might be beneficial, I would want to I would want to get him in line for that. So hopefully, something can be done to change that.
Zoe Rothblatt 15:58
Yeah, those results really surprised me too. But also, it was just good chatting with you clearing up some of this, like what we know and don’t know about COVID and the new guidance that may or may not be coming out.
Steven Newmark 16:09
Yeah, well, we hope that you learn something too. And before we go, we definitely want to encourage everyone to check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 16:18
And if you have any questions, comments, episode topics, just want to say hi, you could email us at [email protected]. Well, everyone thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating, write a review, and hit that subscribe button wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 16:38
I’m Steven Newmark. We’ll see you next time.
Narrator 16:44
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Health Equity and Black History Month: Breaking Down Barriers
Black History Month is a time to celebrate the great achievements and commemorate important Black heroes and events throughout our history. It’s also a time to reflect and raise awareness of racial and ethnic disparities across health care sectors.
The Health Advocates are joined by Sarah Shaw, Senior Manager of BIPOC Community Outreach at GHLF for a discussion on the disproportionate burden of chronic disease in the Black community, barriers to health care, addressing racism in health care, and ultimately how we can come together as a community and advocate for our health year-round. In this conversation, we delve into actionable steps for fostering inclusivity and driving future advancements in health care access and equity.
Health Equity and Black History Month: Breaking Down Barriers with Sarah Shaw
Narrator 00:00
Be inspired, supported and empowered. This is The Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:21
Our goal is to help you understand what’s happening in the healthcare world to make informed decisions to live your best life.
Zoe Rothblatt 00:28
And today we’re joined by Sarah Shaw, Senior Manager of BIPOC, that’s Black, Indigenous, People of Color, Outreach at GHLF. And she’s here to talk about Black History Month things with us and get into the health disparities of it all and what we can do to help raise the voices in communities of color. But first, we do have a few news updates.
Steven Newmark 00:48
Yes, so this week, we’re early February, the opening offers on Medicare price negotiations are beginning. This stems from the Inflation Reduction Act, which passed Congress and was signed into law in late 2022. And the US Department of Health and Human Services, HHS, through its Centers for Medicare and Medicaid Services, CMS, sent initial offers to the participating drug companies of the first 10 prescription drugs selected for negotiation in the first cycle of the Medicare drug price negotiation program. That was a mouthful.
Zoe Rothblatt 01:20
Yeah, well, this is kind of like the first key step after they announced the 10 drugs. I don’t think anything has happened yet, really. So this is the first step in actually getting to that negotiated price, right?
Steven Newmark 01:31
Correct. So the negotiations have begun, so each drugmaker now has until early March to accept the offer or to propose a counteroffer to the government. And then a series of negotiation sessions could follow with the process set to conclude by August.
Zoe Rothblatt 01:45
And then once the price is agreed upon, it’ll take place in 2026.
Steven Newmark 01:49
Correct, which is, by my calculations two years away. So two years, and we’ve still yet to see how this is going to impact the prices that patients themselves directly pay. So, well we’ll see.
Zoe Rothblatt 02:02
That’s really important to stay on the lookout for.
Steven Newmark 02:05
Yes, another important issue is the Supreme Court has agreed to take up a case on COVID misinformation.
Zoe Rothblatt 02:11
We’ve talked a lot about the misinformation on social media during COVID. Whether it was about vaccine safety, mask effectiveness, COVID’s origins and the shutdowns that happened, and Biden officials had urged platforms to pull down post and delete accounts and amplify correct information. And now the Supreme Court is going to decide if that violated first amendment rights.
Steven Newmark 02:34
Yeah, fascinating to watch. I’m a lawyer and I’d say it’s difficult to go to law school without having some kind of an interest at least if not an affinity for the First Amendment. Those cases were always a little more interesting than your contract law classes. So, this is a big First Amendment case.
Zoe Rothblatt 02:49
So, just from that perspective, Steven, what do you think is likely to come out of this?
Steven Newmark 02:54
I’m gonna play it very lawyerly.
Zoe Rothblatt 02:56
I knew that was coming.
Steven Newmark 02:57
Actually, no in true ignorance, though, I honestly I’ve not read the filings. So I don’t want to miss state anything. I’ll tell you this. I promise to do the research and read, but you know, it is interesting. There’s a balancing act there’s not an unlimited right to free speech. As we all know, you can’t yell fire in a crowded movie theater, is probably the most prominent example of that. Government has a compelling interest in curtailing certain forms of speech and when public health is involved, we’re talking about misinformation. There’s also the issue, it gets even trickier because these social media sites are not necessarily the ones that are posting it’s individuals who are posting onto these social media sites some of the misleading information, I say, misleading, you know, let’s let’s be a little more real and say outright lies about vaccine safety, etc.
Zoe Rothblatt 03:44
Well, regardless of what the outcome is, it will, though have major implications for what role that public health officials can play in the spreading of information on social media.
Steven Newmark 03:55
Totally. By the way, we should mention the case is called Murthy vs. Missour and it alleges that federal officials coerced social media and search engine giants like Facebook, Twitter, YouTube and Google to remove or to downgrade posts that question vaccine safety, COVID’s origins, or shutdown measures. And the Department of Justice lawyers argue that officials made the request but never actually forced the companies to do this.
Zoe Rothblatt 04:19
Well, as we said, arguments are set to come March. so next month. So, looks like we have some updates soon.
Steven Newmark 04:25
Yeah and my nerdy lawyerlyness is definitely excited. I’ll say that much. But let’s move on to our topic of the day, an important topic for us here at GHLF. We spend a lot of time talking about health equity, and also the interplay of race and public health outcomes. And it’s February is Black History Month, so we’re excited to bring on Sarah and talk a little bit about some of the work that we are doing at GHLF and some of the importance of Black History Month generally even outside of GHLF.
Zoe Rothblatt 04:55
Yeah, welcome back, Sarah. It’s been a while since we’ve had you on but our listeners should remember you because you’ve been here before. How are you?
Sarah Shaw 05:02
Yeah, it feels like I’ve stepped into a home again, coming back. I always enjoy talking with you and Steven about anything that’s going on, so honored to be here today.
Zoe Rothblatt 05:12
So, why don’t you take a minute if we have any new listeners to introduce yourself and your role at GHLF.
Sarah Shaw 05:18
Sure, so my name is Sarah. I’m the BIPOC Community Outreach Manager at GHLF. A lot of what I do centers and amplifies the voices of BIPOC patients within our communities, making sure that they have a megaphone to get their experiences and needs kind of heard throughout all the work that we do the various projects. I also am a person that lives with a few chronic illnesses myself, such as migraine, and I help run patient councils and I’m involved in a lot of work regarding to asthma, IBD, dermatology, cancer, and migraine, and arthritis as well. So, happy to be here on the show.
Zoe Rothblatt 05:55
And I think you just highlighted something really important about just mentioning all the diseases and the fact that these issues span across diseases. A lot of what we’re going to talk about today with health disparities and racism and healthcare and social determinants of health, it’s not just one disease, it really does span across the patient journey.
Sarah Shaw 06:14
Absolutely. It’s something that I think in terms of I’m talking about the black community, we already know that there are health disparities in terms of just in general BIPOC patients going to the doctor not having trust in the system. And so having these conversations and having us dedicate time to health equity is what’s going to help bridge that gap to ensure that it’s equitable across all communities, not just BIPOC, but just in general. So, it’s really important the work that we’re doing and hoping that it impacts patients in a positive way.
Steven Newmark 06:47
Can you give our listeners some examples of the burden of chronic disease and its disproportionate impact on the black community?
Sarah Shaw 06:55
Absolutely. This is a really good question. I know I can start off with COVID. You know, when 2020 hit, it was a hard time across all patient communities. But it especially hit really hard for black and brown communities. I think the statistic was black and brown communities were hit three times more with COVID illnesses versus their white counterparts. And I think a lot of the marketing that was done to kind of help that in terms of engaging people to go get vaccinated to help those disparities, but it is still an ongoing process. I think a couple other things that come to mind is regarding dermatology, specifically psoriasis and eczema present differently on darker skin tones. And so for the patients that we work with, that have darker skin tones, black or brown communities, there’s been a lot of misdiagnosis for them. Their chronic pain or chronic illness journey takes much longer to get a diagnosis. So doctors specifically have not been trained to recognize the differences of what psoriasis or eczema looks like on darker skin. So it’s just a matter of implementing that in medical school to have examples, to have people show that. Because I think back to a patient that we work with very well she’s a wonderful woman, Diane Talbert, and her story specifically of having to, trying to get a diagnosis for years of where people just thought she was contagious, when in fact we know psoriasis is not contagious. It’s an autoimmune disease inside the body, but it took her a very long time to get a diagnosis. Those two things are front of mind and then cancer as well. Cancer, lupus, and sickle cell it definitely affects black communities a lot harder than our white counterparts.
Zoe Rothblatt 06:58
Sarah, it’s interesting you bring up about how psoriasis appears differently on skin of color, I actually was just reading and I put it in our outline here this research study published in Arthritis Care and Research and it was about fixing the education gap for assessing lesions in lupus patients of color. And like you mentioned, black patients have a three to five fold increase of incidence of lupus verses our white patients, but they’re often completely absent from training materials in medical school or residency, doctors are just not seeing what these lesions look like on patients of color exactly as you said. So, to address this, a group of researchers had created this interactive tool that included over 100 images from patients of color. And following the training module, there was a significant improvement among providers in being able to identify these lesions among patients, and they surveyed them and they were able to describe the rashes, and they were much more confident in diagnosing the patients. And it’s just wild to me that something as simple as including images can really make such a difference for improving that time to diagnosis, improving access to treatments because the sooner you’re diagnosed, the sooner you’re getting on treatments, and that there’s just really simple ways we can address this like systemic racism that’s in our health care system.
Sarah Shaw 09:47
Absolutely. Even some things that are very old school still being taught in medical school, black skin is thicker than white skin. We know that that is not accurate, but until we can have that corrected from the beginning to when we’re bringing people in to training to be doctors, to be physicians, to be nurses, that it needs to be autocorrected from the beginning so that the stereotypes are not implemented. And speaking of like medical school, an article that I wrote with which I’ll drop at the end is I found that in the US, specifically, only 5.7 percent of doctors are black. And this is important for me to bring up in general just because of the mistrust that the black community has in healthcare in general, being able to see a doctor that reflects like your background, your ethnicity, is a huge way to help bridge those healthcare disparities, they’re more likely to go to the doctor if they see someone that looks like them. And just seeing that number be so low is a reason why we still have these disparities. So everything that we can do to make medical school and just different things that are related to health care more diverse is going to help fix those problems.
Zoe Rothblatt 10:56
And can you talk about in your journey you mentioned you have migraine and other chronic diseases, did you have trouble finding a provider of color? What was it like when you found one? Has it been helpful? Like tell us everything about that? Or give us a synopsis because we could probably do another 10 episodes on that.
Sarah Shaw 11:12
I’ll try and do the abridged version, I ramble, but I will try my best to keep it centered. So I appreciate you asking me that Zoe, because I did not have a very good relationship with healthcare when I was younger or growing up. There was a lot that happened where I was told I was making things up, it was all on my head. When I was younger, oh, these are just growing pains, she’s doing this for attention. I just have to say something here, I’m also a transracial adoptee, so I was raised in a white family. And so I had my dad when I was younger advocating along there with me and when he unfortunately passed away, that’s when I started to notice a lot more mistreatment in terms of specifically with migraine. There was certain comments made to me about how oh, you don’t cry like my other patients when they’re getting injections, or where am I going to find all your head under all this hair when I was when I was getting injections.
Steven Newmark 12:06
Oh my gosh.
Sarah Shaw 12:07
For migraine treatment and it’s just for me, I didn’t speak up. And I think I was so early on in my patient journey that I didn’t know that, like I could have a voice and those doctor’s appointments. And so for me, I left I moved away, I specifically dedicated a lot of time and energy to find providers that looked like me. And it took a while it’s not easy. And I also have to say I have a lot of privilege, I have good health care and I know some people are in these deserts in America, not literal deserts, where they have to travel very, very far to find doctors that look like them and sometimes they have to just work with what they have. For me in my situation, I have a car, I have a partner who can drive me to my appointments that are about an hour and a half away. And that’s where I see my queer and black neurologist, who I have a wonderful relationship with, we have good back and forth in terms of shared decision-making when it comes to my disease. And then in terms of mental health, I think it’s so important because we know mental health is something that impacts the entire patient community, specifically the black community, we need more mental health tools and resources. And for me, it was very important where I had therapists in the past that were white, there were just certain things that couldn’t be addressed in terms of racism, or chronic pain. And I was very intentional in my search, I think two and a half years ago, I think I’ve been seeing my therapist for two years. And it’s made a world of difference of just having someone who understands where you feel safe and can go about when we code switch and stuff like that. And it’s made a tremendous impact on not just my physical health, but my mental health of not having to worry, am I going to get shot down by another doctor? Or am I gonna have to deal with a microaggression at the doctor’s office and those are just two examples. And that’s honestly what I want for all patients in general, I want them to have wonderful relationships with their doctors, with their physicians, because not going to the doctor when you have a chronic illness, it’s tough and it will make us sicker if we can’t put our health first. And I’ll end it really soon. I think another caveat for a lot of BIPOC patients is not having time to prioritize our health where usually a lot of other things come first ,family, raising kids, juggling multiple jobs, and not having accessible hours for patients to be able to take time, whether it’s the morning, whether it’s on the weekend, whether it’s late at night, I do know that I’ve spoken with quite a few black patients where they’re like, I don’t have the time because I don’t have a flexible schedule to be able to go to the doctor. And then another access issue too is you know, affordability for treatments. And I think that was a big part of my journey. But also I got to a point where I was like, I need to make this better not just for me, but for all patients and so that’s why I do what I do here.
Steven Newmark 12:27
Yeah, that’s very well said I’m just thinking out loud. It’s what you’re saying, a lot of it is it’s tough to say it like this, but it’s just the act of doing it on the individual level. I mean, first of all, we’re talking about so many things. And I’m putting aside the systemic racism in healthcare and putting aside some of the social determinants of health for now, but talking specifically about the access issues that you’re describing, and I’m going to even put aside the global access issues to talk on the individual level. Just the act of getting yourself to the doctor, advocating for yourself, advocating to try and find a provider that has hours that you can get to in your care, advocating to obtain needed health insurance, whether it’s Medicaid or private insurance through an employer or through the Affordable Care Act exchanges. It’s daunting to say the least, but I think the three of us can agree that the more you do it, the less daunting it becomes. Is that a fair, I hope that’s a fair statement, right, which is the one advantage those of us, the three of us who are chronically ill have is that unfortunately, we have experience going into doctor’s offices. I don’t know I have a degree in navigating the healthcare system, whatever that degree is.
Sarah Shaw 16:01
The ups and downs of the ins and outs that able bodied people don’t understand until it happens to them. Even me before I was diagnosed with chronic migraine and endometriosis. It was an eye opener into how our healthcare system works and all of the access issues that are riddled throughout. And I think we’re moving the needle forward. But there’s always more to do.
Steven Newmark 16:22
Yeah, yeah. And I’m sorry to be so pessimistic but I’m being realistic and saying there’s no one that’s ever going to be a better advocate for your own health care than you are, or a potentially a loved one who, you know, has helped take control. But let’s talk about more on the global scales, reducing disparities and looking to a brighter future that when we have you back on the podcast in 10 years, in 20 years. How are we going to get there? How are we going to reduce these disparities?
Sarah Shaw 16:45
My first and foremost thing is together, together. I think a lot of burden falls on patients and you’re right, Steven, sometimes the best advocate for your health is you. You know your body inside and out. But I do think that there are ways that medical schools, physicians, patient advocacy organizations like ours, who are able to represent and amplify and center patient voices that typically do not get heard and sharing that back with pharmaceutical companies to make sure that the patient voice is embedded through every aspect of what we’re doing. I know there’s also a talk about clinical trials, making sure that there’s diverse patients in clinical trials. And it’s just going to take a group effort, and I think we’re on the right page. But my equitable future dream is just all of us working together to make sure no person is not getting health care due to access issues. That’s my dream.
Steven Newmark 17:39
I think just to bounce off that it’s important to be an advocate for yourself. Once you have attained that level of being able to advocate for yourself or as a caregiver for a loved one, the next step is to advocate for others, and which is what we do here and what all of our patients, and our particular 50-State Network patients do, is to advocate for a better world.
Sarah Shaw 17:57
You mentioned caregivers, I have to give a shout out to my partner Tara, who comes with me on almost every single one of my doctor’s appointments for that extra support and remembering things that I forget. Just having that extra support to know that you’re not advocating alone is a lot, or even having you prep with your loved one or partner before you go to your appointment is effective. That’s all I wanted to say about that.
Zoe Rothblatt 18:19
And I was just going to add that, of course we do awareness all year long, but having a month like Black History Month really provides a dedicated time where you can go and listen and learn about people’s stories. And then think about ways you can get involved like Steven and Sarah are saying and advocate. But I think it’s really a great opportunity to just sometimes take a step back and learn and hear what conversations are happening outside of your traditional community and go on social media and see what people are talking about. Send this podcast to a friend, hear what Sarah has to say. I think it’s really important, especially as a privileged, cisgendered white person to just like sit back and listen to the voices of the community.
Sarah Shaw 18:59
And what you said is very powerful Zoe, I think with Black History Month in terms of what it means to me, it’s a time for our allies to to listen and not center themselves, like during these conversations where it’s sometimes very vulnerable for us to share and be open because some of these things involve medical trauma, medical PTSD, and listening and then offering how can I help you? Whether that’s just as simple as you said, sharing their articles sharing, their podcast story, offering other layers of support. But Black History Month is also it’s a time to look back, but it’s also a time to reflect and celebrate Black excellence, Black joy. I know for some black people, it’s a history that’s ingrained in the US. but there’s also this joy that comes out of seeing achievements, seeing our Black patient advocates celebrated, not just in February throughout the entirety of the year and it’s a really, I don’t know, magical month, I think for a lot of us so I appreciate that we can talk about these discussions and figure out ways to continue to help not just black patients, but all patients.
Zoe Rothblatt 20:03
Well, one last fun question for you, Sarah, before you go, are there any traditions you partake in during this month, restaurants you visit, special dishes you make? Yeah, we’d love to hear from you about that.
Sarah Shaw 20:14
No, that’s a fun question. It’s funny, Tara and I were talking about that just last week. I’m like, hey, it’s Black History Month, like, I want to get some African food and like, it’s just simple things like that like honoring and putting money towards like black owned businesses, whether that’s small Etsy shops or restaurants just being able to do that is a solid way to support the black community who put so much love and energy into whether the outfits that they make, the jewelry that they make, the food that they make. And it’s a way for me to stay connected to my culture and it’s a fun tradition that we started and I love it.
Steven Newmark 20:49
That’s fantastic. All right. Well, this has been great. Thank you so much, Sarah, for taking the time. There’s a lot of work to be done. But it’s great that we’re working towards it. And like I said, if we were around 50 years, I hope that we can look back and talk about the improvements but certainly in shorter increments than that.
Sarah Shaw 21:05
Thank you. Thank you, Steven and Zoe for having me on the podcast. And just one thing I wanted to mention in regards to what we’re doing at GHLF for Black History Month is we have a page that’s going up that was updated last year, that’s going to be updated qlso throughout the month. It’s ghlf.org/black-history-month and that’s where you can find a lot of patient stories, a lot of articles, a lot of podcasts that are centering black voices throughout the month and throughout the rest of the year.
Zoe Rothblatt 21:35
And we’ll put that in the show notes, so everyone can find it. And if you’re curious about any of the resources we mentioned during today’s episode, check out the show notes, all the links will be there. But yeah, thank you, Sarah, so much for coming on and sharing your story and sharing the experiences of the community. Like you mentioned, it’s not always easy to do so because it brings up a lot but it’s of course important to do so. So thank you so much.
Steven Newmark 21:57
Yeah, thank you.
Sarah Shaw 21:58
Thank you.
Zoe Rothblatt 22:01
Well, everyone thanks for listening to The Health Advocates a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, give us a rating write a review and hit that subscribe button. I’m Zoe Rothblatt.
Steven Newmark 22:14
I’m Steven Newmark. We’ll see you next time.
Narrator 22:19
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Prescription Drug Affordability Boards: What Patients Need to Know
About half of U.S. adults say it is difficult to afford health care costs, and about one in five adults say they have not filled a prescription because of the cost. So, what can we do about lowering costs to ensure timely access to affordable care and treatment? In this episode, the hosts give us the 411 on Prescription Drug Affordability Boards (PDABs), how they aim to reduce drug prices, and why patients must be part of this process.
Prescription Drug Affordability Boards: What Patients Need to Know
Zoe Rothblatt 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:06
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:22
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:28
So Steven, last week, Corey co-hosted with me and we talked a lot about policy and advocacy for 2024, the usual stuff like step therapy and copay accumulators, but a big topic that came up was these Prescription Drug Advisory Boards or PDABs for short, and we thought it would be good, you know, you and me to devote an episode to it after reflecting more on that.
Steven Newmark 00:49
Yeah, absolutely. This is a somewhat new phenomenon, these Prescription Drug Advisory Boards, and their overarching aim, if you will, is to take a look at prescription drugs generally at the state level and to impose some price controls over some of these trucks.
Zoe Rothblatt 01:04
So, maybe we could take a step back and talk about health care costs being high in general.
Steven Newmark 01:10
Yes.
Zoe Rothblatt 01:11
Kaiser Family Foundation always puts out really good data on this. And I found some that was published on their site end of last year. So are you ready for this?
Steven Newmark 01:20
Yeah.
Zoe Rothblatt 01:20
About half of US adults say it’s difficult to afford health care costs, and one in four say that they are a family member and their households had problems for paying for health care in the last 12 months.
Zoe Rothblatt 01:31
Yeah, that’s right, Steven. One in four adults said that they skipped and that also can lead to higher costs later on. Because when you delay unnecessary care, like it could end up in a more devastating way nd you could end up in the ER and…
Steven Newmark 01:31
Yeah, so one in four put off paying for health care in the past 12 months. Interesting. I presume it includes skipping or postponing getting health care that they needed because of the cost.
Zoe Rothblatt 01:53
Yeah.
Zoe Rothblatt 01:53
You know, we always talk about preventative and early care is really important, obviously, for your health, but also for keeping costs down.
Steven Newmark 02:00
Yeah. But I am just curious, when they do surveys on high costs, is there anything that people would respond to and say, no, those costs are not high. I feel like when asked people will say yeah, restaurants are expensive. Yeah, food costs are high. Yeah, car costs are high. Yeah, gasoline costs are like, I’m just curious, like, when do people say that something is not expensive?
Zoe Rothblatt 02:19
That’s a good point. And my thought is like that there’s some good data in here about what we just said that they’re skipping or postponing care. Or like this next stat about one in five adults say they haven’t filled a prescription. So yeah, I can complain that my health care is expensive. But me, Zoe, is still paying for it. I’ve never forgone care, fortunately, because of the price. But in here, it shows that people are actually foregoing the care. So I think that’s like the nuance there that we could say it’s not just complaining.
Steven Newmark 02:51
Totally and I apologize for sounding glib, there is a difference with health care and other items. When it comes to costs. Health care is necessary, of course, or it directly affects your health and your ability to live your life. So there’s a difference. I was more like poking fun, I guess the survey, if you will.
Zoe Rothblatt 03:08
Yeah, like who’s gonna be like, I love the price of my drug.
Steven Newmark 03:11
Yeah, I know. I know.
Zoe Rothblatt 03:13
So yeah, about one in five adults said they’ve not filled a prescription because of costs.
Steven Newmark 03:18
Okay.
Zoe Rothblatt 03:18
One in 10 said they’ve cut pills in half or skipped doses of medicine in the last year because of cost.
Steven Newmark 03:24
I’ve done that. Not in the last year. But I’ve done that. Yes.
Zoe Rothblatt 03:27
Really?
Steven Newmark 03:27
Back in my younger days.
Zoe Rothblatt 03:28
Steven, you’ve got to take it as your doctor prescribes, you can’t be cutting pills.
Steven Newmark 03:34
Well, when I was in law school, finances were tight. What can I say? That’s all I’ll say about that, I guess.
Zoe Rothblatt 03:38
And then all this is to say is that even if you have health care insurance costs can still be a burden, right? So this isn’t just like uninsured people that are paying ridiculous amounts. This is also people on health insurance. The last stat I have here is about four in 10 insured adults worry about affording their monthly health insurance premium, and 48 percent worry about affording their deductible before their health insurance kicks in. That’s a lot of stress. You know?
Steven Newmark 04:06
Absolutely. It’s very stressful. And not to put too fine a point on it. But when you have a chronic condition, I’m sure that gets even magnified even more because you’re taking prescription drugs likely for life.
Zoe Rothblatt 04:16
Yeah, chronic condition equals chronically paying.
Steven Newmark 04:20
Right, so that fear is I would say almost always omnipresent. Even if it abates a little bit here and there and you’re in a financial position to pay for something or you have an insurance carrier that enables you to pay there is always that fear of when that could get cut off at some point or costs can rise. So yeah, that is an ever present concern.
Steven Newmark 04:37
So, what do we do about it? In come these PDABs.
Steven Newmark 04:41
So, Prescription Drug Advisory Boards were designed as a way to help lower drug prices at the state level. They are created through state legislation and are small boards appointed by the governor or legislators. The goal is to reduce government and commercial market spending on prescription drugs to increase affordability.
Zoe Rothblatt 04:58
So how do they do this? How can this group of appointed people just come in and lower the price of drugs?
Steven Newmark 05:05
Right. So, what they do is they conduct what are called affordability reviews, or they assess if a prescription drug cost is too high for patients and insurers to afford and they try to understand what prices are being charged for certain treatments, and then they make recommendations to the legislature on ways to lower government spending on prescription drugs.
Zoe Rothblatt 05:25
Okay, so I’m just wondering why now, like, I know drug prices are high, we just went through the data, but…
Steven Newmark 05:32
Right.
Zoe Rothblatt 05:32
What kind of kick started these PDABs?
Steven Newmark 05:35
Why is 2024 to the year of Prescription Drug Advisory boards?
Zoe Rothblatt 05:38
Yeah, it’s like the night of Passover, I have the four questions.
Steven Newmark 05:41
Right.
Zoe Rothblatt 05:41
Why now? How do they do it? What drugs? Let’s break it all down.
Steven Newmark 05:46
Well, why now? I guess the overarching answer to that is that policymakers are always looking for ways to cut costs throughout the state. And they are particularly interested in cutting costs on prescription drugs, it’s a very salient issue, it gets a lot of media attention, more so than cutting costs in other areas, perhaps. So it’s something that’s always top of mind, if you will, for state policymakers and federal policymakers, for that matter. Specifically, in 2024, the interests of the state level, it really kicked off because of what happened at the federal level with the inflation Reduction Act. And the Inflation Reduction Act included a provision, as you may recall, for federal drug price negotiations, Medicare drug price negotiations.
Zoe Rothblatt 06:23
Oh, right. Yeah.
Steven Newmark 06:24
Yes.
Zoe Rothblatt 06:25
Back in August, we talked about the first ten drugs, right?
Steven Newmark 06:28
Exactly. So, in August, CMS announced that the first ten drugs that will be up for negotiation, and the prices will become effective in 2026. So that kind of kick started the idea to do something similar at the state level.
Zoe Rothblatt 06:41
So how do we know what drugs get reviewed? We just mentioned that CMS announced the ten drugs, was there some announcement among the states? How do we know what’s going on?
Steven Newmark 06:50
Well, every state is different. I mean, it seems to be coming fast and furious. And there are 50 states and it looks like already on the books, including in late 2023, at least a half a dozen that I could think of between November and this upcoming spring with more probably coming on the way. In each state, it varies, each board specifically varies how it selects the prescription drugs that they want to review. And if a board determines that a drug is unaffordable in their terms, it can take a variety of steps depending on their degree of authority granted to them by their state legislature, including making recommendations to the legislature on ways to lower drug spending, potentially, they might have the power to negotiate how much a state pays a manufacturer for a prescription drug, or they could set what are called upper payment limits, which are caps on what is the will specifically spend on a prescription drug?
Zoe Rothblatt 07:37
And do we know like how long this would take to go into effect. I know for federally, those first ten drugs are going to happen in 2026. So it’s like a little ways away. So I assume patients can expect any price changes so quickly?
Steven Newmark 07:50
You know, at the state level, the laws could be different, the way that they’re written by again by the legislature and rules could be implemented in a much more rapid fashion than at the federal level.
Zoe Rothblatt 08:00
Very cool. Okay, so we’ll keep our patients updated as we see what these boards decide.
Steven Newmark 08:05
Yes, but I do want to highlight that these boards may not be the panacea that they appear to be.
Zoe Rothblatt 08:10
Oh, tell us more?
Steven Newmark 08:12
Well, first and foremost, these boards are made up of individuals selected as you said by the legislature or the governor, they’re not made up of patients. So they don’t necessarily have the patient perspective in mind when discussing you know how to formulate these drugs and the impact it’s going to have on patients, they tend to be health economic professionals or other healthcare professionals. But that’s why we do what we do is to get involved and insert the patient voice where possible.
Zoe Rothblatt 08:37
Exactly, because at the end of the day, these are decisions being made for patients that will impact patients who are taking these drugs. So we ought to have the patient perspective.
Steven Newmark 08:47
Absolutely
Zoe Rothblatt 08:47
In these meetings in order to decide what is the right price for patients
Steven Newmark 08:52
Exactly. You know, first and foremost, if there are going to be savings they need to go to the patient. If the patient’s not going to see the savings, we want to ensure that a patient is not going to have a reduction in access to medications that you’re taking. You know, we were talking about costs earlier and costs are a factor but another factor is actual access to medications. You need to take your drugs to stay healthy and again not to go back to this well but when you have a chronic condition it is absolutely critical to stay current with your medications.
Zoe Rothblatt 09:20
For sure. And I even had just in the new year like insurance can reset and things aren’t like all lined up and for my biologic for like a day or two I thought I was on the line for $5,000 and I was freaking out. I didn’t have a supply in my fridge. I didn’t want to miss my meds.
Steven Newmark 09:38
Oh man.
Zoe Rothblatt 09:38
There’s no way I’m paying $5,000. I called the specialty pharmacy. They helped, they got the manufacturer copay assistance payment and thank God for that. But..
Steven Newmark 09:47
Wow.
Zoe Rothblatt 09:48
It’s scary out there with these meds. You know?
Steven Newmark 09:50
I know.
Zoe Rothblatt 09:51
And I’m educated I work in healthcare and I knew something was wrong.
Steven Newmark 09:55
Yeah.
Zoe Rothblatt 09:56
And there’s no way I’m going to be on the line for this but there’s so many people that just what know what to do in that scenario.
Steven Newmark 10:02
Healthcare is so intimidating. The thing I would say is, I think it is very natural to be intimidated when dealing with monetary situations in which you are a somewhat of a novice or not an expert, and very few people are experts when it comes to health care. I am very fortunate I understand health care similar to you, this is what we do. It’s not fun, but I know how to get my health care paid for and how to fight and how to call the insurance companies and be patient and press the right buttons on the phone and when to like speak to the right person, and all that kind of stuff, and how to advocate for myself. But there are places in this world where I’m not comfortable. I had an issue with my car and I don’t have a level of comfort when trying to get my car fixed, for example. I don’t know how, I’m not familiar with that world, I’m not a car person, and it’s very intimidating. And it opened my eyes to what it must be like for so many people who encountered the health care system, what they must deal with when trying to deal with financial issues from healthcare providers, from drug manufacturers, from local pharmacies.
Zoe Rothblatt 11:00
And I feel like you just nailed it there at the end. There’s so many stakeholders in healthcare too. You just said the doctor’s office, the pharmacy, there’s the hospital, the health insurance, there’s so many things sometimes you don’t even know who to call first, or where to go and…
Steven Newmark 11:14
Right.
Zoe Rothblatt 11:14
They’re all telling you different things, it’s so challenging,
Steven Newmark 11:17
It’s very challenging, it’s very challenging, but to bring it around, I think that our role in the healthcare ecosystem, if you will, is to ensure that patients have the voice and that the patient voice is not forgotten. Ultimately, all of this entire ecosystem is built around serving patients, whether it’s a hospital, a pharmacy, or a health insurance provider, Medicare, Medicaid, they’re all there because of the patient. And we as patient advocates have to make sure that the patient voice is heard and is felt by policymakers.
Zoe Rothblatt 11:47
One hundred percent. and for our listeners, if you’re curious about how you got involved in share your voice, Corey, in the last episode gave a really good breakdown of what states are active and with what medications and how to share your story. But the ultimate point he made was that whether you’re currently on the drug or have been on it, it’s really important just to share your story and your experience. It’s really like true to you and it’s not like some complicated policy thing you have to learn. You just have to share your experience.
Steven Newmark 12:15
Yeah, wow. Well said by Corey. Yeah, and that includes for these Prescription Drug Advisory Boards when they arise, we want to make sure our voices heard and we at GHLF will send out alerts to our list if you’re on our list about upcoming board meetings and ways to get involved and make sure that the patient voice gets heard in terms of your medications that you may be taking and the importance of retaining access to such medications.
Zoe Rothblatt 12:41
On that note, Steven that brings us to the close of our show. Tell us one thing you learned about PDABs today?
Steven Newmark 12:47
Well, I guess the big thing is how prevalent they are becoming in 2024. It seems to be sort of the issue du jour at the state level. And it’s something that we will continue to watch and continue to insert our voice and dare I say, continue to need help from our patient advocates to insert in your voice.
Zoe Rothblatt 13:04
And I learned that it’s really different states and federally and between the states as well. So it’s important to keep an eye out for what each of them are putting out.
Zoe Rothblatt 13:13
Well, we hope that you learn something too. And before we go, we want to encourage everyone to check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 13:21
And if you have any questions, comments, episode topics, just want to say hi to us, email us at [email protected] Well, everyone thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it. If you like this episode, give us a rating, write a review and hit that subscribe button. I’m Zoe Rothblatt.
Steven Newmark 13:41
I’m Steven Newmark. We’ll see you next time.
Narrator 13:47
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Advocacy in Action: Shaping 2024’s Health Care Policies with Corey Greenblatt
Corey Greenblatt, Associate Director of Policy and Advocacy at GHLF, joins Zoe Rothblatt, Associate Director of Community Outreach at GHLF, as co-host of this episode to share advocacy and policy priorities for the patient community in 2024. Corey breaks down which states are active in passing legislation that protects patients from step therapy and copay accumulators, and how patients can share their story to help pass these laws. Corey also highlights the need for patients to share their story to prescription drug affordability boards (PDABs). Finally, Corey shares federal policy updates, including exciting momentum for The Safe Step Act.
Advocacy in Action: Shaping 2024’s Health Care Policies with Corey Greenblatt
Corey Greenblatt 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Zoe Rothblatt 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Zoe Rothblatt, Associate Director of Community Outreach at the Global Healthy Living Foundation.
Corey Greenblatt 00:19
And I’m Corey Greenblatt, Associate Director of Policy and Advocacy at GHLF.
Zoe Rothblatt 00:22
Our goal is to help you understand what’s happening in the health care world to help you make informed decisions to live your best life. And just like you heard, I’m joined by Corey Greenblatt today to co-host and update us on all things advocacy and policy for 2024. So Corey, welcome back to The Health Advocates.
Corey Greenblatt 00:40
Thank you so much for having me, Zoe. Excited to talk to you and excited to talk about some state policy stuff going on this year.
Zoe Rothblatt 00:46
Me too. I feel like you’re our unofficial official fill in co host. So we appreciate you coming on.
Corey Greenblatt 00:52
I tell Steven all the time, I’m always happy to pitch it. It’s my pleasure.
Zoe Rothblatt 00:57
Awesome. Well, before we get into everything that you have to share with me and our listeners today, I just wanted to quickly talk about these quick poll results. So we often share here the results of these quick polls which are sent to our Patient Support Program and they’re on a variety of topics. This time it was about for people living with psoriasis about how satisfied they are with their treatment. And as I’m sure you know, Corey, there’s a bunch of different types of treatments for psoriasis, you could do things like topicals, or take more like systemic medication that’s a pill or injection. So we wanted to know, what was people’s experience with those and how do they feel about them? Sorry, ready to hear?
Corey Greenblatt 01:33
Yeah, let’s hear what they had to say.
Zoe Rothblatt 01:34
So, for the people that were currently taking a topical cream, such as a corticosteroid to treat their psoriasis, about half said that they were, and what was really interesting was that 55 percent were neutral or disagree that they were satisfied with that topicals ability to prevent or treat their condition. So that means like over half aren’t really feeling like it’s doing a great job.
Corey Greenblatt 01:58
That’s a lot higher than it should be if we’re being completely honest.
Zoe Rothblatt 02:01
But then there’s some good news, as the poll went on, we asked about a systemic medication, such as a pill injection, or infusion to treat psoriasis, and 65 percent said they’re taking one. And then when asked the same question about if they’re satisfied with their medications’ ability to prevent or treat the condition 74 percent agreed or strongly agreed with that. So, what this just told me was that if you’re not feeling satisfied with your treatment, talk to your doctor about it, there’s probably more options that you can try maybe something in this scenario, like a systemic medication is working on the whole body versus a topical just in the area you put it. So it just told me the importance of advocating for yourself and bringing up these concerns with your doctor.
Corey Greenblatt 02:43
Yeah, and I think one of the really great things that shows is for many things, many conditions, as you said, there are options, you’re not locked into a single option or treatment. And the more you communicate with your doctors, the more you have an open dialogue with your team to really kind of express what you like about your treatment, what you don’t like about your treatment, what you’re finding beneficial, what’s not beneficial, the more likely you can actually move to something that will impact you in a positive way. And that you will see a benefit from.
Zoe Rothblatt 03:12
Definitely, I really couldn’t agree more. And while we’re here, I can’t not plug it. As you know, we have a webinar coming up next week, Monday, January 29 at 4pm eastern time. This is part of our HEROES program, we did an episode about HEROES, maybe last season, we could stick it in the show notes along with the registration. But this is a webinar that brings together a bunch of stakeholders, a dermatologist, a patient, a hairstylist, a psychologist, and we’re really just talking a lot about exactly what you and I were just talking about, you know, managing your psoriasis in everyday life and at the doctor’s office and how you could bring together all these people to feel your best.
Corey Greenblatt 03:48
Yeah, I really recommend that everyone checks the link in the episode description, registers, and does whatever they can to take part in this webinar.
Zoe Rothblatt 03:58
Great. So, one month into 2024. Tell us what’s on the horizon for this year for our 50-State Network.
Corey Greenblatt 04:05
Yeah, this is going to be an interesting year from advocacy perspective. So in 2024, we are once again in a presidential election year that has a lot of implications for state government, state governments are on different sessions from the federal government, we talk about this, often. States’ governments have their own session length. So you can look at a state that has four weeks of a session like Oregon, where you need to really get your ducks in a row as quickly as possible, because they’re trying to get the work done as fast as possible. Or you look at a state like Massachusetts, which they’re in business all year long. They’re open the entire year, which gives us a long time to work on stuff but also means that there’s a lot of dead time in between. So there are positives and negatives to both but the good thing is, is that we have an opportunity to do some great work across the entire country in a number of different areas and really excited to possibly do that.
Zoe Rothblatt 04:54
So tell us about those areas. What are some of the target states or target issues that we’re looking at?
Corey Greenblatt 04:59
Yeah, so I’ve been here a couple times and going over the issues. So, I won’t dive into all of the issues as much, you can check out kind of previous updates and previous episodes we’ve done to break down things like copay accumulator adjusters and step therapy. But, generally speaking, a lot of what we’re doing this year still revolves around access issues. So things like step therapy, primarily this year, there are going to be efforts in New Jersey and Michigan. And we’re really excited, we think that there’s a chance to really do some great work there. But the big kind of policy this year, the thing we’re seeing in many states is going to once again be copay, accumulator adjusters. And this is something we’ve discussed at length in a number of different podcasts. It’s something that we have seen success at, at the state level through the last couple of years, but we’re continuing to start to really see some progress and getting more states covered under these laws. So before I go into my kind of Howard Dean like listing of the states, which is a nice 90s political reference for anyone who’s listening. The other issue area that I wanted to kind of bring up briefly is something called Prescription Drug Affordability Boards, or PDAB for short. And these are efforts by state governments to study certain drugs and evaluate them on a cost effectiveness basis to see if the state government can do something similar to what the federal government is doing with drug price negotiation and try to find a way to make medications more affordable at the state level for state employees, state government employees, health plans that are regulated by the state government. But so the thing we are seeing with regards to Prescription Drug Affordability Boards, or PDABs, for short, is that these are chances for patients to be able to share their experience with the state government review boards on what it’s like taking certain medications. So we had a chance last year to do this with some patients in Colorado, and we’re able to get them to share their experience taking things like Enbrel Stelara, and really got the ability to share with state regulators what it was like from a patient perspective to take these medications, to rely on these medications, utilize their copay assistance programs, and everything all in between there. And it was very valuable. And we’re excited to kind of get into it more so this year with more states.
Corey Greenblatt 05:25
And when patient share their stories to talk about how important this medication is, does that sort of then tell the PDABs to say this is important medication, we have to lower the price, like how is it all connected there?
Corey Greenblatt 07:27
It’s a really interesting question. So they’re not looking to kind of say this is really important, let’s make it as cheap as possible, because it has to come into a bit of a give and take. Say, you’re going to lower the price to $1, so this medication is a cheaper everyone in the state. Well, the manufacturer might say, I’m not going to sell it to patients in that state anymore, because I can’t profitably make any money on that, because you’re making me lose a significant amount of money. Now, we should not make healthcare decisions based solely on cost. And we should hold pharmaceutical companies and insurance companies to that same standard. That being said, that is not always the case. And so we have to ensure that there is a bit of a give and take. These companies are producing life saving medications, so we want them to continue to exist, continue to innovate, and continue to produce these medications, and we want them to be able to continue to give them to patients across the entire country. However, they’re still very expensive. So states are trying to figure out where that middle ground is for that line of what they can regulate. And that’s what these PDABs are trying to do. They’re trying to see what value they can kind of determine these drugs have on the patient’s lives. And if increasing or decreasing the threshold with which these pharmaceutical companies can charge will impact that value, they may try to do that. Or they might set non price thresholds on things, they’re really just trying to get a better understanding of what these drugs impact patients on a day to day basis do and what the financial aspect plays into that.
Zoe Rothblatt 08:56
And this is an interesting one for patients to get involved in. Because really all you have to do is talk about improved your quality of life vs something like maybe step therapy, I know we always say you don’t have to necessarily experience step therapy you could also tell your story. But there’s not like you had to experience something negative in order to advocate for this, you really could just talk about how much medication has helped you, which I think allows like an avenue for more patients to get involved in advocacy.
Corey Greenblatt 09:21
I couldn’t agree more. I think it’s a unique opportunity for advocacy with regards to these kinds of Prescription Drug Affordability Boards, because as you said, they just want to hear from patients. They don’t care if it’s positive or negative anything in between. They just want to hear what it was like for you to take these medications. And it doesn’t matter if you are currently on the medication. If you previously took it and had to switch off of it. All of those things are very important. So when we start to get into the states that are starting to look at these things, if you’re in one of these states, really keep in mind that this isn’t just something where you maybe have to go to a state house and spend all day in an advocacy day. This is something that by and large is virtual many of them to take place at local time, so you can be at the non work hours. So you can kind of take this from your home computer, share your story, and it cuts out a lot of the problems and things that come up with in person advocacy participation. And I think it’s a really interesting and exciting experience and opportunity.
Zoe Rothblatt 10:18
So which states have meetings on the horizon that patients can get involved in?
Corey Greenblatt 10:23
Yeah, so we’ll start with the PDAB issue, because we were just talking about that. So states that have already passed legislation regarding PDABs, and are now currently soliciting stories from patients, there are three of them. So Colorado, they started their listening sessions last year, and as of January 24, started to open up surveys for more responses. Today is the last day that the surveys for Enbrel and Genvoya are open, but they’re going to later in the spring, open up surveys, for Stelara and a couple other medications, we will of course, send out notices to everyone in all the patients in our networks. So if this is an issue that you are interested in, I highly recommend you sign up for the 50-State Network, CreakyJoints, the Patient Support Program, basically everything, just sign up for them all, to make sure that you get your notice. SO, Colorado is the one that is the furthest along. Oregon is another state that they have a virtual meeting in February. So next month, we will be participating. We encourage anyone who lives in Oregon to reach out and if you’re interested in sharing your story on a certain medications, we can share which medications they’re looking at. And if you’re able to share your story, it’s very simple to do so. And we’ll help you do that. And finally, Maryland is the other state that has already passed legislation and is now starting the implementation phase and starting to solicit patient stories. So if you’re in Colorado, Maryland, or Oregon, and you are interested in kind of talking to a Prescription Drug Affordability Board, keep this in mind, and there might be an opportunity for you to do so. Additionally, there are a couple of states that are looking at passing legislation that would allow them to do their own version of a Prescription Drug Affordability Board. So these are states that they aren’t looking for patient stories yet, but they very likely will be. So that’s Illinois, Michigan, Virginia, Connecticut, and Arizona. So these five states are in the process of passing their own version of legislation and looking at what the impact of prescription drugs have on their health system. And eventually, very soon, will likely be soliciting their own version of patient stories as well. So if you live in those five states or the previous three, and you are interested in sharing your own experience, taking certain medications, or curious what medications they’re looking at, please reach out to us at our advocacy team, the 50-State Network. And we really would love to find ways to work with you on these issues and get your story and your experience out there.
Zoe Rothblatt 12:45
Absolutely. You could always email us at [email protected]. And one of us will get back to you.
Corey Greenblatt 12:52
Yeah, for sure. And now finally, moving on to the big project, the major policy that we are seeing across the country copay accumulator adjusters, this is our bread and butter, this is the thing we have talked about for years and worked on for years had a lot of success at the states. And now we’re hoping to have some more. So the list of states that have current active legislation. So if you live in one of these states, these states have bills that you can support right now California, Massachusetts, Florida, Michigan, Missouri, New Hampshire, Ohio, Oregon, Rhode Island, Vermont, Wisconsin.
Zoe Rothblatt 13:25
Wow.
Corey Greenblatt 13:26
And just for all my Howard Dean fans out there, woo!
Corey Greenblatt 13:28
So, all of these states currently have bills that have numbers, some of them are and we’ll get into this in a little bit, some of them have hearings already scheduled. And there are also a number of states that have advocacy days already scheduled. So if you live in any of these states, there’s 11 states there. And again, going back to something that Zoe briefly mentioned, even if you haven’t experienced a copay accumulator, even if you haven’t experienced step therapy, your voice still matters. If you live in these states, you are a constituent, these legislators are literally paid by you to listen to you. It is their job to listen to you. So if you live in these states, and you care about these issues, whether you’ve experienced them or not, you still have a valuable point of view, you still can walk into an office and share your experience having your condition, having your disease. I personally thankfully have never experienced a copay accumulator adjuster, but I can still talk about the burden of disease as a type one diabetes patient, I can still let legislators know if I did go through a copay accumulator adjuster, this is how it would affect me. And this is how it would affect my entire life. And that point of view is very valuable. So while you’re listening to this episode, if you’re thinking to yourself, oh, that issue hasn’t affected me it hasn’t affected a loved one, maybe sometime in the future. I want you to just keep in mind doesn’t need to your voice is still important. Your voice still matters. So if you want to get involved in these states for these issues, do. Please do and we can help you connect you to the right people. So please reach out to that [email protected] email and And we will make sure that we put you in touch with the right people. So from the standpoint of advocacy days, there’s a couple in February and March and one in April, specifically related to copay accumulator adjustors. So if you want to join any of these, just let us know. And we’ll help put you in front of the right people. So those advocacy days just so we can kind of list them and I’ll stop talking afterwards and let Zoe ask your question, because I realized I’ve been going on a bit of a rant but on February 6, Missouri in the state capitol is holding an advocacy day. February 8, the National Multiple Sclerosis Society is holding an advocacy day in Florida. On February 12th, the bleeding disorders organization is holding a capitol day in Oregon in Salem. On February 29 and on March 18, there are a couple of different organizations holding advocacy days in Sacramento, California. So if you are able to make one of those two, please let us know we will put you in touch with the right people. And finally, on April 9, Columbus, Ohio, they’re having an advocacy day all of these are related to copay accumulator adjusters, so they want to get as many patients there as possible. Again, you don’t need to have gone through an accumulator adjuster, you don’t need to have had any issue accessing or affording your medication. You don’t even really need to have a condition or disease, you can just show up, you’re a constituent, your voice matters. If this is something that matters to you, or the people you love. And you’re able to do it. Please do.
Zoe Rothblatt 13:28
Woo!
Zoe Rothblatt 13:34
Awesome.
Corey Greenblatt 13:44
So I’ll take a break from there.
Corey Greenblatt 15:55
By the way, never apologize for going on and on. That’s what earned you spot is unofficial official co-host.
Corey Greenblatt 16:29
Well, I’m glad to hear that I’m always happy to come by and get a little ranting in.
Zoe Rothblatt 16:33
So, we talked a lot about the states, should we move to some federal advocacy?
Corey Greenblatt 16:38
Yeah, I’m happy to do that. So the federal advocacy isn’t as exciting from the state side in a lot of ways, because federal advocacy admittedly takes quite a bit longer. Things move a lot slower federally, because things are a lot larger. The size of the federal government versus the size of state governments mean that things take a lot longer, you need a lot more people to agree on things. And so things we’ve been talking about for years are still major issues. So, The Safe Step Act is the federal version of the step therapy law. Now, what’s exciting is that this year, we really do seem like there is momentum to get this bill passed into law, pharmacy benefit managers are a major point of emphasis in the current setup of Congress. So there’s a big effort to get a reform package passed for PBMs at the federal level. There is real momentum to include The Safe Step Act in this final language for the PBM reform law. So groups like GHLF, and many other patient groups around the country have been working very hard in the beginning of this year to ensure that it remains in the final language for the bill. There is a lot that can happen between now and the bills final passage, we at first thought we were gonna have to do it this month. But there’s some budget things that happens and now we haven’t a little bit extra time to pass this. So we have basically until March 1 and March 8 to keep pushing support for this law and ensure that as the final PBM reform bill language is completed and finalized, The Safe Step Act is not cut from that language as a result of making it a smaller, more easily passable bill. This is something that has bipartisan support in both chambers and shouldn’t be difficult and shouldn’t be one of the things that’s cut just to make the bill smaller. So that’s what’s on us to really work and make sure that that happens. We are going to be participating in a federal hill day on March 5 with the Digestive Disease National Coalition where we will be supporting this as well as the HELP Copays Act, which is the federal version of the copay accumulator adjuster law. And we will also be participating in another one in April with the Alliance for Transparent and Affordable Prescriptions. So if you want to get active on federal legislation as well, specifically, by the way, if you have a digestive disease, there is an opportunity for you to participate in the DDNC’s federal advocacy spring policy forum as well. So if you are interested in doing some advocacy work in DC in March and would like to get involved that way, again, please reach out to our advocacy email, we will connect you to the right people, we will make sure that you are able to share your voice at the federal level as well as the state level. And finally, the last kind of federal update is with regards to the HELP Copays act. So again, something we’ve talked about a couple of times federal version of a copay accumulator adjuster law, something that isn’t as far along as The Safe Step Act, in part because it was introduced a few years later. So it’s just a little bit behind. But we are hopeful about this as well continuing to garner support and get a little bit closer to a potential passage. And that’s really it at the federal side. There are opportunities from a non legislation standpoint to share your experience with CMS during their drug price negotiation hearings. They’re continuing to try and solicit information from patients similar to the way that the PDABs are doing at the state level. If you are interested in sharing your experience with the federal government, again, just keep an eye out for our emails, we will make sure that we will send out information about surveys about opportunities for advocacy about listening sessions, the best way you can get all of this information is to sign up for the 50-State Network and let us know what things you are interested in, so we can then make sure you are aware of them. And I think that’s everything from the advocacy update. Unless you have any questions or want to dive into anything specifically.
Zoe Rothblatt 20:28
No, that’s a lot. And it’s really exciting that so much is coming up in 2024. I would just say, you know, if you’re listening to this, and you feel like any sense of overwhelm by how much there is, know that there’s many different ways to get involved. You can, like Corey mentioned, go talk to your legislators, we can also share your story on social media or in the 50-State Network newsletter. Advocacy is really what you make of it and what you want it to be. And I always say like there’s no act of advocacy that’s too small, you talks about the momentum around The Safe Step Act and I think that we’ve gotten there, because every year there’s a little bit more people sharing their stories and putting more pressure. So whatever way you want to get involved in share your story, we’re here to help.
Corey Greenblatt 21:09
Couldn’t agree more. Everyone has a valuable experience to share everyone’s individual disease journey is important. Whether you’ve gone through these policy or these issues in the past or not. The average person in America doesn’t know what it’s like to live with your condition. So if you can simply just share with legislators what it’s like to live every day with a chronic disease that has value.
Zoe Rothblatt 21:33
Awesome. Well, thank you so much, Corey, I learned a ton from you today on where we’re getting active and how we can get involved. So thanks so much for co-hosting with me, and we’ll have to have you back on to give updates as the year goes on.
Corey Greenblatt 21:46
Yeah, I can’t wait. I’m always happy to join you, Zoe, and always happy to step in for Steven when it’s necessary. And yeah, if anyone is interested in learning more about any of these advocacy opportunities or ways to get involved, I’m always available. I know our advocacy team is always available, and we’re excited to see what 2024 has in store for us.
Zoe Rothblatt 22:06
Well, everyone, thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating write a review on Apple podcasts and hit that subscribe button. Wherever you listen, we’ll have more people like you find us. I’m Zoe Rothblatt.
Corey Greenblatt 22:23
And I’m Corey Greenblatt. We’ll see you next time.
Narrator 22:29
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Measles Outbreak: Where’s the Public in Public Health?
With measles outbreaks making headlines in the U.S., The Health Advocates are diving into the history of measles in this country, how we got to these outbreaks after eliminating measles, the role of public health trust, and where we go from here to rebuild public health authority.
“I think there tends to be this idea that the measles is just a rash or some spots on your skin. But no, and when you contract it, it’s pretty bad,” says Steven Newmark, Director of Policy at GHLF.
Measles Outbreak: Where's the Public in Public Health?
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:21
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:27
Today we’ll talk about the recent measles outbreaks in the news and kind of get into where’s the public in public health so let’s dive in.
Steven Newmark 00:36
So measles, I thought that was eradicated. I got my vaccines many many, many years ago, I believe, as everyone in my family. So what’s going on?
Zoe Rothblatt 00:44
Yeah, what is going on? Same same, I got my vaccines when I was an itty baby, but it seems like it’s popping up in the news. So a few states, first, we saw the Virginia Department of Health put out a news release over this past weekend saying that they’re aware of a person with a confirmed case of measles who recently traveled to northern Virginia after being overseas.
Steven Newmark 01:06
Yeah.
Zoe Rothblatt 01:06
So, this exposure was linked to international arrivals at Dulles Airport, and then also at Ronald Reagan Washington International Airport. And these were both on January three and four.
Steven Newmark 01:18
And then there were cases in New Jersey, in Camden County, and in Philadelphia a measles outbreak that has so far infected eight people. And at the end of the last year in Delaware, around 20-30 people. So that’s a dangerous quarter there from New Jersey down to Virginia, I suppose. So let’s talk about who is at risk with measles.
Zoe Rothblatt 01:35
Yeah. So, you know, if you’re exposed, you’re at risk of developing symptoms. And health officials say that if you do develop symptoms, you should isolate immediately. And what are those symptoms? They usually appear within one to two weeks and they include, you know, your typical things like fever, cough, runny nose, also a rash, red watery eyes or pink eye. But really, who’s at risk? It’s anyone who’s not gotten the vaccine or not already got it measles.
Steven Newmark 02:02
So we’re good, right?
Zoe Rothblatt 02:04
Yeah, you shouldn’t worry. Actually, according to the CDC, one dose of the measles vaccine is 93 percent effective at preventing it.
Steven Newmark 02:12
Excellent. I’ve had two doses. So what’s that?
Zoe Rothblatt 02:14
97 percent.
Steven Newmark 02:16
Excellent.
Zoe Rothblatt 02:17
Looks like we’re hopefully in the clear.
Steven Newmark 02:18
Yeah, still, it’s definitely like a head scratcher. There’s no need to worry it or anything by any means. But it’s just the idea that another disease that was essentially eradicated is making a comeback, if you will. And I think it’s important to note that children under the age of 12 months are at risk because they have not gotten one dose yet. And that is scary for two reasons. Number one, one of these exposures. I think it was the one in New Jersey, I may be wrong took place at a daycare center. And I think the one in Philadelphia took place at a children’s hospital where there are necessarily children to the age of 12.
Steven Newmark 02:50
A few years ago, there was an outbreak in New York. I remember when I was in college, there was a case in Boston and we got an email from our university saying that there was a confirmed case and I definitely felt so nervous being immunocompromised at all, but it never turned into anything big. And I guess we can attribute that to the successful vaccine campaign for the measles, but things are looking like a little different today when it comes to vaccinations.
Steven Newmark 03:15
Also, I think measles is one of the most highly contagious viruses in the world.
Zoe Rothblatt 03:21
It is, it’s spread through respiratory droplets. The thing that’s like so I guess intense about it is that it can be airborne for up to two hours after someone with measles has been in the area.
Steven Newmark 03:33
That’s a long time.
Zoe Rothblatt 03:34
Yeah. Which like explains why that case in the airport was so concerning, because think about how many people could be exposed.
Steven Newmark 03:41
Right.
Zoe Rothblatt 03:41
That’s living in the two airports for two hours afterwards.
Steven Newmark 03:45
Right.
Steven Newmark 03:46
So what’s the deal with measles? Let’s talk a little bit about the history of measles.
Zoe Rothblatt 03:50
Go for it.
Steven Newmark 03:51
I know that 1912 was the first year we began reporting on measles. It became a nationally notifiable disease in the United States requiring US healthcare providers and laboratories to report all diagnosed cases. And in the first decade of reporting, according to the CDC, an average of 6,000 measles related deaths were reported each year. I think there tends to be this idea that the measles is like, oh, it’s just a rash or some spots on your skin. But no, and when you contract it, it’s pretty bad. It causes death.
Zoe Rothblatt 04:17
Yeah and in the decade before the vaccine, it’s estimated that three to four million people each year in the United States were infected. And just a little deeper into those numbers among reported cases in each year, an estimated 400 to 500 people died, 48,000 were hospitalized, and 1,000 suffered encephalitis, which is swelling of the brain, all from measles. So you know, that’s like a pretty big impact on society when you think about it.
Steven Newmark 04:44
Yeah, absolutely. We got the vaccine in 1963. Then an improved vaccine actually came out in 1968, which set us on a new goal, which was to eradicate measles.
Zoe Rothblatt 04:55
Yeah, so in 1978, I guess 10 years after that improved vaccine those see You see saw how successful it was and they set a goal to eliminate measles from the United States by 1982. Obviously, this goal was not met, but widespread use of the vaccine significantly reduced the disease rates.
Zoe Rothblatt 05:13
Right, so sort of cutting to the chase in 1989, there was a little bit of a measles outbreak amongst vaccine aged schoolchildren, which prompted the Advisory Committee on Immunization Practices and the American Academy of Pediatrics to recommend a second dose of the vaccine for all children. Cases then continued to decline further, and drumroll. There you go. Measles was declared eliminated from the United States in the year 2000. And it was all thanks to an effective vaccine program. There you go.
Zoe Rothblatt 05:43
I will say our listeners can’t see but Mac was wagging his tail when we did the drum roll, he wanted to add in.
Steven Newmark 05:49
There you go. Boom. So measles was declared eliminated 24 years ago, and yet here it is.
Zoe Rothblatt 05:56
And yet here it is. Yeah. Why are we talking about it today? If it was eliminated…
Steven Newmark 06:00
From the United States.
Zoe Rothblatt 06:00
From the United States. Well, yeah, that kind of leads us into how we’re talking about it. So despite the successful campaign in the US, measles is still prevalent in other parts of the world. So if you’re not vaccinated, and you travel, you can get it and bring it here.
Steven Newmark 06:16
Yeah, so a few things. Number one, like you said, people can travel and bring it here. Of course, generally speaking, the overwhelming majority of Americans are vaccinated against it, and it’s an effective vaccine so it’s going to be hard to spread it that way. But one thing that has dropped recently are vaccine rates of schoolchildren. So for 10 years, the share of kindergarteners who had received two doses of the MMR vaccine was 95 percent, but that rates started to fall and has been continuing to fall. While the people claiming vaccine exemptions for their children has risen as well over the past few years.
Zoe Rothblatt 06:58
Well, before we get to the third point here, just thinking about why are people not vaccinated. Number one, just kind of simple, like families got off schedule with childhood vaccination in COVID.
Steven Newmark 07:11
Very fair.
Zoe Rothblatt 07:11
You know, we’re in lockdown, you weren’t going to the doctor and then…
Steven Newmark 07:14
Totally.
Zoe Rothblatt 07:14
Life gets busy and you forget about it. Of course, health should not be something you forget, it should be a priority. But it happens when that contributes.
Steven Newmark 07:22
Yes, but…
Zoe Rothblatt 07:23
Go with the but.
Steven Newmark 07:24
You’re still required to get your MMR vaccine, if you want to attend public schools in the United States.
Zoe Rothblatt 07:29
That was a good but. And then vaccine hesitancy is increasing, and parents are opting their children out of getting vaccines at a high rate.
Steven Newmark 07:37
Right, it’s almost it’s been given more permission to put it simply to get an exemption to vaccines. And there’s certainly more folks looking for exemptions to vaccines. Ironic considering that it was a vaccine that helped get us out of a major pandemic and reduce a global health crisis into merely a global health pain in the ass or whatever, whatever stage we’re in. But even with that great success of the COVID vaccine, the irony is that the uptake in folks being vaccine hesitant, has risen.
Zoe Rothblatt 08:09
Yeah, and it feels like a lot of that is connected to, we talked about this, I don’t know maybe a year ago or more just like how the trust in public health is broken.
Steven Newmark 08:17
Yeah.
Zoe Rothblatt 08:18
And especially since COVID, I would say from my perspective, a lot of that has to do with the messages and COVID weren’t perfect and was changing, experts were learning at the same time as we were.
Steven Newmark 08:28
Right.
Zoe Rothblatt 08:28
And that contributed to people losing trust in public health authority.
Steven Newmark 08:33
Right. It’s like people were unhappy that like when the house was on fire, the instructions were not like to the letter perfect every single time. And by the way, it was like a fire that no one had ever seen before, that no one had ever understood and people were learning on the fly how to deal with it.
Zoe Rothblatt 08:47
And the fires like changing, you know, like the mutations, the variants.
Steven Newmark 08:53
Right, our metaphor is somewaht butchered, but the point remains. Look, let’s face facts living in the post emergency era of COVID people have come out and are clearly it was a tough, tough few years. 2020 was just, it was horrible. It was an awful awful year. 2021 wasn’t much better, and so on and so forth. And there’s definitely a level of anger and resentment. I think it’s a natural impulse to try and blame someone for that anger. And oftentimes, when you’re angry, you look to someone to blame. And there’s not always somebody that’s at fault, per se. So, the folks that seem to be taking some in certain quarters, some of the incoming for this, are public health officials who may have gotten some of the messaging wrong or didn’t adequately predict something that was essentially unpredictable or to the public face, if you will like someone like Dr. Fauci who was a public face of protecting the public at large and it makes it difficult to convince others of public health concepts generally.
Zoe Rothblatt 09:49
Yeah, I want to go to that point of like, it makes it hard to talk about public health, like a lot of public health successes are sort of invisible, like when you think about…
Steven Newmark 09:59
Right.
Zoe Rothblatt 10:00
Like measles before this, like you’re not seeing it spread around. So you’re not thinking of it as a big threat. Even thinking about like clean water and garbage in the streets, public health was instrumental in cleaning up our cities, and you don’t see people smoking indoors, like great public health successes, you just don’t see. So, it’s hard to grasp how important and like the change that they’ve made.
Steven Newmark 10:22
If you come from if you’re a generation or two generations or three generations removed from a certain illness, and you don’t see the impact, I guess, also, that’s a natural thing not to understand how bad that particular virus was, or illness was. I’ve seen people on YouTube rant about polio, the polio vaccine, and they’re saying how it’s not so great. And look, that’s before my time, but I’ve read my books, and I understand what it was like. And I’ve spoken to my dad who got his first polio vaccine, oh, I think roughly at the age of 10. And he would talk about how there will be outbreaks at the local public pool.
Zoe Rothblatt 10:55
Yeah.
Steven Newmark 10:56
Friends of his contracted polio when they were seven, eight years old. And to this day, they’re still paralyzed from the waist down, et cetera. I mean, it was a really debilitating illness, something that every community saw. And when the vaccine came out, that generation certainly understood what it was, and probably the generation after that, as well. But if you’re so far removed from it, that concept is so far away for you. It’s probably similar to measles with certain individuals or whatnot.
Zoe Rothblatt 11:19
For sure. And I have the same thing with my mom, she always talked about the girl in my classs that had polio. And I’m just thinking we’re even one removed from it and we kind of get it a little bit, but we never really saw it as a threat. And…
Steven Newmark 11:31
Right.
Zoe Rothblatt 11:31
Do you talk about that with your kids? Like, do you think your kids know about polio?
Steven Newmark 11:35
Well, yeah, because of who I am. I had like the little board books of Dr. Jonas Salk, you know what I mean?
Zoe Rothblatt 11:42
There’s bias there.
Steven Newmark 11:43
So, let’s be fair, actually, fun fact, I bragging that I live down the block from where Jonas Salk grew up, and I make sure my kids know that. The other thing too, is the idea of individualism versus public health. And the idea of public health being something we’re trying to do this to protect the public health, because on an individual level, if you or I don’t get the polio vaccine, the odds of us contracting polio are like nil, the odds of us contracting polio and then spreading it or like, nil, right? So it begs the question, well, what if there’s some side effect, it’s not known? Bad example, because there is no side effect. The polio vaccine has been around for decades, et cetera, et cetera. And we’re using the Sabin vaccine now, which I don’t want to get into the difference being that Sabin and Salk vaccine, but whatever. But why do it? Because as seen with the measles example, if we don’t all continue to get vaccinated, it can come back and we don’t want it to ever come back.
Zoe Rothblatt 11:44
Exactly. Public health is the idea of setting up our society for the common good. Like we have a responsibility towards each other to build a society that has conditions that allows for people to be healthy. And of course, there’s individual health choices and decisions within that. But the way that public health works enables you to make those decisions like even think about when I talk to my doctor about eating healthy foods, I’m only able to do that because there’s public health people that said people need access to fresh groceries and you need to have that in the area.
Steven Newmark 13:03
I guess everyone has individual rights to do what you want live your life to the way you want. But you don’t have a right to live their life the way you want when it is impeding someone else’s rights. You know, an easy example in the public health realm is, well first and foremost, there are rules that we implore upon all of society because we have decided as society that your individual rights are trumped by the rights of society, for example, you have to wear a seatbelt I believe in all 50 states and your individual right now to do that has been taken away. I believe all 50 States if not, the majority require you to wear a helmet when riding motorcycle because your individual right to do as you please and potentially put your life at risk is outweighed by the harm to society of you having an accident and having to deal, with society having to deal with the fallout from something of that nature. In a very simple public health example, I think about the workplace. I know of people in workplace settings that go to work, even when they know they are knowingly ill. In fact, years ago, not that long ago, it was considered a badge of honor almost to go to work when you still had a cold, if not worse, like yeah, I’m sick, but whatever, I’m tough, I’m going to tough it out. But even in a post COVID world, people are still doing that where the idea should be no, if you don’t have to be a work if you’re not being paid by the hour, and you can be in a setting where you can stay at home and call in for a sick day. That’s important to your co-workers and the people around you as well.
Zoe Rothblatt 14:26
Absolutely. And I fee like I say this all the time, but when you’re immunocompromised like a cold just isn’t a cold it’s like it gets so much more intense. If I’m around someone that has a cold, I have Crohn’s and arthritis and like it goes straight to my gut and joints, everything flares up, it’s terrible and it makes a minor cold so scary because your body is falling apart before your eyes and yeah, like just taking the extra step of people to be careful and stay home and you know, just not put everyone at risk is like it’s huge. I don’t think people understand, first of all, like looking at me you don’t know that I’m immunocompromised and people just also don’t understand, like how much your sniffily nose can get me sick.
Steven Newmark 15:06
Or you could live with somebody that’s immunocompromised.
Zoe Rothblatt 15:09
Yeah.
Steven Newmark 15:09
You know, anyway,
Steven Newmark 15:10
Anyways, where do we go from here?
Steven Newmark 15:10
Yes, where do we go from here? You know, I think it’s incumbent upon all of us to better educate folks on public health and the seriousness of public health threats.
Zoe Rothblatt 15:20
Yeah, even just like today’s example, with the measles, like it was eliminated because of such a successful vaccine campaign like first they eliminated cases by 80 percent. and then even more, we know, education and campaigns like that work.
Steven Newmark 15:34
Absolutely and I think on the individual level, I’m not very good at PR, so I don’t know how to do it in mass, but certainly on the individual level, talking to folks about vaccine safety, misinformation, combating it on a one on one basis and supporting legislation that requires vaccines and minimizes the opportunity for opt outs, for example, to keep the entire public health wealth.
Zoe Rothblatt 15:57
Yeah, we do a lot of work with our 50-State Network on supporting vaccine legislation. And sometimes it could feel like there’s a really loud minority there of people who are shouting that vaccines are bad, but there’s a lot of good work being done at the state level that you can support.
Steven Newmark 16:13
Absolutely. Well, this was a good discussion.
Zoe Rothblatt 16:16
Yeah.
Steven Newmark 16:17
I feel better than I did when I started.
Zoe Rothblatt 16:18
Well, talking about feeling better, like what’s one thing you learned today, or in preparation for today, that’s helping you feel better?
Steven Newmark 16:25
I learned that measles is not dead, but I’m still not worried about it, at least on an individual level, if you will, to go back to that word.
Zoe Rothblatt 16:31
Yeah and for me, it was just like a really good conversation on the importance of public health and going through the history of things just even you know, breaking down with you the history of measles and how we got to where we are today just helps me realize that we have the tools to combat it.
Steven Newmark 16:45
Yeah. Well, we hope that you learn something too. And before we go, we definitely want to encourage everyone to check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 16:53
And if you have any questions, comments, episode topics, definitely email us at [email protected]. Well, everyone thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you like this episode, give us a rating right have you on Apple podcast, tell us how great we are and hit that subscribe button. I’m Zoe Rothblatt.
Steven Newmark 17:16
I’m Steven Newmark. We’ll see you next time.
Narrator 17:22
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
The Latest News: Drug Imports, Biosimilars, and COVID/Flu/RSV Season
The Health Advocates are back and breaking down all the latest news so far in 2024. Steven gives us a debrief on what to look for this election year. We then dive into Florida’s plan to import drugs, why you may be switched from Humira to a biosimilar, and finally the latest hospitalizations and case rates this respiratory illness season.
The Latest News: Drug Imports, Biosimilars, and COVID/Flu/RSV Season
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:22
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:27
Well, Happy New Year, Steven.
Steven Newmark 00:29
Happy New Year.
Zoe Rothblatt 00:30
Welcome to the new season of The Health Advocates.
Steven Newmark 00:30
Yeah, so how are you feeling? 2024. Did you take a little break? I hope and recharge the batteries as they say?
Zoe Rothblatt 00:39
I took a break. I like filled up my content plate. I watched a lot of TV, read some books. It was good.
Steven Newmark 00:46
Anything we’re sharing?
Zoe Rothblatt 00:47
Yeah, I really liked that new mini series Lessons in Chemistry. It was a book that was turned into a series I thought it was great.
Steven Newmark 00:54
Oh my god, the world is so stratified. I don’t even know what the heck you’re talking about.
Zoe Rothblatt 00:59
That one’s probably for the girls. But…
Steven Newmark 01:01
Fair enough. Fair enough. I binge watched the crown. I finished it. And my wife left me on the last season. She said I’m not in but I went all the way and I liked it and I had fun.
Zoe Rothblatt 01:10
That’s good. It’s always good to like melt your brain a little bit reset. Now we’re ready to dive into 2024 advocacy.
Zoe Rothblatt 01:17
It looks like we’ll be active around the states for copay accumulators, drug pricing review boards. We have a lot of good stuff coming up this year to help protect patients.
Steven Newmark 01:17
Yeah.
Steven Newmark 01:28
And we should start off by saying it’s 2024. And that is a big election year. And while there are technically primaries in the Democratic and Republican parties, I’d say you won’t lose any money in Las Vegas betting on a rematch from 2020. And polls show the one thing that does unite Democrats and Republicans is that they do not want that rematch. But, so here, we are hurtling towards an election that the majority of the country doesn’t seem to want. But to paraphrase someone, you go to the election booth with the candidate you have, not the candidates you want. Barring something unforeseen in November, it’s going to be Trump versus Biden. But we’ll talk more about that throughout the year. But we should mention that Iowa is hosting the Republican caucus next week. So anything can still happen, though Donald Trump is the heavy favorite. Nikki Haley, the former governor of South Carolina and former ambassador to UN is within striking distance sort of in New Hampshire, which hosts the first primary in the country. But behind New Hampshire, it’s hard to see where Nikki Haley or really any other Republican can gain ground on Trump. So far, the Republicans are basically acting like well, maybe he’ll go to jail before the primary but that hasn’t worked out too well for them and likely won’t. So the primary probably will be packed up pretty shortly on the Republican side. And Joe Biden is also technically in a primary, though betting on one of his opponents would be like betting on my son’s flag football to you to be the University of Michigan football. You like that? I got in a shot about the national champions. All right, I’m done. Let’s get into what else is happening out there and 2024 or at least January 2024.
Zoe Rothblatt 02:49
Yeah, we have some few news items to start off the year. We’re going to talk about the importing of drugs, biosimilars, and this boost in respiratory, COVID cases. So let’s jump into our first bit of news that Florida can now import a limited set of drugs from Canada.
Steven Newmark 03:05
Yeah. So the FDA has approved Florida Governor Ron DeSantis, by the way, also a candidate in the Republican primary for the President, his plan to import a limited set of brand drugs from Canada.
Zoe Rothblatt 03:15
So when you think about has this happened before? The answer is no, this approval is a really big deal from the FDA. It’s like a longtime debate in public health, whether to import drugs from other countries. And just to dive into the history a little bit in 2003, Congress passed a law to let wholesalers and pharmacists import Canadian drugs but only if the FDA approved it as safe. So that’s where this comes from. And then in November 2020, the Trump administration published a regulation that allows states to propose plans to import the drugs and Florida was the first to do so.
Steven Newmark 03:51
So if the state imports these drugs, who’s going to be eligible to receive these drugs in Florida?
Zoe Rothblatt 03:56
Yeah, so in Florida, it would be made available to patients at county health departments managed by the State Department of Health inmates at state correctional facilities and certain others served by state agencies, and the program would then expand to Medicaid enrollees.
Steven Newmark 04:12
So at least at the outset, the average Florida citizen is not going to be shall I say, directly affected by this, will not be able to obtain one of these important drugs.
Zoe Rothblatt 04:21
Yeah, that’s right.
Steven Newmark 04:21
And what drugs are we talking about? For how long?
Zoe Rothblatt 04:24
Yeah, there’s a list of drugs that includes treatments for HIV, mental health, cancer, things like that. This approval allows Florida to import drugs for two years. So I assume you know, there’ll be looking at what impact it’s having and decide whether to continue to do so, stop the program, expand the program, etc.
Steven Newmark 04:43
So, what are the next steps what needs to happen for this program to get implemented?
Zoe Rothblatt 04:47
So yeah, like all things in public health, it doesn’t just happen immediately.
Steven Newmark 04:52
It’s not just the public health thing, by the way, is all bureaucracies.
Zoe Rothblatt 04:55
Yes.
Steven Newmark 04:56
All government all levels.
Zoe Rothblatt 04:58
That is very true. So Florida has to submit some drug specific information to the FDA. And this just ensures that the medications that are being imported have been tested and comply with FDA standards. So all good things there, just dotting our i’s and crossing our t’s, and then the FDA will re-label them consistent with the FDA rules and labeling here in the US.
Steven Newmark 05:21
And there have to be drugs available. Right? Yeah. I mean, Canada is not stockpiling drugs for American patients, I assume. So there have to be enough drugs available for importation.
Zoe Rothblatt 05:30
Yeah, I think Canada is facing some shortages of its own. So, it’ll be interesting to see how this plays out. Especially because some other states have also submitted plans or planning to submit plans to import drugs from Canada.
Steven Newmark 05:44
Well, very fascinating. So we’ll keep our eye on that and see what happens and see down the road, how it might affect prices to consumers. But for now, we’ll monitor.
Zoe Rothblatt 05:52
Yeah, and I guess just to wrap that up, we always want to see what the benefit is to the patient and how it’s saving the patient money. So, we’ll be looking closely, like we mentioned, it won’t be like a widespread thing that impacts most people in the state. But as we get the reports about how this is going, we’ll be seeing how the savings go to the patient or not.
Steven Newmark 06:13
Excellent. Excellent. Up next, I see in the news that CVS Caremark is going to be replacing Humira with biosimilar on their formulary benefit.
Zoe Rothblatt 06:22
So as we know, last year, a bunch of biosimilars came out for Humira. I think there’s about eight.
Zoe Rothblatt 06:29
And now CVS Caremark, which is one of the largest pharmacy benefit managers in the US, they announced that they’re gonna remove Humira from their major national commercial formularies, which would be effective on April one and instead offer biosimilars of Humira. So just to clarify there, it’s not all plans, there are certain plans that like select choice, I think they mentioned that you’ll still have an option. So it’s just good to double check what type of plan you have, maybe call your insurer call your doctor to see.
Steven Newmark 06:29
Mhm.
Steven Newmark 07:01
Yeah, it’s definitely something to I wouldn’t want to raise a five alarm fire, but certainly something to be concerned about. If you’re taking Humira and in good health as a result, you know, you never want to be non-medically switched if things are working well. So, it’s definitely something to be aware of.
Zoe Rothblatt 07:17
So I’m actually one of those people, plot twist here. You know, it’s funny because I’ve hosted the Breaking Down Biosimilars podcast and I’ve learned a lot about them in my time at GHLF. And I was thinking…
Steven Newmark 07:28
Yeah.
Zoe Rothblatt 07:28
Like, if I got this news a few years ago, it would have been like, what the hell’s a biosimilar?
Steven Newmark 07:32
Right right.
Zoe Rothblatt 07:33
What am I gonna do? I’ve been on Humira for a few years, this is so scary. But, when I saw the news, I just proactively emailed my doctor saying, if this happens, is that okay? And she said, yes, like double check your insurance plan, see if we could opt out, let’s look at the options available to us. But ultimately, it’s fine. And I think I feel good about it because, you know, I’ve learned so much about biosimilars. So my advice for patients that are in a similar scenario would be to learn now, they said it’s effective April 1, we’re recording on January 10, you have some time to learn more about biosimilars ask your doctor questions. So you can feel comfortable if you get switched. And then also just something to note, since the biosimilar is a different manufacturer, like the actual pen might just look different. So don’t be nervous that you got the wrong medication.
Steven Newmark 08:20
Yeah, well, it’s interesting. Essentially, what you’re saying it sounds like is that knowledge is power.
Zoe Rothblatt 08:25
Yes.
Steven Newmark 08:25
The more knowledgeable you are, the more power you have to make the proper decisions and hopefully the more comfortable you feel with whatever comes your way.
Zoe Rothblatt 08:33
Definitely, definitely, definitely. Especially when it comes to chronic health conditions and the weird terminology, there’s a bunch of terms with biosimilars, like interchangeable and stuff like that. And it can seem confusing on the surface, but it’s actually pretty simple once you start diving in and we have great resources to help you get there.
Steven Newmark 08:51
Excellent. All right, next big topic. It is winter, we are in the thick of winter and respiratory virus season is hitting pretty hard.
Zoe Rothblatt 08:59
Yeah, it’s 2024 we’re still talking about COVID sometimes it can feel so like fatigued and like we got COVID, flu, RSV it’s a lot.
Steven Newmark 09:09
It’s a lot. That’s why like I think it’s simpler to just say the respiratory virus.
Zoe Rothblatt 09:13
Yes.
Steven Newmark 09:14
Respiratory virus season.
Zoe Rothblatt 09:15
So let’s dive in. We’re seeing a lot of flu. The CDC data shows a rise in infection after the holidays. 38 states have high or very high levels for respiratory illnesses with fever cough other symptoms so that includes COVID and RSV and flu. CDC says flu has been increasing most dramatically. Flu typically peaks between December and February and the CDC Director Dr. Mandy Cohen expects it to peak by the end of this month.
Steven Newmark 09:43
The good news experts say that the flu shot this year is a good match for the strain that is spreading most in the community.
Zoe Rothblatt 09:49
Yeah, that’s always good to hear. We know that it’s a guess but it’s an educated guess because it’s done based on the southern hemisphere and predicting patterns, especially as we see a rising it’s good to know the vaccines doing its thing to prevent severe illness.
Steven Newmark 10:04
Right. All right, so COVID. Flu, COVID. COVID is putting more people in the hospital than the flu. According to CDC data, COVID-19 hospitalizations have increased for eight consecutive weeks rising 20% in the most recent week, but so far still remaining lower than this time last year.
Zoe Rothblatt 10:20
Yeah, that’s always good to hear. Obviously, it’s bad to hear there’s hospitalizations and a rise in consecutive weeks. But it’s good to see the data shows that not only is it lower than last year, but also the last three winters. So it seems like every year with COVID, it’s getting a little bit better.
Steven Newmark 10:37
Absolutely. That is good news.
Zoe Rothblatt 10:38
So, there is a new subvariant on the block.
Steven Newmark 10:41
Right, I was about to mention that. Yep. Yeah, JN1.
Zoe Rothblatt 10:43
I can’t even keep track of these anymore. If I’m gonna be honest.
Steven Newmark 10:47
Well, JN1 is officially a descendant of Omicron, which is what the vaccines were targeted for. And the data shows that the updates in the vaccines, do you have effective measures against this variant and the COVID rapid tests that hopefully have hoarded and medical treatments are still effective as well.
Zoe Rothblatt 11:02
Yeah, I was actually seeing some stuff this morning about maybe testing on day three of symptoms instead of day five about the test. So…
Steven Newmark 11:09
All right.
Zoe Rothblatt 11:10
It’s always changing your feelings that call your doctor do some Googling or just test, you know.
Steven Newmark 11:16
And I would just add cases are rising. The peak, we’re not the peak, it’s it’s difficult to predict peaks, but some models project the COVID-19 will peak sometime in mid to late January, closer to late January, like you said, but wastewater levels, which is an early indicator of community transmission seems to be very, very high for COVID.
Zoe Rothblatt 11:34
Yeah well, I got my flu shot and updated COVID vaccine earlier this fall, so I hope I am protected for this peak. I’ll probably be laying low a little bit. It’s kind of just like throughout the pandemic, throughout COVID, whatever you want to call it. It’s like, you know, bringing back some of the measures at times like avoiding subway at rush hour, bringing the mask back out, you know, maybe yeah, cooking dinner, instead of being at a restaurant, just small changes to reduce the chance of getting it.
Steven Newmark 12:05
Yeah, I’m back fully masked myself, even though I’m also fully vaccinated and feel pretty good. It’s interesting, I wear the mask indoors, I would say a lot not going to put a percentage on it most of the time, but it’s not 100%. And you know, somebody said, well, isn’t that a little hypocritical? I’m like, I don’t think hypocrisy is the right word for that. It’s like when I take taxis in New York City, I don’t put on a seatbelt because they often don’t have seatbelts in the backseat. But that doesn’t mean the next time I get into a car where I’m able to put on a seatbelt, I still put the seatbelt on if that makes sense. The seatbelt still provides protection. I feel like for the next few weeks winter, this is where approaching the peak, as you said, I’ve got the vaccines, I’ve got my own personal health that I try to keep in as strong position as possible. But then it’s the mask. It’s the N95, KN95 mask, that is the frontline protection, I think, so hopefully it helps.
Zoe Rothblatt 12:53
Yeah, hopefully, we know the tools and we’ll try our best to stay safe.
Steven Newmark 12:58
Right. Let’s talk about the final major respiratory illness this season, which is RSV.
Zoe Rothblatt 13:03
Yeah, RSV activity. Also no surprise that remains elevated in areas of the country, though there have been decreases in some areas recently. So I guess maybe that peak is kind of going down a bit.
Steven Newmark 13:16
Yes, that’s true, it seems to be slowing down, which is good. That being said, hospitalizations, cases, we’ll see where we are in probably a few weeks.
Zoe Rothblatt 13:24
And just to share some of our data, we often share our quick poll results on here, which are given to our Patient Support Program. So at the end of last year, we did a poll on the RSV vaccine, but just a reminder that this is only available to a select few groups. So it’s people older than 60, infants, and pregnant women. So they were screened out if they weren’t in that category. Infants weren’t taking this, so this is mostly data on people over 60.
Steven Newmark 13:51
Right, right.
Zoe Rothblatt 13:52
And they said 41% said that they received the RSV vaccine. So this was like early December. And then we were wondering for the 59% that hadn’t gotten the vaccine, why not? 30% said they plan to get it they hadn’t gotten around to it. 20% said they don’t want it and 18% said their doctor didn’t recommend it. Like they didn’t have a chance to talk to their doctor yet.
Steven Newmark 14:15
Wow. Interesting findings, to say the least.
Zoe Rothblatt 14:18
Another big concern that kind of sparked us wanting to do this poll was questions about side effects. We’ve had a lot of emails from the community asking what side effects people got from the vaccine. More than half who got the vaccine said they didn’t have any side effects. And for those who did get the RSV vaccine, the side effects were kind of the typical ones you expect like fatigue, muscle or joint pain, headache, only 6% had a fever. So really just like the expected things from mild side effects.
Steven Newmark 14:48
Yeah. Which are usually better than getting the actual virus itself, right.
Zoe Rothblatt 14:52
For sure. Yeah, I would take those side effects any day.
Zoe Rothblatt 14:56
I notice if I just hydrate a ton and actually eat a lot, and eat good food the day of vaccines, like the side effects are pretty minimal to me. I don’t have any science to back that up, but.
Steven Newmark 14:56
Yeah.
Steven Newmark 15:08
I’ll remember that I gotta say, I got the COVID shot. I felt like I got shot in the arm for like a day.
Zoe Rothblatt 15:13
I was swinging my arm around and it was not sore, like at all.
Steven Newmark 15:18
Really?
Zoe Rothblatt 15:19
Yeah, you got to keep it moving.
Steven Newmark 15:20
All right. Good to know. All right. Well, on that note, we will close by saying that vaccines are the best prediction. So if you haven’t been vaccinated with an updated COVID vaccine or gotten a flu shot, it’s not too late. There are also new vaccines and mono clonal antibodies to protect against RSV recommended for certain populations, which include older adults, pregnant people and young children.
Zoe Rothblatt 15:41
Yep, get your vaccine and talk to your doctor about the vaccine and staying safe and what’s best for you.
Steven Newmark 15:47
Excellent.
Zoe Rothblatt 15:49
That brings us to the cause of our show. Steven, what did you learn today?
Steven Newmark 15:52
Well, as always, I always find it fascinating to hear about our polls, and it was good to hear about the side effects. Number one, the amount of folks who experienced no side effects of the RSV vaccine and then number two that the side effects were as you put it, somewhat normal and certainly less debilitating than getting the actual virus itself.
Zoe Rothblatt 16:10
Yes, I’m for me just doing some research on the news to prepare for this episode, I learned more about the drug importation to Florida and kind of the history around there what we can expect.
Steven Newmark 16:20
Well, we hope that you learn something too. And before we go, we definitely want to encourage everyone to check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 16:29
And if you have any questions comments episode topics, definitely email us at [email protected] and thanks for listening to The Health Advocates, a podcast that breaks down major health news every week to help you make sense of it all. If you like this episode, please give us a rating, write a review on Apple podcasts, and definitely hit that subscribe button. Wherever you listen. It’ll help more people like you find out. I’m Zoe Rothblatt.
Steven Newmark 16:53
I’m Steven Newmark. We’ll see you next time.
Narrator 16:58
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
From Frustrations to Action: Lessons Learned from the PMR Community
In the third episode of our three-part series on polymyalgia rheumatica (PMR), we are joined by JP Summers, Patient Advocate and Community Outreach Manager at GHLF. JP shares what she’s learned from people living with PMR about managing their symptoms and advocating for themselves at doctor’s appointments.
JP and Zoe Rothblatt, Associate Director of Community Outreach at GHLF, talk about the challenges of discussing health issues with loved ones but emphasize how these conversations can provide crucial support in diagnosing and managing PMR.
This episode was made possible with support from Sanofi.
From Frustrations to Action: Lessons Learned from the PMR Community
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:22
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:28
And today’s episode is part three of a special three part series focused on polymyalgia rheumatica or PMR, for short. Over the course of these episodes, we learned about PMR from Dr. Grace Wright and patient advocate Linda Rinaldi. Now today, we’re joined by JP summers, Patient Advocate and Community Outreach Manager on our advocacy team with GHLF. And we’ll be talking with JP about advocating for yourself in everyday life, at the doctor, and with stakeholders when it comes to living with PMR.
Steven Newmark 00:58
But before we listened to your interview with JP, you should know that this is our last episode of the year.
Zoe Rothblatt 01:03
That’s true, that’s a wrap on 2023 season.
Steven Newmark 01:06
That is a wrap. Before we depart for the year, Zoe what are your highlights from the year?
Zoe Rothblatt 01:13
That’s a good question.
Steven Newmark 01:14
In podcasting world, I mean.
Zoe Rothblatt 01:16
In podcasting, well, I got to join Conner and Robert on Healthcare Matters, which is a really fun experience. But in terms of our podcast, the one interview that really stands out to me was the one that we did with Julie Baak.
Steven Newmark 01:30
Yeah.
Zoe Rothblatt 01:30
She talks about being an office manager and how she advocates one patient at a time, arm in arm, saying, you know, let’s do this together. And just the amount of people it takes to help patients get good care. Julie’s patients are so lucky to have her and it left me feeling like everyone needs a Julie.
Steven Newmark 01:47
Yeah, absolutely. That’s a good one.
Zoe Rothblatt 01:49
How about you? What are some highlights?
Steven Newmark 01:51
Well, my biggest highlight of the year in terms of advocacy was getting back to some of the states, I had the good fortune of being able to visit some state capitals with some of our fantastic patient advocates. And just to be out there, again, with our patients felt really good, and it had been too long, so that was good stuff.
Zoe Rothblatt 02:08
For sure. I remember after our team was on the West Coast, they had mentioned that it was the first time a legislator had heard directly from a patient about their story and the impact that made so that was definitely a highlight just hearing about that and thinking about how many others haven’t heard from patients and the work we could do in 2024 to make that happen.
Steven Newmark 02:28
Yeah, I just want to take a moment to express how grateful we are. And a big thank you to our 50-State Network advocates across the country. We are so humbled to do what we do and to work with such dedicated and hardworking patients such as yourselves, so thank you.
Zoe Rothblatt 02:42
Definitely, I second that. It’s exhausting living with a chronic illness and it can be exhausting what feels like fighting the same advocacy battle year after year. But each year, we see a little bit of incremental change around the states and more momentum federally. So, thank you to all of you who put yourselves out there with our network and share your story.
Steven Newmark 03:03
So, with that, let’s go to the interview with JP.
Zoe Rothblatt 03:05
JP, we’re so happy to have you here today. Welcome to The Health Advocates. How are you doing?
JP Summers 03:10
I’m doing really good, Zoe, thank you for having me on here.
Zoe Rothblatt 03:13
Of course. Thank you for joining, why don’t you start off by introducing yourself to our listeners.
JP Summers 03:18
My name is JP summers, I am a patient and a caregiver, and my role at GHLF is Patient Outreach Manager and I focus on patient advocacy.
Zoe Rothblatt 03:28
And part of that role you did a lot of outreach over the past couple of months with PMR patients. Can you talk to me about some of the main themes that came up and doing this outreach and chatting with patients?
JP Summers 03:39
Sure. So during these conversations, I found that pretty much everyone I spoke with took immediate action. That you don’t hear too often. The second they started to notice a change in their normal. When I say normal, like they were noticing symptoms, especially in their shoulders, they knew that they needed to do something about it. And so they took the initiative to check into what could be causing it. And that to me was such a great way to see how people really do pay attention to what’s going on with your bodies. And another thing was that once they received the diagnosis shortly after seeking help, they immediately sprung into action they did whatever was needed to be done. And as a patient, I just love how again, they were just so mindful of themselves and what wasn’t normal for them. And I just found these conversations to be very insightful. I learned a lot from them.
Zoe Rothblatt 04:37
That’s great to hear. When you say take action, you mean like go to the doctor’s office and say hey, something’s wrong. Is that what you’re talking about?
JP Summers 04:45
Yes, yes. So they would either call their primary care physician, there was a few that actually went into urgent care because again, all of a sudden they found theirself debilitated to the point where they’re like, okay, something isn’t right. Did I hurt myself? They took notice of those debilitating symptoms and so they sought out either a primary care physician and even from that point, they sought out a referral to see what’s going on with their bodies.
Zoe Rothblatt 05:11
And in learning about those stories, did you learn any like important questions or symptoms that patients brought up with their doctors about PMR?
JP Summers 05:20
Definitely, I did learn that for most of the people I spoke with, they were very active, whether they did exercising, or they had a full time job. And their concern was, I can’t do my normal daily activities. And for them to note those differences already, they had those questions already to ask whenever they were seeking, again, consultation. And again, that’s important to note these changes down and then ask them whenever you go to your appointment, because as someone who deals with symptoms almost on a daily basis, I know that when something isn’t right, you always make sure to bring that up during an appointment. Because again, the best way to get answers is to be very proactive, and seek out what could possibly be wrong with you. And so that was something that a lot of them actually said that they walked in to their appointments, or again, when they went to urgent care they listed everything that they could not do on a daily basis.
Zoe Rothblatt 06:21
And in thinking about those things of what you can’t do. And all of a sudden things that you’re used to doing, as I guess taken away from you because now from the pain and symptoms, you’re not capable of doing that, it can definitely cause I guess some like stigma with those around you and you’re not acting like you used to and people can think, why are you being lazy? JP, do you have advice on how to advocate for yourself amongst family and friends or explained to them, like how symptoms are impacting your daily life?
JP Summers 06:51
Yes. So when you are looking at a possible diagnosis, or if you are diagnosed with something, it’s so important to educate the ones around you, whether it’s coworkers, family, your friends, just speaking openly about what you’re going through can be very helpful not only to let them know what’s going on, but also mentally, it could be something that helps you to accept what’s happening in your life. And again, you need support. So by speaking openly with the people in your lives, that helps you to find that support, or who could possibly be there while you’re going to these appointments. Or you could just vent to when you’re frustrated with something, a treatment isn’t going right, or you’re just having a bad day. So definitely, you know, raising awareness is as important part of, I call it a part of your treatment, because you have the different things you do you know, you seek consultation from a medical provider, then you go onto your treatment, whatever that may be, but then another component is having that support of the ones around you.
Zoe Rothblatt 07:57
Yeah, I love that you call it part of your treatment. It’s so true. Like, there’s no shame in asking for help, especially if help is gonna get you to a place of feeling good. And if you need someone to lend you some spoons, because you’re out of them, that’s totally okay. Can you maybe share some advice on how you ask for help if people are feeling really stuck or embarrassed? I know PMR can often come on later in life and this may be a group of people that like haven’t asked for help before. So, what’s your advice for just even getting started with how to bring up that conversation?
JP Summers 08:30
So yes, the conversations can be very challenging to have mainly because you may feel that people are going to think that you’re either seeking out attention or that the situation that you’re currently in may not be as important because again, everyone sees themselves as, they don’t want to be a burden. So, the best way to lessen or ease your mind is to start a conversation. Just explain this is what’s been going on with me, you know, I have concerns, and I just wanted to share this with you. Because you’re an important person in my life, you play an important role. And I hope that you can be there, whether it be maybe helping get me to appointments or just being there to listen, but I really do need support right now. And this would be again, a way for them to open that conversation. Because you don’t know, you don’t know what’s going to happen and that’s the scary part. You have no idea what the next steps are going to be, especially if you’re newly diagnosed. So, just opening up your mind to having those conversations with people in your life can make the transition into this diagnosis so much easier. And again, I know a lot of people tend to not want to feel like a burden. But at the same time when you’re having those conversations, it does make it a little bit easier to deal with what you could be going through in the future. And I feel that the more conversations you have with the people in your lives, it can lead to even a better outcome because people don’t realize mental health is a form of self care. And if you’re having a bad day, if your symptoms are so debilitating, if PMR has you having these symptoms that keep you from again, doing the exercises, keep you from going to a family events, then these people are going to understand because you had that conversation with them, that you were comfortable enough that you expressed your concerns early on. So that again, if down the line, you need to seek out some kind of, you know, just having someone there can definitely help with the process of going through this diagnosis, this new life, because it is a new life that you’re leading. And it’s just how to navigate through that and these people again, around you play an important role, even though they may not realize it, let them know. And it’s hard to bring up conversation sometimes, but if you ease into it, I feel that more people will understand. And then you’re raising awareness, you’re getting them involved. Because I know personally, there’s so many people I talked to, you know, I learned from them. And again, being chronically ill, you go through different challenges. And I feel that a lot of people didn’t even know certain things could happen in your life. And once you have those conversations, once you open that door, it does make a huge difference on the relationship between you and them, it can actually strengthen it, a lot of people feel like I don’t want to bring it up. But at the same time, I’ve had my relationships strengthened because I stopped worrying about what people were gonna think. And I had those conversations, and it has been the best thing for me physically and mentally.
Zoe Rothblatt 11:36
I really relate to that piece you just said about you know, people may not even know. As you know, I live with chronic illness also, and in the beginning of my journey, I used to get really frustrated when people wouldn’t check in on me. And I slowly learned that I could just say, hey guys, I’m struggling today, or this is what’s going on. And they were then much more likely to ask questions or reach out and it made me realize it’s a two way street and people can’t read my mind and know what’s going on. And it’s really important to bring up my symptoms, what’s going on, because physically from the outside people may not know that I’m living with these conditions are having a hard day. So, while it takes a lot of courage to bring it up, it definitely like you’re saying is worth it in the end.
JP Summers 12:20
Yes, and I love that two way street because it truly is. People may not realize you’re struggling and they may not check on you as often as you think maybe they should. But at the same time, even you reaching out to them, telling them I’m having a difficult moment, I’m having a difficult day, that can truly again, strengthen that bond. And again, help them understand that you may be okay for a few days. But then there’s those tough days where you really need that support, and just even telling them through text or a call to say, you know, I just need to have someone there for me, that makes a huge difference. It really does. And it took me a long time to realize that, that sometimes I just need to say, hey, I just need to have someone listen to me. I had a really terrible doctor’s appointment, I got answers, but it wasn’t what I wanted. And I just need someone that’s there that could just listen to me. And I love that it is a two way street and sometimes you do have to be the one to make the initiative. But it does pay off when you do because I feel like that, again helps them understand your struggles, what it’s like to be a patient, what it’s like to have that diagnosis.
Zoe Rothblatt 13:27
Definitely. And actually what you just said about like, you know, you just want to vent about the doctor’s appointment that kind of made me think like sometimes it’s even helpful when you’re asking like friends, family, your provider, for help to say like right now I just want to vent so can you listen? Or like, I could really use like physical help, where you can go run an errand for me or saying like, I actually really need your advice on what I should ask my doctor or I need accommodations at work, like how did you go about doing that? And sometimes even just framing what kind of support and response you want from someone in that moment can be really helpful.
JP Summers 14:01
I agree with that because definitely, you know, having someone there to help you through this, like running errands so people don’t realize how hard it can be when you’re in a flare up. As you learn how to do your daily task when you’re in a flare up. It’s one of those things where if someone was to offer like just to go to the pharmacy for you or drop something off, it makes a huge difference. And it also helps you to feel a little bit better about what you’re struggling with. And I know how important it is to have that little bit of extra help. But when I say a little bit I mean something is small is huge for someone who is chronically ill, and someone with PMR when they have those debilitating flare ups, it can make a huge difference on how you can go about your day and again, just how to make it out of bed to just do the simple tasks like brushing your teeth, taking a shower just making a cup of coffee can be a challenge. I know like, I have friends that dropped coffee by for me, they’ll just say, hey, I know that you were having a bad morning because again, reaching out, I sent a text saying, Gof, I’m really I’m not feeling the greatest and then they’ll be like, do you need anything? And I was like, well, you know,
Zoe Rothblatt 15:14
Aw you have such sweet friends.
JP Summers 15:16
I could use you know something or hey, I could you maybe pick this up for me, I was gonna go out to the store. But again, saving spoons, saving my energy, because I know that I have a long day ahead of me, especially when you wake up in the morning, you’re like, okay, how am I going to make it through this day? So, yes, I agree with a lot of what you’re saying, I really do.
Zoe Rothblatt 15:34
So, switching gears a little bit, we talked a lot about advocating for yourself with like family, friends, and the doctor. But there’s also larger scale advocacy work that we do, that you do, about like engaging with legislators, stakeholders, policy. Can you tell us about how you work with our 50-State Network advocates, and you do a lot of the outreach calls and learn about their story and maybe it would just be helpful to learn from your perspective, like how you talk to patients about getting started on their advocacy journey?
JP Summers 16:03
Sure. So I would say the number one thing I do when I make these calls, is I listen, I listen to what they have to say, what did they go through? What are they going through, and from there, then I know what direction to go because a lot of times, some people are comfortable with being in front of a group of people, some people would rather do virtual advocacy, some people would love to write down their story, and which can be given as a written testimonial. But the main thing is everyone has a reason why they wanted to be a part of the 50-State Network. Fifty percent I would say is out of frustration. I know, that’s why I signed up originally, because you’re frustrated with the outcome, whether it be the insurance company, or that you’re getting nowhere with your treatments, or you keep having issues with your health. And when someone shares that information, again, that helps us to know how to guide them into which direction maybe they could help us with in the 50-State Network with advocacy. And I know doing in person advocacy, for me personally has been so life affirming, it has made a huge difference, because I can’t get back the time that I lost from the time as early diagnosed with my chronic conditions. But being able to talk about it with legislatures, being able to share what happened to me my experiences has made a huge impact on me on a mental level and emotionally, I feel like I’ve gotten a little pieces of my life back, that makes me feel good about the fact that I was able to make it this far in life, despite what my chronic condition has done to me as far as debilitating wise with the symptoms. But I know that when these people sign up for the 50-State Network, they have something to say, they want to share their experiences. And a lot of them mainly do it because they want to help make a difference. They want people to know what they’ve gone through. And that is so important because when you paint the story of just the simplest things that you try to do on a daily basis and if you need to get access to medication, and you’re having all these unnecessary obstacles, these people that want to take action are very passionate, and they want to raise awareness. And then again, that goes back to what we’re talking about when you’re speaking to family and friends, co workers, that’s a form of advocacy. And right there, that’s a way to raise awareness. And that actually is practice to doing in person advocacy, or again, virtual advocacy, because the more you talk about your condition, I feel like it’s healing. I know for me personally, it can be hard at times to discuss what’s happened in the past. But at the same time, I feel a little bit I like I’ve healed myself that it’s like, you know what, I found a way to get back the times that the moments that I lost with my kids, the events I couldn’t go to, the time where I lost access to my medication and advocacy has made me look at life in a positive way. And I say that because when someone goes through all these life changes, it can definitely make you think about how am I even going to make it day to day. And advocacy truly is something that I know can help others to continue to fight to continue to look at this new way of life. And for most people, if they’re able to share their story and raise awareness, that is something that they really want to do. And again speaking to your family and friends as a way to get started and then just all these things that come up that we can have these patient advocates get involved with, it’s a way for them to feel like they have some control. That’s one way that you can regain that control of your life.
Zoe Rothblatt 19:46
Yeah, that’s really beautiful JP, I love like you’re saying that you’re healing yourself while you’re sharing your story. And just to bring it back to PMR really quickly is that I noticed in a lot of my outreach with patients that when they were diagnosed with PMR, they had no idea what it was. And when they were Googling, there wasn’t a lot of information out there. And they said they like maybe had heard of one other person that had it. And I think what you’re saying resonates probably even deeper with the PMR community in the sense that it’s so important to share your story because despite PMR being a popular disease, and a common diagnosis, for some reason, there just like isn’t a really loud vocal community around it. And we’re here today to talk about it to try and change that. And I think it gets so important that even if one person feels less alone, this is what Linda said in the interview with her, like we’ve at least helped that one person. And it’s important to think about all these different conditions and how we can continue to raise voices.
JP Summers 20:44
Yes, and I completely agree with that. Because it can be a huge challenge to have the day to day when you’re chronically ill. But when speaking to the patients with PMR, even a few caregivers that I spoke with, there was another common thing I heard is that it was frustrating. It was frustrating, because again, all of a sudden, they couldn’t do something they were used to doing, and they wanted answers. And when they got those answers, a lot of them were very discouraged or upset, and they didn’t realize it, but they were starting their own advocacy by pushing for answers. And when I spoke with a lot of the people I said, you know, you definitely advocated for yourself when you walked into that doctor’s office, when you went into urgent care, when you got an answer that maybe wasn’t what you wanted to hear, you were already advocating. And I think a lot of them were just kind of shocked, because they didn’t realize that that was a form of advocacy. And to hear them even though they were going through that situation with the symptoms, talking about how their lives have already changed in the early stages, a lot of them were optimistic about you know, I’m going to start this new treatment, I hope I see good results. So, just hearing positivity already in their voices that made me happy because I love when another patient or caregiver I speak with has something positive to say about a situation they had no control over.
Zoe Rothblatt 22:08
I think that’s a beautiful note to end on. You know, there’s no act of advocacy too small, just by walking into a doctor’s office you’re advocating for yourself. Like JP mentioned, talking with your family and friends is advocating for yourself. Even just doing simple tasks for yourself is a form of advocacy. And if you aren’t, join our 50-State Network and get on a larger scale in front of legislators and stakeholders, we’re here to support you in that journey as well. But just the message that there’s a lot of ways to advocate and we’re here supporting you. Thanks so much, JP, for joining us today.
JP Summers 22:40
Yes, thank you for having me, Zoe.
Steven Newmark 22:44
Wow, that was a really great interview with JP. It was fascinating to hear her talk about her work in getting community support and leaning on friends. And I think that there’s some useful information there for our larger community.
Zoe Rothblatt 22:56
Yeah, definitely. I learned so much from JP about advocating for yourself, whether it’s living with PMR, or another chronic illness and just leaning on those around you.
Steven Newmark 23:05
Well, we hope that you learned something too. And before we go, we want to encourage everyone to check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 23:14
And if you have any questions, comments, episode topics, definitely email us at [email protected]. Well everyone, thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you like this episode, please give us a rating and write a review on Apple podcasts and hit that subscribe button wherever you listen. It’ll help more people like you find us. I’m Zoe Rothblatt.
Steven Newmark 23:38
I’m Steven Newmark. We’ll see ya in 2024.
Zoe Rothblatt 23:40
Next year.
Narrator 23:45
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
My Gut Check: When I Took Charge of My IBD with Basmah
Basmah joins The Health Advocates to share her Crohn’s disease patient journey. Initially, Basmah admits to not paying much attention or learning about her Crohn’s — and she fell behind because of her symptoms. This sparked her to do an online deep dive, learn about the disease, and start a journey of trial and error with lifestyle interventions and medicine.
Basmah’s advice for others: “If one treatment or one lifestyle doesn’t work out for you, there are so many other options right now. And the important thing is that you educate yourself, you have the opportunity and the resources to do so. And it’s so important to connect with other people who have similar experiences with you.”
This episode was made possible with support from Walgreens.
My Gut Check: When I Took Charge of My IBD with Basmah
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Zoe Rothblatt 00:08
Welcome to The Health Advocates a podcast that breaks down major health news of the week to help you make sense of it all. I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF. And our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life. Today, we’re joined by Basmah Ali, who lives with inflammatory bowel disease. Basmah shares her story about getting diagnosed, what resources were available at the time and ultimately how lifestyle changes and community really helped support her in her health journey. So Basmah, welcome to The Health Advocates.
Basmah 00:44
Hi, I’m so happy to be here. Thank you for having me.
Zoe Rothblatt 00:47
Awesome. Why don’t you start off by introducing yourself to our listeners, a little bit about you,where you’re from, maybe how we got connected?
Basmah 00:54
My name is Basmah. I live in Minnesota and have Crohn’s disease. I’ve been living with it for about 20 years now and have been on social media since 2016, or 17. And we got connected through one of our mutual friends, Tina Aswani Omprakash. She’s a health advocate with Crohn’s disease as well. And she has been doing amazing work with IBD Desis and South Asian IBD Alliance, which I’m starting to do some collaboration with them right now but that’s how we connected.
Zoe Rothblatt 01:28
Awesome. Well, thank you so much for joining and I’m excited to get to know you and it’s so nice, like working with South Asian IBD Alliance and being connected more with the community there. So let’s dive into your story. Tell us a bit about what your diagnosis with Crohn’s was like and your experience learning about IBD? Did you know about it before? Was it a total surprise when you were diagnosed?
Basmah 01:50
No, so I was diagnosed about 20 years ago in 2003. And I just turned 16 at the time. About a month after my birthday, I started experiencing some symptoms mostly in relation to fatigue. I was just very, very tired all the time. I wanted to sleep most of the day. And I wasn’t a very active kid but this was unusual. And then I started experiencing bowel issues, mostly diarrhea, which I’ve kind of been a sickly kid growing up and the last few years were even more so before I was diagnosed. But this was just felt like it was all of a sudden and so my parents took me to the doctor. And my pediatrician was asking me about my eating habits, mostly not sure if she was thinking I had a disordered eating because I wasn’t eating much either. But my parents, my mom, especially it was like no, something’s going on, we need to check her out. So luckily, my pediatrician listened to that and sent me to a GI doctor after getting some tests done and I was diagnosed with Crohn’s disease within a few months. But at the time, there was absolutely no information about it. I think the only person in my family who knew about it was my mom, because she studied medical school in Egypt, that’s where my family’s from. But she only knew the basics at the time and I didn’t really think to look it up online. I was just like, okay, so I didn’t really even fully understand that this was something I would have to live with my whole life. It was just okay, how do we fix this? But then as I was taking medications, I spent the entire summer just laying in bed trying to get used to some of the medications that I had to take. Then I felt like maybe after a year or so I said, it kind of hit me that okay, I guess I have to figure this out, you know, but it wasn’t until even after college, I just felt like throughout my education and my first few years of working, I was just trying to kind of get by without actually learning about the disease. And it was really difficult because college itself was really difficult for me, I just kind of had to do part time because full time was too much. Actually it kind of put me in the hospital multiple times, I couldn’t focus on my studies and I was falling behind a lot to the point where I was put on academic probation when I was in sophomore year, I believe. And then work was difficult as well. And so I work in mental health and social services, I was even fired from a job when I was in low income housing and that’s when I started realizing, okay, what I’m doing right now is not helping, like I was taking medication, but I wasn’t really empowering myself with knowledge on how to take care of myself. And so that’s when I started getting into okay, well now we do have information, I do have high speed internet, I can look this up online, and so there wasn’t much at the time, but I still had enough to realize, okay, these are the things that I have control over my diet, my lifestyle, adhering to my medication more consistently, all sorts of stuff that I just didn’t really take seriously before. And thankfully, I’ve been in remission since 2019. So, knock on wood, thank God.
Zoe Rothblatt 05:20
Oh, good, yes, knock on wood for that, by the way, I also have Crohn’s disease and it’s interesting to hear you say that, like, after some time, there was a period where you realize like, oh, this is actually chronic, I had the same thing where I was like, just so excited to have an answer I didn’t think about the fact that this was something I would be dealing with for so long. And I want to hear more about that moment for you when you realize that it’s something you have to deal with for a long time. And then you said, or you went to go look at resources, like what did you find? And how is it different now with what resources are available, especially being connected to South Asian IBD Alliance and the great stuff that they put out? Do you feel like there’s more better resources now compared to when you were diagnosed? Or what’s still needed?
Basmah 06:03
Absolutely, absolutely. Like I said, there was pretty much nothing when I was first diagnosed. And so I just kind of had to take the word of my doctors, my doctors have been fantastic so far, I know not everybody has that kind of experience but I’ve always had pretty decent relationships with my doctors. But you know, you only meet them for, if you’re lucky half an hour.
Zoe Rothblatt 06:27
Right.
Basmah 06:28
And so there’s only so much that I could learn from them. But for years, I was just trying to say, okay, I’m just gonna do whatever it is they tell me to do. But also as a teenager, I was thinking this could go away if I just ignored it, which I’ll say Crohn’s caused some mental health, depression, anxiety in me that kind of thought, in my mind, if I avoid it, it doesn’t really exist, which, obviously, that doesn’t work that way.
Zoe Rothblatt 06:56
So what are some of the things that you did, like when you realized you shouldn’t avoid it anymore?
Basmah 07:01
I think it really just hit me when I was interning for a little bit in Seattle, Washington. I was interning at the Children’s Hospital, and I was getting sick there and then I said, okay, you know what, I have some time, I need to see what’s going on, or what are some things that I can do. And then they kind of hit me saying, oh, this has affected my digestive system, let’s see if there any diet changes. I didn’t learn anything about that. I just was told there are foods I should avoid. But I said okay, what is it can I eat? What should I be looking into more? And so I started with a gluten free diet, basically and I started seeing improvement within weeks, minimal improvement, but there was something that made me realize I could be on the right track here. And so I did more and then when I came back to Minnesota, because my internship was a temporary one, I started working for a few years, and then I was feeling relatively fine, but not fantastic. And so I started seeing an acupuncturist, who told me that I need to focus more on eating vegetables, which before it was like, okay, avoid fiber as much as possible. But eat your vegetables, very well cooked, focus on getting your protein through meat, seafood, all sorts of stuff and that just go back to the basics. And then over time, once you start feeling better, you can reintroduce more foods. But she also emphasized on exercise, and getting enough sleep, stress management, all of the stuff that we hear about now is like the four cores of your overall well being and so I really focused on that. And it was really helping me out, but there was a time when I had a lapse of insurance in between jobs. So, when I got my new job, I was a case manager for low income housing at the time, and I didn’t get my medications on time and so it caused me to get into a huge flare. So my point here is that medication alone didn’t work for me, and diet and a holistic lifestyle didn’t work for me either. So like I said, I was fired from that job within a few months and then I just said, okay, now I have to focus on figuring out ways to take care of myself. So that’s when I went on internet overdrive, and started really connecting with other people with IBD and other chronic illnesses. And it was also part of the reason I started my platform to begin with was I wanted to share my health journey to the public more specifically because I realized there wasn’t a lot of representation, a diverse representation, I should say, and I wanted to just share my story in hopes that it will connect with other people from my middle eastern North African background, and as well as other Muslims, because I realized there were some cultural barriers as well. Especially when I was fixating on my diet, you know, I had to bring my own food to other people’s places, and in our culture, we love to show our love through food.
Zoe Rothblatt 10:23
Yeah. How did you explain that, like what was going through your head at that time when you had to show up with other food, and then like, not only physically be different than everyone in the room, but then have to explain it too?
Basmah 10:35
Oh, so it was interesting at first. And so luckily, my community and my family understand it now. But at first, it was just so hard because all of my aunts and my friends and uncles were like, can’t you just eat a little bit of this, it won’t hurt you? When I know, it would kill me for a week or so.
Zoe Rothblatt 10:57
Right.
Basmah 10:57
And it was really hard because I felt like, well, number one, I didn’t want to hurt other people’s feelings. And two, I kind of felt left out because these were foods that I grew up with and so there was that grieving process of I can’t do everything that others can do, too. So it took some time and there came a point where I was avoiding events as well, which wasn’t helpful. But at the same time, it kind of eased some pressure off of me, but it got to be pretty lonely after a while. And so it was one of those things that I had to learn that people just do things because they genuinely care. But they also wanted me to feel better, too. So I think over time, it was understood. Now that I’ve been feeling so much better, it’s not so much of an issue anymore, because I mostly just stay away from bread and dairy when I go out, but had to take some time to understand that, okay, this is what’s making Basmah feel better. I had more energy, I was more outgoing, I wasn’t so bedridden all of the time. And so I think just helping the others see that really made a difference in the way that things were approached.
Zoe Rothblatt 12:18
Yeah, I think taking that time and like figuring out what works for you and going through different like phases of how you can engage with the world as your disease is so important. We often talk about like the trial and error when it comes to medications. But there’s also a lot of trial and error with lifestyle with this disease. And like you’re mentioning, you know, like going to social events, taking a step back and really figuring out what works for you is so important when managing a chronic condition. Because at the end of the day, like you’re saying you don’t want to hurt people’s feelings, but it’s also you and if eating, something’s gonna put you out for a week, you have to like go weigh the consequences there and think about, you know, how am I going to succeed in this situation and feel my best and be able to make memories with the people I love.
Basmah 13:04
Absolutely. And you made a really good point that not one thing works for everyone and I just want to give my advice out there. If one treatment or one lifestyle doesn’t work out for you, there are so many other options right now. And the important thing is that you do educate yourself, you have the opportunity and the resources to do so. And it’s so important to connect with other people who have similar experiences with you. Because as much as my family and the people that I grew up with, are really very caring and have been helping me out. It’s really different when you get the support and have the connection with other people who are living with IBD who get it or other chronic illnesses to like, they just understand what it’s like to navigate everything to accommodate your own needs.
Zoe Rothblatt 14:00
Yeah, I think that’s like an amazing note to end on with that advice to say, you know, keep trying to figure out what works for you. It may be exhausting, but there’s a lot of community support out there and options. So, thank you so much for joining us.
Basmah 14:14
Absolutely. And I just wanted to say the ultimate thing I have so much advice to give, but ultimately you just have a lot of compassion for yourself. You’re not gonna figure things out right away. And there’s a lot of trial and error. But just like I said, educate yourself, connect with other people and also find time to enjoy life do the things that you like, life is too short to wait around until you feel a lot better.
Zoe Rothblatt 14:39
Definitely, well thank you so much for sharing that and where can our listeners follow you on social media to learn more about your story?
Basmah 14:46
So, I have an Instagram account actually also Twitter and TikTok, I’m not very good on those platforms. So just follow me on Instagram – @thisimmunelife.
Zoe Rothblatt 14:59
Awesome, we’ll follow you there. Thank you so much.
Basmah 15:02
Thank you for having me.
Zoe Rothblatt 15:05
Well, everyone, thanks for listening to The Health Advocates a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating write a review on Apple podcasts and definitely hit that subscribe button. Wherever you listen. It’ll help more people like you find us on Zoe Rothblatt. We’ll see you next time.
Narrator 15:28
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Linda’s Polymyalgia Rheumatica Journey: From Extreme Pain to Advocate
About a year ago Linda Rinaldi began to feel full body pain. It felt like she had exercised too much, but when it became more extreme, she knew something was wrong. In a matter of days, she was diagnosed with polymyalgia rheumatica (PMR), a condition she had never heard of. Linda joins this episode of The Health Advocates to share her PMR patient journey and how the diagnosis ultimately led her to becoming a health advocate through sharing her story.
Linda encourages others to listen to their body and speak up: “My advice is: don’t stop. Tell the doctor; tell as many doctors as will listen to you what your symptoms are and advocate for yourself. You have to because if you don’t, nobody else will do it. And nobody knows your body, what you’re feeling, and what you’re going through better than you.”
This episode was made possible with support from Sanofi.
Linda’s Polymyalgia Rheumatica Journey: From Extreme Pain to Advocate
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Zoe Rothblatt 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF. And our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life. So today is episode two of a special three part series focused on polymyalgia rheumatica or PMR for short. Over the course of these episodes, we’ll speak with a physician and a patient who deals with PMR in their daily life so we can get a better understanding of what PMR is and the journey that patients go through to get diagnosed and treated. If you missed our first episode with Dr. Wright, please take a listen when you have time. In today’s episode, we’re joined by Linda Rinaldi, a PMR patient, and we’ll hear from her about when she recognized symptoms, what her diagnosis was like, her treatment, and how she’s feeling today. Welcome, Linda to The Health Advocates, we’re happy to have you here. Now why don’t you start off by introducing yourself.
Linda Rinaldi 01:07
My name is Linda Rinaldi. I am from South Jersey, and I am a criminal prosecutor, that’s what I was for 26 years but I’m now retired. And I live right outside of Philadelphia, I live in South Jersey, but I live in right outside of Philadelphia.
Zoe Rothblatt 01:21
Okay, well, I guess I’m on the other end of you. I’m from Northern jersey, but living in New York City. So not too far. We’ll have to hang out. But in the meantime, we get you virtually to learn more about your polymyalgia rheumatica diagnosis, can you tell us a little bit about what that journey was like with getting a diagnosis and some of your initial symptoms, how long it took to even get the diagnosis.
Linda Rinaldi 01:45
My initial symptoms were I felt like I had exercised too much. That’s how I felt and I stopped exercising. I, you know, I went to visit my granddaughter in London, and I knew I was gonna get sick because she was just two and I hadn’t been around two year olds in a long time. And I did get sick. But as I was getting sick, I started feeling the symptoms of PMR that I didn’t know that I had and it was like I exercise too much. That’s what it was like.
Zoe Rothblatt 02:12
And it was like all over your body or localized to an area?
Linda Rinaldi 02:16
Yes, no, all over my body from my neck down to my toes. My head was not involved, but I couldn’t move my head. It took about a day or a couple of days to get a diagnosis because I called my family physician and she told me to stop the Crestor that I was taking because sometimes if you’re on it too long it causes muscle aches and can do something with your muscles. So, I stopped right away. That did not do a thing, did not do a thing. So I called her back and she was stumped. She’s like now what? Maybe you should see a rheumatologist. So I said well, okay, I’ve never been to a rheumatologist. So I will go to a rheumatologist. So I called, she gave me the names of couple people, and those couple people had appointments for like six weeks away. It’s like, I cannot live like this for six weeks. I just can’t because I couldn’t move. I couldn’t do anything, I couldn’t drive, I couldn’t wash, I couldn’t wash my hair, I couldn’t brush my teeth, I couldn’t take a shower, I mean, I couldn’t turn my neck, I couldn’t even roll over in bed. That’s how bad it was.
Zoe Rothblatt 03:18
And then yeah, obviously, like you’re saying you couldn’t do any of this. Like something was telling you that something was really wrong and that you couldn’t wait six to eight weeks for a rheumatologist. So what happened? Were you able to get an appointment sooner? Did you have to wait? What happened when you got to the rheumatologist?
Linda Rinaldi 03:34
Well, first of all, I said to the woman, I cannot wait that long. I have to see somebody today or tomorrow or the next day. I mean, I can’t move I have to see somebody. So she gave me this one doctor, and the doctor knew right away that it was PMR. But at the time, I had no idea what it was. I could just barely walk into the office there. I had to drive there but I had to keep my hands on the lower part of the steering wheel because I couldn’t raise my arms. I couldn’t turn my head. It was very, very scary driving because I couldn’t do anything that you would normally do when you’re driving.
Zoe Rothblatt 04:07
Yeah, it’s so scary to have like any symptoms appear but also such a sudden extreme onset is so scary.
Linda Rinaldi 04:14
Yes, that’s what it was. It was very sudden, very extreme, very scary.
Zoe Rothblatt 04:19
So what went through your head when you got the diagnosis? Was it like relief? Oh, there’s a name for this, confusion like you said, what even is this? What do I do now?
Linda Rinaldi 04:27
I guess it was all those things. What do I do now? Yes, there’s, I was glad that there was a name for it but I didn’t know what the name was. You know, I mean, the doctor told me that it was not fibromyalgia and she said that specifically. It’s not fibromyalgia we’re talking polymyalgia had no idea what she was talking about.
Zoe Rothblatt 04:45
And yeah, I think also like learning something has a name often means that there’s a treatment associated with it. You know if we can call it what it is, then we can treat it. So what happened there, like what was the treatment recommended to you or did you talk about options with the doctor?
Linda Rinaldi 05:00
No, I didn’t talk any options out, she just put me on a steroid, which I really did not want to go on because I’ve heard such bad things about steroids. But that was the only option that I was given is to go on the steroid and she started me out at 15 milligrams. And then each time that I saw her, which was every two weeks, she would taper down 14 milligrams, 13 milligrams, 11 milligrams till we got to where we are now, which is a year later. And it’s one milligram and I’m starting to have symptoms again. So she’s just this last time I saw her on November 21, she is kicking it back up to two to three milligrams. So one day, I’m taking three one day, I’m taking two, one day, I’m taking three one day, I’m taking two. So if it works, it’s fine.
Zoe Rothblatt 05:45
Yeah, I’m sorry to hear you’ve been having symptoms again. And I kind of relate to that, I hear a feeling and your voice where you’re like it kind of like it is what it is like you have this diagnosis. I have inflammatory arthritis and Crohn’s disease. So obviously different than what you have but I understand like the chronic nature of the ups and downs of it and trying to figure it out. But it’s really good to hear that you have a care team that you trust that’s figuring it out with you as new symptoms crop up.
Linda Rinaldi 06:14
Yes, it is really, really helpful to have that. And especially, she calls me, she does my bloodwork, like every other time that I’m there to see if I’m inflamed or if there’s any change in my bloodwork. And there hasn’t been for the past year, but I’ve been on the steroids.
Zoe Rothblatt 06:30
Can you tell me a little bit more about like how you describe your symptoms, I know polymyalgia rheumatica is really common, but it feels like a lot of patients don’t know about it. And I wonder if maybe you tell us like a little bit more about how you explain your pain, or experience your pain of that could have helped some of our listeners identify it themselves.
Linda Rinaldi 06:47
I guess I couldn’t get in bed, I couldn’t put the covers over me. I couldn’t roll over, I had to get my son to come down and roll me over in bed because I couldn’t roll over in bed. And I couldn’t drive, I couldn’t lift my arms, I couldn’t walk, I couldn’t brush my teeth, I couldn’t wash myself, I couldn’t take a shower, I couldn’t wash my hair. I just couldn’t do anything. It didn’t really hurt, it wasn’t pain, I just couldn’t move.
Zoe Rothblatt 07:14
Which is like almost scarier than pain, right? Because all of the sudden you can do all these basic things in your life that you go about doing without even thinking about, like rolling over in bed isn’t something you would have ever put thought to and now all of a sudden it’s taken away from you.
Linda Rinaldi 07:29
Those are things you don’t think about you just do them because you have to, you know, and all of a sudden I couldn’t do them.
Zoe Rothblatt 07:34
And then once you started on those steroids did those things begin to improve? Like how did you feel?
Linda Rinaldi 07:40
Yeah, the steroids helped within a couple of days, they started to lessen the symptoms a little bit. And then I would say within four days, it was better in terms of the movement.
Zoe Rothblatt 07:52
I think it’s like, yeah, it’s a lot to experience within the span of it sounds like almost within a week to two weeks. It was like you had this extreme pain.
Linda Rinaldi 08:02
Yes.
Zoe Rothblatt 08:02
Extreme inability to do things, not knowing what’s happening, getting answers and then getting relief pretty quickly.
Linda Rinaldi 08:08
Yes, within the four or five days, I got relief, thank God. And I was really very grateful that the rheumatologist knew what PMR was, because I had never heard of it. In fact, usually when you’re diagnosed with something you hear all kinds of people have they’ve had this they’ve had that, only one person 35 years ago had PMR. That’s it and nobody, everyone says really, you have what it is called again? I have to look it up, because no one has ever heard of it. So for you to say that it’s common, I’m thinking really, is it really that common?
Zoe Rothblatt 08:41
I know. I only learned about it recently, actually, I don’t think it’s like…
Linda Rinaldi 08:45
Okay.
Zoe Rothblatt 08:45
Common in knowledge. But I do think a lot of people are living with it either undiagnosed, or just getting diagnosed. We actually did some outreach, like over the summer and I spoke to so many patients who have PMR, you know, experienced PMR symptoms for some time. And they had the same exact thought of like, I didn’t know anyone else with this and I like scoured the internet to find people which is also part of the reason we’re interviewing you and trying to get information out there and let people know while it may be totally scary to experience these things, like it is normal, like it happens to people and here is Linda sharing her story. So yeah, what’s that like for you now to like, openly share your story and even I think a big part of what your story was that you advocated for yourself saying like, something’s really wrong, and I need to get to the doctor now. I guess I’m just like one saying it’s amazing that you self advocate it in that way because a lot of people it takes so many years to get diagnosed and for you, you were like, I know my body, this is wrong, I’m going to get there. And maybe like what’s your advice for other patients so that they can you know, feel confident to do the same?
Linda Rinaldi 09:53
My advice is, don’t stop. Tell the doctor, tell as many doctors as will listen to you what your symptoms are and advocate for yourself, you have to because if you don’t, nobody else will do it. And nobody knows your body, what you’re feeling and what you’re feeling going through better than you, you know, and you have to, you have to advocate for yourself, you just have to.
Zoe Rothblatt 10:15
It’s so true. I mean, we’re The Health Advocates, I totally agree. It’s like, you have to advocate for yourself first, and then others will join along in the fight. And you know, we’re here to support you. But it really has to start with you speaking up. And it can be really challenging, especially like the power dynamic with a doctor and patient and insurance company and all these players in the healthcare system can make it feel hard, but know that there’s a community out there that we’re here and willing to help you along.
Linda Rinaldi 10:43
Exactly.
Zoe Rothblatt 10:44
So you know, thinking about getting that diagnosis, and like you said, you didn’t know anyone with that you hadn’t heard of it? Where did you go to learn more about it?
Linda Rinaldi 10:52
I googled it. Like everybody, I Googled it, you know, and then I learned so much. I had every single symptom that, I guess it was a an educational piece that I googled and came across and I had every single symptom. You kind of forget how badly it is until you’re reminded that yeah, it was really, really, really bad. I mean, I could not do anything. I could not move. I could not do anything.
Zoe Rothblatt 11:19
Yeah, I really relate to that. It’s like you almost protect yourself and forget.
Linda Rinaldi 11:23
Yeah.
Zoe Rothblatt 11:24
What the worst of it was.
Linda Rinaldi 11:25
Yes.
Zoe Rothblatt 11:26
But it’s always a part of you.
Linda Rinaldi 11:28
Exactly. I think it has to be a part of you, because you just can’t forget those symptoms when you can’t move. But that’s why I’m hesitating with the exercising, because that’s what I feel again. And I asked the doctor specifically, is this going to come back? And she said to me, I don’t know. It depends on your body, it depends. We’ll see. You know, we’ll taper down. We’ll go through the whole procedure, and we’ll see where you are. And she was very disappointed when I had the symptoms again.
Zoe Rothblatt 11:55
Well, yeah, of course, it’s disappointing. At the same time, it’s also nice to know that like she’s feeling that disappointment with you.
Linda Rinaldi 12:03
Yes.
Zoe Rothblatt 12:03
And can sit in that with you a little bit.
Linda Rinaldi 12:06
Yes, definitely.
Zoe Rothblatt 12:07
So, what inspired you to start sharing your story? You know, you’ve done another video with us, now on The Health Advocates like what was the reasoning behind saying, let me get this out there?
Linda Rinaldi 12:18
If I can help even one person know what the heck this is, I will help one person because one person is one person, that’s not too many. One person is one person. And I’ve always wanted to help people that don’t know, so to speak, whatever I can do, I will do because I just don’t want anybody to be in pain and not know what it is and not be able to move.
Zoe Rothblatt 12:41
Yeah, I totally agree. That’s why I started sharing my story as well. Just like knowing how alone and scared I felt.
Linda Rinaldi 12:50
Yeah
Zoe Rothblatt 12:50
And not wanting others to feel the same and wanting to help reduce that experience for other people.
Linda Rinaldi 12:56
Right.
Zoe Rothblatt 12:57
And like you’re saying, if it’s just one person, it makes such a difference. That’s like a whole quality of life.
Linda Rinaldi 13:03
Yes, it definitely is. And if you can help one person, then that’s one person that you’ve helped, you know.
Zoe Rothblatt 13:09
And especially because PMR tends to get diagnosed later in life and I think a lot of people can make excuses around like, oh, this is just part of getting older and stuff like that. So it’s really important to spread the word to say like, if something feels off to you like it’s probably off and go call the doctor.
Linda Rinaldi 13:27
And don’t let it get to, I would say the point that I got to which I couldn’t move, but it happened so quickly that I didn’t even wait. You know, I just knew, I knew, that there was something wrong.
Zoe Rothblatt 13:39
Yeah, well, Linda, thank you so much for sharing your story with me and our listeners and like I love the messages of hope you left us with and like I hope you continue to work closely with your doctor and that your symptoms lessen.
Linda Rinaldi 13:54
I hope so too. Thank you very much. Thank you.
Zoe Rothblatt 13:58
Well, everyone thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating write a review on Apple podcasts and hit that subscribe button. Wherever you listen. It’ll help more people like you find us. I’m Zoe Rothblatt, we’ll see you next time.
Narrator 14:20
Be inspired, supported and empowered. This is the global Healthy Living Foundation Podcast Network.
Crohn’s and Colitis Awareness Week with Pharmacist Mallory Schmoll
It’s Crohn’s and Colitis Awareness Week and we are joined by Mallory Schmoll, PharmD, Clinical Pharmacy Strategy at Walgreens. Mallory explains what IBD is, how it differs from irritable bowel syndromes (IBS), and the available treatments for patients. We also discuss the different types of remission, along with what it means to achieve remission, and questions to ask your doctor or pharmacist as you develop a treatment plan.
This episode was made possible with support from Walgreens.
Crohn’s and Colitis Awareness Week with Pharmacist Mallory Schmoll
Narrator 00:00
Be inspired, supported and empowered. This is the global Healthy Living Foundation Podcast Network.
Zoe Rothblatt 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF. Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life. Today, we’re joined by Mallory Schmoll. Mallory’s a pharmacist with nearly 20 years of clinical experience in both retail and specialty pharmacy settings. She currently leads clinical pharmacy strategy, supporting the gastroenterology rheumatology and dermatology conditions across the Walgreens enterprise. So this week, it’s Crohn’s and Colitis Awareness Week, and we’re talking to Mallory about inflammatory bowel disease, what it is, the treatment landscape. We’ll also cover options available for treating Crohn’s and colitis, and how to talk to your doctor and pharmacist about these medications. So Mallory, welcome to The Health Advocates.
Mallory Schmoll 01:02
Thank you. Thank you for having me.
Zoe Rothblatt 01:04
Why don’t you start off by introducing yourself to our listeners?
Mallory Schmoll 01:07
Sure! My name is Mallory Schmoll and I’m a pharmacist with Walgreens with lots of clinical experience and then recently started exploring clinical pharmacy strategy with Walgreens. And I’m really passionate about helping patients with complex conditions like Crohn’s and ulcerative colitis, and also passionate about the role that pharmacists can play in managing those conditions and helping patients achieve goals of therapy. So just to expand if I can, on the role of the pharmacist really click, each patient has such a unique journey and is at a different point in that journey in whatever condition they’re dealing with. So while one patient may be trying to achieve remission and get their symptoms under control, another patient with Crohn’s or ulcerative colitis might be on cruise control and maintaining remission beautifully and just wants to take that long trip or go to a wedding and not have any flare ups. So I think pharmacists can really connect with patients on that individual level and meet them where they are and achieve those goals. So that’s kind of a little bit of background.
Zoe Rothblatt 02:08
Thank you so much. I’m so happy to have you here and hear more from the pharmacist perspective. Before we dive in a little bit more into that journey. Can we take a step back? And can you give us an overview of IBD, or inflammatory bowel disease?
Mallory Schmoll 02:21
Absolutely. And that’s a great place to start because IBD is often confused with IBS. So I think we can get that out of the way and clarify that and it’ll give us a great starting point. And actually, your GHLF website does a great job explaining the difference as well. So that’s a great resource. But while both IBS and IBD are chronic GI conditions. IBS is irritable bowel syndrome, and IBD is inflammatory bowel disease. So IBS is called a syndrome because ultimately, it’s a functional disorder or group of symptoms without any physical damage to the GI tract. There’s no physical damage detected on imaging like a colonoscopy, for example, and the immune system is really not involved. So the symptoms are still bothersome and can impact quality of life and do need appropriate management but there’s not any physical damage or autoimmune response. IBD, on the other hand, inflammatory bowel disease, what we’re focusing on today is an autoimmune disorder. Under the IBD umbrella is Crohn’s disease and ulcerative colitis. So those two conditions are types of inflammatory bowel disease. Because of the autoimmune component symptoms can appear outside the GI tract with IBD. So things like fever, joint pain, rashes, you would not get that with IBS, but you may with Crohn’s or ulcerative colitis. Ulcerative colitis is limited to the large intestine or colon and Crohn’s disease can cause damage at any part of the GI tract, even starting with the mouth. So things like intestinal bleeding can be seen in both and quality of life can really be impacted with IBD if the symptoms aren’t controlled.
Zoe Rothblatt 04:03
Thanks so much for that overview. So I’m hearing two things from you. One is the difference between IBS and IBD. And then two is under IBD, we have ulcerative colitis and Crohn’s. So really good breakdown there, as some of our listeners may know, actually, I have Crohn’s disease, so I’m pretty familiar and this week is Crohn’s and Colitis Awareness Week, which is run by the Crohn’s and Colitis Foundation and for me as a patient and health advocate, it’s a really great time to spread awareness and help share my story. Sometimes with a GI condition it can feel like a little embarrassing, or some stigma around with sharing your story. So it’s just like a really great chance to rally around as a community. But I wanted to hear from you as a pharmacist, why are awareness weeks like this important?
Mallory Schmoll 04:47
Yeah, I think awareness is so important Zoe and you know this and I appreciate you sharing that, because GI symptoms can be uncomfortable to talk about it feels personal and private, but it’s something so many people go through. Three million adults in the US have been diagnosed with IBD and there are about 70,000 new cases diagnosed every year. So this is likely not a journey that you’re walking alone. There’s lots of people affected and lots of support out there. I think awareness is so important because one in 10 people experiencing GI symptoms remain undiagnosed or misdiagnosed for about five years leading up to an accurate IBD diagnosis of Crohn’s or ulcerative colitis. So that’s five years of struggling with symptoms and not really knowing what’s going on before we get an accurate diagnosis. So hopefully, by talking about it, reducing the stigma and increasing awareness, we can get patients diagnosed sooner. Another thing is the majority of people that are affected by Crohn’s, or ulcerative colitis, are diagnosed between the ages of 15 and 35. So that’s pretty young, and that group of people is very busy. They’re usually working, they might be growing their family, having kids, working on their career. So sometimes that GI symptoms, especially, are just easy to push aside and chalk it up to something you ate but hopefully we can through our conversation, we can increase awareness and get those health concerns taken care of.
Zoe Rothblatt 06:13
And can you talk to me a little bit more about the challenges around IBD? You mentioned time to diagnosis. I know also all too well, that there’s a lot of challenges around treatment, too. Let’s hear more from your perspective about that.
Mallory Schmoll 06:26
Yeah, so some of the main challenges are, like you said, the time to diagnosis that can take five years or longer of struggling with symptoms to get an accurate diagnosis, then the other component is finding the right treatment. And that can be a process as well. Treatment for these conditions is highly individualized. So some therapies are oral, there are injectable options and their IV infusion options. And it can be a bit of an art, there can be some trial and error before we find the perfect therapy that’s controlling the symptoms the best. So our goal is really to help patients achieve remission, maintain remission and control inflammation. If we can do that we can improve patient’s quality of life and they can do things like travel and go to weddings and go to family events. So that’s really the whole goal. The challenge is that only about 20 or 30 percent of patients achieve remission from their initial treatment, it can take dose adjustments, possible medication changes, and other adjustments to identify what treatment will be the best at reducing symptoms and what treatment fits with your lifestyle. So that’s another piece of individualizing the treatment. Is a once weekly dose gonna work the best and how can we fit the medication dosing into your schedule, then the challenge if we can control the symptoms and achieve remission, the next challenge becomes maintaining remission. So of the patients that achieve remission and get their symptoms under control up to 50 percent will experience disease relapse or a disease flare in the first year. So flares require add on treatments like steroids, and those come with their own side effects. So one of the goals in maintaining remission is to reduce or prevent the need for steroids. So lots of nuances in the IBD treatment landscape. But those are just a few points.
Zoe Rothblatt 08:14
And can we talk about remission for a second? So IBD is chronic, which means it’s lifelong, like you mentioned, like symptoms can go away or flare up. Is there like an overall definition for remission? Or how can patients look at achieving remission?
Mallory Schmoll 08:30
That’s a great question. So achieving remission is usually defined by that initial control of symptoms. So just symptom relief from the bothersome GI symptoms and feeling a little bit back to normal having your quality of life back. That is the initial definition, then there are other ways to look at remission, there’s something called deep remission or clinical remission and that would be where we actually see the damage that’s been done to the GI tract that you can see on a colonoscopy or imaging, we would see that start to normalize or start to go away. So if we can first control the symptoms, and then get clinical remission, where we’re actually seeing less inflammation and less damage to the GI tract and more healing to the GI tract. That’s a continuation of remission as well.
Zoe Rothblatt 09:19
That’s really helpful, thanks. So it kind of seems like patients should talk to their doctor about what remission means for them and what those differences in clinical or symptom relief looks like for each individual person.
Mallory Schmoll 09:31
Absolutely. It’s such a relief to get that initial symptom control but still important to continue that relationship with your provider and pharmacist to be able to maintain remission and prevent those flares. It does take lifelong monitoring.
Zoe Rothblatt 09:45
So you mentioned that patients often encounter a trial and error, wait and see period with IBD. I know I’ve dealt with this and a bunch of my friends with IBD have dealt with this and it can feel a little frustrating at times, but also there’s a lot of hope baked into that it. So could you explain some of the reasons behind these phases and provide insights into what patients should anticipate during this time?
Mallory Schmoll 10:08
Sure. So it definitely can be frustrating if you try a treatment and it doesn’t work right away. So like we talked about, it can take a little bit of trial and error, and we have to give the GI tract time to heal from the medications. So it can take time to find the right medication, the right dose, the right schedule, and also where the side effects are minimal. Or ideally, there are no side effects. So I’ve heard a lot of patients report symptom improvement within days or weeks of starting a medication, but there’s also a bigger picture. So once the symptoms are controlled, we have to see how long we can go without a flare, the longer the better. If we start seeing more flares, we’ll have to adjust the dose. And it’s just a lifelong process. So flares are going to come up they can be caused by stress or dietary changes. So figuring out the cause of the flares, whether it was a trigger, or there does truly need to be an adjustment in the medication is all part of that process.
Zoe Rothblatt 11:04
Yeah, something actually that’s really helped me is just paying attention to those symptoms and writing it down. Like even if it seems minor, it’s good to just write it down and kind of keep track of it. Because I guess I see my doctors like every three months or so and you could kind of forget what’s going on in the meantime. And like you said, it’s a process and things are changing, so just jot your symptoms down and then when you go to the doctor, you could bring it up and see if maybe that does classify as a flare, it was just a one off symptom there.
Mallory Schmoll 11:33
Right and it seems so elementary to keep a journal or to record those symptoms, but it’s so worth it. Because you might otherwise not be able to know what caused a flare up. Trying to remember oh, what did I eat the other day? Have I been stressed? Like trying to go through all that in your head, it’ll be so much easier if you have that written down and can identify a pattern.
Zoe Rothblatt 11:53
So let’s talk about the treatment options themselves. We’ve talked about kind of the process around them and what it looks like with communicating with your doctor and what you should pay attention to. But what treatments are actually out there available for treating Crohn’s and colitis?
Mallory Schmoll 12:07
Yeah, so a lot of these medications are a mouthful. But if you’re familiar with the conditions, you might recognize some of these names and choosing and starting a medication can be intimidating and confusing. So hopefully, it’s a shared decision making process between you and your provider and your pharmacist and you feel empowered to advocate for what will work best for your schedule, what concerns you have about side effects, and I would flat out ask that as the treatment options are discussed. What are the risks and benefits of every single option out there? So just to name a few drug classes that that might be a starting point for someone newly diagnosed, there’s a group of drugs called aminosalicylates, you might have heard of mesalamine, or sulfasalazine. And those can be used commonly for mild or moderate symptoms, and they control inflammation in the GI tract, they do work best if only the colon is affected by the disease. So another group might be corticosteroids that could be tried, and those are used for moderate to severe symptoms and also used for flare ups, they really kind of calmed down the overactive immune system, and will likely help you achieve remission, but they’re really not long term choices, because they do have quite a few side effects. So prednisone or methylprednisolone, are examples of those. Then you move into immunomodulators, so methotrexate, tacrolimus. Those are examples that lower the activity of the immune system and also reduced inflammation, probably most commonly what’s used are the biologics. And those are usually injectable medications that lower inflammation by actually blocking certain proteins in the immune system. So IBD is an autoimmune condition and if those other medications don’t work, then we use the biologics to take even more control of that overactive immune response. So some of where you start is actually also determined by insurance. Another important role that the pharmacist can play is helping navigate what insurance is going to cover and exploring financial assistance if needed as well. So it’s really a balance of what’s going to control the symptoms, what’s covered on insurance, what will work for your schedule and taking all those things into consideration to make treatment decisions.
Zoe Rothblatt 14:21
And then under the umbrella of biologics, we have sort of these newer kids on the block called biosimilars. Can you talk to us a little bit about those of what patients should expect to know there?
Mallory Schmoll 14:33
Absolutely. So biosimilars have been entering the market and multiple biosimilars for Humira entered the market in July and they’re getting a lot of attention right now. They are clinically equivalent to the brand name medication. So for example, we have Humira and we have biosimilars for Humira. They haven’t achieved the same status as generic medications, but they are clinically getting the same results as the original drug. So they have the chance to save the health system and potentially save patients a lot of money just like generics have in the past. So we’re kind of at the beginning phases of biosimilars entering the market and it’ll be interesting to see how that evolves. And the GHLF website actually has great resources on that. And don’t you all have a podcast on that topic as well?
Zoe Rothblatt 15:22
We sure do, and I’m actually the host of that podcast, so thanks for the shout out. Yeah, biosimilars can seem really confusing, and there’s a lot of questions around them. But I think it’s like at the end of the day, so you’re talking about like, talk to your doctor about the options, the risks and benefits and ask them lots of questions, also something with biologics and similarly, with biosimilars that I think a pharmacist can help you with is setting you up with the patient support program to help with the cost assistance as well.
Mallory Schmoll 15:50
Absolutely, really important to us, your full care team and all the resources available to you, your provider, pharmacist, all of that.
Zoe Rothblatt 15:58
And you know, outside of traditional medication treatments, I think it’s natural with the gut to think about supplements, vitamins, what other things IBD patients can do to help with their symptom control. Can you talk a little bit more about these like outside traditional pharmacologic methods for treating IBD?
Mallory Schmoll 16:17
Absolutely, and supplements and vitamins definitely have a role, and they can be an important part of treatment. So we want to maintain nutrition, especially if we’re talking about GI conditions that can affect the absorption of vitamins and nutrients, supplements may be really beneficial and help. But I would also encourage always asking a pharmacist or your provider before taking any supplements or vitamins, because they can sometimes have interactions with your prescription medication. So I would always just check a resource with your provider or pharmacist before starting a new supplement. Like I said, they definitely can help they can keep us healthy, they have a role in therapy, especially with GI conditions, but just making sure that it’s not going to do the opposite and interfere with the prescription medication or cause more harm.
Zoe Rothblatt 17:06
I’m hearing a lot about talk to your doctor, I think it’s really great advice. Can you give us what are some other questions that patients should be asking their doctors about their medications.
Mallory Schmoll 17:16
So always ask about the options. And we talked a little bit about this, but always ask about the risks and benefits of each treatment option that’s available to you so that you feel informed and to make the best decision and you’re going to feel confident that it’s going to work, it’s going to be effective, it’s going to fit within your schedule, the side effects will be minimal, that will give you more confidence in managing your condition and in the treatment itself. So ask about those risks and benefits. And then ask the doctor what they’ve seen in their clinical experience. So we can read online and the doctors can read in textbooks, but what have they seen from patients that they’ve worked with? What has worked well, in terms of nutrition for other patients? What have they seen cause flare ups? What may put you at risk for a disease flare? So anything that’s on your mind, I don’t think anything is off the table. Any question that’s on your mind, I would ask it’ll make you feel much more comfortable going through the treatment journey.
Zoe Rothblatt 18:11
It’s so true. Yeah, there’s no dumb questions. It’s your health and it’s your body and it’s so important to feel confident in the treatment you’re choosing and the shared decision making. And you know, as we have you here a pharmacist, can you talk to us about what questions you should ask your pharmacist or what role or pharmacist can play alongside your doctor in choosing these medications?
Mallory Schmoll 18:33
Yeah, absolutely. And pharmacists are so accessible, right? So you have appointments monthly or every few weeks or every few months with your provider, but pharmacists are there all the time. So, take advantage of that and don’t hesitate to ask them questions either. Pharmacists are really the drug experts. So any question you have about medications, side effects, also what they’ve seen in clinical experience. They’re a great resource and can also advocate for you with your provider. So the providers and pharmacists can make a great team and their knowledge can play off of each other to really give you the best care. I think pharmacists are also very familiar with financial resources for copay assistance and navigating insurance. So if insurance formulary prefers a specific medication, we can advocate for getting that approved for you work with the insurance, get the financial assistance and try to take some of that burden off your plate because you’re trying to manage symptoms and navigating a new diagnosis possibly so leverage your pharmacy to manage some of the insurance and administrative type burdens for you.
Zoe Rothblatt 19:37
Thank you. Yeah, that’s so helpful. Like we always say how having a chronic disease is like having another job and just knowing we have pharmacists like you to help in taking care of all those complicated things and the insurance terms that who knows what they mean it’s so hard to keep up something I’m so it’s really great to know that there’s resources out there for patients.
Mallory Schmoll 19:57
Absolutely. And one more thing is never feel like you’re bothering a pharmacist. Because, yes, we have to check the accuracy of prescriptions and make sure we’re dispensing the right medications. But I think every pharmacist would say the best part of their job is actually talking to patients and learning from them and being able to help provide education or help contribute to controlling those symptoms. So just never be afraid to ask any question.
Zoe Rothblatt 20:20
I love that. Thank you for that. And on that note of just like being real people in daily life, we talked a lot about symptom control and remission, but I wanted to just end on the note of like, what this all actually means in quality of life. At least for myself, you know, less frequent bathroom trips, and less pain has allowed me to have a better social life, a better working life and really be present in every day. And sometimes I’ll notice I’m a little more tired or have to step back then compared to my friends who are quote, unquote, healthy. But having a medication has really allowed me to live I guess, like normally you would call it sometimes there’s not such a great word for this. Can you talk to us from your perspective about how these medications can enhance quality of life for patients?
Mallory Schmoll 21:02
Yeah, thank you, Zoe. I think it’s so valuable to hear that from you as well. But the beginning of a diagnosis can be overwhelming and trying to get the symptoms under control. But once we get the medication right, and the dosing right, and minimize the side effects. I think like you said, having a great quality of life and really being minimally impacted is possible. Like you mentioned, you have to listen to your body, be in tune with your body. If you’re tired, or you feel symptoms coming on, listen to that and take steps needed to help yourself. But I think being able to take the vacations and being as social as you would like, I think all of those things are possible. So I think you just offered hope for patients struggling with these conditions.
Zoe Rothblatt 21:44
Thank you so much. Thank you for joining us today. And I just want to you know, reiterate your message from before about don’t be afraid to ask questions. There’s people out there to help you and hopefully this episode helps you feel less alone and more supported in your journey.
Mallory Schmoll 21:59
Thank you so much, Zoe.
Zoe Rothblatt 22:02
Well, everyone thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating and write a review on Apple podcasts and definitely hit that subscribe button w you listen, it’ll help more people like you find us. I’m Zoe Rothblatt. We’ll see you next time.
Narrator 22:25
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Talking Turkey Day and Copay Assistance
It’s our annual Turkey Day Talking Points episode! Our hosts discuss their favorite Thanksgiving foods and what they are especially grateful for. For this year’s Thanksgiving table conversation, our hosts are focused on copay assistance, accumulators and maximizers. They break down how to start a conversation about your advocacy efforts, and the topline points of what you and your friends and family need to know about these assistance programs and insurance practices.
Talking Turkey Day and Copay Assistance
Zoe Rothblatt 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:22
Our goal is to help you understand what’s happening in the healthcare world, to help you make informed decisions to live your best life.
Zoe Rothblatt 00:28
And today we have our annual turkey day talking points episode, but first let’s chit chat. Steven, what are your Thanksgiving plans?
Steven Newmark 00:36
My plans are to eat a lot, a lot, a lot, a lot, a lot of food that my mother in law will be cooking so I don’t have to cook. I just have to eat. So I’m very excited. How about you Zoe?
Zoe Rothblatt 00:47
Same eating a lot. I think I’m most looking forward to the stuffing. I can’t believe we have to wait all year to eat stuffing. I’m kind of wondering why we don’t eat that more often. But what’s your favorite food?
Steven Newmark 00:58
That’s a good question. My favorite food is the sweet potatoes.
Zoe Rothblatt 01:02
Yes.
Steven Newmark 01:02
Sweet potato pie with the marshmallows. Yeah, that’s my favorite.
Zoe Rothblatt 01:05
That’s the best. You know, this year, actually, Thanksgiving comes right after we went to the American College of Rheumatology conference. And…
Steven Newmark 01:15
Yeah.
Zoe Rothblatt 01:15
I think that Thanksgiving is a nice time to just reflect on what you’re thankful for what you’re grateful for. Sometimes in busy life, it’s hard to take a pause and remember that.
Steven Newmark 01:24
Definitely.
Zoe Rothblatt 01:25
And this year, I’m just really feeling a ton of gratefulness after the conference. One is the researchers and doctors that are doing so much to study these diseases and learn about them so they can provide better care for their patients. But most of all, I got to meet some of the advocates that we work with in person who I’ve known online for a long time. And it was just really nice to see the sense of community. I was actually talking to a friend who is going into surgery, and she had been at a surgical conference where there was no patients who attended. And I was thinking about the difference in that community vs. ours, and how…
Steven Newmark 02:00
Wow.
Zoe Rothblatt 02:01
You know surgery can often be like a one off thing and there’s not so much of a sense of community as there is in this chronic disease rheumatic community. So I was just feeling so grateful that we have that and like how exciting it was that it’s more than just somebody else living with the disease. But like, these are our friends. And it was nice to get together.
Steven Newmark 02:19
Yeah, that is fantastic. And you’re very lucky that you got to be with such great advocates such greed, patients, and it was fascinating listening to the interviews that you were able to do out there at ACR. So thank you for that. So I guess I’m grateful to have the opportunity to listen to those podcasts. And I’m grateful to be part of an organization with such great people on such great volunteers.
Zoe Rothblatt 02:41
Yeah, and we can’t forget our 50-State Network of advocates. You know, we’re so grateful for all that you do, and all that you advocate for. And today, we wanted to pick out you know, one topic from something we advocate for to have a conversation at your Thanksgiving table. It’s a really great time when families gathering and walls are down. Everyone’s eating good food and feeling all buttered up. So it’s a nice time to talk about what’s going on in your life and how you advocate.
Steven Newmark 03:09
Yeah, absolutely. This is my favorite episode of the year to record. Every year we talk about folks get together for the holiday and like you said, it’s a good time to bring forward some of the issues that we deal with as patients and as patient advocates to help your loved ones understand what it is that you’re going through, and perhaps even recruit them to be fellow advocates on your behalf. So let’s get into it. Let’s talk about the kinds of conversations that you could have and we’ll specifically focus this year on copay assistance. So let’s get into it.
Zoe Rothblatt 03:38
I think it’s really important, you know, step one is like how do you even start a conversation? Sometimes it can feel so awkward, especially if you know people around you don’t live with these chronic illnesses or advocate in the way you do. So I think a really easy…
Steven Newmark 03:52
Yeah.
Zoe Rothblatt 03:52
Level set that I usually use is just explaining why I got involved in the 50-State Network and advocacy, I share my story, I try to keep it brief, just explaining a little bit about the journey to diagnosis and how challenging it was and how now having access to affordable care and treatment has really helped me feel a lot better. And I think that starting on that personal note helps bring people in and understand it a little better.
Steven Newmark 04:19
Yeah, I fully agree. And once you’ve got them, sort of that’s the hook is your story, your personal story, you can then get into the discussion. And as I said, for this year, we’re going to focus on copay assistance. We’ll start with what is copay assistance, a copay assistance card, also known as a copay savings program, copay coupon or simply a copay card is essentially a coupon that makes a medication way less expensive for you as a patient. You simply sign up for the program, download or get your card in the mail and you show it at the pharmacy when you go to fill your prescription. Instead of paying a high copay, perhaps $50, $75, or even more, depending on the specifics of your insurance coverage, you pay a lot less. In some cases you might not owe anything at all.
Zoe Rothblatt 05:00
Yeah, I love these. I use them myself. And it often brings my copay down to $5 or zero, which is so nice because these are meds that I have to order every single month. So it does make a huge difference in order to not have to pay that high cost.
Steven Newmark 05:16
Yeah, no, absolutely, absolutely.
Zoe Rothblatt 05:18
But then like all things health insurance, it can’t be that simple in comes, copay accumulator adjusters and maximizers. Steven, why don’t you tell us about those.
Steven Newmark 05:28
Sure. Accumulators and maximizers essentially stop the patient assistance from counting towards your deductible and out of pocket maximum. This means that the insurer or the pharmacy benefit manager, PBM, is receiving the benefit of the assistance because the patient is able to purchase or able to obtain the medication, but the patient is not actually getting the full assistance as needed.
Zoe Rothblatt 05:52
Yeah, it’s almost like you’re paying twice because like someone’s paying on your behalf, sure. But that money is not going towards these deductibles and out of pocket maximums that need to be met. So you still have to pay that. So it’s like, why is the patient so responsible financially.
Zoe Rothblatt 06:09
Right, it makes it more difficult, essentially, to reach your out of pocket maximum if the drugs that you’re attaining are not counted towards that maximum.
Zoe Rothblatt 06:17
The good news is that there is something to do about these programs, you know, our network advocates strongly for laws among the states and federally that helped pass protections so that insurance companies cannot do this to patients.
Steven Newmark 06:30
Yeah. In fact, 19 states have passed laws to protect patient assistance programs with these are laws that ban accumulators and maximizers, our 50-State Network advocates at the state and federal level have fought in support of these laws.
Zoe Rothblatt 06:43
And it’s been many years of fighting for these laws. I think there’s been a lot of momentum in the last year or two. And it’s going to be a priority in 2024, which is why we’re talking about it today. Because it’s something that’s great about policy and advocacy is when there’s momentum around the issue, it’s like really good to keep talking about and getting the ear of legislators. So that’s why like this year, it’s especially important because we’ve seen like a good growth in states passing these laws.
Steven Newmark 07:09
Yeah. So why would anyone be opposed to these laws that help patients save money?
Zoe Rothblatt 07:13
So true, wondering the same myself. So, it’s always important in policy making to think about what is the other side arguing and basically, insurance companies as an pharmacy benefit managers say that these laws will actually increase the insurance costs, so premiums, the monthly amount that patients pay towards to get their health insurance, and they say that, you know, the money will just go elsewhere, doesn’t matter if you’re saving there, it’ll increase premiums,
Steven Newmark 07:42
Right, so they’re saying, hey, we’re going to increase premiums. However, studies notably done by GHLF demonstrated that banning accumulators and maximizers had not increased the cost of health insurance in the states with such laws. Since then, six more states have passed laws protecting patient assistance. So another year of health care costs have become available for us to look at since our initial study passing laws that protect patient assistance by banning accumulators and maximizers still has not led to an increase in insurance costs.
Zoe Rothblatt 08:11
This is great because we’ve been telling patients stories for a long time about how important copay assistance is and how damaging it is financially when these accumulators or maximizers are in place. But having the data to support the counter argument is so valuable when we’re having meetings with legislators and stakeholders.
Steven Newmark 08:32
Absolutely, absolutely. So this is it. This is what you do you engage in a conversation it takes about what was that five to seven minutes going at a very slow pace, and you explain to your friends, so you encourage your friends and family to become advocates in our 50-State Network. And if you have a story about using copay assistance and encountering and accumulator or maximizer, or please email us at [email protected].
Zoe Rothblatt 08:54
Yeah, definitely email us. Also share with us what you’re thankful for this year.
Steven Newmark 08:58
Yes.
Zoe Rothblatt 08:58
We love from our listeners.
Steven Newmark 09:00
Yes, yes, yes. As we said, we’re grateful for all that you do on behalf of patients. And it is exciting, just going back to the co pays and maximizers, it is exciting when we get to advocate at the state level and go to a state capitol and then we find out that particular state passed a copay accumulator ban, for example. It kind of energizes you to keep going, if that makes sense.
Zoe Rothblatt 09:23
100%, it’s so energizing. And also we often get to bring patients in the community advocates along and it’s really great to feel like we’re all in it together.
Steven Newmark 09:33
Yeah. Well, thank you again, and we’re grateful for all you do.
Zoe Rothblatt 09:38
Well, Happy Thanksgiving everyone. Thank you for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating, write a review on Apple podcasts, and definitely hit that subscribe button wherever you listen. And if you have any questions, comments episode topics, email us at [email protected]. I’m Zoe Rothblatt.
Steven Newmark 10:02
I’m Steven Newmark. We’ll see you next time.
Zoe Rothblatt 10:04
Happy Thanksgiving.
Steven Newmark 10:05
Happy Thanksgiving.
Narrator 10:10
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
American College of Rheumatology Convergence 2023: Live with Shelley Fritz, Patient Education Fellow at GHLF
Zoe is live at the American College of Rheumatology (ACR) 2023 Convergence and is joined by patient advocate Shelley Fritz who lives with rheumatoid arthritis (RA).
Shelley describes her patient perspectives poster about how using the Mediterranean diet has led to significant enhancements in her quality of life through increased energy, reduced fatigue, less pain, and a greater willingness to socialize with family and friends.
American College of Rheumatology Convergence 2023: Live with Shelley Fritz, Patient Education Fellow at GHLF
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Zoe Rothblatt 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Zoe Rothblatt and I’m live at the American College of Rheumatology 2023 convergence. And I’m here in the poster hall at the patient perspective posters with Shelley Fritz. Hey, Shelly, how are you doing?
Shelley Fritz 00:25
I’m doing great, Zoe. Thank you.
Zoe Rothblatt 00:27
Why don’t you start off by introducing yourself to our listeners?
Shelley Fritz 00:31
Hi, I’m Shelly Fritz. I am a patient advocate and I’m a patient fellow with Global Healthy Living Foundation.
Zoe Rothblatt 00:37
And we’re here at your poster that’s called, “Saved by Plants: How a Necessary Lifestyle Change Led to a Happier Life with Decreased Rheumatoid Arthritis Pain and Fatigue.” So tell us about the inspiration behind this poster. And what are the main findings here?
Shelley Fritz 00:50
Well, the inspiration was I was not feeling as well as my bloodwork showed that I should be feeling. And because my bloodwork looked great, and my rheumatologist felt really happy with that I had been tracking my pain, my fatigue, my sleep levels, and some other symptoms from my rheumatoid arthritis using the ArthritisPower app, which is now called Patient Spot. And I have been tracking it really ever since it was in a beta version in 2015. But I decided to follow the RA integrative treatment guidelines, which said that the Mediterranean diet is conditionally recommended, and I thought, well, why not try it? I haven’t tried that. I’ve tried seven biologics. I’ve tried lots of medication combinations that haven’t quite done the trick to keep my fatigue low and give me a good night’s of sleep and help me with my pain levels. So I decided to implement the Mediterranean diet.
Zoe Rothblatt 01:41
And how’s that going for you?
Shelley Fritz 01:42
It is going great. My key I think was dropping processed foods and red meat. That had been a big part of my diet. And now it’s not. I dropped sugar, for the most part. I already was eating gluten free and dairy free. But because the Mediterranean diet is plant based at its core, it’s really helped me to minimize my inflammation. And I tried the diet for four months tracking fatigue, my sleep disturbance and my satisfaction in social roles. I really didn’t want to go out, I didn’t feel well. So I didn’t want to go out and do anything with friends. So I decided I track it for four months, but I’m still on it. That was months ago. And I’ve stayed on it because I feel better. My fatigue levels are really low. I can sleep now. I’m out at this conference and I’m presenting and I feel great.
Zoe Rothblatt 02:27
That’s awesome. I think that oftentimes it feels almost intimidating to try and start a diet. What’s your advice to patients who are looking to do something like this?
Shelley Fritz 02:36
I think that if you start small, I brought it in a little bit at a time, I didn’t just drop everything and throw out all my cereal and protein bars and things like that, you know, I eased into it. And I also got my husband on board. It helps if you live with your partner, that your family that your friends that other people support you. They don’t have to be on the same meal plan as you but they just need to support you. So I stopped buying junk at the story stayed out of the center of the store, and I only go to the perimeter now.
Zoe Rothblatt 03:05
That’s awesome. Thanks, Shelley. And finally, what does it mean to you to be able to present your poster like this at ACR?
Shelley Fritz 03:11
It means so much. I’ve spoken with so many different people today, scientists, I’ve spoken with people from the industry, other patients too. I’ve shared the app with several people today who didn’t know about it and are interested in tracking their own symptoms. So it’s just been great to be able to share my story and share something that worked for me.
Zoe Rothblatt 03:29
Awesome, thanks so much for joining us on The Health Advocates. [Shelley] Thanks, Zoe. [Zoe] Well, everyone thanks for listening to this special episode of The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you like this episode, please give us a rating, write a review on Apple podcasts and definitely hit that subscribe button wherever you listen. And if you have any questions, comments, episode topics, please email us at [email protected] I’m Zoe Rothblatt live from ACR.
Narrator 04:01
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
American College of Rheumatology Convergence 2023: Live with Patient Eileen Davidson
Zoe is live at the American College of Rheumatology (ACR) 2023 Convergence and is joined by patient advocate Eileen Davidson who lives with rheumatoid arthritis.
Eileen discusses her patient perspectives poster about building a support group as a secure haven for people living with arthritis. Eileen describes how connecting with peers can transform the patient journey.
American College of Rheumatology Convergence 2023: Live with Patient Eileen Davidson
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Zoe Rothblatt 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Zoe Rothblatt and I’m live at the American College of Rheumatology 2023 convergence standing in the patient perspectives hallway of the posters with Eileen Davidson. Hey, Eileen, how’s it going?
Eileen Davidson 00:26
It’s going great.
Zoe Rothblatt 00:27
Why don’t you start by introducing yourself to our listeners?
Eileen Davidson 00:29
All right, well, my name is Eileen Davidson, or online people know me as Chronic Eileen. I’ve been a writer with CreakyJoints since 2019 and on social media a lot. I’m also a patient partner with Arthritis Research Canada and various other organizations. So research is something I’m really passionate about, as well as education.
Zoe Rothblatt 00:46
And we’re standing in front of your poster titled “You Can’t Get This From a Doctor: The Role of a Support Group for Young Adults with Rheumatic Diseases.” Can you tell us about the inspiration behind the poster and the main takeaways?
Eileen Davidson 00:58
Yeah, so I was made aware of a grant that the Arthritis Society was hosting. And I looked at it and I was like, I’m going to apply for this, but I needed to come up with an idea. And given that I had gone through the pandemic like everybody else, it it caused a lot of isolation and loneliness, especially being somebody who lives with a rheumatic condition. So I wanted to get out of that funk that the pandemic kind of had put me into. And then I also remember, like, the educational classes that I had gone through before, but they were really dry. They’re only like, clinician instructed, there was no time for patients to talk and just kind of sit there in a room and hear from them. But I could tell like you were able to talk a little bit, patients are really wanting to talk to each other, but there was no opportunity to. So it kind of dawned on me like, well, why not create a support group where I can have these perspectives of clinicians that I know through Arthritis Research Canada, come in, talk to us for two hours, focus on themes that are important to people living with arthritis, like fatigue, mental health, sleep, work, relationships, art, exercise, and why not make it fun and supportive? So the whole point of my program is to show support gives people more resources, information on their disease, I know a lot of somebody who participates in research, plus all the clinicians and researchers that I would involve. And then also just hearing from other patients, it’s so important, we speak a different language to each other. And that’s not something that a doctor can offer. So it was important for me to create this because I saw the need, especially for people and age range of 20 to 50s. Because there’s lots of support groups for children with diseases or their support groups, senior groups, things like that, but nothing for my age range. And I also wanted to make it fun. So we do different activities like exercise programs, and every session I pull up art supplies, because art is very therapeutic. So people can create art while we talk and do things. And yeah, it’s been a really rewarding experience. And the whole reason I’m here presenting at ACR about it is I’m hoping to influence other people in other organizations to create kind of grants like this or opportunities for support groups, because it is so needed. Online ones are great, but they’re just not the same as in person.
Zoe Rothblatt 03:07
Yeah, that’s awesome. I mean, it’s amazing to hear about you bringing the community together. I’ve known you online for so long, we’re finally meeting in person and it’s also nice to like get the sense of community here at ACR, what does it mean for you to be able to present this at ACR?
Eileen Davidson 03:23
Well, it definitely means a lot. It’s not easy to get here, you know, you got to have some insider information on when to apply, how to have support from other organizations, things like that. So it definitely means a lot. I take it very serious. I might want to educate others. I want to learn more. I want to inspire others, like I said, hopefully there’s gonna be some more arthritis social hours popping up elsewhere.
Zoe Rothblatt 03:45
And what’s been a highlight for you so far in the conference? [Eileen] Obviously, meeting you! [Zoe] Okay, what else?
Eileen Davidson 03:51
Well, that the patient perspective posters are actually in the poster hall this year.
Zoe Rothblatt 03:55
Yes. snaps to that, right.
Eileen Davidson 03:57
Yeah. So, I feel like the conference is only just started. I haven’t even seen many of the highlights yet. But I guess just being here, the people that I get to connect with the things that I’m going to be learning.
Zoe Rothblatt 04:10
Awesome. Well, thank you so much, Eileen, for joining us on The Health Advocates and enjoy the rest of the conference.
Eileen Davidson 04:15
All right, thank you so much.
Zoe Rothblatt 04:18
Well, everyone thanks for listening to this special episode of The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you like this episode, please give us a rating, write a review on Apple podcasts and definitely hit that subscribe button wherever you listen. And if you have any questions, comments, episode topics, please email us at [email protected]. I’m Zoe Rothblatt Live from ACR.
Narrator 04:45
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
American College of Rheumatology Convergence 2023: Live with Occupational Therapist and Patient Cheryl Crow
Zoe is live at the American College of Rheumatology (ACR) 2023 Convergence and is joined by occupational therapist and patient advocate Cheryl Crow, who lives with rheumatoid arthritis.
Cheryl discusses her involvement with ACR, shares her key takeaways from this year’s conference, and offers a sneak peek into her two upcoming talks centered around podcasting and helping her peers with rheumatic disease navigate the workplace.
American College of Rheumatology Convergence 2023: Live with Occupational Therapist and Patient Cheryl Crow
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Zoe Rothblatt 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Zoe Rothblatt and I’m live at the American College of Rheumatology 2023 convergence, and I’m here with Cheryl Crow. Hey, Cheryl.
Cheryl Crow 00:22
Hi. It’s so great to see you in person.
Zoe Rothblatt 00:24
It’s so great. We’ve been internet friends for a while, and we finally met. But why don’t you start off by introducing yourself to our audience?
Cheryl Crow 00:31
Yeah, hi. So I am an occupational therapist. And I’ve been living with rheumatoid arthritis for 20 years. And I run my own podcast called Arthritis Life and some patient education and support groups called Rheum to Thrive.
Zoe Rothblatt 00:41
And how did you originally get involved with ACR? What brings you here?
Cheryl Crow 00:45
Yeah, at first, I was doing a research project for occupational therapy on actually the power of social media groups for a community and connection between people with rheumatoid arthritis. And then I ended up meeting a whole bunch of other people at the conference and realized how much fun and how exciting conferences were. So now I just come to them all to learn.
Zoe Rothblatt 01:05
And you’re giving two talks this year. Could you tell us a little bit about both of them?
Cheryl Crow 01:10
Yeah, I’m on two different panels. So the first one is all about actually tips for starting your own rheumatology themed podcast, actually Zoe, you would be amazing on that panel too. And I’m going to be speaking specifically about using social media to amplify your podcast content. And then on Tuesday, I’m going to be on an interdisciplinary panel about meeting the comprehensive needs of people with rheumatic disease at work beyond just ergonomics and pain, but looking at how fatigue and psychosocial factors make work difficult for so many of us.
Zoe Rothblatt 01:41
And what does it mean to you to be able to present that ACR is both someone living with rheumatoid arthritis, but also as an occupational therapist?
Cheryl Crow 01:49
It’s really incredible. I’ve had previously been to occupational therapy specific conferences, which are fantastic, but there is something really special about a multidisciplinary conference. I’m talking to, you know, pharmacists, nurses, rheumatologists, nurse practitioners, patient partners, researchers and a nonprofit associations, drug companies. There’s just everyone’s here. And so there’s just a overall like vibe of excitement and enthusiasm. And I will say, as a patient, it’s particularly gratifying that I found rheumatologists and rheumatology providers have really been welcomed my patient voice like they’ll say, I want you to come on this panel, not just as an occupational therapist, but also because we honor your perspective as a patient. So that’s very gratifying.
Zoe Rothblatt 02:30
Yeah, that’s awesome. I mean, we’re standing here in the poster hall and the patient perspectives section. And it’s so fun, like coming up and meeting everyone tell me what’s been a highlight for you so far.
Cheryl Crow 02:41
Oh, my gash, literally, I haven’t even done very many things yet. And already, I can’t even choose a highlight. But I think I just saw a poster by Dana, that is all about like the power of creating your own data tracking for symptom tracking, she made her own tracking method. And for me, I really think the more practical tips and tricks I can take away from this conference, the better. So that really stood out to me, she actually had a QR code that you can download her exact Excel sheet tracker. On that same note, this morning, I went to a great session on oral health and tooth care for rheumatic disease. And I’ve been having some jaw pain lately. And they had some really specific tips, like ways to do like your own self massage for your jaw. And so you know, there’s just so many things like that here. And I’m looking forward to learning even more, especially about fatigue. That’s the main thing I made one goal for myself at this conference is to really have some specific takeaways for fatigue. And there’s some great posters on that tomorrow. So yeah, I guess you asked me for the highlight. I can’t even choose one already.
Zoe Rothblatt 03:40
No, I love that. I mean, yeah, the goal of us chatting now is to bring it back to the community for everyone who can’t be here. And I’ll say, a highlight for me, obviously, is meeting you. [Cheryl] Oh my gosh how can I forget? [Zoe]Also, this is audio only, and people can’t see that Cheryl made friendship bracelets. So I now have an arthritis lifeline. And it’s been so fun watching Cheryl, go around and share them with others. And just the sense of community that has brought to the conference and connecting patients together has been awesome.
Zoe Rothblatt 04:08
Awesome. Cheryl, thanks so much for joining us on The Health Advocates and enjoy the rest of the conference.
Cheryl Crow 04:08
You’re so kind and I do want to give Dr. Jeanne Liu who goes by Rheum_Cat on Twitter, I want to give her credit. That was her idea. I know you and I are both big Swifties she is too and she had the idea to connect the idea of friendship bracelets from Taylor Swift concerts to hey, why instead of just making these for concerts, let’s make rheumatology ones and yeah, it’s been a great icebreaker. I’ve met people in the elevators or on the escalators just being like, hey, do you want a bracelet? And it’s been really fun. So thank you. And yes, meeting you was delightful, of course.
Cheryl Crow 04:41
Thank you so much. You too.
Zoe Rothblatt 04:44
Well, everyone thanks for listening to this special episode of The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you like this episode, please give us a rating write a review on Apple podcasts and definitely hit that subscribe button wherever you listen, and if you have any questions comments episodes topics, please email us at [email protected]. I’m Zoe Rothblatt live from ACR.
Narrator 05:11
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
American College of Rheumatology Convergence 2023: Live with Patient Dana Guglielmo
In this special episode, Zoe is live at the American College of Rheumatology (ACR) 2023 Convergence and is joined by patient advocate Dana Guglielmo who lives with rheumatoid arthritis.
Dana shares about her patient perspectives poster where she uses data to manage her health information. She encourages patients to make their own “Dana’s Dashboard” and find what works for them to take control over their health information.
Episode Note:
You can download Dana’s dashboard template via the link below: https://docs.google.com/spreadsheets/u/0/d/1RPCM-4KZ_tXb7uZGxNirZ_l5aiXwZyLjKAZ1CIhpU2M/htmlview
American College of Rheumatology Convergence 2023: Live with Patient Dana Guglielmo
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Zoe Rothblatt 00:08
Welcome to The Health Advocates a podcast that breaks down major health news of the week to help you make sense of it all. I’m Zoe Rothblatt and I’m live at the American College of Rheumatology 2023 convergence, and I’m here at the patient perspective posters with Dana Guglielmo. Hi, Dana, how are you? Why don’t you start off by introducing yourself to our listeners?
Dana Guglielmo 00:30
Sure, thanks Zoe. My name is Dana. And I’m here at ACR presenting my patient perspectives poster, I am a patient with rheumatoid arthritis. And I live in LA.
Zoe Rothblatt 00:40
And tell us about your poster. I’m here looking at Dana’s data dashboard. How did you decide to put this together?
Dana Guglielmo 00:46
So I do public health research. And I work with a lot of data in my job. And I feel really confident managing large volumes of data, analyzing it, presenting it at work, but I realized that with my health management, I felt like I was like, very disorganized, things were falling through the cracks. I wasn’t getting my routine labs. And so I realized that I just wanted to change my approach. And it’s worked out really great. I’ve gotten much more organized, and I’m on top of things now. And I feel like I’m approaching it the same way I would approach my job.
Zoe Rothblatt 01:19
That’s awesome. And I love that you’re taking control of your health. I’m looking at your poster here, and I see different categories like vaccines or rheumatology. Could you walk us through the dashboard and how you decide what to put where?
Dana Guglielmo 01:31
Sure, absolutely. So with each specialty, I list the condition, a high level summary of how things are going like excellent, you know, needs help really needs an action, the status. And so when I go to all my different appointments, such as like a rheumatology appointment, I can I just show the dashboard. And yeah, if a lot of it is green, then it means that things are going really well. If it’s like yellow or red, then it means that you know, there’s changes that need to be made. And then as far as the provider information, basically, I just wanted to streamline this so that way, if I have an appointment, I can just click it, and then it’ll pull up directions. Or I can just click it and it’ll call the doctor. And then the other one is a treatment, I decided I never want to list out all my medications and dosages again. So I do it on my dashboard, and I print it out. And then I can just cut and paste it onto the new patient form. So it saved me a tremendous amount of time.
Zoe Rothblatt 02:26
That’s awesome. I always hate how little room there is to write all of your medications. This is so smart. And finally, could you tell us what it means for you to be here at ACR and what you hope people learn from your poster?
Dana Guglielmo 02:40
Sure. So it means so much to me to be here at ACR, I really value that ACR is really good about incorporating patient voices into research and practice as well as their clinical guidelines. So I feel really valued here. And as far as what people can take away from my poster, there is a template with like a starter dashboard, if you want to copy that and just, yeah personalize it, make it into something that works for you. Or the other thing is I really want people to take away that you should really identify like what your own strengths are and try to bring that into your health management. Like let’s say like you’re not a data person, but you really love art, you can turn it into like an art project or something that really speaks to you. So I hope that people take away that inspiration.
Zoe Rothblatt 03:25
That’s great. Thank you so much. And we’ll put a link to your dashboard template in the show notes so everyone can see it. Thanks so much for joining us on The Health Advocates, Dana.
Dana Guglielmo 03:34
Thanks for having me, Zoe.
Zoe Rothblatt 03:37
Well everyone thanks for listening to this special episode of The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you like this episode, please give us a rating write a review on Apple podcasts and definitely hit that subscribe button wherever you listen. And if you have any questions comments episodes topics, please email us at [email protected] I’m Zoe Rothblatt Live from ACR.
Narrator 04:04
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
S6, Ep 26- Diagnosis, Symptoms and Treatment: Understanding Polymyalgia Rheumatica with Dr. Grace Wright
The Health Advocates are joined by rheumatologist Dr. Grace Wright to learn about polymylagia rheumatica (PMR). Dr. Wright shares about the diagnosis process of PMR and how we must do better on shortening the time to diagnosis and getting patients treated. She also discusses common symptoms and telltale signs of PMR interfering in everyday life.
“I think the most important thing always in rheumatology is to remember the [patient] story is the most critical,” says Dr. Grace Wright.
This episode was made possible with support from Sanofi.
S6, Ep 26- Diagnosis, Symptoms and Treatment: Understanding Polymyalgia Rheumatica with Dr. Grace Wright
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Steven Newmark 00:17
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:22
Our goal is to help you understand what’s happening in the healthcare world, to help you make informed decisions to live your best life. Today’s episode is part of a special three part series focusing on polymyalgia, rheumatica or PMR. Over the course of these episodes, we will speak with a physician and a patient who deals with PMR in their daily lives so that we can get a better understanding of PMR and the journey that patients go on to find treatment.
Zoe Rothblatt 00:44
And today, we’re very excited to speak with a longtime friend of our organization and incredible advocate for patients and physician Dr. Grace Wright. Welcome, Dr. Wright.
Dr. Grace Wright 00:54
Thank you so much for having me. I’m so delighted to be here.
Zoe Rothblatt 00:58
Do you want to start by introducing yourself to our audience?
Dr. Grace Wright 01:01
Sure. So I am a consultant rheumatologist in New York City. And I see patients across the spectrum trained in New York, actually at the NYU School of Medicine and served as Clinical Associate Professor of Medicine there and really spend my time now in my practice, as well as leading the amazing organization, the Association of Women in Rheumatology, in which we help fight for the rights of our physicians and our patients and educate across the spectrum about our diseases and the importance of equity in the management of rheumatic diseases.
Zoe Rothblatt 01:34
Well, thank you, Dr. Wright, for all you do, and for joining us today to help us better understand polymyalgia rheumatica.
Dr. Grace Wright 01:40
Oh, it’s my pleasure to be here.
Steven Newmark 01:42
So let’s begin. Dr. Wright. Thank you, again for joining us. So why don’t we begin with the basics, what exactly is PMR, and how is it different from other types of arthritis?
Dr. Grace Wright 01:50
So as the name polymyalgia implies, this is a disease in which there is stiffness and achiness as people perceive it in their muscles, but the important muscles are in the shoulder area and in the hip area. So you may feel pain and stiffness that’s in the neck, the shoulders, the upper arms, or in the hip and the thighs as well. And most often, this can be something that sort of gradually builds. But for some people, they get up one day and they’re stiff. The things that make you aware of what that stiffness is, is you have difficulty getting out of a chair, you find yourself using your arms to push up because your hip is so sore, or raising your arms up to brush your teeth, you know, get some food brush, your hair. So it’s a sort of thing that if you don’t really think about it, you don’t realize it’s happening until you walk in sort of with this, “oh my gosh, I have so much difficulty I need to stretch, and I’m in pain all the time.”
Steven Newmark 02:44
So a quick follow up is PMR curable or is it chronic?
Dr. Grace Wright 02:47
So PMR can be managed quite effectively. And for many people, we can treat them get rid of symptoms, get them off medicines, and they go along quite happily, others may need to be on a longer course of medicine. In fact, this disease tends to occur in the later ages. So in late 60s and 70s. And we say if you’re younger than 50, then we should think of something else. But this is a disease that is typically seen in 50 years and older. So we have to think of other things that this could be is this osteoarthritis, is this something that’s affecting the spine and causing pinched nerves? A variety of things, but really, that’s really how that starts and how we manage it.
Zoe Rothblatt 03:25
Can you tell us a little bit more about that diagnosis process? And is it easy to diagnose someone with PMR? You’re saying it could mimic some other conditions perhaps? And yeah, tell us how easy or difficult and what kind of things you look for.
Dr. Grace Wright 03:38
Yeah, so you know, typically a person would present to their primary care provider saying I have pain or stiffness in my hips or my neck. And that is such a general complaint that often the first thought is this person has arthritis or a pinched nerve. And so they go down that path, things that make it a little clearer for us or when we look at the blood test. And we see for instance, that the blood count may be low. So the red cell count or the hemoglobin, or hematocrit, those are all measures of the same thing that there’s a mild anemia, or that the things that we use to measure inflammation in blood, such as the sedimentation rate and the C reactive protein to other blood tests, those can be quite high. And so when we look at the high inflammatory markers separate and CRP, a mild anemia and the complaints, then polymyalgia rheumatica rises to the top of that diagnosis. But just seeing the complaints doesn’t often make it clear because many other things can sound the same, but present quite differently when you look at the bloodwork.
Zoe Rothblatt 04:36
And have you noticed any shortcomings in the diagnosis process or the treatment process when it comes to polymyalgia rheumatica?
Dr. Grace Wright 04:44
Yeah, so one of the biggest issues we have is that there’s a huge delay between when that person feels the first symptoms and when they get to a rheumatologist to get proper treatment because for rheumatology, this is how we think right we put PMR kind of much higher on the list of things that we’re thinking about. But a primary care provider may really sort of believe this is arthritis of the spine. And for some patients, if it’s not so clearly localized, you start to think, well, maybe it’s rheumatoid arthritis because I can give you pain and shoulders and pain in the hips. But that tends to involve hands and feet as well. There’s another area of diagnoses in which this can evolve called vasculitis, where the inflammation is actually in the blood vessels. And there in fact, some people who start off as PMR and evolve into giant cell arthritis or one of these kinds of vacular diseases. So there may be quite a length of time between when you first feel symptoms, and we come up with the right name. And that’s time that we want to shorten so that you can get on treatment much more quickly.
Steven Newmark 05:45
Moving over to prevalence, how prevalent is PMR compared to other types of arthritis, such as rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis.
Dr. Grace Wright 05:55
Yeah, so that’s a great question. If we do an age cut and say, if we’re looking at the 60 and 70 year old, it is probably the most common of our inflammatory arthritides, because that’s where it is, it’s really in the above 50, whereas rheumatoid, you’ll see made 20s and 30s, and 40s, and even some teenagers and children with rheumatoid arthritis. So if you look at that age group, and you say there’s inflammatory arthritis, that is just starting PMR should be the top of the list, you know, because it’s about 750,000 people in the US about two thirds of who are women and 1/3 men, it’s a little bit more prominent in women, a bit more prominent in people of Caucasian descent. But again, it has not really been looked at in those of other descents such as Asian and African ancestry. So we may be underreporting in that group. But again, it is not an uncommon or rare disease in an older group of people. And
Zoe Rothblatt 06:48
Dr. Wright, as someone who treats PMR patients, what’s your biggest advice for people who are seeking help for PMR? You mentioned there’s a big gap in time to diagnosis maybe what are some things that patients should bring up with their doctor if they’re experiencing and how can they ease their pain in everyday life?
Dr. Grace Wright 07:08
Yes, sure. So there are definitely strategies that the patient can do. But there are lots of things that we can do as healthcare providers. And I think the most important thing always in rheumatology is to remember the story is the most critical. So I want to know, when did you have this? When does it bother you the most? Is it when you get up in the morning that you’re stiff? How are you functioning in your daily things? The part that’s a little deceptive is we accommodate around our pain and dysfunction. (Zoe) Right. (Dr. Wright) You find yourself doing things differently, you say, well, no, my shoulders work. But you can’t get it above your head! Well, then I just lift my whole body up, or I put this on a lower shelf. It doesn’t make it go away. It’s just that we’ve learned to sort of work around it. So it’s really important to think about have I changed the way I function in order to function? That becomes a key clue to me that there’s something wrong, that my hips are stiffer that my hips hurt, am I doing fewer walks? Am I not taking the train or walking upstairs, because I’m avoiding pain? Not just saying, oh, I don’t have pain, because I figured out how to deal with it. That’s just having the disease control you, not you controlling yourself and living outside of that. So it’s important to really sort of think through that particular thing, because we hide things from ourselves. And then thinking about am I more fatigued because fatigue comes with this so that I can come in with a list of carefully thought out things. Now, if somebody mentions that they think you have PMR, ask to see a rheumatologist because we are a lot faster at honing to this diagnosis compared to all of the others that it could be. What I really don’t like to see somebody who’s 60 years old, sort of popping a lot of nonsteroidals over the counter pain medicines, because those come with risks, and they don’t actually get rid of the disease. So we have more effective therapies to do that. And this way, we can shorten the time on drug shorten the amount of time you’re suffering and get you to a more effective path of treatment.
Steven Newmark 08:59
Well, yeah, that kind of resonated with me, I know you didn’t say it like this, but sort of covering up an injury or an ache and just compensating in different ways. And instead of actually addressing the need, I think that’s really important for folks to understand that those things can be addressed rather than worked around. In fact, you know, this entire conversation has really been enlightening and helpful. One final question, Dr. Wright, before we wrap up what resources are currently out there that can help patients cope with the physical and mental challenges of living with PMR?
Dr. Grace Wright 09:26
Well, for certain there are lots of resources in the patient space and in the physician space, right? So going to the American College of Rheumatology, they have patient the material for what the symptoms are and how this treated. Global Healthy Living Foundation has lots of resources to help us think through not every pain is the same pain. Not every pain is the same diagnosis. Arthritis Foundation also has important resources, but I think really speaking with your doctor, with your health care provider to say is this something that is appropriate for my age or not? So that we can get you because there really are lots of things that we can do so that you’re not just living with the disease, you’re actually conquering the disease. Right? For me, the way that I like to approach is how do I get rid of this so that I could get on with life different from how do I sort of live with this and modify my life around it?
Dr. Grace Wright 09:27
Yeah, absolutely. Well, we’re hopeful that podcasts like this and other resources that we put out, and others that you’d mentioned will add to help benefit patients moving forward. And we thank you, again, for joining us. And we learned a lot, and I’m sure our listeners did too. Before you go. Is there anything you’d like to discuss while you’re here today?
Dr. Grace Wright 10:27
Sure. Just to say that, you know, one of our focuses, we’re aware of the was using acronyms, right, this Association of Rheumatology, right. So we do a lot of work to really drive the importance of equity and advocacy for all patients. I mentioned that sometimes we underestimate prevalence of disease, because nobody’s looking at a certain population of patients. And when we look at our patients of Latin ancestry of African ancestry, we’re not actually asking these questions. And sometimes these diseases go unrecognized. So be a part of the community in which we’re researching and asking and aware is doing a lot to try and get clinical trials and research to people who are actually suffering from these diseases so that we can make sure that we’re asking the right questions, and that we’re creating the right therapies that will work for everyone wherever they come from, or what their ancestry is. So check us out. We’re really happy to partner with Global Healthy [Living Foundation] on a variety of these initiatives, because equity matters.
Steven Newmark 11:29
Yeah, absolutely. It’s certainly a topic that we’ve discussed a lot. And we’ve spoken a little bit about AWR as well on this podcast. And so our listeners hopefully will know the great part that you guys are doing already.
Zoe Rothblatt 11:39
Thank you so much for joining us today and for helping break down PMR. I know while there are a lot of resources out there, there’s still more conversation to be had. And we really appreciate your time. Thank you, Dr. Wright.
Steven Newmark 11:51
Yeah. Thank you so much.
Dr. Grace Wright 11:52
Thanks so much.
Steven Newmark 11:55
Well, Zoe, that was a great conversation I thought we had with Dr. Wright. And I know I certainly learned a bit about PMR. And hopefully we can educate some people about this disease.
Zoe Rothblatt 12:04
And I really liked her tips for patients to pay attention to about your pains and how you’re interacting in daily life. Really great stuff there.
Steven Newmark 12:12
Totally yeah, that definitely hit home. And the idea of compensating in other ways is, I guess, a little bit of a bandaid, if you will, but really got to address the underlying issue.
Zoe Rothblatt 12:21
And yeah, just by recognizing your symptoms is like a part of advocacy for yourself, and then you’re going to your doctor and tell you about is a really big step and just encourage everyone to advocate for themselves in that way.
Steven Newmark 12:33
Definitely. Well, we hope that you took something from this podcast as well. And before we go, we definitely want to encourage everyone to check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 12:45
Well, everyone thanks for listening to The Health Advocates a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating and review on Apple podcasts and definitely hit that subscribe button wherever you listen. I’m Zoe Rothblatt
Steven Newmark 13:00
and I’m Steven Newmark. We’ll see you next time.
Narrator 13:06
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
S6, Ep 25- Your Guide to Open Enrollment: From Deciphering Insurance Jargon to Making Informed Choices
The Health Advocates discuss the latest news on the change in insurance coverage of COVID-19 treatments and a recent approval of a meningococcal vaccine. For the main topic, The Health Advocates dive into everything you need to know about open enrollment for health insurance. They cover common insurance terms, the difference in plans, what enrollment numbers look like, and what you should look out for when choosing a plan.
“Many people are surprised to find out that even within the same ‘metal tier,’ the range of services and network coverage can differ significantly. That’s why it’s crucial to read the plan details, not just the price tag,” says Steven Newmark, Director of Policy at GHLF.
S6, Ep 25- Your Guide to Open Enrollment: From Deciphering Insurance Jargon to Making Informed Choices
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates, a podcast that breaks down and major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:21
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:28
And today, we’re going to talk about open enrollment for health insurance. But as usual, we do have a few news updates first.
Steven Newmark 00:36
Well, it’s November, which means that insurance coverage is changing for COVID treatment.
Zoe Rothblatt 00:40
That’s right. So coverage of COVID treatments, including Paxlovid will transition to commercial plans, as opposed to through the government. It’s unclear how much patients will have to pay through copays right now, it’s going to be one of those wait and see, as it rolls out.
Steven Newmark 00:56
Right. There are still millions of free doses that have been procured by the federal government that are likely to be available across the country, in hospitals, doctors offices and pharmacies for a short period of time until those treatments run out.
Zoe Rothblatt 01:07
And let’s also not forget that those who are uninsured and those with Medicare or Medicaid coverage, we’ll still be able to get Paxlovid at no cost until the end of 2024.
Steven Newmark 01:18
Yeah, and there will also be patient support programs sponsored by the pharmaceutical manufacturers to help patients as well.
Zoe Rothblatt 01:24
That’s a really good point. And also just something to note is that, you know, when the new COVID vaccines began rolling out, there were some reports that insurers weren’t covering the shots. But it was really because they hadn’t uploaded their codes in time. Hopefully, we don’t see this with Paxlovid but I did hear about a few people in the community going, you know, shortly after it was approved and encountering that issue. So if you do have that issue, just call the insurance company and double check there.
Steven Newmark 01:49
Good to know, good to know. Yeah, I want to take a moment to just remind listeners that GHLF remains steadfast promoting accurate evidence based insights regarding vaccines and vaccine research. We’ve gathered all of our vaccine resources in one place, it’s at ghlf.org/vaccine-resources.
Zoe Rothblatt 02:07
And we also have the Informed Immunity podcast as part of this resource, which is really cool. It’s a new series that addresses the most pressing topics in vaccines, including, you know, debunking myths and advocating for public health. So I definitely recommend everyone to check these resources out. And you can find the links to both of our vaccine series and the page in the episode description.
Steven Newmark 02:30
Excellent. Yeah, what else is happening in the world?
Zoe Rothblatt 02:33
So another more vaccine news actually, the FDA approved a meningococcal vaccine. This basically combines two existing meningococcal vaccines into one shot. So it’s called Prenbaya, I think that’s how you pronounce it, and it’s the first vaccine that in you know, one vaccine, it protects against the five most common meningococcal bacteria groups.
Steven Newmark 02:56
That’s fantastic news. Really good to hear, it’s always good when more vaccines become available. So that’s great.
Zoe Rothblatt 03:03
Yeah, and just you know, a reminder, what is meningococcal? It’s rare, but it’s a bacterial infection that can affect the brain, spinal cord, and bloodstream. And what’s really dangerous about it is that it can progress from mild flu like symptoms to death in a matter of hours, and survivors are often left with long term disabilities. So, it’s a really important vaccine to have on the horizon to prevent such serious illness.
Steven Newmark 03:27
Great, great. Well, let’s talk about open enrollment, like we mentioned, it’s that time of year, and it’s an important time of year time to start looking into plans for 2024 and make decisions that will impact your health access issues.
Zoe Rothblatt 03:41
Yeah. So you know, let’s start with the basics. You mentioned open enrollment starts November 1, and this is for federal and state exchanges. Some of the states have like a little bit of different dates, so it’s good to just double check. But I guess you know, the earlier the better to ensure that you’re getting your coverage.
Steven Newmark 03:58
Yeah, most states it tends to run through January 15. But again, check your particular state, California, for example, goes until January 31. But Idaho ends on December 15. So something to keep in mind.
Zoe Rothblatt 04:11
And in most states in order to get coverage that kicks in on January 1 in the new year, you want to be enrolled by December 15. So just also think about when you need your coverage to start.
Steven Newmark 04:23
And so and how do you enroll, where do you go to enroll?
Zoe Rothblatt 04:25
There’s a one stop shop healthcare.gov. Most states I think about 32 operate on the federal marketplace, some states have their own, so, that’s I think 18 states and Washington D.C., but you can go to healthcare.gov and you can find that information out once you start inputting information and it will lead you to the state exchanges website if you need to go there. And there’s also a number on the site where you can call and talk to a broker and get some one on one help like that.
Steven Newmark 04:52
Excellent. And let’s talk a little bit about the importance of health coverage. You know, at its most basic, it helps pay for both foreseen care that we all need, as well as unforeseen care that we all need.
Zoe Rothblatt 05:04
Right. I mean, I’m someone that lives with two chronic diseases, I use my health insurance a lot. I’m hitting that deductible fairly quickly. And I’m so fortunate that I have a plan that helps cover my meds, covers my doctors. But on the flip side, there’s also preventative care that is really important, like we’re talking about getting vaccines and being really proactive about your health and insurance coverage really comes in handy there.
Steven Newmark 05:29
Right.
Zoe Rothblatt 05:29
You know, a yearly physical, all those things.
Steven Newmark 05:32
Yeah, you mentioned hitting your deductible early. I think that’s important, when trying to pick a plan, it can be quite confusing. Some plans, the monthly fees are high, but they may have a lower deductible. Some plans are the opposite, that fees may be lower, but they have a higher deductible. So it takes a while for that to kick in.
Zoe Rothblatt 05:50
Well, you know, let’s talk about that for a minute. So the monthly fees are called premiums. This is just like the basic rate you pay every month, kind of like paying rent for your apartment.
Zoe Rothblatt 06:00
The deductible is that amount you’re responsible for before the insurance totally kicks in.
Steven Newmark 06:00
Right.
Steven Newmark 06:06
Right.
Zoe Rothblatt 06:07
And then we have things like copay, which is a portion of the doctor visit, the medication, the service that you’re responsible for. And that’s a flat rate, and coinsurance is similar to a copay, but it’s a percentage of that. Those are just some like basic terms to keep in mind as you look at plans.
Steven Newmark 06:26
Right. So again, it behooves you to take the time to figure out what you expect your costs to be your foreseen costs, so to speak. If you have a chronic condition, it might be simpler to figure that out. And if you’re expected to have high medical costs, you have to weigh that in whether you want to get a plan with a low deductible and pay a higher monthly premium.
Zoe Rothblatt 06:46
And, let’s not forget how important it is to check for coverage for your providers, your local hospitals, the medications you take, even if you’re going to enroll in the same plan as last year, it’s really important to just double check that that the coverage is still there.
Steven Newmark 07:02
Totally. Yeah, that’s perhaps the most important thing actually is making sure that your medications and your doctors will be part of your plan for 2024. Yeah, so that’s important stuff. What do we expect the numbers to look like in 2024?
Zoe Rothblatt 07:14
So for last year, an estimated 16.3 million signed up during open enrollment, which is, you know, that’s a great number. We talked a lot about how people this year lost Medicaid coverage because of the change in eligibility from COVID. So many of these, you will now be eligible for marketplace plans. So we could probably expect that number to boost and hopefully they’ll enroll you know?
Steven Newmark 07:36
Yeah, yeah, I guess we’ll take a look at that and see what that looks like.
Zoe Rothblatt 07:39
Also interesting to note is that, you know, we always heard how 26 is the cutoff age to get off your parents plan.
Steven Newmark 07:46
Right.
Zoe Rothblatt 07:46
Apparently now, rather than lose coverage on your 26th birthday, you get coverage extended through the calendar year in which you turn 26.
Steven Newmark 07:55
I guess that’s good news. If you’re turning 26 Next year, and you’re on your parents plan. So this year, there’s gonna be about 100 plans to choose from, for 2024, which is down from about 114 that were available in 2023, according to CMS.
Zoe Rothblatt 08:09
Yeah, I think the goal here is like sometimes too much choice is really confusing. And it’s just more, you know, like whittling it down. But while they’re doing that, I think there’s a larger range of insurers they could choose from. So while it may seem like the plans are being reduced, there’s still more choices within the plans.
Steven Newmark 08:28
Right, right and let’s talk about the plans. The Affordable Care Act plans, the marketplace plans are still grouped into the color tiers, bronze, silver, gold and platinum. And that’s based largely on how much cost sharing they require bronze plans offer the lowest premiums, and it goes in ascending order all the way up to the platinum.
Zoe Rothblatt 08:45
And let’s also not forget that there’s a lot of subsidies given on a sliding scale based on income. So we know that subsidies were enhanced during the pandemic and the Inflation Reduction Act extended that. There’s actually an online calculator on healthcare.gov that can provide subsidy estimates along with the tax credit estimates. So you know, as you’re looking at these plans, plug into that calculator and see what makes most sense for you.
Steven Newmark 09:11
Yeah, excellent, excellent. Well, a lot to think about. It’s an important time when you’re choosing your plans. We should also say that if you’re getting an employer based plan, oftentimes there are decisions to be made with those plans as well. You may have different options. So this is what we were discussing about premiums and deductibles doesn’t just hold for marketplace plans, but also for the general employer plans as well.
Zoe Rothblatt 09:35
You know, just a little anecdote if you’re hearing all these words and feeling confused, you’re totally not alone. I remember when I was first diagnosed with my chronic illness, I was 20 and I got a bill and I called the doctor’s office and said, why do I have this bill? And the person said, you haven’t met your deductible and I was like, could you hang on for a second? I’m like whispering to my mom. Mom, what’s the deductible? I had no idea what was going on, and I was learning on the spot.
Steven Newmark 10:02
I know.
Zoe Rothblatt 10:02
And now years later I know what I’m talking about, but there was definitely a learning curve. So if you’re feeling that too, you’re not alone.
Steven Newmark 10:09
Totally you need like a mini PhD in healthcare or something to understand what’s going on.
Zoe Rothblatt 10:15
Yeah. And oftentimes, you know, like you’re diagnosed with your chronic disease, you’re trying to figure that out plus become a health insurance expert at the same time and it’s a lot at once.
Steven Newmark 10:24
Yeah, no, look, we all have different areas where we have more knowledge, those of us who have dealt with health care, perhaps have more knowledge in this space, which is good. And then we all have areas where we just don’t have as much knowledge, you know, frankly, when I need car repairs, I have no idea what the heck they’re talking about. That’s just how it goes. And I could try to become a little more learned in the subject. But it’s just not something I deal with on a regular basis. And as a result, I am far from an expert on that. But I do understand health care and health insurance.
Zoe Rothblatt 10:52
And there’s so many resources out there to help just as I mentioned before, you know, you can call up on the marketplace and have a broker help you walk through it. So even if your knowledge is limited, try not to be intimidated and reach out to those who can help you including our 50-State Network.
Steven Newmark 11:09
Absolutely. Absolutely.
Zoe Rothblatt 11:12
All right, Steven that brings us to the goals of our show. What did you learn today?
Steven Newmark 11:16
Oh, well, I learned about the new vaccine pentavalent vaccine that you had mentioned, it was just FDA approved. And that’s always good news as more vaccines become available to help stop the spread of diseases.
Zoe Rothblatt 11:26
And yeah, I was just reminded of the importance of health care coverage and you know the difference in the plans that the Marketplace offers.
Steven Newmark 11:35
Well, we hope that you’ll learn something, too. And before we go, we want to encourage everyone to check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 11:43
And if you have any questions, comments, episode topics, definitely email us at [email protected]. Well, everyone, thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating write a review on Apple podcasts and hit that subscribe button wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 12:05
I’m Steven Newmark. We’ll see you next time.
Narrator 12:10
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
S6, Ep 24- The Road to an IgG4-RD Diagnosis: How Nika Beamon Advocated
The Health Advocates are joined by Nika Beamon who lives with IgG4-related disease (IgG-RD), a group of fibroinflammatory conditions that can impact various tissues, often leading to tumor-like growth or organ dysfunction. Nika shares her 17-year journey to an IgG4-RD diagnosis, including how she advocated for herself. She offers valuable tips for fellow chronic illness patients, highlighting the unique considerations people with autoimmune diseases have in everyday life.
“So there’s so many things that do alter your life. But at the end of the day, you got one life, so you got to live it, and so I just choose to live it regardless of the fact that this is how it’s built,” says Nika.
This episode was made possible with support from Horizon Therapeutics.
S6, Ep 24- The Road to an IgG4-RD Diagnosis: How Nika Beamon Advocated
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:21
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:27
Today on The Health Advocates we’re joined by Nika Beamon. Nika has come on to talk about her journey with IgG4, you know, getting a diagnosis and how she’s advocated for herself.
Steven Newmark 00:39
All right, let’s get into it.
Zoe Rothblatt 00:41
So welcome, Nika. I’m excited to have you on The Health Advocates. Why don’t you start off by introducing yourself, telling us a little bit about you and your diagnosis,
Nika Beamon 00:50
It started somewhere back in college. So, I’m Nika Beeman and I’ve actually written extensively about my illness. But I didn’t start writing about it until about I would say about 10 or 11 years ago, it was a condition that I was aware that there was something wrong with me since college. So we’re talking about the late 90s, I was aware that I was not the same given the fact that I was an athlete and did all of those things and at the time, only weighed about 122-125 pounds. It was very strange to me that I was tired all the time running spontaneous fevers, having joint pain, something I didn’t have, unless obviously, I did too much in the weight room, I did not have that issue. And so in college, we started to realize my junior year in college that something wasn’t quite right. But of course, you go to the clinicians there, and they tell you, you have mono because everybody has mono or you have something common but all of those tests always came back negative. And so we sort of just decided, well, there’s something wrong, but maybe it’s not that major, just kind of blew it off. But as my 20s went along, I got sicker and sicker. And we’re like, this is strange, other things started going wrong and we’re like, okay, so we got the spontaneous fevers, now we’ve got the joint pain, now we’ve got other strange things happen. And we really need to figure that out. At some point, you know, again, over the years, I’ve had 37 procedures. I’ve had everything from I’ve had to do my stomach twice. I’ve had extensive gastro reflux disorder, I’ve had pancreatitis, at some point, I’ve had, you know, I’ve got non-alcoholic fatty liver disease and at some point, they thought my liver was struggling and having issues. So it’s been so many things. I’ve had pseudo tumors, just cysts that seem to appear random places, and chronic lymphadenopathy, where my lymph nodes had been swollen. You know, at one point, it was swollen for months at a time to the point where I actually ultimately had seven surgical lymph node biopsy and removals one year, and then had to repeat it the following year, because they suspected cancer. So it was one of those things where you know, and then in my 30s it got even more interesting, I had two strokes, which they couldn’t figure out. Two TIAs, two trans ischemic strokes, and they could not figure out why that was either. And all of a sudden, all of these things were just going wrong. And from the outside, it did not appear that that should be the case. I had no family history of any real illnesses and so it became really quite interesting to figure out. The one thing I did always have was the host of doctors thinks something was wrong, just not knowing what it was. My frustration was that generally they would test me for the same things over and over and over again. And most of them were just based on my appearance because just from the outside appeared to only be an African American female, that’s all they would test me for. You must have lupus, you must have sarcoidosis, you must have rheumatoid arthritis, you must have something that’s sickle cell anemia, you must have something that’s common for people who are African American. And even though I did not, they would just repeat those tests because they didn’t know what else to do. I think that again, what scared me straight and ultimately, what made me write the memoir that I wrote about my journey to find a diagnosis, it took me 17 years to do it, was that what I realized was that part of it was my fault. Because I did not really A. advocate for myself, and B. do the things that as a patient we’re not taught to do but you have to do, which is have all of your medical records. Because when they told me that I might die in my early 30s well that you know, it’s enough to make anybody sort of go like how did I get to this point? Like the lymph nodes were swollen all of this time, and I didn’t say hey, we got to do more tests or anything, because I assumed that they knew what they were talking about. What I also assumed at the time was that my doctors were talking to each other. We live in a different age now where there are patient portals, and so they can see and talk to each other. But back then they did not do that. And so I had test results and I was talking about other parts that were going wrong that they didn’t see. And so nobody was able to put all the pieces together simply because I never provided them with all the pieces. You would think it’d be something that somebody say what other doctors you’ve gone through. But again, when it comes to your health, I learned that I don’t expect anybody else to care more about it than I do. And so I learned to collect my records, drag my records everywhere. And for me, that’s all it took. I brought literally a collection of the records of my condition over the years, including the scans, the X-rays, and all of those things and the reports and I said, well, I’m gonna sit down and figure out who the best rheumatologist is. It seems like it’s autoimmune. A couple of people have said that, how do I figure this out? And I said, well, I’m a journalist, it’s easy. You go to figure out who’s the best, who can I talk to that’s the best in this field. And so that’s what I did. And I went to like the Castle 10 Guide and other guides of the best doctors and hospitals in the country. I just started making appointments. And on my third appointment, I saw a rheumatologist here in New York, Dr. Paula Rackoff, who at the time was in the top 10, for rheumatologist in the country. And I brought in my files and she said, okay, leave them and come back in a week. And I thought, oh, that’s the end and all I’m gonna hear from her. And sure enough, I come back in a week, and she writes down on a piece of paper, you have this, I think, and I thought, wait, what? Nobody’s ever said they thought that I had anything.
Zoe Rothblatt 05:35
Yeah, what was that moment like for you? When you were finally like, given a name for something?
Nika Beamon 05:41
First, it was relief. And then I looked at the paper was like, what the hell was that? I had no idea what IgG4-RD was, it meant nothing to me, it meant nothing to anybody that I told it to. They’re like, what is that? And so we started looking into what is that? And to my frustration, the first funny thing was A, that you realized that you could do a blood test to test all of your IgG enzymes one through four and it’s a simple blood test, somebody just has to know to run it. And the second thing was that I had left Boston, I had gone to Boston College, I had left Boston for New York when I was working and the biggest IgG4 center in the U.S. is in Massachusetts at Mass General Hospital. So it’s like I was down the road the whole damn time. So that was incredibly frustrating to realize that even with that center being there, either nobody knew what the condition was, they didn’t expect me to have it, or they didn’t know how to look for it. So that was incredibly astounding. I eventually did go to Mass General and met Dr. Stone and we talked about my case. But I ultimately have now for the last 20 plus years, still been with Dr. Rackoff here in New York City, because it’s easier for me. But you know, it was pretty much the same. And over the years, what I’ve learned is that drugs get better, and people get better, you get better at caring for yourself, and so sort of stuck with it. But I never told anybody. So I was working in TV since I got out of college since I was 20 years old. And I never thought that it was somebody else’s problem that this is the way I was built. And so I never told anyone. And then back in 2014, Rita Wilson, who is Tom Hanks’ wife, started a column at the Huffington Post and she asked for stories. She was asking for stories, almost like survival stories and she was asking for stories. And so my coworker and one of the only people who actually knew what was going on with me said you should write a story. I thought, There’s no way I tell other people story, don’t tell my own. But I decided to send the story anyway. And I sent the story. And I got a note back saying we’re going to run your story. And then there was panic, because I thought, u oh, I take medication every day. I’m sure my co workers probably think their vitamins. I do have a lot of doctor’s appointments, but they don’t know what they’re for and now they’re going to know, this is my life that this is who I am. And so I called my boss and I said, hey, look, I want you to know, I wrote this article for The Huffington Post, it’s coming out and before anybody stumbles across it, because that’s what they do here, I’d like to share it with the staff and so that’s what I did. And I found a whole bunch of people who spend the whole, you know, days investigating other people’s lives very shocked that they knew nothing about the person sitting next to them. And my co worker said, you see the shock and amazement here, it’s something you need to share with other people. And so I started for once writing something other than my blog more about me. And so I wrote my memoir, Misdiagnosed: The Search for Dr. House, and I called it the search for Dr. House because after I had my stomach redone… The second time I had to redo, I was at home and I was bored and my now husband says to me, did you ever watch the show about a master diagnostician a guy who can diagnose the rarest conditions? Wouldn’t it have been cool if you had that? And I was like, oh, my God, it would be cool, but I never heard of the show and so I started watching the show and I was like, how come there are not more doctors and every hospital doesn’t have a department like this? And so that’s how it ended up in the title of my book and I tell people how I went through the process of trying to figure out what was wrong with me and then figuring out you know, what you need to do in order to save your life and in the back, I decided to give people some tips about how to save themselves, because I thought that was important.
Zoe Rothblatt 08:59
And can you share some of those tips with us? Again, looking back, what are some of the telltale signs of IgG4-RD that you think people should know? And how can somebody else avoid these like 17 grueling years that it took you to get a diagnosis?
Nika Beamon 09:14
What I’ve learned over the years is that autoimmune diseases are the hardest to diagnose, because the symptoms mimic so many things. And so that’s so difficult, because just saying you’re tired, because most people just say I’m tired. You don’t say like I feel like I’ve run a marathon and I’m standing still. We’re not used to being A, that dramatic when you go to the doctor and B, sharing that much. A doctor for most people is a stranger, somebody you see once or twice, maybe twice a year, unless something else goes wrong. And so it’s not something that we’re all taught or familiar with. You’re also never taught to be a good patient. And somebody said to me once what does that mean? I said being a good patient also means that you do your homework meaning you make sure that the doctor is appropriate for what’s going on with you, that you have a doctor who’s actually listening to you. The doctor can’t listen to you while you’re there, then make sure they have a way to reach them outside of office hours in case something else pops up or something else you remember. We don’t remember to keep a diary of the symptoms, like when did the pain start and you go, I don’t know, because you don’t know. So you got to write it down. When the pain starts, write it down, you got to write down your symptoms, because you’ll forget one. If you can’t feel comfortable talking to your doctor, then bring someone with you. Have your records, you know, if you don’t want to carry them with you that join patient portals. It’s important for two reasons. Not only can your other doctor see the information, but you can also see them yourself. So you can look at test results and see when they’re out of range, you can look up what those test results are telling. And one of the other important things and one of the things that I faulted myself for is when you know something’s wrong, your gut tells you something is wrong, no one knows you better than you.
Zoe Rothblatt 10:39
That’s so true.
Nika Beamon 10:40
So when your gut tells you something is wrong, don’t give up until you get at least an answer as to what that is. Lik in my case, in a lot of cases, with autoimmune diseases, there is no solution, meaning there is no end in sight, necessarily, because there is no cure for most of them. But what you can do is get better treatments, it’s also part of your job, once you find out what you have, is to keep up with what the treatments are. And also pay attention to the side effects of the treatments that you’re getting. I spoke once at the Autoimmune Disease Association’s conference in Detroit and a young woman had a very similar condition to mine and she was also taking a drug called Plaquenil, which a lot of people heard about during the pandemic, we take it for other reasons. And it can cause retinal detachment and one of the things they tell you, when you first start it is make sure you go see an ophthalmologist to check out your eyes, not just a regular old eye doctor, but make sure you check out the retina to make sure it doesn’t detatch because it can do so. And she said she started feeling pain in her eyes but she never went to check it out. Because the drug itself made the rest of her body feel better, so she just blew it off. Well, now she’s going blind, because retinal detachment is something that will make you go blind. And I thought, why would she sit there and ignore the fact that it’s affecting your vision, because we do sometimes because your doctor said take this and you don’t want to cause either problems or make waves or it’s making you feel better in another way that you ignore other symptoms that can be causing problems. So it’s always again, important to update your doctors when you have a reaction. I know for me with my stomach and stuff like that over the years, I found that I was taking a drug called Reglan because it improved the ability for me to swallow. And it gave me facial tics and facial seizures and so I don’t take that drug anymore. So you can’t be afraid to tell them what’s really going on with you. And I also tell people, if you have any level of pain, please don’t look at that happy face chart and ever hit zero because what it does is, it sort of makes them disregard your pain. We all want to be brave, we all want to be these heroes, be like I can take it. You don’t have to take it the world is not necessarily designed for you to just take it. You do need to let them know that you’re in pain so if always, never just pick the perfectly happy face on the chart. And you also can’t forget to ask for help financially, these diseases are debilitating for most people. And so you can’t forget to explain to your doctor if they give you a pill when it’s very expensive, to say, does this come as a generic, is it okay, if I take them? Do you have any samples? How about do you have any samples? These things are important, sign up for the discount cards to get your medication, you don’t want to skip it simply because you can’t afford it, you just got to find another way around it.
Zoe Rothblatt 13:01
It’s so true. A lot of what I’m hearing you’re saying is just how having a chronic illness is a full time job and really requires a lot of advocacy, but also a lot of dedication to you know, learning about what’s out there, whether it’s what you were just saying about financial means to help you. A lot of people don’t know about that until you become like a seasonedly chronic ill person and learn from others in the community or just asking the right questions can be so hard. You’re talking about how you freeze up at the doctor’s office sometimes, it’s just challenging to find the right words and often you feel like you’re playing catch up. And I just so appreciate how simply you’ve outlined all these suggestions for how people can advocate for themselves in the doctor’s office and all around in their care. I wanted to ask how you’re doing today and how has like IgG4 affected your quality of life? We’re doing this in the middle of your work day and you obviously have a busy career. And I just wanted to know like how you keep up, like what’s happened since that article went live?
Nika Beamon 14:00
The interesting part is that again, I always considered a part of me but it’s not everything about who I am. Certainly that shifted a little bit during the pandemic because what I learned is especially now on the other what people consider the other side, although technically, it was never, it’s an endemic, it’s not really over and it never will be because it’ll be a seasonal thing. But for everybody else the world goes back to the same. For those of us who are semi-immunocompromised and are already battling illnesses, it’s something that just one more thing we have to live with. It’s something that people don’t understand. They just assume that it just goes away and you’re good and it’s not that big a deal. But for me like when I had COVID I was sick for 33 days. I required a steroid nasal spray every prescription cough medicine, I required a lot of things that everybody else did not. My husband got it at the same time, he went back to work and five days, I was still at home not able to get out of bed for almost 10. So I already have joint pain. I didn’t need additional joint pain, like that’s annoying.
Zoe Rothblatt 14:52
You’re like, I’ll pass, thanks.
Nika Beamon 14:53
So yeah, like this was you know, and so when you try to explain that to people for them, it’s just like, oh, it was no more than a cold. For you, you know for me a cold becomes an ammonia for you a cold, it’s just a cold. I mean, the interesting thing about getting older is A, you get older, so things break down normally, when you have an autoimmune disease, they break down more. So the regular aches and pains that you get as you get older, for me are a little exacerbated because they’re happening faster and easier no matter how much I work out, no matter how much I do, my joints are still wearing away because that’s what autoimmune diseases do, they usually attack your joints and your organs. And so the inflammation attacks my joints, and it pushes out all the fluid in my knees. So I need to fill those with synvisc, I call it the Tin Man Syndrome, I’m always feeling something I’m shooting my hands with steroids or shooting my knees with Synvisc or shooting steroids in my feet to get rid of all the joint pain there or burning the nerves in my back so I don’t have spinal pain because I have inflammation in my spine. It is a full time job. It’s making sure your medication is refilled. I’m like I’m on 30 days, I gotta go back to Rite Aid. It’s making sure you do those, it’s making sure that you’ve got every kind of ologists that exists. I’ve got every ologists that you can think of a neurologist, you name it a rheumatologist, every kind of ologists that most people have never heard of. But I also tell my coworkers I’m like, I’m probably more scan than the rest of you, I might outlive you all who knows, because they’re always looking and they’re always checking. And I’m always checking to make sure that I can have the best quality of life that I can, so I do spend the money to fill my joints, I do spend the money to check all these things, because I want to live the best life that I can the way that I am. And so that’s all you can do. But it is harder with my job not just because that I have a condition. But you know, as you get older, you just don’t want to I don’t want to travel out in the snowstorms. But I certainly don’t want to do it with an autoimmune condition because I don’t want to risk injuring myself more than I’m already injured, it already causes enough damage, I don’t want to add to it. And you know, my coworkers are fine, they’re perfectly nice people, but I don’t want to be around them if you’re coming to work when you’re still sick, because you don’t realize how inconsiderate and how dangerous that is to me. I didn’t mind sitting in an open newsroom pit until I realized that sitting in open newsroom pit put me in danger of all of the germs that they’re carrying and now I got to worry about COVID too, these are things that are going to be a constant concern as you get older, but life is doable, it becomes something you get used to it becomes something that you know, like said you realize that whether you’re sick or not some of these things, you should be paying attention to any way but you don’t give up on your quality of life just because this is the hand you were dealt, you just play it. And I try to still play it I still try to write outside of work. I try to blog. Sometimes I have bad days, I blog about the bad days, I blog about the good days, because you don’t want people to think that you don’t have bad days. My parents, both of them recently died in the last three years. And for me it was a scary prospect, not just because I don’t have parents, I didn’t expect that at 50, but it was also because my parents were our main caregivers. They were the ones who knew exactly what to do, removed all the bandages over the years and done all of those things. And this is what she likes to eat when she’s sick. And this is what she can swallow when she’s got throat inflammation. And so to hoist all of that on my husband was something that I dreaded. I was like, at what point is he going to resent that this is how I am. So there’s so many things that do alter your life. But at the end of the day, you got one life, so you got to live it and so I just choose to live it regardless of the fact that this is how it’s built.
Zoe Rothblatt 18:00
Yeah, thank you so much for being so vulnerable and and sharing all that. I’m sorry for the loss of your parents and also congratulations on your wedding. I just appreciate that you’re highlighting how having an autoimmune condition really does impact every aspect of your life. And there’s a lot to consider both in and outside of the doctor’s office. Before we go, I wanted to just ask you, what’s one thing that you want people to know about IgG4-RD? It’s not such a common disease, you mentioned you hadn’t heard about it when you were diagnosed. Can you share just like one important thing about it for our listeners?
Nika Beamon 18:34
I mean, I think they mentioned rare diseases and to every person, every disease is rare because every disease manifests in a person differently. So I can’t tell you that if you’re diagnosed with IgG4-RD, that you’ll turn out just like me or that you’ll you know or that you won’t I don’t know the answer to that. What I do know is that it is perfectly livable. It’s a part of me, it’s not everything that I am, I insist on living the best life that I can with the people that I can. So surround yourself with people who don’t see you justice as a disease, who see you as a person, who are willing to help not enable because you don’t need to be enabled. You just need help. And it’s okay to ask for help. Because anybody can need help anytime. But certainly you’re going to need it more battling a disease. So advocate for yourself, surround yourself with a good village so you have the help that you need. And never forget, it’s just a part of you, the rest of your life is whatever you choose to make it.
Zoe Rothblatt 19:30
Thank you so much. I’m actually a patient myself, I live with Crohn’s and spondyloarthritis and I just like so appreciate the hopeful message and what you’re saying. I think a lot of times we can get a bit down in the dumps about our disease and sort of vent a lot with each other which has its place it’s so important to complain but it’s like a breath of fresh air hearing what you’re saying. So thank you so much.
Nika Beamon 19:55
Thank you, no thank you for sharing as well.
Zoe Rothblatt 19:58
That brings us to the close of our show. What did you learn today, Steven?
Steven Newmark 20:02
Yeah, my big learning is just on a more global scale. As advocates, we really have to shorten the time to diagnosis, so it’s so important.
Zoe Rothblatt 20:10
Definitely. I really learned from her more about how you have to be prepared and advocate for yourself and really keep a hold of all your documents and timeline of everything in order to show up prepared to appointments.
Steven Newmark 20:25
Yeah, well, we hope that you learn something too. And before we go, we definitely want to encourage everyone to check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 20:34
And if you have any questions, comments, episode topics, definitely email us at [email protected]. Well everyone, thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating, write a review on Apple podcasts and definitely hit that subscribe button. I’m Zoe Rothblatt.
Steven Newmark 20:56
I’m Steven Newmark. We’ll see you next time.
Narrator 21:01
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
S6, Ep 23- Nobel Prize Recognizes Scientists Behind COVID-19 Vaccine
Our hosts discuss the latest news on the Novavax COVID vaccine approval, a lawsuit benefitting patients using copay assistance, and what cases the Supreme Court will hear this month. For the main topic, The Health Advocates congratulate Katalin Karikó and Drew Weissman, who were awarded the Novel Prize for their work on the COVID vaccine, and take a look at the pathway to discovering mRNA technology.
“They [Katalin Karikó and Drew Weissman] get a cash award… but even more than that, they have the satisfaction of knowing that their work has saved millions of lives already and will continue to save millions more in the decades to come,” says Steven Newmark, Director of Policy at GHLF.
S6, Ep 23- Nobel Prize Recognizes Scientists Behind COVID-19 Vaccine
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates, a podcast that breaks down and major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt Associate Director of Community Outreach at GHLF.
Steven Newmark 00:21
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:27
And today we’re going to talk about the 2023 Nobel Prize winners, but first, we do have a few news updates.
Steven Newmark 00:34
All right, let’s get into it.
Zoe Rothblatt 00:36
Okay, well, first on the docket, we have another authorized COVID shot, which is Novavax. We’ve been waiting for that. So the FDA approved Novavax for people ages 12 and older, it’s targeted towards the most recent Omicron subvariant similar to the mRNA vaccines, and it’s now available to anyone in that age group. So 12 and older as long as it’s been at least two months since they had a previous COVID vaccine.
Steven Newmark 01:02
Great. Always good to have more tools in the arsenal, right?
Zoe Rothblatt 01:05
Yeah, definitely is great to have another option. mRNA is more recent, and some people prefer the older technology. So it’s nice to have options for those who would like it.
Steven Newmark 01:15
Excellent, excellent. In other news and a very big win for patients and for GHLF who participated in this particular lawsuit. A federal court has struck down a Trump administration federal rule that allowed health insurers to not count drug manufacturer copay assistance towards the beneficiaries out of pocket costs. The ruling is particularly important for patients who depend on copay assistance and whose insurers implemented copay accumulator policies by using accumulators, health insurance, pocket copay assistance patients receive rather than allowing it to assist patients and paying for the necessary medication.
Zoe Rothblatt 01:48
Yeah, this is exciting, big win for patients.
Steven Newmark 01:51
Absolutely.
Zoe Rothblatt 01:52
I know, we were really active in this along with I think almost like 30 patient groups. So it’s nice when we all come together and are able to see changes.
Steven Newmark 02:00
Definitely this is a really big deal. And essentially, the Court recognized the rules essentially was unlawful insurers are not going to have to abide by a federal rule that governed previously and under that rule, copay accumulators are permissible only for branded drugs, but generic equivalent if it’s allowed under state law. So this is definitely a benefit to patients, this is very good news.
Zoe Rothblatt 02:21
And this should take effect right away, right?
Steven Newmark 02:23
Yes, immediately. If something is illegal, there’s no like, oh, you can keep doing illegal activity for a few more weeks. This is it, it’s over.
Zoe Rothblatt 02:31
So what does this mean for like the HELP Copays Act and all the state advocacy that we’ve been doing?
Steven Newmark 02:38
That’s a good question. Those are obviously different branches of government. But if anything, it’ll probably help bring more pressure to bear on legislators to pass these bills, it’ll probably have the indirect impact, if you will, of just, you know, strengthening our cause being more excitable about our cause, if you will, and showing lawmakers that even courts have ruled in favor of what we’re seeking. So I think on the whole, it will be helpful for sure.
Zoe Rothblatt 03:06
That’s great, nice win for patients. Were we expecting that or did this kind of come out of nowhere?
Steven Newmark 03:12
Yeah, we expected it. So I don’t want to say I’m surprised. Yeah, I would say I’m happy. But I’m not going to say I’m pleasantly surprised. You know, I was confident.
Zoe Rothblatt 03:20
That’s awesome. Yeah, because we posted on social media, we got a lot of great responses from patients saying thanks so much for the advocacy. And there was like a lot of excitement around this happening. So yeah, it’s great to share the news with the patient community.
Steven Newmark 03:33
Yeah, of course. Excellent. I’m glad to hear that. Well, in other legal news, we’re in October, which means that the United States Supreme Court is back and slated the arguments this very week on health care matters. There’s one case in particular that’s getting a lot of attention regarding disability rights case, and the case is called Acheson Hotels versus Laufer and the justices are going to consider whether a self appointed civil rights quote unquote, tester, I’ll explain what that means in a second has the legal right to bring a lawsuit under the Americans with Disabilities Act. So essentially, the plaintiff in this case, I won’t get into it is no longer the plaintiff, but that’s a whole other thing. But the plaintiff in this case has physical disabilities and she filed a federal lawsuit in a federal court in Maine alleging that the website for an inn violated the ADA because it did not contain information about the inn’s accommodations for people with disabilities. So essentially, the question for the court is can you bring a case under federal law, in this case, the Americans with Disabilities Act simply because the information about accommodations for people with disabilities was not listed on a website and that’s why she’s considered a quote unquote, tester. She never actually went to the inn itself to see whether they were compliant with the Disabilities Act. The lower court dismissed the lawsuit holding that the plaintiff did not have a legal right to sue she did not have what’s known as standing because she had no plans to visit the hotel. She was just as I use the term a tester and therefore she was not injured by the lack of information on the website, a federal appeals court reinstated the lawsuit. And now it’s headed to the Supreme Court. So we’ll see what happens.
Zoe Rothblatt 05:07
This is interesting. So is there I guess you didn’t want to get into, I was gonna say who are the plaintiff snow? Is there a group of people that are saying, hey, I agree with this person? Like…
Steven Newmark 05:16
Yeah, you know, I’m going to embarrass myself a little bit by saying I’m not entirely certain who the litigants are on the plaintiff side, at least the defense is clearly who they are. Interestingly, most, the Department of Justice has taken mostly neutral stance, not taking one side or the other, you know, because it is kind of a tricky area, and a slippery slope that goes well beyond the Americans with Disabilities Act, the idea of standing is something that’s long held in American jurisprudence. So you don’t want to just give up that precedent, so to speak, but we’ll see what happens. She wasn’t the best plaintiff in the sense that she has filed, I think, literally hundreds of cases around the country, various cases under various laws, civil litigation cases to try and obtain money. It’s almost as if she was professional plaintiff, so to speak. So but we’ll say, but we’ll see whether it holds certainly just in terms of outside of the law, it makes sense, the idea of if you need a place with accommodations, and you go on a website, and it doesn’t explain to you that there are accommodations, then that’s troubling, right?
Zoe Rothblatt 06:19
Yeah, I was about to say the same thing. Like in hearing this, the message to me is like to be upfront about your accommodations, whether you have them or don’t.
Steven Newmark 06:28
Right.
Zoe Rothblatt 06:28
Especially because sometimes, you know, it’s not so easy to pick up the phone and call like, people don’t have that capability sometimes. So it’s just a good reminder to take a look at your resources, your establishments and see what information you’re putting out and try and make it as robust as possible.
Steven Newmark 06:46
Right, right. So it’ll be interesting, quote, unquote, to test whether a law is actually be followed, you know, some parallel to this is our civil rights advocates, who in the 1960s, would intentionally rode segregated buses in the 50s and 60s to spark litigation or try to rent apartments they didn’t intend to occupy to test whether they will be turned away because of race. So those cases were brought forward. So…
Zoe Rothblatt 07:10
And then are there other topics that the Supreme Court is slated to look at this month?
Steven Newmark 07:14
There are always topics related to healthcare. I think that the one of interest is that just this past summer, the Justice Department asked the Supreme Court to take up the mifepristone battle after a lower court partially upheld access limits that override the FDA’s authority. So the Justice Department is seeking to, shall I say, and redeem the FDA’s authority. The court has not yet agreed to take it up. But we shall see what happens.
Zoe Rothblatt 07:37
Yeah, I got kind of confused where this was left. Because, you know, as someone that doesn’t really know a lot about the court system, it has a lot of players involved here. So it’s just interesting to hear this update and see what news we’ll get this month.
Steven Newmark 07:49
Yeah. Yeah. I mean, I actually think that ADA case that we were just talking about is quite interesting, because I think it goes beyond you could be a layperson and sort of understand the facts of that case. It’s not very complicated. You want hotels to comply, and you have someone that was looking into hotels, even though she had no desire to actually stay at the hotel. And the question is, is that a way to go about enforcing the law? Yes or no, but we’ll have to see how the Supreme Court rules on that. Moving on our top story of the week, 2023 Nobel Prize winners for Physiology or Medicine went to the Hungarian American Katalin Kariko and American Drew Weissman for their work on mRNA vaccines. They were cited for, quote, contributing to the unprecedented rate of vaccine development during one of the greatest threats to human health.
Zoe Rothblatt 08:35
Really cool. We’ve been talking about how awesome this mRNA technology is, and the potential to move even past vaccines and into treatments, especially for things like cancer care.
Steven Newmark 08:45
Yeah.
Zoe Rothblatt 08:45
So it’s great to see it recognized at such a high level, I think we can, you know, walk through the problem, how they looked at mRNA and leveraged it for the pandemic, right.
Steven Newmark 08:56
Yeah, absolutely. You know, I don’t think we need to give the history of a Nobel Prize, but it’s a pretty big deal. And the fact that it’s being recognized for folks who contributed to our, a public health issue that involves literally every person on Earth is pretty exciting, to say the least. But let’s walk through how we got here.
Zoe Rothblatt 09:13
Yeah, so you know, going back how did we discover RNA in 1961, we saw RNA as a string of letters that gives ourselves instructions on how to function.
Steven Newmark 09:24
Yep.
Zoe Rothblatt 09:24
You know, we’re not scientists here. We know our basics from Bio 101. So bear with us as we go through this.
Steven Newmark 09:32
Yeah, I didn’t get that far. But I took High School bio.
Zoe Rothblatt 09:35
So you know at first scientist explored how synthetic messenger RNA so mRNA.
Steven Newmark 09:41
Right.
Zoe Rothblatt 09:41
Could be leveraged in gene therapy. And this was attractive because it meant we didn’t actually have to change our DNA, there would be no risk of accidentally introducing mutations that could affect how healthy genes work or worst case cause cancer.
Steven Newmark 09:55
Yep.
Zoe Rothblatt 09:55
But then every time mRNA was introduced into our cells for gene replacement, it caused a profound immune response. So in other words, our immune system was doing its job it was recognizing a foreign agent and trying to get rid of it.
Steven Newmark 10:09
Right? That’s huge. So there’s something coming into your system, you recognize it and are trying to get rid of it. So this cause scientists to pivot as there’s an obvious application for a situation where you want an immune response, namely, a vaccination.
Zoe Rothblatt 10:21
Yeah. So in 1993, an mRNA influenza test showed successful induction of anti influenza T cells in mice, this was really exciting in the science world, but there was still a major challenge, right, so that mRNA vaccines activated the immune system too early. And it resulted in like a kind of mediocre antibody response and diverted T cells from a pathway that supported antibody production.
Steven Newmark 10:49
Right. So here’s where I guess things get interesting. So traditional vaccines require you grow viruses or pieces of virus, and you implant them into the vaccine into the body, and your body learns how to essentially fight off the virus with mRNA. The approach starts with a snippet of genetic code, which carries the instructions for making the protein. So if you pick the right virus protein to target, the body sort of turns itself into a mini vaccine factory to fight off infection.
Zoe Rothblatt 11:16
And you know, where do our Nobel Prize winners come into this process here.
Steven Newmark 11:21
So at some point along the way, most of the scientific community sort of gave up on the idea of mRNA, and its application for vaccines. But Kariko, along with her colleague, Weissman were convinced that they could fashion a vaccine from mRNA. So they essentially kept at it and in 2005, they were able to come up with a bunch of RNA letter changes or modifications to the mRNA, at which they were able to publish in the publication Immunity, which is one of the top journal fields in immunology.
Zoe Rothblatt 11:50
And I guess, you know, in that time, when they were looking at this, there wasn’t such a big push, because then COVID came along, and like really amplified the need for vaccines. And I guess that kind of, you know, you put the fire under them to say, maybe we can really get this mRNA research going.
Steven Newmark 12:08
Right, right. So mRNA vaccines were already being tested for disease like Zika, flu, rabies, but the pandemic really accelerated this approach. So you know, it basically they came together to say, alright, this is it, we’ve got to figure this out in a very short and rapid response time. And it was interesting, I read what the Nobel Prize committee put out, and it wasn’t just that they were awarding them for the creation of the vaccine. And I’m gonna repeat what I said earlier, to the unprecedented rate of the vaccine development. So they were really giving them the award based on the speed in which they worked under very difficult circumstances, I can imagine while a global pandemic is raging.
Zoe Rothblatt 12:46
Definitely, I mean, it’s interesting to know that for decades they were looking into this technology and testing it out in other disease areas, and that there was early phase clinical trials for other mRNA vaccines, but that when you get a huge public health threat, it can really…
Steven Newmark 13:05
Totally.
Zoe Rothblatt 13:06
It can really amplify the need for something like this. And it just makes me think how our job is advocates is really important to make noise around issues, because when you make noise about issues and how it’s affecting people, it helps progress research and research leads us into these better therapies.
Steven Newmark 13:24
Yeah, I think ultimately, what it comes down to is you want to encourage research at all times, and you have to keep the underlying research going at some particular rate doesn’t have to be at the rate as if there’s a pandemic going on. But then when an emergency happens, you have the ability to then pick up that research and accelerate it. Whereas if we had sort of walked away from mRNA, 20 years ago, we may not have had that opportunity.
Steven Newmark 13:24
Right, it’s never backed down, you know, go for what you believe in and keep studying it.
Steven Newmark 13:37
Yeah. So, you know, it’s not an understatement to say that their discovery totally transformed our approach to vaccines, you would have a hard time naming a virus and public health importance for which an mRNA vaccine isn’t being attempted, which is fantastic. So I think it’s great to say that the mRNA vaccine, COVID-19 vaccine, is Nobel Prize worthy and an excellent example of our gains from decades long road of scientific discovery.
Zoe Rothblatt 14:15
It’s definitely well deserved. It’s exciting to see the recognition for something like this, especially there’s no denying there’s a lot of misinformation and disinformation out there about the vaccine. So it’s really nice to see the recognition here.
Steven Newmark 14:28
Totally, totally. So they get a cash award of 11 million Swedish kronor, which is about a 1 million American dollars. Very nice. But even more than that, they have the satisfaction of knowing that their work has saved millions of lives already and will continue to save millions more in the decades to come.
Zoe Rothblatt 14:44
Well, yeah. Here’s our congratulations and thank you for all your research.
Steven Newmark 14:49
Definitely, definitely.
Zoe Rothblatt 14:52
That brings us to the close of our show. What did you learn today, Steven?
Steven Newmark 14:55
Well, I learned, we were just talking about the mRNA vaccine but we also have a new updated non-mRNA vaccine available Novavax. So that is now available for folks twelve and up.
Zoe Rothblatt 15:04
And I learned from you a little bit more about the concept of a tester and how that works in litigation.
Steven Newmark 15:13
Yeah, well, we hope that you learn something too. And before we go, we definitely want to encourage everyone to check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 15:21
And if you have any questions, comments, episode topics, definitely email us at [email protected]. Well, everyone, thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating write a review on Apple podcasts and definitely hit that subscribe button. I’m Zoe Rothblatt.
Steven Newmark 15:43
I’m Steven Newmark. We’ll see you next time.
Narrator 15:49
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
S6, Ep 22- Advocating One Patient at a Time with Julie Baak
The Health Advocates are joined by rheumatology practice manager Julie Baak who talks about how insurance practices like utilization management delay treatments for patients, how she and her practice advocate for patients, and how she makes noise about these issues within the rheumatology community.
“You know, the right medicine for the right patient is really the driving focus of our practice. And I don’t have a magic wand. I advocate one patient at a time, and I’m pretty successful at it,” says Julie.
S6, Ep 22- Advocating One Patient at a Time with Julie Baak
Narrator 00:00
Be inspired, supported and empowered. This is the global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week and help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:21
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:27
Today, we’re joined by Julie Baak, an expert in rheumatologists practice management. Julie’s done a lot of advocacy around drug access issues to improve patient access to care. And we’re really excited to learn more about her work and advocacy today. So welcome, Julie.
Julie Baak 00:42
Thank you guys. Happy to be here.
Steven Newmark 00:44
Yeah, welcome. Why don’t you start by introducing yourself and tell us a little bit about what you do? What exactly is rheumatology practice management?
Julie Baak 00:52
So I run a rheumatology office on the business side on the practice management side. So we all know rheumatology is you know, arthritis, there’s 100 different kinds of arthritis, we do lupus, autoimmune issues, anything weird rheumatology gets. So I have one rheumatologist in my office, I have four mid levels, so three nurse practitioners, one physician assistant, and a staff of 25 that support that one MD. That is because we are a nimble organization and we just want to help as many people as possible. We’ve had to come to with all these administrative people because of the burdens of the insurance companies at the pharmacy benefit managers. But essentially, we are stamping out disease and saving lives in Bridgeton, Missouri, we see new rheumatology patients in one to three days by physician referral, which is sort of unheard of in the industry. But we are looking to manage and help patients deal with their chronic diseases. We’re not curing I think, just managing them and making them able to live their best lives.
Steven Newmark 01:48
Wow, that’s quite a staff size before management. And you touched on some of those issues but can you tell us a little bit more about why you require such a sizable staff to deal with it? What are the issues that you guys are dealing with?
Julie Baak 02:01
Sure. So in rheumatology, there’s a giant target on our backs because of the expensive drugs we prescribe. So there’s IV drugs, that we have an infusion suite, there’s oral drugs, which we call PO drugs. And then there’s self injectable drugs, which the patients do at home. So all of these drugs are very expensive drugs. Now, because of that, all the insurance companies want to, you know, use utilization management, and they have these formularies that are constructed based on how much rebates they get from the manufacturers, and they set up these formularies and they change every year. Sometimes they change over the quarter, but most of the time, they change every year. And what they do is, what I call it as the pay to play list, right. So if a pharmacy company pays enough money, they’ll put a drug in position one, two, and three, well, that doesn’t work for a rheumatology patient, because once we find a drug that works for them, they stay on that until it doesn’t work for them. So that’s what happens is that’s called a non-medical switch. So it is detrimental to everyone, the patient, the physician, the employer, everyone, the system to move patients on and off drug for profit. So what we do is we have to argue every one of those and we advocate one patient at a time we do not do non-medical switches, we do not change patients off the drugs. And if patients change insurance, we can still get that stuff overwritten. But it’s a whole other host set of problems because now you have a different insurance company that has a different formulary construction. So the non-medical switches is a huge issue that that’s what I need a huge staff to manage. We have to prior authorize everything, we frequently advocate to our patients to just cash pay your maintenance medicine and a local pharmacy if you can even find an independent one left that’s not been put out of business by the PBMs. But even my staff we cash pay our maintenance medicine at a local pharmacy, because it’s cheaper than going through your insurance. I mean, insurance is really turned into a scam. So because of those administrative burdens. That’s why we have to have such a large staff.
Steven Newmark 04:02
You know, you mentioned to changes year to year with the formularies. How do you keep up?
Julie Baak 04:06
Well, I keep up because I have this giant staff that helps me keep up. I have an infusion staff. I have about 10 specialists in the background that work just on the infusion side and I use a partner on that. So they’re not even on my staff. They’re just part of, and they’re not included in my 25. I’m talking about 25 belly buttons on the ground in my office. Okay, but I have 4400 square foot office, I have nine exam rooms, I have two ultrasound suites. We are literally serving the working class people and if we can get them in, get them an office visit, they can get their infusion, they might need an injection, we do it all in one day because my patients don’t have another $50 copay. These are the working folks and we want to keep them working. So we just serve them and get them done and get on with their lives.
Zoe Rothblatt 04:52
Can you talk to us a little bit about when these issues like non-medical switching or prior authorization delays come up how you communicate that with patients? I know often like it can seem like so much health insurance terms and gets confusing. How do you break this down to the patient explain what’s going on?
Julie Baak 05:09
Sure. So, on those office side with the subcutaneous drugs, I have seven back office medical systems that are on the ground in my Bridgeton office that do nothing but prior authorizations on the office side. So they’re really quite experts at getting this stuff done. The rheumatology patients are pretty savvy because this isn’t their first rodeo. Okay, and we see 25 new patients a week and there is such a volume of patients, they’ve been bounced around to different rheumatologists, they’ve gone to different doctors, they have got fibromyalgia written in their chart, therefore no one will accept them as a patient. Like there’s so many things to communicate to patients about. We have a website, we use all social media, we frequently engage with patients, one on one, any difficult case lands on my desk, and I will personally work on it and I get the patient on the phone, the very first thing I do is get the patient on the phone and say do you want me to advocate for access to care on a non-medical switch for you? Because if I don’t have the patient standing shoulder to shoulder with me, I’m not going to waste my time.
Steven Newmark 06:11
You may not be able to answer this, but how common is it for practices to do what your practice does? In other words, how common is it to have the good fortune to be a patient if I may say that, that goes to an office with such dedicated folks such as yourself?
Julie Baak 06:25
Well, there’s lots of good rheumatology offices, but the independent ones are obviously dwindling, because of just the whole economics of it all. I have two full time people on my advocacy team, myself and my assistant, Claudia Holley, and we’re a little bit different because I’m married to a physician. Okay, so he and I have been married for 33 years, we’ve only worked together in this business for eight years and we started this business, but we don’t cross swords. So I can like completely go soup to nuts with my advocacy and he stays on the clinical side. But we also have put a lot of resources and money into staff, you know, I’m pushing the envelope here, I am not for everyone. There’s a lot of practices that are not willing to use Twitter and with redacted cases, I know that if we’re on the right side of things, then I’m going to throw down and I won’t give up and writing the letters once you’ve done a couple of them. And I’ve actually spoke nationally on this process. I was just down in New Orleans two weeks ago, speaking at the National Healthcare Advocacy Conference, there’s a huge need for staff to learn these techniques but it takes a lot. You know, it takes what it takes. If I’m on the right side of things. I’m going to take it to the mat and I’m going to advocate for access to patient care. So an answer to your questions committee staff people have a Julie Baak, I’d say a handful of them, but we need more and people are afraid.
Steven Newmark 07:46
Yeah. And I guess my natural follow up would be do you have any advice for patients that may not necessarily have a Julie Baak at their local practice?
Julie Baak 07:55
Well, there’s lots of resources. There’s CreakyJoints, there’s Arthritis Foundation, there’s Coalition of State Rheumatology Organization. There’s a lot of areas that you can get help as a practice manager. In fact, on the CSRO website, the Coalition of State Rheumatology Organization, I sit on their payer response committee, there’s an opportunity to upload for practice managers to redact and upload their entire case up there. And we will look at that case, there’s about 15 really smart people, me included, that are looking at those cases, and we will write back and say, here’s what you need to do 1, 2, 3, 4. And sometimes, if it’s compelling, the CSRO will write a letter to the employer. That actually one of my patients one of Dr. Baak’s patients in 2021 was an Edward Jones patient, and they were all mandated the entire Edward Jones company was mandated to white bag infusion drug, that’s another disaster. And I actually with the advocacy and the sealing the deal was the CSRO president, Dr. Madeline Feldman’s letter saying, hey, this is not right. And you can see those letters on the CSRO website. So there’s education out there, we just need to get the word out. Because there’s no cost to do any of this stuff. This is a group of people that work on these committees, myself included, because we want to help, and we want to have education and advocacy for access to care.
Zoe Rothblatt 09:13
A common theme I’m seeing and hearing from you is working together as a community in this committee, working together with the patient, working together with the doctor, you know, with your other staff. And I just think it’s remarkable, like how many people it takes to get the patient the care that they need. And I’m just remarking on how much time is wasted and used to fight these insurance companies where it can just go to seeing more patients. And it’s great to know that there’s people like you out there doing this work, but it’s also so frustrating, especially as a patient myself to hear about all of the resources that need to go into getting patients the right care.
Julie Baak 09:49
I mean, it is it just it takes what it takes, but everybody is a patient, okay. And everyone has a story to tell. And if your physician writes a prescription, that should be his prior authorization, all this other nonsense, or delays and denials and for profit for the PBMs and the insurance companies. You know, the right medicine for the right patient is really the driving focus of our practice. And I don’t have a magic wand. I advocate one patient at a time, and I’m pretty successful at it.
Steven Newmark 10:21
Well, it’s amazing what you do for patients. And we’re so appreciative for all that you do for the hard work that you put in to help patients. And thank you for coming on today and telling your story as we help spread the word and help patients ourselves around the country.
Zoe Rothblatt 10:35
Yes. Thank you so much, Julie.
Julie Baak 10:37
Of course. Thank you, too.
Steven Newmark 10:38
Well, I was great. Really talking to Julie and learning what she goes through.
Zoe Rothblatt 10:42
Yeah, it’s great to hear from someone that just like fiercely advocates for their patients and understands you know, that it’s hard to live with these conditions and every day that goes by is more symptoms and it’s great to know that she’s out there fighting for patients to get what they need.
Steven Newmark 10:58
Yeah, absolutely. Absolutely. I think the learning for this week is very easy. You know how lucky some patients can be to have office managers such as Julie Baak helping as they go through their difficult patient journey.
Zoe Rothblatt 11:11
Definitely. And also just to educate yourself on these issues. Julie brought up a few…
Steven Newmark 11:16
Yeah.
Zoe Rothblatt 11:16
And we know that there’s so many more. So it’s really important just to learn about what’s happening in your health.
Steven Newmark 11:21
Yeah, let me add also Julie did say this, you still are the number one advocate for yourself. It’s great to have Julie, but you still have to be an advocate yourself as she said, she won’t advocate for you unless you want it.
Zoe Rothblatt 11:32
Definitely.
Steven Newmark 11:35
So with that, we hope that you learned something, too. And before we go, we definitely want to encourage everyone to check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 11:45
Well, everyone thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating and write a review on Apple podcasts and definitely hit that subscribe button wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 12:00
I’m Steven Newmark. We’ll see you next time.
Narrator 12:06
Be inspired, supported and empowered. This is the global Healthy Living Foundation Podcast Network.
S6, Ep 21- Time to Roll Up Your Sleeves: Prepping for the 2023-2024 COVID Vaccine
Our hosts discuss the latest news on a federal health care transparency bill and what you need to know this Asthma Peak Week. For the main topic, The Health Advocates break down all that was discussed during the recent Advisory Committee for Immunization Practices (ACIP) meeting about the fall COVID shots. They talk about the recent vaccine approvals, COVID hospitalization rates, long COVID, and vaccine effectiveness.
“We learned [during the ACIP meeting] that with hospitalizations, rates across all groups have been rising since July 2023… The most prevalent underlying condition amongst adults ages 18 and older for those who are hospitalized for COVID included cardiovascular disease, neurologic disorders, diabetes, obesity, asthma, and chronic lung disease,” says Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
S6, Ep 21- Time to Roll Up Your Sleeves: Prepping for the 2023-2024 COVID Vaccine
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:18
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:22
Our goal is to help you understand what’s happening in the healthcare world help you make informed decisions to live your best life.
Zoe Rothblatt 00:29
And today, we’re going to talk about the 2023-2024 COVID vaccine and the recent approvals there. But first, we do have a few news updates.
Steven Newmark 00:37
Yeah, so first turning to Washington, there’s a bill that we’ve been talking about that would increase transparency and shine a light on PBMs to help with the ultimate aim of lowering health care costs. And this has been a big focus in the House and Senate this year. And, of course, a big focus of ours at GHLF. Right now, the house was set to vote on the bill earlier this week. But it was pulled from the calendar so it’s unclear when it’s going to be scheduled for a final vote. So we’ll keep doing what we do to advocate for the bill and we’ll keep you informed.
Zoe Rothblatt 01:07
Yeah and I think as you say that it just reminds you of how we always talk about that incremental change is always important in advocacy. And that even though it was pulled from getting a vote still has been up for discussion this year. So regardless of what happens, it adds to the possibility of it being passed in the future.
Steven Newmark 01:26
Absolutely.
Zoe Rothblatt 01:26
Next on our news item, it’s Asthma Peak Week. So Asthma Peak Week takes place each year during the third week of September in the US and it’s really a time when environmental factors like pollen molds, weather changes back to school, it all exacerbates asthma symptoms. And typically the highest concentration of asthma flare ups and hospitalizations are during this week out of the whole year. So in comes Asthma Peak Week. as a way to spread awareness about this time a year and make sure people can get control of their asthma.
Steven Newmark 01:57
Yeah, absolutely. That’s not fun, but being aware of it can help mitigate symptoms in the next few weeks.
Zoe Rothblatt 02:03
So here’s a few tips for keeping your asthma under control. Of course, there’s a lot of things out of your control, and you can’t always avoid triggers and some people have uncontrolled asthma. But a really good way to get started is one, keep up with your preventative asthma medications. Two, have an asthma action plan up to date and share it with your family members or your friends or school teachers. Three, wash your hands frequently and try as best you can to avoid your triggers. Four, stay up to date on your annual flu vaccine. And five, consult with your health care providers for any questions you have about your asthma.
Steven Newmark 02:37
Yeah, great advice. Thank you for that. Now moving on to our big topic of the week – vaccines. The COVID vaccine boosters of the approvals are here. We got the green light from the FDA a few weeks ago, and then the Advisory Committee on Immunization Practices, ACIP, which is a group of medical and public health experts who guide vaccination recommendations in the United States also met to vote on recommendations for who should get the vaccine. So let’s talk about what they discussed and voted out in their meeting.
Zoe Rothblatt 03:06
Yeah, and what’s pretty cool is that the meeting is broadcasted live, so anyone can join. So we got the good fortune of joining and hearing all the news updates live and witnessing the vote and the new CDC director, Dr. Mandy Cohen, it started the meeting saying I know we’re going to talk about COVID. But also I just want to acknowledge that there’s a lot of viruses circulating this season. She mentioned how we’re in a different place than we were in the beginning of the pandemic and we’re in a really strong position to fight COVID as well as flu and RSV because we have the tools to fight these viruses through vaccines and medications. And I just thought that was like a really hopeful opening.
Steven Newmark 03:42
Yeah, no, that is good. There’s so much junk that’s out there, floating viruses and whatnot. Unfortunately, had some folks I know come down with RSV recently, which was probably amongst flu and COVID number three on the list, if you will, and a lot of coughing led to what the heck is this? I’m like, yeah, COVID. No, it’s not COVID. Well, what is it? What is it? What is it anyway?
Zoe Rothblatt 04:03
Was it adults or kids?
Steven Newmark 04:04
Adults, adults, okay, and they’re all I think, fine now. So going back to COVID vaccine. So what’s different this year? First and foremost, it’s a monovalent vaccine, which means that it’s only targeting one strain, and that’s the current Omicron strain, which is circulating, it does not contain the original strain of the virus anymore. So they’re calling it the 23-24 mRNA COVID-19 vaccine.
Zoe Rothblatt 04:26
Yeah, I think that’s a move away from calling it a booster shot, which kind of makes sense. Like we don’t call our flu vaccine, a booster shot. It’s just the annual flu shot.
Steven Newmark 04:35
Good point, yeah.
Zoe Rothblatt 04:37
So this one is just now moving to 23-24 COVID vaccine.
Steven Newmark 04:42
That’s a really good point. You know, I’m embarrassed to say I didn’t pick up on that little nuance there. Good point, though. It’s not a booster. It’s a vaccine, like a flu every year.
Zoe Rothblatt 04:50
Yeah. I mean, it was just like an interesting point in history, I guess where we get to witness that change and see how the nomenclature moves as we learn more and like continue to live with this virus, you know.
Steven Newmark 05:01
I would have been okay not living through this part of history. All right, so who was recommended? Everyone ages five and older is recommended to receive at least one dose of the 23-24 mRNA COVID-19 vaccine and people who are immunocompromised may receive an additional dose at least two months after.
Zoe Rothblatt 05:17
And they’re still like an initial dosing series. So just important to you know, check those recommendations, you know, two doses for Moderna or three for Pfizer with at least one dose of the updated, but definitely make sure to talk to your doctor about your scheduling. And then finally, the last thing that was recommended or rather not recommended is that the bivalent mRNA vaccine, the one we got last year is no longer recommended in the US.
Steven Newmark 05:43
Yeah, they do their job. They’re done. And we know that the mRNA vaccines, those are produced by Pfizer and Moderna. What about the non mRNA vaccine?
Zoe Rothblatt 05:52
True, so this actually came up during the meeting, someone said, you know, what, about Novavax? When can we expect authorization for that vaccine? And the FDA spokesperson that was there said how there’s definitely interest in an alternative to mRNA vaccines and we look forward to the potential authorization. But basically, we’re just waiting for that review and for the FDA to authorize it. So it sounded like it’s coming soon, but we’ll have to wait and see.
Steven Newmark 06:17
Okay, so we’re waiting for FDA review. Let’s talk about the current landscape of COVID itself. So it sounds like we’ve got the vaccine. That’s great. But where are we in terms of hospitalizations, long? COVID, vaccine effectiveness? Let’s start with hospitalizations.
Zoe Rothblatt 06:33
Sure. And yeah, this is like kind of how it went along in the meeting. They looked at all this data before they came to the vote. So I guess for our audience, people with chronic conditions, our summary will focus on the parts that were mentioned about that. So first, we learned that with hospitalizations, rates across all groups have been rising since July 2023. And when you look at who was hospitalized 54 percent of children hospitalized had underlying conditions, with the most popular being being premature, neurologic disorders and asthma. And for adults, the rates of hospitalization were highest among adults older than 75. That’s not really surprising to us. But the most prevalent underlying condition amongst adults ages 18 and older for those who are hospitalized for COVID included cardiovascular disease, neurologic disorders, diabetes, obesity, asthma and chronic lung disease.
Steven Newmark 07:26
Oh, wow. Okay. Interesting.
Zoe Rothblatt 07:28
Like it’s a good reminder of why we get the vaccine. I’ve been hearing from people recently of like, you know, if I get COVID, it’s fine. It’s not a big deal. But it’s actually like it really can be a big deal for people with underlying conditions, as evident by this data. We know that vaccines work best when more people are vaccinated, because it provides like a level of herd immunity.
Steven Newmark 07:49
Totally.
Zoe Rothblatt 07:49
And we haven’t reached that with COVID and we probably won’t, but it just a really important reminder of like caring for your neighbor, you know.
Steven Newmark 07:56
Yeah, that’s a fantastic point. I can’t emphasize that enough. Absolutely. Same thing, if you’re feeling sick, stay home and avoid being in front of other people. And if you for some reason, absolutely must be around others, please do wear a mask in those situations. Absolutely though, yeah. You don’t want to spread the disease, even if you yourself are not fearful of it. So what about long COVID?
Zoe Rothblatt 08:16
So the data showed that the prevalence of long COVID was highest amongst 35 to 49 year olds, and some other noteworthy data was so one in four people with long COVID symptoms reported significant activity limitations in everyday life, which that’s a lot of people, one in four. Groups associated with higher likelihood of developing long COVID included female sex, older age severity of your COVID illness, underlying health conditions prior to COVID infections, lower socioeconomic status, and if you did not get the COVID vaccine.
Steven Newmark 08:51
Wow. So that’s interesting about the vaccine because I’ve been reading that there’s accumulating evidence that COVID-19 vaccination reduces post COVID conditions among both adults and children. Yet another reason to get the vaccine
Zoe Rothblatt 09:04
I was about to say, there you go, another reason to get it.
Steven Newmark 09:07
Totally, totally the thing I’m most scared of with COVID is long COVID. Like, alright, I feel like I’ll be okay with COVID. But I don’t want this long COVID because who the heck that knows what that is, and how long it will last.
Zoe Rothblatt 09:17
Yeah, me too. You know, just personally, I had COVID once, as far as I know. And it was like New Years this past year, and for like, a month or two later, I felt so dizzy. And I was really nervous. Do I have long COVID? When is this going to end?
Steven Newmark 09:31
Yeah.
Zoe Rothblatt 09:32
It slowly faded away. But it was like more so once it was gone, I realized how bad it actually was. And it’s definitely no joke, these lingering symptoms.
Steven Newmark 09:41
Yeah.
Zoe Rothblatt 09:41
And I can only imagine how much worse that would have been if I hadn’t just gotten the booster.
Steven Newmark 09:46
Yeah, for sure. Well, glad that you’re fine now and hopefully more folks will get vaccinated to avoid folks getting ill again.
Zoe Rothblatt 09:52
Yeah, there was a long conversation about vaccine effectiveness in order to come to a vote about what to recommend for this year, they looked at all the data about how vaccines have been working. And just one thing to pull out here is in the conversation about immunocompromised, the data showed that people who are immunocompromised may have reduced protection from COVID vaccines compared to those who are not immunocompromised. This isn’t surprising. We’ve seen this throughout the pandemic. You know, even for flu shot, we know people who are immunocompromised can get a higher dose, sometimes with their doctor. And based on this, that’s why immunocompromised people have been able to get additional doses of the vaccine. I think one really important point here is despite having lower protection, it still does provide protection. So it’s really important to get the vaccine.
Steven Newmark 10:41
Yeah, for sure, for sure. So to find importantly, to find a COVID vaccine near you, you can visit vaccines.gov. With the end of the public health emergencies, it’s important to double check your insurance coverage to make sure you’re getting the vaccine in network. So go to vaccines.gov to find out where or talk to your doctor, of course,
Zoe Rothblatt 11:00
What about if you’re uninsured? What do you do?
Steven Newmark 11:02
Well, uninsured children can get vaccines through the VFC program. That’s the Vaccines for Children program, you could find information on that online, just go to Vaccines for Children. And adults who are uninsured or underinsured will be able to receive no cost vaccines through the temporary Bridge Access Program for COVID-19. So I would say just look for bridge access program to find out more about that.
Zoe Rothblatt 11:24
Yeah, that’s right. We have the tools to fight these viruses, which is a really hopeful place to be as we enter the fall season.
Steven Newmark 11:32
Absolutely. Absolutely. That’s well said. I will say that as my learning that we’re just summing it up, we’re in a better place to fight these viruses than we ever have been so good on us.
Zoe Rothblatt 11:45
And learning for me is I guess, like the terminology moving away from booster and just regular vaccine.
Steven Newmark 11:51
Oh, yeah, that was a cool one. All right. Well, we hope that you learn something too. And before we go, we definitely want to encourage everyone to check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 12:02
And if you have any questions, comments, episode topics, definitely email us at [email protected]. Well everyone thanks for listening to The Health Advocates podcast that breaks down major health news of the week to help you make sense of it all. If you like this episode, please give us a rating and write a review on Apple podcasts and hit that subscribe button wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 12:24
I’m Steven Newmark. We’ll see you next time.
Narrator 12:30
Be inspired and supported and empowered. This is the global Healthy Living Foundation Podcast Network.
S6, Ep 20- The Inflation Reduction Act: What Chronic Illness Patients Need to Know
The Health Advocates are joined by Corey Greenblatt, Associate Director of Policy and Advocacy at GHLF. Together, they take a close look at the provisions in the Inflation Reduction Act (IRA), how these impacts health care costs, and what it means for people living with chronic illness.
“We have to really look at it through all sides, and really have to make sure that patients are staying involved in understanding the impact of this provision [drug pricing negotiation], because this provision will have an impact on patients,” says Corey.
S6, Ep 20- The Inflation Reduction Act: What Chronic Illness Patients Need to Know
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:06
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:18
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:22
Our goal is to help you understand what’s happening in the healthcare world help you make informed decisions to live your best life. Today, we’re going to talk about a new federal law that will have a major impact on the healthcare industry, the Inflation Reduction Act known as the IRA. We’re joined today by our colleague and policy expert Corey Greenblatt GHLF’s Associate Director of Policy and Advocacy to discuss this law and how it impacts patients nationwide.
Zoe Rothblatt 00:46
We sure are welcome to The Health Advocates, Corey.
Corey Greenblatt 00:49
Thank you for having me back Zoe and Steven, happy to be here.
Zoe Rothblatt 00:53
So let’s dive in. We’re here today to talk about the Inflation Reduction Act. Steven and I’ve talked about it a little bit, but we’re so excited to have you on Corey to talk about how this impacts patients. Maybe you can kick it off with some quick facts just to level set here.
Corey Greenblatt 01:09
Sure, I’m happy to do that. So the Inflation Reduction Act was signed into law by President Biden on August 16, of 2022. The bill was a very large piece of legislation, it included over $891 billion, that’s billion with a b, in climate spending tax credits and other reforms that many of which have a direct impact on patient access and affordability, both in the short term and the long term of the US. The couple of the health care provisions mainly apply to Medicare patients, because that’s who the federal government typically has the most control over on a year to year basis, though a few of them have actually spilled over into the commercial market as well and we’ll get into that a little later. The provisions that mainly impact health care relate to things like a monthly out of pocket cost for insulin, an annual cap of spending for Medicare beneficiaries and for the first time ever granting the secretary of Health Care and Human Services, the authority to negotiate drug prices for a specific group of medications. All of this we’ll get into more in a bit.
Steven Newmark 02:12
Great. So let’s get into it. Corey, can you talk a little bit about the spending caps that were implemented in the IRA and what effect they have had or will have for patients?
Corey Greenblatt 02:21
Yeah, I’m happy to. These are really the ones that made the most news for regards to patients, because in a lot of ways, they’re the ones that patients will see the most immediately, the IRA implemented two major spending caps. The first one, as I previously mentioned, was a monthly cap on insulin costs. For anyone who gets their insulin through Medicare, they implemented that insulin would no longer cost more than $35 per month for Medicare beneficiaries. And then they instituted an annual cap of $2,000 spending for all Medicare beneficiaries. So one of the great things about this is that this kind of showed what happens when the federal government passes legislation and enforces things on the areas that they have authority to do so and how insurance companies manufacturers, and these large companies that are working in many different areas will usually just keep whatever regulations they have to do for the government for all other plans as well. And this is what we saw with insulin prices, insulin prices were capped at $35 a month for Medicare beneficiaries. And in the time, since the law was passed, Sanofi and Eli Lilly, two of the producers of insulin announced that they would extend these price cuts to commercial health insurance as well, which means that it’s going to benefit non Medicare beneficiaries, because it’s easier for them just to follow one set of rules than to have multiple pricing structures for different types of health plans, which is another reason why we keep passing and pushing to support laws at the federal level in hopes that they will be implemented outside of those federal plans as well. For the annual cap, the IRA implemented a spending cap of $2,000, meaning that for patients on Medicare, they will never pay more than $2,000 during the year for their health care costs. And for many patients, this reduced the financial burden by over half of what they were previously spending. And unlike many of the other provisions in the IRA, these took effect almost immediately. So patients are already starting to benefit from these changes.
Zoe Rothblatt 04:19
That’s great to hear that patients are benefiting from these spending caps. You mentioned, unlike some of the other provisions, maybe we could get into that I know the headliner provision in the IRA is the drug pricing negotiation. Can you talk to us Corey about what it is and why it’s caused so much noise in the healthcare industry?
Corey Greenblatt 04:38
Yeah, you know, that’s a great question. And it’s not really an easy one to answer because a lot of the impact is kind of theoretical. We’re not sure what’s going to happen because we’ve never been put in a situation where the United States government had been able to negotiate drug prices, so we don’t really have a point of comparison, but to get into it a little bit for the first time ever the Inflation Reduction Act gave the federal government the ability to negotiate drug prices for Medicare patients for some of the most expensive drugs on the market that have been on the market for a set number of years. This is something they’ve never been able to do, despite the fact that Medicare is the largest health insurance payer in this country.
Steven Newmark 05:18
Corey, can you just unpack that for a moment? Why was Medicare unable to negotiate drug prices, everyone else can negotiate drug prices, other countries can negotiate drug prices, private health insurance and negotiate drug prices. Why was Medicare our government unable to do so?
Corey Greenblatt 05:32
You know, it has to go back to how Medicare and specifically the Drug Benefit Plan Part D medicare was created when it was created under the Bush administration, one of the stipulations of its creation was that Medicare would not be able to negotiate drug prices. So because that was signed into law, when this aspect of Medicare was created, it would take another law to actually change that. And in the time between when Part D was created, and the IRA was signed, there was never enough momentum to actually change that aspect of the law.
Steven Newmark 06:06
So prior to the Part D implementation in the early 2000s, there was no drug benefit to Medicare.
Corey Greenblatt 06:12
Correct, patients would have to get a second type of insurance, which would oftentimes be prohibitively expensive for patients who did not have an income in their retired life. So Part D was created as a way to fold the drug benefit into Medicare. But in order to get a bipartisan support on it, they had to create a stipulation that was that Medicare would not be able to negotiate drug prices. So it’s a complicated structure. And this is why it’s been so difficult to make this change. And why this provision has the chance to really be a huge impact on just not only patients, but on the healthcare industry on the manufacturer industry on innovation, both good and bad. And we have to acknowledge that there potentially might be some bad and this is why we have to really look at it through all sides, and really have to make sure that patients are staying involved in understanding the impact of this provision, because this provision will have an impact on patients. So to get into it a little bit further, the provision specifically states that the Secretary has the authority to negotiate Medicare drug prices for a quote unquote, select list of high priced single source drugs that have been on the market for a set number of years. Now, that is a sentence that was made in a bureaucratic lab, because that is not something that a patient is going to read and actually understand what that says.
Zoe Rothblatt 07:42
Yeah, I’m a patient and a policy person a bit. And I’m confused. So, Corey break it down for us.
Corey Greenblatt 07:48
Yeah. So this is where actually, we’re at a really interesting inflection point of the IRA, because we are at the process where the federal government is starting to build the guidelines and the regulations by which they’re going to follow as they implement these laws. And one of the things that has actually been lacking up to this point has been the transparency at which they’re going to determine what drugs are going to be on their list of negotiated drugs. They said this sentence, this high price single source drugs for a set number of years, but they haven’t necessarily said what the price point is. They haven’t said what the state set number of years that the drugs will have to be on the market is, and they haven’t really brought stakeholders into the discussion to figure out what the impacts of these changes are going to be. The list will be published next year. So CMS says that the list will be published in 2024. And at that point, they will then negotiate the prices over a period of time. And the negotiated prices will then go into effect in 2026, with additional drugs added annually. So they are saying that they will continue to update this in hopes that they will eventually get drug prices in mass down.
Steven Newmark 09:03
So just to take a pause here. So first and foremost, you started off by talking about the insulin cow how insulin prices were capped at $35 a month for all Medicare beneficiaries. And as a result, manufacturers then lowered the price of these price cuts to all commercial plans as well. So what goes on in the Medicare space has an impact on the private health insurance space as well. So now we’re talking about the drug negotiation space. So the issue becomes if Medicare starts negotiating drug prices that are different, potentially lower than what is being negotiated in the commercial space, that is going to have an impact necessarily.
Corey Greenblatt 09:40
Yes, it’s got a theoretical impact. And we’ve seen…
Steven Newmark 09:43
Theoretical, everything is theoretical.
Corey Greenblatt 09:45
Everything is theoretical, but we have seen that happening with the other parts of the IRA. And there is evidence to show that when federal regulations like this go into effect.
Corey Greenblatt 09:57
Large companies don’t want to have more multiple sets of pricing or formularies, or whatever it might be, they choose to do the thing that is easiest. And the thing that is easiest is follow the most strict regulation, this drug pricing negotiation definitely has the most potential to drastically reduce drug prices as some of the most common and most expensive drugs on the market, and hopefully lead to savings for patients.
Steven Newmark 09:57
Right.
Steven Newmark 10:22
Great.
Corey Greenblatt 10:23
We don’t know that or fact. But we can hope that’s the case.
Steven Newmark 10:25
Okay.
Corey Greenblatt 10:26
It’s difficult to say for sure, because as we’ve said, there’s no point of comparison. However, we also have to look at the potential negatives.
Steven Newmark 10:33
Now patients on Medicare are paying a maximum of $2,000 a month out-of-pocket no matter what, yearly, sorry.
Corey Greenblatt 10:39
Yes.
Steven Newmark 10:40
In part D. So even if drugs were to cost millions upon millions of dollars to the individual patient on Medicare Part D, you’re still only paying $2,000 a year maximum.
Corey Greenblatt 10:50
Correct. So for them, they’re not going to notice as much. But yes, from the government standpoint, they will be the ones who will notice the most difference. And this is where people are hoping that the trickle down will happen on commercial plans. Because if drug prices have to be lowered for commercial plans as well, that’s where you’re going to start to see patients who don’t have an annual out-of-pocket cap of $2,000 start to get these savings. So again, it’s reliant on that trickle down aspect of things.
Steven Newmark 11:19
Is there a possibility that a manufacturer could pull a drug from the market that’s currently on the market?
Corey Greenblatt 11:26
There is potential for that, and they have said that that is the case, if they cannot agree to a price that makes sense for them. Now, again, it goes back to the lack of transparency. We don’t necessarily know what that price point is. But we can’t look at manufacturers and say that they’re not being honest here, because they have access to much more information on what this impact of the price negotiations will be to them. And we also have to look at what the potential and innovation will be as well, ignoring the fact that there are current drugs on the market, and those will probably stay on the market in some form of another, we have to look at what the downstream impact of these pricing negotiations are going to be on drug developments, drug developments will still happen. But we have to acknowledge that we are living in a time when more drugs are being developed for more conditions than ever before, we are at a point where patients have arguably more choice than they have ever had. And if drug developments begin to slow because manufacturers are not able to invest as much into research and development, then patients who are previously waiting five years for a new treatment now might wait 10 years or might wait even longer. And that could potentially mean a patient with a rare condition doesn’t actually see the day that their treatment is created for them. And so we can’t just look at this as a oh, this is doom and gloom. This is a potential and how do we get around this is we make sure that stakeholders are involved in the implementation process of the Inflation Reduction Act, we make sure that patient voices are heard, what would be the impact of this delay on a patient with a rare condition, we need to make sure that manufacturers are heard, what’s the realistic aspect that these innovations would be paused or that this would be taken off the market. And again, going back to patients, what’s the impact on patients if something is not accessible to them when it previously had been? We know that that’s a negative, but we want to make sure that the people who are implementing this, hear it directly from patients, we want to make sure that patients are getting involved and telling them to make sure that they are not forgotten in all of this, the government’s bottom line doesn’t become the most important factor in all of this.
Zoe Rothblatt 13:43
So how can patients get involved in who should they be sharing their story to?
Corey Greenblatt 13:48
It’s a great question. So patients can first off sign up for the 50-State Network, a little self promotion there. But they can get involved by specifically reaching out to their federal legislators making sure that they are aware of their stories, they are aware of their struggles, their experiences, but also there are opportunities to get involved directly with CMS to provide patient perspectives at various stakeholder listening groups, I think the biggest thing to do is to raise your hand and say this is something that potentially impacts me, and I want to work to make sure it is implemented properly. And honestly once that happens, identify yourself with an organization like us and other patient advocacy organizations, we can help figure out where to use that story best. So I really recommend that if this is something you are interested in, tell us and let us figure out where to use your voice.
Zoe Rothblatt 14:39
And like you’re saying this impacts all patients you know, currently there’s a lot in Medicare but it has the potential to affect private insurance as well. So it’s really any patient anyone that wants to raise their voice can step up and do so.
Corey Greenblatt 14:55
Yeah, definitely patients caregivers, family members, this how has the potential to impact everyone. So we should make sure that everyone’s voices raised for this.
Steven Newmark 15:05
And we should mention that there are lawsuits ongoing about specifically about the constitutionality of the IRA.
Corey Greenblatt 15:12
Yes. So a lot of things can change pending those lawsuits, but based on reporting, and I mean, the government always thinks it’s on standard footing when it passes legislation. But it does seem like this is going to be a drawn out process. And we will definitely be tracking, we as in GHLF, will be tracking very closely the pending lawsuits, we’ll be tracking how things are implemented to make sure that accessibility is not sacrificed for any type of minimal savings.
Zoe Rothblatt 15:40
Oh, I love that accessibility is not sacrificed for any type of minimal savings. Okay. You know, I’m always thinking about the patient. I’m a patient myself, and we’re talking about a lot of impacts in this legislation that would help people with chronic disease afford their medications better. And I’m wondering how for people who are healthy for lack of a better term and aren’t dealing with these conditions, how do you explain and square away this kind of legislation? When we’re talking about stifling innovation and lowering costs? How do you present that to the public and deal with these impacts? When you’re dealing with two different groups, someone with chronic disease who takes a lot of medications and someone over here who doesn’t and this will impact them?
Steven Newmark 16:21
Sure. I can answer this one if that’s okay, Corey, essentially, when you read about the IRA in the press, to the extent that you do, you’ll hear a lot about drug costs being lowered, or the idea of holding drug companies accountable, you won’t hear much about the innovation effects or to the extent you do, it’s really buried deeper in these articles. But here’s the deal. Ultimately, we are patient advocates, we speak on behalf of patients with chronic diseases, which is a little bit different than the average American who thankfully doesn’t have the same conditions that our patients are going through. And the idea that we’re going to, the government is going to spend what amounts to a few pennies more for drugs per American citizen to help lead to greater developments and late and better drugs to help those chronically ill patients is something that for our patients is a no brainer. The idea a few pennies, absolutely. So I can live a better life. Absolutely. Absolutely. The cost is not going to go up for me as an individual patient. Absolutely. And how do you say that to the other individuals who don’t take these drugs, what they’re dealing with, you know, that is life, that is how it goes, we all pay for things that we don’t use, there are people that pay who live in cities that pay for public transportation, they never use public transportation, there are people that pay for the fire department, and have never once called the fire department to come to their house. In the insurance world, there are people that are very healthy, and pay a lot of money for insurance, and don’t use the insurance in the same capacity that a lot of sicker individuals pay for. And that’s life. That’s the way it goes. And life can be unfair and talk about unfair, we represent a bunch of patients who, through the dint of the unfairness of life had been given a blow of living with chronic condition. And what we’re saying is if the rest of our society can pay a few pennies more, if our government could pay a few pennies more to help these individuals obtain better medications, medications that will continue to work longer into their lives, and have them live their best lives. That is a much better society that we should all want.
Zoe Rothblatt 18:20
100% like you’re saying, it helps you live your best life so you can get up and go to work every day and participate in society in ways that you may not be able to without your medication. I like, you know, you brought it back to society, it’s not just about the individual and saying, oh, this only impacts these people, it’s going to cost me money. It really does end up impacting society as a whole.
Steven Newmark 18:41
Yeah, it’s a society thing. Again, we pay for things that we don’t use people without children pay taxes for schools that they will never use. But do you want to live in a society where kids don’t go to school? Do you want to live in a society where people don’t have access to medications that are potentially life saving, or potentially allowing them to get out of their beds and go to work and be productive members of our society? That’s not what we want. And if a law like this is going to stifle innovation, and is going to lead to less development of drugs, then that is a law that needs to be remedied to say the least.
Corey Greenblatt 19:12
I couldn’t have said it better myself. And I think one of the other things to say is this is something that we are constantly looking for more patient perspectives on, we as the organization. So if you have seen your access, be impacted by this in whatever way, reach out. And I know it’s hard to kind of say that that happened. But if you think it happened, reach out, tell us what your access issues might be. Or if this is something that you’re worried about, let us know. Let us know what your perspective is on these kind of laws and how they’re implemented because we want to make sure we’re accurately representing you patients.
Zoe Rothblatt 19:48
Definitely and even if you don’t know like, where to get started or how this law may be impacting you, still reach out and we can we’ll walk through it with you and look at it together and help share your story.
Steven Newmark 19:58
Yeah, absolutely. And I guess to put a cap on this, these laws affect all of us. So the articles may seem a little dry, but the news articles but they’re worth reading.
Corey Greenblatt 20:07
Completely agree.
Zoe Rothblatt 20:08
Or just listen to The Health Advocates.
Steven Newmark 20:11
Fair. Yeah, fair point.
Corey Greenblatt 20:13
Well, Zoe, Steven, thank you for having me today to discuss this. This a lot of fun.
Steven Newmark 20:17
Corey, thank you for joining us and explaining the Inflation Reduction Act, the IRA. The IRA, is not just something that funds your retirement, I guess, who knew.
Zoe Rothblatt 20:25
It’s not just a guy named Ira?
Steven Newmark 20:28
It’s not just my uncle Ira.
Corey Greenblatt 20:30
We all got an uncle Ira.
Zoe Rothblatt 20:31
Definitely. Well, Corey yeah, thank you so much for breaking this down for us and our listeners, we really appreciate you coming on.
Corey Greenblatt 20:38
Happy to be here and always happy to join you too.
Zoe Rothblatt 20:41
Well, Steven, that was a great interview with Corey.
Steven Newmark 20:43
Yeah, absolutely.
Zoe Rothblatt 20:46
What did you learn today?
Steven Newmark 20:47
You know, I learned how difficult it can be to get your head around complex legislation and new laws and Corey was great in breaking that down for us, and most importantly, its impact on patients.
Zoe Rothblatt 20:58
Definitely. I totally agree with that Corey really broke down for me, you know what changes have happened now and what to look forward to in the next few years what we should keep our eye on. So I’m really grateful for that.
Steven Newmark 21:12
Well, we hope that you’ll learn something too. And before we go, we definitely want to encourage everyone to check out all of our [email protected]/listen.
Zoe Rothblatt 21:21
Well, everyone. Thanks for listening to The Health Advocates a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating and write a review on Apple podcasts and definitely hit that subscribe button wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 21:36
I’m Steven Newmark. We’ll see you next time.
Narrator 21:42
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
S6, Ep 19- Steering Through Pirola: A New COVID Variant on the Horizon
Our hosts cover the latest news on Medicare price negotiations, new CDC data on asthma related emergency visits, and the RSV vaccine. For the main topic, The Health Advocates take a look at yet another COVID variant and its potentially worrisome mutations, the rise in COVID related ER visits, masking practices, and what this means for the fall booster shot.
“And you know, despite the increase, just going back to the point, I just made it still far below what we’ve seen in the U.S. in the past, the current level of COVID hospitalizations is a third of it was a year ago at this time,” says Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
S6, Ep 19- Steering Through Pirola: A New COVID Variant on the Horizon
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:22
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:27
Today, we’re going to again talk about COVID. And the wave that’s going around it feels really important with our community to talk about the recent rise in cases. First, we do have a few news updates, though as always.
Steven Newmark 00:43
So the first thing to mention is Medicare price negotiations, the Biden administration is set to announce a list of the first 10 drugs up for negotiation by Medicare.
Zoe Rothblatt 00:52
This is in an effort to lower prescription drug prices by leveraging the government’s purchasing power, and it’s a result from the recently passed Inflation Reduction Act.
Steven Newmark 01:02
Over the next two years, another 30 drugs are going to be selected for negotiated prices beginning in 2027, and 2028, respectively. So we’ll be watching to see how this might affect the medications many of our listeners take as well as how this will impact innovation and the development of future drugs.
Zoe Rothblatt 01:20
for sure. And if you are a Medicare beneficiary, you likely won’t feel the effects of this until 2026.
Steven Newmark 01:27
In other news, asthma related and emergency visits increased during the wildfire smoke episodes recently. New CDC data shows that such emergency department visits were 17% higher than expected in the U.S. on days when the wildfires in Canada carried heavy smoke into parts of the United States.
Zoe Rothblatt 01:43
Yeah, on the worst air quality day in New York that we had this June, emergency department visits related to asthma jumped 82% higher than expected statewide.
Steven Newmark 01:54
Yeah, from a public health perspective, as wildfire smoke becomes more frequent and widespread, there really needs to be better protection for people at risk of asthma attacks.
Zoe Rothblatt 02:02
And on a personal level, if you live with asthma, Asthma Peak Week is coming up. This is the third week of September and it’s a time in the U.S. where due to the change in weather, environmental triggers and back to school, there’s a rise in asthma attacks and a rise in hospital visits. So it’s just you know, along with this new data and knowing Peak Week is coming, it’s a good reminder to stay up to date on your treatment plan and call your provider to set up an asthma action plan if you don’t have one already.
Steven Newmark 02:31
Yeah. In other news, there’s good news on the vaccine front, the FDA approved a vaccine that aims to protect newborns against RSV by vaccinating pregnant people in the latter part of their pregnancy.
Zoe Rothblatt 02:41
This vaccine has also been approved for use in adults 60 and older. So now it’s just getting another authorization.
Steven Newmark 02:48
Before it can be used the Advisory Committee on Immunization Practices must first recommend the vaccine and then the CDC director must accept that recommendation. This is expected but the next meeting is not set until October and so something to be warned about.
Zoe Rothblatt 03:01
But you know, since the peak of RSV may come sooner, I saw that a special meeting may be called so we’ll definitely stay up to date on that.
Steven Newmark 03:10
Great. Hopefully that does happen. Then moving on COVID. We just talked about EG.5, which is spreading quickly. But experts say that it is not more dangerous and other variants. And now we’re hearing about yet another new variant.
Zoe Rothblatt 03:22
I know so this new variant has been seen in multiple countries around the world, including the US its numeric name BA 2.86, also nicknamed pirola on social media. There haven’t been so many cases of this as compared to what we’re seeing with the EG.5 variant but there’s a lot of discussion around it because it’s highly mutated and looks like it could go past our existing immunity.
Steven Newmark 03:47
Yeah, when compared to the XBB 1.5 variant, which drove away earlier this year and was picked out to be targeted for the fall booster shots. This new variant has 36 mutations. And these mutations include changes that key parts of the virus that could help the variant escape the body’s immune defenses from prior infections or vaccinations.
Steven Newmark 04:07
Yeah, so what precautions should we be taking? The CDC data shows that emergency room visits for COVID in adolescents has nearly doubled over the past week. It’s important to note that not all emergency room visits turn into hospital admissions necessarily, but it is a metric that officials are closely tracking as an early indicator of the spread up the virus especially as official case counts become unreliable to measure infections.
Zoe Rothblatt 04:07
And experts still consider this new variant technically a part of the Omicron variant family, though that said it could change if it spreads more widely. You know, as more people become infected, it gathers in the host it’s able to mutate and change. So we have to keep a close watch on it and just get a clearer understanding of the transmissibility in the coming weeks.
Zoe Rothblatt 04:53
You know, this increase coincides with back to school both like university and younger children which begs the question of if masked mandates should come back at schools.
Steven Newmark 05:04
I think based upon past performance, your it is going to be a near impossibility to have any kind of a mandate for a masking anywhere in the United States. That’s just what I think.
Zoe Rothblatt 05:16
Yeah, I agree. But we know they work, so you can stick them on.
Steven Newmark 05:20
That’s true. That’s true. But hopefully, we have reached a point in much of the country where at least you have the ability to wear a mask. In fact, I remember a brief moment where there was actually talk of having a mandate to the effect of that you’re not allowed to wear a mask in school. So I think we’re at this stasis point where you can sort of as my kids say, you do you, so I think we’re sort of at that stasis point. Walking around and traveling around, I see a higher number of people in masks and I definitely at least again, from my vantage point, anecdotal, nothing, no statistics involved, I don’t see folks being bothered who are wearing masks.
Zoe Rothblatt 05:56
Yeah, I agree. The pushback has definitely lessened. It’s under the category of you do you. I will say, though, that a lot of communities are at a medium COVID level category I saw the CDC put out and they said consider returning to masking and other precautions, especially for at risk Americans. There’s no formal guidelines, but it’s good to look up transmission rates in your community, the CDC is still putting out that data.
Steven Newmark 06:23
Yeah, absolutely. Consider where you are considering how you know what how close in proximity you are to strangers and act accordingly. I’m back to wearing a KN95 mask when I’m on public transportation and other close quarters. And that’s a personal choice of mine.
Zoe Rothblatt 06:38
And just looking at some of the other numbers. So deaths, obviously one of the other main indicators from the CDC on the COVID landscape rose this week for the third week in a row. It’s up 21.4% from the previous week, although I will say it’s still you know, less than what we’ve seen in the past.
Steven Newmark 06:58
Yeah, and we’re specifically seeing more emergency department visits in states in the southeast, which is not surprising. It’s very hot there. And a lot of those folks are indoors or it’s more where it’s obviously it’s more transmissible. But ED rates, emergency department visit rates have risen in Louisiana, Mississippi, Alabama, Florida and South Carolina this week.
Zoe Rothblatt 07:19
And you know, despite the increase, just going back to the point, I just made it still far below what we’ve seen in the U.S. in the past, the current level of COVID hospitalizations is a third of it was a year ago at this time. So even with the bad news, that yeah, we’re seeing a rise in visits, and it should set off some alarm bells to be careful. It’s good to know that it’s not as much as it’s been in the past years.
Steven Newmark 07:42
Yeah, no, absolutely. I guess that’s right to sort of level set it and just worry about where we are. We do have Labor Day coming up and we’ve seen rises in the past after certain gatherings. But hopefully, labor days is one that we do outside. So but that being said, even with that we’ll expect to see some rise probably after post Labor Day.
Zoe Rothblatt 08:00
And I know at home tests aren’t as perhaps easy to come by since the end of the emergencies. We talked about the different insurance coverage in a recent episode. But we still have those tests. So probably a good idea to just test before you gather this weekend. A good question is will COVID tests pick up the new variant? And they are expected to still work based on early analysis but obviously experts are going to keep looking into that as it spreads.
Steven Newmark 08:26
Right. Absolutely. So we’ll see how that works. So talking about tests. That’s good news. Of course, the big question is whether the vaccines are going to work on this. And for that it’s too soon to know.
Zoe Rothblatt 08:37
Yeah, the CDC Advisory Committee is scheduled to meet on September 12, to discuss whether to recommend updated vaccines, of course, it’s expected that they will and that those shots should be available soon after, like around mid September. And as a reminder, the vaccines will once again be monovalent targeting the single strain instead of the bivalent, that we’ve gotten in the last year,
Steven Newmark 09:01
Right. And there’s a balance between wanting to protect folks now during this rising cases, but also wanting to protect folks for the bigger peaks that are expected to happen in November, December. And so we know that if we vaccinate too early immunity wanes, and that could have more severe consequences on a later peak. So it’s a real tough balancing act. And obviously, for individuals, you talk to your doctor and figure out what’s best to do and for the public health at large. Well that’ll be really for the CDC and state and local health departments to try and figure out what’s best. You know, when to get people vaccinated.
Zoe Rothblatt 09:33
Definitely I always arranged with my specialists about when to time my flu and COVID shot and what they think is best for me. So definitely encourage everyone else to work with your doctors as well.
Steven Newmark 09:44
Totally.
Zoe Rothblatt 09:46
All right, Steven, that brings us to the cause of our show. What did you learn today?
Steven Newmark 09:50
Well, I learned about the asthma related emergency visits increasing during wildfire smoke episodes. I guess that sounds like it should be axiomatic but it was still good information to learn and then get some specific numbers.
Zoe Rothblatt 10:01
And also for me just getting some numbers around hospitalizations and deaths around the country and what we should be looking at in terms of the rising COVID cases right now.
Steven Newmark 10:12
Absolutely. Well, we hope that you’ve learned something too. And before we go, we definitely want to encourage everyone to check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 10:22
And don’t forget to email us at [email protected]. If you have any questions, comments, thoughts on that episode, we’d love to hear from you. Well, everyone thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you like this episode, please give us a rating and write a review on Apple podcasts and definitely hit that subscribe button wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 10:44
I’m Steven Newmark. We’ll see you next time.
Narrator 10:50
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
S6, Ep18- Navigating the New Wave: Staying Safe During EG.5
Our hosts cover the latest news on large health insurers’ plans to drop prior authorization requirements and the latest CDC data on long COVID in the U.S. For the main topic, the Health Advocates continue their discussion from the last episode on the rise in COVID cases and answer some common questions. They break down what you need to know about insurance coverage and expiration of at-home COVID tests, quarantine requirements for a positive test, how long you can expect to be symptomatic, and masking guidelines.
“Some places are seeing 50% or more increases week to week, there’s no mistaking two things; Number one COVID is back, number two, it’s not as bad as it was in the past,” says Steven Newmark, Director of Policy at GHLF.
S6, Ep18- Navigating the New Wave: Staying Safe During EG.5
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:22
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life. Today, we’re going to continue our discussion on COVID and the recent rise in cases with the new variant that we started talking about in our last episode. But first, let’s start with some news updates.
Zoe Rothblatt 00:39
That’s right first on our list is some prior authorization news. So starting next month, UnitedHealthcare says it will move forward with plans to drop prior authorization requirements for a range of procedures, including dozens of radiology services and genetic tests, among others.
Steven Newmark 00:56
Great, great news. United says the removals will take effect September 1 and November 1, depending on which plan you have across the vast majority of its plans.
Zoe Rothblatt 01:05
And UnitedHealthcare is not alone in making this decision. Other health insurance plans have stepped up and said the same thing. Cigna and Aetna announced plans to roll back some prior authorization requirements. So this is good news. We hear a lot from providers saying how it’s an administrative burden and a very large time suck, time that could be spent with patients. And then we hear a lot from patients in getting delayed about their medication because the process just goes on and on. And then…
Steven Newmark 01:32
Totally.
Zoe Rothblatt 01:33
Obviously they’re not getting their medication, they don’t feel good, it’s like a big cycle.
Steven Newmark 01:37
Totally, and for the procedures that you’re describing the idea of not needing a prior auth, that’s a really big deal for patients, just streamline the process. So very happy to hear that.
Zoe Rothblatt 01:48
Definitely. And it’s great to see that other plans are following suit. And hopefully we’ll have more news on that as it gets rolled out.
Steven Newmark 01:54
Excellent. Well, more good news. A new report from the CDC said the percentage of US adults living with long COVID has fallen to 6%.
Zoe Rothblatt 02:03
That’s right. In early June 2022, the CDC found that 7.5% of Americans aged 18 and older were experiencing long COVID symptoms. Meaning they were still having symptoms at least four weeks after they cleared the infection. And now the new study said by mid June 2023, so a year later that number has fallen to 6%.
Steven Newmark 02:24
Yeah, I mean, this could mean that in a certain period of time long COVID just goes away, it could mean that the newer variants are not causing long COVID as much as the older ones, you know, it could be variety of factors, and it’s something that more research is needed to pinpoint. But all in all, obviously, this is good news.
Zoe Rothblatt 02:40
The CDC report did say though, that more than one in four, 26.4%, of long COVID patients reported significant limitations in their ability to perform day to day activities. And that was currently in June 2023. And the author said this percentage had not changed much since the year before. So what this is saying basically that the people that it’s still impacting, so you know that 6%, it’s one in four of them are impacted on a day to day basis.
Steven Newmark 03:09
Yeah, so which brings us back to what we always like to say it highlights the importance of COVID prevention itself. So that includes vaccines, masking when appropriate, and just staying the heck away from anyone who may have been exposed to COVID.
Zoe Rothblatt 03:23
We mentioned recently in a news update on our show that the NIH is looking into long COVID treatments. So hopefully I know 6% can sound low, but it still is a large group of people dealing with these impacts. So hopefully we’ll have more answers on treating long COVID soon.
Steven Newmark 03:39
Yeah, absolutely. Absolutely. Well, to get into our main topic. In our last episode, we spoke about rising COVID cases being seen around the country. Some places are seeing 50% or more increases week to week, there’s no mistaking two things. Number one COVID is back number two is not as bad as was in the past.
Zoe Rothblatt 03:58
Well back, did it ever go away? But I know what you mean, it’s now more prominent than it has been this summer.
Steven Newmark 04:05
It’s like that houseguest that you sort of forgot, like, oh, is are they still living with us?
Zoe Rothblatt 04:10
So as a reminder, from our last episode, there’s a new variant going around, which is one of the reasons why we’re seeing the rising cases. It’s the EG.5 variant, which is the largest portion of new COVID infections in the US. The good news, it’s from the Omicron family and as with other variants, it’s been you know, less lethal and more mild symptoms.
Steven Newmark 04:33
Yeah, so we’ll see, you know, keep tracking it. You know, we thought now would be a good time to review some basics as we deal with this next round of COVID. Here we go. Dog days of summer, 2023 still talking COVID.
Zoe Rothblatt 04:45
Well, here’s a good question. We’re in summer 2023, the public health emergencies have ended like what does this mean for insurance coverage of at-home tests?
Steven Newmark 04:55
A great question. So it depends on your insurance. Those on Medicaid, tests are covered until September of 2024, you have a little over a year to still obtain at-home tests. Private insurance, the coverage is now optional, so you have to check with your private health insurer, very few are covering at-home tests. If you have a flexible spending account, an FSA, or a health savings account, an HSA, you can use that money to purchase at-home COVID-19 tests. And then for those who are uninsured, there is a stockpile of free tests. And you can go to testinglocator.cdc.gov to find a location of where to get an at-home test. That’s testinglocator.cdc.gov.
Zoe Rothblatt 05:39
And for in person testing, it’s also just really important to check the providers in your network and check the coverage there as well.
Steven Newmark 05:47
Yeah, absolutely. Good, good point, Zoe.
Zoe Rothblatt 05:50
Well, another big question I have is do the at-home tests expire? I still have some of those free ones that came from the government. And recently I was thinking like, can I even still use those?
Steven Newmark 06:01
Yeah, check the box. Expiration dates generally range on these tests from six months to two years, depending on the particular brand. The data in the box may actually be incorrect, as the FDA itself extended some of those dates in that some of those dates were actually listed as almost too soon, if you will. But yeah, definitely check the dates. And when you use tests that you have, perhaps stockpiled yourself, start with the ones that are going to be expiring first. You know, another thing to keep in mind is that the at home tests can get too hot or too cold. You know, these tests are made to withstand normal temperature conditions from regular shipping processes. But if your test has been, you know, living inside your car all summer, you know, that might be caused to consider it deffective or technically expired.
Zoe Rothblatt 06:48
So kinda like you know, your medications. I know some medications have to be refrigerated. But typically for pills, it’s like just keep them in a room temperature environment.
Steven Newmark 06:57
Right, right. You don’t want to keep that stuff in your car, things like that are something to keep aware of. You know, when you take the test, we’ve all probably this point taken the test multiple times, if you get a positive, you’re infectious. Don’t try to talk yourself out of it and say, yeah, I don’t know how accurate these tests are. Positive is positive, full stop, you’re infectious.
Zoe Rothblatt 07:00
Or like me you do a second one and you think it’s gonna be differen and it’s not.
Steven Newmark 07:21
Yeah, it’s not how it works. When they say that the tests are not entirely accurate. It’s the other way, in the sense that sometimes you get a false negative. But that being said, the faintness of the line does provide clues. The stronger the line, the more bold it is, that means you’re very contagious. If you can barely see the line, it means that you’re at the beginning or at the end of your window.
Zoe Rothblatt 07:43
That’s right. I remember when I was positive, the line turn dark, like immediately when my sample hit the test.
Steven Newmark 07:50
Yeah, no 15 minute wait, necessary. Yeah, I remember that too.
Zoe Rothblatt 07:53
I know, I shut off that timer nearly immediately. And then when I tested the 10 days after to see what was going on, it definitely took some time. And it was very faint. So yeah, I guess just confirming that I had that experience.
Steven Newmark 08:06
Ya no, for sure.
Zoe Rothblatt 08:08
So if you do an at-home test should you be reporting this to the Health Department?
Steven Newmark 08:14
Nope, not anymore. Not really necessary. Wastewater is where it’s at these days. And fortunately, that doesn’t require you to do anything.
Zoe Rothblatt 08:22
And like we talked about with the end of the emergencies, like the way CDC has been tracking information is a little bit different. So along with wastewater, they’re also looking at hospitalization as like an important indicator of the severity of COVID.
Steven Newmark 08:35
You know, I would also say if you test positive, you should isolate for five days at a minimum. So five days starting from day zero and day zero is the first day of symptoms, it’s not the first day that you tested positive. So you started feeling symptoms, but didn’t test for two days, I would count the zero as when you first started feeling symptoms. Yeah.
Zoe Rothblatt 08:55
And in terms of leaving isolation, technically, the CDC says day five, but two out of three people will still be infectious. So if you do leave isolation on day five, it’s important to still wear a mask, it’s really best to stay in isolation until you have a negative test or it’s been at least 10 days. And obviously this goes without saying wait till you feel okay, which might be a little bit longer for people in our community who tend to get a little bit more of a severe infection. So just definitely like call your doctor and wait till you’re okay to be out and about.
Steven Newmark 09:26
Yeah, if you’re curious about when you were infected or where you were infected, it’s basically give or take about 48 hours before your symptoms first began. Just a little side digression. I definitely whenever I get sick, you know from a contagious virus. I am always thinking where did this come from? Where did I get it? And I retrace my steps and as my wife always reminds me, it is impossible to figure out where you got it from. So it is such an, a futile exercise and yet I go through it every single time.
Zoe Rothblatt 09:53
Especially living in New York City like the possibilities are endless.
Steven Newmark 09:58
Yeah, totally. It happens. that’s part of life is getting sick.
Zoe Rothblatt 10:01
And if you are infected, you know, if you’re eligible, get Paxlovid, talk to your provider also in advance of getting COVID. So you can be prepared and have a plan. I know when I’m sick, it’s like making a phone call and making a plan feels impossible when you feel so sick. So it’s always best to be prepared and have that plan in place, especially if you know, you may not be able to reach your doctor so quickly. So you could get feeling better, as quick as you can.
Steven Newmark 10:25
Yeah, if you’re lucky enough to have a good relationship with your doctor, you know, maybe you can just send him a note to get you the prescription for Paxlovid. And, you know, go from there to make life that much more manageable. So how long will you have symptoma for?
Zoe Rothblatt 10:39
That’s a good question. Obviously, this is really nuanced, given the long COVID discussion, but typically six to 12 days, maybe longer, maybe shorter, it really depends on a lot of individual factors. Having symptoms doesn’t necessarily mean you’re infectious. Like we said, people have lingering symptoms once the infection has cleared. And a great way to know if you’re infectious is obviously you know, to test. If you’re negative, you’re clear.
Steven Newmark 11:05
Yeah. Should you wear a mask?
Zoe Rothblatt 11:07
Well, okay, if you’re in your house, masks work, let’s repeat that masks do work, especially N95, a high quality mask is really important.
Steven Newmark 11:18
Yeah.
Zoe Rothblatt 11:19
And if you’re going outside, you know, you don’t necessarily need to wear a mask, if you’re walking your dog, let’s say, and you’re not going to be around people. But just be mindful if you live in a busy area, it might be best to throw on a mask.
Steven Newmark 11:32
Definitely. Obviously, if you live in an apartment building, you’re gonna go walk a dog, the chances of you interacting with somebody in an apartment building are much higher than if you live in a more sparse neighborhood and you have a house, use common sense. I think we all know if you do have housemates, loved ones, living under the same roof, definitely mask up definitely folks should mask up, you know, while you’re still testing positive.
Zoe Rothblatt 11:56
And perhaps the biggest question on all of our minds, or maybe just my mind, if you do get infected now, like, how long are you immune for?
Steven Newmark 12:05
That’s a great question. I mean, I was trying to cheer up a friend of mine who just got sick. And I said, well, you know, look, you probably got the latest variant, and it’ll give you some protection in the coming months, something less to worry about, you know, wasn’t really working because he was miserable. But, you know, my nonmedical thought on this is that, yeah, it would probably confer some kind of a little bit of quasi immunity. Gosh, is that how mealy mouthed can I be about saying that, but yeah, it’ll probably be helpful. There is no updated vaccine just yet. We’re expecting it to be available in around September, I think is the latest. I don’t know if you’ve heard anything differently. Zoe?
Zoe Rothblatt 12:44
Yeah, I think I’ve heard the same as you.
Steven Newmark 12:47
Yeah, I would almost consider if you were to contract COVID now, I would almost consider to be like getting a booster for now. And then of course, talk to your provider about when it means you should actually get the fall booster when it’s available. And it most likely would mean delaying when you get the fall booster.
Zoe Rothblatt 13:02
Right. That makes sense. You know, so the bottom line, another COVID wave is here. Thanks to our immunity, 2023 looks very different. That’s immunity from the vaccine and like we just said, from infections, but we can always still use our go to tools to help minimize the spread like handwashing, distancing, masking. And yeah, we’ll stay up to date on what the vaccine schedule be for this fall.
Steven Newmark 13:26
Yeah, absolutely. So we shall stay on top of it.
Zoe Rothblatt 13:30
As we always do. All right, Steven, that brings us to the close of our show. What did you learn today?
Steven Newmark 13:36
Well, I was very happy to learn about the prior authorization requirements being dropped from a range of procedures from UnitedHealthcare. So that’s great to hear. And great to hear that other health insurers are following suit. So good news.
Zoe Rothblatt 13:49
And I learned from you about the distinctions in coverage of at-home tests depending on what insurance you have.
Steven Newmark 13:59
We hope that you learn something too. And before we go, we definitely want to encourage everyone to check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 14:08
And if you have any questions, comments, episode topics, definitely email us at [email protected]. I heard from a few of you this week, and that was really exciting. Thanks, everyone for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating and write a review on Apple podcasts and hit that subscribe button wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 14:33
I’m Steven Newmark. We’ll see you next time.
Narrator 14:39
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
S6, Ep17- New COVID Subvariant: How Worried Should You Be?
Our hosts cover the latest news on the CDC recommendations for the RSV shot for infants and what access issues patients are experiencing when filling their methotrexate. For the main topic, the Health Advocates give an update on this new phase of COVID and discuss the rise in cases in the U.S., the new subvariant, and COVID projections.
“COVID-19, as with other illnesses is different if you have a chronic condition… so it hits different portions of the population differently. And for our population, it still matters. And you know, frankly, it should matter for everyone. And even if you don’t have a chronic condition, you likely don’t want to contract COVID. But also, you don’t want to spread COVID to others who are more vulnerable than you are,” says Steven Newmark, Director of Policy at GHLF.
S6, Ep17- New COVID Subvariant: How Worried Should You Be?
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:22
Our goal is to help you understand what’s happening in the healthcare world, to help you make informed decisions to live your best life.
Zoe Rothblatt 00:28
Today we’re gonna talk about COVID, the recent rising cases and what’s the same and what’s different during this new phase, but first, we do have a few news updates.
Steven Newmark 00:36
A CDC panel recommends a RSV shot for infants. A few episodes ago, we reported about how the FDA approved an RSV shot for infants, and now the CDC panel is recommending the same.
Zoe Rothblatt 00:50
Yes. So it’s the Advisory Committee on Immunization Practices. And they voted unanimously for this shot to be given to babies under eight months who are entering their first RSV season. And the other group is those ages 18 to 19 months who are increased risk of severe diseases if they’re entering their second season of RSV.
Steven Newmark 01:10
Yeah, the panel also unanimously voted to include the new drug to the federally funded Vaccines for Children program, which would provide the shot at no cost to eligible children whose families are unable to pay.
Zoe Rothblatt 01:10
And this monoclonal antibody is actually the first of its kind to be widely available beyond just like a small population of immunocompromised children. The other option is recommended only for high risk infants who are born severely premature at 29 weeks or earlier. So it’s exciting to see approvals here for some more children.
Steven Newmark 01:44
Yeah, it’s great that we now have a preventive shot for infants for RSV. RSV was one of those multitude of illnesses that were floating around in the ether last winter, and certainly put a little sliver of fear in the air. So hopefully, one less thing to worry about.
Zoe Rothblatt 02:12
For sure. And we already have the RSV vaccine for adults age 60 and older, there might be one coming soon for pregnant women. So you know, we’re seeing good advancements here on protections for RSV.
Steven Newmark 02:25
Excellent. Excellent. Well update on drug shortages, we’ve been hearing here at GHLF from our patients about issues getting methotrexate either they have been denied the prefilled syringe and had to go to a vial and syringe. I don’t know if you’ve heard of that, Zoe?
Zoe Rothblatt 02:39
Yeah, that actually happened to me.
Steven Newmark 02:41
Oh, dear.
Zoe Rothblatt 02:42
I got denied my prefilled pens and had to go to vial and syringe and when I went to the local pharmacy, it was out of stock, they were able to order it, but they had a lot of questions on when the next shipment would come through. I ended up getting it fine. But I’ve definitely heard the same thing from a few people in the community. Actually, someone just reached back out today who was having issues and they said their pharmacy got them a three month supply of methotrexate. So that was really exciting to hear from them about that update. So I’d say if you’re having trouble getting it, definitely talk to your pharmacist about options like getting an extended prescription. So you know when there is supply, you can get it. I also heard of another patient saying that there’s a distinction between methotrexate with preservatives or not. And they spoke to their pharmacist and doctor about it because one of them was in stock versus another there would be a delay for and they figured out that they could take it. So just it’s important to talk to your doctor and pharmacist about the different options during this time. And obviously, we want everyone to have access to regular treatment. We know how hard it is to get disrupted and delays. You know, of course the physical impact is obvious, but it’s really like emotionally taxing to have to go through all of this.
Steven Newmark 03:50
Yeah, absolutely. It’s awful. You know, there’s no sugarcoating it, that we live with these chronic conditions. And now more things are put in our way more barriers, if you will, are put it in our way to obtain needed medications. All we can do is power through and fight through and do what we can. And I would just say if you’re having issues, please do let us know at GHLF. You know, we will do our best to continue to advocate on a more global level while everyone advocates individually for themselves, we will do so on a larger level.
Zoe Rothblatt 04:17
Definitely. And you could always email us at [email protected] and we’ll get back to you.
Steven Newmark 04:23
Great. Well, turning to our main issue today, an issue that I think you may have heard of, this diseased called what is it called?
Zoe Rothblatt 04:32
Does it start with a C?
Steven Newmark 04:34
Yeah, yes, gosh, it’s terrible to talk about yet again, COVID. But we actually put together this episode with the intention of just giving a generic update, but unfortunately, we are seeing an uptick in COVID around the country. So let’s get into it to see where we are currently. So summer 2023 update. We are in a very different place than we were of course six months ago, 12 months ago, 24 months ago, but COVID-19 is still around. And I hope you continue to join us as we continue to relay information relevant to our community. So here we go our current state of affairs.
Zoe Rothblatt 05:08
Well just a pause there before we jump into the current state of affairs. I think it’s really important because public health messaging has been dwindling. And I don’t know about like lacking, but it really hasn’t been as much as it has been around COVID. So I feel like it’s really important.
Steven Newmark 05:22
Yeah.
Zoe Rothblatt 05:23
That we dive into these updates together, especially for our community who’s hungry for information, we still send out bi-weekly newsletters with COVID updates, but it’s an important time to take a pause, especially as we enter the fall season.
Steven Newmark 05:23
Yeah, for sure. We’ve spoken about this many times on the podcast. But COVID-19, as with other illnesses is different if you have a chronic condition, it’s different, of course, if you’re elderly, so it hits different portions of the population differently. And for our population, it still matters. And you know, frankly, it should matter for everyone. And even if you don’t have a chronic condition, you likely don’t want to contract COVID. But also you don’t want to spread COVID to others who are more vulnerable than you are.
Zoe Rothblatt 06:03
So let’s jump into the state of affairs. We had what seemed like a quiet few months here in the US.
Steven Newmark 06:09
Yeah, it was great.
Zoe Rothblatt 06:10
Now we’re seeing an uptick in cases. There’s actually a new variant, which we’ll get into a little bit more in the episode. We’re also seeing a rise in hospitalizations. It’s not a concerning amount, but it’s definitely still something to be mindful of.
Steven Newmark 06:24
Yeah, no, absolutely. Absolutely. You know, according to the CDC, there’s three early indicators that are starting to rise, wastewater, emergency room visits and positive tests. Now, to be fair, these were at very low levels just a few short months ago. But still, we are starting to see increases, which is not surprising. We’ve seen this sort of southern summer wave throughout the pandemic, it gets very hot and people go back indoors getting their air conditioning. So it’s not unsurprising to say the least
Zoe Rothblatt 06:54
Right? Like that just jogged my memory, like Delta got big in the summer, what was that two years ago? So it’s definitely not surprising, but this is definitely like, much less severe than Delta was.
Steven Newmark 07:06
Yeah, for sure. You know, some good news since late January 23, excess deaths have reached pre pandemic levels. So we return to our pre pandemic levels when it comes to excess deaths in the country. And this has been a massive reprieve, of course, now, not to be morbid, there are some reasons for this, and one of them is morbid, and that is essentially you can’t die twice. COVID-19 has made its way through a lot of the most medically fragile people over the last three years and those deaths perhaps are leading to fewer deaths today.
Zoe Rothblatt 07:35
And also just immunity from either the vaccine or contracting COVID. Majority of the population probably has some level of immunity now and it’s holding up.
Steven Newmark 07:45
Definitely.
Zoe Rothblatt 07:45
To keep us protected and reduce death rates.
Steven Newmark 07:48
Yeah. So, we’ll be watching as the fall approaches, which is the traditional start of respiratory illness season in the US. So we’ll see what happens.
Zoe Rothblatt 07:56
Well, also, Steven, we’ve been talking about, I feel like in our news updates a lot recently, how millions of Americans have lost Medicaid, especially when the public health emergency ended in the last few months, it’s been a really big surge of people losing coverage. So I just wonder how also that’ll impact case rates this fall.
Steven Newmark 08:13
Yeah, it’ll certainly affect access to treatments. And I don’t know how it will affect actual case rates. It may be that when you don’t have insurance, you’re less likely to proactively seek out medical advice generally, which may mean you don’t seek out the vaccine come the fall, which could have an impact. It could also have an impact on the numbers in this regard. Folks who don’t have insurance are maybe less likely to show up at a hospital or a doctor’s office. So those particular numbers may not be reported. So we’ll see what happens.
Zoe Rothblatt 08:46
That’s literally the motto with COVID – we’ll see what happens. We’re always chasing this ever evolving virus.
Steven Newmark 08:53
Yeah, I know.
Zoe Rothblatt 08:54
So the new variant, we got another kid on the block EG.5, it now makes up the largest portion of new COVID infections in the US.
Steven Newmark 09:03
Okay, yeah, I know EG.5, it’s been nicknamed Eris. The WHO designated Eris as one of its, quote, variants under monitoring. So it is not yet a variant of interest or concern monitoring is a lower designation, if you will.
Zoe Rothblatt 09:18
That’s good.
Steven Newmark 09:18
Yeah, I guess that’s good. It’s part of the Omicron chain. It’s as with other Omicron variants, it’s less invasive and less lethal in the body.
Zoe Rothblatt 09:27
And similar symptoms to look out for cough fever, chills, shortness of breath, fatigue, muscle aches, headaches, runny nose, those seem to be the symptoms for every virus.
Steven Newmark 09:37
Yeah, I know.
Zoe Rothblatt 09:38
Yeah. Hard to distinguish what’s going on, but you have symptoms that get checked out.
Steven Newmark 09:43
So we’ll see. I mean, the prediction is that EG.5 may be responsible for more hospitalizations, but as not increasing the number of cases in intensive care or deaths. So keep our fingers crossed on that. Now the big question, of course, is whether our new boosters are going to work against EG.5.
Zoe Rothblatt 10:00
That is a good question. As we know, health officials have been preparing for this fall with a new COVID vaccine with the formula targeting that XBB sub variants that have accounted for most of the infections in 2023. So it’s different than what we’ve previously got that always had the original strain and the vaccine.
Steven Newmark 10:17
Yeah, the rise of the new subvariant highlights the public health challenges we’ve been talking about with COVID, you know, trying to constantly keep up with this ever evolving virus, which is why other measures are so important, like masking, washing hands, social distancing, you know, when the need arises.
Zoe Rothblatt 10:33
Yeah, like, it’s so important to keep up with all those measures. It does seem like there’s enough overlap between these variants that the new booster will protect against EG.5, but I guess, like we said before, the motto, we’ll just have to wait and see how it plays out in the real world.
Steven Newmark 10:49
Yeah, absolutely. So what’s different now that the public health emergencies are over? Or at least a declaration of public health emergency is over in the United States?
Zoe Rothblatt 10:57
Yeah, it’s a good question. You know, resources to combat the virus are not the same like it was, it’s a big push to get resources, especially when it comes to testing. We don’t have the free tests through the government anymore. And major insurers also stopped paying for over the counter test once the requirement ended.
Steven Newmark 11:16
Yeah, you know, testing, of course, is important for both preventive and before a gathering, for example, or if you’re experiencing symptoms, to not go out into the world and spread the disease. But if you don’t have any more free tests, or if you’re very limited in the amount of tests you have, you’re less likely to do that.
Zoe Rothblatt 11:32
And you know, with hospital admissions going up, like we said, it’s more important to have testing available to like you said, stop this spread, but also try to reduce some of the stress on the healthcare system if we’re able to test proactively and reduce cases and reduce hospitalizations and keep the healthcare system running as it should. So what’s next? Like, what should we be on the lookout for in the next few months in the US?
Steven Newmark 11:57
Yeah, the COVID-19 modeling hub, which is comprised of eight academic teams across the United States just released their projections for the next two years. And they predict that hospitalizations and deaths will likely stay within last year’s range, which is unfortunate, because it means we should expect to lose about 55,000 to 450,000 Americans on depending on how things go due to COVID 19.
Zoe Rothblatt 12:22
Welll if that’s not a cautionary tale to get your vaccine, I’m not sure what it is.
Steven Newmark 12:26
Yeah. And speaking of vaccines, we’re waiting still for full vaccine eligibility decision from the CDC, which we anticipate will happen sometime in September. So stay tuned. And of course, we will report on that.
Zoe Rothblatt 12:39
Yeah, of course. Yeah, we’ll definitely report on that. And the bottom line is just COVID cases are increasing. Don’t be surprised to hear if people around you are getting infected. You know, it’s not a reason to freak out. We said it’s part of the Omicron lineage. It’s not as lethal or severe infection. So those are all pieces of good news.
Steven Newmark 12:59
Yeah.
Zoe Rothblatt 13:00
And we’ll just see where this leads us.
Steven Newmark 13:02
I think that sounds right. And I like what you said, don’t freak out. It’s going to happen, you know, cases are going to increase and it’s going to fluctuate, probably forever, but no, no reason to freak out.
Zoe Rothblatt 13:13
Okay, Steven, that brings us to the close of our show. What did you learn today?
Steven Newmark 13:17
Well I learned during our discussion about the new EG.5 variants. I frankly, was not that familiar with it prior to our prep work for this episode. So we’ll see where it goes. Hopefully, we’ll never hear of it again. But I learned what it is. And I also learned what a very under monitoring is, the designation by the WHO.
Zoe Rothblatt 13:34
And from you that last point about the COVID modeling hub and just hearing about how, you know, we’ve gotten better projections for the next two years, as opposed to where we’ve been in the past with projecting COVID cases.
Steven Newmark 13:48
Yeah, well, we hope that you learn something too. And before we go, we definitely want to encourage everyone to check out all of our [email protected]/listen.
Zoe Rothblatt 13:58
And don’t forget to email us at [email protected]. If you have any questions, comments, or episode topics. Well, everyone thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating and write a review on Apple podcasts and definitely hit that subscribe button wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 14:20
I’m Steven Newmark. We’ll see you next time.
Narrator 14:25
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
S6, Ep16- Rising Temperatures: A Public Health Concern
Our hosts cover the latest news on new trials for treatment for long COVID and the surge of people losing Medicaid coverage. For the main topic, our Health Advocates discuss heat waves’ impact on public health, how we can advocate and be better prepared, and what you need to know as someone who lives with chronic illness.
“It’s frustrating that we even have to take an episode to talk about the weather, but it truly is a public health hazard… For quite a number of years, we could look at heat and say that’s something that happens elsewhere, but it’s here, it’s in the United States, it affects all of us,” says Steven Newmark, Director of Policy at GHLF.
S6, Ep16- Rising Temperatures: A Public Health Concern
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:18
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:22
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:28
Today, we’re going to talk about the heatwave and its impact on public health and what it means for you as someone living with chronic disease. But first we do you have a few news updates.
Steven Newmark 00:38
Let’s start with some long COVID trials, the National Institutes of Health, the NIH is launching clinical trials to test for four possible treatments for long COVID, including administering the antiviral Paxlovid over a longer course than is used for treating new infections.
Zoe Rothblatt 00:54
This is really cool.
Steven Newmark 00:55
Definitely.
Zoe Rothblatt 00:56
I know, we’ve had a lot of discussion around long COVID and its impact but I haven’t seen much about what’s happening with treatment. So I’m excited that as we go into the fall where typically we can expect a COVID surge that this is now being researched.
Steven Newmark 01:09
For sure, yeah, this is good stuff. And it’s something we hear a lot about from our community concern about long COVID. And sometimes we hear those with suffering from lung COVID or be ignored. But clearly that’s not the case from the standpoint of the NIH at least.
Zoe Rothblatt 01:23
And researchers are specifically testing potential treatments for associated cognitive issues, sleep issues and problems with the autonomic nervous system. And another trial still under development will focus on exercise intolerance and fatigue, and any additional trials will be announced on a rolling basis. So definitely like a wide variety of symptoms being addressed.
Steven Newmark 01:44
Yeah, absolutely. So that’s really good news. Other news, in these dog days of August, there is a surge unfortunately, of people losing Medicaid coverage, a decline in Medicaid coverage was expected at the end of the public health emergency, but health officials are raising concerns about the large numbers of people being dropped on the rolls for failing to return forms or follow simple procedures or I shouldn’t call them simple procedures. That’s not right, for failing to follow certain procedures, if you will.
Zoe Rothblatt 02:09
That’s right. And if you look at the numbers, so in 18 states that began a post pandemic review of their Medicaid rolls in April, health coverage was continued for about 1 million recipients and ended for about 715,000.
Steven Newmark 02:23
Yeah, of those four in five, so 80% were dropped for procedural reasons according to newly released data from the Centers for Medicare and Medicaid Services.
Zoe Rothblatt 02:33
That’s a lot.
Steven Newmark 02:33
Yeah.
Zoe Rothblatt 02:34
Especially over something that could maybe be avoided, especially like a lot of it had to do with mail because there wasn’t digital forms available for people to fill out and things were lost.
Steven Newmark 02:44
Excuse my crudity, but filling out forms sucks.
Zoe Rothblatt 02:47
Yeah.
Steven Newmark 02:48
And it’s easy to make a mistake when you fill out a form.
Zoe Rothblatt 02:50
That’s right.
Steven Newmark 02:51
Your health shouldn’t suffer as a result. And if you lose Medicaid, if you lose your insurance carrier, essentially, your health is likely to suffer.
Zoe Rothblatt 02:58
Definitely. And also, like I know, there’s guidelines about when you can re enroll in health insurance. I’m not exactly sure how it works for Medicaid. But hopefully these people don’t experience like too big of a drop in a lack of coverage.
Steven Newmark 03:11
Yeah, I agree wholeheartedly. And it’s why we raise it because we advocate for those who need us for sure.
Zoe Rothblatt 03:17
And the Secretary of the Health and Human Services did send a letter to all governors encouraging them to support efforts to retain people on Medicaid, also encouraging them to use electronic information for other federal programs, such as food stamps, so hopefully that’ll help confirm people’s eligibility for Medicaid and other programs.
Steven Newmark 03:36
Yeah, excellent. Hopefully, that happens. And we can report back some good news on our next program.
Zoe Rothblatt 03:40
Oh, my gosh, I hope so.
Steven Newmark 03:42
Alright, well, we said is the dog days of August, but starting in July, and actually probably started even earlier than that the US has faced record high temperatures and levels of heat exposure that have never been seen before. In our country. Just in the last few weeks, in July, more than 140 million people were under heat advisories in nearly three dozen states, from coast to coast.
Zoe Rothblatt 04:02
Yeah, in the Midwest temperatures are up to 20 degrees above normal. And similarly, in the northeast and mid Atlantic, there’s been dangerous heat waves as well. Actually, if you look back at just like how common heat waves were in the 1960s, Americans saw about two heat waves a year. And by the 2010s, over six per year, according to the EPA.
Steven Newmark 04:22
Yeah and I just want to take a pause to say why we’re talking about this. First of all, it is top of mind for a lot of folks, as we mentioned, the millions upon millions of Americans that are affected and as we’ll get into heat is a threat to public health. It impacts all of us it has a disproportionate impact, of course on the elderly, but you know, this is not particular cause celeb, like non medical switching or something that we’ve spoken about before it’s still important to advocate to let folks know how these heat waves are affecting you.
Zoe Rothblatt 04:49
For sure. And just aside from general advocacy, also self advocacy, like you mentioned, we’ll talk about some of the personal health risks but it’s really important as an individual just generally, but especially someone who lives with chronic disease to know your risk and talk to your doctor, so you could have a prepared plan. You know, you mentioned this isn’t advocacy like non medical switching, this also isn’t a virus in the way COVID is, but it’s still something that impacts your health on a day to day basis in this season.
Steven Newmark 05:16
Right. And also, let’s not forget, there’s a cost angle to this too, it’s expensive to run your air conditioner and we know that having a chronic illness can also be expensive. So to add another cost layer to this and depending on your job situation, you know, there may be lost productivity to deal with for yourself or for your loved ones. So there are other attendant costs associated with these heat waves.
Zoe Rothblatt 05:38
For sure, there’s a lot at play here so I’m glad we’re gonna talk about it together. And let’s dive into some of the health impacts. So the obvious one heat stroke is one of the most common and deadly heat related illnesses and obviously becomes more significant during heat waves. And then what’s really interesting here is that heat deaths and illnesses are totally preventable, but extreme heat is the number one weather related killer in the US.
Steven Newmark 06:03
Yeah, the past few decades have seen a 54% increase in heat related mortality among people 65 and older.
Zoe Rothblatt 06:10
So yeah, you hit that that’s one group that’s at risk, 65 and older. Similarly, the very young people with underlying health conditions, those who are overweight and those who are on certain medications. I mean, we talk about these groups a lot. They’re at risk for other illnesses, and it’s no surprise that they would be at risk here.
Steven Newmark 06:28
Yeah, and there are other ways that heat impacts your health. Air pollution gets worse as rising temperatures increase the rate of formation of hazards like ozone, such pollutants in turn exasperate heart and lung problems. The rise in nighttime temperatures is particularly worrisome for public health. Without much overnight cooling people living through a heatwave experienced higher cumulative heat stress, increasing risks of problems like dehydration and disrupting sleep, which can further worsen exhaustion and stress from high temperatures.
Zoe Rothblatt 06:54
You know, it’s really interesting when I was reading up on this before recording, I saw that experts say there is no absolute temperature at which he can turn dangerous, it really depends on the individual and how acclimated they are to heat.
Steven Newmark 07:07
Yeah.
Zoe Rothblatt 07:07
So this is often why heat waves earlier in the season or in places you don’t typically expect them to happen can have greater public health impacts, because either people themselves aren’t acclimated to the heat, or there’s not enough cooling infrastructures in place.
Steven Newmark 07:22
Oh, interesting. Yeah, I guess that makes total sense. I mean, if you’re someone that lives in a particularly warm climate, and it raises a few degrees, it’s very different than if you’re in a place that has changing climates and you go suddenly from 60s 70s. And all of a sudden shooting up through the hundreds that can be yeah, that can be quite troubling to say the least.
Zoe Rothblatt 07:39
Yeah, because your body’s built in defense, right sweat, you know, that system is used to work and used to operating and I guess it takes like a little bit longer for your body to catch up if you’re not acclimated.
Steven Newmark 07:50
Another issue with heat waves is that they can exasperate social inequalities while cities can warm up faster than their surroundings, poor neighborhoods, which are disproportionately home to people of color tend to get hotter, these neighborhoods often have less tree cover and green spaces, more paved surfaces that soak up the heat. And at the same time, lower income residents may have a hard time affording crucial air conditioning and cooling units.
Zoe Rothblatt 08:11
That’s right. And this same pattern of heat inequality plays out on an international scale too, with lower income countries already facing higher health and economic costs from heat waves as well. So it’s really important advocacy as you and you think about you know, where you can raise your voice, you know, where you live shouldn’t affect your ability to cool and good health when it’s hot out.
Steven Newmark 08:32
Yeah, absolutely. So just, I guess some non medical advice, if you will, from non doctors. A few things to keep in mind, heatstroke is not an actual stroke, it’s when the body quickly overheats, and can no longer use its usual tricks like sweat, as you mentioned, to call itself down, providers need to call the person quickly, ideally, within the first half hour of symptoms.
Zoe Rothblatt 08:52
And there’s a problem here is that there’s no actual like alert system in the emergency room like there is for a standard stroke. So ER staffers are often left scrambling. And heatstroke can also present in a way that looks like symptoms, like other illnesses that bring people into the ER.
Steven Newmark 09:08
Right.
Zoe Rothblatt 09:08
So there isn’t like always a rapid response around huge stroke, which is really critical, because like you said, you want to cool down the person within the first half hour.
Steven Newmark 09:17
Right. And this is something that emergency rooms are starting to incorporate climate into their thinking and adopt the medical system to have programs in place to help patients with climate related illnesses such as this.
Zoe Rothblatt 09:28
For sure and thinking about just like what else can be done as a public health person, I would say improve public health outreach and provide more cooling resources and education, particularly in those vulnerable neighborhoods that you just mentioned, where we could reduce some of the worst effects on people.
Steven Newmark 09:43
Yeah, absolutely. You know, I’ll just say it’s frustrating that we even have to take an episode to talk about the weather, if you will, but it truly is a public health hazard. And it’s something that is international and for quite a number of years, we could look at heat and say that that’s something that happens elsewhere, but It’s here, it’s in the United States, it affects all of us. Earlier this summer, we spoke about the Canadian wildfires. And even if you’re as far north as Canada, you’re being impacted by the changes in our environment. So there is a health angle, and we want everyone to be as safe and healthy as possible.
Zoe Rothblatt 10:15
And we’re still getting a lot of those air quality alerts. Most days here in New York, I noticed that it’s elevated. And that coupled with the heat, I don’t have respiratory issues, but it certainly does make it harder to breathe outside.
Steven Newmark 10:28
I know.
Zoe Rothblatt 10:28
Yeah it’s not just like something that’s on the news. It’s really something being felt on the individual level.
Steven Newmark 10:33
I know we need to dig a bunker and go live there, it’s our only chances, it’s our only chance, Zoe.
Zoe Rothblatt 10:38
As long as we can bring the dogs with us. Mac, you’re ready to go?
Steven Newmark 10:42
Yes, we’ll have a dog friendly bunker. Well, anyway, again, I wish we didn’t have to have an episode like this. But it’s happening, it’s on top of mind and you know, it’s something we’ll stay on top of.
Zoe Rothblatt 10:52
Yeah. And don’t forget to talk to your doctors about your health and your medication risk and what the heat means for you. Because it’s always a good idea to have those conversations ahead of time.
Steven Newmark 11:03
Yeah, absolutely.
Zoe Rothblatt 11:06
Okay, Steven, that brings us to the close of our show. What do you learn today?
Steven Newmark 11:09
You know, I learned from you just a few moments ago, how it’s less about the actual temperature and more about the change in temperature that affects a heat stroke. So I thought that was interesting. Thank you for sharing that, Zoe
Zoe Rothblatt 11:19
And I learned from you just highlighting some of the inequalities in our society and how he can have a major impact on certain vulnerable groups.
Steven Newmark 11:30
Yeah, well, we hope that you learn something too. And before we go, we definitely want to encourage everyone to check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 11:39
And if you have any questions, comments or topic ideas, don’t forget to email us at [email protected]. Well, everyone, thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating and write a review on Apple podcasts and definitely subscribe wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 12:00
I’m Steven Newmark. We’ll see you next time.
Narrator 12:06
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
S6, Ep15- 2023 Health Policy: Where Are We At?
Conner Mertens, Patient Advocate and Community Outreach Manager at GHLF, joins our host Zoe Rothblatt, Associate Director of Community Outreach, as guest co-host to cover the latest news on the FDA approved RSV shot for infants, a new pandemic preparedness office, insurance coverage for mental health, and results from our latest quick poll. For the main topic, Conner and Zoe discuss active health care bills around the states, updates on the Safe Step Act and HELP Copays Act and how our 50-State Network is advocating.
“It really is powerful when you get to walk into a lawmaker’s office with a patient who has a very personal story, and that the laws that these folks are passing can really impact their lives. And to hear from those lawmakers that it’s the first time they’ve spoken directly to a patient about how these bills that they’re working on will change their day to day is a wonderful thing that we get to see firsthand,” says Conner.
S6, Ep15- 2023 Health Policy: Where Are We At?
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Zoe Rothblatt 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF. Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life. Today I’m joined by Healthcare Matters co host Conner Mertens, who so generously offered to step in for Steven and co host with me this week. Hey Conner, how are you doing?
Conner Mertens 00:35
Hey Zoe, good to be here. Thanks for having me and another fellow alumni of Breaking Down Biosimilars.
Zoe Rothblatt 00:41
Oh, yeah, we do have a podcast together. We’re pros at this. So we’re gonna dive into some news and then do a policy landscape. You know, we’re halfway through 2023. Let’s see where we’re at around the states and federally.
Conner Mertens 00:54
Let’s do it.
Zoe Rothblatt 00:56
Our first bit of news is that an RSV shot was approved for infants. So Conner what’s interesting here is that it’s not a vaccine. It’s a shot that protects infants and vulnerable toddlers against RSV. It’s a preventative shot similar to how in COVID our community who is immunocompromised was able to get Evusheld as a preventative measure. This too is a monoclonal antibody that will act as a preventative for RSV.
Conner Mertens 01:21
This is great. I just had a neice a year and a half ago because right around fall and November and during COVID. So we didn’t have to just worry about COVID, we were also worried about RSV. So this kind of hits home for us and definitely my family. I think this is a great advancement. I heard that the FDA is also considering approval of RSV vaccine by Pfizer for pregnant women, which means they’ll have that protection when infants are born from the virus.
Zoe Rothblatt 01:45
That’s right. And yeah, the efforts have been focused around vulnerable groups. So in recent months, FDA also approved two vaccines against RSV for adults 60 and older. There’s been no word yet for immunocompromised but we’ll of course keep an eye and ear out for our community as we get updates, but it’s good to see that those who were affected last season are hopefully gonna get protection going into this season. Moving on to our next bit of news, the White House launched a permanent pandemic office. The name of the office is the Office of Pandemic Preparedness and Sesponse Policy.
Conner Mertens 02:18
That’s a mouthful.
Zoe Rothblatt 02:19
For sure. We love acronyms, it is O.P.P.R. So President Biden has chosen Dr. Paul Friedrichs to head to a new White House Office created by Congress to prepare for managed biological threats. This appointment will take place on August 7, and then it’ll be up to him to set up the new office. So we’ll wait to hear more there.
Conner Mertens 02:39
Yeah and this appointment really signals a more permanent and coordinated effort to prepare for and respond to pandemics. As you know, something happened recently. I can’t really put my finger on it, but it’s clear that we need to have better responses to these looming pandemics.
Zoe Rothblatt 02:53
Oh, you mean the COVID-19 global pandemic?
Conner Mertens 02:56
Oh, that’s right. That’s the one. Okay.
Zoe Rothblatt 02:58
So yeah, hopefully this will bring a more coordinated effort. When you think about what is the job entail? So it gives the authority to oversee domestic biosecurity preparedness, they’ll need to work on the development of next generation vaccines, ensure adequate supplies in stockpile and ramp up surveillance and monitoring of biological threats. Also a key component to this which Steven and I have talked a lot about getting funding for pandemic preparedness. And this in this role he’ll have to work with Congress in order to get funding for preparedness efforts.
Conner Mertens 03:31
That’s great. I mean, all these things are certainly, as we saw recently, very important for ensuring public health, that strategic national stockpile and surveillance up and coming in new biological threats is imperative to making sure that we have a healthy future.
Zoe Rothblatt 03:46
This next bit of news, actually, I’m so curious for your thoughts, because I know you’ve been a big advocate for mental health. So President Biden recently announced that his administration is moving forward with new rules meant to push insurance companies to increase their coverage of mental health treatments. Basically, the Mental Health Parity and Addiction Equity Act requires that health insurance cover the same level for both mental and physical health care, and they’re gonna look to see whether this is actually happening. And if it’s not make necessary adjustments to make sure mental health is covered.
Conner Mertens 04:19
I think this is so forward thinking and long overdue, we should treat mental and physical health the same and we should provide the coverage and the care for both of those that every patient needs. So this is it’s a really exciting step in the right direction. I actually ended up watching Biden’s announcement of this when it was on TV, and it was definitely something that I think a lot of people can look forward to.
Zoe Rothblatt 04:39
For sure, especially when you live with a chronic disease, it’s so intertwined with your mental health and caring for your mental health is just so important because the symptoms really do overlap and impact each other and we know how expensive health care is right? You and Robert talk about this a lot on your podcast, and it’s so important to have access through health insurance to know that you can get care at an affordable rate. And finally, for our last bit of news, we have our latest quick poll results. So Conner, you know about these quick polls, we send them out to our community to learn their thoughts on various topics most often having to do with COVID. But this time about our HEROES program. And for those of you don’t know about our HEROES program, it’s about you know, reaching patients where they’re at through their salon and stylists and you can go a few episodes back and hear Seth Ginsberg talk about the hero’s program and everything you need to know about it there. But okay, so let’s get into the results.
Conner Mertens 05:36
Let’s do it.
Zoe Rothblatt 05:36
A key takeaway that we learned is that 56% of respondents reported that they feel their stylist is educated in skin and scalp conditions “never” or “very few times.”
Conner Mertens 05:46
Yeah, I mean, that’s such an important statistic. I think when we talk about hairdressers, and stylists, and folks that work in the beauty industry, they’re kind of often on the front lines of seeing these skin conditions, maybe even before a very clients see them. So I think it’s very important that this HEROES program exists as this quick poll shows.
Zoe Rothblatt 06:03
And you got it perfectly led me into the next point is that 78% of participants reported that a program like our HEROES program would be helpful in their community. So it’s great to get that feedback as we launch this program and figure out what exactly patients need in order to feel comfortable in their everyday life with their stylist and getting the care that they need from their doctor as well.
Conner Mertens 06:27
Well, you know, so we actually took this HEROES program to the International Beauty Show in Vegas recently, and were able to meet with a lot of stylists and hairdressers. And they were so receptive. And it was really validating to hear that they, you know, care about their clients so much that they want to invest in this program and have more tools to be able to help them. It’s a really cool program. That’s, I think, going to help a lot of people.
Zoe Rothblatt 06:49
I agree. And Conner, also just transitioning into our big topic for today about health policy. I know you went on a little advocacy road trip, so maybe we could start there and hear about what you’ve been working on in the West Coast. And just the impact of bringing patients to state capitals and what you’ve been hearing from the stakeholders as well.
Conner Mertens 07:09
Yeah, we had a great West Coast advocacy road trip, my colleague and I, Corey Greenblatt jumped in the car and visited Olympia, Washington, Salem, Oregon, and Sacramento, California to meet with lawmakers and stakeholders and bring the patient perspective to those tables. You know, obviously all the same discussions about copay accumulator adjustors, and transparency. And you know, the things that we’ve been fighting for so long, but it really is powerful when you get to walk into a lawmakers office with a patient who has a very personal story, and that the laws that these folks are passing can really impact their lives. And to hear from those lawmakers that it’s the first time they’ve spoken directly to a patient about how these bills that they’re working on will change their day to day. So it’s a wonderful thing that we get to see firsthand. And it’s also just really powerful when we’re trying to make that change in the legislature.
Zoe Rothblatt 07:57
For sure. And what’s really remarkable to think about what you just said that it’s the first time they heard from patients, it really just underscores for me the importance of our 50-State Network, what we do and the power in the patient voice to come to the table and share a story that’s not always so easy to share.
Conner Mertens 08:14
Yeah. And I guess that begs the next question is, if this is the first time that they’re seeing patients who and what are the interests of all the other folks that are coming into their office to lobby for or against these bills. So I think it to reiterate your point, our 50-State Network and ensuring that patients have a seat at this table is so essential.
Zoe Rothblatt 08:32
For sure. Because at the end of the day, you know, the patient is at the heart of health care. And it’s a very important seat at the table.
Conner Mertens 08:39
Yeah, well, they better be or else we’ll have some words.
Zoe Rothblatt 08:42
Haha so true. Well, okay, so thinking about some other states moving across the country, most state legislations are out of session right now. So that means they’re not able to pass legislation or only may be able to pass very specific issues related to special sessions. But we are active in many of the states still open. California has taken our accumulator bill off the table this year, but it’s still being considered for next year. So if you’re a listener, and you have a story in California about copay accumulator, we’d love to get to know you and see how we can raise your voice. So definitely write in to us, you can email us at [email protected]. Conner, we’re also supporting a lot of bills in Massachusetts, so I think our colleagues are actually there right now as we record setting up meetings with stakeholders. Similarly, there is accumulator bill and we’re also supporting a non medical switching ban and other reforms to the PBM pharmacy benefit manager industry. So there’s a lot going on in Massachusetts, they’re really trying to lead the way.
Conner Mertens 09:38
Yeah, no, you said it, Massachusetts has a lot of really good legislation in the works that can really help patients and bring down costs and achieve the goal that we’re always trying to achieve which is making health care better and more accessible for folks living with chronic disease. Shout out Massachusetts.
Zoe Rothblatt 09:53
Shout out! And there’s a lot of momentum across the country, Michigan, Ohio, Wisconsin all have active accumulator bans that we’re supporting as well as Pennsylvania, in addition to a non medical switching ban. So, you know, keeping busy in our advocacy despite fewer active states.
Conner Mertens 10:10
Yeah, Zoe you know, we’re always staying busy on the state level, but with a watchful eye on the federal level as well, lots and lots of bills there that we’ve been keeping our eye on and lobbying for the last couple of years.
Zoe Rothblatt 10:21
Yeah, actually, there’s two big ones we could talk about here the Safe Step Act, which helps reduce step therapy happening to patients when you have to try and fail a drug before you can get the one prescribed by your doctor. So the Safe Step Act was brought up as an amendment recently in the House hearing to be added to a larger healthcare bill. And while this amendment was withdrawn, the chair the committee promised to give this issue more consideration and agreed it’s something to be reformed. And on the Senate side, there’s a procedural vote scheduled later this month that will possibly allow it to be included in the PBM reform bill that the Senate is putting together. You know, this is the first time the Safe Step Act has gotten a vote of any kind so it’s really a big deal, because we’ve been advocating, as you said, for years, and it kind of just shows that our hard work pays off. And movement can be slow, especially federally, but it’s important to keep up because now you know, we’re seeing that there’s potential for this to get passed.
Conner Mertens 11:16
Yeah, we love to see this movement. And it’s a testament to the tireless efforts of patient advocates like yourself, and the folks that join us to share their stories and share how these practices of non medical switching and step therapy, how negatively they can impact folks care.
Zoe Rothblatt 11:33
And the other big bill federally that we’ve been watching is the HELP Copays Act, and there hasn’t been much movement, which is it’s not surprising. It’s, I would say about three to five years behind the Safe Step Act from an advocacy perspective. So again, it’s just you know, continuing to raise our voice, the voice of our community, share patient stories and keep the momentum up. And hopefully in in a few years time it can get to the place where the Safe Step Act is now.
Conner Mertens 12:01
Yeah, Zoe that’s that is a thorough review of where we’re at about halfway through the year, you know, we’re obviously gonna keep an eye on things and keep advocating for all those folks at home. And we’ll see how the rest of the year shakes out. But some really good things in the pipeline that can again positively impact patients lives. So let’s cross our fingers and make our voices heard, huh?
Zoe Rothblatt 12:20
Love it. On that note, that brings us to the close of our show, Conner, what did you learn today?
Conner Mertens 12:25
I learned that y’all have a good time on the show and cover a lot of really important topics. It’s a fun little podcast. I’m happy to be here.
Zoe Rothblatt 12:31
Thanks and we’re so happy to have you aboard today really appreciate you filling in. And also, I learned from you about your recent road trip and just a reminder of how important it is to bring the patient voice to legislators. So thanks for all that you do, Conner.
Conner Mertens 12:45
Yeah, of course. And if your listeners feel so inclined, they should definitely go and check out another really good podcast I’ve heard of called Healthcare Matters. It’s hosted by Dr. Robert Popovian and Conner Mertens, we dive deeper into healthcare economics and policy. So we’d love to see some of your listeners over there.
Zoe Rothblatt 13:02
Definitely. We’ve actually had a back to back week of you and Robert here on Health Advocates. So we’re huge fans, some may say.
Conner Mertens 13:09
Yeah, it’s an elaborate plan to take over your show, so.
Zoe Rothblatt 13:14
Well, everyone thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you like this episode, please give us a rating and write a review on Apple podcasts and check us out on YouTube. I’m Zoe Rothblatt. We’ll see you next time.
Narrator 13:33
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
S6, Ep14- Why Safeguarding and Advocating for Patient Assistance Programs is Important?
The Health Advocates are joined by Dr. Robert Popovian, Chief Science Policy Officer at GHLF, to learn about a free, interactive tool which shows that state laws banning accumulator and maximizer clauses in health insurance policies have not increased the cost of health insurance. Robert breaks down health care terms, talks about the impact of insurance practices on patient’s access to affordable care, and how we can use this tool to advocate amongst stakeholders.
“So these patient assistance programs get captured by Pharmacy Benefit Managers (PBMs) and the insurers as profit, and the patient is almost like double billed, because not only do they have to pay for their medicine, but they have to also pay for the deductible twice,” says Dr. Robert Popovian.
S6, Ep14- Why Safeguarding and Advocating for Patient Assistance Programs is Important?
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Zoe Rothblatt 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. Yes, you heard that right. It’s me, Zoe Rothblatt, Associate Director of Community Outreach at GHLF. And today, instead of being joined with Steven, my usual co host, I’m joined with Robert Popovian. The host of Healthcare Matters. Robert is the Chief Science Policy Officer at GHLF. Robert and our colleagues have been working on this tool which looks into the laws passed across the US that have banned copay accumulators. We’ll hear today from Robert about these insurance practices, the findings and what it means for patients. Welcome, Robert, I’m excited to have you aboard today.
Dr. Robert Popovian 00:47
Thank you, Zoe. This is the first time I think I’m on your podcast. I’m very excited to be on. You know, we’ve hosted you couple of times on Healthcare Matters. So it’s two to one.
Zoe Rothblatt 00:57
I know and I had so much fun with you guys. So I promise I’m gonna make today fun in return.
Dr. Robert Popovian 01:03
Excellent.
Zoe Rothblatt 01:03
So okay, maybe some not fun things are some insurance terms. Can you start by breaking some of that down for us the differences between copay, coinsurance deductible maximum out of pocket costs, there’s a lot of terms flying around. I think it’ll help us frame our discussion today if we break it down.
Dr. Robert Popovian 01:21
Yeah, Zoe, that’s something I’m always asked, because when you’re in the healthcare field, like you and I and Ben our producer, we all assume we know all these terms that everybody knows these terms, right? So we move on and try to utilize these terminology without really understanding or appreciating that not everyone understands what we’re talking about. So what is a copay and copay is really, let’s start with that one, because that’s an easy one that’s copay is a set amount. So when you walk into a pharmacy or physician’s office, your set amount to pay for that office visit or for that prescription you pay that you walk out, you get your prescription, or you are seen by your healthcare professional. And you know that upfront when before you even go to pick up your drug or your visit with your healthcare professional or your provider, coinsurance is a little bit difference. It was introduced probably about 10 years ago into benefit designed for health insurance. And in that case, it’s a percentage of the cost of whether it’s the medicine or the office visits. So it’s a percentage. So it’s not a set amount. It depends on how much the charge is. And you pay a percentage of that as coinsurance. What is deductible? Deductible is something that all of us now almost all of us, actually I should say have in our benefit design. And it’s something that we need to pay off before we can even start utilizing our insurance benefit. And finally, maximum out of pocket costs is the maximum amount that you are exposed as a patient to pay for something before the insurance completely then covers 100% of the cost. So those are the terms typically used when we were talking about health insurance.
Zoe Rothblatt 02:58
That’s really helpful, thank you, and then diving into a little bit about what you’ve been looking at. So there are programs done by pharmaceutical companies that provide patient assistance to help pay these co pays. And I was wondering if you could explain to us like why you think that these companies have these programs?
Dr. Robert Popovian 03:16
So first and foremost, pharma companies do it because they believe you know that patients need to stay adherent to their therapies. As we’ve gone through many years of benefit design changes, patients on especially brand name medicines get significant exposure to out of pocket costs. And we know historically, when out of pocket costs reach a certain level for individual drug, patients stop taking it. Because of that reason, over the last maybe dozen years, pharmaceutical industry has introduced what they call patient assistance programs, or manufacturer assistance programs, also referred to, to help patients defray the costs of those out of pocket costs so they can stay on their therapy, and they can be adherent and benefit from those treatments.
Zoe Rothblatt 03:59
You know, it’s great to hear about the programs that are coming up to help patients afford their medications. But as these programs arise, there’s also programs arise that make it more difficult for patients to maybe afford other aspects of their care, like meeting their deductible. Can you talk about these programs known as accumulators and maximizers, and what the difference is between the two?
Dr. Robert Popovian 04:22
So accumulators and maximizers came about maybe about five years ago where insurers and pharmacy benefit management companies started to introduce these sorts of benefits schemes where if a patient got a patient assistance program from a manufacturer, they would not count that towards a patient’s deductible or maximum out of pocket costs. So in essence, they were leaving patients in perpetual phase of deductible, right? So they would never meet them as they would get those benefits from the manufacturers. The difference between accumulators and maximizes is that with the accumulators, uh, you know, you keep draining your patient assistance program, they never meet their deductible and then in like the third or fourth month, because you finished up all your patient assistance program, patient would get the surprise bill in middle of the year. All of the sudden, they were paying nothing, maybe the first two, three months of the year, they run out the available funds. And all of a sudden they get this surprise bill. What the maximizer did is to sort of say to the patient, okay, we’re going to maximize your patient assistance program. So they took the whole amount of the patient assistance program and divided over 12 months, so it sort of eliminated that surprise billing in the middle of the year. But just as the accumulators, none of the funds that are provided by pharma companies under the maximizer program applies to the deductible so the patient is still on perpetual deductible. And Zoe, as you well know, I mean, you’re a chronic disease patient. Chronic disease patients are not just paying for their medicines, they’re paying for office visits to see their healthcare professional on a regular basis. They may have lab work, they may have MRIs, CT scans, X rays, all these things that accumulate. And because they’re not meeting any of their deductibles, even though this for one, this one drug under the maximizer program, the patient is quote unquote, made whole, because of the lack of the funds applying to the deductible, they still have to pay and double pay for the deductible until they meet it out of their own pocket.
Zoe Rothblatt 06:15
Yeah, that’s right. And I mean, you said it, it’s chronic, the costs are chronic too. And they add up. And it’s like really a burden, when you’re thinking about just trying to make ends meet and all other aspects of your life to be strapped with these bills that, like you said, you’re paying double. And it’s just these programs that are making it impossible to reach. Are there alternative funding programs or organizations available to patients?
Dr. Robert Popovian 06:39
Yeah. So there are organizations actually working with the pharmacy benefit managers to sort of apply these to these programs. So one of them is Savon SP has gotten a lot of airtime in the last few months because of the litigation that’s been filed from the Johnson and Johnson against Savon SP and in that case, Savon SP is an organization that sort of works with the PBM, it requires that the patient has to sign up with them for them to be able to reutilize the patient manufacturer assistance program. But the difficulty with that one is that it’s getting even worse. So in some cases with these alternative funding programs, these organizations like the PBM, or even the Savon SP types, go to the employer and say, you know, employers only you don’t have to cover specialty pharmaceuticals for your patient population that you are covering through as employment benefits, what we’ll do at Savon SP go hunt for patient assistance program. In essence, if let’s say Ben, who is an employee of yours needs a specialty drug, technically, they will not have any coverage, well, what we’ll go do at Savon SP is look for these patient assistance program and pull it out and utilize that. But what happens if the company doesn’t have a patient assistance program or refuses to provide the patient assistance program, which a lot of them are doing if they find out they’re under to maximize a program or accumulated program or these alternative funding programs, you’re left with no coverage. And technically, that is what is happening with these alternative funding programs is that organizations like Savon SP are utilizing a loophole in the Affordable Care Act terminology about drugs and drug coverage and denying coverage of medicines specialty drugs to their employees. Now, a lot of folks believe this is illegal. And when you hear them pitch this idea to employers, Zoe, it’s interesting, every other word is that well, there’s some gray legality and gray area of legality issues here. And you need to check with your general counsel or your attorneys to make sure that this is kosher, this is going to be a problem. And this is a major problem. Because in essence, as a patient, if you’re under one of these alternative funding programs, like Savon SP types or maximize or Savon SP programs, you as a patient don’t have any coverage for specialty drugs, you’re depending on the patient assistance programs from these pharma companies.
Zoe Rothblatt 08:55
And like you said, those programs run out. So it’s like not feasible to just depend on those programs.
Dr. Robert Popovian 09:02
Yeah, I think the unfortunate part for all of this, and you alluded to it a little bit is that patients are double paying. So these patients this program get captured by the PBMs. And the insurers as profit, and the patient is almost like double billed, because not only they have to pay for their medicine, but they have to also pay for the deductible twice, even though the deductible you know, the Patient Assistance could have easily fulfilled that requirement. And it’s unfortunate because it’s all profit for the PBM. That’s going to go directly to the pockets of the PBMs and the insurers.
Zoe Rothblatt 09:33
I was gonna say how can they get away with this? But in some cases they’re not. I know that I briefly mentioned at the top that there are state laws that help protect patients, can you talk to us a little bit about these laws and how they help protect against these policies.
Dr. Robert Popovian 09:48
So you live in New York, Zoe?
Zoe Rothblatt 09:50
That’s right. Yes.
Dr. Robert Popovian 09:51
You are in one of the states that’s actually done the right thing, it’s protecting the patients. It’s prohibiting schemes like accumulators and maximizers to happen. So in the case of the state of New York, they required that any kind of assistance no matter where it came from, whether it came from manufacturer, or your uncle Charlie, has to be able to be applied to your deductible. So there are 18 other states similar to New York. So total of 19 states that have passed legislation, policymakers have passed legislation to protect patients, that’s really good. And to be honest with you, they’re both large and small states, there’s New York and Texas, two of the largest states in the country, have passed it. We also have states like Illinois, and Oklahoma and Louisiana who have done so as well. So more to come, hopefully in 20, the rest of 2023 and 2024, where state policymakers are stepping up and trying to protect patients. And you know, one of the things that you always get pushback from we try to address through our tool on the GHLF website. But one of the things I have to say is that the state legislation is not enough. And the reason it’s not enough is because state legislation really regulates state regulated health insurance. So if you’re fully insured person, yes, you will benefit from that. And I know Zoe you’re under one of those plans through Global Healthy Living Foundation. But if you’re in an ERISA plan, which is a self funded plan, these state laws do not protect you. So in essence, we need federal legislation to be able to capture everyone.
Zoe Rothblatt 11:17
And there is legislation at the federal level, The HELP Copays Act, which our 50-State Network has been really active in advocating for but it’s kind of like working backwards, the states should help fill in the gaps of the federal legislation. But it is good to hear about the momentum around the states and that, you know, nearly half of the states are passing these laws.
Dr. Robert Popovian 11:37
That’s right, and Cory Greenblatt that works with us, he does a great job of promoting that on behalf of Global Healthy Living Foundation with state and federal legislators.
Zoe Rothblatt 11:46
So talk to us about this tool and how it can help again, some of that pushback you’re talking about.
Dr. Robert Popovian 11:52
So the pushback really, from the insurers and the PBMs it’s the boogey man issue, right, so every time a policymaker or an advocacy group, or Corey, for example, brings this up as a solution to help patients out, one of the biggest lies that the insurers and PBMs tell people is that premiums are going to skyrocket. Just know that if you pass this legislation to help patients and protect patients, all of a sudden these premiums are going to go up. So last year, we decided to release a tool which is publicly available, it’s all public data, and it’s open to anyone that wants to go, whether it’s the insurer or the PBM, any patient advocacy group, policy makers, they can go in there, take a look at it. What we found is that last year that there was absolutely zero impact on premiums. That means passage of these laws and regulations in the states to protect patients had no impact on whether or not the premiums went up or went down. In fact, we have a really nice graph of the states that have passed it and the states that have not passed legislation yet to protect patients, and guess what premiums are identical and the up and down level is identical. It makes no difference. And so this year, we decided and this is why we’re talking about it again, is we rereleased it with newer data going back all the way, I think, to 2014, that we have information for premiums, and anybody can go again. And we updated it with now 19 states passing it again, nothing changed. In other words, the boogeyman is really a lie. It’s something that is brought up by the insurers and the PBMs constantly to scare policymakers from doing the right thing.
Zoe Rothblatt 13:20
And have you brought this to policymakers yet and gotten any feedback? I’m wondering what have been the perspectives from stakeholders when they hear that this boogeyman isn’t so buggy?
Dr. Robert Popovian 13:30
That’s a great question. So yeah, we know personally, I know that there are several legislative bodies have utilized the information to be able to introduce or pass laws, most recently, you know, one of our colleagues, JP was both in Texas and in Wisconsin advocating for utilizing this information to be able to advocate for it. But you know, since we introduced this tool last year, I think it was end of last year, like November or October of last year, over 2000 people have visited the site have taken a look at it. So our assumption is that people are using it, people are trying to utilize it to push back on the major the number one sort of complaint that the insurers and the PBMs have or have convinced employers and policymakers, which is this increasing premiums, which is absolutely not true, there’s no truth to it.
Zoe Rothblatt 14:16
That’s great to hear. And we’ll drop a link to the tool in the show notes. Because you know, our listeners, our patients and our network, you guys can all use this tool and bring it to your legislators, share it on social media and use it to help advocate for these laws because I’m sure I know I’m affected by this, if you live with a chronic condition, you most likely are too and we shouldn’t be paying double, we should be getting health care at an affordable rate.
Dr. Robert Popovian 14:41
And you should benefit 100% from the patient assistance, which is meant for patients not PBMs. The P stands for patients PAP not PBMs.
Zoe Rothblatt 14:49
That’s right. So Robert, are there other policy issues that are in play that can protect patients from other predatory schemes like this?
Dr. Robert Popovian 14:58
Yes, definitely one other thing that we’ve seen in the states that protects and sort of undercuts this whole accumulators and maximizers, besides passing these bands in the state level is anti steering laws, anti steering laws prohibit and Texas passed the first one, and it’s probably the most effective one, it prohibits pharmacy benefit management to mandate the patient has to go to a PBM owned pharmacy, so the patient can go to any specialty pharmacy to acquire their drug. And those are that’s important because one of the ways that PBMs and insurers sort of mobilize on these accumulators and maximizers is to mandate everybody to go to their PBM owned pharmacy. And this is another little secret that nobody knows not so much little anymore, because we’ve been talking about it. But specialty pharmacy where majority of these programs are impacted, right specialty drugs, almost 70% of specialty drugs in this country are dispensed through PBM, the three largest PBM owned pharmacy, so Optum, CVS Health and ESI dispense about 70% of specialty medicines in the United States. And that’s another problem with this market is that it’s so manipulated, and there’s so little competition or lack of competition that drives this type of behavior and makes it so successful PBMs. And insurers really to take advantage of patients.
Zoe Rothblatt 16:14
Yeah, I mean, it’s exactly that it is taking advantage of patients. And you know, that’s why our network is so important to bring patient voices to the table, because it really is about us at the end of the day, and us feeling good, and it is our everyday life. And I think that it’s hard to remember that these are real people with real symptoms, and that each law each, like little policy really does make a difference in someone’s life.
Dr. Robert Popovian 16:37
Without doubt. And you know, and I want to make sure that everybody knows and you talked about the link for tool because people need to be educated, the more educated we are, the better pushback we can give to these predatory type of schemes that take place and take advantage of patients and to the profit maximization of PBMs and insurers. And one other thing I know Ben is going to take care of this, but we are having a webinar on July 27.
Zoe Rothblatt 17:01
Right, right. Tell us about that.
Dr. Robert Popovian 17:03
Yeah, we have a webinar scheduled right now on July 27, from 12pm to 1pm Eastern Standard Time, it’s gonna be a live webinar, we’re going to discuss the tool we’re going to discuss we’re going to have JP on, you know, as a patient who has experienced accumulators and maximizers, herself as a patient to talk about her experience. And we’re going to record that webinar and we’re going to keep it alive on the site. For anybody who cannot attend. We want them to come on live and ask questions. But if you cannot, we will have it as something that you can go back and look at later on.
Zoe Rothblatt 17:33
Yeah, and we’ll put that link in the show notes as well. I definitely encourage all of our listeners to go, I’ll be there. And Robert, thanks for giving us the first scoop on The Health Advocates.
Dr. Robert Popovian 17:43
Absolutely. You guys get the first one. So we haven’t even done it in Healthcare Matters. So Ben, we gotta get cracking on that one.
Zoe Rothblatt 17:52
Well, thank you so much for joining us today. Congratulations on the launch of this tool. And I know it’s just going to help so many patients, it’s already making a difference, like you mentioned among stakeholders. So thanks for all that you do, Robert.
Dr. Robert Popovian 18:04
And thank you for having me. And we want to have you come back on and talk about some of your experiences as a patient but also as a policy expert. I know you work a lot on different therapeutic areas as a policy lead, and we would love to have you back on the Healthcare Matters podcast one of these days to talk about some of the work that you’re doing.
Zoe Rothblatt 18:21
Thank you. Well, it’s been a month of insurance battles. So I’m like ready to vent on Healthcare Matters any day.
Dr. Robert Popovian 18:29
Bring it on.
Zoe Rothblatt 18:32
Well, everyone, thanks for listening to The Health Advocates a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating and review on Apple podcasts. And don’t forget to check us out on YouTube. I’m Zoe Rothblatt. We’ll see you next time.
Narrator 18:51
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
S6, Ep13- Pandemic Preparedness and the Rising Malaria Threat
Our hosts cover the latest news on drug shortages in the U.S., and the reauthorization of the Pandemic and All Hazards Preparedness Act (PAHPA). For the main topic of the episode, our Health Advocates discuss what we know so far about the recent malaria cases in the U.S., and the importance of a public health response and local health advocacy to make your voice heard.
“For the first time in two decades, federal health officials have confirmed malaria infections in people who did not travel outside of the United States, leading officials to warn about the potential transmission of the mosquito-borne disease within our country,” says Steven Newmark, Director of Policy at GHLF.
S6, Ep13- Pandemic Preparedness and the Rising Malaria Threat
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:18
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:22
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:29
Today, we’re going to talk about some recent malaria cases in the US and how it impacts public health. But first, we do have a few news updates.
Steven Newmark 00:38
Yeah, so first, some bad news. The drug shortage in our country is continuing a few episodes ago, we talked about the drug shortage and it is still an issue, especially for cancer drugs. Other drugs, like some antibiotics are also in short supply.
Zoe Rothblatt 00:52
And we talked about this being a result of the generic market with little incentive to invest in generics, also quality control in some facilities. Everyone could definitely check out that episode for more information. But I guess an important thing to highlight here is that a drug that many in our community use, methotrexate, is in shortage. So we had asked on social media if people are affected by the methotrexate shortage. 78% said no, 22% said yes. Obviously, it’s good to see that the majority are not affected but 22% is still people affected and anyone affected is you know, a life that’s being altered. Maybe someone’s in pain or can make it to work are just is really struggling through the day. So if you’ve been affected by the shortage, definitely let us know you could email us at [email protected]. We’re staying on top of the news and hope that everybody has access to their drugs.
Steven Newmark 01:43
Yeah. A spokesman from the FDA announced just a few days ago that the agency is bringing in cancer drugs from China, which by the way, in a funny way, speaks to our complicated relationship with China back and forth. So anyway, we will keep monitoring and keep updating as appropriate.
Zoe Rothblatt 01:59
Definitely. So next on our news list is about the pandemic preparedness bill. So the Pandemic and All Hazards Preparedness Act is a landmark bipartisan legislation that has successfully like steered our nation’s biosecurity policy ever since 2006. And it’s currently under reauthorization. It expires at the end of September of this year.
Steven Newmark 02:20
Yeah, if COVID has taught us anything, it is the importance of being prepared and strengthening public health responses in advance of a pandemic and that’s something we’ll talk about a little bit more later in the episode.
Zoe Rothblatt 02:31
So the House Energy and Commerce Committee held a hearing in June for this legislation, and it included various proposals. The Senate Health, Education, Labor, and Pensions Committee Chair Bernie Sanders and ranking member Bill Cassidy released a discussion draft including more changes in early July. So you know, there’s discussions happening, but there’s no final ruling yet.
Steven Newmark 02:54
We will continue to monitor and continue to advocate for its reauthorization, of course, and keep you updated. So moving on to our main topics for today, we want to talk about generally the importance of public health. And specifically, we’re going to talk about malaria, because for the first time in two decades, federal health officials have confirmed malaria infections in people who did not travel outside the United States, leading officials to warn about the potential transmission of the mosquito borne disease within our country.
Zoe Rothblatt 03:25
Yeah, this is surprising because malaria was declared endemic, right and it’s not been in the U.S. unless people travel outside. So what’s going on? Why is it appearing in the U.S. all of a sudden?
Steven Newmark 03:36
Yeah, let’s just say first and foremost, malaria is a huge issue when it comes to global health. And in fact, half of the world’s population, mostly in poorer, hotter countries are impacted by malaria. And it’s one of the leading causes of death in developing countries. But essentially, as our climate is changing, it’s bringing warmer weather further north, which means more mosquitoes traveling further north. So two things are happening when it comes to these mosquitoes that carry the disease. Number one, as I mentioned, is the migration. malaria mosquitoes are moving, you know, they’re already here but it’s not just malaria mosquitoes is other mosquitoes that aren’t native to the U.S. that are also moving further north. And we’ve seen other mosquito borne diseases over the last decade or so Dengue fever, Zika virus have started to show up in the U.S. and in Europe. And the second major issue is transmission. It’s easier for mosquitoes to transmit diseases in warmer climates so as temperatures rise, it’s easier for it to be transmitted.
Zoe Rothblatt 04:33
So given that migration and transmission, should we expect that we’re going to have a massive malaria outbreak here in the U.S.?
Steven Newmark 04:40
Not anytime soon, thankfully. You know, just to be clear, we’re not issuing a flashing red light warning to batten the hatches this week. But I think as we have this conversation, we’ll see the importance of for preparedness like we were talking about with the legislation upcoming in Congress and its issue. In terms of the specific outbreak or the specific cases, I won’t even call it an outbreak, teams in Florida and Texas are already spraying insecticides in the areas where cases were reported and were able to keep it under control. Years ago, I remember being active in public health when Zika came first appeared. And there was a response in terms of the insecticide spraying to keep it at bay. And we did, so the risk to the public today in the United States is very, very low. However, it could be the kind of thing that if we don’t take action, or if we ignore it, we may start to see something in the next 10 or 20 years.
Zoe Rothblatt 05:30
It’s like an ominous warning on the importance of public health. A lot of times those public health, it’s hard to see the victories in it because when public health is successful, you’re not seeing an outbreak, right, like nothing should be happening. So it’s like hard to imagine you in 10 to 20 years we could see this, we have to act now. But it’s really important to bolster public health response. But that’s obviously hard because as we know, we’ve been losing trust in public health.
Steven Newmark 05:55
Exactly. There are certainly things that we know that we can do to bolster public health when it comes to malaria and other another mosquito, we’ll call it mosquito borne viruses and other tropical diseases that may find their way north. But we can’t wait until it’s too late and like you said, it’s hard to prepare for invisible diseases. It’s so hard. I’ve worked in government and it’s hard to get funding for snowplows in the middle of summer, because you don’t see the problem. You don’t, nobody wants to spend money on something that they don’t see the problem for. And that’s just how it goes. And a lot of times, as you said, a successful eradication of a potential pandemic is not really praised very much, you know, going back to viruses like Zika, which, you know, never fully made its way here, Ebola, we were able to tamp that down, H1N1 flu, all the various flus that came from Asia over the last 15-20 years. And then of course, it was COVID, which shows what can happen, which can lead to a pandemic, and what we’re seeing is an increase in the number of viruses present in the human population around the world number one, and number two, an increase in travel, of course, people travel more than they’ve ever traveled. And that could combine to you know, cause a heart ache if we don’t do something.
Zoe Rothblatt 07:11
So how, how can we do this? We’ve been talking about combating misinformation, gathering public trust, like, yeah, I guess it’s important to highlight where in lies the issue and what could we do next in order to help bolster public health to show what a good functioning health program can be to eliminate risks like malaria?
Steven Newmark 07:30
Yeah, that’s a billion dollar question, maybe even a trillion dollar question, depending on how much these pandemics costs us worldwide. I’m speechless. I don’t know the answer. I think no, look, I think ultimately, it comes down to you know, public health is inherently political, it’s public, it’s in the word meeting, and requires buy in from the public from the people it needs to be, you need to have a bi directional conversation with the public, you can’t put people down who are anti public health, if you will, if somebody is opposed to vaccines, or has interesting, shall we say, ideas about sources of viruses, or is disbelieving in viruses. I think you have to treat each person as an individual and try to have those conversations. And I think the ultimate thing to ask is, you know, somebody once asked me, how do you convince someone that they have their facts wrong? And I don’t have an answer for that, other than to say, what would it take for you to be convinced otherwise? And if they don’t have a proper answer for that, then I know that they’re not being intellectually honest. And I wouldn’t bother expending my time and energy trying to engage that person. But if they do say, look, I could be convinced if I only knew this, this, this and this, then at least we could start, that’s where the dialogue begins. And it’s almost a one on one. And I think, you know, overarching, I think perhaps it means training our public health officials to be better communicators.
Zoe Rothblatt 08:52
Yeah. I mean, we talk about this a lot in our community for people with chronic disease and right, you know, just expressing your risk and what makes you comfortable, and especially in COVID, talking about how the vaccine is important for you and for those around you to be vaccinated because it helps protect you. And I think you’re right, it like has to do a lot of conversation and communication and just learning over time about these issues.
Steven Newmark 09:17
Yeah, exactly. I think some of it just in talking out loud. When you hear leaders talk down about public health, that obviously has a dispiriting quality to it, when you hear leaders talk positively about public health it has a reverse opinion, and I think what we do at GHLF, we bring people to meet with policymakers, elected officials and tell their stories. And in so doing, it makes it more difficult for leaders to speak negatively about public health. It gives leaders a lens of sympathy, in some cases, empathy to make it simpler for these leaders to take a positive stance when it comes to public health, which sort of has a trickle down effect, if you will, and to the public at large. So I think it’s getting buy in from nonpublic health folks in leadership positions, for sure. And I think we do that here at GHLF. I think a lot of our listeners are folks who have joined us in meeting with these policymakers. And that’s a big deal. And we have to just keep doing that. And when it comes to the science side of things, perhaps part of it is becoming better communicators, and figuring out a way to speak to the public at large in a better way. But of course, it’s difficult, because we’re all so siloed in our different worlds of where we get our information.
Zoe Rothblatt 10:31
Right.
Steven Newmark 10:31
And I’ll just add on a federal judge in Louisiana on July 4 of all days, July 4, issued a ruling restricting government administrators from communicating with social media platforms about broad swaths of content online. And, you know, a lot of folks have said that this ruling was really aimed at the Biden administration, particularly the health and science folks communicating with social media companies about misinformation on their websites. This is not about the case, it’s not about the Biden administration, or any administration stopping the publication of such information, it was more about just engaging the dialogue like, hey, just so you know, there’s so and so is publishing false information, and they have a lot of followers, it’s something you may want to be flagging. And there’s a whole host of First Amendment issues that we’re not going to get into here. But it certainly will make it more difficult for public health folks in government to communicate with the social media companies. And as I said, we live in our silos and if your silo is such that you’re getting a feed of misinformation constantly, it is hard to combat that.
Zoe Rothblatt 11:36
So is that restriction staying in place? Or is someone arguing against it?
Steven Newmark 11:41
So the government actually very quickly filed an appeal to the Fifth Circuit Court of Appeals, and we’ll see where that leads. You know, like I said, it’s more complicated than we’re able to get into on this podcast. But it should be known as the kind of thing that has implications for public health. It’s and beyond public health, although there are hate groups, for example, that pop up online that spew certain information and collect followers and the FBI could go, at least prior to this ruling could go to social media companies and say, hey, there’s this group on on your feed that’s collecting 1000s upon 10s of 1000s upon 10s, of 1000s of followers, and we think it’s something you should take a look at, or there’s a certain group that’s spreading misinformation. And we have reason to believe it’s it’s actually a foreign actor who is publishing this information to discord in our country, something you should take a look at. So it goes beyond public health, just to be clear, but yeah, it makes it harder when we continue to be siloed.
Zoe Rothblatt 12:35
Definitely. Well, you know what I was also thinking, we’ve talked in our news updates before how there’s going to be a new CDC director, and there’s reorganization within the CDC. So I wonder how also that will play into public trust and communication amongst our leaders as well.
Steven Newmark 12:50
Yeah, for sure. It’s interesting, there’s a lot of articles in my feed my social media feeding, because we all have our silos. And I’m seeing a fair amount of articles about the pandemic, looking back from journalists that I like, who are talking about what I got, right and what I got wrong in the last three and a half years. And it’s kind of interesting, because I think for the most part, most of what was said wasn’t wrong, it was working within a very difficult circumstances to try and pass along the best information possible. And there was no way you could have gotten everything perfectly right. That would have been, that would have been Zika. That would have been Ebola. That would have been one of the other crises that we mentioned that never materialized. So it was a difficult situation. And and I think latching on to mistakes that you made doesn’t make it bad. I mean, look, I love sports, right? You could watch the Super Bowl, the Super Bowl winning team and the day after, you could have a video showing all the mistakes that the winner of the Super Bowl made and if you only focused on like, oh my god, they had that fumble, oh, my god they had that run play, you know, they lost the yard and that run play that when you’re in the heat of the moment, nobody executes perfectly. It’s a near impossibility, particularly with something that had never happened before. And I hope that going forward, the judgment is fair, you know, judging by the circumstances, not with 2020 hindsight.
Zoe Rothblatt 14:12
So what can people in our community do, I would say, call your elected officials and talk about the importance of public health and that you would want them to support any, like pro public health legislation that arises.
Steven Newmark 14:25
Right, right. I mean, I think it’s everything that we continue to talk about it, talk one on one with your own family members, one on one with people in your community, talk on a larger scale with local public officials talk on an even larger scale. Join us when we make our trips to state capitals into Washington and express our views and make sure your voice is heard. And that’s really what it’s all about. And it’s not about you know, I certainly don’t think it’s helpful to engage, as I said, in ad hominem attacks against people who have different views. It’s certainly not helpful to just dismiss and yell and scream that really doesn’t help, you can try to engage in a dialogue one on one that’s can be difficult but as needed, it’s those dialogues and just continuing to spew what I would call the proper information and when it comes to public health and its importance, and hopefully will continue to be a loud voice.
Zoe Rothblatt 15:16
Well, that’s a great message to end on. Thank you, Steven. What did you learn today?
Steven Newmark 15:20
You know, I learned in the course of our discussion, just how important public health is and how difficult it is to actually come up with a response on how to increase the public’s exposure to public health and its positive aspects on society.
Zoe Rothblatt 15:34
Definitely. And I learned from you just about the responses we’ve had in the past to different public health threats.
Steven Newmark 15:43
Well, we hope that you learned something too. And before we go, we want to encourage everyone to check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 15:52
And don’t forget to email us at [email protected]. If you have any questions, comments, topics you want us to dive into. Well, thanks everyone for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating and write a review on Apple podcasts and definitely hit that subscribe button wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 16:14
I’m Steven Newmark. We’ll see you next time.
Narrator 16:20
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
S6, Ep12- Navigating COVID Updates: The Latest from the FDA
Our hosts cover the latest on new CDC leadership, why millions are getting disenrolled from Medicaid, and the latest quick poll results from GHLF’s Patient Support Program. For the main topic of the episode, our Health Advocates dive into the recent FDA committee meeting on recommendations for the COVID-19 vaccine.
“The FDA uses advisory committees generally to: 1. get advice from experts who work outside the agency; 2. work towards transparent and open government; and, 3. to encourage patients, health care providers, and other interested people to share their views during open public hearings or by submitting comments to their docket,” says Steven Newmark, Director of Policy at GHLF.
S6, Ep12- Navigating COVID Updates: The Latest from the FDA
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:18
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:22
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:28
Today, we’re going to talk about what’s going on with the recent FDA meeting about vaccines, along with news updates on new CDC leadership and also the disenrollment from Medicaid.
Steven Newmark 00:39
All right, well, let’s get into it. As you just mentioned, there’s a new director at the CDC. President Biden announced plans to appoint Dr. Mandy Cohen, the former North Carolina Health Secretary as the next Director of the CDC.
Zoe Rothblatt 00:52
And Dr. Cohen will take over for Dr. Rochelle Walensky. This appointment actually does not require Senate confirmation, meaning Dr. Cohen can just go into the role as soon as Dr. Walensky steps down, although Congress did recently passed legislation requiring the agency’s director to be confirmed but this won’t take effect until 2025.
Steven Newmark 01:14
Dr. Cohen will oversee the CDC’s recently revised efforts to track the Coronavirus including in wastewater, she will also be responsible for a vast set of public health crises handled across the agency’s centers, including other infectious disease outbreaks and opioid misuse.
Zoe Rothblatt 01:29
And, Steven, we’ve talked about this on here and just amongst ourselves generally, how trust in the CDC has gone down over the pandemic. So I think it’ll be interesting to see how this leadership change impacts that trust. And there’s also an overhaul in the CDC, a reorganization of work to change positions, modernize data systems and improve CDC communication. So Dr. Cohen will also be in charge with overseeing this, so it’ll be interesting to see how, you know, public perception of the CDC changes with leadership.
Steven Newmark 02:00
Yeah, some other news, we’re learning that millions of people as predicted are getting disenrolled from Medicaid. This is a result of post public health emergency procedures.
Zoe Rothblatt 02:12
And the Biden administration actually asked states to slow the removal of beneficiaries from their Medicaid because we’ve seen so many lose coverage so quickly.
Steven Newmark 02:21
Yeah, more than a million Americans have lost coverage since pandemic protections ended in April. And this is mostly we’re just highlighting this as an issue and reminder to double check your insurance.
Zoe Rothblatt 02:31
And lastly, on our news updates, we have the results of our quick poll on COVID. So as a reminder, these are polls that are sent out to our COVID-19 Patient Support Program. And this was kind of to see where people are at with COVID protections and their experience with COVID generally. So let’s get into the results. We found that about half have gotten COVID and half have not I found that really interesting because when I…
Steven Newmark 02:56
Half have gotten COVID since 2020?
Zoe Rothblatt 02:58
Mhm.
Steven Newmark 02:59
Wow, it’s pretty low.
Zoe Rothblatt 03:00
Yeah, because when I think about your my circles, I don’t think I know anyone personally that hasn’t gotten COVID yet.
Steven Newmark 03:08
Yeah, I thought the numbers across the United States were in the 80s and 90s but okay.
Zoe Rothblatt 03:13
Well, this may help explain some of that, because we also asked about masking and generally it seems like people are masking indoors over half said, around 60% said they mask in an indoor public space, 60% said they mask in public transportation, about 50% at an indoor event. Versus the outdoor masking was around 15%. So you know, that probably contributes to the fact that yeah, only half have gotten COVID.
Steven Newmark 03:41
Yeah, for sure. I suspect that the rates of masking are much higher than in the general population at large, which is a testament I guess.
Zoe Rothblatt 03:48
Let’s jump into our main topic for today. The recent committee meeting for the FDA, it’s called the V R B P A C, VRBPAC, which stands for Vaccines and Related Biological Products Advisory Committee. That’s a mouthful, but you know, we’ll dive into all that was discussed.
Steven Newmark 04:07
Yeah, so they met on June 15. And by way of background, the role of VRBPAC is to provide non binding recommendations for consideration by the FDA, with a final decision on approval to be made by the FDA and the FDA uses advisory committees generally to number one, get advice from experts who work outside the agency. Number two, work towards transparent and open government and number three to encourage patients, healthcare providers and other interested people to share their views during open public hearings or by submitting comments to their docket.
Zoe Rothblatt 04:36
And the committee’s discussions are just designed to help ensure that the public is clear about the FDA’s expectations for data to support the safety and effectiveness of products so that you know the public can be confident that the required regulatory standards will be met for you know all products.
Steven Newmark 04:53
So this meeting was on COVID-19 vaccines going forward. And so let’s get into it some of the takeaways. So, you know, why are we updating the COVID-19 vaccines? Well, we could keep the same formula this fall but there are several reasons that were presented, why we should update and they are. Number one, COVID continues to mutate quickly, now two times faster than the flu. It’s normal to update vaccines when the virus mutates quickly. For example, we update the flu sort of every year and we don’t update vaccines for the measles, which hasn’t mutated in a meaningful way for many decades.
Zoe Rothblatt 05:27
Yeah, that’s so interesting, two times faster than the flu just to you know, to compare it to something seasonally. What were some of the other reasons?
Steven Newmark 05:35
Well the current Omicron variant known as XBB is circulating meaningfully different, that’s their quote, meaningfully different, than other Omicron variants and presentations indicated that an updated vaccine with XBB would help our immune systems recognize the change. And finally, COVID-19 vaccines are waning in protection. This is happening faster when we are exposed to XBB virus compared to other Omicron variants. Oh, and I should mention too, I guess is the recommendation was to go from a bivalent back to a monovalent agai. If you recall, the original vaccine was a monovalent that means it was targeted towards one variant, which was the original Wuhan variant. Then in 2022, the vaccine formula was updated to buy bivlaent, which was targeting two variants, the original variant as well as the Omicron ba.4 5 variant. Now the FDA wants to go back to monovalent, targeting only Omicron XBB.
Zoe Rothblatt 06:25
And when we say back to a monovalent, we don’t mean back to that first vaccine.
Steven Newmark 06:29
Correct.
Zoe Rothblatt 06:29
Just back to targeting one strain but targeting this new strain.
Steven Newmark 06:33
Correct.
Zoe Rothblatt 06:34
And you know, we do this for a few reasons. This isn’t an on the whim decision, but you know, the WHO is not seeing any evidence that the earliest variant is still circulating, so we can focus on you know, XBB, really the only strain out there now. It’s smart to train our immune system to target what’s currently circulating, and Novavax found that a monovalent vaccine may be more advantageous to mice’s immune systems than a bivalent and Maderna found the same thing. So yeah, you know, interesting to see these results and how they’ll end up working in the real world.
Steven Newmark 07:07
Yeah, I mean, obviously, there is the possibility of a variant popping out of nowhere, which would favor putting another variant to the vaccine. But right now, we don’t see another variant. So predicting what that might be is close to impossible. So to come up with a bivalent for no particular reason makes no sense so looks like we’re going to be sticking with the monovalent.
Zoe Rothblatt 07:25
And I guess what we have on our side is all the new variants are really subvariants, because they’re still in that Omicron lineage. We’re not getting into a whole new territory. So I guess that’s still in our favor when we think about, you know, like having less fear about another variant popping up.
Steven Newmark 07:41
Right. Some other interesting snippets from the presentation, Novavax will be an option this fall. Nextgen vaccines are at least two years away, if we’re lucky, be patient. Remember, this was preserved in the federal budget deal that was part of the debt ceiling negotiations. The rest of the year will be telling to see whether COVID-19 has started to settle into this seasonal predictable pattern fingers crossed as that would you know, if we can get something predictable, that’s obviously to our benefit, you know, comparing COVID-19 to the flu is helpful. But some presenters said that the processes are different and needs to be communicated better, or that these are different viruses, and they do will respond somewhat differently.
Zoe Rothblatt 08:18
Yeah, I mean, that’s like actually a really important point, because I like to compare to the flu. And I think it’s almost comforting to compare to the flu saying, we’ll get this shot annually, we know how the flu works, it’s very predictable. But we do have to remember that it’s not the same we just said earlier in the episode COVID is mutating faster than the flu. So although it can be comforting, it’s important to remember that distinction.
Steven Newmark 08:42
Yeah, absolutely. One presenter, I really liked this, he said, don’t let anyone tell you there is no human data on these vaccines, every vaccine manufacturer presented data from humans and animals. So don’t anyone tell you that these are not tested on humans.
Zoe Rothblatt 08:55
And there’s also post market surveillance, right, you know.
Steven Newmark 08:59
Of course, yeah.
Zoe Rothblatt 08:59
The vaccines go out into the world, and they’re still studied. So you know, we have a lot of data there. And another big takeaway, there seems to finally be global alignment. This was not the case last year, when the WHO recommended ba.1 in the US chose ba. 4 5 vaccine formulas This year, the US, EU, and WHO all seem to agree on XBB, which is a welcome development when we think about you know, tackling this globally together.
Steven Newmark 09:25
Yeah. and finally, there was one of the members talked about communication, she said, we need to ensure that we are, quote, sending the right messages and setting the right expectations and quote for the public, including risk communications. Which is exactly why we are discussing this today and why we will continue discussing vaccines and newfound vaccines that are coming our way across different platforms here at GHLF.
Zoe Rothblatt 09:47
And actually, was anything mentioned in the meeting about number of shots for people with weakened immune systems?
Steven Newmark 09:53
No, not yet.
Zoe Rothblatt 09:54
Or are we still waiting to hear because this is a committee meeting. So once the FDA does approval we’ll probably hear on that. Right?
Steven Newmark 10:02
Correct, yes, yes. We don’t know and nothing was discussed as to who might be eligible for these vaccines, whether it would be for only for the elderly or immunocompromised community or none or whether It’s going to be for the public at large. We shall see.
Zoe Rothblatt 10:17
We shall see. So you know, what’s next?
Steven Newmark 10:19
This is my non medical interpretation, I got strong vibes that it seems as though it’s going to be available for all and it’ll be available earlier for the elderly and the immunocompromised in order to allow those populations to obtain their vaccines sooner as far as the number there was no indication as to when there would they would be more than one vaccine needed for this population.
Zoe Rothblatt 10:40
Well, we’ll stay tuned and see if those strong vibes are, in fact, the truth.
Steven Newmark 10:45
So Pfizer, Maderna and Novavax will start manufacturing millions of vaccines. Once they are ready, the FDA will approve the updated vaccine, then the Advisory Committee on Immunization Practices will determine who should get the vaccine. So that’s what we were just talking about – ACIP, this is a group of medical and public health experts that develops recommendations on how to how to use vaccines and control diseases in the United States. So we’ll see what they say and I would say expect this to happen in the late summer or early fall at the latest.
Zoe Rothblatt 11:13
So enjoy your summer vacation and wait to hear what the next vaccine is going to be once you’re all relaxed and tanned and…
Steven Newmark 11:22
Yep.
Zoe Rothblatt 11:22
Get that salt fresh air from the ocean.
Steven Newmark 11:25
Yeah. Right, right.
Zoe Rothblatt 11:26
I’m dreaming of vacation.
Steven Newmark 11:28
All right, all right. I hear you.
Zoe Rothblatt 11:30
I’m like we can’t get to another, you know, cold fall, variants circulating. I love this outdoor time. So you know, we’ll stay tuned on those meetings. Alright, Steven, that brings us to the close of our show. What did you learn today?
Steven Newmark 11:44
You know, as always, I love learning about our quick polls and another learning that our listeners are definitely in the higher range I think when it comes to mask usage still, which is great.
Zoe Rothblatt 11:54
And I learned from you, that was really interesting that COVID is mutating two times faster than the flu. I feel like I really like to compare the two and it’s a good reminder of the distinction between them.
Steven Newmark 12:07
We hope that you learned something, too. And before we go, we definitely want to encourage everyone to check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 12:16
Well, everyone thanks for listening to The Health Advocates a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating and write a review on Apple podcasts and definitely hit that subscribe button wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 12:32
I’m Steven Newmark. We’ll see you next time.
Narrator 12:37
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
S6, Ep11- Breaking the Stigma: GHLF HEROES
This week, our hosts are joined by Seth Ginsberg, Co-founder and President of the Global Healthy Living Foundation, to learn about the HEROES (Health Education + Reliable Outreach + Empathetic Support) program. HEROES is a free education and outreach initiative that equips beauty professionals to better support clients living with scalp and other skin conditions. Seth reminds us of the importance of community support, personalized care, and empathy toward each other.
“As patients, this is a chance to really not just fight stigma, but beat it back. And it starts literally at a place like a salon or barbershop where this is like a house of influence, if you will. And if we can give them at least what they ought to know and think about these conditions that’s a massive leap forward,” says Seth Ginsberg.
S6, Ep11- Breaking the Stigma: GHLF HEROES
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:22
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life. This week, we have a very special episode with Seth Ginsberg, the President and co-founder of GHLF.
Zoe Rothblatt 00:34
That’s right, Steven, and I’m so excited to have Seth here today, he will talk to us about a new GHLF initiative about making a difference in the community for people living with skin conditions. The program is called the HEROES project, which stands for health education, reliable outreach, and empathetic support. So, welcome to The Health Advocates Seth.
Seth Ginsberg 00:54
Hey, It’s so good to be here.
Zoe Rothblatt 00:56
Why don’t you start off by introducing yourself to our listeners? And you know, just tell them how you got started in this work supporting patients with chronic diseases?
Steven Newmark 01:05
Wow. Well, “none of us is as strong as all of us.” I totally get that in the advocacy world. I don’t get it for a local bank, but okay.
Seth Ginsberg 01:05
Absolutely. Well, I happen to be the co founder and the president of the organization, Global Healthy Living Foundation. And I’m with you today wearing the biggest smile and such happy pride and joy for both joining you all, but also having the chance to talk about this HEROES program that we’re doing now with the Global Healthy Living Foundation. So just to help folks who might not know, I was diagnosed with a form of arthritis called spondyloarthropathy at the age of 13, and I spent my childhood my teenage years really active throughout the community and volunteering for the Arthritis Foundation and doing anything I could to help folks living with arthritis. And then I went away to college, I was a first year student at Babson College and I emailed in the middle of the night, the first month of school, my former high school internship boss, a guy called Lou Tharp. And I said in one sentence, I was miserable and I was having a flare and like life wasn’t going as planned first month of school and I said, there’s got to be a way to bring people together in a positive environment where we could share strength and experience with each other. There have to be other people going through something similar. And when Lou woke up just a few hours later, he wrote, you know, I’d like to become a social entrepreneur, how about we do this together. And then that afternoon later on that day, CreakyJoints was a website, and we’re rounding the corner on 25 years, which is wild, that CreakyJoints has been a real now worldwide force for good really to bring people living with all kinds of rheumatic diseases together. And over the years, you know, when you do this for that length of time, and you just show up every single day to do something to help other people, you know, you aim to evolve. And fortunately, over the years, we’ve really evolved from CreakyJoints into The Global Healthy Living Foundation, which is the official nonprofit 501(C)(3) organization that is the parent of the CreakyJoints online community, and we have the opportunity to advocate and to support and to educate and do research with people living with many different forms of chronic conditions, some related to rheumatic diseases, some not. And working in different areas of focus now, you know, specifically dermatology, for example, skin and scalp health as essentially a sister condition to so many of these autoimmune conditions and rheumatic diseases that we started in really like is the proof of that evolution and speaks to like the need for us all to advocate for each other. And my little soapbox rant here with this local community, I believe it was a bank growing up had this amazing slogan that they would run in the newspaper back when those things were printed. And it said, “none of us is as strong as all of us.” And that really has been like a guiding principle for the advocacy work that we do. And so amazing to get to work with you all and do things like The Health Advocates that we get to really make that difference as a collective.
Seth Ginsberg 03:52
Hey, local marketing.
Steven Newmark 03:54
No, no, no, absolutely. Well, there’s so many great things that GHLF, we at GHLF have done. So many great programs that we’ve run to help patients and let’s talk today about the launch of our latest program, the HEROES program. Tell us what the program is and how this idea came about.
Seth Ginsberg 04:19
Awesome. Yeah, this is one of those fun things we get to talk about in the present and future tense because the HEROES program as Zoe mentioned stands for health education, reliable outreach, and empathetic support. And this is an initiative that GHLF is kicking off literally now as a world wide movement. And our aim with the HEROES program is to equip is to help is to support anybody in the appearance enhancement service provider industry. These are people who are licensed to take care of the way you look essentially, whether it’s your skin as an esthetician, your scalp and your hair as a beauty stylist, or barber or your nails in a manicure pedicure spa. They’re licensed, they have to literally get permission from your state to do these things for you. And our aim is to equip these folks with the information that they need to know about what it’s like living with common skin and scalp conditions so that they can essentially be better at what they are and do and as importantly, be there to support those of us living with skin and scalp conditions and make that a better and quicker and more, you know, healthier process for us. These are folks we all go to, or if not most of us to get our hairs cut, to get something waxed here and there, to get something you know, done and touched up and knowing that the person on the other side of that counter or behind us in that chair is knowledgeable and knowledgeable by GHLF, and trained and a part of our programming means not only are they going to know about these conditions, but they’re going to be an empathetic, helpful and proper steward for that individual. And that’s what HEROES is and why we’re so excited to launch it.
Zoe Rothblatt 06:08
That’s great. That’s so exciting. And I want to pick up on something you said about equipping stylists with information. So we talked to people living with chronic disease all day long. We know a lot about their needs, and what kind of support and research and advocacy they want from us. But I’m wondering, you know, what do stylists want to know? I think we conducted a survey. Could you talk to us a little about the findings there and what stylists want from this program?
Seth Ginsberg 06:33
Absolutely. First, of course, being GHLF we did a survey, we did a study, and we put our absolute Grade A research team in all their PhD glories on to developing and creating a survey that would both inform us and the development of this program, but also to make for the successful implementation to deliver on to these folks that which they want and need. And what we found very clearly, in overwhelmingly positive ways was the fact that these folks are familiar with these conditions. And by the way, I should have stated earlier, we’re talking about common conditions like psoriasis, or atopic dermatitis, which is just a fancy way of saying eczema, or of course, alopecia, which is the loss of hair through a medical condition. And what we want to do is deliver to these folks, these salon HEROES information about psoriasis, eczema alopecia that they can then use in their day to day conversations with their clients, with the people whose hair they’re cutting. This survey said that loud and clear. They’re familiar, they know these conditions are out there, these salons and barbers, but they have no clue essentially, or they’re completely lacking in an understanding and appreciation for what these conditions are all about. And most importantly, and what the study showed us was they want to know, they absolutely need to know and are interested in this. And then we learn things throughout the process, like best ways to send them the information, still very old school, which we appreciate, you know, in terms of wanting flyers and brochures and things like that. But of course, being GHLF, we’re taking to the Instagram. And we have lots of opportunities to have conversations with folks on our Instagram handle, which is GHLF_HEROES, h e r o e s. Zoe, that was I hope an efficient plug.
Zoe Rothblatt 08:26
Amazing plug, if our listeners could see I’m smiling behind the screen.
Steven Newmark 08:29
We may hear that URL a few more times.
Seth Ginsberg 08:31
We need to and I mean, that’s just Instagram. So what happens, let me take a moment here to share a little bit on how it works. So if you are a licensed appearance enhancement service provider, and we’re first starting just to give us an order of operations with our hair salons and barber shops. If you’re a barber or stylist or even work at a barber shop or stylist as a clerk or a hair washer, or whatever you can join HEROES, you enroll in the program to become a hero. And it’s simple, it’s free, of course, totally free. And you basically sign up with an email, cell phone number for text messaging, or an Instagram handle and then select which of those channels you want to get information from and then we have a series and we have various pieces of information as well as invitations to participate in Q&As and events and things like that over time. But not to get ahead of ourselves, it’s a simple enrollment. It’s a very basic program where we’re happy to send you information about these conditions in very human very plain and very, I think, hopefully effective ways. So our aim is for folks to sign up. If you’ve had the opportunity to ever meet someone with psoriasis or eczema or alopecia and wanted to understand more about what they’re going through GHLF is here, GHLF wants you to know there’s a large community of patients who are willing and able to help share their experiences coupled with the medical information that of course you need to know evidence based medical information and then hopefully the world could be a more empathic place.
Steven Newmark 09:03
Seth, what are some ways that patients can advocate for themselves?
Seth Ginsberg 10:04
So, you know, we’re talking about tens of millions of people throughout just the United States and hundreds of millions around the world who live with these skin and scalp conditions and not to digress too much. But you know, psoriasis, for example, it’s an autoimmune condition. It’s like the first cousin, if not the step sibling of rheumatoid arthritis or Crohn’s disease. These are the three kind of rheumatic dermatologic and gastroenterology conditions. But psoriasis is a condition that we need to understand is very present, and nearly 8 million people with a diagnosis of it and many million living undiagnosed, and it affects their lives in treacherous ways, potentially, for a lot of folks, whether that’s from the inside with respect to their immune system, or from the outside from the ways in which the world interacts with you if you have a skin condition like psoriasis. And regardless of whether or not you’re personally impacted, if you have Crohn’s disease, or if you have RA or psoriatic arthritis, this is an opportunity to help one another. And the way in which you can do that is to help enroll folks into this HEROES program, is to allow your salon or your barber to know about this program with encouragement from you who obviously are hopefully you know each other, and if you could share just a moment about your experience, and then an invitation to enroll in HEROES you know, it is the quickest way to help people. And I would say the easiest way, because you’re theoretically going to be sitting in the barber chair or stylists chair in the next few months at least. So if you could direct them to our heroes page, and that’s ghlf.org/heroes, H E R O E S, and if our tech gods are smiling on us, you might even be able to get there just by going to ghlf.org. But fingers are still crossed on that one. But I believe that will be there as well. Anyway, if you could direct your barber or your stylist, that really lovely lady who takes your appointments and checks you in and all that, you could let them know that there’s a program now just for them. And you know, have them take out their phone and have them go to the website right there and have them sign up. And if you can do that, you would really help us and we get to make a massive impact with this movement.
Zoe Rothblatt 12:29
That’s so great. I think many patients can relate to the feeling of not wanting to sit in a chair for three hours of hair dye because their joint stiffness acts up and it’s really uncomfortable or delaying a hair appointment because their skin condition is flaring, and they don’t feel comfortable going it will cause a lot of pain. I can think of so many scenarios where patients were probably shut down or embarrassed by someone in the salon because they weren’t familiar with the condition and the fact that we have potential to change all of those scenarios and help people feel comfortable in everyday life at you know a place that should make you feel beautiful and make you just so comfortable. I’m so excited about this program and I hope that our listeners nominate their stylists.
Seth Ginsberg 13:10
That’s awesome. And that was really well said and exactly right. And I think that when we think about it from our own shared experience standpoint, as patients, this is a chance to really not just fight stigma, but beat it back. And it starts literally at a place like a salon or barber shop where this is like a house of influence, if you will. And if we can give them at least what they ought to know and think about these conditions like that’s a massive leap forward. And then I think if we were to put our heads around what someone’s going through going to that barber or stylist for many years having something like psoriasis, but never really dealing with it correctly. They’re putting themselves at grave danger by ignoring an autoimmune condition, at least from a just general health standpoint and needing to have a proper medical professional aware and a part of what it is, allow for that doctor or nurse to be you know the person to say what they could potentially or not ignore. But so for someone to be able to spot something like that in a very holistic way and hopefully it just accelerate the diagnosis the process that you know getting that person better I think the better and so there are lots of folks that HEROES program aims to help and we need your help and we need everybody’s involvement because your town big or small is going to have a salon or a barber and this person is welcomed to our program. Welcomed to our organization and welcomed to our community of people who want to help others and that’s what the HEROES program is all about and why we need your help.
Steven Newmark 14:50
Seth, before we let you go it speaking to stylists directly, what do you think the number one message is that is important for stylists to know about skin and scalp conditions?
Seth Ginsberg 14:59
I think the stylists can appreciate more and need to know how important they are, and the role they play in being a community health ambassador, and that’s the message to them, and your barber and your stylist, but also your, you know, many other appearance enhancement service providers. But if we just started with our hair, you are a proper health ambassador. And I want you, we want you, GHLF needs you to know about things like skin and scalp conditions. We also want and need and have to have, you know, about things like vaccines and other and a major medical conditions. But we’ll get there eventually. That’s not today’s objective. Today’s objective is a focused one on skin and scalp conditions, because tens of millions of Americans are affected by them. And you know, we haven’t even talked about the need for people with skin of color and I want to talk about that, and the need to create more of a balanced health equity discussion and awareness and just general share of energy around the skin of color and the importance of focus on that with respect to skin and scalp conditions, like psoriasis, and eczema and alopecia. So HEROES has a, you know, tall aim to really make this impact. And GHLF is literally the only organization that could make this what it needs to be.
Zoe Rothblatt 14:59
Well, thank you so much for joining us today. We’ll have to have you back to dissect that last point a bit more, because there’s so much to talk about there. But thank you so much, Seth.
Steven Newmark 16:28
Yeah, really exciting stuff.
Seth Ginsberg 16:30
I didn’t even get to say how much and I need to tell you how much I love listening to this podcast. It’s my favorite podcast. It’s the one that I download and listen to first. And I do also get to remind my friends and family, especially my family, because there’s no excuse, but they need to leave an honest five star review. And they need to write about in the comments what they heard about and thought about and hopefully even plan to do about these things because of The Health Advocates and so is one of my favorite podcasts.
Zoe Rothblatt 17:02
Well, listeners, you heard it here, leave an honest five star review.
Steven Newmark 17:05
Yeah, thank you for that, Seth. Much appreciated.
Seth Ginsberg 17:07
I’ll come back to you soon now that I figured out how to work this microphone.
Zoe Rothblatt 17:11
Amazing. Well, Steven, we heard a lot from Seth today really informative. Do you want to share one piece that you learned today?
Steven Newmark 17:19
Yeah, I mean, I’ve learned several times the URL for our website and our Instagram page, which is great. And I’m definitely going to be checking it out. And it’s just amazing to know how many different ways there are to connect with people, individuals and patients and really make sure that people are living their best lives. So I’m excited to see where we go with this HEROES program.
Zoe Rothblatt 17:39
And I learned a lot from Seth about the survey and how needed this information is in the community.
Steven Newmark 17:44
Absolutely. Well, we hope that you learned something, too. And before we go, we definitely want to encourage everyone to check out all of our [email protected]/listen.
Zoe Rothblatt 17:56
And if you have any questions or topics you want to hear more about, shoot us an email at [email protected]. Well everyone thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating and write a review on Apple podcasts and definitely hit that subscribe button wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 18:19
I’m Steven Newmark. We’ll see you next time.
Narrator 18:24
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
S6, Ep10- Debt Ceiling Catastrophe Averted: How Health Care is Impacted
Our hosts discuss the Canadian wildfires and what you need to know about the air-quality alerts in the U.S. They also cover the latest news on arguments about ACA preventive care coverage, a new CDC report on prescription drugs, and the FDA’s decision to revoke authorization of the Johnson & Johnson COVID-19 vaccine. Later in the episode, the hosts have a discussion on the debt ceiling negotiations, the budget cuts, and how the deal impacts health care going forward.
“The Republican Party took power in the House of Representatives and over the last election, they had a set of priorities and things that they wanted to negotiate. The Democrats hold the Senate and the White House, and they have their priorities. They came together and hammered out a deal that leaves both parties, both sides, equally happy and also dissatisfied at the same time,” says Steven Newmark, Director of Policy at GHLF.
S6, Ep10- Debt Ceiling Catastrophe Averted: How Health Care is Impacted
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothbart, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:22
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:28
And today we’re going to talk about the debt ceilings, what negotiations have been made there, along with some news coverage on the preventative coverage arguments in the appeals court, new reports from the CDC, the J&J COVID vaccine, and also the wildfires going on.
Steven Newmark 00:45
Yeah, It’s wild. Let’s start there. We’re recording, it’s Wednesday, June 7 in the morning. And, you know, news changes fast so things may have changed by the time you’ve heard this, a little disclaimer. Zoe and I are both waking up in New York City under a haze of smoke coming from these wildfires in Canada, which seems to have engulfed a large swath of the East Coast, if you will.
Zoe Rothblatt 01:06
And I’m especially thinking about our asthma community, people with respiratory issues. Obviously, this is damaging for health generally, but…
Steven Newmark 01:16
Yeah.
Zoe Rothblatt 01:16
It’s really important to focus on people’s chronic disease in this situation, and think how we can advocate, what you can do. Number one is try to stay at home as much as possible.
Steven Newmark 01:27
Yeah.
Zoe Rothblatt 01:27
Or keep your windows closed.
Steven Newmark 01:29
Yep.
Zoe Rothblatt 01:30
If you have to go outside, It’s important to wear a mask.
Steven Newmark 01:33
Yes, a good mask. And we know what that means by now, right? N95, KN95, everyone knows.
Zoe Rothblatt 01:39
And then in terms of advocacy, I wonder, can you call your legislators? What is there to do in a situation like this?
Steven Newmark 01:46
You know, this is somewhat I don’t wanna say unprecedented, but I think for the Northeast, at least, where we live, it is unprecedented. In California, it’s a somewhat commonplace thing. You know, in terms of advocacy, I think the number one thing is just to make sure that folks are informed, making sure that you have the ability to avoid being outdoors, if necessary, if you have a chronic respiratory illness, such as asthma, or lung cancer, something of that nature, working with your employer to potentially not come in, if necessary, not leave your home, is probably the most important thing. And you know, making sure that the local policymakers are at least keeping the citizenry informed and up to date on what’s happening and what it all means.
Zoe Rothblatt 02:32
Yeah, knowing your rights is really important. You might have protections through the Disabilities Act. Also just having your, especially for asthma, having your preventative medications, your rescue meds nearby, and just making sure that you have the right supply of what you need, in case you encounter more breathing challenges during this time.
Steven Newmark 02:51
Yeah.
Zoe Rothblatt 02:51
I don’t have respiratory illness, but when I went out last night, like I felt like it was definitely heavier to breathe, so I can only imagine how much more so.
Steven Newmark 02:59
Yeah, I mean, we’re focusing on individuals who have respiratory conditions. But really, it’s anyone, at least from what I’m hearing and reading and, you know, learning on the fly. Local health officials are saying, really everyone should avoid being outdoors when necessary and avoid doing strenuous activity outdoors, if at all possible. And if outdoors, do wear a mask, you know, it’s kind of ironic, I took my children to school this morning, I said “you got to wear a mask, but this time, you got to wear a mask outdoors.” So it’s a change, and at least from what I’m reading, and again, I’m basing this on readings from, that I’m finding online. It said not too dissimilar to COVID, I suppose, but it said that the cloth masks and even the surgical masks, are really not very helpful for this, for these pollutants, so you need a strong mask, which is particularly tough for children, because they definitely do not make n95 masks for children. I do have KN95 masks and for my kids and I was able to force that on them, like I said outdoors. But yes, not fun times. So I have to just say, just bringing more levity if I may, it was really spooky looking outside last night here in New York, it was just an orange glow over the city. I literally was able to look in fact, I’m able to look right now at the sun outside my window without sunglasses or anything of that nature, which is, you know, kind of spooky, to say the least. But I don’t know, I don’t know what else to say other than hopefully this passes soon and it’s the way of the future, I guess, with these wildfires that continue to grow year by year.
Zoe Rothblatt 04:28
Yeah, exactly. And just like our hearts go out to everyone affected by this. And…
Steven Newmark 04:34
Absolutely, yeah.
Zoe Rothblatt 04:35
You know, I think It’s just important to talk about it and the impact on health and we’ll continue to do so.
Steven Newmark 04:41
For Sure.
Zoe Rothblatt 04:42
Speaking about the impact on health, on our news list we have this week the Appeals Court heard arguments on the ACA preventive coverage. So…
Steven Newmark 04:50
Yeah.
Zoe Rothblatt 04:50
If you remember a few weeks ago, a few months ago, I’v lost track of time now. A judge had said that the mandate in the Affordable Care Act, Obamacare, to provide preventive care coverage, that employers need to provide preventative care coverage. He was saying that, you know, take down this requirement.
Steven Newmark 05:08
Yep.
Zoe Rothblatt 05:09
So arguments have started to be heard. Those who are in favor of preventive coverage argued that this would cause enormous harms to the 150 million people whose insurance under the ACA. You know, the side arguing against it said that’s overstating the effect and insurers won’t just drop all this coverage. So there’s no ruling just yet, but it could come soon. And I read the decision is expected to be appealed to the Supreme Court, but seems like we’ll continue got news on this for a while.
Steven Newmark 05:39
Yeah, you said it all. So we’ll see. Stay tuned, I guess is the report. There’s also a new report from the CDC on prescription medications. Most adults between the ages of 18 and 64 took at least one prescription medication in 2021. But more than 8% of them, about 9.2 million people, said that they tried to save money by skipping doses, taking less than the prescribed dosage or delaying a prescription fill, according to CDC data. Obviously, that’s troubling. You know, you want to take those that you’re supposed to take for your condition. Adults with disabilities, which is about 20% of those surveyed are more likely than adults without disabilities to skip a medication to reduce costs. So that’s certainly something that’s concerning and all I could say is that would urge everyone to take your medication as prescribed. And I do understand that there is a cost burden involved sometimes with that, but it’s important to do.
Zoe Rothblatt 06:30
This just says to me, there’s like a lot of work left to do with our 50-State Network, our group of advocates and to help pass state laws that make medications more affordable and get patients their medication sooner.
Steven Newmark 06:42
Absolutely. Absolutely. And finally, the FDA has revoked authorization of Johnson and Johnson’s COVID vaccine, and after the company’s Janssen unit requested his withdrawal, they informed the FDA that shots bought by the government had expired, and there was no demand for the product in the United States, it’s just not being used. So hence, it’s been revoked.
Zoe Rothblatt 07:01
Yeah, it’s interesting to talk about this bit of news. It’s not like, oh, the vaccine was bad or something, it was just looking at the current demand, we have more updated shots that target the new variants. And this is just saying that we need to get the vaccine into the hands of people globally that need it and here in the US, it’s just not needed right now.
Steven Newmark 07:21
Exactly. All right. Well, with that, let’s turn to our topic for today, which is the debt ceiling catastrophe, how it was averted and how the deal that was struck impacts health care going forward. Before we start, I was remarking the other day internally to colleagues, including you Zoe, about how I’ve been a student, if you will, a politics for many years, and you sort of hit this moment, when you study something for so long that it’s hard to be surprised. But I was surprised not shocked or blown away or anything but I was definitely mildly surprised by how quickly the deal came together, and just really the end result of the deal itself. There was, on the Democratic side of the ledger, you had a lot of people, a lot of Democrats and left leaning folks complaining that President Biden was not negotiating, or he shouldn’t have been negotiating, or he wasn’t negotiating properly, or he wasn’t using his tools of the office properly. And on the other side, with Kevin McCarthy, there was this thought that he couldn’t really negotiate at all because he was at the whim of the far right of House Republicans. And even if he makes a deal, how’s that going to get through? And in the end, I think, like I said, they surprise me and I’m certainly not the only one. President Biden was able to get a deal and Kevin McCarthy was able to make a deal and also suffer minimal backlash, if you will, from that far right in the house and get that deal passed with a majority of Republicans voting for it as well as majority of Democrats as well. So it was fascinating to see bipartisan action like this still exists on something so major, so interesting.
Zoe Rothblatt 08:48
And you know, what do you think led to the ability to do that? Is it just the pressing nature, the deadline where the debt ceiling was gonna be hit like I was, I’m just wondering you know, for future negotiations?
Steven Newmark 09:00
That’s a good question. I think it’s like any expert in negotiations will tell you, you have to know what each side actually wants. For the Democrats and for Biden, they just they wanted a deal first and foremost, and they wanted a deal with as few cuts as possible, particularly to programs that they consider to be important. Let’s put it that way. It wasn’t really that complicated from the Biden side. Biden also wanted a deal that avoided anything, any kind of quote unquote shenanigans, either the idea of printing a trillion dollar coin to raise the debt ceiling or something like that. For McCarthy and the Republicans. the interesting thing is they didn’t have an overarching agenda. You know, the agenda was they want cuts, but really, it was more they’re looking to hurt President Biden, there’s an election coming up in a year and a half, politics was up was more at play than anything else. There were some pet projects here and there, but ultimately, fiscal policy is not really the main driver for Republicans particularly far right Republicans the way it once had been in the Republican Party many years ago. And I think it just was not something that the far right was going up a hill that they were willing to die on. I think that’s number one. And the other thing is people talk about Kevin McCarthy being a very weak speaker, he barely got in, and he’s at the whim of these folks. But I guess he figured out or someone figured out that he, there is actually no alternative for these far right members of the Republican Party, there’s only a handful of them, maybe a dozen, maybe a few dozen, at best, the overwhelming majority of Republicans are not in that caucus. So it’s not as if they could anoint someone from within their caucus to then elevate to become speaker. And if they were to try to find a replacement for McCarthy, well number one, nobody really even wants the job and number two, they’re not going to, there’s just nobody in the waiting in the wings. So he was sort of in a stronger position than then I think we had realized and folks and realize. He also very smartly did something under the radar, he got Donald Trump to stay silent about the deal, because if Trump had been chirping as a bad deal, what have you getting on Fox News and some of these other outlets that would have applied pressure in a way and really upped the ante. So he was able to tamp down that. And he also got two of the biggest folks on the far right Congress members, Jim Jordan and Marjorie Taylor Greene to be on his side. And he gave them some concessions on things they wanted. So whatever he did, behind the scenes with those folks was a pretty big deal. And it also does show his political acumen, if you will.
Zoe Rothblatt 11:21
So lots of factors at play, let’s dive into what was actually negotiated, what it means for public health.
Steven Newmark 11:28
Yeah.
Zoe Rothblatt 11:28
How big are the budget cuts?
Steven Newmark 11:30
Not very big, essentially, there’s some cuts to domestic programs in 2024, but not heavy, and then it limits spending growth to 1% in fiscal year 2025. Now, that’s still a cut, even though it’s a 1% growth, because after accounting for inflation, 1% growth is still considered a cut. But a couple things to remember about two thirds of the $6 trillion federal budget is mandatory spending on programs like Social Security, Medicare, and Medicaid. Those happen without any action by Congress. Those are mandatory. The rest is determined by Congress and that is the list that will be affected by this deal.
Zoe Rothblatt 12:04
So yeah, just to highlight there – Medicare, Medicaid, you’ve mentioned social security, too. But those two public insurance programs are safe.
Steven Newmark 12:12
Well, with the caveat for now, for now. Yes.
Zoe Rothblatt 12:15
Oversimplifying, but yeah.
Steven Newmark 12:18
Yeah, absolutely, absolutely. The exact cuts are going to be set by legislation, you know that Congress is going to pass later this year for the budget. And if they don’t pass legislation the’re going to be automatic spending cuts of 1% across the board in the federal government, excluding mandatory spending on programs like Social Security, Medicare and Medicaid, but those spending cuts do include the military, which both parties vehemently would oppose spending cuts on so yeah, there’s a strong likelihood that a bill will get passed. So you were meant, you know, you were we were talking about Medicare and Medicaid. One of the things that had been part of the negotiations, as we understand it was a work requirement for Medicaid. Work requirement that was part of the original legislation passed by House Republicans for Medicaid recipients was not part of the final act. The final deal however, the debt ceiling deal does include work requirements for Supplemental Nutritional Assistance Program, SNAP, commonly known as food stamps, and a temporary assistance for needy families or TANF, or some people call it cash welfare, both of which already include work requirements, by the way, but there’s an increase in work requirements. And currently, the way it works is for SNAP, childless adults between the ages of 18 and 49, who do not have a physical or mental condition affecting their ability to work are required to work or volunteer for 80 hours a month, essentially. Now, the change here is they expanded the range from 18 to 49, to go all as high as 50 to 54 year olds. So while it may not seem significant, it could have an impact on people applying for disability support who unable to work. People do get sicker as they get older in their 50s. And, you know, so I don’t want to minimize the effect that it was going to have on these individuals.
Zoe Rothblatt 13:56
Definitely especially, I mean, we started at the top of the episode talking about, you know, the impact of the wildfires, COVID still going on. There’s a lot of things impacting our health and ability to work. So even though it might see minor any little minor change is really big impact in the individuals life, especially for people who rely on these programs.
Steven Newmark 14:15
Absolutely. Another part of the debt ceiling is a clawback on unspent COVID aid. And this is something that Republicans have talked about since taking back the house. You know, they were they’re looking to clawback, take back, money that was unspent during the pandemic, and they did secure a win in this deal with the White House agreeing to reclaim some of the funding in the name of reducing spending. However, and this is important, the deal exempts some of the remaining COVID funding, including, I would say importantly, I was gonna say most importantly, but you know, that’s up for debate, I guess. But very importantly, it leaves in money set aside to help develop next generation of vaccines, as well as funding that pays for COVID vaccines and treatment for uninsured Americans. So that was a pretty big deal to stay in on in terms of future vaccine development and future vaccine distribution.
Zoe Rothblatt 15:01
If we’ve learned anything from COVID, it’s we need to keep innovating and finding you know new update vaccines, updated treatments to help protect people. So it’s good to hear that money is still going toward that.
Steven Newmark 15:12
Right? Right. Some of the money that could be at jeopardy is money set aside for data modernization at the CDC and public health surveillance and that could be in jeopardy. But you know, it’s hard to know exactly where these cuts are gonna come from. But one thing we know is at least it was protected for vaccine development. So overall, with the pandemic winding down, and important funding streams unaffected, public health experts for the most part, are not too worried about this aspect of the deal when it comes to COVID. So could be worse.
Zoe Rothblatt 15:39
And yeah, it seems like overall, we won’t feel the impact of this in our daily life, but things might emerge and we’ll see just like some overall bigger changes.
Steven Newmark 15:48
Yeah. Look, if you’re a 52 year old on, collecting SNAP benefits, and you don’t currently work, you’re gonna feel that.
Zoe Rothblatt 15:55
Right.
Steven Newmark 15:55
But the majority of Americans will not feel this, which is a good thing. That’s good. And, you know, just to go back to What I was saying, at the top, what I hinted at is there’s something healthy, no pun intended, or pun intended, I’m not even sure, about this is how it’s supposed to work. The Republican Party took power in the House of Representatives. And over the last election, they had a set of priorities and things that they wanted to negotiate. The Democrats hold the Senate and the White House, and they have their priorities. And they came together and hammered out a deal that leaves both parties, both sides equally happy and also dissatisfied at the same time. So that’s how governing is supposed to work.
Zoe Rothblatt 16:31
Well, thanks for that recap Steven, I learned a lot from you today, especially just about you know, these inner negotiations and how we came together to get the deal. What did you learn today?
Steven Newmark 16:41
Well, I learned from our prep that the, about the revocation of the J&J COVID vaccine, I’ll light a candle.
Zoe Rothblatt 16:47
In memoriam.
Steven Newmark 16:50
In memoriam J&J COVID vaccine 2020 to 2023. Well, we hope that you learned something too. And before we go, we definitely want to encourage everyone to check out all of our [email protected]/listen.
Zoe Rothblatt 17:04
And if you have any questions for us, topic suggestions, definitely email us at [email protected]. Well, everyone, thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating and write a review on Apple podcasts. And definitely hit that subscribe button wherever you listen, I’m Zoe Rothblatt.
Steven Newmark 17:27
I’m Steven Newmark. We’ll see you next time.
Narrator 17:33
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
S6, Ep9- COVID After the End of the Emergency: What We’re Seeing
The hosts discuss the current state of COVID since the end of the public health emergency, including updates on case and hospitalization rates, CDC recommendations for improving air quality, promising results on an Evusheld replacement, and vaccine plans for the fall. They also cover the latest news on the debt ceiling, and recent FDA approval of Paxlovid, the antiviral treatment for COVID.
“Researchers estimated that based on COVID rates in January, Paxlovid can lead to 1,500 lives saved and 13,000 hospitalizations averted each week in the United States,” says Steven Newmark, Director of Policy at GHLF.
S6, Ep09- COVID After the End of the Emergency: What We’re Seeing
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:22
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:28
Today, we’re going to talk about the current state of COVID. What’s going on since the end of the public health emergency, but first, we do have a few news updates, including updates about the debt ceiling. Steven, why don’t you tell us what’s going on there?
Steven Newmark 00:42
Yeah, so as we’re recording, it looks like a deal has been set. And it’s still awaiting passage, but the Speaker of the House, Kevin McCarthy and the President Joe Biden came together for a deal over Memorial Day weekend, and they believe that they have enough votes in the House to get it passed. The leaders of the Senate, Mitch McConnell, the minority leader, and the Majority Leader, Chuck Schumer, have both come out and said that they have the votes on the Senate side of things. So knock wood, it sounds like a deal has been made. And that does avert what many economists were predicting would have been an economic disaster.
Zoe Rothblatt 01:16
So there’s one important piece in here that I wanted to highlight for our community, which is about the COVID clawbacks.
Steven Newmark 01:22
Sure.
Zoe Rothblatt 01:23
So this current deal would take nearly $30 billion in unspent COVID relief funds.
Steven Newmark 01:29
Yeah.
Zoe Rothblatt 01:29
And this would be, come out of dozens of programs. That doesn’t mean all COVID programming will stop, there definitely is money for some programs, such as veterans health care, COVID treatment and vaccine research. But it definitely is a little uneasy to hear that all this money will be taken out.
Steven Newmark 01:45
Yeah. I mean, look, I think the big picture is, you know, the debt ceiling was an opportunity, if you will, a moment for Republicans to impose their agenda, which included the idea to cut spending, and the idea that you were going to get through some cuts of spending and not have it touch health care was probably not something that’s realistic. That said the deal, for the most part avoided a large swath of health care costs, you never want to hear that there were cuts to health care and COVID-19 and relief funds. However, I think it’s important to note that the deal as currently constituted preserves funding for NextGen. That’s the program that is working to develop the next iteration of COVID vaccines. So that’s pretty important. And it would have been really severe having reached the debt limit without a deal. The disruptions to hospitals, providers, really would have been severe in terms of Medicare Medicaid costs, and most importantly, there have not been cuts to Medicare or Medicaid.
Zoe Rothblatt 02:39
Right, right. Yeah. Well, when you put it in that perspective, I guess you win some you lose some.
Steven Newmark 02:44
Yeah. Yeah, exactly.
Zoe Rothblatt 02:46
So when do we think we could see next steps on this? What should we be on the lookout for?
Steven Newmark 02:51
Well, we are recording on Wednesday, May 31, there’s discussion that it could go for the House vote as early as today, possibly tomorrow. Hopefully this week, the Treasury Secretary says that we’re scheduled to run out of money on June 5, so this would have to get asked by both houses and signed by the president before then if we want to truly avoid the debt ceiling crisis. There are some far right Republicans who are making noise and stating opposition to the bill. But it looks as though there are enough of a combination of Republicans and Democrats in the House to get it passed. And it also looks as though incredibly speaker McCarthy will live to survive and if anything come out actually stronger based on these negotiations with which is quite fascinating.
Zoe Rothblatt 03:38
Yeah. Is it the first time a negotiation like this has happened?
Steven Newmark 03:41
No, no, there have been other debt ceiling crises, the most well known one was in 2011. From Republicans pretty similar, you had an incumbent Democrat seeking reelection a year and a half later, and they imposed a deal that called for, they called the sequestration deal, which, you know, essentially froze a lot of funding in place through the election. So it’s not the first time and it’s been threatened at other times throughout as well.
Zoe Rothblatt 04:07
Okay, well, we’ll keep our eye out on that and our community updated.
Steven Newmark 04:11
Yes.
Zoe Rothblatt 04:11
The next bit of news, the US Food and Drug Administration granted full approval to the COVID treatment paxlovid. This is the antiviral that’s for adults who are at high risk of getting severely sick.
Steven Newmark 04:24
Yeah, you know, this jumped out at me, the researchers estimated that based on COVID rates in January, paxlovid and I’m quoting now can lead to 1500 lives saved and 13,000 hospitalizations averted each week in the United States so this is great news. It’s good to have a full approval and some more tools in our arsenal as we go forward.
Zoe Rothblatt 04:43
Definitely and part of the FDA’s role is post market surveillance. So once a drug is available, they look at how it’s going. This was made first available in December 2021 under the emergency use authorization and it’s good to hear that after they’ve seen it in the real world that now it’s getting this full approval.
Steven Newmark 05:01
Yeah. Well, moving on as we enter the summer, if you will, the unofficial start of summer after Memorial Day, we’ll talk about where we are we, you know, we got through the public health emergency and talk about the current state of affairs. So let’s get into it.
Zoe Rothblatt 05:13
So first on our list, surveillance. What’s happening with the numbers? I think we’re all kind of watching, the public health emergency ends. Does this mean COVID is going to explode? Does the virus know our emergency has ended? What’s going on?
Steven Newmark 05:27
Yeah, well, the numbers are showing that COVID-19 is nosediving across all metrics in all regions of the United States, hospitalizations are down, deaths are down, emergency room visits are down. And also wastewater surveillance, that’s still tracking are showing numbers that are down although the caseload is seen in wastewater still higher than it was in 2020, and 21.
Zoe Rothblatt 05:49
So all in all good news that cases are going down, especially what you said, hospitalizations and deaths are going down. I know, those are the numbers that we’re really looking at now.
Steven Newmark 05:59
Yeah.
Zoe Rothblatt 05:59
And it’s great to hear that this is going down, of course, we have to remain cautious. We always know that in the summer, the trends we’ve seen is that cases go down and in the fall, they come up. So of course, we’ll keep a watchful eye, but it’s good to see that the same pattern is occurring.
Steven Newmark 06:13
Yeah and I think the number one metric is really deaths, because that’s the worst possible outcome. And right now, excess deaths in the United States are hovering about 1% above the pre pandemic rates. And just by comparison, at the height of the pandemic, excess deaths were hovering at around 47%. So that’s a pretty good, you know, statistic to look at.
Zoe Rothblatt 06:33
Of course, because I mean, those percentages are a loved one to someone. And, you know, it breaks my heart to think about where we were three years ago, at this time, here in New York City, we had morgues in the street. And it’s amazing to think about how far we’ve come but also just to take a moment and recognize how many people lost loved ones.
Steven Newmark 06:52
Yeah, for sure. So you know, let’s turn to some noteworthy COVID-19 news. Number one indoor air quality. Up until now, the CDC recommended that we quote unquote, improve ventilation to reduce transmission, but didn’t really provide much guidance until about two weeks ago. So the CDC says aim to deliver five or more air changes per hour. And I can’t believe there’s actually an acronym for this, ACH, air changes per hour of clean air.
Zoe Rothblatt 07:19
If it’s healthcare, there’s always an acronym. Right?
Steven Newmark 07:22
I guess that’s true, I don’t even think it’s a health care thing. But anyway, five or more air changes per hour, which is a combination of air ventilation filtration to reach this target.
Zoe Rothblatt 07:34
And they also recommended upgrading filters. So just using higher rated filters in your heating or air conditioning system, turn your HVAC system on.
Steven Newmark 07:44
Yes.
Zoe Rothblatt 07:45
Set your ventilation system to circulate more air when people are in the building. Yeah, these are things that we’ve heard all along, but I guess it’s more specifics now.
Steven Newmark 07:53
Yeah, absolutely. Absolutely. They also recommended adding fresh air opening windows, when you’re able to do so using air purifiers, I got a giant one and you should see it.
Zoe Rothblatt 08:04
Do you feel like your air is more clean your breathing fresher?
Steven Newmark 08:08
I don’t actually but whatever, I’m glad It’s there. And to be fair, I should note this but these are more recommendations for the public at large. I think in your own individual house and apartment, you’re really only dealing with your family. But the idea of turning the HVAC system on I think that’s really meant for particularly places of business where strangers are gathering and coming and going at all different times.
Zoe Rothblatt 08:27
That’s actually what I was about to ask. So these are just recommendations from the CDC for businesses and public areas. But I guess there’s there’s no way to check if this is really happening in those places?
Steven Newmark 08:39
That is true. Yeah, that’s true. That’s true. There’s no way to know. But the whole idea is I suppose it starts up on high, the CDC issues their recommendations, and they start to trickle down. You see them a lot in public buildings. You know, a good example of this would be local districts might impose these roles on schools, for example, so that schools can adopt some of these programs keeping their HVACs, on using air filters, things of that nature. Now these costs money, so I don’t know how likely is that school is going to have this in their budget. Just as an example of how this can sort of trickle down. You can, you could start to get ordinances, local city councils, town councils can start to issue ordinances for businesses to either keep an HVAC system on at all times or have an open vinto open window, things of that nature.
Zoe Rothblatt 09:24
It’d be great if there was some like how the restaurants have the letter grade if there was some grade of air quality and people could go in and make like more informed health decisions about what they feel comfortable with knowing the air quality.
Steven Newmark 09:37
True, although I think for every single person living in Los Angeles or in New York, that air quality would probably always be zero, but so true, but yeah, no, I agree with that. I agree with that. Yeah, I got my air purifier because I had people working in my apartment doing construction and I’ve kept it because hopefully it helps smog or something of that nature.
Zoe Rothblatt 09:59
And then the last two on their list was install UV air treatment systems that can kill germs in the air and use portable carbon dioxide monitors.
Steven Newmark 10:09
Yes, a portable co2 monitor helps you determine how stale or fresh the air is in a room. So I guess that would be how you would test and give these grades that Zoe wants to give out to all the buildings.
Zoe Rothblatt 10:20
I’m cracking down.
Steven Newmark 10:22
Right.
Zoe Rothblatt 10:22
The Health Advocates are giving out grades.
Steven Newmark 10:25
Right, exactly. And I don’t know what rhis means, but according to the CDC readings above 800 parts per million suggest that you may need to bring more fresh outdoor air into the space. At least there’s a there’s some kind of a guideline, at least.
Zoe Rothblatt 10:37
Yeah, that is interesting as air quality is I’m so curious about fall boosters, I saw some talk about, you know, maybe eliminating the original strain from the booster, what’s going on there?
Steven Newmark 10:48
Well, the World Health Organization officially now recommends a one strain booster that targets XBB, that’s the Omicron, that’s one of the Omicron sub variants, this fall. So we’re, so the recommendation is to no longer use the original vaccine, which makes sense. Of course, countries don’t have to follow what the WHO says but that’s likely where we’re headed. There’s a big FDA meeting in June to discuss what we’re going to be doing here in the United States.
Zoe Rothblatt 11:13
And this would be the first time that the original strain isn’t included in a vaccine because even when we had the updated vaccine, it was still bivalent booster. So it had the original and the new strain goes through this would be the first time it’s just entirely updated.
Steven Newmark 11:27
Turning to masks, there was a poll conducted by Morning Consult, it was taken between May 6 and May 9, and it’s found that 46% of respondents wear a mask at least some of the time in the past seven days, just looking out my window now, I was very surprised by this number, but so I’m not really sure what it means. But I do know that it is still important to improve masking amongst older adults, especially in times of high transmission which could reoccur we’re in a lull now, but you know, when things come back, hopefully the masks will as well.
Zoe Rothblatt 11:58
Definitely, yeah, I really haven’t seen a lot of masks around. I know people in our community are still masking but when I’m just out and about, it’s few and far between.
Steven Newmark 12:07
Yeah, for sure, and we’ve spoken about this before, that might be a realistic future where the masks mostly come off during a time of a lull, which in some respects makes it easier to then mask up or get folks to mask up when there’s an uptick. You’re certainly not going to have a situation where everyone is going to mask as they did at the height of the pandemic, that will never happen again. But I don’t think it’s unrealistic to say when the situation gets bad, people will put their masks up. And I think also, it’s also it has become and hopefully will continue to remain more socially acceptable or more common, or when an individual feels that they have a cold or something floating around their system to put on a mask to protect others.
Zoe Rothblatt 12:53
Definitely. I mean, that should always have been common courtesy. Like if you have a sniffle or a cough stay home, especially because I know I would sit in class sometimes and someone next to me is sick and I’m like, oh great, I’m immunocompromised, I know I’m gonna get some version of this and just feel so crappy. And you have to sometimes delay your treatment and it’s so much more than a cold when you have a chronic disease it like sometimes can flare up your underlying condition. It’s just, it should be common courtesy to stay home and mask up, especially if you’re not feeling well.
Steven Newmark 13:27
Yeah, for sure, for sure. And also some good news, it looks like we’re on track for an Evusheld replacement, there’s a phase three clinical trial that is showing promising results, and emergency use authorization could be here by the second half of this year. So that’s another more tools in the arsenal to help.
Zoe Rothblatt 13:44
That’s exciting. That’s something our community has been asking for since Evusheld lost, or was taken off of emergency use authorization or just not recommended. As a reminder, this is the preventative COVID treatment for people who are at high risk of getting COVID. So you know, it’s really exciting. The community has been asking a lot, when are we going to get something like this again? You know, does my first one still have any effects? I’m really yearning for this, so it’s exciting to see that that could be coming soon.
Steven Newmark 14:14
Yeah, excellent. A few other quick things, the risk of long COVID after a second infection, studies are showing it’s greatly reduced. It’s not zero, but there’s a new study out that’s coming out that found that the risk of long COVID after a second infection is one in 40 for those over 16 years old and one in 165 for those under 60 years old. I thought as comparison I thought this was kind of interesting, that annual risk of getting into a car accident is one in 30. So it’s less of a risk to contract long COVID after a second infection.
Zoe Rothblatt 14:45
That’s good news and simultaneously research on long COVID is ramping up.
Steven Newmark 14:50
Yeah.
Zoe Rothblatt 14:50
There are still a lot of unanswered questions and people are out there suffering and living with debilitating symptoms and it’s good that attention is still being brought to how can we help these patients?
Steven Newmark 15:03
Yeah. And one last thing I just want to mention before we wrap up, sad thing is that the COVID vaccines rates amongst children are just abysmal. There was a study that came out that said, if we had reached flu vaccine coverage levels, just this past winter, we would have prevented over 10,000 pediatric hospitalizations and over 5 million days of school absences, just by having gotten those vaccines up so you know, better luck next year. I don’t know. That’s unfortunate.
Zoe Rothblatt 15:29
Yeah, I mean, 10,000 pediatric hospitalizations. It’s not a small number.
Steven Newmark 15:33
Yeah, yeah. And every time, I’m gonna put on my old hospital hat, every time a doctor is working on someone who comes into the ER, it means that they’re not working on someone else who is also coming into the ER, their attention is diverted. So it doesn’t just affect those 10,000 individuals coming in. It affects others who are also trying to get into the emergency room as well.
Zoe Rothblatt 15:53
So true. Well, you know, what’s next? We are headed into summer, we’ve seen rates go down, we should get news, like you said, there’s a big meeting coming up about the COVID fall vaccine.
Steven Newmark 16:05
Yes.
Zoe Rothblatt 16:05
So I guess we’ll just stay tuned and wait for more, which seems like the motto of this pandemic. Stay tuned. See what’s next.
Steven Newmark 16:12
Yeah. And if you’re able to get outside and breathe in some good air away from others, which is what summer makes summer so great, right?
Zoe Rothblatt 16:22
Definitely. I know, teah, it’s nice everyone coming out and you realize how many neighbors you have. And how many people live around here because all sudden everyone’s out and walking around and breathing that good air.
Steven Newmark 16:32
Yeah.
Zoe Rothblatt 16:33
So, you know, hoping for good health for everyone this summer and beyond.
Steven Newmark 16:36
Absolutely. Absolutely.
Zoe Rothblatt 16:39
Steven, that brings us to the close of our show. What did you learn today?
Steven Newmark 16:43
Well, you know, I learned in prepping for the show how the numbers are particularly good with COVID and I was again very struck by the death count.
Zoe Rothblatt 16:52
And I learned from you about the debt ceiling and negotiations going on there.
Steven Newmark 16:59
Excellent. Well, we hope that you learn something too. And we’d love to hear from you about all of your stories, you can email us at our new email address [email protected]. We hope to hear from you soon.
Zoe Rothblatt 17:09
Well, everyone thanks for listening to The Health Advocates a podcast that breaks down major health news of the week to help you make sense of it all. If you like this episode, please give us a rating and write a review on Apple podcasts and hit that subscribe button wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 17:24
I’m Steven Newmark. We’ll see you next time.
Narrator 17:30
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
S6, Ep8- Drug Shortages: What Patients Need to Know
In this episode, our hosts shine a light on a critical issue affecting patients all over the U.S. – drug shortages. Shortages have been reported for hundreds of drugs, and here we cover why this is happening and what you can do. We also cover the latest news on Ohio legislation to protect patients from copay accumulator adjustors and movement on the federal PBM transparency bill.
“Drug shortages is not a new problem, but currently, there are hundreds of drugs in scarce supply and that’s just hitting an all-time high for the U.S. It’s a really scary place to be in if you don’t know when the next shipment of your medication is going to be,” says Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
S6, Ep08- Drug Shortages: What Patients Need to Know
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates a podcast that breaks down major health news of the week, to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:17
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:22
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions live your best life.
Zoe Rothblatt 00:28
And in today’s episode, we’re shining a light on a critical issue affecting patients across the US – that is drug shortages. But first, we do have a news update on our work in Ohio to help bring protections against copay accumulator adjusters.
Steven Newmark 00:44
Yes, excellent. The bill we’re advocating for in Ohio was just officially reintroduced yesterday in the Ohio House as House Bill 177.
Zoe Rothblatt 00:52
So this bill, it’s great, it’s identical to others that have passed in 17 other states. So it’s always good to see that model legislation being used. And it’s working its way federally through Congress as the HELP Copays Act. So it’s good to see momentum around the country as we try to get this passed in Ohio.
Steven Newmark 01:10
Absolutely. Absolutely. I also do want to mention in the house of representatives in Washington, the House Energy and Commerce Committee unanimously advanced the package of health policies that will strengthen price transparency rules for hospitals and insurers, and most importantly, for our listeners will increase scrutiny over pharmacy benefit managers or PBMs.
Zoe Rothblatt 01:29
I was gonna say that’s, you know, great news in the states and great news federally.
Steven Newmark 01:33
Absolutely, so that’s where we are. We’re in Washington, but we’re in all 50 states. And that’s why we advocate, that’s why we do what we do. So hopefully, some of this legislation will become law.
Steven Newmark 01:42
And what’s the next step for the PBM transparency? Who has to review it next? Or what do we think the likelihood of passage is?
Steven Newmark 01:49
So yeah, it advanced out of committee, so it goes to the full house. So we have to hope that it gets attached to a package or at least, or perhaps gets voted on as a standalone measure and in the full house, and if it passes there and then goes on to the Senate and passes there, then it gets reconciled. But that’s a whole other thing, before it finally gets to the President’s desk.
Zoe Rothblatt 02:08
Okay. Well, you know, we’ve talked about this a lot, little increments are pretty big when it comes to policy, and it’s great to see it moving forward.
Steven Newmark 02:15
Absolutely. Absolutely. Well, let’s turn now to our topic for today, something that has been in the news, and is certainly of interest to folks. This should be of interest to all Americans, but certainly those who are listening to our program, and that topic is drug shortages. So drug shortages occur, obviously, when there’s an inadequate supply of medications to meet the demand.
Zoe Rothblatt 02:34
And this impacts people because obviously, it leads to delays in treatment. Sometimes it means inadequate dosing, if someone’s trying to space out the medications, they already have to last or even a complete lack of access altogether to essential medications, because there’s just no end in sight for when the shortage will be over. It’s so important for patients to have regular access to treatment. And It’s a really scary place to be in if you don’t know when the next shipment of your medication is going to be.
Steven Newmark 03:05
Yeah, absolutely. It’s definitely a frustrating feeling to know that your medication is due for a refill as an example, and you’re being told it’s on backorder or whatever the case may be, you know, so what causes these drug shortages? What’s going on?
Zoe Rothblatt 03:16
So yeah, generally, there’s many reasons that can contribute to drug shortage. Number one could be manufacturing issues directly where the drug is coming from. There’s also supply chain disruptions. We definitely saw this in COVID. And then there’s also a high demand, like, remember, in COVID, we saw an increase in demand for hydroxychloroquine. And people were taking it and it took it away from people that needed it most. There could be regulatory challenges. There’s a lot of factors at play when it comes to drug shortages.
Steven Newmark 03:47
Yeah, for sure. So what’s happening now?
Zoe Rothblatt 03:49
Well, like we said, drug shortages is not a new problem, but currently there’s hundreds of drugs in scarce supply and that’s just hitting an all time high for the US. So these drugs include critical drugs for cancer care. I think that’s the one people are most focused on right now. But others on the list include sterile fluid for injections, some antibiotics, ADHD medications and children’s Tylenol.
Steven Newmark 04:13
Yeah, very scary. I saw that the American Cancer Society warned earlier this month about potentially life threatening supply problems of chemotherapy drugs, which don’t have an effective alternative.
Zoe Rothblatt 04:24
That’s scary, you know, don’t have an effective alternative. These are people’s lives. I’m sure we all know someone that’s impacted whether it’s cancer or by a condition, and it’s scary to hear that phrase, there’s no effective alternative. And when you’re living with a condition, especially something like cancer that can be so life threatening, you really don’t want your doctor like having to experiment with alternatives simply because of a drug shortage when you know that there are medications that can help.
Steven Newmark 04:51
Yeah, so what’s going on? What’s the reason for these challenges?
Zoe Rothblatt 04:56
It’s a good question. You know, there’s a few reasons so some are just the old fashioned supply and demand challenges like children’s Tylenol, for instance, one on the list after we had this big flu, RSV and COVID season, yeah people stocked up, Tylenol was in demand and now we’re seeing the effects of it. So, a lot of experts are pointing to the generic drug market. We know that when it comes to medications, there’s a brand name and once it loses its patent, often a generic version comes out, that’s much cheaper, and generics account for 90% of all drugs in the US. And in a few cases, we said high demand or over prescribing may be to blame. But for the most part, the drugs that are in shortage, are in short supply, are from this generic drug list. So experts are saying, well, what’s going on in the generic market that’s causing all of these drugs to be in short supply? And there’s a number of factors that could be contributing, you know, one of the makers of Adderall, which has been in shortage announced plans to scale back its generic business because of low profitability. Lidocaine is in short supply, and the manufacturer there announced a financial restructuring.
Zoe Rothblatt 06:11
So it’s a lot, it sounds like there’s a lot of little things that are contributing, that are maybe disconnected perhaps, particularly when you’re dealing with the generic industry. You’re talking different manufacturers have different reasons. But all in all, it’s contributing to this overall, dare I say chaos.
Zoe Rothblatt 06:29
Exactly. So what happens next? How do we deal with this? Of course, the Biden administration has to get involved players like the FDA, and they are all looking at it. The Biden administration has assembled a team to find long term solutions for you know, making sure that we have a smooth running pharma supply chain. The FDA, they have a team that works day to day to mitigate and report on drug shortages, you can go to their website and type in drugs and look at what’s in shortage, like they’re really on top of reporting that and they’re looking into what additional information they can gather. There’s also four Senate bills with bipartisan support that could help get generic drugs to market more quickly by addressing different tactics or loopholes that cause delays. So there’s definitely attention being drawn to this issue. But a lot of it right now is information gathering and figuring out the exact cause of what’s going on here.
Steven Newmark 07:24
All right, that good that they’re gathering the information. Most importantly, what do you do if you’re affected or potentially affected? And what can you, let’s take it into two steps. What can you do if to prepare yourself? Some of the basics, knowing your medications, know what alternatives might exist? Talk to your doctor, am I on the right path, Zoe?
Zoe Rothblatt 07:43
Definitely, I would say yeah, definitely talk to your doctor, number one. Even if you’re a drug isn’t on a shortage list right now. And I don’t want to scare people. Like I’m not saying your drug will be on the list.
Steven Newmark 07:55
Right right right, no, of course.
Zoe Rothblatt 07:56
But definitely just talk to your doctor say, you know, I heard The Health Advocates talking about this, is this something that could impact me? And if so, what’s our plan, and it’s just great to talk about options ahead of time. So you can really get comfortable with it before you’re faced with it, and often just like it’s a high stress anxiety situation, and you feel like you don’t have a lot of control. So just talking to your doctor about options and alternatives ahead of time is really helpful.
Steven Newmark 08:22
Yeah, absolutely. I would also add to that, talk to your pharmacist, I mean, I have personal experience where a pharmacist, I ran to a drug shortage and a pharmacist recommended or alternative to which I said absolutely not, I like my drug the way it is, damn it. I lucked out, it was able to arrive before I needed it. But I actually subsequently saw my doctor and I mentioned that to her, and she said yeah, yeah, you could have certainly taken this other drug, I would have sent that prescription over in a heartbeat. That’s that would have been fine. So you know, it’s definitely good to talk to your health providers and I would include pharmacists in that conversation as well.
Zoe Rothblatt 08:55
And your pharmacists also may have an idea of when a next shipment could come in or stuff like that, and give you a little foresight into timelines on different delays.
Steven Newmark 09:04
Yeah, yeah, you know, I always get the largest quantity that I’m able to get of a supply of a drug. So sometimes that’s 90 days, sometimes it can only be 30 days, depending on the drugs and for reasons, honestly, with all of our policy expertise, I don’t know why that is, but when I’m able to get a 90 day supply, I always do so.
Zoe Rothblatt 09:24
Me too. I noticed that in COVID actually, that was the first time I was able to start regularly filling 90 day supplies and for most of my medications, it’s stuck and it’s really nice to be able to do that. And it wasn’t like a benefit that was told to me, one day my doctor just tried it and it worked. So it’s always good to just try these things and see what your health plan will cover.
Steven Newmark 09:45
Good tips, you know, hopefully folks are okay and just staying on top of things like this and once again, talking to your provider if something were to happen, look for alternatives and you know, knock on wood that everyone will be okay.
Zoe Rothblatt 09:58
And as always advocate, you know, speak up and share your experiences, call your local elected officials and let them know that their sense of urgency around this issue, encourage them to support legislation that helps bring access to medications. Because, you know, we always talk about how important it is for legislators to hear the story, they can see these things in the news, but to know that it’s impacting real people and their constituents makes such a difference.
Steven Newmark 10:23
Absolutely. Well, this has been great, I think, informative. You know, before we wrap up, I should mention we’re recording this right before Memorial Day weekend. So we hope that folks are able to have a nice three day weekend and, of course, on Monday, we hope that everyone takes a moment to think about those we’ve lost in service to our country.
Zoe Rothblatt 10:42
With that, bring out your white pants and enjoy the start of summer. Well Steven, that brings us to the close of our show, what did you learn today?
Steven Newmark 10:51
Well, I learned from you and I had known about these drug shortages, but I didn’t know that ties to the generic market and how it affects it. So thank you for educating me and our listeners on that.
Zoe Rothblatt 11:01
And I learned about momentum around the PBM transparency. I hope it passes. And by the way to our listeners if you have learnings or any questions for Steven or me, we’ve set up a new email address for all of our podcasts series, which is [email protected]. Send us your questions, your thoughts, suggestions on topics, we’d love to hear from you.
Steven Newmark 11:23
Excellent. Well, we hope that you learned something today. And before we go, we definitely want to encourage everyone to check out all of our [email protected]/listen.
Zoe Rothblatt 11:33
Well everyone, thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you like this episode, please give us a rating and write a review on Apple podcasts and hit that subscribe button wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 11:48
I’m Steven Newmark. We’ll see you next time.
Narrator 11:53
Be inspired, supported and empowered. This is the global Healthy Living Foundation Podcast Network.
S6, Ep7- Loneliness: A Public Health Crisis
U.S. Surgeon General Dr. Vivek Murthy recently announced a new crisis that is unfolding – “the epidemic of loneliness and isolation.” The hosts discuss the impact of loneliness, the reasons for the rise in social isolation, and break down the framework for proposed solutions. This episode also covers the latest news on The Safe Step Act, and quick poll results on chronic illness patients’ plans to get the second bivalent COVID booster.
“A new report from the Surgeon General says that social isolation’s effects on mortality are the equivalent of smoking up to 15 cigarettes a day,” says Steven Newmark, Director of Policy at GHLF.
S6, Ep07- Loneliness: A Public Health Crisis
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:18
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:22
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:28
And today we’re going to talk about a new public health crisis unfolding across the United States that is of loneliness. First, we do have a few news updates on the Safe Step Act and our latest quick poll results on the bivalent booster. So, let’s jump into that. Steven, what’s happening with the Safe Step Act?
Steven Newmark 00:47
Yeah, so some good news – After over six years of hard work from patient and provider advocate communities around the country, the Safe Step Act was included in a piece of legislation that is passed out of a Senate committee and it has real momentum at becoming law. Senator Lisa Murkowski, Republican of Alaska, introduced the Safe Step Act as an amendment to a large pharmacy benefit manager reform bill that is being led by Senators Bernie Sanders and Bill Cassidy, the chair and ranking member of the Senate Health Committee that’s, Health, Education, Labor and Pensions Committee.
Zoe Rothblatt 01:17
So this is really exciting and it’s the same bill text as the act has been all along, it’s just included in a larger bill, which helps bring it momentum. So Steven, what’s the next steps for this bill?
Steven Newmark 01:29
I’m glad you asked. The next step for this bill is for it to receive a committee vote and then a full Senate vote before heading to the House for the process to start new in that chamber. I don’t know if you remember that from the great cartoon when a bill becomes a law. Excellent cartoon for those.
Zoe Rothblatt 01:44
Oh yes.
Steven Newmark 01:45
So bills that are led by the bipartisan leaders of the committee do have the best chance of actually taking these steps. So with bipartisan support, we’ll see where it goes. We’re not just going to sit back and be passive observers, of course, but we’re going to do everything we can to ensure that the next steps are taken. The Safe Step Act is a relatively small part of an overall bill so the likelihood that will be cut during the amendment process is slim, because its fiscal impact is quite small. And with over 100 sponsors of the Safe Step Act already in the House, it has an even smaller chance of being cut there during any possible discussions. So we’ll see what happens all in all, where we are right now, this is a huge accomplishment for the advocacy community. But we still have a lot of work to do before this bill becomes a law.
Zoe Rothblatt 02:26
Definitely. And for everyone that’s advocated for step therapy reform, whether as part of this bill federally or also within your own state, it’s definitely helped increase the momentum with states passing laws to help get federal protections and just you know, thank you to everyone in the community has been advocating for so long, and now we get to see the fruits of our labor and see action being taken.
Steven Newmark 02:49
Yeah, absolutely. So we shall see. And we shall continue fighting until it becomes law and signed by the President.
Zoe Rothblatt 02:55
Definitely switching gears a little bit, I have the updates from our latest COVID-19 Patient Support Program quick poll.
Zoe Rothblatt 03:02
This one was about the second bivalent booster. So we talked about this a few episodes ago probably about how a second booster was authorized for people over 65, and people with compromised immune systems. So we wanted to know our community’s plans on getting this booster. And here’s what we found out. Only 12% said they don’t plan on getting it, nearly 43% said that they plan to get it, 22% said they already got it and the other 22% are going to speak to their doctor.
Steven Newmark 03:02
Let’s hear it.
Steven Newmark 03:33
Excellent.
Zoe Rothblatt 03:33
That was really interesting to hear about our community’s plans and that everyone is getting protected and feeling good about it.
Steven Newmark 03:40
Yeah, as folks should. So that’s that puts us in a good place.
Zoe Rothblatt 03:44
And for those who said no, in the free response section, they were able to elaborate and people just mention how they got side effects from the vaccine or it flared their disease or it’s been a lot of shots. Those were some of the common reasons that came up, which is understandable. But I definitely encourage everyone to at least talk to their doctor about these options and what’s right for them.
Steven Newmark 04:04
For sure. All right. Well, let’s get into our main topic for today, which is about loneliness. A new report from the Surgeon General says that social isolation’s effects on mortality are the equivalent of smoking up to 15 cigarettes a day. And I do know from health class in high school that smoking 15 cigarettes a day is definitely not a good thing.
Zoe Rothblatt 04:23
Definitely not. It’s interesting that we’re able to assess that something so physical as smoking to something more, I guess, you know, a mental emotional state of social isolation. There are physical aspects, of course, but wow, that’s shocking to hear that those two are equivalent.
Steven Newmark 04:41
Yeah, research on social isolation and loneliness finds that it contributes to a person having a higher risk of heart disease, stroke, anxiety, depression and dementia, and it makes people more susceptible to infectious diseases. Reports from the Surgeon General are usually reserved for urgent public health issues that require immediate action. So the fact that this report came out from our what we call the nation’s top public health official is a pretty big deal.
Zoe Rothblatt 05:03
Well, yeah, it definitely is a big deal. I’m glad that issues like this are coming to the forefront. Especially, I believe everything you just said about higher risk of these conditions. As someone who is chronically ill, and I hear it a lot from our community, we know how intertwined mental and emotional health are with physical health. And sometimes it’s hard to quantify that or there isn’t exactly treatments that go for both all the time and it’s great to hear a public health leader talking about this so we can get some solutions.
Steven Newmark 05:33
Yeah, it is fascinating. Having read the report myself, I’m not totally shocked and although I was surprised that the report heavily emphasized that its findings were based on trends that were taking place before the pandemic, and they were exasperated during that period of isolation of the pandemic. It was very strongly emphasized in multiple places around the report that these are not due to the pandemic, but if anything, was only exasperated by the pandemic. So let’s get into it. Let’s see what they did. The advisory itself breaks down the measures of social isolation and loneliness in the United States, how they can affect people’s health and introduces recommendations about how to alleviate the epidemic of loneliness. So here are the reports main takeaways. So we’ll start with the first one, Americans are lonelier and more isolated than ever, yet Americans are experiencing more loneliness and isolation than at any time in recent memory. As I said, the trends were underway well before the COVID-19 pandemic, though, of course, living through three years of a public health crisis has likely accelerated these issues, at least for some folks.
Zoe Rothblatt 06:31
And did they talk about how they’re defining loneliness?
Steven Newmark 06:35
Yes. So taking a step back social isolation is an objective measure of lacking connection to family, friends and communities. And loneliness is more is a subjective measure, almost through surveys, like we do a subjective measure of feeling disconnected, generally.
Zoe Rothblatt 06:49
Okay.
Steven Newmark 06:50
And the findings found the findings in the report said, half of Americans say they experienced loneliness, less than 40% said in a 2022 study that they felt quote, very connected to others. Again, It’s subjective and the reports note that a certain amount of solitude even can actually help people become more resilient and has some positive effects. But more objective measures of social isolation also reveal that we’re increasingly feeling more and more isolated from one another.
Zoe Rothblatt 07:16
I was just thinking about how in this day and age, you would think with all the technology we would be even more connected and how this would decrease. And then…
Steven Newmark 07:24
Yeah.
Zoe Rothblatt 07:24
My second thought was, well, Zoe, remember, in COVID, there was all these great virtual options for people and slowly they’ve disappeared and so many people in our community, I know, these studies aren’t specific to our community, but I’m always thinking about our community. And so many people in our community are still isolating and taking more precautions than the general public and a lot of us are upset that the virtual options have gone away. And I definitely think that contributes to these statistics.
Steven Newmark 07:51
Yeah, that that can be a factor. I actually heard an interview with Dr. Murthy, where he talked about the pre pandemic, one of the ways he found himself actually, you know I’m not spilling the beans on the good doctor, because he said this in a very public forum, he said that he experienced his nadir, if you will, in 2018, feeling loneliness, which was where it was first brought to his attention. And one of the ways he helped dig himself out was he got together with two of his friends. So a group of three, and they would get together virtually and again, this was pre pandemic, they would gather virtually, and meet and discuss I don’t remember if he said weekly or monthly, but it was one of the ways he dug out getting together with close friends, even though he couldn’t do so in person, he was able to do so virtually and keep conversations flowing. And probably I don’t recall exactly what he said, but probably, you know, to dive deep and talk about what they were experiencing and help them and help each other out.
Zoe Rothblatt 08:44
Definitely, I actually started something similar with one of my friends we’ll press play on the same show or movie at the same time and talk about it. So it’s yeah, it’s connecting virtually, and it helps like having a plan and reducing that loneliness, for sure.
Steven Newmark 08:58
Yeah, no, for sure. I mean, the other thing about being online and connected and hyper connected, the report does talk about social media and inherent in the phrae social media is the word social, you know, there are a lot of negative effects of social media, as I think most folks are cognizant of these negative emotions that can run deep. It’s not truly connecting you necessarily to people, you’re not actually engaging or interacting. Not to mention sometimes you see very curated lifestyles on Instagram and …
Zoe Rothblatt 09:29
For sure.
Steven Newmark 09:29
It can have a negative effect on you. That said, there is a positive side of course to social media. Groups that have been traditionally marginalized, particularly groups and groups that are in if I will say small numbers in certain communities are able to find a community online in a way that they may not be able to in their physical community. And I think it’s fair to say that certainly holds true for people living with chronic conditions. The online community, one of which is our online community can be a home can be a place is where folks can come together and feel a little bit less isolated. And I think it’s, it is one of the great services that an organization like a GHLF provides. But you know, you have to take the good with the bad and try to accentuate the good if you’re going to be using social media and be aware of its downside as well.
Zoe Rothblatt 10:14
Of course. Taking a step back a little bit, we talked about how the loneliness and social isolation started a bit before COVID, not necessarily a result of the pandemic. So what are some of the other reasons for this increase in isolation and loneliness?
Steven Newmark 10:29
Yeah, well, I mentioned technology, that’s a big deal and all that. Americans are less likely to belong to organizations. Number one being religious organizations, historically, Americans tended to be active religiously, even if they were not, quote unquote, “religious beings.” Being a part of your local church, synagogue, mosque, was a place of social interaction, and certainly a sense of community with numbers. Those numbers have decreased precipitously, local organizations, like I don’t know what you call it, the Elks club, things like that, I don’t know what you call those groups, those are not as popular as it used to be. For kids groups like the Girl Scouts, Boy Scouts, groups that really existed just to almost be places to socially engage, or have lost in terms of popular culture, if you will.
Zoe Rothblatt 11:15
Yeah, you know, it’s so interesting to think about that slowly those things have just like quietly slipped away without you even realizing it and now here we are today, where we’re having the Surgeon General come out and say that we need to fix loneliness. So what is the next step?
Steven Newmark 11:31
Yeah, well, you know, there are other places too. People used to be more, Americans generally were more engaged in their communities more engaged I don’t want to say politics per se, but engaged in being a part of building their communities, a lot of that takes place online now. A lot of it can be vitriolic online, which is actually discouraging to getting people more active as a result. So okay, before we get to what we can do to address let’s also talk about the second major takeaway from the report, which is that loneliness and social isolation affect not just a person’s health, but it also affects the report found that it actually affects the community’s health, which is quite fascinating. So not surprisingly, what we’re talking about isolation and can contribute to a person feeling higher amount of stress, which affects emotional well-being, mental well-being as well as causing the body to release stress hormones. So that’s on the individual level. However, the report also concluded that social isolation in a community actually results in the community at large are having a decrease in life expectancy and higher rates of heart disease, stroke, hypertension, many other illnesses.
Zoe Rothblatt 12:36
Wow.
Steven Newmark 12:36
Yeah, sorry, sorry, to be a downer.
Zoe Rothblatt 12:38
Well, it’s just interesting because when you think about loneliness, like you really think about that as a personal thing, and you’re feeling the loneliness and isolation, but then to say, a community could be feeling that experience together. It’s just so interesting to say community is together and feeling the isolation, and it also causes all these tremendous health issues.
Steven Newmark 13:01
Yeah, absolutely. Which is why it’s being taken so seriously by the surgeon general. You know, another thing I think worth noting is the report itself was focused on the United States. And while things like this may be happening elsewhere, it did touch upon discussions of some other countries and not all countries are experiencing that. The United States is a very individualistic country, we pride our individualism, we pride success based upon the individual. That is somewhat foreign to other countries, if you will, I mean, Alexis de Tocqueville wrote about this way back when, you know, this is who we are as a nation, but it’s gotten to the point where it’s become an issue worth addressing, because it’s affecting our physical health as well.
Zoe Rothblatt 13:42
And to address it, the report mentioned these six pillars. It’s sort of a framework it’s not, you know, a perfect solution mapped out just yet, but there are six pillars to help Americans feel more connected and less isolated from one another. So let’s go through them one by one.
Steven Newmark 13:59
Okay, so the first of the pillars for making Americans feeling more connected and less isolated. Number one is strengthening the social infrastructure creating more communal spaces, more social activities, and better infrastructure to help people access these. So in other words, there should be more places where people to socialize and gather.
Zoe Rothblatt 14:17
And I also want to add, like a better job that I don’t know like, familiarizing each other with those spaces and talking about it more, inviting friends to spaces like I think one is that of course, we need leadership setting up these spaces, but I’m thinking about what could you do on an individual level, invite one friend to come to a new thing with you and just reach out to each other.
Steven Newmark 14:40
Totally, totally. Yeah, that’s actually a big one. Just the idea of talking to your friends. I mean, one of the things that I saw commentary about the report say when somebody calls pick up the phone, I mean, how often does somebody call and you look at your phone, like, I’m not picking up the phone. Who is this person calling without texting me first to give me a warning? But little things like that just picking up the phone and actually having a human to human conversation for a few minutes can go a long way.
Zoe Rothblatt 15:04
It certainly can. I mean, even think about how, I mean I can only speak for myself, but I get so energized after we do these recordings. And you know, we only get to interact with our listeners in a limited capacity but even hearing from all you all, you guys, when you leave comments and email us like, it’s definitely such a community in it of itself.
Steven Newmark 15:23
Yeah, I talk in social circles about how I miss adult interaction, because so much of work has become remote. And being on a Zoom call, I mean, I’m very fortunate that I have a job that I can work remotely that I could be on Zoom and conduct meetings in that fashion, but you miss a lot. You know the meeting starts, you’re lucky to get a perfunctory 10 seconds of “hey how are you”, but right into the meeting and the meeting ends and you press X and that’s it, and you go to your next meeting. Whereas in the olden days, or if you’re fortunate enough to be able to have more in person interactions before the meeting actually starts, you can have some social interactions with the people that are in the room, maybe before or after and you know, it helps foster that.
Zoe Rothblatt 16:04
Definitely. So number two on our list, develop pro connection public policies that account for the need to foster connection when passing laws or formulating regulations this includes anything from transportation to education to housing.
Steven Newmark 16:19
Yeah, essentially getting people to get together more, you know, sharing, carpool, whatever. Number three, mobilize the health sector and train healthcare providers to identify people at risk of isolation and better equip health providers to connect patients with other forms of social support they may need.
Zoe Rothblatt 16:35
This is so needed, we actually it’s Arthritis Awareness Month and Mental Health Awareness Month, and we asked on social media about if people bring up their mental health to their rheumatologist and a lot of people said that there isn’t time or their rheumatologist says, “talk about that with your other doctor.” So we definitely need better resources at our current health care providers to connect us to the next resource or just help us get the support we need.
Steven Newmark 17:01
Yeah, absolutely. Absolutely. All right. Number four, reform digital environments. Not surprising, require more transparency from large tech companies and establish safeguards such as restrictions for young people that can help ameliorate some of the worst effects of social media on vulnerable populations.
Zoe Rothblatt 17:17
Yeah, it sounds obvious, but how do we actually get that done?
Steven Newmark 17:21
Yeah, It’s a tough one. And the reports spent a lot of time talking about the particularly the effects of social media on minors, which, you know, we’re not gonna spend too much time talking about here, there is legislation that would require verification of someone’s age, when they’re under 18, would require parental approval, it would require actually folks who are under the age of 13, to be unable to access social media sites. And for people between the ages of 13 and 18, to have parental approval in order to access social media sites. How is that going to actually be verified? I don’t know.
Zoe Rothblatt 17:53
We’ll see. We’ll wait to hear more.
Steven Newmark 17:55
Right. Yeah, It’s funny. I don’t know if you ever got on a website for like, like, Budweiser or an alcohol company, they asked you to plug in your date of birth?
Zoe Rothblatt 18:03
Yeah. Are you 21? Yes.
Steven Newmark 18:06
So I don’t know how effective that is. But you know, I guess, start somewhere. And I mean, technically, if the safeguards are not strong enough, and they’re finding folks are getting around it, they can invite themselves up for more scrutiny and more, which is not something that big tech wants. So we shall see.
Zoe Rothblatt 18:21
We shall see. Okay, moving on, number five.
Steven Newmark 18:24
Deepen our knowledge, support, academic research, and public information campaigns to improve our understanding of the connections between isolation and health and make people more aware of the problem in the first place. So we are doing that right now. We are making people aware of the issue and helping to spread that. So Dr. Murthy, we’re doing our job here on The Health Advocates podcast.
Zoe Rothblatt 18:44
This feels like the core of public health to me, doing more research, information campaigns, letting each other know, this is what public health is all about.
Steven Newmark 18:53
Yeah, it’s like cigarettes, you know, first step is finding out that they’re bad for you. Second step is doing dozens upon dozens of more research to confirm that it’s bad for you. But then when a tree falls in the forest, you got to make sure someone hears it, so you have actually have to do the public campaigns to let folks know the ill health effects from smoking. And as a result, our smoking rates are way down versus what they had been in the past. Right?
Zoe Rothblatt 19:17
Yes. And hopefully we can get there with isolation. Lastly, we have number six, which is cultivate a culture of connection. So just really reinforcing the values of connection and reducing the polarization that can lead to people feeling more isolated. We know that we’re so polarized these days, like…
Steven Newmark 19:35
Yeah.
Zoe Rothblatt 19:36
In politics, of course, and we’ve seen it a lot in COVID. But you know, it’s also come up in a lot of other ways, even simple social things. Like if you don’t watch a TV show, you’re totally isolated from that conversation all that sudden, you know?
Steven Newmark 19:49
Right, although I was thinking about it in a different way, when it comes to pop culture. I felt like I felt like decades ago, most people did watch particular TV show, whatever the show du jour was and then you come to the office the next day or work and go to the watercooler and you chitchat about the show. Now the shows are all over the place. And people have such curated lists of what they watch. And it actually can foster connection, if you watch the show Succession and you’re a diehard fan, you got five people in your office who are diehard fans, the six of you are going to have some great connection there. But I think about it more with pop culture, the polarization, if you will. When I was a kid, I had records and cassettes dating myself of certain music, but I still listened, I still knew what everything was in the top 40, I had heard everything because you listen to the radio and that’s just It’s somewhat universal. Whereas with Spotify, and all these other things that we use, not everybody gets exposed to the same music, I was always exposed to music that I wasn’t interested in, in listening to if that makes sense.
Zoe Rothblatt 20:51
Yeah, that makes sense. Well, definitely right now is the moment to become a Swiftie, because…
Steven Newmark 20:56
Okay.
Zoe Rothblatt 20:57
The whole Swiftie community is together online, like looking at the same things that happen every weekend at her tour. And it kind of is exactly what you’re talking about everyone coming together talking about…
Steven Newmark 21:11
Yeah.
Zoe Rothblatt 21:11
The little neat tricks she did on stage or the surprise songs, or who got the hat this week. And it’s really fun to all be in it together, even with strangers, just seeing what they’re talking about.
Steven Newmark 21:22
Well, that is like a community, you know, I have my music that I like, and when I go to the concerts, part of what you’re paying for it is that community connection that everyone’s there. And it is interesting, because I’ve also go to concerts of bands that I am not a diehard fan of and I do feel like what’s what these people, they are like in a cult. There’s a fine line between a good social connection and a good cult. Yes, but ya no, that’s certainly a place where people can feel connected, you know, you have a shared interest. I don’t know if that can replace religion, or as a place for us to gather as Americans. But I was gonna say it does whether we like it or not. But yeah, you know, at least at least with music, it’s benign, I’ll say that.
Steven Newmark 22:00
Yes.
Zoe Rothblatt 22:00
For sure. Well, you know, we have these six points. They’re really big undertakings and this is just scratching the surface.
Zoe Rothblatt 22:01
So we’ll see how things develop. But it’s always good to get the conversation started, especially from such a high ranking official.
Steven Newmark 22:17
Yes. We thank Dr. Murthy, for getting the conversation started. And we thank you for listening and being a part of our community and making us feel less isolated.
Zoe Rothblatt 22:24
Oh, yes, I will second that any day of the week. Okay, Steven, that brings us to the close of our show. What do you learn today?
Steven Newmark 22:32
Well I learned a lot. When it comes to loneliness, I think just being here and being with you, and just talking things through, it helps me on a personal level, be less lonely, and I’m appreciative of that appreciate about the connections that I have. And I think going forward, I’m going to try to be even more appreciative and because I know that it’s for my own health, so there’s that.
Zoe Rothblatt 22:51
Yeah, that second part, actually, what you said is trying to appreciate it more just recognizing it is so important. So often we go through the day and don’t recognize little moments and it’s definitely worthwhile to take a step back and take it in. For me my quick learning was just about the Safe Step Act and the momentum there and hopefully we’ll see passage.
Steven Newmark 23:13
Well, we hope that you learned something, too. And before we go, we want you to encourage everyone to check out all of our [email protected]/listen.
Zoe Rothblatt 23:21
Well everyone thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating and write a review on Apple podcasts and definitely check us out on YouTube. I’m Zoe Rothblatt.
Steven Newmark 23:37
I’m Steven Newmark. We’ll see you next time.
Narrator 23:42
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
S6, Ep6- Moving Beyond the COVID Emergency: What It Means for Your Health Coverage
This week our hosts discuss the end of the COVID-19 public health emergency declarations in the U.S. by the World Health Organization (WHO). They dive into what this means for public health and access to vaccines, testing, treatments, and data collection.
“The emergency phase is over, but sadly, as we know, COVID itself is here to stay. On recommendation from the Emergency Committee, the WHO is setting up a review committee to advise on the creation of recommendations for countries on the long-term management of COVID,” says Steven Newmark, Director of Policy at GHLF.
S6, Ep06- Moving Beyond the COVID Emergency: What It Means for Your Health Coverage
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Welcome to The Health Advocates a podcast that breaks down major health news of the week and help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:18
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:23
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:29
And today, we’re gonna talk about the end of the public health emergencies here in the US for COVID. And the recent World Health Organization announcement, you know, what will change and what it means for our community and public health at large?
Steven Newmark 00:42
Yeah, excellent. So, let’s get into it. The World Health Organization has announced that it’s ending the COVID global health emergency just last week, they declared that COVID is quote, “no longer constitutes a public health emergency of international concern.”
Zoe Rothblatt 00:57
And this decision was made as all these decisions are by a panel of experts and majority agreed that COVID no longer meets this criteria of public health emergency of international concern. And It’s not to say, you know, COVID doesn’t exist anymore. Of course, the virus exists, it’s just not in this heightened state.
Steven Newmark 01:18
Right, essentially they are saying the emergency phase is over but sadly, as we know, COVID itself is here to stay, you know, on recommendation from the Emergency Committee, the WHO is setting up a review committee to advise on the creation of recommendations for countries on the long term management of COVID.
Zoe Rothblatt 01:34
So, that’s really good to hear that although the emergency phase is ending there’s still plans for this next phase and navigating it together and how to manage COVID going forward.
Steven Newmark 01:44
Yeah. So let’s talk a little bit about what this all actually means. What changes are coming, and let’s begin with the vaccines, the COVID vaccines.
Zoe Rothblatt 01:52
Yeah, we’ve actually got a bunch of questions about this from our community, especially because the second bivalent booster was just authorized for our community. People have been emailing and asking us if vaccines are still going to be available for free or at what cost and what’s going to happen given the end of the emergency this week.
Steven Newmark 02:11
Yeah, well, as you know, the federal government has been supplying COVID vaccines, including boosters free of charge to everyone regardless of insurance. Now, this is not expected to change just yet, but may change if the government does not replenish its stockpile of vaccines, not to mention its funding for vaccines. So something that probably can’t be counted on particularly the latter.
Zoe Rothblatt 02:30
And until the stockpile is depleted, people enrolled in certain Medicare programs and most private insurance should still be able to receive vaccines from in network providers with no out of pocket costs. Medicaid members will have vaccines covered without copays through September 30, 2024. And Medicaid will also continue to cover future boosters that are recommended by the CDC.
Steven Newmark 02:55
The Provider Relief Fund, which has supported free vaccines, tests and treatment for individuals who are uninsured was exhausted unfortunately, over a year ago in April of 2022. Late last month, however, the Department of Health and Human Services, HHS announced a $1.1 billion public private partnership to maintain COVID vaccine access as well as some treatments such as antiviral medications for the uninsured. And those funds are expected to last through December of 2024.
Zoe Rothblatt 03:20
Okay, so bottom line for vaccines for now, things are still going to be operating as usual.
Steven Newmark 03:26
Yeah.
Zoe Rothblatt 03:26
But I would say definitely check in with your insurance before you get one just to make sure it’s in coverage or just to be totally aware of what’s happening.
Steven Newmark 03:35
For sure. So, let’s talk about treatments and medications.
Zoe Rothblatt 03:38
Right. We’ve gotten these antivirals that have been authorized during the pandemic that have been extremely life saving, especially for our community who’s at risk for severe COVID. It’s been amazing to have access to these and many are wondering, will I still be able to get these for free?
Steven Newmark 03:56
Well, similar to the vaccine stockpiles, when the supply runs out, manufacturers will set prices for the medications and any additional charge to consumers will depend on individual’s health care plans.
Zoe Rothblatt 04:07
So it kind of seems like it’ll depend on your plan, just like any other treatment or medication, you know, just how it goes regularly for other types of medications.
Steven Newmark 04:16
Exactly, exactly. So you’ll have to check with your provider, you’ll have to check with your specific plan. If you know something happens and you need to obtain medication for those on Medicaid. They will continue to cover treatments at no cost to patients through September 30, 2024. Afterward, the coverage is going to vary state by state, however.
Zoe Rothblatt 04:35
And for people with Medicare, plans that include drug coverage, we’ll continue to have COVID medications covered without costs.
Steven Newmark 04:43
Great. So next, what about the COVID tests?
Zoe Rothblatt 04:46
Oh, boy, Steven, we’ve loved getting the free tests through the government.
Steven Newmark 04:51
Yeah, it was good. It was helpful. Anecdotal story, I was meeting a friend last week and he had some sniffles and he said let me just test to make sure were low and behold, he was positive. So we didn’t meet. So you know, tests still have a value.
Zoe Rothblatt 05:05
Totally. Thank goodness you guys thought of doing the test and had it available. I am seeing some articles depending on what our episode comes out or not how useful this advice is. But before the emergency, you can stockpile or get your supply if you hadn’t yet.
Steven Newmark 05:21
Yeah.
Zoe Rothblatt 05:22
Before it ends and you can still cash in on those like eight free tests a month for your insurance. I’m not exactly sure what it is.
Steven Newmark 05:29
Yeah.
Zoe Rothblatt 05:30
It might be a good idea to get a few now, although remember to check the expiration date because tests do expire.
Steven Newmark 05:36
Right, tests expire, use the older ones first, and so on so forth. Yeah, like I said, I mean, I think that they are still useful if you’re going to be an enclosed environment, and with one or more people and you think someone is developing an illness, test and to be safe, but you know, so we’ll see, we’ll see the future of tests. Hopefully, we’ll get a multitask at some point, something that tests for both flu and COVID simultaneously at-home. But anyway, in terms of the public health emergency ending private insurance companies will no longer be required to cover both at home and lab COVID tests for free. So any out of pocket costs for individuals will depend on your specific plan.
Zoe Rothblatt 06:15
And for Medicare enrollees on certain plans will also have to pay for at-home tests. But laboratory tests ordered by healthcare providers are still fully covered by the dederal insurance program and Medicaid will cover tests without charge similarly until that date, September 30, 2024. And then coverage will depend on states.
Steven Newmark 06:37
Great. So we covered vaccines, we cover treatment, and we cover the tests. So those are the basics of COVID specific stuff. Now what about telehealth? Something we saw a big increase of during the pandemic.
Zoe Rothblatt 06:47
Definitely we saw a huge growth, widespread acceptance of telehealth. People in our community really loved it because we see doctors regularly when we have chronic disease. It was scary when we were in lockdown, and to say I’m gonna miss an appointment, it’s not safe to go in and low and behold, we had telehealth and it was just incredible source of technology for our community to maintain our health. So the reason we had that was because of the public health emergencies and policies that helped expanded it. So now we can assume that some of that is going to go away.
Steven Newmark 07:21
Yeah, for sure.
Zoe Rothblatt 07:22
But I would say the main things to look out for is that you know insurance companies did cover telehealth before, so a lot of those flexibilities will stay in effect.
Steven Newmark 07:33
Yeah.
Zoe Rothblatt 07:33
The main thing is that there was loosening restrictions around what technology you can use and providers treating patients across state lines. So those will probably no longer be waived. So technology systems that don’t comply with HIPAA, you’re probably not going to be able to use that anymore. And if your providers out of state from you, they might not be able to treat you via telehealth anymore.
Steven Newmark 07:55
Yeah.
Zoe Rothblatt 07:56
The requirement to be in the same, licensed in the same state will probably take effect again. But again, you should check with your provider because they could be licensed in your state.
Steven Newmark 08:06
Yeah, exactly. So we’ve spoken a lot about telehealth in the past on this show. And you know, it’s still being figured out to say the least in terms of reimbursement rates and what doctors charge when you have less overhead and when you’re seeing a patient perhaps for less time or as I said with less overhead not having to use an office and clean an office before and after an individual visits, scrub it down the way you would perhaps the costs are less. So perhaps the charges will decrease. And there’ll be some kind of a hybrid mix for providers, which will make it financially beneficial to all.
Zoe Rothblatt 08:37
So you know, another big topic we’ve been relying a lot on these weekly morbidity and mortality reports from the CDC. And a big discussion is how will CDC report on COVID data going forward? I think this is extremely important for our community, because we watch as cases rise, we adjust our safety precautions that we’re taking. And, you know like you said maybe encourage those around us to take tests more frequently. So how will we know about COVID cases going forward?
Steven Newmark 09:08
Yeah, well, the CDC did announce his plan for collecting and reporting COVID data going forward is going to focus less on case rates and more heavily on hospital and death data. And one of the biggest hospitalization data changes is that reporting of suspected cases won’t be required anymore. The CDC will still use its hospitalization surveillance network to collect clinical information to better understand the disease and any changes that occur with severity and symptoms.
Zoe Rothblatt 09:31
And I saw that they were talking about how case data has become less reliable because of the rise in home testing and reporting step downs in some jurisdictions. So leaning into the hospital data is actually more accurate.
Steven Newmark 09:45
Yeah, that’s great. We’re also going to be watching the variants which will tracking will continue but the CDC will adjust some of the metrics it uses to model variant proportions. State level estimates of varying proportions will go away but regional estimate will remain. So we’ll see we’ll see how this goes.
Zoe Rothblatt 10:02
And the CDC will also maintain traveler surveillance, testing wastewater on airplanes in an effort to spot new incoming threats.
Steven Newmark 10:11
Great. And starting in June, the CDC will update its vaccination data on a monthly basis. So that’s where we are.
Zoe Rothblatt 10:18
Ya, overall, it’s not as frequent data as we were getting. But it’s in line with saying that we’re out of this emergency phase and let’s start to monitor COVID, similarly to how we do other diseases, and we’ll look at the data that is relevant now. Because looking at, you know, the same way we reported in 2020, it isn’t the same COVID in 2023, we have to think about it a little differently, especially given the at home testing and new things that we have going on now.
Steven Newmark 10:48
Yeah, absolutely. Absolutely. So, you know, I think the bottom line, it’s fair to say that this is great news. We are moving out of the emergency phase, we can downgrade somewhat from where we had been, vis-a-vis this being classified as emergency and COVID still exists. Of course, other diseases still exist that are out there. But you know, you think back on the last three years, 2020 2021, 2022 or 2023, each year certainly was progressively better. 2020 was, you know, I don’t even want to think about it. 2021 we had vaccines. 2022, things start to get a little bit better, and 2023, we’re able to lift the veil of the emergency, it doesn’t mean if you don’t feel comfortable, if you depending on your comfort level, depending on your discussions with your doctors, that might mean still wearing a mask, or you know, a high quality mask out in public, of course, but things are moving in the right direction, for sure. Which is great news.
Zoe Rothblatt 11:39
I agree with a lot of what you said. And to me, it feels like our day to day life isn’t going to change all the sudden, May 11 when the emergency order ends.
Steven Newmark 11:48
Yeah.
Zoe Rothblatt 11:49
It’s more just now being extra mindful about insurance coverage and when you do get a vaccine, test, treatmen. I mean, us chronic illness people like we’re pros at checking insurance. I’m not too worried. But it will be a bit shocking to have to pay attention to this now. And if we do get a bill, I know people have gotten crazy bills for testing. But I hope that as we move forward and plans are put in place by the government that there is a widespread availability still because these measures are key to keeping COVID at bay.
Steven Newmark 12:21
Yeah, totally. I agree. And I think It’s good. I think it’ll be good collectively for our mental health as well. You can’t live years and years in a constant state of emergency. Zoe, I don’t know how much you remember, you’re so young. But in the mid 2000s, after 9/11, they instituted this color coded thing. And I think every day was like yellow, yellow was like, like we were always in a heightened state. It was always a heightened state. And that’s a horrible way for society to live. And then sometimes we would get these alerts to say we’re in orange today, like what we’re in orange, what the hell is going on. And it’s not a healthy way to live, it doesn’t mean that there’s not a threat, that bad things can happen and that happens every day, depending on where you live. You and I both live in the New York City area, there’s crime, but you know, you can’t let crime dictate your day to day life, and you take your precautions as needed. And similarly, with a virus that is out there, we’ll take our precautions as needed for those of us in the current legal community, and some folks need a higher level of precaution and that’s what we’ll do.
Zoe Rothblatt 13:17
And one final thought I was just thinking about how we’ve had a bunch of public health threats in my lifetime, Zika, Ebola, swine ’09. And I don’t really remember there being such discussion around the end of them, kind of one day I just realized we stopped talking about it. And maybe I was younger so I wasn’t reading news as much. But it feels like a lot of conversation and thought is going into ending these public health emergencies which brings me comfort.
Steven Newmark 13:44
Yeah, I was around for those and I was working in public health for Zika and for swine flu, H1N1, and the major difference, frankly, was that the case load went down to zero. It was almost as if we stopped that in what would be the equivalent of March of 2020, before the case loads got high. So to the extent we declared the emergency, it never got to an elevated point.
Zoe Rothblatt 14:08
Well, that brings us to the close of our show. What did you learn today?
Steven Newmark 14:12
You know, I learned actually, in the course of this discussion, I was a little cautious about the end of the emergency but just in talking to you it’s almost therapeutic. I feel pretty happy and that this is something to be celebrated. I learned to look on the bright side and be very happy about this.
Zoe Rothblatt 14:25
For sure, and I learned a bit more about what insurance coverage is going to look like going forward for private health plans, Medicaid, and Medicare.
Steven Newmark 14:35
Excellent. Well, we hope that you learned something too. And before we go, we definitely want to encourage everyone to check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 14:44
Well everyone thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you like this episode, please give us a rating and write a review on Apple podcasts and check us out on YouTube. I’m Zoe Rothblatt.
Steven Newmark 14:58
I’m Steven Newmark. We’ll see you in next time.
Narrator 15:04
Be inspired supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
S6, Ep5- A Multifaceted Discussion on Policy and Health: Debt-Ceiling Debate, PBM Transparency, RSV Vaccines, and Osteoporosis
Today our hosts talk about the latest news on the debt ceiling, pharmacy benefit manager (PBM) reform, RSV vaccines, and 50-State Network advocacy activities in D.C. Our hosts are also joined by GHLF colleagues Adam Kegley, Manager of Global Partnerships, and Angel Tapia, Senior Manager of Hispanic Community Outreach, who discuss their work in osteoporosis advocacy, awareness, and education.
“Over 200 million people around the world live with it [osteoporosis]. It’s a pretty staggering number already, but the thing is that so many people go undiagnosed, because they think a fracture is just a fracture,” says Adam.
S6, Ep05- A Multifaceted Discussion on Policy and Health: Debt-Ceiling Debate, PBM Transparency, RSV Vaccines, and Osteoporosis
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:09
Welcome to the Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Stephen Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:18
And I’m Zoe Rothbart, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:23
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:29
Today, we’re going to talk about the latest news on the debt ceiling, PBM reform, RSV vaccines and advocacy activities in DC. Steven, I’m excited to hear from you. And we also will hear from two others later in the episode, Adam Kegley, and Angel Tapia on osteoporosis awareness and advocacy. So let’s dive into our news.
Steven Newmark 00:50
Yeah, it’s the beginning of May and unfortunately, this could be the last month that the United States is able to pay our bills, because Treasury Secretary Janet Yellen says that we’re going to run out of money unless our debt ceiling is increased by June 1st. So, welcome to May everyone.
Zoe Rothblatt 01:06
More happy news that we just pile on every episode, right?
Steven Newmark 01:10
Yeah.
Zoe Rothblatt 01:10
Okay. So what does this mean? What is happening? What might happen to stop this?
Steven Newmark 01:16
Well, I’m not gonna take the deepest dive into what a debt ceiling standoff is all about. I’ll just say, essentially, you accrue bills, and you have to pay them, right? You at home, you, you take your credit card, you go out and you pay for things, you have a mortgage, perhaps, or what have you. You don’t then decide whether or not you actually want to pay the bills. In the United States, a government, we have a law that says, “In order to pay the bills in order to increase your debt, even after agreeing to pay these bills, you then have to vote to increase the debt limit afterwards.” So It’s like saying, “Hey, we just ran up the credit card tab. This is from a few years ago, actually. And now those bills are coming due. It’s time to pay the bills.” Now, if you don’t pay your bills, what happens to you as an individual? You get a bad credit rating. You get – now, if, as a government, you decide not to pay your bills, or sometimes even if you threaten to not pay your bills, you can affect your credit rating, which is not a position anyone wants to be in. Folks holding treasury bonds, which are considered to be amongst – if not the safest investment you could possibly hold – they will shake up the markets, to say the least. So it’s not something anyone wants to see happen. But what’s going on right now is that attention is in the Senate as the standoff over raising the debt ceiling continues. So Republicans are using the opportunity of the debt ceiling, it being hit, they’re raising the debt ceiling to put pressure on both the Senate and the White House to try and get through some policies that they favor. So they put forth a bill, the House, put forth a bill. It squeaked by with 217 votes. I think that was one more one, now. They got it by one vote to increase the debt ceiling that – but it also includes a laundry list of deep cuts, shall we say, which are – which have essentially been declared dead on arrival by the Senate Majority Leader, Democratic Majority Leader, Chuck Schumer. And it’s also, you know, even if it somehow miraculously passes the Senate, it’s shortly going to be vetoed by President Biden. However, it’s the opening salvo in negotiations. So it’s probably what we should talk about. And we should talk a little bit about what’s in there in terms of health care policies, because, you know, that’s what we do on the show is we discuss what’s going on. So the Republicans are using the debt ceiling standoff to advocate for one of their long standing goals, which is requiring more low income Americans to work in order to receive government benefits, primarily food stamps and Medicaid. So Republicans tend to see work requirements as almost a twofer. It allows them to reduce government spending, while also bolstering the nation’s labor force at a time when some businesses are stuck struggling to find staff. Still, you know, some Republicans also argue that work requirements can lift people out of poverty, and then their reliance on the government. Critics, of course, see the mandates as an attempt to shrink what many consider the vital safety net programs without regard for the people who will be left struggling to put food on the table as a result of losing their food benefits and Medicaid insurance. So let me just take a pause and say what is actually in the plan that passed the House of Representatives. So what’s in the plan is that if childless, able-bodied adults ages 18 to 55 could get food stamps for only three months out of every three years unless they are employed for at least 20 hours a week or meet some other criteria. Currently, the mandate applies to those ages 18 to 49. That was suspended during the COVID public emergency, which expires next month. Medicaid, the Medicaid work requirements – it should be noted – Medicaid has never had a work requirement, but the Trump administration did grant waivers to several states to impose a mandate on certain enrollees, but that those never went through in full force because of litigation. Now, the Congressional Budget Office estimates that about 1.5 million adults, on average, would lose funding for Medicaid if this were to go through. So – but, the analysis also does say that it’s very possible that states might pick up the tab for some of these folks, or actually more than half of them. So it’s ironically a way of – in trying to save money for the federal government – shifting some money back to the state governments. Also, it should be noted for working age Medicaid beneficiaries without disability, 61% were working in 2021, according to the Kaiser Family Foundation, but of course, they held such low wage jobs that they still qualified for Medicaid. You know, there was one small sample set in Arkansas that, that did mandate work requirements for a little while before it was stopped by the court. And the result there in that small sample size, did – it showed that there was not an increase in [……]. So I’ll pause there and just say that’s, that’s where we are, the debt ceiling debate. The opening salvo includes Medicaid work requirements, which could have an impact on 1.5 million adults.
Steven Newmark 01:45
So thank you, for all that. That was a lot of rich information there, especially in the context of healthcare. I want to ask what happens next? What should we be on the lookout for?
Steven Newmark 06:00
Well, like I said, so now it moves to the Senate. So we’re speaking in the first week of May. The house is in recess this week, and the Senate is conducting hearings specifically on this bill where essentially the Democrats in the Senate are – that control the committees – are basically holding hearings to dismantle the bill, politically, if you will, but we’ll see where that goes. You know, as for the long term plan, that’s tough to say. The White House says they won’t negotiate over the debt ceiling, which I would argue that’s saying you’re not negotiating is actually a way of negotiating in some respects, right? You say, “I’m not going to negotiate over that?” “Well, what if I give you this, what if I give you this.” ” I’m not gonna negotiate.” You know? It’s like going to the car dealer and walking away, like, that’s part of the negotiating strategy, in some respects. So what that ultimately means, who knows? There’s all kinds of tricks that the Treasury Department can make in terms of this June 1st deadline, maybe make it a little bit later. Sometimes they could pass extenders, extend the debt ceiling for a month, two months, tied into the budget negotiations, which is a whole other rabbit hole I don’t want to go down for our listeners. But ultimately, it will affect the entire economy. Because if we do hit the debt ceiling – in 2011 we came close to hitting the debt ceiling, and our credit rating was affected. The United States’s credit rating, I’m referring to. So if that were to happen again, yeah, it could be – I don’t want to be alarmist and use the word catastrophic. That’s an overused term, but it could have an impact on the economy and ripple through and affect essentially everyone, and in terms of healthcare, you could start seeing, legitimately, cuts that have to take place, if the government is forced to pay their bills, and they don’t have – we don’t have the money, you could start to see true draconian cuts across the board, including in the healthcare space, including places like NIH, including places like FDA, HHS, and so forth.
Zoe Rothblatt 07:45
Yeah, that’s definitely, you know, like, scary as someone – just a regular person, but someone with chronic illness that relies on all of the research being done in these authorities to help guide us and we know the COVID public health emergency’s expiring soon. So now feels like a time to bolster all of these authorities, and it’s a little scary to hear that the opposite could happen.
Steven Newmark 08:07
Yeah, I know. I wish I had better news. I wish there were more exciting things to talk about. Well actually I do a better news; I do have better news. I’ve spent some time in Washington the last few weeks and on a very positive front, the issue of PBM reform is really gaining traction. Senators Bernie Sanders, an independent but of course caucuses with the Democrats, and Bill Cassidy, a Republican, have reached a deal on new legislation that aims to increase transparency measures on PBMs, Pharmacy Benefit Managers, as we all know, listeners know, are essentially the middlemen who help raise the price. So these senators, the two of them, lead the powerful Senate committee called the Health Education, Labor and Pensions Committee or the HELP committee. And so they are working on a legislative package to essentially reform the PBM process. They actually held hearings on Tuesday of this week, Tuesday, May 2nd, and ,in what’s called – known as a markup. So we’ll see where that goes. We – and I say ‘we’ – I mean GHLF, and our advocates have been in Washington, and have been pushing to make sure, you know, ensure that a PBM reform is included in the final piece of legislation, which is really a years long effort on our part just to get PBM – the idea of PBMs – even recognized by lawmakers. So it’s fascinating, talking to a colleague, just a few years ago, we would go down to Washington and talk to legislators, and they didn’t know what a PBM was. So you were talking PBM 101 with them, and now we’re at the point where we’re very close to this actually being a part of a major piece of legislation that – bipartisan legislation – has a strong chance of passing. So now where we are in the advocacy phase is as things sort of get into the muck of the sausage making, we want to make sure that our – us – I’m losing the metaphor but our clump of meat gets, gets to stay in that sausage, if you will, before the final bill gets to the full Senate. So that’s where we are. The bill, I should mention, would increase transparency plans to use PBMs as well as impose transparency measures on PBMs themselves. It would also ban spread pricing and mandate that PBMs pass 100% of the rebates collected from rebates from drug makers to health plans. We advocate that the rebates savings should go to, should go to patients. But I think, due to accounting tricks in terms of legislation and getting it marked up and savings to the government, that’s why they it’s going to health plans. And just to define ‘spread pricing’ for those who don’t know: it refers to the margin between the amount charged to a health plan and the amount paid by a PBM to pharmacies or prescriptions. So that difference would be banned essentially.
Zoe Rothblatt 10:36
And there’s a lot of mystery around what PBMs do and the deals behind, so this bill would help uncover some of that and put the practices more into light and put patients in a stronger position.
Steven Newmark 10:47
Totally. So I think transparency is the key, and I should mention there’s growing momentum on the House side as well. So we hope to see something, so if this does get through the Senate, we’re hopeful on the House side as well. So fingers crossed, we’ll see where we are. More than fingers crossed, because we’re actually going to do work to keep fighting for that.
Zoe Rothblatt 11:05
Exactly. Like you said, it’s years of advocating, and we know policy change takes time, and it’s exciting to see that work pay off.
Steven Newmark 11:14
Absolutely. Absolutely. Yeah, like you said, it is the culmination of years of so many folks doing this, and it’s not just GHLF and our members, but we are members of coalitions that come together from different organizations and different backgrounds, different disease states. Just last week, we participated in a congressional briefing with the Coalition for Skin Diseases. We had the opportunity to meet directly with legislative officials in their offices, as well as a luncheon with dozens of attendees of lawmakers’ offices. It was a great opportunity to educate policymakers about what it’s like to live with a chronic skin condition and how pending legislation can make a difference in the lives of these patients.
Zoe Rothblatt 11:52
That’s great. It’s also, I mean, we’ll hear more from Adam and Angel later in the episode but it’s also – you know – a ton of Awareness months, and I think we have the ear of policymakers during this time. And it’s a great time to just get active and do what you’re doing, what our network is doing and help raise the voice of people living with chronic conditions
Steven Newmark 12:11
For sure. So off with Capitol Hill. Zoe, why don’t you tell us what’s going on with the FDA?
Zoe Rothblatt 12:17
Sure. So in exciting news, the FDA is considering an approval of an RSV vaccine for older adults. So an advisory committee to the FDA voted in favor of approving two different vaccines for older adults for protection against RSV. They were looking at Pfizer and GSK vaccines. So let me tell you a little bit about the data that was shown. We know RSV had a huge impact last flu, winter season. So it’s exciting to see this come out now, ahead of the next you know, winter season when stuff usually crops up. So the data they were looking at, the Pfizer data showed that the vaccine was about 67% effective at preventing people from getting two or more symptoms of RSV-associated lower respiratory tract illness and also 86% effective at preventing three or more symptoms. And then similarly the GSK data showed the vaccine was about 83% effective against RSV lower respiratory tract disease and 94% effective at preventing severe RSV. So this was great data to see. This doesn’t mean the vaccines are approved, though the FDA usually follows guidance from the advisory panel, and their decision is expected this month, during May.
Steven Newmark 13:34
What a difference it would be to have a vaccine for the flu or RSV and for COVID next year.
Steven Newmark 13:43
Right. This one’s specifically for older adults, but I think we could expect that next would come immunocompromised [people] or young children, thinking about the groups that RSV poses the greatest risk to. It’s like we’re getting the foot in the door kind of like with policy, you know? You do one change, and then you add on. So hopefully this means that more news is coming.
Steven Newmark 14:06
Yeah, that’s great. That’s great. Thanks for keeping us informed about that, these important updates. That’s fantastic.
Zoe Rothblatt 14:11
Well, like I mentioned, today I’m joined by Adam Kegley and Angel Tapia to talk about their work in osteoporosis both with awareness, advocacy, and helping patients here and globally. So hi, guys, welcome to the Health Advocates!
Adam Kegley 14:25
Hello!
Angel Tapia 14:26
Hi!
Adam Kegley 14:26
Thanks for having us!
Zoe Rothblatt 14:27
I’m so happy to have you guys here. Why don’t you start off by introducing yourselves and telling our listeners a little bit about you. Angel, I think you’ve been here before, so welcome back!
Angel Tapia 14:37
Thank you! Yes, this is my second appearance on the Health Advocates. So super excited to be back. I’ll reintroduce myself. I’m the Senior Manager of Hispanic Outreach. And I also am the host of Wellness Evolution podcast with Global Healthy Living Foundation. So I’m happy to be back and to be here to really share the great work that we’ve been developing to help raise awareness and support engagement for osteoporosis, fracture prevention and healthy aging.
Adam Kegley 15:02
And I am Adam Kegley. I’m the Manager of Global Partnerships at the Global Healthy Living Foundation. My work is all about -well, you may have guessed it – building partnerships with people, organizations, institutions around the world so that we can really continue to better the lives of people living with chronic conditions. I’m super proud of the work we’ve been doing, and especially about leading our Strong Bones & Me global osteoporosis initiative alongside Angel, which I think we might be here to talk about today.
Zoe Rothblatt 15:31
Definitely. So let’s take it back a few steps. Can you guys both – or one of you – briefly explain osteoporosis, and then I’d love to hear from both of you about, you know, what drew you both to advocate for this condition and help patients.
Adam Kegley 15:45
Sure. So osteoporosis is quote unquote, a “bone thinning” disease. It essentially occurs when your body no longer creates new bone as quickly as it removes old bone, which means that your bones kind of become weak and brittle and are pretty abnormally porous and compressible, kind of like a sponge, actually. And at that point, a fall, or even mild stress, like coughing, sometimes – in the worst cases – can actually cause a bone to break. And, you know, most common osteoporotic fractures include the hip and the wrist, but also the spine, which is something that I think a lot of people forget about, or maybe don’t know about. It’s also known as the “silent thief” as a condition because it kind of silently steals your bone density, often kind of – without knowledge – until someone really experiences a fracture or receives a diagnosis, which unfortunately, means it’s pretty successful thief.
Angel Tapia 16:39
And I’ll say, for me, just being a part of the project was, first off, like, we all have bones. So it was very interesting to be part of a project that even though it’s a diagnosis that I don’t have, it’s something that I could learn from, and because it is something that is preventable, and [related to] the importance of healthy aging. So when Adam brought me into the project, I was just very interested in the education, you know? I had a general understanding of osteoporosis. But when you start looking at the research, and you learn the statistics, like one in three women worldwide, over the age of 50, will experience a broken bone due to osteoporosis, and one in five men will – worldwide – will have that experience as well over the age of 50, to experience the broken bone due to osteoporosis. That, like, brings it home, because it is something that can affect all of us at some point. Also, learning about the different communities that are at higher risk was very interesting. And finding out the differences between first fracture and second fracture and those that are not aware of the resources that are available, or maybe don’t know how to talk to their doctor about their bone health. It just really spoke to my empathy, that we can create something that can be helpful for them to engage in better health, to be able to have more education around how to ask questions to their physicians, and then also how to better take care of themselves.
Adam Kegley 17:57
That’s exactly right. And I could only second everything that Angel said so beautifully. I thought, also, it was kind of touching on what she said, it’s so pervasive and kind of rather insidious, in its nature globally. And when I kind of realized one of the statistics as well, that’s over 200 million people around the world live with it, it’s a pretty staggering number already, but the thing is that so many people go undiagnosed, because they think a fracture is just a fracture. Sometimes doctors or hospitals, when they come in, they just send them right back on their way without any follow up or without receiving a bone density scan, which is also known as a DEXA scan, which is kind of a crucial testing element to be able to determine whether your bone density is thinning over time. It’s a key way to determine whether somebody is either at risk for osteoporosis or has osteoporosis already. So these things were really interesting, I think, to both of us and really hit home that we could hopefully help make a difference in people’s lives, you know, who’ve been affected by it.
Angel Tapia 18:59
And even the creativity with figuring out, you know, what some of the barriers are to access and again to the education that’s so important. And us being able to have partners where we can really bridge the gap for a lot of these communities, I think is a part that we’ve really enjoyed about this project.
Zoe Rothblatt 19:17
Thank you so much for all the work you both are doing. You may know this, I’m not sure, but about a year ago, I found out about a family history with osteoporosis and we knew nothing about it. A lot of what you’re talking about just undiagnosed. And it was just, you know, preventative run of the mill scan and it was like, “Okay, this is what’s going on.” And in turn, now, I’m taking preventative steps because of my risk, which includes bone strengthening exercises and daily calcium, and it just – I feel so fortunate that at a young age, I found out about this and I’m able to take the right steps. But I really didn’t know anything about it until it showed up and as so many in our community know it’s like really intimidating when there’s a diagnosis in the family, and it can feel overwhelming. And I just think the work you’re doing to help give people the education and tools upfront is so important, especially because you said one in three women, so many people worldwide, are dealing with this and not enough is being talked about.
Angel Tapia 20:16
And it’s another condition where we have to think about stigma as well, because when we think about our bones, we’re thinking about when we get older, when we get to a certain age. And when you start learning that, as you said, there’s those preventative measures that we can start taking now, there’s history that we could find out from our family members that, you know, makes this even more important. So advocating for those loved ones to get tested, when they get to the age that they should have these testings and then sharing that information, you know, within the family so that those that aren’t of age yet but need to really start paying attention to family history, and really having that focus on how to maintain healthy bones, I missed an important conversation,
Adam Kegley 20:55
I was just going to build on what both of you said, actually, I think it’s a really important point. And what you mentioned, Zoe, is that, you know, outside of family history as well and I think a lot of people don’t realize that if you’re over 50, and you’ve broken a bone, you need to get a DEXA scan. And there are other situations as well, that the average risk person, it’s 65 or older for women and 70 or older for men, but somebody maybe who’s living with a chronic condition that’s been linked to osteoporosis or bone loss or on medications that have been linked to bone loss- those people, no matter the age, they should also be getting a DEXA scan because they’re at a heightened risk for bone density loss.
Zoe Rothblatt 21:35
And just so it’s clear to people talking about that with their primary care, or is there a specialist that that they would go to for this
Adam Kegley 21:42
That’s a great question. The first step I think would be to talk to your primary care provider. There are specialists as well. If you’re involved with an endocrinologist, or perhaps an orthopedic surgeon, or seeing somebody for bone related issues, of course, you can talk to them as well. But your first step would also be your primary care provider.
Zoe Rothblatt 22:02
So tell us about the Strong Bones & Me program. I’m so excited you guys teased it a little bit. Tell us what’s going on there.
Adam Kegley 22:09
Yeah, the Strong Bones & Me program is basically GHLF’s new global osteoporosis initiative. Our focus is really to educate and inform and engage people living with or affected by osteoporosis, as well as providers and others around the world on the risks of the condition, including multiple fractures and prevention of them how people might ask for support and treatment, or especially follow up care if they’ve experienced a fracture from their providers, as well as additional support from caregivers, family and friends.
Angel Tapia 22:42
I was going to add another great part about it is also the partnerships that we’re creating with this project. Since it is a global initiative, we’re working with many organizations worldwide, that are bone health experts. And that’s a way for us to collaborate with those that are leaders really in bone health and to work with the groups that are represented through our Global Council. So we’ve dubbed it a little bit of “friend raising”. And the key there is because we’re cultivating the partnerships and the support. It’s really supporting each other. We don’t see ourselves as the bone health experts, we know that those are already out there, and we’re partnering with them as part of our Global Council. So really, it is just our goal to help connect the education to the populations that are most at-risk, to make sure that we’re amplifying the education that these organizations are already creating, and that we enhance that with the research that we have also found with the content that we’re able to create, and that we’re able to do this in various languages as well, working in countries that may have limited resources to really amplify this gives us an opportunity to use this material in several languages to reach across the world.
Zoe Rothblatt 23:54
That’s great. making things accessible in so many languages is such a huge part of advocacy and giving people the tools to be able to you know, speak up and advocate for themselves. And I’m curious, you know, what’s it like working with these different groups? Tell us about the global perspectives and your experience there.
Angel Tapia 24:11
So aside from the varied time zones that we all have to get very comfortable with quickly, there is a lot of great learnings. I think the experiences have shown us some of the similarities and differences between the communities that we have in the US and the communities that we have worldwide. I specifically work with the Hispanic community and what I’ve seen with some of the partners that we are now engaging is that the similarities for caring for our aging population is something that’s very important, making sure that we are advocating for our loved ones looking out for the barriers that they may have to health care and also providing financial and emotional support to our elders is something that’s very important in a lot of the countries that we’re working in. So our idea to make sure that caregivers find support, that physicians are hearing patients’ stories so that they’re aware of how their community is being affected once they leave their office, and also just an opportunity for voices to be heard around the world, people sharing their stories that may have different circumstances. So it really brings about that even though there are different languages, we are all sharing this human experience that we are all aging, or we have family members that are aging, so we can learn this education for ourselves, and we can share it with others and realize that better health is always a value, no matter where you are in the world.
Zoe Rothblatt 25:32
That’s great. How can people get involved what’s coming next?
Angel Tapia 25:36
we are going to be launching the Strong Bones & Me website very soon. So we’re going to be sharing great content there that has been created to really highlight the osteoporosis and fracture prevention education. We also will be having a social media promotion happening for Osteoporosis Awareness Month, which is May, and that will be on GHLF, as well as CreakyJoints, social media channels and website. So there’ll be more information to come with that. And I’m sure that we could share more content or a few links for some of our resources on the page for this interview.
Adam Kegley 26:09
That’s right! And we’re also having an osteoporosis and bone health-themed live CreakyChats, one of our great CreakyChats on Twitter on the 15th of May, that’s Monday at 7pm Eastern Time. And we would love for any and all of you to join the chat. We’ll have several co-host organizations from our Global Council and a special guest doctor who is an endocrinologist.
Zoe Rothblatt 26:33
Very cool! So we’ll see everyone on Twitter. You could either do #CreakyChats or follow @CreakyJoints to get the information. Very cool. I’m so excited that there’s ways for our community get involved in the great work you both are doing. Thank you so much for joining us today.
Angel Tapia 26:49
Thank you, Zoe!
Adam Kegley 26:50
Thank you, Zoe!
Steven Newmark 26:53
Wow, that was fantastic, Zoe. It was great hearing from Adam and Angel and hearing what they had to say about osteoporosis.
Zoe Rothblatt 26:59
Well, that brings us to the close of our show. Would you learn today?
Zoe Rothblatt 27:02
Well, I learned from you about the great work that is being done in RSV vaccines for older adults, and how there’s some hope that there may be a vaccine as we go into the winter and knock wood hopefully also for you know, beyond just the older adults.
Zoe Rothblatt 27:17
Definitely, and I learned from you a lot about the debt ceiling. There’s so much to recap there and thank you for breaking it down simply for us.
Steven Newmark 27:25
Well, we hope that you learned something, too. And before we go, we definitely want to encourage everyone to check out all of our podcasts at GHLF.org/listen.
Zoe Rothblatt 27:30
Well everyone, thanks for listening to the Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating and write a review on Apple Podcasts. And definitely check us out on YouTube. I’m Zoe Rothblatt.
Steven Newmark 27:52
I’m Steven Newmark. We’ll see you next time!
Narrator 27:57
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
S6, Ep4- The Future of COVID Booster Shots
In this episode, our hosts discuss the learnings from the recent Advisory Committee on Immunization Practices (ACIP) meeting and what it means for COVID vaccine scheduling going forward. They also break down the latest on new COVID boosters, mifepristone, and results from the latest quick poll on stress and chronic illness.
“I feel like we’re not getting news specific to our community, so it feels really important for us to be breaking it down and talking about it. Because… a lot of science is talked about, and it’s hard to read the data sometimes, so just having time together to break it down is helpful,” says Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
S6, Ep04- The Future of COVID Booster Shots
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Zoe Rothblatt 00:08
Today we’re going to talk about the recent ACIP committee meeting who advises the CDC on vaccines. We’ll talk about the second bivalent booster available, a mifepristone update, and of course some quick poll results on stress and chronic illness.
Steven Newmark 00:26
Welcome to The Health Advocates a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:35
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:40
Our goal is to help you understand what’s happening in the health care world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:46
And today’s Steven, we’re going to talk about the future of COVID vaccine scheduling, what was discussed at the recent committee meeting. But first, as always, let’s hop into the news updates.
Steven Newmark 00:57
Well, speaking about vaccines, the second Omicron boosters are here. The FDA recently authorized an additional round of bivalent boosters for those 65 and older and those with weakened immune system.
Zoe Rothblatt 01:08
So the shots are given in two different time increments. So if you’re 65, plus, it’s four months after your first bivalent booster. And if you’re immunocompromised like many in our community, it will be two months after your first bivalent shot.
Steven Newmark 01:22
These updates are a little different because they say these groups can choose to get these vaccines, they are not a requirement.
Zoe Rothblatt 01:28
Yeah, I thought that was interesting as well. I guess our community has been asking a lot of questions about when the next vaccine is going to be. So it’s good to see that these updates are happening. And I know we’ll get a little bit more into this as we go into the committee meeting. But It’s interesting that it’s not a requirement or recommendation, but rather just a choice.
Steven Newmark 01:49
Also interesting is the FDA is withdrawing authorization for the older vaccines targeting the original strain. And so essentially, anyone who is unvaccinated still can get a single dose of the by bivalent booster, so they don’t have to go through the whole primary series to get the updated booster.
Zoe Rothblatt 02:04
Pretty cool and makes sense because we’re seeing that those are the variants that are circulating, and we’re not really seeing any of the original cases, so I’m glad to see this update.
Steven Newmark 02:14
Yeah, definitely. We also have a mifepristone update from the Supreme Court. The Supreme Court preserved access to the medication ordering that the drug should remain broadly available as the litigation plays out in a lower court.
Zoe Rothblatt 02:25
Yes. So basically, this didn’t end the legal battles over the drug that we’ve been talking about but it just assures that mifepristone will remain available until the justice has decided otherwise.
Steven Newmark 02:36
Yeah, the next steps are the case is going to be heard in the United States Fifth Circuit Court of Appeals on May 17. Although the Supreme Court order is likely to stay in place, even after the Fifth Circuit rules so that any decision would be appealed back to the Supreme Court for a final ruling.
Zoe Rothblatt 02:51
Which might not happen for a while, so I guess we’ll keep updating on this as we learn more.
Steven Newmark 02:56
Stay tuned.
Zoe Rothblatt 02:57
And then our third bit of news here, we have a quick poll update. So we asked our community about stress, specifically stress related to their chronic illness and 75% of the people that answered the poll said that in the past seven days they’ve been moderately or very stressed due to their chronic illness.
Steven Newmark 03:15
I’ve been there. What did they do to manage their stress?
Zoe Rothblatt 03:18
That’s a good question. We also asked about that. So people could select all that apply. 61% said they watch TV or movies. Definitely agree with that. And then nearly half had selected each of these options: they listen to music, read a book, go for a walk or a hike or talk to family and friends.
Steven Newmark 03:36
Those are probably healthier than watching a movie or TV but whatever works, right?
Zoe Rothblatt 03:41
I know. Yeah, I guess It’s like a mix.
Steven Newmark 03:43
You gotta mix. Right? You gotta mix it up, for sure. You’re right, you’re right.
Zoe Rothblatt 03:46
Alright, so let’s hop into our big topic of today. So there was another meeting of the Advisory Committee on Immunization Practices, ACIP for short. This is a committee that advises the CDC and let’s talk about what they discussed. There was a lot of updates on the COVID vaccine specifically. I think we’ll get into some data on the effectiveness, what hospitalizations are looking like, and then ultimately, where does vaccination policy go from here?
Steven Newmark 04:14
First, there was lots of discussion around the vaccine effectiveness and waning immunity and talking about pediatrics. The committee advised that children should stay up to date with COVID vaccines No surprise there. The data showed that monovalent primary series vaccination helped provide protections for children ages three to five against symptomatic COVID infections for at least the first three months after vaccination. It started to wane after roughly the 46 months after the second dose.
Zoe Rothblatt 04:42
And this is similar to the patterns that we’ve seen in adults right, you know, there’s no surprises here.
Steven Newmark 04:48
Exactly. So for most people who got the monovalent shot and are eligible for a bivalent booster it’s been more than a year since their monovalent dose and because of waning immunity, they may have limited protection and it may be time to get that booster.
Zoe Rothblatt 05:01
So yeah, when thinking about what I gathered from this discussion was that in all age groups, there is waning immunity at the four to six month mark, and many people haven’t been vaccinated in over a year. So there’s a lot of people out there that have limited protection.
Steven Newmark 05:17
Absolutely. They also looked at hospitalizations…
Zoe Rothblatt 05:19
And yeah, so the 65 plus age group had the highest rates of COVID associated hospitalization. This isn’t surprising.
Steven Newmark 05:26
No, not at all.
Zoe Rothblatt 05:27
It also makes sense with you know, the new recommendations that 65 plus can get the second bivalent booster. The data did show that they looked at the first bivalent booster and you know, how protective was it for hospitalizations? It showed that it did in fact provide additional protection against emergency department and urgent care encounters and hospitalizations. And most importantly, it showed that the vaccines provide protection against most critical illness, which is you know, being on a ventilator or dying.
Steven Newmark 05:55
Yeah, and then there was also some updates to a COVID vaccine policy. The ultimate goal as for the CDC is to take steps towards simple recommendations to increase the vaccine uptake and they came up with three ways to simplify. The first is a single formulation for mRNA vaccines, the second is to do a single, possibly an annual dose for most individuals to make things easier similar to the flu vaccine. And the third is to allow for flexibility for vulnerable populations including the immunocompromised.
Zoe Rothblatt 06:23
So let’s break down each of these. We’ll start with number one, the single formulation for mRNA COVID vaccines. So basically the committee is supporting the FDA and that transition from the monovalent primary series to the bivalent shot or the mRNA vaccines. That’s a little important distinction, there’s no change for Novavax, or Johnson & Johnson just yet. This is specifically about the mRNA vaccines.
Steven Newmark 06:48
Right. You know, the situation is that many of the monovalent COVID vaccine products have already expired, others are going to expire soon. So the FDA removed authorizations for the monovalent mRNA COVID vaccine products.
Zoe Rothblatt 07:01
And I guess what’s the data to support this? They looked at that in the meeting. And there was a lot of science going on there. And we could just break it down in simple terms as advocates.
Steven Newmark 07:11
That’s what we do here.
Zoe Rothblatt 07:12
So they showed that the bivalent COVID vaccines induce an immune response when given either as a primary series or a booster and when the bivalent shot was given as a primary series induced an antibody response that was 25 times higher than the original monovalent vaccine, which was really good to know that we’re replacing the monovalent shot with the bivalent, and it is in fact producing a higher antibody response.
Steven Newmark 07:40
Yeah, no, that’s great. I mean, there’s limited data to directly compare COVID outcomes after getting the monovalent or the bivalent vaccines, but most studies show that bivalent vaccines expanded the immune response.
Zoe Rothblatt 07:50
So overall, number one, that makes sense, simplify it, get the bivalent shot instead of the monovalent.
Zoe Rothblatt 07:57
Yeah.
Zoe Rothblatt 07:58
Now, what was number two again? That was about a single annual shot, right?
Steven Newmark 08:02
Correct. So when thinking about how frequently people should get a COVID vaccine, data showed that there is an increase in cases in the winter months, and also when there’s an emergence of new variants, of course.
Zoe Rothblatt 08:12
And in the summary, the committee said that they plan for a fall booster that could provide added protections at a time when one you know, the cold weather’s coming, like you just said, or two many would be one year from their last dose and it would help with that waning immunity, right?
Steven Newmark 08:28
I think it would almost sound somewhat similar to this year where many people got the flu and COVID vaccines in tandem, some literally on the same day, some within a few weeks of each other and that looks like we’re going into the future.
Zoe Rothblatt 08:41
That’s what I did. I got them, like within a few days of each other, and it felt good. Just to get that done both together, on a schedule, now I have protections, especially with… I have to hold one of my meds. So it gets a little annoying. And it’s nice to do it together, and just everything at once out of the way.
Steven Newmark 08:59
Definitely, definitely. Hopefully it will be as seamless in the sense that the public emergency is ending. And it will be as simple as going to a pharmacy to get the shots, as many of us did last year, as many of us have done for many, many years with the flu vaccine. So we’ll see. We’ll see what it looks like in the fall. But I’m hopeful that it’ll be pretty, pretty straightforward.
Zoe Rothblatt 09:20
So that was briefly mentioned in the meeting about COVID vaccine cost after the emergency order ends in May. And the committee said that all vaccines purchased by the US government will still be available for free. But there was you know, a few notes on the commercialization of vaccines and having private entities buying vaccines. So we’ll have to see how it all plays out with what it costs. But for now, it’s looking like it’s still covered.
Steven Newmark 09:45
I didn’t quite grasp… they mentioned… I know what you’re referring to in the hearing. Did you happen to grasp or get a sense of whether the U.S. government was going to be purchasing the same quantities that they had been in the past or having a more limited supply and targeted only to those with financial needs, or if it was more likely to be a free for all into the far future. I couldn’t tell.
Zoe Rothblatt 10:06
I couldn’t tell either. From what I saw, it felt vague, kind of like: Oh, this is on our minds, and maybe we’ll discuss it at the next meeting.
Steven Newmark 10:14
All right, well, that’s good. But our preference here as advocates would be for vaccines to be as widely available as possible. We want individuals who are immunocompromised to, of course, get the vaccines and be protected. But we also want the general population to get vaccinated as much as possible to help stop the spread of whatever’s coming our way next fall next winter. So the more accessible these medications, if they’re free, that makes it easier if they’re available at local pharmacies, that makes it easier and more seamless. You know, whatever increases accessibility for the entire population is something that we will continue to advocate for.
Zoe Rothblatt 10:49
Definitely. And one last note on this single annual dose. The data showed that children will likely still need a primary series and a booster to optimize immunity. Like we talked about that data before that immunity was waning in children under five. It’s depending on age, there’s a little bit of difference in how things will go. So always talk to your doctor, I guess is the ultimate rule of thumb. Check in with your doctor about what the timing, when you should get it, which you should get, and all the good stuff there.
Steven Newmark 11:20
Yeah. oh, and then the third piece was the flexibility for vulnerable populations.
Zoe Rothblatt 11:24
Yeah, this goes in line with what we talked about the top of the episode. So this third part with the FDA authorizing a second bivalent booster for 65 plus and immunocompromised, the committee, you know, looked at that decision and were talking about it and ultimately said that right now, there isn’t enough data to support a routine recommendation for both of these groups and just acknowledging that they have to be flexible with vaccine recommendations. So what this ultimately means is, we don’t really know the next step right now for or how often 65 plus and immunocompromised will need a COVID vaccine, but they will continue to look at the data and give recommendations on what feels right and what the data is showing.
Steven Newmark 12:04
Excellent. Well, thank you, Zoe, for covering that for for GHLF. And learning all that you learned from feeding.
Zoe Rothblatt 12:10
Yeah, same to you. It’s good to talk about this. I haven’t seen any big news. I saw news on the boosters. But the rest of these recommendations, it’s like, I feel like we’re not getting news specific to our community. So it feels really important for us to be breaking it down and talking about it. Because again, like a lot of science is talked about, and it’s hard to read the data sometimes. So just having time together to break it down is helpful.
Steven Newmark 12:35
Definitely, definitely. Well, we’ll continue to do that.
Zoe Rothblatt 12:39
Alright, Steven, that brings us to the close of our show. What did you learn today?
Steven Newmark 12:43
You know, I learned a lot about what happened, at the ACIP meeting from you and your great reporting, if you will, on the ground. And I think generally, my takeaway is that we’re in a good spot, and I feel comfortable about where we’re going in terms of the vaccines moving forward into the future as the public health emergency ends.
Zoe Rothblatt 13:00
Me too. I would agree with that. My takeaway was just that we have a lot of good data now. And it seems like we’re getting stronger in recommendations for how to move forward than just kind of letting you know COVID lead the way. It feels like we’re really leading now.
Steven Newmark 13:14
For sure. But we hope that you’ll learn something too, and before we go, we definitely want to encourage everyone to check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 13:26
Well everyone thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you like this episode, please give us a rating and write a review on Apple Podcasta. And don’t forget to check us out on YouTube. I’m Zoe Rothblatt.
Steven Newmark 13:40
I’m Steven Newmark. We’ll see you next time.
Narrator 13:46
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
S6, Ep3- Breaking Down the Latest Health Headlines with Corey Greenblatt
In this episode, The Health Advocates are joined by guest co-host Corey Greenblatt, Associate Director of Policy and Advocacy at GHLF. Zoe and Corey dive into the latest news on mifepristone and the court ruling, promising research on a new mRNA cancer vaccine, and plans to expand health insurance coverage to DACA (Deferred Action for Childhood Arrivals) recipients.
“Nearly half of DACA recipients are uninsured, so when we talk about the importance of Medicaid expansion, or the importance of the Affordable Care Act expansion, or just generally affordable access to health care, this is something that is just exponentially more important for this group of people,” says Corey.
S6, Ep03- Breaking Down the Latest Health Headlines with Corey Greenblatt
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Zoe Rothblatt 00:08
Today on The Health Advocates, I’m joined by guest co host, Corey Greenblatt and we’ll cover the latest news on mifepristone and the court ruling, promising results on a new mRNA cancer vaccine, and plans to expand health insurance coverage to DACA recipients.
Zoe Rothblatt 00:28
Welcome to The Health Advocates a podcast that breaks down major health news of the week to help you make sense of it all. I’m Zoe Rothblatt, Associate Director of Community Outreach at the Global Healthy Living Foundation. Our goal is to help you understand what’s happening in the health care world to help you make informed decisions to live your best life. Today, I’m joined with a special guest, co host Corey Greenblatt.
Corey Greenblatt 00:50
That’s right. I’m Corey Greenblatt, Associate Director of Policy and Advocacy at GHLF. And I’m really excited to be joining you as co host today.
Zoe Rothblatt 00:56
Well, thanks for joining us, Corey. I’m excited to have you here. We have a bunch of news items, and I’m looking forward to hearing your thoughts and insights on these.
Zoe Rothblatt 01:05
But first, how are you? Do you have any advocacy updates for us?
Corey Greenblatt 01:09
I’m well, Zoe, I’m doing really well. And yeah, actually, there’s a lot going on in the advocacy world right now. Myself and our Director of Policy, Steven Newmark, your normal co host are going to be in D.C. this week to advocate for reforms for pharmacy benefit managers, as well as a copay accumulator adjuster ban and holding our second congressional briefing to highlight these issues. And then later next month, our colleague JP Summers and I are going to be taking stops at the state capitals in Wisconsin and Ohio along with some local patients there to support copay accumulator adjuster bands there. So that’s obviously a big issue for us, and we’re hoping to see some things done both statewide and federally. So if you are listening to this, and you have any friends in Ohio, and Wisconsin that are interested in getting involved, we’d love to work with them on this.
Zoe Rothblatt 01:57
Very cool and where can they go in order to work with you on that?
Corey Greenblatt 02:01
Well, the first thing to do would be to sign up at the 50-State Network, and then talk to some of our staff members who will give you a call after you sign up and tell them that this is what you’re interested in doing. Because we’d love to work with you.
Zoe Rothblatt 02:11
That’s great. It’s really cool to hear about all the work you and our network are doing both federally and state-side. We’ll definitely have to have you back on in a few weeks for a recap to hear how it goes, how legislators are thinking about these bills, and the overall impact that you’re seeing.
Corey Greenblatt 02:26
Love to come back.
Zoe Rothblatt 02:27
Okay, so let’s dive into our news. First off, we have an update on mifepristone. So last week, we talked about… Steven and I debriefed our listeners about what’s happening with this drug and how this ruling impacts patient access, FDA authority and ultimately, the biopharma industry. So maybe before we jump into the news update here, Corey, do you have any thoughts you wanted to share on this issue? And just you know, what it means that an FDA approved drug can be attacked like this? I’m curious for your thoughts.
Corey Greenblatt 02:57
You know, I have a lot of thoughts on this. Obviously, this is not something that should happen. The FDA has legal authority to say whether a drug is safe or not safe. And simply put, judges are not trained in scientific matters to be able to understand things in the way that the FDA should. So they shouldn’t be making decisions that overrule these decisions. I have a lot more thoughts, but I’ll keep it to that for now.
Zoe Rothblatt 03:21
Totally agreed. Yeah, especially for our chronic disease community. We know how important drugs are in the review process and the safety, the trust we have in the FDA. So hearing this news is definitely scary for us. So the news update here is on Friday, U.S. Supreme Court, Justice Alito temporarily blocked lower court rulings that impose tighter restrictions on mifepristone. So this block is in place until midnight on Wednesday of this week, that’s April 19th. And basically what it does is it just gives justices more time to review the case. And it gives the groups challenging the FDA time to submit a written argument. So it doesn’t necessarily signal which way the court is leaning and how they’ll rule, it just overall, you know, delays the process a bit to get more opinions out there and thinking.
Corey Greenblatt 04:09
Yeah, I think that this is something that it ultimately helps patients right now. I think that making any decision in a snap judgment would ultimately harm the country. So I think that this was the right decision, and we’ll see what happens during written arguments.
Zoe Rothblatt 04:24
Definitely. We’ll see what happens and we’ll keep our listeners updated. Our second news item; This is pretty cool. There’s progress on mRNA cancer vaccines. So I was reading that this Moderna-Merck mRNA vaccine shows promise against skin cancer. And the researchers presented these findings at an American Association for Cancer Research meeting, and it showed that in combination with Merck’s immunotherapy, it cut the risk of death or recurrence of the most deadly skin cancer by 44%.
Corey Greenblatt 04:55
You know, that’s really incredible. The findings also suggested that adding this personalized cancer vaccine to immunotherapy treatments could prolong the time that patients have without reoccurrence, or death. These vaccines are custom built based on an analysis of the patient’s tumors after surgical removal. And they’re designed to train the immune system to recognize and attack specific mutations in cancer cells. You know, this is amazing, it shows how innovation can take something like the COVID vaccine and turn it into a vaccine that impacts cancer across the country and across the world and could have effects for decades down the road.
Zoe Rothblatt 05:32
Exactly. I heard two elements from what you were saying, one, it’s amazing the technology that we got from the COVID vaccine. And so quickly, we’re seeing mRNA vaccines in use, but also too, you talked about how this vaccine is custom built, and you know, using precision medicine, in order to tailor the treatment to the patient is so cool. We see it a lot in the cancer space, we’re starting to see it in the arthritis chronic disease space. But just seeing this in the cancer space, I guess gives me hope. I know patients in our community have cancer, but most of them are living with auto inflammatory conditions, and it gives me hope that we might see something in our space soon.
Corey Greenblatt 06:09
For sure. And you know, while we aren’t scientists, we can, as you said, talk to the use of precision medicine. We’ve seen it with arthritis starting up. And this is just something that I hope to see more of as we’re going down the line.
Zoe Rothblatt 06:22
Me too, and talking about something we hope to see more of our third news item here is insurance expansion for DACA recipients. So the Biden administration announced a plan to expand access to Affordable Care Act and Medicaid coverage for DACA recipients.
Corey Greenblatt 06:37
Yeah, for just a little background. DACA was created in 2012 by the Obama administration, and allows roughly 600,000 immigrants who were brought to the U.S. illegally as children to live and work in the country, legally,
Zoe Rothblatt 06:51
And DACA recipients are already eligible to apply for some health services in the U.S., but it’s primarily around emergency Medicaid. So it’ll pay, you know, for emergency medical treatment for people who meet the state’s Medicaid eligibility requirements, but not the citizenship and immigration status requirements that DACA recipients don’t meet. And you know, I just think like, it’s just not fair to say you’ll only cover emergency services, especially when you live with chronic conditions. And we always talk about preventative care is so important, and how just detrimental it is to wait for someone to get in that emergency state and have to go seek care at this point so I think this is long overdue to allow access to these coverages.
Corey Greenblatt 07:38
Yeah, and I think something that’s really important to point out, especially as it relates to kind of the health care industry that we occupy, nearly half of DACA recipients are uninsured. So when we talk about the importance of Medicaid expansion, or the importance of the Affordable Care Act expansion, or just generally affordable access to health care, this is something that is just exponentially more important for this group of people.
Zoe Rothblatt 08:03
Totally agreed. I have to ask Corey, we know DACA is currently under threat, how likely do you think this is to go through?
Corey Greenblatt 08:10
You know, it’s hard to predict anything at the court level. But the White House has set a goal for finalizing the measure by the end of the month. And then the program is not currently open to new applicants because of legal challenges. So like always, we’ll keep an eye on the courts. We’ll continue to update people through our podcast. And we’ll hope for the best case scenario in this case.
Zoe Rothblatt 08:30
Especially this is coinciding as millions are about to be losing their Medicaid status because of the emergency health orders. So I think it’s really important that these measures are popping up to increase access to health care as one has reduced and other pops up to help our community.
Corey Greenblatt 08:48
Completely agree.
Zoe Rothblatt 08:50
Okay, Corey, that brings us to the close of our show. What did you learn today?
Corey Greenblatt 08:54
You know, I learned about the new technologies related to mRNA vaccines. I think that when the COVID vaccine was first created with this technology, we all heard that this was the potential gateway to some really exciting things. And to see that start to pay off is really incredible and makes me really excited for where it could go.
Zoe Rothblatt 09:14
Amen to that. And I learned from you about all the great work happening federally and state side in order to help our patients get access to the care that they need. And listeners, we hope you learned something, too. Before we go we definitely want to shout out all of our podcasts and you can check them out at ghlf.org/listen. Well, everyone thanks for listening to The Health Advocates a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating and write a review on Apple podcasts and definitely check us out on YouTube. I’m Zoe Rothblatt.
Corey Greenblatt 09:50
And I’m Corey Greenblatt. We’ll see you next time.
Narrator 09:55
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network
S6, Ep2- Revoking FDA Approval: The Implications for Drug Regulation and Patient Care
Our hosts share the latest news updates on COVID boosters, our patient support program quick poll results on exercise habits, and the recent decision by the Texas district federal court to ban the use of mifepristone, which threatens the authority of the U.S. Food and Drug Administration (FDA).
“This is the first time a judge has essentially overruled the FDA, and this ruling could open the door to lawsuits, to contest approvals or regulatory decisions related to other medications or vaccines,” says Steven Newmark, Director of Policy at GHLF.
S6, Ep02- Revoking FDA Approval: The Implications for Drug Regulation and Patient Care
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
Last week a federal judge in Texas issued a ruling to revoke the Food and Drug Administration’s 23-year-old approval of a medication. This poses threats to the US government’s regulatory that can go far beyond any one drug, and this appears to be the first time a court has moved toward the ordering of removal of an approved drug from the market over the objection of the FDA. The ruling could open the door to lawsuits to contest approvals, or regulatory decisions related to other medications and if upheld, the Texas decision would shake the very framework of our reliance on the FDA’s pathways for developing new drugs.
Steven Newmark 00:44
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt
00:53
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:57
Our goal is to help you understand what’s happening in the health care world and help you make informed decisions to live your best life.
Zoe Rothblatt 01:03
And today we’re going to talk about a recent ruling by a federal judge around some medication that’s been approved decades ago, and you know how this impacts our community living with chronic disease. But before we get into that, we do have a few news updates.
Steven Newmark 01:18
Yeah, so let’s get into it. The FDA is set to authorize a second booster.
Zoe Rothblatt 01:23
Very cool. So yeah, they’re expected to announce this and this would be a second Omicron-specific booster for those who are 65 and older, and those with a weakened immune system, so very pertinent to our community.
Steven Newmark 01:36
Yeah, absolutely. Once authorized eligible individuals can get it if it has been four months since the first shot of the bivalent booster.
Zoe Rothblatt 01:43
Yeah, we’ll definitely keep our community updated on this. Our second news item; I know you love these, we have quick poll results. This time, we asked about exercise habits, essentially, because COVID just changed the way a lot of us exercise. Like for instance, we don’t have a commute anymore. So we lost that daily walking that we once had, and have to find different ways. And we’re just curious what our community does, especially living with chronic disease where it’s unpredictable. So this is what the results showed: Most people in fact exercise daily or weekly, about half said, you know, multiple times a week to every day. And then about 20% said often weekly. So that means that around 70% are exercising daily or weekly, which was pretty surprising.
Steven Newmark 02:27
Pretty high, for sure. What does that mean exercise? I’m just curious. How do you define exercise? Like walking into the garage to get the car? Does that count? When do you cross the threshold?
Zoe Rothblatt 02:38
I think it’s like about intentional movement. We didn’t ask specifically about what kinds of exercise, it was more looking at how often and what barriers. So two of the biggest barriers were chronic pain and chronic fatigue that stop people from exercising. But I would say it’s more just like with the intention to get movement into your day would count as exercise.
Steven Newmark 02:57
Interesting. I mean, when it comes to intentionally exercising as you put it, or intentionally moving, intentional movement, personally, I find the biggest barrier to be time… to set aside time. Like you said, if you’re commuting, you don’t have to set aside time if you’re walking, you know, that’s sort of built into your day. But if you need to set aside time to go to a gym, or to set aside time to say; Hey, I’m gonna walk for the next 30 minutes around the neighborhood. That’s my number one barrier.
Zoe Rothblatt 03:22
19% agree with you. They said not enough time.
Steven Newmark 03:25
Here you go. It’s like Family Feud, number three on the board. But I will say this, talking about like changing habits because of the pandemic, so I used to… I like working out in the middle of the day, I’ve never been someone who is able to wake up early and work an exercise. I’ve never been somebody who’s able to exercise at the end of a workday. I’m just too exhausted. And I find, frankly, to my dismay, that the gyms are much more crowded during the day because people have much more flexibility and their workday. So I don’t get that. I used to like going to the gym, particularly when it was less crowded, so now I don’t have that advantage. So now I find myself going earlier and earlier into like the seven o’clock hour, which I don’t like to do. But anyway, you know, just one digression on how exercise habits have changed in that sense.
Zoe Rothblatt 04:07
Exactly. It’s different for everyone. And like you said, you have to find what works for you in order to make it a regular practice.
Steven Newmark 04:14
Definitely, definitely.
Zoe Rothblatt 04:15
So let’s jump into our topic. Steven, I’m hoping you could walk us through the timeline, some of the big, you know, rulings here as a lawyer, I’d love to hear your perspective on what’s going on.
Steven Newmark 04:26
So what we’re talking about is that last week, a federal judge in Texas issued a ruling to revoke the Food and Drug Administration’s 23-year-old approval of a medication known as mifepristone. Now this medication is used primarily for terminating pregnancy and also has other medical uses as well. It was approved in the year 2000. So It’s been on the market for 23 years, but the judge is essentially over ruling the FTA’s rule approval and saying that it’s not safe and effective. And I’m really oversimplifying things. In a real… in the real world scenario as we’re recording, the judge put a seven day stay on. The Department of Justice is asking to have that state extended, is looking to get to the appellate court. That’s the Fifth Circuit Court of Appeals to have that listened to. But in blunt terms, as best as any… as legal commentators can tell, this is the first time a judge has essentially overruled the FDA. And this ruling could open the door to lawsuits, to contest approvals or regulatory decisions related to other medications or vaccines. We live in this crazy anti-vax world, and if this decision is upheld, it could really shake the very framework of patients’ reliance and doctors’ reliance and the pharmaceutical’s industry reliance on the FDA’s pathways for developing new drugs.
Zoe Rothblatt 05:41
There’s so many layers to this. I think the first is that, like you said, this is undermining the FDA’s authority. We talk about this all the time, as our listeners may know, I have another podcast called Breaking Down Biosimilars, and especially we talk about this in the context of biosimilars about the FDA’s is rigorous studying of medications and how they look at safety and efficacy and how they have to run animal studies, human clinical trials, post market surveillance, all this stuff to say that a medication’s safe. This one in particular has been around 23 years, you know, we look at that and say: Okay, this is like a tried and true medication that’s been around for a long time. We see the effects of it, and we know that it’s safe in post-market surveillance. So it’s really shocking to see that for the first time a court has moved to order the removal of a drug like this.
Steven Newmark 06:29
Yeah, to remove it from the market is quite unprece… You know, I don’t want to hate to overuse the word, but it’s unbelievable, to say the least. You know, let’s just take a step back and give a little bit of background on who the FDA is, where their authority comes from. In 1939, Congress gave the FDA overarching authority to determine whether drugs are safe and effective in the Food, Drug and Cosmetic Act of 1938. Drug companies must conduct a series of animal studies and human clinical trials that can take years and millions of dollars, frankly, to provide enough evidence to the FDA that a drug is safe and effective in treating a disease or a medical condition.
Zoe Rothblatt 07:06
And now this ruling is coming in and contradicting all that work that the FDA does. It’s put the FDA’s authority into a spotlight like never before. And the case is probably going to go to the Supreme Court and just as someone living with chronic illness, and you know, we represent people with chronic illness, it genuinely scares me that judges and people in this country are able to fight and undermine the FDA like this, especially as someone who relies on medications to keep me functioning in everyday life. I’m just wondering to what end… where does this go?
Steven Newmark 07:39
Yeah, that’s a… that’s a great question. Like, you know, we were saying earlier, it’s scary because if a judge, a single judge, anywhere in the country is able to essentially pull a product from the market, you can envision scenarios where anti-vax folks are able to find an anti-vax judge with sympathetic views and pull a vaccine on the market based upon similar ruling, if you will. And you know, not to mention, basically any medication folks don’t like, and they can get to a judge, and the judge could issue the ruling. So it’s scary to say the least. I mean, since the Food Drug and Cosmetic Act passed in 1938, courts have usually defered to the federal agencies’ scientific expertise and oversight.
Zoe Rothblatt 08:18
And you know, we saw this this past summer with methotrexate access, and while that seems to have died down, and of course, people were restricted access, it seems to the situation improved a bit. But we know that when situations like this are happening, it also does cause you know, pharmacists to take pause, doctors to take pause. And even though we don’t know the final ruling, yet, people could have restricted access already, even though it’s still available. And all this news gets people to be overly cautious and people are not able to access their medications like how we saw with methotrexate. I’ve seen some states are already stockpiling this medication, specifically so people can have access. But it’s also just the implication of the news going around has such an impact on, you know, direct patient access already.
Steven Newmark 09:07
Yeah, no, absolutely. Like you said, it essentially throws chaos into the world of the pharmaceutical industry, the medical community and the patient community. It’s a head scratcher, and people don’t know what to do. And oftentimes people can be cautious and say: Well, I’d rather just not get involved and the easiest way to do that is if I’m a doctor not to prescribe a medication, if I’m a pharmacist, it’s not to fulfill certain prescriptions. And it’s scary if you’re a patient because throughout all of this, the patient’s voice tends to get lost, the individuals who are out there being most affected by such a I call it a perverse authority seen in our judiciary.
Zoe Rothblatt 09:41
So let’s walk through some of the timeline of this what happened exactly after the judge, you know, declared that this approval should be invalid?
Steven Newmark 09:50
Sure. As I mentioned, he did put a seven day stay on that… on the exact same day, I guess coincidentally, or perhaps not coincidentally, I don’t really know, a case in Washington state that was brought by Democratic Attorney General’s from 17 states, and the District of Columbia was live and it was challenging extra restrictions that the FDA imposes on Mifepristone. And in a preliminary injunction, the judge there in Washington State ordered the FDA specifically not to limit the drugs availability in those jurisdictions. So you’re talking about 17 states plus the District of Columbia have been ordered not to limit the availability. So now you have essentially two competing rulings, and those are in two different circuits not to get too bogged down, but the appellate courts in the United States are broken down into nine circuits. So you’re dealing with two separate circuits, one out of Texas and one out of Washington State. And if there’s a conflict at the circuit level as well, eventually, it’s likely to make its way up to the Supreme Court. And in the immediate aftermath in the Texas case, the Justice Department, which is representing the FDA, of course, immediately said it would appeal the Texas injunction to the Fifth Circuit Court of Appeals.
Zoe Rothblatt 10:54
So what happens next? This is like the lot of legal jargon.
Steven Newmark 10:58
Yeah, there’s a lot of legal jargon. That’s true. So some folks have called upon the Biden administration and Health and Human Services to ignore the judge’s ruling. They have actually come out and said that they will not ignore a judge’s ruling. That’s probably not the smartest move. It’s also not a way to endear yourself to the Supreme Court where you ultimately want to get a ruling in your favor. So the likely scenario is that this makes its way to the Supreme Court. Now, does the ruling get stayed until it gets the Supreme Court, that remains to be seen? And what happens in those 17 states versus the rest of the country? Again, it’s very chaotic, to say the least we’re dealing with one specific drug. I will add, they’re starting to become political pressure there, that the medical community and the pharmaceutical industry have put out, missives decrying this ruling. So we’ll see where it goes is my tepid answer. I know, it’s not fun to say that. Let me get back into more comfortable waters for myself. I will just say the ruling could violate the Constitution’s Commerce Clause, which prohibits states from impairing interstate commerce, and also the Supremacy Clause which says the federal laws – in this case Congress’s decision to authorize the FDA to regulate drugs – have priority over conflicting state laws. This theory has rarely been tested in court. However, there was a case that involved Massachusetts about a decade ago, where Massachusetts tried to ban a new opioid because state officials worried that the drug itself could be abused, leading to addiction or overdose. A federal judge in that case ruled that states do not have authority on their own to ban such drug. So not exactly on point because that was done by the state of Massachusetts and not by a federal judge. But it gives you an idea of how the federal judiciary has differed generally to the FDA.
Zoe Rothblatt 12:41
Right. So could this case be used then in support of the precedent to uphold the availability of the drug?
Steven Newmark 12:47
Yeah, absolutely. Absolutely. General precedent is under the Commerce Clause, and under the Supremacy Clause. You defer to Congress’s decision to authorize the FDA to regulate drugs such as the one issue here.
Zoe Rothblatt 13:01
Well, you know, that kind of just begs me to ask how then a judge is even capable of making this ruling in the first place if these clauses are in place at federal power?
Steven Newmark 13:11
Well, you know, rulings are made by judges, judges are humans, humans, they’re not always… they don’t always get things right, and that you get overturned. That’s why there are appellate courts to sometimes overrule lower courts and so forth. And even then, even at the highest level judges, shall we say, sometimes get things wrong. We’ve had some horrific decisions over the years and are even at the Supreme Court level, we’ve had the Dred Scott case Plessy versus Ferguson, which said that separate but equal did not violate equal protection clauses of the 14th amendment that was overturned decades later by Brown versus Board of Education. So there are bad rulings that occur. What a lot of legal scholars were considered to be bad rulings, it happens. And you know, that’s just how I guess that’s the best answer I can possibly give is how it can be done. But I will add, judges are human so they are receptive to the real world. And in this situation, upending the FDA is authority could be disruptive to an entire industry, the pharmaceutical industry, to patients to the medical community. You know, the industry itself spends many years and millions of dollars looking for drug approval. If FDA approval can be withheld by a judge, by one federal judge, somewhere in the United States, this could really stifle drug manufacturers from seeking out new therapies. So, again, these folks live in the real world, these judges, so hopefully, they’ll be receptive to the real world consequences of their ruling.
Zoe Rothblatt 14:34
Well, that’s right. That’s what’s scary, too, right. It’s not just attacking a current drug. It also has implications for innovation and just uncertainty for the entire biopharma industry for years to come if this is actually capable of going through.
Steven Newmark 14:48
Right. Yeah, it’s scary. Knock on wood. You know, we’ll certainly keep our eyes on This. And we’ll see where it goes. As I said, it’s likely to end up all the way to Supreme Court.
Zoe Rothblatt 14:56
In a scenario like this is there anything that we can do, just as a patient, as a person, like who can we call when something goes to the Supreme Court like this?
Steven Newmark 15:06
Sure. Well, there is nothing at the Supreme Court. So there’s no one to call right now. I think we’re at the phase where it’s just getting educated and on what this does. Inserting your voice to elected officials is always a welcome thing. The idea that you don’t want to live in a world where you’re worried that you take certain cocktail of drugs, and you don’t want to find… you know, you don’t want to live in a world where a non-experted medical expert judge can revoke the use of those drugs is something that is scary for you. And that’s something that can be expressed, certainly to elected officials. And, you know, there may come a moment where there’s an opportunity to insert yourself in the litigation itself as an… as an amicus curiae, which means friend of the court. Those are individuals who may not be litigants in the case, plaintiff or defendant, but have, you know, some particular special concern about the outcome of how that case could affect them going forward. So that’s… that could be an area where groups like the Global Healthy Living Foundation might insert themselves and might be seeking patients to help with that.
Zoe Rothblatt 16:04
So bottom line, get educated and stay tuned. We will certainly keep our community updated and raise your voice wherever you can.
Steven Newmark 16:11
Absolutely. Absolutely. Yeah.
Zoe Rothblatt 16:14
All right, Steven, that brings us to the close of our show. What did you learn today?
Steven Newmark 16:18
I learned that our folks, our GHLF folks like to exercise so it’s good for everyone.
Zoe Rothblatt 16:23
Excellent. I almost forgot about that in the middle of all of this chaos. And you know, for me, I just learned a lot about the judicial process and all of this from you. So thank you for that debrief.
Steven Newmark 16:35
Well, we hope that you’ll learned something too. And before you go, we definitely want you to check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 16:44
Thanks everyone for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating and check us out on YouTube. Hit that subscribe button wherever you listen. I’m Zoe Rothblatt.
Steven Newmark 16:58
I’m Steven Newmark. We’ll see you next time.
Narrator 17:03
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
S6, Ep1- Protecting Patient Access to Health Care
Our hosts discuss important pieces of legislation in the U.S. that help improve access to care, both federally and around the states, and how the Global Healthy Living Foundation’s 50-State Network has been advocating on the ground. The hosts also break down big news in health insurance, including the recent attacks on the Affordable Care Act and why millions may soon lose access to Medicaid.
“During the pandemic… Medicaid enrollment grew by 5 million people between 2020 and 2022. So that’s a lot of people who are on it [Medicaid] and could potentially be losing coverage, maybe even more than that. And it’s already starting to happen around some states,” says Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
S6, Ep01- Protecting Patient Access to Health Care
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Zoe Rothblatt 00:08
“Millions are potentially going to lose access to Medicaid what is going on?
Steven Newmark 00:13
Yeah, so during the pandemic, the government suspended procedures that would remove people from Medicaid rolls. In the past, people would regularly lose their Medicaid coverage if they started making too much money to qualify for the program or if they moved out of state.”
Steven Newmark 00:30
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:39
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:44
Our goal is to help you understand what’s happening in the health care world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:50
Thanks everyone for your patience during our break, we are back with a new season. Season six, how exciting!
Steven Newmark 00:57
Very exciting. Thanks to all our listeners, and today we’re going to catch up on some news together, and also about some important bills that we’ve been following around the country.
Zoe Rothblatt 01:06
Yeah, so let’s start there. We’ve been busy advocating. Let’s do a: ‘Here’s what you should know’, both federally and around the states. Steven, maybe you could kick it off. I know you’re recently in D.C.
Steven Newmark 01:16
Yes, I was in Washington D.C. talking about copay accumulators with some great individuals starting with JP Summers. She is a Patient Advocate and Community Outreach Manager here at GHLF. I was also joined at the event by the Association of Women in Rheumatology or AWIR, and we were able to discuss the issue of copay accumulators and their detrimental impact on patients. Specifically, we were there to talk about a piece of legislation called the Help Copays Act, which we’re hoping will pass in Congress this year, and as a result, it would ensure that all payments made by patients or on behalf of patients are counted towards their deductible. Using accumulators is a tool that insurance companies often deploy when patients are able to use copay, coupons or have others pay for their high cost medications. It does not count towards their deductible, so it makes it harder for them to reach their deductible and thus, they continue to remain on the hook for this… for payments later in the calendar year.
Zoe Rothblatt 02:16
And what was the sense when you were there? Did you feel like the legislation could pass this year? Were the legislators overall supportive? Do people have any interesting questions?
Steven Newmark 02:26
That’s a great question. There was definitely… I think it was a combination of meeting with folks who were already strong supporters on both sides of the aisle, which is great trying to get them to push a little bit harder, meeting folks who were at the opposite end of the spectrum, not in a sense that they were not supporters, but in the sense that they were not aware of these programs, and not familiar with these programs. So it was a good first step to engage these folks on accumulators and what they do detrimentally towards patients. And then there was a cluster of folks who were sort of in the middle. They were aware of these programs, perhaps a little more educated, they hadn’t yet signed on to the legislation, and they’re interested in continuing the dialogues. So it’s a good… I’d say we’re in a good phase. Look, we have legislation that’s introduced, it’s bipartisan. Is it likely to pass? The one thing I will say in my professional career dealing with policy and advocacy is that patience is most certainly a virtue. It takes time and sometimes it takes several legislative sessions, that’s unfortunate. In certain cases, that’s actually a good thing to let legislation simmer for a bit. You know, obviously we want to pass it as quickly as possible but I think that there are still a lot of elected officials and staff who are unaware of what accumulators are, who don’t get to hear the patient perspective enough. And I think it says to us; we have more work to do. And to anyone listening, it’s important to continue to play a role and to let folks, policymakers, and elected officials know what it’s like to live with a chronic condition, and when dealing with accumulators, the affordability issues at play
Zoe Rothblatt 03:53
100%. And I mean, this one, it’s such a simple issue, but also confusing, like, you might not even know you have an accumulator. It’s like kind of hidden in there. I didn’t even realize I had one at first, and then it’s obviously so upsetting when you learn about it, and you’re paying so much money to take care of yourself. So yeah, I mean, everyone can definitely join our 50-State Network or contact your local representatives and let them know that this issue is important to you. We also had the opportunity to advocate for this Help Copays Act and the Safe Step Act, at the DDNC spring forum, so that’s the Digestive Disease National Coalition, which is always fun for us. We join every year. This year our colleague, Corey Greenblatt, Associate Director of Policy and Advocacy went and he led a few teams around to advocate for these bills and felt similarly that legislators knew the basics of these bills and it wasn’t like the 101 explaining and now we could get into deeper conversation and Corey felt like that’s always a good sign. Of course, there’s more work to be done. But the fact that there’s more comfortability among the legislative offices with these bills is really exciting for us.
Steven Newmark 05:00
For sure, it’s great work that we’re doing around the 50 states, and it’s good to get out there. And with DDNC that was a great opportunity for us to join with a coalition of other like-minded groups and continue to inform elected officials and their staffs about what’s happening with chronically ill individuals and how some of this legislation can help.
Zoe Rothblatt 05:16
And then around the States, we’ve been pretty active. JP, you mentioned before, she was able to testify in Austin, Texas for, you know, similarly, about co pays, but this time on the state level, so she was able to share perspective as an advocate from GHLF. But also as someone who experienced co pays herself and it just always powerful to hear directly from patients.
Steven Newmark 05:40
Yeah, absolutely. And in Texas, there is legislation at the state level that is working its way through the House Select Committee. So hopefully, we’ll get some news to report out of there.
Zoe Rothblatt 05:50
I hope so too. And then some West Coast advocacy that we’ve been involved in. Our colleagues did a little advocacy road trip with some patient advocates going to Washington, Oregon and California. Unfortunately, both the bills in Washington and Oregon died in session. But like we said before, it’s good to lay a foundation. Patience is important, stuff can get reintroduced. So one of those in Oregon was focused on copay accumulator adjusters, and then the other one in Washington was focused on Share The Savings. I’m not sure if we mentioned this so much on the podcast, so it might be worth a quick summary of what that means. It basically requires that patients benefit from the savings that insurers receive from manufacturers. So this bill specifically would require that at least 75% of the rebates and fees negotiated by insurers and pharmacy benefit managers are passed on to patients. Ultimately, this helps reduce financial burden and protect access to affordable medications.
Steven Newmark 06:47
Yeah, excellent. No, that’s great. Unfortunately, we need more legislation like this. And it takes a lot of work to keep pushing ahead. I know these issues can sound esoteric, they can be tough to wrap your head around. And you know, that’s why we have to keep fighting.
Zoe Rothblatt 07:01
Yeah. And then in California, we focused on a legislation that helps again with copay accumulator adjusters. And what was so interesting was that two different legislative offices said that with GHLF coming with patients, it was the first time they ever heard directly from patients about these bills. So like you’re saying; more work to be done.
Steven Newmark 07:22
I mean, that’s incredible. And that really speaks to the work of GHLF in bringing patients to state capitals, to Washington, to meet directly with legislators. There is nothing more powerful for a legislator than to hear directly from person impacted by a piece of legislation. And in our case, there’s nothing more powerful than hearing directly from a patient. So it’s great that our 50-State Network members can join us when we try to advocate around the 50 states and in Washington.
Zoe Rothblatt 07:50
Exactly. It brings it back down to the individual. And that’s what we’re all about: making sure patients feel good. So let’s transition a little bit. That was our recap what’s going on around the states advocating, but there’s also some insurance things been going on the past few weeks.
Steven Newmark 08:07
Some bad news going on actually. I don’t want to talk about it.
Zoe Rothblatt 08:11
I know.
Steven Newmark 08:11
But let’s do it. Let’s do it. We have to.
Zoe Rothblatt 08:13
Okay, so the first on our agenda is Medicaid. Millions are potentially going to lose access to Medicaid. What is going on?
Steven Newmark 08:21
Yeah, so in simplest terms, during the pandemic, the government suspended procedures that would remove people from Medicaid rolls. In the past, people would regularly lose their Medicaid coverage if they started making too much money to qualify for the program, or if they moved out of state. This was somewhat common for people who are… they call them on the bubble, where any given year they might be above or below the threshold. It’s almost ironically a disincentive sometimes to earn more money. But during the pandemic, these procedures were removed, so folks wouldn’t have to worry about that and get kicked off the rolls.
Zoe Rothblatt 08:52
And in fact, during the pandemic, because this was removed, or I guess… we can assume because this was removed, Medicaid enrollment grew by 5 million people between 2020 and 2022. So that’s a lot of people who are on it and could potentially be losing coverage, maybe even more than that. And it’s already starting to happen around some states. I think we’re going to see more throughout April. The good news is that not all ineligible people will be dropped at once. States have different timelines. Most states are expected to take between nine months and a full year to complete this verification process. So there’s a good amount of time to check in on what’s happening.
Steven Newmark 09:33
Yeah, and check in is really the operative phrase there because many people are not being notified about this until it’s happening. And we could end up in limbo in with these individuals with no insurance, because they make too much for Medicaid, but they don’t make enough to get subsidies for the Affordable Care Act.
Zoe Rothblatt 09:51
So you know, what can you do if you’re on Medicaid; look out for the renewal form and any notifications whether it’s mail, phone, text, email. You have 30 days to fill out the form. So definitely keep an eye out to see if you’ve received any of those or we’ll be receiving soon.
Steven Newmark 10:07
Yeah, absolutely. And if you are removed, other options that you have, you know, potentially employer-based insurance, if that’s an option, you have the Affordable Care Act marketplace, including all the subsidies to help you afford different plans. You should note that your child may still be eligible under CHIP. That’s the Children’s Health Insurance Program. And there’s a special enrollment for people who are dropped from Medicaid, which started on March 31, and will last through July 31, 2024. And you can apply for coverage 60 days before your Medicaid is scheduled to end.
Zoe Rothblatt 10:38
Yeah, well that’s good to know because hopefully, that’ll stop some people from ending up in limbo. Obviously, we talk about this all the time, like insurance is so important. Regularly… but especially when you have a chronic illness and we take you know, prescriptions regularly, see our doctors regularly, it’s… Insurance is a lifeline, and it’s scary to potentially lose that access. Hopefully, there’s enough supports out there that people can get a new plan. And if you do change plans, I know you guys know this, but always remember to check your doctor coverage and prescription coverage to make sure that you’ll be able to continue your care as you were.
Steven Newmark 11:13
Definitely. There were some other news as well, regarding the Affordable Care Act, and specifically the provision in the Affordable Care Act about preventive health care. A federal judge in Texas ruled that employers cannot be required to cover specified preventive health services under the Affordable Care Act.
Zoe Rothblatt 11:30
I know. This was like so surprising to me, I thought we were done attacking the ACA, but apparently not.
Steven Newmark 11:36
Right. Well, this is one of the most popular provisions of the ACA, if you will, the idea that insurance coverage is required to cover certain preventive health screenings. You know, it’s important for folks who are healthy and folks who are not healthy to get preventive care and get regular checkups. And you know, so we’ll see what kind of damage this does. The Biden administration is appealing that decision and the case is now on its way to the Fifth Circuit Court of Appeals.
Zoe Rothblatt 12:01
So we’ll wait to hear more news. We don’t know the full extent of the impact, especially as it gets appealed. But it could limit access to keep running of services, you know, aimed at early detection of disease, like lung and colorectal cancer, depression, hypertension, a lot of these are comorbidities for people in our community who live with various chronic diseases. And it’s just really hard to learn that these services that were free now, while they still may be offered, they just might have a co-pay or deductible attached to them.
Steven Newmark 12:32
Yeah, and let’s not forget insurance plans still have the option, of course to cover these services for free. But without this in place, they may start charging co-pays and cut into deductibles. So something to think about.
Zoe Rothblatt 12:43
Definitely. Well, you know, we’ll keep everyone informed on these insurance issues and around the states.
Zoe Rothblatt 12:50
That brings us to the close of our show, Steven, what did you learn today?
Steven Newmark 12:53
Well, I didn’t know that we… we apparently were the first group to bring patients at the California state legislature or at least to the specific offices that we got to visit. So it just shows a great work that we are doing here.
Zoe Rothblatt 13:05
And I learned from you a bit more about what’s going on with Medicaid enrollment and why people may be losing access.
Steven Newmark 13:13
Well, we hope that you’ll learn something too. We also want to mention; check out all of our great podcasts at GHLF. A specific one we’ll talk about is Talking Head Pain hosted by our friend Joe Coe where he interviews neurology experts and people living with migraine.
Zoe Rothblatt 13:27
Definitely, check it out. Thanks, everyone for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating and check us out on YouTube. I’m Zoe Rothblatt.
Steven Newmark 13:40
I’m Steven Newmark. We’ll see you next time.
Narrator 13:45
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
S5, Ep23- COVID at Year 3: What We’ve Learned
It’s been three years since the World Health Organization declared COVID-19 a pandemic. Our hosts talk about where we are at now with fighting the virus, what we’ve learned over the years, and how our community is feeling.
“Early on, I felt like there was a high level of concern for the community, for others. People masking up for others, for those in the community who have chronic disease, who are elderly. And that seems to have just gone by the wayside,” says co-host Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
S5, Ep23- COVID at Year 3: What We’ve Learned
Narrator 00:00
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:09
Early on, I felt like there was a high level of concern for the community, for others, people masking up for others for those in the community who have chronic disease, who are elderly. And that seems to have just gone by the wayside.
Steven Newmark 00:24
Welcome to The Health Advocates, a podcast that breaks down and major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:33
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:38
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:44
Today, we’re gonna discuss COVID and where we’re at now, since it’s been three years since the World Health Organization declared COVID a pandemic. Pretty hard to believe. First, we do have a news update.
Steven Newmark 00:56
First of all three years, okay, feels like three decades. But okay, but you mentioned a news update. Last week in a recent episode, we discussed the Cochrane review on masking and how the findings were misleading. And that it made it seem as though masks were not effective. Cochrane has now revised their summary owning up to the fact that their wording was misleading.
Zoe Rothblatt 01:17
Yeah, they basically explained that the review examined whether interventions to promote mask wearing helped slow the spread of respiratory viruses. So COVID and flu. And then, you know, they said, given the limitations in the evidence, the review is not able to, you know, make a conclusion on the question of whether mass wearing itself reduces people’s risk of contracting or spreading respiratory viruses, just you know, if they were looking at whether masks were promoted if people wore them.
Steven Newmark 01:48
Right, and that’s basically what we discussed a few episodes back. Essentially, what we learned from the Cochrane Review is that, especially before the pandemic, distributing masks did not lead people to wear them, which is why their effect on transmission could not be confidently evaluated.
Zoe Rothblatt 02:02
That rings true here, you know, it was hard to get people to wear a mask, even I see free masks out there sometimes and signs and people aren’t wearing them. So I guess, to me, that conclusion makes sense.
Steven Newmark 02:15
Yeah. And that’s during the pandemic, post pandemic, whatever your you know, when masking became somewhat normal, so you can only imagine what it was like trying to distribute and get people to wear masks in the before times. In fact, not so funny story. I remember traveling on an airline in February of 2020, you know, when the word COVID was in the ether, but not fully out there. A guy came on the plane with a mask. And I remember thinking to myself, “What a weirdo.” Shame on me, that’s where we were three years and one month ago, if you will.
Zoe Rothblatt 02:47
Yeah, that’s where we were. I remember, like starting to see people wipe things down. And I’m like, “Okay, maybe should I do that? That’s a little weird.” And it’s like, now you look at at where we’ve come through years later. And it’s a totally different mindset.
Steven Newmark 03:03
Right, right. Well, you know, that brings us to our topic for today, just discussing where we are, we’re at the three year anniversary, whatever you want to call it, of when COVID was declared a World Health pandemic. And we talked about this last year for COVID at year two, we mentioned the things that have changed or were brought to light during the COVID. And it wasn’t all bad. We got telehealth, for example.
Zoe Rothblatt 03:25
I haven’t used telehealth recently, but I’m like so glad that we still have the option there. I’m worried about what’s to come in May when the health emergency ends, we’ll see how that affects providers. I know one of my friends got a message from her provider saying that, you know, when the health emergency ends in May, and they won’t be able to do telehealth anymore. So you know, there’s a lot to see on that in the coming months.
Steven Newmark 03:49
Absolutely. We learn new lingo things like zoom fatigue, social bubbles, six feet, social distancing, and in potentially positive we learn to enjoy outdoor dining. Depending on your take. I don’t know how you feel about that.
Zoe Rothblatt 04:03
I mean, I remember in New York, they set up these like great establishments outside just like brought the city to life to have that so yeah, there were some good things. There was also some negatives negatives to say the least. Yeah, right. COVID really highlighted the glaring health disparities in our system. We saw who was getting sicker and hospitalized from marginalized communities, our mental health has certainly suffered. It’s been a long three years and I know we say like it’s hard to believe it’s three years and then that time has gone by but it’s also had a huge impact on our communities mental health and you know, the public generally.
Steven Newmark 04:40
Yea, no know, for sure our mental health is definitely suffered. I guess one positive to that, if I may turn that is that I think we’re more aware of our mental health than we were three years ago. So hopefully, we can address those issues better than we might have been able to pre pandemic.
Zoe Rothblatt 04:56
I think so too. And then ultimately, you know, we got vaccines, treatments, rapid tests; a lot of innovation.
Steven Newmark 05:02
Yeah, the medical and scientific communities really came together. And dare I say, saved us through the vaccines through their treatments through rapid tests. And then it was, you know, great to see the marshaling of those resources and, and what can be done when you put your mind to it.
Zoe Rothblatt 05:16
So where are we at now, the death toll is nearing 7 million worldwide and 1.1 million deaths in the US. Um, you know, I saw an interesting statistic from the Wall Street Journal, the virus ranked as the nation’s third leading cause of death in 2020, and 2021. Right behind heart disease and cancer.
Steven Newmark 05:35
Yeah. And infectious disease hasn’t ranked that high, since the combination of pneumonia and flu 85 years ago,
Zoe Rothblatt 05:41
Wow. COVID just become a part of our everyday life. And sometimes I just find it important to look at these statistics. And remember that you know, those 7 million deaths are each a person that has a family and loved ones out there. And, you know, it is really serious. And when you say, you know, something as ranked as high since 85 years ago, like it really is a stark reminder of the impact of COVID.
Steven Newmark 06:06
Yeah, absolutely. But let’s also remember that vaccines, as well as past infections, have less than a threat right now. People are getting less severe illnesses on a whole compared to where we were two years ago, three years ago, of course,
Zoe Rothblatt 06:18
Yeah. And that’s definitely a positive, I would say that we still have a lot of questions about how the virus behaves, its mutations and long term effects. And while we do have vaccines and treatment, you know, we’re still learning a lot.
Steven Newmark 06:31
Yeah, no, absolutely. And you mentioned mutations, one, knock on wood, please, please, please knock on wood. We’re still in the Omicron phase, and it has not mutated out of Omicron, thankfully, which is good. But of course, there’s always that threat.
Zoe Rothblatt 06:46
I know, do not threaten me with that COVID, our mental health can’t handle it. You know, I thought it would be a little interesting to look at the flu for a minute. I was like, what happened there in the end? And how did we get out of it? Or how did it become, you know, the way it is today. So just a quick timeline, the influenza pandemic lasted 1918 to 20. And it wasn’t until the 30s and 40s, that researchers were studying the flu viruses and developed flu vaccines. At this time, it was mainly military members that could get the vaccine first. And then ultimately, in 1945, the first flu vaccines were approved for people who were in the military. And I just thought that timeline was so interesting, because when you think about like COVID, hit 2020. At December 2020, health care workers are getting vaccines, right? It’s right. It’s like incredible what we’ve done.
Steven Newmark 07:40
Yeah, it’s incredible how much faster we’re able to respond. That’s that’s certainly something to be positive about based on the flu curve. As you mentioned, we’re way ahead of that curve. And you know, it look, it took decades to figure out the vaccines, it took a while also to figure out the seasonal nature of the flu. Right, you know, and the system for predicting flu is still not perfect. It’s far from it. But you know, hopefully with more scientists and virologists working their magic, we can get better production as the years go on.
Zoe Rothblatt 08:09
Yeah. And I guess I learned from this that like, it can take time, you know, scientists are really working on this. And while it may feel like we might be behind the curve with COVID, because we don’t know the patterns yet. Like, it just might take some time to figure out but this brought me comfort that it will get figured out just looking at the pattern of flu and the timeline and that history.
Steven Newmark 08:32
Yeah, I agree with that. I think it will get out, you know, get figured out. It’ll be a normal part of our lives the way flu is a normal part of our lives. And you know, we’re not at that stage yet. But we’re also not at the phase we were in one year ago, two years ago, three years ago.
Zoe Rothblatt 08:44
I know, it’s good. We’re not at that phase. It’s hard to think back on it.
Steven Newmark 08:49
I know. I try not to.
Zoe Rothblatt 08:50
So what our vaccine rates looking like in the US right now?
Steven Newmark 08:56
Well, according to the CDC, only 16% of United States have received the bi-vaillant booster shot. The majority who got it are in the 65 and over group or almost 42% of that age group got the booster. That compares to only the primary series by comparison. 69% completed the primary series of the first few shots.
Zoe Rothblatt 09:15
That’s a huge lag off, 69 to 16%.
Steven Newmark 09:20
Yes, it is. Don’t forget, a lot of people even who have been vaccinated, still contracted COVID. So that’s I’m oversimplifying, I could do that. Because I’m not a doctor. It’s almost like getting a booster if you will to have contracted it. But yeah, it is a big drop off. I think there was definitely less of a push for the bi-vaillant boosters, there was definitely fatigue and, you know, the anti vaccine voices are loud. And you know, there are more than a few who will say, “Look, I’ll do I’ll do the first two, but that’s it. I’m stopping there.” So we’ll see. We’ll see where that goes when it comes to the similarities with the flu vaccine and going forward.
Zoe Rothblatt 09:55
I was about to say that I’m curious if once it becomes an annual shot and this regular thing if rates go up and people are more willing to just get the annual shot, because when you look at flu shot rates, it’s similar to last year, it’s at around 47% this year, 44% last year. It’s interesting that that number is so much higher than the people getting the bi-vaillant booster shot.
Steven Newmark 10:22
Yeah, I mean, again, it probably has, there’s so many factors at play. One is that the flu vaccine has been around as maybe more part of that your normal course, your annual course. It probably has something to do with the idea that the people believe the flu vaccine perhaps has been tested more, if you will, even though it’s not necessarily accurate, but it’s been around longer. And it probably has something to do with as I mentioned, earlier, folks have contracted COVID, even after getting the vaccine, so they felt that there was some protection that they had built in.
Zoe Rothblatt 10:54
I got COVID I hope I’m super protected now against these new.
Steven Newmark 10:58
Ah, yeah, well, they say the ultimate protection is, I don’t have it in front of me these studies, but they do say the ultimate protection is the combination of the vaccine and an infection is the highest level.
Zoe Rothblatt 11:09
Yeah, I get that memory like deep in your body. Never forget this virus and.
Steven Newmark 11:14
Right, right, that’s a good thing in some strange way that you had it and you’re fine. I had it and I’m fine. You know, we’ll see what happens. I also sometimes do wonder, by the way, I don’t know about you, but you had it more recently than me. I sometimes wonder whether I’ve contracted it and didn’t know it. Since then. If my body was so ready to fight that it came, my body knew what was going on, and took care of it.
Zoe Rothblatt 11:35
Sometimes I play that game like is it my chronic illness? Or did I catch COVID? The flu? Is it allergies? Symptoms can get you thinking like so deep and wide.
Steven Newmark 11:47
Definitely, definitely. Frankly, I think it’s more than a 50% chance it invaded my body at least a second more than once a second time, if that makes sense.
Zoe Rothblatt 11:56
Yeah. You know, whatever helps you sleep at night. I know, we just mentioned mental health, it’s like, I have to believe that that infection helped give me antibodies. Oh, for sure. You know, speaking of just like mental health, our community, we can’t stress this enough that people in our community are still feeling ignored, whether it be by society, friends and family. We get a lot of messages in our COVID Support Program asking, you know, for help about how they can be with family in a safe way, and that they’re feeling a little pressured. And you also get messages that people sometimes feel ignored by their doctors, you know, the health care facilities, a lot of them are removing masks now and people in our community are asking what to do in that setting and saying, “Could there be a separate waiting room for people with masks versus not masks”. And I just think it’s really important to share that concern that’s coming from people with chronic illness.
Steven Newmark 12:56
We’ve mentioned it so many times. But I think one of the sad things, results of this pandemic was early on, I felt like there was a high level of concern for the community for others, people masking up for others for those of the community who have chronic disease who are elderly, and that seems to have just gone by the wayside. It seems we’re in this every man, every person for themselves situation now, which is just sad.
Zoe Rothblatt 13:24
Yeah. And you know, aside from from that feeling, people really want specific information, you know, similar to seeking out information on your chronic disease and how it affects your life, like people really want COVID information that’s specific to someone with an autoimmune disease or chronic disease, whatever it may be. And while researchers are looking into these, it’s not talked about enough in mainstream media. And I feel like we have a really important role to report stuff like that out.
Steven Newmark 13:53
Absolutely. The last thing we should discuss is long COVID and where we are with long COVID. Well long COVID was frankly, my biggest fear by far during the pandemic once I you know, I hunkered down. I wasn’t afraid of getting sick early on, if that makes sense. I mean, I was just like everyone else was, you know, I was comfortable enough that I could get to a hospital if I needed to, but I was always afraid what would happen with what is This long, COVID thing, but we’re starting to get more and more information about long COVID, dare I say more and more comforting information, in some respects about long COVID. Because obviously, the more you know about something, I think the more you’re able to address your fears if that if that makes sense. You know, if You’re afraid of bats like Batman, the more you learn about bats, the better the better. You feel, I think.
Zoe Rothblatt 14:37
I totally agree that that was also one of my biggest fears, is long COVID especially as someone that lives with chronic illness. It’s like, yeah, you sit there like begging please don’t give me another thing to deal with.
Steven Newmark 14:51
Right, right. I mean, I think the number one thing is almost universally it’s accepted that long COVID is not a chronic illness. It’s not a lifetime thing. It doesn’t I’m not trying to minimize it by any means. But that, for me was one of my biggest fears. Who needs another chronic illness tapped on top of this? Again, not good, but not as, you know, scary, I think, as some of us had thought. And it also seems to be following pattern that other coronaviruses when it comes to the long tail of the illness.
Zoe Rothblatt 15:21
Yeah, I think it’s exactly what you said, it’s not a chronic illness, it’s these lingering symptoms, right. And it’s a little hard because there’s no clear definition or consensus generally about what long COVID is, you know, what are the symptoms included under that they really vary from like a cough to GI symptoms, it really varies. And I think that, you know, a lot of researchers are just trying to piece together all of these diverse studies and symptoms to try and figure it out.
Steven Newmark 15:52
Yeah, absolutely. I still think the worst part of long COVID and I didn’t have long COVID, as far as I know, is the profound stigmatization of people who disbelieve that long COVID is actually a thing. That’s quite, you know, unfortunate, because it is a thing and folks who contract COVID end up getting long COVID end up suffering for a lot longer than your traditional COVID suffer, if you will.
Zoe Rothblatt 16:15
And I actually saw that there could eventually be a blood test to help predict who will get long COVID for you know, these persistent symptoms by looking at certain blood protein levels. Researchers are starting to look at it. And, of course, you know, it may be different for people in our community who have different bloodwork. But yeah, that would be really cool.
Steven Newmark 16:37
Yeah, that would that is interesting. It’s always good to know your risk levels when it comes to certain things. So that’s, that’s good to know. I also actually read a study saying that the risk of long COVID drops after a second infections compared to first infections. So that’s kind of good. It’s good news. And bad news is good news that it drops. In fact, it drops apparently, very precipitously. But the bad news is the risk is not zero.
Zoe Rothblatt 16:59
Well, you know, let’s end on, I guess, a positive note. Yeah, a few things that we’ve learned in these three years, I would say number one, mRNA vaccines are safe and effective, it’s easy to forget that now, like, you know, we have this new technology. And it’s pretty remarkable that we have that.
Steven Newmark 17:16
That’s fantastic. And another thing that we learned, if we didn’t know before we now you know, there are enough studies to show that masks actually work. So if you’re concerned if you’re going out there, wear a mask, or an n95 Mask where it KN94 mask, and they work.
Zoe Rothblatt 17:32
On that note, indoor air quality matters. Better ventilation, we saw, reduces transmission. I had never, you know, given much thought to that before. But yeah, these are all just like really important public health learnings for the future.
Steven Newmark 17:47
Yeah, no, absolutely. I would also say that tracking viral evolution is key. Countries and health agencies around the world have now established genomic surveillance to track novel concerning variants. So that’s great that the world is working together to track these things.
Zoe Rothblatt 18:03
Agreed. I think that’s a great note to end on with these positives. Steven, would you learn today?
Steven Newmark 18:08
Well, I learned from you that there’s potential blood tests to determine if you might be at higher risk for long COVID. I didn’t know that. Going into today’s recording. So thanks, Zoe.
Zoe Rothblatt 18:17
Yeah, for sure. It’s great learning. I learned from you, you know, top of the episode talking about the Cochrane Review and just you know, re establishing the learnings there and the misleading could be and why.
Steven Newmark 18:31
Great. Well, we hope that you learned something, too. And before we go, we want to give a shout out to Healthcare Matters, where our colleagues, Conner and Robert, do a deep dive on health policy. Check it out, along with all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 18:47
Well, everyone thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating and write a review on Apple Podcasts. And definitely check us out on YouTube. I’m Zoe Rothblatt.
Steven Newmark 19:02
I’m Steven Newmark. We’ll see you next time.
Narrator 19:05
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation Podcast Network.
S5, Ep22- A Closer Look at COVID Data and Vaccines
This week, our hosts break down discussions from the recent meeting held by the Advisory Committee on Immunization Practices (ACIP), a group of advisors to the U.S. Centers for Disease Control and Prevention (CDC). The updates include reassuring data on the safety of vaccines, who is getting hospitalized for COVID, and the role of vaccine boosters now and in the future.
“The goal is not to stop COVID entirely; it’s about the prevention of severe disease. To me, this is similar to the flu, nobody in public health rationally thinks that we can ever stop flu via vaccination in a given year,” says Steven Newmark, Director of Policy at GHLF. “But public health officials recommend vaccinations to help slow the spread to those most vulnerable and to protect against severe disease.”
S5, Ep22- A Closer Look at COVID Data and Vaccines
Narrator 00:00
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:06
The goal is not to stop COVID entirely, it’s about the prevention of severe disease. To me, this is similar to the flu, nobody in public health rationally thinks that we can ever stop flu via vaccination in a given year. But public health officials recommend vaccinations to help slow the spread to those most vulnerable and to protect against severe disease. Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:41
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:46
Our goal is to help you understand what’s happening in the healthcare world, to help you make informed decisions to live your best life.
Zoe Rothblatt 00:52
And to help you make informed decisions, today we’re going to talk about the recent Advisory Committee on Immunization Practices. They had a meeting, and we’ll talk about what it means for our community. So let’s dive into that.
Steven Newmark 01:06
Yeah, the committee recently met and this is the CDCs external advisory group of expert scientists, and they met to discuss all vaccines. This was part of their regularly scheduled meeting, you know, in other words, these things happen with or without a pandemic. And on this particular morning, they focused on COVID-19 vaccines.
Zoe Rothblatt 01:23
So this discussion was really highly anticipated because it followed the meeting where the FDA discussed the future of boosters in the US for COVID. We talked about that recently, on an episode of The Health Advocates, we had a lot of unanswered questions, you know, will it be a bi-vaillant dose from now on instead of the primary series? Will it be an annual shot? We’re kind of left with suggestions, but up in the air.
Steven Newmark 01:47
Yeah, so some top lines from the meeting. First of all, the top top top top top top top line is that vaccines continued to be safe. There was more reassuring data presented on the safety of COVID-19 vaccines.
Zoe Rothblatt 02:00
I wish our listeners could see that I was smiling, as you said that. Always good to know that vaccines continue to be safe, especially for our community where there’s like a lot of considerations with just you know, your condition, your meds, so it’s great to hear this news.
Steven Newmark 02:15
The second what I think is a big top line is that the vast majority of COVID hospitalizations are actually for COVID-19. What I mean by that a lot of detractors say that the number of COVID hospitalizations is misleading, because it includes people who go to the hospital for some other ailment and quote unquote, happen to have COVID. But the data presented last week actually says the opposite.
Zoe Rothblatt 02:38
Okay. So you know, what does that mean exactly?
Steven Newmark 02:41
The data on hospitalizations for and with. So for means the primary reason that you entered the hospital with is a coincidental coinciding ailment that you may present with when you’re at the hospital. The vast majority of COVID-19 hospitalizations between 80 and 90% for those under age five years, and over 50 are for COVID itself. And this has not changed over time. So yes, COVID-19 is still a problem.
Zoe Rothblatt 03:06
So that’s just basically saying, you know, if I’m sick and going to the hospital for COVID, that’s more likely the case, then I have Crohn’s flare, and I happen to also test positive for COVID while I’m in the hospital. We’re saying that first case COVID’s still problem people are going into the hospital for COVID.
Steven Newmark 03:23
Right, exactly, exactly. So another big deal that jumped out at me is that for adults, 96% had at least one underlying condition. So that’s not surprising. It’s something you know, that those of us in the immunocompromised community are well aware of. Amongst kids, however, 49% had no underlying condition. So essentially, it was 50/50. That’s a really big deal. Half of the children presenting at hospitals with COVID had no underlying health conditions.
Zoe Rothblatt 03:53
And that surprised me that, you know, half of these cases of COVID hospitalizations amongst kids are with no underlying health condition. So that seems like a really big deal to me, given that we’ve said in the past that it hasn’t affected kids so strongly.
Steven Newmark 04:07
Absolutely. So something just to be aware of, to say the least. And you know, another reason why why children should get vaccinated, frankly, regardless of whether you have an underlying condition.
Zoe Rothblatt 04:16
So, you know, when we talk about adolescents, you know, the risk benefit there. I think that they talked about that there’s a lot of chatter around whether you know, the benefits of the COVID vaccines still outweigh the risks for adolescents. You know, where myocarditis is rare but still real risk. So the CDC ran a risk benefit analysis on the bi-vaillant boosters. And what they found is that, you know, when they looked at for 1 million bi-vaillant vaccines given to ages 12 to 17 years old, they found that the benefits did outweigh the risks. So that’s really good to know. This is looking at bi-vaillant boosters, so it’s more recent data, which is always nice to hear.
Steven Newmark 04:57
Yeah, and we should say that the benefits described by the committee were limited to severe disease. Other benefits that they didn’t even discuss include preventing infections, generally, long COVID, days of work that were missed, reduced transmission, etc. So there are even more benefits harder to calculate, if you will.
Zoe Rothblatt 05:15
So we’re looking at this data on protection by age. Where does that lead us for older adults?
Steven Newmark 05:22
Well, older adults were vaccinated in September are coming up on six months on post vaccine. So do they need another vaccine? Or do they wait until the fall like everyone else. It’s clear that protection does wane. You know, it’s unclear as to where we’re going in terms of trying to increase the dosage or decrease, if you will, the time between dosages.
Zoe Rothblatt 05:41
Right. And it’s also an interesting time right now, because we’re headed into spring in the northern hemisphere, which is typically when you know, COVID cases start to go down. So I guess like our immunity would be waning, as the cases are waiting too. So it’s just interesting to see about how, you know, we’ll move forward, whether it’s an annual dose or whatever, but I did see in the meeting that, you know, the CDC clarified the ultimate goal of vaccines is prevention of severe disease, which that’s what they’re doing.
Steven Newmark 06:13
And I think this is an important point that sometimes gets lost. The goal is not to stop COVID entirely, it’s about the prevention of severe disease. To me, this is similar to the flu, nobody in public health rationally thinks that we can ever stop flu via vaccination in a given year. But public health officials recommend vaccinations to help slow the spread to those most vulnerable and to protect against severe disease
Zoe Rothblatt 06:39
Because of this concept that you know, we’re preventing severe disease and it is working in that sense, the committee decided there was insufficient evidence right now to suggest that older adults and immunocompromised need another bi-valiant booster at this time. They did say that could change in the future based on a few things. So the first hospitalization rates among those who got the bi-valiant booster start to increase if we see that, that may be pointing to a reason to get another shot. Other signals of waning vaccine effectiveness of bi-vaillant vaccines and COVID significantly mutates of course, that would be you know, a reason to take a look at when the next dose should be. But as for right now, it seems like the recommendations are that that everyone will be eligible for one shot per year.
Steven Newmark 07:27
Yep. But as we’ve learned, we have to be flexible as this could change. And we you know, we’ll see where we go next.
Zoe Rothblatt 07:32
That’s been the motto the whole pandemic, right, like we know our protective things, you know, handwashing, masking, distancing vaccines, but ultimately, it’s like, we’ll see where we go next. With each season brings a new wave of either relief or concerns. You know, we got relief this year when it stayed in the Omicron lineage and we didn’t get a new original variant. But then again, we got these ones in lineage that that were more transmissible. So it really is about watching and waiting and trusting in the experts that they will lead us in the right direction.
Steven Newmark 08:06
Absolutely. So stay tuned. And it was a good meeting, we learned some interesting stuff. And we’ll keep our ears to the ground again to see what else comes of it.
Zoe Rothblatt 08:15
Well, Steven, that brings us to the close of our show. But did you learn today from the committee?
Steven Newmark 08:20
Well, I learned a lot. I think the most important thing I learned from the committee, for me, is that the vast majority of COVID hospitalizations are for COVID. I was surprised I actually bought into the idea that a lot of the hospitalization numbers in dealing with COVID were for folks who actually presented with something else and turned out that they had COVID.
Zoe Rothblatt 08:39
And for me, it was a good reminder that the ultimate goal of vaccines is to stop severe disease. I think like I say that a lot. But it’s it’s tough to internalize it because we do get caught up in you know, testing positive and what does that mean, but it really is helpful to know that that in this committee, they’re determining that the vaccines are doing their job at stopping severe disease.
Steven Newmark 09:01
Well, we hope that you learn something too. And before we go, we’d like to shout out to Healthcare Matters hosted by our colleagues, Conner and Robert where they do a deep dive on health policy. Check it out, along with all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 09:16
Well, everyone, thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you like this episode, please give us a rating and write a review on Apple Podcasts and definitely check us out on YouTube. I’m Zoe Rothblatt.
Steven Newmark 09:31
I’m Steven Newmark. We’ll see you next time.
Narrator 09:34
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation Podcast Network.
S5, Ep 21- Exploring Meta Analysis of COVID Masking Study
This week the hosts cover the latest news on the origins of the COVID-19 pandemic, the newly authorized rapid at-home test for flu and COVID, and new RSV vaccines on the horizon. The hosts dive deep into a new Cochrane review about the effectiveness of masks against flu and COVID, and how it compares to other studies on how masks work.
“Based on the studies that are out there in controlled environments when individuals are masked properly, it does help stop the spread and it certainly protects those who are wearing the masks,” says Steven Newmark, Director of Policy at GHLF.
S5, Ep. 21- Exploring Meta Analysis of COVID Masking Study
Narrator 00:00
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:06
Based on the studies that are out there in controlled environments when individuals are masked properly, it does help stop the spread and it certainly protects those who are wearing the masks. Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:33
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:37
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life. Today, we will talk about a new study about the effectiveness of masks and break down its conclusion and what it means for our community.
Zoe Rothblatt 00:49
I’m really excited to dive into that topic with you, Steven. First, we do have a few COVID infectious disease related news updates. The first on our list is this lab leak theory.
Steven Newmark 01:00
Yeah, I don’t think we can really call it a theory anymore. Or maybe we still can. But several US agencies, including the Department of Energy and the FBI, now say that Coronavirus pandemic was likely caused by a leak at a laboratory in Wuhan.
Zoe Rothblatt 01:17
You know, this adds to previous intelligence that in 2021, a few other intelligence agencies said that, you know, with low confidence, they thought the virus emerged through natural transmission, you know, which would be whether it’s through the market or just jumping around, but they had low confidence. And now it seems like we’re getting new information that it did come out of a lab. We weren’t told what the new information is. It’s just that now that’s leaning towards that this is the true origin, which you know, what does this mean for the future is the big question, right?
Steven Newmark 01:50
First thing we should say is we’ll probably never know definitively where this started, because it’s been three years, and China is not allowing any foreign agencies to actually go and inspect and to try and learn the truth of the origins. But the closer we come to learning where the virus originated, the better we can do in the future to help contain viruses generally speaking.
Zoe Rothblatt 02:12
Exactly and be proactive about how to protect ourselves, especially for our community, who it’s so important. I mean, it’s important for everyone to stay safe, but especially for our community, it’s helpful to be proactive about health.
Steven Newmark 02:24
Absolutely, absolutely. So we continue to learn more, we’ve spoken about it on this podcast, the idea that it came from a laboratory that happens to be situated in Wuhan, I don’t think should come as a total shock to most folks, even despite the transience of China in allowing inspectors in. Hopefully, we will continue to learn more about the origins.
Zoe Rothblatt 02:43
Next up on our news lists we have the FDA authorized the first over the counter at home test for flu and COVID. This is really exciting.
Steven Newmark 02:52
Yeah, that is great. It’s funny, that’s one of the questions, we would scratch our head about, like, hey, why don’t we just have one test for both? And as best as I can recall, I don’t. I’ve never even I don’t recall ever knowing about an at home test for flu at all. Unless I’m wrong.
Zoe Rothblatt 03:07
I don’t think so.
Steven Newmark 03:08
So that’s fantastic. So if you’re feeling ill, you can now take a test and you’ll at least be able to recognize whether you have flu or COVID. And both of those are, of course, illnesses that you want to treat as quickly as possible. And for flu, we talked about it a lot less than COVID. But if you can get yourself on medications early during the course of your illness, it certainly bodes well for outcomes.
Zoe Rothblatt 03:28
And we’ll have to see how this is covered by insurance. I couldn’t find any information yet, because it’s so new. We’ll keep everyone updated as we learn that.
Steven Newmark 03:37
What gets even crazier, the company that produced the actual test filed for bankruptcy. So, so so it’s we’re not exactly, we don’t exactly have the tests ready to go. But certainly we should knock on wood by next flu season.
Zoe Rothblatt 03:52
Yeah, I was about to say hopefully for next flu season, we can be using these.
Steven Newmark 03:57
Yeah, that will be great. And in terms of obtaining them through insurance or whatnot, TBD.
Zoe Rothblatt 04:02
And lastly, big news this week in a narrow vote that FDA advisors recommended that the agency approves the country’s first RSV vaccine, and this would be for people ages 60 years old and up.
Steven Newmark 04:15
That’s more good news that there’s a vaccine out there that will certainly be out into the public. The vote was close, as you said it was seven to four with one abstention. But you know, we will soon have a single dose shot that has been shown to reduce the risk of illness from RSV by 86%.
Zoe Rothblatt 04:31
That sounds pretty great to me. 86%, I’ll take it except obviously I’m not 60 and up, we’ll see what happens for immunocompromised. I bet that that’ll be you know, the next group that they focus on. But as we’ve seen these vaccines get rolled out with certain groups in mind first with how the studies go.
Steven Newmark 04:48
So we’ll see how that goes. The Advisory Committee has also made about another RSV vaccine for older adults, more vaccines that are out there to help the better and certainly the more likely that some of these might get approval down the road or in short order for the immunocompromised population as well.
Zoe Rothblatt 05:04
Now, if only we can combine all these into one vaccine not only go to the pharmacy, but it’s better to make some trips than get sick.
Steven Newmark 05:13
Better to live today than 100 years ago. So be grateful for what we have.
Zoe Rothblatt 05:17
That is true. I am grateful that aside from vaccines, biologics exists now and keep me healthy and our community healthy. There’s a lot of great advancements. Let’s dive into our big story. Do masks work? There’s a new study that seems to show that masks don’t help stop the spread of COVID. This was like super alarming when I read it. You know, I was just really surprised when I learned about this. And I was thinking has everything we’ve been told and learned about this whole time getting unraveled now?
Steven Newmark 05:48
I wouldn’t say it’s getting unraveled. But there’s certainly been a study that came out called the Cochrane Study and it’s a very reputable source. In fact, for medical questions, they are a major source of high quality meta analysis. They’re a UK based nonprofit that publishes long and comprehensive analysis of current evidence on medical and therapeutic interventions. Generally speaking, to boil it down, they kind of aggregate existing studies to produce reviews that are frequently called the gold standard. This study concluded and I’m quoting, “wearing masks in the community probably makes little or no difference to the outcome of laboratory confirmed influenza/SARS-CoV-2 compared to not wearing masks,” that was their official statement.
Zoe Rothblatt 06:32
Okay, lots of confusion. When I hear that, yes, it seems to undo everything we’ve learned. But what’s important is that this was a meta analysis, right? “ooked at a lot of studies.
Steven Newmark 06:44
78 to be exact.
Zoe Rothblatt 06:45
So let’s dive into that. What did they actually look at? And how did they get to this conclusion?
Steven Newmark 06:51
Okay, so that’s a good question. So first of all, they looked at 78 studies, only six were actually conducted during the COVID 19 pandemic.
Zoe Rothblatt 06:59
Wait, hang on, only 6 of the 78 were during COVID. But the conclusion is about masks makes little to no difference for COVID?
Steven Newmark 07:10
For COVID and flu, correct, Okay. In fact, the majority of the studies looked at flu transmission under normal conditions, and many of them are about other interventions like hand washing, not about mask wearing. Only two of the studies were specifically about COVID and masking in particular. And furthermore, neither of those two studies look directly at whether people actually wear masks. But instead, whether people were encouraged or told to wear masks by the researchers. If telling people to wear masks doesn’t lead to reduce infections, it could of course be that masks don’t work. Or it could just be that people don’t wear the masks when they’re told to or they’re just not wearing them properly.
Zoe Rothblatt 07:48
Which we’ve learned about that in the pandemic. But you know, what I’m hearing here is that that conclusion, when you dive a little bit deeper, it’s not what it seems, because very few studies were about COVID.
Steven Newmark 08:01
Right.
Zoe Rothblatt 08:02
You know, somewhere about the flu. So maybe we can make a link there but unclear about COVID. And, you know, very, very few of them, he said two only looked at masking and it wasn’t even a strong study about you know, do masks work, it was more about feelings and attitudes towards mask if I’m getting this right.
Steven Newmark 08:21
Right, exactly. So people want to know a very simple answer to what should be a simple question does wearing a mask work? But that’s a very loaded question. What does work mean? What kind of a mask are you talking about? During what period of transmission? You know, is the individual shedding at a high rate at that particular moment? What is the disease? Are we talking about influenza? Are we talking about COVID? Are we talking about a different virus altogether? And what social context? How close are you? Are you within six feet of another individual, three feet of another individual? What’s the age factor situation? Are you indoors? Are you outdoors? So there are so many questions. You know, I would just sort of come back to this, do you masks work against COVID 19? I would start almost by asking a physics question. Can a masks physically stop droplets and aerosols from coming in and going out? In other words, calling out when you are sick and shedding and can spread a virus and coming in to protect yourself when wearing it?
Zoe Rothblatt 09:22
Okay. Yes, important question. And it’s a little confusing, right? Because we’ve heard a lot over the course of the pandemic. If we go way back to March 2020, we were told not to wear masks, in part because there was a shortage of PPE and we needed to save it for our essential workers. Then, you know, it was like any cloth mask could be good. Later, we learned that that might not be as effective and we really need an N95, KN95, you know, a tighter fitting stronger mask. So where are we today? How do we answer that physics questions, Steven you know, is that true do masks stop these aerosols from coming in?
Steven Newmark 09:59
For the specific experiments, scientists place test subjects in a very tightly controlled environments with equipment that precisely measures the number of particles that were released when wearing a mask or inhaled while wearing different masks. And they inhale them while doing different things while whispering while coughing while laughing to get different variations. And multiple studies have shown that masks help protect the person wearing the mask against COVID-19. In other words, they reduced the number of particles inhaled by someone. Also, the masks reduced the number of particles emitted by a person. One study, in fact found that surgical masks and KN95 masks reduce the outward particle emissions by 90%, or at least 75% in some cases. So when worn properly, masks do prevent emission from individuals that are shedding. And they do prevent inhalation for individuals that are trying to protect themselves.
Zoe Rothblatt 10:56
So it seems like from this, I’m gathering that masks work on an individual level, you know, to help just person to person oftentimes we talk a lot about the population level and public health in that sense. But it seems like this study is proving that even if you as an individual wearing a mask, and especially if the other individual you’re talking to is wearing a mask, it really does reduce what you inhale and what you would emit.
Steven Newmark 11:20
For the most part. And I say for the most part, because, you know, these are studies that are done in tightly controlled environments, which are very different from the real world. In the real world, too many people, of course, don’t wear masks at all. As an example, if you’re in a crowded subway car were very few people are masked and a bunch of them have a virus and are shedding and are coughing, your protection may be limited. Those who do wear masks don’t always wear the proper masks or the highest level of protection, the N95 masks, KN95 masks. Even when wearing masks, folks don’t always wear them properly to get the proper seal. So within the real world, the conditions are quite different. But yes, based on the studies that are out there, in controlled environments, when individuals are masked, properly, it does help stop the spread. And it certainly protects those who are wearing the masks.
Zoe Rothblatt 12:12
So you know, linking this back to that study we were talking about at the top that had a different conclusion, I wish they would have looked at this and seen how this would have altered their results. If they included this study, you always have to look deeper at what’s going on. Because this is a study that’s actually looking at the effectiveness of masks and how aerosols and droplets transmit whereas that meta analysis didn’t look at that.
Steven Newmark 12:38
Correct. Correct. Correct. Because they were looking also don’t forget, they were looking mostly at non COVID-19 viruses, they were looking particularly influenza, which is different. And they were looking at a lot of studies that took place in the real world where it’s hard to get a gauge on on how folks were wearing the masks, and not to mention what kind of masks they were wearing.
Zoe Rothblatt 12:57
I feel like we still have some unanswered questions.
Steven Newmark 12:59
Some?
Zoe Rothblatt 13:02
Well, I mean, we’re going almost three years into the pandemic, I think we’re hitting that mark, but it’s just like, you know, do masks work on an individual level? Do they work on a population level? How do we know what the right mask is? What happens if you don’t have that right fit that you were talking about and there’s leakage? Which is a lot of these questions come to mind. And does it lead to less severe disease, if you are wearing a mask?
Steven Newmark 13:27
I’m a big proponent without any scientific evidence of the last one, the idea that, you know, if nothing else, my hope in wearing a mask is that I will inhale less of the virus and have a smaller viral load, which would lead to either if I were to get infected, either an asymptomatic infection or less severity of an infection. So it’s sort of like, I don’t know, like a strainer? I don’t know what that I don’t know how to describe it.
Zoe Rothblatt 13:53
Like explaining the stuff at the top of your soup.
Steven Newmark 13:57
Right, right. But we don’t have anything definitive that says, you know, I could be, you know, what, that what I’m doing is actually protecting for that particular instance. You know, I think ultimately, the main problem with taking too much out of the Cochrane Review is is is just that too many people in the real world were not masked properly. And it’s hard to extrapolate that because people were not masked properly, that the virus spread. And as a result, we shouldn’t encourage masking any means.
Zoe Rothblatt 14:30
Wait, can you explain that last part?
Steven Newmark 14:32
Well, you know, basically, you don’t want to I think it’s dangerous to say the top line takeaway is that masks don’t work because study after study shows that they do help to decrease the spread when worn properly. They do help to protect the individual on an individual level when worn properly. And if you care about others, if you’re not sick, you help to stop the spread if you have an asymptomatic infection, or if you actually know that you’re sick, you certainly should be matched up if you have to be outside. You know, I don’t think too much can be put into this. Look, the bottom line when you go to get surgery, do you see people wearing masks?
Zoe Rothblatt 15:09
Yeah, I would be terrified if they weren’t. Right.
Steven Newmark 15:12
Right. Exactly. And they would be to they’re doing it for themselves. Yes. So I think the beat goes on, we still have a lot more to learn. And we’re still living the world we’re living in where those of us who want to remain masked can do so you know, I’ll continue to wear mine in public settings, I’ll continue to wear my N95 masks or which, you know, which I feel does provide robust protection when needed.
Zoe Rothblatt 15:36
I think it’s tough because it’s like, where do we go from here? You just mentioned what you’ll keep doing. And I guess at this point is become an individual thing. What’s helpful for me is to think about what we talked at the top of the episode, you know, there’s now a new test for COVID and flu, you know, there might be a new vaccine for RSV coming. And I think it’s helpful that we have all these other supports outside of masking and they can all come together to help us feel safer.
Steven Newmark 16:05
Right. Absolutely. Absolutely. You know, we’d love to hear from you. I’m curious what our listeners think on this subject. We’ll keep reporting what we know until we hear otherwise, as the studies keep showing the efficacy and safety in wearing masks, we’ll continue encouraging folks to do that when in certain situations.
Zoe Rothblatt 16:22
Absolutely. And, you know, we know masking is so important to our community. We hear about it all the time on the internet and just through one on one conversation. So you know, do what you feel is comfortable for you. And like Steven said, we’ll we’ll keep everybody updated. Steven, that brings us to the close of our show. What’d you learn today?
Steven Newmark 16:40
I learned I guess in preparation for today, I learned about the at home over the counter test for flu and COVID. I’m excited when that’s actually available to purchase at my local Walgreens.
Zoe Rothblatt 16:52
Awesome. Yeah, me too. And I learned from you just how to do a deeper dive onto these studies that are meta analyses and like really, really dive in and see what they’re looking at and with a critical eye.
Steven Newmark 17:03
Well, we hope that you learned something too. And before we go, we want to give a shout out to Talking Head Pain, the podcast hosted by Joe Coe, featuring interviews with patients and leaders in the migraine community. Check it out along with all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 17:20
Well, everyone. Thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating and write a review on Apple Podcasts and check us out on YouTube. I’m Zoe Rothblatt.
Steven Newmark 17:34
I’m Steven Newmark. We’ll see you next time.
Narrator 17:36
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation Podcast Network.
S5, Ep 20- Paying it Forward: The Journey to Becoming a Psoriatic Arthritis Advocate
This week, the hosts cover the latest news on the HELP Copays Act, new research findings on COVID reinfection hospitalizations, and tips related to Heart Health Month. The hosts are also joined by patient advocate Eddie Applegate, who shares his psoriatic arthritis journey.
“If I’m able to share my story with others in a way that can help them in a way that I didn’t have when I was first diagnosed … that would be just a great opportunity to pay it forward,” says Eddie.
S5, Ep 20- Paying it Forward: The Journey to Becoming a Psoriatic Arthritis Advocate
Narrator 00:00
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation Podcast Network.
Eddie Applegate 00:10
If I’m able to share my story with others in a way that can help them in a way that I didn’t have when I was first diagnosed, I thought that that would be just a great opportunity to pay it forward.
Steven Newmark 00:22
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:31
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:36
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:41
Today we have an interview with Eddie Applegate, we talked about Eddie’s psoriatic arthritis journey, advocating for yourself with your doctor, and also just how the chronic disease community helps support each other. It was a really great interviewer, I’m excited for you all to listen. First, we do have some news updates.
Steven Newmark 00:59
The HELP Copays Act was introduced this week in the house. The Help Ensure Lower Patient, or HELP, Copays Act to protect patients from harmful insurance and pharmacy benefit manager practices that raise out of pocket drug care costs.
Zoe Rothblatt 01:12
And this is a federal legislation that helps fill in the gaps that people are left behind. Because the state doesn’t cover everyone. Not every state has a law. And this is basically saying that if you use any money that you use towards a copay, whether it’s a copay card or you know a coupon, something from the manufacturer, or any of those will count towards your deductible. So you can help meet your deductible faster, and the insurance companies aren’t double dipping. So this is huge, because we know our community relies on regular medication.
Steven Newmark 01:46
Absolutely. This is legislation that we at GHLF have sought for many years. And I can’t emphasize enough the bipartisan nature of this legislation. I know, we hear a lot about dysfunction in Washington, particularly in Congress. But this is an area that has bipartisan support. And with that support, or hopefully it’ll get pushed through or hope it gets pushed into law.
Zoe Rothblatt 02:10
And similar to the discussions we’ve had with the Safe Step Act, this is something that’s been introduced in years past, which always is more hopeful as we gain more co sponsors on the act. And finally shout out to our colleague, JP Summers, Patient Advocate, Community Outreach Manager here at GHLF. Yes, she advocated and spoke at a Wisconsin Press Conference on the importance of this bill and how it helps patients. So thank you, JP, for all your work with the 50 State Network.
Eddie Applegate 02:38
Absolutely. Great job by JP.
Zoe Rothblatt 02:41
Our next news update is a little bit of research news. So we have some answers on protection from a previous COVID infection. This new study, it was a meta analysis, which means they analyzed 65 studies from 19 different countries, it was published in The Lancet. And what they found was that risk of hospitalization from COVID among people who were previously affected is 89 to 90% lower for at least 10 months post infection.
Steven Newmark 03:10
Yeah, excellent news for pretty much everyone. It’s great news if you have been infected, of course, but it’s also good news if you’ve not been infected, because it means that there are folks walking around who have been infected who have greater protections for themselves, which will endure to greater protections for the community as a whole.
Zoe Rothblatt 03:28
Exactly. And the study did find that protection from past infection from the earlier variants was high, but it was substantially lower for like the Omicron BA.1 lineage. And you know, obviously the study authors recommend that vaccination is still really important and the safest way to get protection, especially because vaccines also are important for you know, older adults in our community with underlying illness who really rely for those around them to have protection. You know, a vaccine is guaranteed protection versus an infection we really don’t know so much.
Steven Newmark 04:02
We also want to mention, this is our last recording in the month of February. And as we end Heart Health Month, there is a few tips that we wanted to share for you and your loved ones.
Zoe Rothblatt 04:11
Let’s hear it. It’s really interesting how much heart health overlaps with chronic illness like inflammatory arthritis, things like that. There’s such an overlap among co conditions, it’s hard to remember to consider it all. So what are the tips, Steven?
Steven Newmark 04:25
Well, some tips are as with anything else, always start with a good team. Start with your primary care doctor and add a cardiologist to the mix when it’s appropriate to talk about your heart health. You know, when you have your team assembled, make sure that you get proper heart tests to get an accurate picture of your cardiovascular health. Obviously, it’s important to make healthy food choices. The Mediterranean Diet has been found to lower the risk of heart attack, stroke, and heart failure. And stay active. Get moving, exercise can improve vascular function and reduce the risk of cardiovascular disease.
Zoe Rothblatt 04:57
Great. I mean, it’s more of the same stuff that we hear for other chronic diseases, which is good news because I might be already be doing some of it. But just adding a little bit more on shouldn’t be too much of a burden. So like I mentioned, I spoke with Eddie Applegate, we had a really great conversation about ways to just speak up for yourself along your journey. You’re whether it’s the beginning of your journey, or you’ve been living with a condition for a while, it’s always important to connect with others and get these tips. So yeah, let’s have a listen to Eddie. Good morning, Eddie. And welcome to The Health Advocates. It’s so great to have you here today.
Eddie Applegate 05:37
Good to be here this morning, Zoe.
Zoe Rothblatt 05:39
So why don’t you begin by introducing yourself. Tell our listeners a little bit about you, your diagnosis, and where you’re at today.
Eddie Applegate 05:46
My name is Eddie Applegate. I am originally from the great state of Alabama. But I’ve been living in the Atlanta, Georgia area for the past 10 years. I work with making sure commercials run correctly. So I’m I’m sorry, I guess since I’m the one that I’m responsible for some commercials and some programs. So like I said, my apologies on that one. I was diagnosed with psoriatic arthritis in it’s been about 20 years now since I was first diagnosed. And I like to say that my diagnosis story is much different than other people’s because I was actually diagnosed early the first time and by an urgent care doctor, which whenever I tell people that they’re like, “You’re kidding.” I was like, No.
Zoe Rothblatt 06:29
Yeah, my jaw dropped when I found that out.
Eddie Applegate 06:32
I mean, it’s it’s I hate that it is such an anomaly in the lore of diagnoses, but I had been having issues with pain and with stiffness. Getting in and out of a car was tough and painful. And so I finally asked my mother at one point in time, do you think that I have arthritis? And she said, I don’t know, you may but you would need to get a referral first. So that’s why I went to an urgent care just to get a referral to a rheumatologist. But I think I had the one urgent care doctor who had heard of psoriatic arthritis. I had never even heard of psoriatic arthritis, but with the symptoms on my chart, and then he looked at me and he looked at my fingernails, which had some pitting in them, and he looked at my skin, which had psoriasis on them. He said, “I know exactly what you have. You have psoriatic arthritis,” and I was able to get a referral to a rheumatologist very quickly because it was a new rheumatologist at the practice. So I didn’t even have to wait a long time, like others do to see the rheumatologist. I think within a month, I was seeing a rheumatologist and that that led on my journey of 20 plus years. Right now I am at a period of lower disease activity. So I’m very thankful for that. Thanks to good medications. I’m very happy with that. That’s my story in a in a quick little nutshell.
Zoe Rothblatt 07:59
I’m so glad to hear that you’re living with low disease activity today. That is such a win. I wanted to ask you got a quick diagnosis. What happened next? When did you start, you know, advocating and sharing your story and being open about your psoriatic arthritis?
Eddie Applegate 08:16
That was a little further down the road. I tried some medications that didn’t work, I’d even gone off of medication at some point in time because my insurance had changed or lost insurance. It’s amazing how having the right job and the right insurance affects our health care. That’s, that’s another story for another day. But that’s it’s very important. But I’d finally been in a good place medically. And I saw something with the Arthritis Foundation actually like, oh, the yearly walk, I was like, Well, you know what, you know, several years ago, would not been able to do this walk. So why not? Why not try it? And so I did a little fundraising for that. And after a few times, somebody that worked there said, “I keep noticing your name. It’s great to meet you know, if I ever have anything, I’ll let you know.” And that led to being a part of an ACR symposium one day on psoriatic arthritis from as the as the patient, there were a lot of clinicians, and then they had some patients sprinkled in there as well to get the patient point of view. And that really is what what started it. And then I met Ben Nowell from GHLF. And he’s like, “Hey, we’ve got something called Patient Governors, were still looking for some and think that you’d be good. So if you’d like to do that?” Sure. Why not? You know, I thought things are being put in my path for a reason these opportunities have been put on my path for a reason why not get a chance to speak as a patient from my point of view, because you know, a doctor can speak 24/7 but it’s different when someone who actually has the disease tells their experience. That’s much more, that hits much closer to home because when I started with psoriatic arthritis, 2003, there wasn’t a whole lot on the internet about psoriatic arthritis. There, there wasn’t social media like there is now 20 years ago, which makes me feel way older than it should. But it was that way there really wasn’t anything to it. There may have been some message boards are some people commenting on things, but there’s not what we have now. So if I’m able to share my story with others in a way that can help them in a way that I didn’t have, when I was first diagnosed, I thought that that would be just a great opportunity to pay it forward.
Zoe Rothblatt 10:33
I love that, I totally agree. It makes such a difference to hear things from other patients. As I think you know, I live with spondyloarthritis and Crohn’s disease and just opening up about my disease, I’ve had a similar experience to you where you meet people along the way that helped you and you in turn can say something that helps someone else recognize symptoms. And it just it makes such a difference having that in between the doctor’s visits, like you mentioned, you know, you go to the doctor, but what happens in between and you have this sense of community advocating with you in between, which is amazing.
Eddie Applegate 11:07
Absolutely. And I have made wonderful friends through my arthritis journey that I talk with, you know, most every day about arthritis things and about non arthritis things. But it’s good to have somebody because not everyone understands like, oh, well, the doctor told me this, or my medication is making me feel like this. The average person is not going to know what that means. So it’s good to have somebody that does know what it means. And also I found out a few friends of mine, that whenever I would post about stuff, they’ve messaged me privately and said, “Thank you for speaking about this, you know, I have psoriatic arthritis. I don’t feel comfortable speaking like you do. But I’m glad that you are speaking out and telling your story. It does mean a lot.” I was like, Wow, thank you.
Zoe Rothblatt 11:50
I think that’s so key everyone, advocates in their own way. And even just like the person that doesn’t want to share, but is reading your story that also is a form of advocacy, because they’re getting the knowledge and really trying to take control of their care. So that’s amazing. Eddie, you joined The Psoriatic Arthritis Club, another podcasts under our umbrella. And I really wanted to bring you on here to do a little crossover and talk about some of the things you mentioned on there. I was listening to your episode, and you said, “Because if you don’t say something than nothing’s going to change. If a change is needed, if you feel a change is needed, and you don’t say anything, the doctor is not going to know.” That was a really powerful quote to me and just like really highlighted to me how much you’ve advocated for yourself on your journey. Even with a quick diagnosis, it’s still may be a long road living with a chronic disease. Can you talk to us about a time you remember speaking up and a change that you felt you needed?
Eddie Applegate 12:50
Absolutely. I think that the medication that I’m on now is because I’ve advocated for myself. You can’t be shy whenever you go to the doctor’s office and go, “Oh, no, I’m fine. I’m Okay,” if you’re actually in pain, because if you say, oh, no, I’m fine. I’m not in pain. That’s what the doctors gonna believe. And if you are in pain, but you say you’re not in pain, the doctor is not, I think I’ve said before to people like, Well, the doctor is not a mind reader, you have to tell the doctor, exactly, or the nurse practitioner, or the physician’s assistant, whoever the medical professional is that you’re seeing, you have to tell them if something is wrong. I know that I kept mentioning to my rheumatologist, “Yeah, I’m having some issues in my ankle and my knee.” He said, “Well, maybe it’s time for a medication change.” He was always great to listen to me, if I was having some issues, there would be times when he would bring out his little ultrasound machine. And you know, run it over my hand, run it over my knee, just to make sure that when they are looking, see, but if you don’t say anything, nothing changed. And that goes for any situation in life, not not just on a medical situation. But any situation in life. If you don’t say anything, nothing’s going to change because people are going to think that everything is good the way that it is. So you have to you have to say something, if you feel that the medication isn’t working, if you have a new symptom, if there are some side effects to the medication, you really need to say something or else you’re going to stay where you are because the doctor will think, hey, where you are is fine. So it’s important that you do speak up so that they know, you don’t want them to say, “Oh, well, you never said that you were feeling bad. Oh, you never said that this was an issue.” Say it, put it out there. And if they don’t listen, make them listen, but at least you know that you’ve said something.
Zoe Rothblatt 14:33
So what advice do you have for others that are maybe a little bit timid to speak up? How can someone get to the place that you’ve got to where you are recognizing symptoms and saying it out loud?
Eddie Applegate 14:45
I think that if you are a little timid and a little hesitant to some people might think oh, you know, well, I don’t want to contradict what the what the doctor is saying I don’t want to, you know, seem like a bother. If saying something is a problem. Write it down. I’m a big advocate of if you know that there’s some issues going in, write down those issues before you get there. Even if you just want to hand it to the nurse, to the nurse practitioner, to the PA, to the doctor, it may be easier than just saying it out loud. This is how I’m feeling today. On the chart, I know that every time I go, I always have to mark on the chart how I’m feeling. Be honest on there. So if you don’t want to say anything, at least be honest on on the chart, that is super helpful, because they’re looking at that over time. Like, “Oh, you were a four yesterday, you were four you know, three months ago or six months ago, but you’re a six today. All right, what’s what’s going on that we have this, this change?” So honesty is the is the number one thing whether that’s honesty in speech or honesty in writing it down, if that makes you feel a little less aggressive or whatever, but just write it down if saying is too much.
Zoe Rothblatt 15:56
I think that’s great advice, especially because sometimes when you get to the appointment, you go blank and forget what you want to say. So just having it there as that little reminder and push to say it is really helpful.
Eddie Applegate 16:08
Absolutely.
Zoe Rothblatt 16:09
Well, Eddie, thank you so much for joining us today. I really appreciate your time and you sharing your story. You know, you mentioned 20 plus years, I feel like we’re just getting started still. Thank you.
Eddie Applegate 16:21
You are very welcome. It’s I’m very glad to be here. And I’m having to keep all this advice fresh in my mind, because I just switched rheumatologist because my rheumatologist of 10 years, just left his practice. And so I’ve started with I’ve started with the new doctor as of this week. And so I had to remember that for myself. So when I knew that this was coming, I was like, Well, this is kind of a good, this is a good way to put my own words into practice. And hopefully I’m listening to myself and, and, and following my own advice so that I can speak up. And that’s what I did. You know, I said, this is how I’m feeling. And I think that he could tell that I had a good knowledge of what was going on. So I was able to be involved in my own treatment plan. And I think that that that really impressed him. But that’s another reason to speak up because you want to be informed you want to know what they’re doing, you are the most vital and integral part of your own treatment plan. So being informed and speaking up is very important because of that.
Zoe Rothblatt 17:20
Well, before we go actually one more question you just mentioned you switch rheumatologist and I’ve been hearing a lot about that in our community, people’s rheumatologist retiring or, you know, there’s not one in their area. How did you go about finding a new one?
Eddie Applegate 17:35
Well, this one I didn’t have much of a choice with because my doctor sold his practice to another group. And they said, “Okay, yes, you can still come to to this location. There’ll be doctors from that practice that are here a few times a week. And so you’ll see them.” So at least I didn’t have to go out and search. But once I found out who it was with, you better believe I went to, to that practices website. Let’s find this doctor. Let’s see what his credentials are. Let’s see what he is, is doing. But the important thing is research. Unfortunately, the first research has to be do they take my insurance? You are running into your insurance website. I have done that on other specialists. Oh, like, Okay, go to my insurance website. Alright, so what specialists are covered? Okay, so now, who’s closest to me in the Atlanta area. It’s a very big area. And so just because somebody is in the Atlanta area, they can still be an hour plus away from me. So I’m like, Okay, so let’s insurance and then closeness. And then All right, let’s see what the websites look like. And, you know, do they have a lot about the doctors and their credentials, and things like that, but I’ve done that with with other specialists, I’ve kind of gone through that, that research. I think I’ve done more research on doctors sometimes than I have on buying a car. Because that’s a little more important. Like, you know, a car is gonna get you where you need to go, but a doctor is going to be the one that you know, make sure that you are able to function, so a doctor is a little more important, but like I said, with this one that was like, Okay, this practice is taking over and then I was kind of like, assigned to doctor. I didn’t even get the doctor’s name until like a week or so ago. So it was Oh, wow. To me. They’re auditioning for me, not the other way around. It’s like do I want to stay with them? Do I trust them enough? That’s how I always look at it. It’s not Am I good enough to see this doctor is like, is this good? Is this doctor good enough to see me?
Zoe Rothblatt 19:30
Yes. I Love how you just framed that it’s it’s under the same umbrella as this medication failed me. I think we need to do so much in flipping the script on what happens in our care and, and we are you know, we’re the person it’s our life. You know, it’s up to us to have a say and be the main person.
Eddie Applegate 19:51
And feel comfortable with the doctor. And so I think that that’s, that is important that we’re not auditioning for the doctor. The doctor is auditioning for us. We want to make sure that we have that comfort level and the that they have the knowledge base that we require of a clinician. So if they don’t we search again and I know that unfortunately, especially with rheumatologists, it is tough to find multiple rheumatologists in an area. And so some people are kind of stuck with who they have just because of the lack of rheumatologists in the area, if you can and have to, you know, find the one that’s right for you.
Zoe Rothblatt 20:27
Well, on that note, thank you, Eddie, for joining us today and sharing your insights and advice from your journey. I know it’s going to help so many people. So thank you.
Eddie Applegate 20:36
You’re very welcome.
Steven Newmark 20:38
Wow, that was really great hearing from Eddie. Now, what a fascinating journey that he’s had with psoriatic arthritis. I’ll preempt your questions only by saying I really learned a lot about you know, advocating for yourself with your doctor. And you know, just hearing from patients like Eddie is so valuable to the community at large.
Zoe Rothblatt 20:55
I totally agree. Listening to Eddie was so important just about his tips about you know, don’t be shy, the doctor is there to help you. Speak up is really helpful reminders.
Steven Newmark 21:06
Well, we hope that you learned something, too. And before we go, we want to give a shout out to Healthcare Matters, fantastic program, run by our colleagues, Conner and Robert and they’ve done many deep dives on important issues and you could check it out, along with all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 21:22
Well, everyone. Thank you for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating and write a review on Apple Podcasts. Hit that subscribe button and check us out on YouTube. I’m Zoe Rothblatt
Steven Newmark 21:38
I’m Steven Newmark. We’ll see you next time.
Narrator 21:41
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation Podcast Network.
S5, Ep 19- Advocating this Black History Month
This week the hosts cover the latest news on copay assistance, the FDA’s finalized guidance on clinical research for cannabis, and New York’s decision to end the mask mandate in health care facilities. The hosts also discuss the importance of sharing Black patient stories this Black History Month while shining a light on health disparities.
“Going to Capitol Hill, going to your state legislators, and just telling them your stories, it’s such a big deal. And when you say amplifying patient voices, that’s what we mean. When we talk about amplifying Black patient voices and their experiences, it’s the exact same thing,” says Steven Newmark.
GHLF Black History Month: https://www.ghlf.org/black-history-month
S5, Ep 19- Advocating this Black History Month
Narrator 00:00
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:09
Going to Capitol Hill going to your state legislators and just telling them your stories, it’s such a big deal. And when you say amplifying patient voices, that’s what we mean. When we talk about amplifying black patient voices and their experiences, it’s the exact same thing. Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:33
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:37
Our goal is to help you understand what’s happening in the healthcare world, and to help you make informed decisions to live your best life. Today we’re going to talk about Black History Month, its importance, some research updates and how we can amplify black patient perspectives.
Zoe Rothblatt 00:52
But first, we do have a few news updates. Steven, I think the most exciting update is this amicus brief that you worked on. Can you tell me in our listeners about it.
Steven Newmark 01:00
GHLF, along with 28 other groups have asked a US District Court to accept our amicus brief in a litigation concerning a 2021 federal rule. The rule essentially says that health insurers do not have to count the value of drug copay assistance programs towards patient out of pocket obligations. This is a big deal. This is something that we have been fighting for for many years, the idea of using copay assistance programs and having it count towards out of pocket cost obligations. If our amicus brief is accepted, it will help the court understand how copay accumulators negatively impact patients, caregivers and health care providers. If we’re successful, it will allow for patients to continue to use copay assistance programs and count them towards out of pocket cost obligations.
Zoe Rothblatt 01:49
This is a really big deal to help patients because often these co pays really add up and if it’s not counting towards the deductible, it just becomes like a big financial burden over the course of the year. Steven, I’m wondering though, what exactly is an amicus brief?
Steven Newmark 02:04
Good question. So typically, civil litigation is only between two parties a plaintiff and a defendant. In this particular case, the litigation was brought by several patients along with some patient organizations that represent those patients. However, in some cases, the outcome of the litigation has the potential to impact people other than the two parties litigating, the plaintiff and defendant. For such cases, you look to file what’s called an amicus curiae, which is Latin for friends of the court. And we are looking to enter as an amicus, or friend of the court, to provide the court with relevant perspectives, information and arguments that show the court how our particular ruling could affect non-litigating parties, in this case, how it will affect patients. Is that helpful?
Zoe Rothblatt 02:46
Yeah, that’s really helpful. It’s ultimately raising the voice of patients within these conversations and saying, you know, this is affecting a large group of us.
Steven Newmark 02:54
Absolutely. It’s kind of like how we advocate in the legislative branch of government, the first branch of government. We go to legislators and seek to educate them on the patient perspective and what patients are dealing with in terms of accessing their needed therapies. This is essentially like advocating to the judicial branch or specifically to a particular court.
Zoe Rothblatt 03:14
Great, well, I’m excited to see what happens here. And I hope that the court is on our side and understands, you know, the need for patients to have a copay assistance and it counting towards their deductible.
Steven Newmark 03:26
Definitely. So we’ll see how that goes. In other news, the Food and Drug Administration finalized a 2020 draft guidance detailing the agency’s recommendations for clinical research for developing cannabis and cannabis derived human drugs.
Zoe Rothblatt 03:41
So this guidance really impacts research and ultimately at the end of the day patients in our community. So it says that, you know, those involved in the clinical research of cannabis can rely on this FDA guidance for a few things; recommended sources of cannabis for clinical research, resources for information on quality and control status, and also how to calculate THC differences. So just a bunch of technical things to help improve the quality of research around cannabis.
Steven Newmark 04:12
This is great news for our community, we’re always looking for any kinds of way we can get help with therapies to make life more bearable. And if there’s something that can be found from hemp, or cannabis that’s going to, you know, clearly make a difference in the lives of our patients. I’m curious if this is something that we spoken with our patients about and any feedback we’ve received,
Zoe Rothblatt 04:32
Actually, it’s interesting you bring that up what the patient perspective is, because in 2019, we did a survey of our community with rheumatic diseases. And we found that over half had tried medicinal cannabis at least once and most commonly for pain. Actually, 96% said that they did it for pain. Further, like whether or not they had used it 66% said they wanted more information about it and over half said they prefer to have that information come from their physician. So I think when we look at this final guidance from the FDA, it will help get some research that patients can talk about with their doctors and sort of legitimize the space.
Steven Newmark 05:13
Yeah. Well, it seems sort of axiomatic that any more information on the use of cannabis and how it might be helpful will certainly be a good thing.
Zoe Rothblatt 05:22
Great. Okay. Well, our last piece of news, New York State ends the mask mandate in healthcare facilities.
Steven Newmark 05:29
As of our recording, actually, this means that healthcare settings, hospitals and nursing homes are essentially setting their own masking rules individually.
Zoe Rothblatt 05:37
So this is in line with what happened federally. Back in September, the CDC removed the federal mandate requiring mask and health care facilities. And I tried to look up what other states are doing. And it was actually really hard to find data, it was all websites that haven’t been updated in some time. So it’s not clear if other states have their health care facilities are still masking. And I guess it’s sort of you have to be local and be going there to find out what’s happening, which is a little concerning that that information isn’t more available.
Steven Newmark 06:07
I wonder if it’s a county by county thing in some states, I actually don’t know. I do know that I’m selfishly very concerned about this, the idea of having to go to a hospital and not knowing what the masking rules are, is concerning the idea of going to a hospital, if you’re immunocompromised, if you’re elderly is a scary thing. Hospital acquired infections are a real thing, you know, I would think pre COVID, the idea of wearing a mask is something that should have been explored. But in a post COVID world where hundreds of people are still dying on a daily basis. And in a facility where let’s be honest, there’s a lot of sick people in that facility.
Zoe Rothblatt 06:43
In a hospital? No way!
Steven Newmark 06:45
You would, you would think that they would want to keep the spread of all diseases to a minimum. So it’s concerning, I just think of a scenario where an elderly relative has to go in for surgery, if you’re not wealthy, you have to share a room during recovery. So you share a room and you’re sharing a room with somebody who doesn’t want a mask and who knows what they’re in there for. And they bring in their relatives during visiting hours. And those relatives aren’t masked and other relatives down the hall, they’re not masked, so on and so on, and so on and so on. And meanwhile, this elderly individual who just came in for surgery is now be exposed potentially to harmful viruses.
Zoe Rothblatt 07:20
Yeah, I mean, also for just our community with chronic disease, who often uses health care facilities just for routine care. I know some of my doctor’s offices are in the hospitals. So I do have to go through the hospital in order to see them. And I just wonder how many people are going to forgo their regular chronic disease care because they don’t want to be put at risk and just end up in a worse health situation overall. I always felt like the rules, the mandates from the state or from the government, at least give the perimeter for the local institution to say, hey, it’s not our policy. It’s kind of like the no dogs in restaurants policy. Like, “Oh, I’m a restaurant or I Love dogs. I would Love to have your dog in my restaurant. But you know, it’s not me. It’s the health department.” But without that excuse, it’s going to make it more difficult for hospitals to implement their own rules, I think. I agree. Well, for now, though, I think New York City announced that masks will still be worn in their public hospital system.
Steven Newmark 08:17
Yes.
Zoe Rothblatt 08:18
So we will see how that holds up.
Steven Newmark 08:21
And the private hospitals in New York City and upstate New York have said that, you know, TBD to be determined, we’ll see we’ll see what they decide to do.
Zoe Rothblatt 08:32
Alright, so let’s jump into our big topic of today. It’s Black History Month, which is a time to just celebrate the great achievements and commemorate important black heroes and events throughout our history. But also as people in public health and the health care world, it’s a time to reflect and raise awareness of racial and ethnic disparities across these health sectors. And you know, what we can do to help change that.
Steven Newmark 08:56
There’s always more work to be done in this space, and GHLF continues to honor, amplify and uplift the experiences of those living with chronic illness in the black community. You can check out a portion of our work at ghlf.org/black-history-month for patients stories, and to learn more about health disparities. And we’ll put this in our show notes as well.
Zoe Rothblatt 09:17
So health disparities, let’s talk about that for a minute. First, I just want to say, why talk about health disparities. It’s important because, you know, recognizing them helps create change, you know, we’re not going to create change if we’re not talking about them. And we need to keep highlighting what’s going on in different communities, say that it isn’t people’s fault. There’s inequities in our system that lead to these health consequences. And you know, there are actions we can take but we can’t blame the individual. It’s on us as a public health community to recognize and take action on these.
Steven Newmark 09:52
We talk about health disparities, it’s a sad state that depending on where you live, your zip code can determine your life expectancy. And there is a range of almost a decade difference of life expectancy from some of our longest living zip codes to some of our lowest life expectancy zip codes. According to the CDC, nearly half of all African American adults have some form of cardiovascular disease and stroke, about two out of every five African American adults have high blood pressure, and less than half of them have it under control. And when it comes to breast cancer, black women have the highest death rates of all racial and ethnic groups and are 40% more likely to die of breast cancer than white women.
Zoe Rothblatt 10:30
You know, the heart wrenching part is that this list can go on and on. That’s just a few of the many health disparities that exist in our healthcare system, especially for our black friends. And it’s important to talk about this and, and let people know that, you know, these exist, and we need to do something about it. I actually saw this recent study that suggested that racism might contribute to inflammation. I know, we already know that racism and discrimination impact many aspects of life. But this recent study looked at how racism and discrimination might disrupt what they call the brain gut microbiome system. They did some MRIs, and also some blood tests and microbiome analyses. And at the end of the day, what they found is that the blood tests revealed that black participants in the high discrimination group had high levels of this enzyme that leads to inflammation and Hispanic participants did as well. And the microbiome analysis revealed that they had high levels of bacteria in the black individuals in the study. And this was where people face high levels of discrimination. So ultimately, what this meant is that bodies are showing that high levels of discrimination lead to higher levels of inflammatory enzymes, protein things in the microbiome that cause inflammation.
Steven Newmark 11:53
Is there a theory that higher levels of stress were causing this enzyme to form? Or was it something that is in the genetic coding of individuals with certain backgrounds?
Zoe Rothblatt 12:04
I think it was the first about stress because they broke them down by discrimination groups. And I think, you know, discrimination isn’t something you’re born with. It’s something you experience.
Steven Newmark 12:16
Oh, interesting, interesting. Did they break it down by socioeconomic status to try and hone in on that? Or
Zoe Rothblatt 12:21
I’d have to look back at that? I don’t think so. I think it was like by white, black, Hispanic, different races.
Steven Newmark 12:29
Interesting. Well, not surprising, unfortunately. But certainly interesting. And I’m sure that’s one of just many, many studies that detail the health disparities in our system.
Zoe Rothblatt 12:39
Yeah. And I hope that research like this, just like shines a light on the injustices and helps people recognize that we need to take action and that these are legitimate things happening to people in altering the chemistry of their body because of discrimination. It’s not Okay.
Steven Newmark 12:57
Absolutely. Absolutely. So what can we do as advocates to help on this front. As a start amplifying black patient voices and their experiences to help fight for equitable access to care is one place to start.
Zoe Rothblatt 13:09
It’s a coincidence this week is headache on the hill. And this is an advocacy event that brings together health professionals, migraine and cluster headache patients, and caregivers, anyone really related to migraine headache to advocate and and give asks of Congress to help improve access and funding towards these diseases. And actually, historically, there’s been a really big lack of representation in the migraine community. And I want to give a shout out to our colleague, Sarah Shaw, who is the Senior Manager of BIPOC Patient Outreach. She’s changing that. She put together a group of BIPOC patients who are right now on the Hill sharing their stories to help affect change for others.
Steven Newmark 13:48
It’s just like we always say going to Capitol Hill going to your state legislators and just telling them your stories. It’s such a big deal. And when we say amplifying patient voices, that’s what we mean. When we talk about amplifying black patient voices and their experiences. It’s the exact same thing with a micro advocacy component to it. And it’s great that Sarah’s doing that, it’s great that she’s brought together this group of patients who will be sharing their stories as well all week.
Zoe Rothblatt 14:11
And really quickly just you know, to end our show, I wanted to share a few quotes from the patients on this council on why they advocate. Lesley says, “As a black woman representation matters in the migraine advocacy space and working to promote health equity as key.” Tamisha says, “I advocate because I know what it’s like to suffer in silence and be misunderstood in regards to the wide array of migraine symptoms. Migraine is far beyond a headache and migraine sufferers deserve more acknowledgement and consideration for their varied symptoms.” Lastly, I’ll share a quote from D’Sena who says, “I also advocate because I believe our voices are worthy of being heard in a system that is constantly trying to push us off as someone not worthy of the care we deserve.”
Steven Newmark 14:55
Very powerful. I would always remind listeners that advocacy comes not just in meeting with legislators but also in one on one meetings you have with your health care providers. Be a strong advocate when you’re talking to your doctor or for your own health care.
Zoe Rothblatt 15:08
Exactly. Find doctors that you feel comfortable with that look like you. I know that’s a really big deal in the black community is to be able to have someone that understands you on a deep level and just have that representation. It really matters. And I’m so excited that Sarah and this group are on the Hill this week advocating for things like that.
Steven Newmark 15:26
Absolutely. Absolutely. So we look forward to hearing back from Sarah and see what she’s able to accomplish down there.
Zoe Rothblatt 15:32
All right, Steven, that brings us to the close of our show. What did you learn today?
Steven Newmark 15:36
Well, I learned about the great interest in the GHLF community about the potential use for medical cannabis, and which just shows the importance of what the FDA is doing and trying to increase research in that field.
Zoe Rothblatt 15:49
And I learned from you about what an amicus brief is and how it can help patients have better access to their care.
Steven Newmark 15:56
Well, we hope that you’ll learn something too. And before we go, we want to give a shout out to The Asthma Podcast, an excellent new podcast. In the first few episodes, our hosts talk with the LGBTQ individuals and how they navigate their identities, relationships and asthma all at the same time.
Zoe Rothblatt 16:10
Definitely check it out at ghlf.org/listen. Well, everyone thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, give us a rating and write a review on Apple Podcasts and definitely check us out on YouTube as well. I’m Zoe Rothblatt.
Steven Newmark 16:29
I’m Steven Newmark. We’ll see you next time.
Narrator 16:32
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation Podcast Network.
S5, Ep 18- Building Better Ancestors with Dr. Mark Rosenberg and Maria Thacker Goethe
The Health Advocates are joined by Dr. Mark Rosenberg and Maria Thacker Goethe to learn about the Building Better Ancestors project, and their work on improving access to affordable care. Dr. Rosenberg and Maria help us understand public health problems, how we can use past learnings as framework to improve our future, and the steps that can lead us to solutions that promote health equity.
“And we’ve taken nine lessons from the eradication of smallpox, that we think make a really useful framework for thinking about diseases, — whether it’s a new pandemic threat, whether it’s a chronic disease, or I think it’s useful even from the perspective of an individual patient,” says Dr. Rosenberg.
S5, Ep 18- Building Better Ancestors with Dr. Mark Rosenberg and Maria Thacker Goethe
Narrator 00:00
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation Podcast Network.
Dr. Mark Rosenberg 00:09
We’ve taken nine lessons from the eradication of smallpox, that we think make a really useful framework for thinking about diseases, whether it’s a new pandemic threat, whether it’s a chronic disease, or I think it’s useful even from the perspective of an individual patient.
Steven Newmark 00:30
Welcome to The Health Advocates, a podcast that breaks down and major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:39
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:43
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:49
Today, we have two special guests with us to talk about their work on the Building Better Ancestors Program Health Equity and Vaccine Access. So listeners please enjoy Dr. Mark Rosenberg and Maria Goethe.
Steven Newmark 01:03
We’re very excited to have with us today Dr. Mark Rosenberg and Maria Thacker Goethe from the Center for Global Health Innovation. So this is a very exciting day for Zoe and me to have these two great guests with us. And before we get into a discussion, I want to just turn it over first to Dr. Rosenberg, to tell us a little about yourself and to Maria as well.
Dr. Mark Rosenberg 01:24
Well, thanks, Steven. I have been very interested in what the patient experience is. I’ve worked in public health, I trained in internal medicine and infectious diseases, and in psychiatry, and spent most of my career working in public health, working on violence prevention, and working on global health issues, large scale diseases that require collaboration, and the collaboration of multiple institutions to try and address these problems.
Zoe Rothblatt 01:55
Thank you so much for all the work that you’ve done, Dr. Rosenberg. And Maria, welcome to The Health Advocates. Can you introduce yourself, please?
Maria Thacker Goethe 02:03
Sure. It’s great to be here. Thanks for inviting us and having the center and of course, Dr. Rosenberg, one of our key community leaders to join us on the podcast. Yes, my name is Maria Thacker Goethe, I’m CEO for the Center for Global Health Innovation. At the core of everything we’ve done for the last almost 17 years now for me, has been around patients, how do we drive innovations and cures and therapies to patients to make them live their best life have access, improved access to care and affordable access to care. And I would say one of the highlights since I took over the organization a few years ago, has been helping to establish one of the only patient advocacy alliances in the southeast. And my role is working with industry and public health leaders is actually bringing them to the table to hear directly from the patient. Beginning this year, I’ll actually be sitting on the governor’s task force for rare diseases, and here in Georgia, and I look forward to being the voice of innovation and industry alongside a number of patient groups for that committee starting this year.
Steven Newmark 03:00
So one of the great things that you guys are working on together is the Building Better Ancestors Project. I wonder, Dr. Rosenberg, if you could tell us a little bit about the impetus for the project and what it is that the project hopes to hopes to learn and hopes to and what it aims to do essentially?
Dr. Mark Rosenberg 03:15
About three years ago, the world celebrated the 40th anniversary of the eradication of smallpox. Smallpox was one of the most devastating diseases ever to hit planet Earth. In the last century alone. In the 20th century, more than 300 million people died from smallpox, and it’s a horrendous, terrifying disease. But in 1980, the World Health Organization declared this disease eradicated. It was the first and only human disease ever wiped off the face of the earth. This was an extraordinary achievement. Really, when you think about the diseases we all live with. Now, this was a terrifying disease that was eradicated. And we thought it would be important to take what are some of the lessons from that success. This was the greatest success, the greatest achievement ever, of global health. We said, Let’s take some of the lessons from that eradication, and see if we can’t use them in fighting future epidemics, future pandemics, and even diseases that we live with every day. Aren’t there some lessons there that would be useful? And so we set about trying to extract the lessons and the things we learned. And we’ve taken nine lessons from the eradication of smallpox, that we think make a really useful framework for thinking about diseases, whether it’s a new pandemic threat, whether it’s a chronic disease, or I think it’s useful even from the perspective of an individual patient. One of the differences between public health and health care is that in public health, you think of everybody who has the disease, the whole population, at risk. In healthcare, you think about the patient who’s in your office right now, that’s your focus. It’s a very important focus. But these are different. And public health is hard. It’s hard to think about how you protect everyone, and how you take everyone into account. And we thought that if we take these nine lessons, it makes it easier to do the work, to see the big picture, to see the problem and understand the problem. And I think these nine lessons are really applicable to an individual dealing with their own illness, and their own disease. I can tell you very quickly what these nine lessons are. The first one is this is a cause and effect world. If you understand the causes, you can change the effects and sciences the way we understand the cause and effect relationship. So it basically says use science to understand your problem. The second lesson is, know the truth, share the truth and act on the truth. Know about this pandemic. Know where it spread, know who’s at risk. Know your enemy. Know the bacteria, know the virus. In terms of an individual’s disease, it means, find out everything you can about your illness, so you can be in charge so you can plot the course. But know the truth. Even if at first you think you can’t stand to know everything. It’s your best course find out, ask the questions know the truth. The third lesson is coalition’s are essential. These problems, whether it be COVID, smallpox, or an individual with severe chronic arthritis, it’s important that we work with other people to solve them. For something like COVID-19 There’s no one individual, there’s no one institution that can solve the problem by themselves. As a patient, we need to form alliances with our care teams, with our families, with our friends, coalition’s are essential. Lesson four is avoid certainty. We don’t know things for certain once and for all, because our knowledge changes, our mind changes. What we need to do to prevent or treat something changes as new things are found out as new treatments and cures, come into being and if you’re certain that you know everything about it. That means you don’t want to learn anything more about this problem. But science evolves things change, avoid certainty. It’s the Achilles heel of science, Lesson five, building evaluation and continuous improvement. We need to evaluate where we are with respect to a disease. And we need to take that information into account and be willing to change course as we go forward. Lesson Six, respect the culture. In global health, a lot of times when we’re working in countries that are foreign to us, we need to understand the culture. We don’t tell people what to do, we work with them. We have to understand their perspective. Even if it’s an individual patient. We need to understand the medical culture. And doctors need to understand us. Lesson number seven, seek strong leadership and management. The best decisions are made with the best science. But the best outcomes really depend on strong leadership and management. Take the help, step up into your disease into your care plan. Help manage what’s going to happen to you. Lesson number eight, mobilize political will. In the world of global health, if you want to get something done, it may involve having the government do it. It may involve having the World Health Organization act. It may involve Congress, but mobilize political will because with it, you can do anything. Without it, almost nothing. And the last lesson, lesson number nine, move towards global health equity. The best solutions move us towards equity and whether it’s the equity of how vaccines are distributed, or whether it’s a public health problem like gun violence. We want to make sure that the people at greatest risk the most vulnerable people get the same attention, have the best chance of fighting this problem as those with the most resources. So those are the nine lessons, I would turn it over to Maria, because she has led some very important work on things like vaccine equity,
10:13
Definitely. And I would add, I’m a patient myself, so I certainly and sit on a patient board and I firmly believe in all these lessons and at the Center for Global Health Innovation the core of our mission is around using innovation to help achieve health equity. And these nine lessons really align with how we operate, and in their integrated in everything we do. Now, all these lessons are crucial to what we do, including the vaccine work we’ve done for the last few years during COVID. And in particular, our work in vaccines has been in getting vaccines to underserveed and vaccine hesitant communities has been one of our biggest efforts during COVID. And also mentioned that how we’re moving I wouldn’t say beyond COVID because we still work in COVID, but how he wants to apply some of the work we’ve been doing to other disease areas is really important. So the center over the last few years has work closely with CDC and other federal agencies to tackle the challenge of talking about vaccines, vaccine hesitation, and building trust. And it has been all around coalition’s. Our project over the last year has actually been the most one of the biggest projects we’ve had and shown us a unique model that we can use to tackle other disease areas. The primary goal of that program is to work in underserved and under vaccinated communities to promote vaccine confidence in COVID-19 vaccine and increased vaccine rates. And to do this, we really leveraged our partner network and our collaborative strategies. So that already speaks to two of the lessons here, including coalition building, as well as management having the proper management to bring together an ecosystem of community health workers, local clinics, health professionals and providers, community based organizations, public health expertise. And by building this coalition and building partnerships, across a diverse set of public private partnerships, we were able to do something that is core to everything we do at the center. And that is work to build trust. We work to have everybody at the table. As we were developing training pathways as we were providing training, we wanted the voice from you know, the person the the academic at Emory and Johns Hopkins. But we also needed to hear from people like Reverend Sheffield, we work with a lot of black churches across the states and understand well what these experts are saying, really resonate with the communities they’re working in and providing parent education into. And by having them there at the front end of this entire process allowed us to build trust, have coalition’s that people believe in. And frankly, now we have the momentum to tackle other things. So really at the core of what we did, we identified and hired over 115 full and part time community health workers across 13 communities in seven states. And through that we’ve been able to mobilize over 75 partner organizations. And we’ve reached over a million people to discuss vaccine hesitancy in just less than six months. Some of it’s through direct intervention through social media, others through community health workers. And really what we’ve done is turn the model on its head, we find community health workers that live and work inside the communities are providing care to, and not all of them are necessarily certified. They go through a training with us and they learn how to deliver care. And the the thing is we’re meeting communities where they’re at. So you know, a nine to five community health worker may not be able to go to a church service or a get together after a church service on a Sunday afternoon because they work Monday through Friday. But us working and identifying community workers that live and work in that faith based area in that particular case, they’re there, they’re at the at the dinners for the community on Saturday, or the soccer game or whatever it might be. The best thing is we’ve had real economic impact into these communities, we’ve created jobs. We pay, of course, the community health workers, we do not come in and say we need you to volunteer for the good of your community. We’re giving you a livable wage for this work. We’ve been able to really tackle a variety of addressed a variety of different social determinants of health through this. And what we’ve seen now is these communities and these community health workers are like, Okay, COVID Great, let’s keep doing that. And now we’re looking to scale this program beyond just vaccine education and training to tackle a lot of these other disease areas. And we’re very excited about, you know, the impact we’re having and the how we’re empowering these communities to take ownership of what of creating the change and and they also learn about these amazing innovations.
Steven Newmark 14:48
Very exciting and we definitely look forward to seeing the public launch of what you’re what you are finding. I’m wondering Maria, if you could tell us or Dr. Rosenberg to both talk about the are the nine key lessons that you describe and and how you think it’s going to impact patients as as the hope is that it develops more in the community, both the healthcare community, as well as the patient community and just the general population.
Dr. Mark Rosenberg 15:16
Good question, Steven. I think that this framework is a way for patients to take control of their health and of their care. And working for many years as a physician and working with patients, I came to understand that being in charge of your own health and your own health care is not easy. It’s kind of like attacking an epidemic or a pandemic, whether it be COVID, or Ebola, or TB, or measles, heart disease, diabetes, it’s not easy. And you need some help, especially since doctors for many, many years didn’t really share information with patients they didn’t. And what patients need, I think, is a framework for understanding everything that can impact their health. And this is a framework that will do it. We have a website called Nine Lessons, the number nine, 9lessons.org. And on that website, anyone can go there. One of the driving forces behind this project was that we wanted to make this information available for free to everyone. The future leaders of patient health and patient care is everybody, everybody who’s a patient. And we may not all think of ourselves as patients yet, but we will be sooner or later we will be. We all spend time in healthcare, we all will spend time in a hospital. And how do we navigate this. So these nine lessons are available for everyone, on 9lessons.org. And there’s a trailer that explains the origins of this project, how it came from, and why it evolved from the lessons of smallpox. Unfortunately, when there’s a pandemic like COVID, everyone gets worked up about it. Everyone at first is scared and frightened. We see pictures of patients on respirators dying in hospitals, overwhelmed doctors and nurses, and healthcare workers. And for a while, but unfortunately, only for a while. We’re all paying attention. We’re doing what we need to do, and we’re learning what we need to learn. But as soon as the big threat passes, we seem to forget the lessons that we learned. And we go back to not investing in developing new vaccines, developing new treatments, informing people as Maria said, it’s really important that people understand and that the doctors and healthcare workers understand the people and where they’re coming from. People are not born with vaccine hesitancy. They’re not born afraid of the hospital. But fear often keeps us back. But these nine lessons, I think, are way to overcome any fears we may have. They’re kinds of clear directions of what we need to take control, whether it’s of a pandemic, or of our own illness. And they’re very useful.
Zoe Rothblatt 18:38
Thank you, Dr. Rosenberg, I, I totally agree. And, Maria, I’ll turn it over to you. What do you hope that people learn and what this will improve for lives of patients and public health generally?
18:49
Well, I really think Mark hit on it all. I think for me, I also hope that it creates some actionable results and efforts. So and that gets around really to who the Center is and what we believe we believe global is local. I think that’s one thing I continue to stress. We have communities that have very poor health impact numbers and health data points. And it’s not just over there. Global is not just over there. We have challenges and southeast southwest Atlanta, we have challenges in Appalachia, we have challenges in a variety of different communities that can be impacted by the work of public health professionals and innovation. My hope is really these lessons are picked up and harnessed by not just future public health leaders and providers, but also innovators. So they understand their piece in the entire puzzle building process here to tackle health inequity. That is what the center was designed to do to really advocate whether that’s through coalition building true policy, educating policymakers and also creating a voice on behalf of public health beyond just other entities. We want to talk about it in our day to day communication. Everything we’re going to do as we move forward, we’ll be tying in these nine lessons. Because coalition building and all the other nine lessons are crucial to everything we do as an organization. And we’ve seen as necessary in order to make change in these communities. So that’s really what our focus is going to be. And that’s how I see these making an impact, at least with the work we’re doing here at the center. But hopefully, also, we’ll be able to elevate the work that many other global health organizations are doing, that many people in the public are unaware of,
Dr. Mark Rosenberg 20:24
I want to leave you with a word about lesson number nine, that the best solutions move us closer to global health equity. And someone I called a brother I was very close to and loved was a tremendous pioneer in the area of global health, named Paul Farmer. And Paul died last year. But one of the things Paul always said is that the source of all evil in this world, is the belief that some lives are worth less than others, the belief that some lives are worth less than others. And it means that if you’re a poor person in a poor country, with a chronic disease, like drug resistant TB, your life is still worth as much as anyone who’s rich from a well developed country. And I think on a personal level, it means that even if we have a disease, or two, or three, that we are just as important as anyone else. Our life is as important as someone who’s not sick at all. If we’re old, our life is as important as someone who’s young, and very healthy. And I think that keeping this in mind, that the best solutions move us towards health equity. You are, we all are, we all are equally important. And I think this notion of taking charge of our health of our health care of our lives and our family. That’s really the core of what these nine lessons are about helping us take charge and move towards becoming better people, becoming better ancestors, and taking what all of us have learned from our experience. And the experience of living with a chronic disease teaches us so much. We learned so much. And this project says take stock of what you’ve learned. And pass it on, pass it on to your children, to your friends, to your family, to the world become a better ancestor. It’s within all of our grasps, it’s within our reach. That’s what it’s about living better lives and passing on what we know, to ensure a better future. So thanks for this chance to talk about these things. We really appreciate what you do and the chance you’re giving us to share our messages.
Steven Newmark 23:15
Yeah. And thank you both for coming on our show and sharing your message and all the work that you’re doing.
Zoe Rothblatt 23:21
Yes, thank you.
23:22
I was just going to close by saying you please go check out the trailer, go to 9lessons.org. These are nine simple, proven and reliable ways to approach global health threats learned from the successful effort to eradicate smallpox. They provide guidance for addressing all sorts of problems from COVID-19 to climate change, structural racism, gender equity, and criminal justice. It really applies to everybody. And it really can be a valuable asset for how you leave your legacy behind.
Zoe Rothblatt 23:51
Thank you both so much for joining us and for all the work that you do to uplift the voices of the community.
Steven Newmark 23:58
That was great hearing from Dr. Rosenberg and Maria. It’s fantastic what the work that they’re doing.
Zoe Rothblatt 24:04
I know so you know, what did you learn today? Give us one there were so many but help pick one out.
Steven Newmark 24:08
I guess my learning is just how many folks are out there doing such great things and to hear about their particular plan in addressing health equity, really eye opening.
Zoe Rothblatt 24:09
And I really loved hearing from Dr. Rosenberg about, you know the value of a life and the importance of each life especially when you’re disabled and have chronic illness that you still matter.
Steven Newmark 24:30
Absolutely. Well, we hope that you will learn something too. And before we go, please make sure you take a listen to Talking Head Pain. New episodes are out. Check it out along with all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 24:43
Well everyone. Thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you like this episode, please give us a rating and write a review on Apple Podcasts. Hit that subscribe button and check out YouTube. I’m Zoe Rothblatt.
Steven Newmark 24:58
I’m Stephen Newmark. See you next time.
Narrator 25:02
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation Podcast Network
S5, Ep 17- The End of the Public Health Emergency: What’s Our COVID Action Plan?
This was a big week for health news. We learned that the U.S. will end the COVID public health emergency in May, Evusheld is no longer authorized by the Food and Drug Administration (FDA) and the FDA is meeting about an annual COVID vaccine strategy. What does this mean for you as someone who lives with chronic illness? The Health Advocates break down the pros, cons, and questions that remain.
“It just is kind of upsetting when you realize how health care can be offered so efficiently and now funds are going to be decreased and barriers are going to be put in place to access these different services. And it’s upsetting to go backwards. And that declaration means we have to go backwards in care,” said Zoe Rothblatt, MPH, Associate Director, Community Outreach.
S5, Ep 17- The End of the Public Health Emergency: What's Our COVID Action Plan?
Narrator 00:00
Be inspired, supported, and empowered. This is the Global Healthy Living Foundation Podcast Network.
Zoe Rothblatt 00:11
It just is kind of upsetting when you realize how health care can be offered so efficiently and now funds are going to be decreased and barriers are going to be put in place to access these different services. And it’s upsetting to go backwards. And that declaration means we have to go backwards in care.
Steven Newmark 00:33
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:42
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:47
Our goal is to help you understand what’s happening in the healthcare world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:54
Hey, speaking about what’s happening in the health care world, a lot has happened since our last episode, Steven.
Steven Newmark 01:00
That’s right, the FDA met to discuss annual COVID shots, we got a COVID-19 Action Plan from the CDC, and we also learned that the COVID public health emergency in the United States will be ending in May.
Zoe Rothblatt 01:11
So let’s break it down for our community what they need to know. And I think we’ll start with the end of the public health emergency, perhaps the biggest news of all.
Steven Newmark 01:20
Yes, for sure. Let’s start there. Earlier this week, President Biden informed Congress that he will end the COVID-19 National Emergency on May 11.
Zoe Rothblatt 01:30
So these are two emergencies that have been extended throughout the pandemic. The first one started at the end of January when Secretary Alex Azar of Health and Human Services declared a public health emergency. And then in March 2020, as you all recall, President Trump declared COVID pandemic a national emergency. And these have just been extended throughout and now it became the final decision to end and stop extending them.
Steven Newmark 01:56
So what is it about this particular week in early February that is leading the White House to make this a declaration?
Zoe Rothblatt 02:04
Republicans in the House have been putting pressure on to end the pandemic, they have the Pandemic is Over Act, which would end the pandemic immediately. And ending something immediately would have serious consequences on our health system and different programs we’ve got throughout the pandemic. So with President Biden stepping in and saying you know it’s going to end on May 11, it gives the system a few months in order to transition slowly.
Steven Newmark 02:31
And what does this mean generally for the public at large? What does it mean to say that the emergency is over as of May 11 is the actual date?
Zoe Rothblatt 02:39
First and foremost, it means that the White House believes our pandemic is in a new phase, one that’s, you know, less of an emergency than it’s been before. What’s interesting to note is that the World Health Organization still has COVID as a global health emergency. I know they did say we’re reaching this sort of inflection point where higher levels of immunity can lower virus related deaths. But you know, we’re still in an emergency according to WHO. So you know, what else does it mean?
Steven Newmark 03:11
Well, specifically here in the United States, it means we have been getting COVID tests and vaccines for free as well as COVID treatments. Now, once the emergency declaration is over, it’s going to depend on your insurance and potentially your state to there may be out of pocket costs for dealing with these issues.
Zoe Rothblatt 03:29
Right. And I was actually thinking, as you said that it may also be harder to find some of these things like for instance, testing. Testing sites have popped up everywhere, especially in New York City. I don’t know how it is now. But I remember, you know, basically, every two blocks, you could find a testing site, and I imagine a bunch of those will shut down now.
Steven Newmark 03:48
Right, that is likely to happen, which to be blunt about it is probably going to have particularly in the short term, an adverse effect, if you will, in the ability to get tested, the ability to obtain vaccines very easily means that they’re more widespread. It’s certainly not going to increase usage of vaccines and increase usage of testing to ensure that folks who are shedding the virus are out there in the public.
Zoe Rothblatt 04:13
One more point on this, are losing these services. But maybe now there’s going to be a little bit more barriers. It just is kind of upsetting when you realize how health care can be offered so efficiently. And now, you know, funds are going to be decreased and barriers are going to be put in place to access these different services. And it’s upsetting to go backwards. And that declaration means we have to go backwards in care.
Steven Newmark 04:41
We should be clear that for our community, for the Global Healthy Living Foundation community, you know, we’ll be watching closely the next three months to see what the transition is like. We’ll certainly be advocating that many of the policies will continue, policies such as the use of telehealth and reimbursement rates for telehealth being commensurate with going in person, such that it’s easy for folks to access their medical providers. Things such as free vaccines, or as much as possible making vaccines as readily available. General promotion of public health we’re gonna keep fighting for. We’re going to continue providing specific COVID support so long as our community needs it.
Zoe Rothblatt 05:17
Amen. An underscore that. The end of the Public Health Emergency does not mean the end of our resources. In fact, I know we talked about these from time to time, we recently did a quick poll to our COVID-19 Patient Support Program to learn more about what do they want to hear from us? What level of community support for COVID do you want. And about 77% want COVID updates from us weekly or twice a month, and then 73% want updates on COVID treatments and vaccines. 70% said they want updates on variants. And then 68% said they want information on how their medical conditions and medications may affect your recovery from COVID. So it’s just interesting to learn this from our community so that we’re able to provide the best resources and learn what our community wants, even as the general public may want something else.
Steven Newmark 06:08
Absolutely, absolutely. So we’ll continue to be a resource and we’ll continue fighting for resources and needs of our community but really public health in the United States.
Zoe Rothblatt 06:18
Yeah, speaking of losing resources, or restricted access, we recently got news that the Food and Drug Administration, the FDA, revised its decision and said that it no longer recommends Evusheld.
Steven Newmark 06:32
Just as a reminder, Evusheld is the preventive treatment for immunocompromised individuals for COVID.
Zoe Rothblatt 06:38
And the reasoning behind this was they said that more than 90% of the COVID cases are from the new variants, and those sub lineages. And data shows that Evusheld isn’t protective against these. So as long as we see these high numbers of the new sub lineages, it’s not going to be recommended to get.
Steven Newmark 06:55
And that’s one of the things I think that we’re going to keep fighting for is the idea of looking for new treatments. I think that’s what we need as we enter this next phase of COVID-19.
Zoe Rothblatt 07:04
You know, we got a lot of messages from our community saying like Evusheld helped me live a normal life and helped me feel protected because I didn’t get enough protection from the vaccine. So you know, we definitely want Evusheld 2.0, whatever that looks like.
Steven Newmark 07:17
Definitely, we need treatments, and we need real push to get proper treatments. So we’ll keep pushing forward on that. If Evusheld is not protective, you know, we don’t want to just give out placebo for no reason, of course, so.
Zoe Rothblatt 07:30
Exactly. It’s a risk benefit analysis. And right now, the benefits don’t outweigh the risks But what we did get was an action plan from the CDC, for people with weakened immune systems. I’m curious for your thoughts. But to me, it felt like more of the same that we’ve been hearing.
Steven Newmark 07:46
I agree. I mean, the outline essentially says get the updated COVID vaccine, like, who doesn’t know that, particularly for those with weakened immune system. Improve ventilation and spend time outdoors. Okay, we’ve been hearing that for almost three years now.
Zoe Rothblatt 07:59
It’s cold that’s not that easy, especially, you know, my aching joints, I don’t want to sit outside in 30 degrees. Thank you.
Steven Newmark 08:06
I know let me go, let me go through the rest of these, you’ll you know, try to refrain from laughing. Learn about testing locations and treatment options before getting exposed or sick. Get tested if you’ve been exposed or have symptoms. Wash your hands often. Wear a well fitting respirator or mask and maintain distance in crowded spaces.
Zoe Rothblatt 08:24
This is what we’ve been hearing since basically 2020. It puts the burden on people with weakened immune systems. The CDC messaging did say like for those in your household too, these things are really important. But it’s just a messaging that says, you know, if you’re the group affected, you have to take action. And it’s not about everybody else, which is really upsetting because there’s just so much burden on people with disabilities already. And now to say like, this is what you have to do in order to stay safe. It’s more of the same. It’s not giving us new answers. So it’s hard for me to formulate thoughts because I just feel like the aching hearts of our community and reading all this news this week,
Steven Newmark 09:04
Just to give a slight positive spin. I guess it formalizes things that we’ve known, which is good, I don’t know.
Zoe Rothblatt 09:10
I guess also, I just thought about, you know, other public health emergencies have ended. And I didn’t look back a few months down the line and said, You know, I really wish that emergency was still here. I didn’t feel the effects. We recently talking about the M-Pox declaration ended and looking back at Zika. Those kinds of things ended and yeah, life went on. And that gives me a better comfort.
Steven Newmark 09:36
No, absolutely. I said, you know, earlier in the podcast, I spoke about the short term effects, the long term effects are likely to be positive. You can’t constantly be in a state of emergency all the time. And it gives some more gravitas in the future should the CDC, should the US generally, need to make another declaration for an emergency for COVID or for another virus. So you know unfortunately, public health as we know, the image has been eroded in recent years living in a constant state of emergency, I think has not helped that. Whereas if we take out the emergency, and then we need to re put it back in at some point, I think we’ll be in a better state long term.
Zoe Rothblatt 10:16
That’s a good way to frame it. Yeah. Thank you, Steven.
Steven Newmark 10:18
Yeah, unfortunately, that doesn’t fit on to a good talking point. A nice talking point. I guess that’s the advantage of being on a podcast, we could talk for about 30 seconds at a time. Let’s move on now and discuss an important meeting that the FDA recently held, where they voted to approve an annual vaccine for COVID, similar to what is done for influenza.
Zoe Rothblatt 10:42
At first, I was wondering why now is this meeting but given all the news, I’m actually so happy that there’s a plan in place for vaccine rollout and that it seems like we’re looking at the strategy going forward, even if an emergencies declaration. So what is this, what did they vote on? Basically, they voted to approve an annual shot like the flu, which would basically say, you know, at this time, you’re eligible. And it might mean two vaccines for immunocompromised, or people that are older. And they also voted, in order to say we should use the bi-vaillant formula going forward. And that you shouldn’t have to start with your primary series and then be eligible. If you just show up, you should be able to get the new formula.
Steven Newmark 11:27
Hopefully, this will be more akin to the flu vaccine. Of course, flu vaccines are not taken by enough of the population as we know, but it at least puts us on a firmer footing, it sets us almost on a path of some regularity when it comes to COVID.
Zoe Rothblatt 11:41
Do you think that we’re at a time where we can look at COVID in that regularity with the waves?
Steven Newmark 11:47
On a positive note, we have had Omicron for over a year now. So there will always be waves. And just like with flu, they’ll always be new variants. Just like with flu, there will be seasons that will be particularly harsh, and others that we hope will be mild, it’s obviously impossible to predict with precision. But the hope is that there’s some level of predictability.
Zoe Rothblatt 12:09
I’m just thinking about how I don’t even think about the flu until the fall comes around. Like it really goes out of my mind in the summer.
Steven Newmark 12:17
Right, it’s much more seasonal.
Zoe Rothblatt 12:19
And I don’t feel like I’ve had that freedom with COVID.
Steven Newmark 12:22
Well, COVID is new, as more people build up some levels of immunity and continue to build some levels of immunity. You know, the hope is it will weaken, there’s a hope that treatments will continue to develop to make it more livable. Like I said, it’s still a new virus, and we’re still adjusting to it. But you know, flu was pretty scary when it first came on the scene in 19, what was it 18, 19.
Zoe Rothblatt 12:45
The original pandemic.
Steven Newmark 12:47
Yeah. Well, the old school, old school virus, yeah, you know, but the hope is, it will not be quite so damaging. I think the scary thing is that is for me, I think back to the early days of 2020, March, April, May, when there was this hope that we would just eradicate COVID, we would stay inside and it would go away. And now it looks like it will be here forever, like the common cold, like the flu. You know, I want to say Man, oh, man, it didn’t have to be this way. But here we are.
Zoe Rothblatt 13:17
I know. Now, you know, we’re almost at March 2023. Three years later, it’s hard to believe even all that time has passed. So I have a question. How would this actually work and getting an annual COVID vaccine, like what happens in predicting the flu shot?
Steven Newmark 13:32
So for the flu scientists at the World Health Organization meet twice a year. For the Northern Hemisphere, the strain decision that they decide to develop a vaccine for is discussed and decided upon in February for a fall vaccine rollout. So essentially look at what’s going on in the southern hemisphere, what’s likely to transpire in the northern hemisphere the following fall.
Zoe Rothblatt 13:52
So that would mean that right now, basically, they’re starting to meet for next year?
Steven Newmark 13:57
Sort of, for COVID-19, the FDA proposed that scientists meet in June for a strain selection for an annual Fall vaccine rollout. The timeline is possible for mRNA vaccines, not for Novavax, that short timeline. So we’re not sure what you know what that what that means exactly.
Zoe Rothblatt 14:14
So what other questions I guess came up that we’re not sure about?
Steven Newmark 14:18
Well, there’s a lot of questions. Let’s start with the first is this just going to be an annual thing or once a year thing? The FDA said winter is when the stress is on the hospital systems, most because of other respiratory viruses. We want to concentrate on getting people as prepped as possible for the winter rush. The FDA also said it seems seasonal patterns. I’m not sure how true that is. But but that’s what they’re saying. There’s a worry that that gives the impression that people only need to worry about COVID during the winter when we know the need is to be concerned at all times.
Zoe Rothblatt 14:47
Yeah, especially for people with weakened immune systems. It’s constantly on our minds. Absolutely. Even if it’s not, you constantly need to be in touch with your doctor and have a plan just in case. It’s not like only in the winter, could this happen.
Steven Newmark 15:03
Absolutely. You know, and just to be clear, look, the FDA is looking to do this annually for now. But that doesn’t necessarily mean it’s set in stone, they, you know, always evaluate and reevaluate, we really just have no idea what the long term plan is going to look like.
Zoe Rothblatt 15:19
Ultimately, I want to move forward and the FDA is looking at data, they’re, of course, much smarter than I am. I guess, with each phase in the pandemic, I always feel like a bit of apprehension going into it, and then I nestle into it. So I, I hope this could be like that. What’s happening with the rest of the world, though?
Steven Newmark 15:36
Well, the WHO provides universal annual recommendations for the flu vaccine, however, many are concerned that the US is going to dictate what is best because this is where the majority of the pharmaceutical industry is located, we have the most buying power. So as the United States goes, the rest of the world may follow. So if we go to an annual plan that may end up becoming harmonized worldwide.
Zoe Rothblatt 15:59
Yeah. It sounds like there’s a lot of discussions being had, unanswered questions. The committee that met, the FDA doesn’t have to take their recommendation, although they usually do. I’m pretty sure they stamp their unanimous vote on using the bi-vaillant formula, but it’s still up in the air about whether we’ll get annual vaccines
Steven Newmark 16:18
Bottom line, it sounds like in the future, we will get an updated COVID-19 vaccines maybe on an annual basis, maybe a booster for some folks like older adults, but not others. But if we use the flu model for COVID, we’re looking at an annual seasonal vaccine.
Zoe Rothblatt 16:34
Okay, Steven, I think that brings us to the close of our show what’d you learn about today?
Steven Newmark 16:39
I learned a lot. There’s too much in my brain right now. Ultimately, just having this discussion, I see the positives and negatives. And also just the tension sometimes between individuals health needs and the populations health needs. And sometimes what’s best for the population at large is not necessarily best for you as an individual. So you as an individual may need to take greater precautions when it comes to dealing with COVID. Still, and it would probably be best for you as an individual if the entire world did the same. But in terms of world population health, you squeeze too tightly and demand too much of people and it could have a negative effect ultimately, as people push back. So you have folks who work in public health, population health, and have a really difficult job in assessing how best to address public health needs.
Zoe Rothblatt 17:27
Well said. Along similar lines, I learned that you know COVID and handling these public health emergencies or situations is an ongoing learning. And it’s important to use our tactics and strategies from the past in order to formulate a plan for the future. But again, it’s unknown and this is why we have experts to continue learning and we’ll keep talking about it so long as it matters.
Steven Newmark 17:50
We hope that you learn something too. Before we go. I hope that you’ll listen to Zoe on Healthcare Matters where she discussed her work with biosimilars.
Zoe Rothblatt 18:00
Yeah, thanks, Steven. It was really fun to join our colleagues over there and Biosimilars are becoming more popular now in 2023. So definitely have a listen. And thank you, our listeners to listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, give us a rating and write a review on Apple Podcasts. Hit that subscribe button and check us out on YouTube. I’m ZOE Rock. We’ll see you next
Narrator 18:28
time. Be inspired, supported, and empowered. This is the Global Healthy Living Foundation Podcast Network.
S5, Ep 16- Vaccine Update: From the Lag in COVID-19 Bivalent Booster Uptake to a Future RSV Vaccine
The Health Advocates discuss the reasons behind lagging vaccination rates for the COVID-19 bivalent booster in the United States, new vaccines on the horizon for RSV, and strategies that can help improve immunization rates.
“The ability for pharmacists to deliver and provide vaccines is important. It’s much easier to go to a pharmacy. Oftentimes you don’t need an appointment. It’s not as scary, you know, for anything else as going to a doctor’s office. It’s not as intimidating,” says Steven Newmark, Director of Policy at GHLF. “And now they’re also able to provide COVID vaccines, and in some jurisdictions, they’re even able to provide routine immunizations as well. So that definitely helps.”
S5, Ep 16- Vaccine Update: From the Lag in COVID-19 Bivalent Booster Uptake to a Future RSV Vaccine
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
“The ability for pharmacists to deliver and provide vaccines is important. It’s much easier to go to a pharmacy. Oftentimes you don’t need an appointment. It’s not as scary, you know, for anything else as going to a doctor’s office. It’s not as intimidating. And now they’re also able to provide COVID vaccines, and in some jurisdictions, they’re even able to provide routine immunizations as well. So that definitely helps. That definitely helps.”
Steven Newmark 00:34
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:43
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:48
Our goal is to help you understand what’s happening in the health care world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:54
So Steven, today we’re going to talk about vaccines. Where we stand with COVID vaccination rates, new vaccines on the horizon and just vaccine strategy overall in the United States.
Steven Newmark 01:04
Great. Well, let’s start with the COVID bivalent booster.
Zoe Rothblatt 01:09
Okay, so… you know, thinking about when this was first authorized and available to us, that was around the end of August of 2022. It got the emergency use authorization, and it became available in September, both the Pfizer and Moderna formulations for adults in the U.S., is that right?
Steven Newmark 01:28
That’s correct. In early October 2022, it was authorized for kids 5 to 17. Depending on the vaccine, Pfizer is a 5 to 11, and Moderna is 6 through 17. And in early December, emergency youth authorization was updated to include children as young as 6 months and older.
Zoe Rothblatt 01:44
So from August to December, all the groups got availability to this new booster and where do we stand now is the big question. What are vaccine rates if every U.S. citizen is eligible for this vaccine?
Steven Newmark 01:58
Well, as of today, only 15.3% of Americans have gotten an updated booster. That’s pretty low.
Zoe Rothblatt 02:04
Wow.
Steven Newmark 02:05
15.3% I’ll say it again. Yeah.
Zoe Rothblatt 02:07
That’s really shocking. Actually, I expected it to be a bit higher.
Steven Newmark 02:11
I know particularly with all of the announcements that you see about the importance of getting vaccinated in winter season leading up to winter season in November and December. There were so many announcements: get vaccinated, get vaccinated! It’s still relatively easy to find a vaccination site, it’s still free. So it is definitely surprising to say the least. There is no doubt that it is the easiest way to protect yourself, is by getting the updated bivalent booster, but here we are 15.3% of us have gotten it.
Zoe Rothblatt 02:41
So why is it so low I guess is the biggest question. And I found a study online that could help us understand this low rate of the bivalent booster compared to the other COVID vaccines. So this was published by the Centers for Disease Control and Prevention and their MMWR. So Morbidity and Mortality Weekly Report and it was about reasons for receiving or not receiving the booster. And what’s interesting is that all of the respondents of the survey had at least two doses of the COVID vaccine. So we’re not talking about a group that was against the vaccine. These are people that got their primary series. Okay, so Steven, the study found that the common reasons for not getting a bivalent booster were; number one lack of awareness about eligibility or vaccine availability, and then also over estimations of their own existing immunity. Whether you know, it’d be from previous vaccines or infections. And I thought that was really interesting.
Steven Newmark 03:42
That is really interesting. I mean, I sort of can understand the second one; the idea of overestimating your own immunity: I’m fine, I’ll be okay, I don’t need this. But the lack of awareness about eligibility or vaccine availability is so high, it boggles my mind. And I guess it sort of shows that we live in a little bit of a bubble, because to my mind, I see notices everywhere, they find me every time I go online. Those are the pop up ads about getting boosted. And you know, the idea that people still don’t know that is very surprising.
Zoe Rothblatt 04:13
You know, I went home to New York, New Jersey a few weeks ago, and I did notice a lot more signage about COVID compared to here in Nashville, there’s really nothing. you know, you go into a pharmacy, of course, there are signs about shots available here. But it’s not broadcasted, like we don’t have a subway system, for example. And that’s where a lot of signs are in New York. And it was like coming home and feeling comforted: Oh, yeah. Here’s my bubble. Here’s my people with my messaging. But I guess it’s hard to understand that people don’t know. But I also understand at the same time, because I see that we’re not getting the right messaging out in other parts of the country.
Steven Newmark 04:52
Yeah. So it’s interesting. I’m going to assume that that study did not break it down by geographical region.
Zoe Rothblatt 04:58
I don’t know.
Steven Newmark 04:59
Okay. Well, fair enough. We don’t We certainly don’t have the data for geographic region. But beyond that, what are the thoughts? What thoughts do you have if I may ask Zoe? Putting you on the spot, what thoughts do you have for better educating folks about the availability of these vaccines? The fact that number one, they are available. Number two, you are eligible if you have not gotten a fourth dose, that means you.
Zoe Rothblatt 05:20
Yeah, I think it’s about meeting people where they are.
Steven Newmark 05:23
Right.
Zoe Rothblatt 05:23
So you know, what are people doing everyday, they’re going to the grocery store, they’re dropping their kids off at school, like just… so they’re carpooling, they’re driving on highways, maybe signage there. I think that we have to reconsider where we’re putting messages that we’re meeting people in their everyday life and not creating an extra burden. Because often, like health care can feel like a burden. Especially for people with chronic illness. But I think it’s just about getting the right messaging out in the right places. And interestingly enough, this survey found that for participants that were given more information on eligibility and availability, 67.8% of those that hadn’t gotten their boosters said they would get one. And then a survey one month later showed that 28.6% had actually done so. So you know, giving information works.
Steven Newmark 06:13
Yeah, absolutely. I totally agree with that. I guess, like you said, it’s meeting people where they are. I mean, there was a time when you couldn’t walk three blocks in a major city without seeing a vaccine. Now, you know, to some extent, you have to seek it out a little bit more affirmatively now, by going to a pharmacy. You know, without diving deep into these numbers. I’m less concerned about chronically ill folks who probably have the right information, at least when it comes to knowing the availability of vaccines, and more concerned about the general public. I’m hoping that the chronically ill community is aware of what’s available and their eligibility. But of course, it is important for the chronically ill individuals that a large swath of the population also gets vaccinated to help control the virus and the spread of the virus.
Zoe Rothblatt 06:55
Exactly. I mean, we can dive so deep on that on the concept of herd immunity, that we thought we could get there with COVID but haven’t, but it’s still does matter that those around you are vaccinated. And then Steven, just really quickly, you know, something else that helps with vaccination rates is pharmacists ability to give vaccines and I wanted to give a shout out to our colleagues, Conner and Robert, on Healthcare Matters. They recently did an episode on this topic, on a report looking at the pharmacists’ role in immunization. And overall, they found that since the pandemic, adult patients were getting vaccines at pharmacies, and just general vaccines, and how important of an access point this is.
Steven Newmark 07:35
Yeah, absolutely, the ability for pharmacists to deliver and provide vaccines is important. As you said, it’s much easier to go to a pharmacy. Oftentimes you don’t need an appointment. You can just walk in. It takes a few minutes. It’s not as, it’s not as scary, you know, for anything else as into a doctor’s office, it’s not as intimidating. And it’s been many years throughout the country where pharmacists have been able to provide flu vaccines. And in the United States now, they’re also able to provide COVID vaccines, of course, and in some jurisdictions, they’re even able to provide routine immunizations as well. So that definitely helps. That definitely helps.
Zoe Rothblatt 08:12
You know, thinking about the COVID vaccines in the low rate, you know, experts are looking in strategy going forward about vaccine timelines. And our recording is before this meeting, but the FDA is considering a shift in the COVID strategy. Because currently, people… I actually just learned this. So currently, people want to get fully vaccinated against COVID, you have to first get your primary vaccines. So those first two shots spaced weeks apart, and then two months later, you’re eligible for the booster. So you can’t just walk into a pharmacy and say, I want the COVID booster if you haven’t got the original series, which has a bit of a disadvantage, because that’s updated to combat the current variants. So now the FDA is gathering to discuss whether or not it should just be similar to an annual flu shot where you don’t have to have this previous injections in order to be eligible for the current shot.
Steven Newmark 09:05
Right. And so that would obviously be a big help. So we’ll see… we’ll see what happens with that.
Zoe Rothblatt 09:09
So you know, what does that mean for immunocompromised? Well, there aren’t guidelines yet. This is just the initial thoughts and a meeting. It says that the FDA would recommend two annual doses of the shot and I was just thinking how it’s kind of annoying for people with chronic illness to have to do two shots because you know, myself like many had to hold my regular injections that treat my arthritis and Crohn’s for the COVID shot, so, you know, doing that twice is like a huge setback in health and…
Steven Newmark 09:40
Yeah.
Zoe Rothblatt 09:40
I know for the flu shot, I get a higher dose with my rheumatologist and I guess you know if anyone’s listening from the FDA, we would like a higher dose so we don’t have to go in twice and skip our meds twice because it’s just you know, a lot of considerations on your body.
Steven Newmark 09:56
That’s true. I’m just thinking out loud. I do wonder if some of that happens to be because having two doses is more effective than getting one stronger dose? I don’t know the answer to that. But I’m just positing that as potential, as well as the side effects of a much stronger dose of COVID vaccine versus a stronger dose of flu vaccine could be more impactful, shall we say, in the 24 hours after receiving it. Just a guess, or just a potential answer. But yes, obviously, getting one vaccine is better than getting two, and simpler.
Zoe Rothblatt 10:25
Yeah. So I mean, we’ll wait to hear the guidance. That’s all really good points. And obviously, I just want to do what’s best and gonna be the most helpful, but it’s just a bunch of considerations. Other things experts are grappling with, as this meeting comes up, you know; is it too soon to rely on annual boosters? Is targeting new variants, the most effective way to combat COVID? A bunch of questions like that.
Steven Newmark 10:48
Yeah. So we’ll see what the FDA does. And we’ll see where we go from there. And we’ll report what we learn as always.
Zoe Rothblatt 10:54
So you know, we covered COVID and flu. Now let’s turn to the other… the third link in our tripledemic: RSV.
Steven Newmark 11:02
Well, yeah, there is no vaccine to prevent RSV. There is a medication that can help protect some babies that are at high risk for severe RSV disease. It’s very costly and requires a monthly injection. But there is another medicine in development for infants that would last for an entire season.
Zoe Rothblatt 11:18
That’s great to hear that there’s something in development. And I think there’s also a bunch of vaccines in development for RSV in both elderly and infant populations.
Steven Newmark 11:28
And Moderna and Pfizer, as we know, produced the COVID vaccine in record times, shaving years off the traditional vaccine research and approval process. And now the same expedited timeline is occurring for RSV in both elderly and infant populations.
Zoe Rothblatt 11:41
So the vaccines, I know for infants, it’s focused on pregnant women to protect their infants by transferring antibodies in utero, which is pretty cool. Actually, one of my friends got the COVID vaccine, in I think the third trimester and her baby was born with protections against COVID. So you know, it’s just really cool that we’re able to do that.
Steven Newmark 11:59
Yeah, absolutely. So we’ll see what happens. Hopefully, we’ll get some development on this, particularly for the elderly population and those with young children.
Zoe Rothblatt 12:08
And I haven’t seen any talk about a vaccine for RSV for immunocompromised, but we could probably expect that next, right, since they’re focused on high risk groups. So we’ll definitely keep our community updated.
Steven Newmark 12:20
For sure.
Zoe Rothblatt 12:22
All right, Steven, that brings us to the close of our show. What did you learn today?
Steven Newmark 12:26
Well, I was definitely surprised when you told me that the top reasons for folks not getting their bivalent boosters is because they’re not aware that they’re eligible, number one. And number two, that they… they’re just not aware about the vaccine generally. It was just surprising. I can’t believe with all of the information that’s out there. It just goes to show you how difficult it is to break through with important information.
Zoe Rothblatt 12:50
For me to. I was so shocked by that 15% have gotten the bivalent booster, especially because it came before the holidays, I really expected that number to be higher.
Steven Newmark 13:02
Well, we hope that you learned something too. And before we go, we definitely want to give a shout out to Healthcare Matters and our colleagues, Conner and Robert. They recently did a deep dive episode into the report on pharmacists role and immunization that we spoke about earlier. You can check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 13:19
Well, everyone thanks for listening to The Health Advocates a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating and write a review on Apple Podcasts and check us out on YouTube. I’m Zoe Rothblatt.
Steven Newmark 13:33
I’m Steven Newmark. We’ll see you next time.
Narrator 13:39
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
S5, Ep 15- Clinical Trials and Management of Chronic Pain Conditions: The Importance of Representation
In this episode, our hosts are joined by Dr. Titilola Falasinnu, Assistant Professor at the Stanford School of Medicine, epidemiologist, and pain scientist. Dr. Falasinnu shares about the importance of increasing diversity in lupus clinical trials, her research supporting the experience of patients with chronic pain, and the need to address the unique needs of autoimmune patients.
“We urgently need guidelines for the management of chronic pain… to address the individual needs of the patients from a biopsychosocial perspective, which is where the physical and emotional well-being of the patients are prioritized. So this requires an interdisciplinary approach where multiple specialties work in concert with rheumatologists to address the complex needs of patients with chronic pain conditions,” says Dr. Falasinnu.
Clinical Trials and Management of Chronic Pain Conditions: The Importance of Representation
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Dr. Lola Falassinu 00:08
“We also urgently need guidelines for the management of chronic pain in these conditions to address the individual needs of the patients from a biopsychosocial perspective, which is where the physical and emotional well-being of the patients are prioritized. So this requires an interdisciplinary approach where multiple specialties work in concert with rheumatologists to address the complex needs of patients with chronic pain conditions.”
Steven Newmark 00:32
Welcome to The Health Advocates a podcast that breaks down major health news of the week to help me make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:41
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:46
Our goal is to help you understand what’s happening in the health care world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:52
Steven, today I’m excited for you to hear the interview I had with Dr. Lola Falasinnu. We talked about the importance of representation of racial minorities, specifically in lupus clinical trials, her research on chronic pain and rheumatic disease, and the value of health advocacy.
Steven Newmark 01:09
Great, I’m excited to listen. But first we have some news updates.
Zoe Rothblatt 01:13
Okay, what’s our first update?
Steven Newmark 01:15
Well, 2022 was a record high year for Affordable Care Act enrollment, also known as Obamacare.
Zoe Rothblatt 01:22
That’s really exciting.
Steven Newmark 01:23
Yeah, open enrollment just ended and close to 16 million people have enrolled in the health insurance platform.
Zoe Rothblatt 01:29
And I think one of the main reasons for that is the increased subsidies, right? These were first put into effect in the Stimulus Bill during COVID, and they were extended in the Inflation Reduction Act, which we did a whole episode on. So it’s really exciting to see it come to life.
Steven Newmark 01:45
Yeah, absolutely. Basically, the subsidies help people pay part or even in some cases, all of their monthly premium.
Zoe Rothblatt 01:51
And we know how costly that can be, you know…
Steven Newmark 01:54
Yup…
Zoe Rothblatt 01:55
But health insurance is so important, especially when you have chronic disease. Like it’s literally a lifeline to getting care. So it’s good to see that Americans are enrolling.
Steven Newmark 02:05
Absolutely. Absolutely. Also following up from our recent episode we did on COVID policy in China, the CDC is expanding airport screening here in the United States.
Zoe Rothblatt 02:14
Yes. So you know, as China moves away from the zero COVID policy, there’s concern over outbreaks, and especially over a new variant and the US is being watchful.
Steven Newmark 02:24
Yeah, as of our recording all passengers two years old and older, originating from China will be required to get a COVID test no more than two days before their departure, regardless of their vaccine status.
Zoe Rothblatt 02:36
Okay, well, it’s good to see the CDC coming out and making some rules. I feel like we haven’t got updated rules from the CDC in a while, so it feels comforting to see that they’re watching this.
Steven Newmark 02:48
Yeah, hopefully it’ll help stem some of the flow and, you know, help us ward off or at least minimize a great influx of some super new variants, but we’ll see. We’ll see what happens.
Zoe Rothblatt 02:58
We’ll see. Alright, Steven. Well, that brings us to the interview portion of our episode. Like I mentioned, I spoke with Dr. Lola Falasinnu. Dr. Falasinnu is assistant professor at Stanford School of Medicine. She’s an epidemiologist, and pain scientist. Her current research interests are focused on developing best practices for adapting electronic health records for use and epidemiological inference in rheumatology with an emphasis on pain, disability and function. Dr. Falasinnu is also an expert in outcomes research and she identifies as Nigerian Canadian and is passionate about increasing the representation of patient and clinician voices impacted by rheumatic diseases in Sub-Saharan Africa. Well, thank you so much for joining us on The Health Advocates. Welcome.
Dr. Lola Falassinu 03:42
Thank you so much.
Zoe Rothblatt 03:43
So why don’t you start by telling me in our audience, you know about yourself, what led you to your research at Stanford, and we talked a little bit in your intro about what you’re working emcompasses now, but maybe you could elaborate for us.
Dr. Lola Falassinu 03:56
So I’m a classically trained epidemiologist. I started off my career after my Master’s Degree in Epidemiology and Public Health Surveillance. I helped coordinate the integration of an electronic HIV registry in health departments in Washington, D.C.. My Doctoral Degree is from the University of British Columbia in Canada, where I also conducted surveillance work at the British Columbia Center for Disease Control. During my PhD I also worked at the World Health Organization where I helped develop policies to guide the adoption of electronic health records in resource limited countries. I also identify as a social epidemiologist. So my PhD involves the development and validation of clinical prediction models and their integration into electronic health records. So during my PhD, I gained an appreciation for sex and gender research, particularly how clinical and structural interventions can best be implemented and adapted to promote health on a population level. And this directly led me to join in Dr. Julia Simard’s Lab at Stanford as a postdoctoral fellow with a broad interest in lupus research. So my current research interests can be condensed into three very broad areas. First, I’m interested in developing tools to study the epidemiology of pain in the general population and also in rheumatology. Second, I’m also interested in explicating the mechanisms of race, ethnic and gender disparities in rheumatology. And finally, I also studied ways to increase ancestral and gender diversity in rheumatology trials.
Zoe Rothblatt 05:25
So going back to your focus, you mentioned that you’re focused on rheumatic disease. Can you talk a little bit about what drew you into this field and why that focus specifically, I know a lot of our listeners live with arthritis so I’m sure they’re excited to hear that you’re doing so much great work in this field.
Dr. Lola Falassinu 05:41
So I am primarily a lupus researcher, but I’m also interested in autoimmune rheumatic diseases. Lupus is a systemic autoimmune disease that disproportionately affects women of childbearing age or women of reproductive age. And lupus has a predilection for racial minorities. So Black, Hispanic, and Asian women have higher risk. My journey to becoming a lupus researcher stems from my experience of losing a very good friend to lupus. During that time, one other friend and a close family member were also diagnosed with lupus. All of them were Black women. So I channeled the helplessness I felt at that time, and this was like a huge inflection point in my life, and I decided to redirect my skills into doing research that will ultimately reduce the pain and suffering in lupus.
Zoe Rothblatt 06:24
I think a lot of our listeners can relate to that and myself as well. I live with two autoimmune diseases and I think whether it’s yourself or someone around you that’s living with these conditions, or, you know, like you mentioned, you lost someone really, you can take that pain and turn it into purpose. So I’m excited to learn from you. Let’s dive into some of the research. You talked about diversity in clinical trials and just diversity in this research in general, why is that important? And what can we do to improve it?
Dr. Lola Falassinu 06:53
So in 2016, we did a review of the representation of racial minorities in lupus trials. We estimated that black patients comprise about 43% of lupus patients in the United States. However, black patients comprise only 14% of trial participants in lupus and black representation actually dropped during the study period from 20% in an earlier time period to 10%, between 2012 and 2017, making this the only race group whose representation had decreased during that time period. So we replicated that study in rheumatoid arthritis and also found under representation of racial minorities and trials. So in that study, we found that black participants represented only 3% of rheumatoid arthritis trials, which was significantly lower than the representation of black people in US census. So the issues of the lack of diversity in clinical trials is not unique to rheumatology. We see it in cancer and cardiovascular disease trials as well. So there are some very important points to consider. For example, the inclusion of race ethnic minorities in trials adds complexity and cost. This includes translation services, transportation and restitution of lost wages. So I usually ask 3 questions when I’m thinking about this line of research. First, are clinicians actively approaching minoritized patients and if we find that they’re not then there are measures and training programs to reduce implicit bias. And the second question usually is: Are minoritized patients refusing to participate in trials when approached, and issues of medical mistrust can be mitigated by having a more diverse trial workforce. And finally, I always ask whether the inclusion or exclusion criteria unintentionally limit the inclusion of race ethnic minorities. For example, black patients have more severe phenotypes of lupus. So are inclusion and exclusion criteria including only milder disease and excluding black patients? And I also think of the following solution. So we need to acknowledge the uniqueness of the lupus patient group. They tend to be very young women who are grappling with their mortality, and they’re also dealing with other life stressors, so they are dealing with schoolwork and relationships. So how can we adapt the traditional trial recruitment framework while acknowledging the challenge of engaging this patient group. First there needs to be very detailed plans to engage women and minoritized patients very early in the development of research questions, so that these questions are relevant to patients across disease severity and subtypes. Second, there needs to be plans to enroll diverse patients in pharmacogenomic and pharmacokinetic studies. And third, within the context of trials, diverse patient perspectives need to be considered in terms of meaningful endpoints and patient reported outcomes. Finally, there needs to be plans to conduct post market surveillance to get a sense of how the drugs are working in different patient groups in which there are minorities and pregnant women. And finally let’s talk logistics. We recently looked at the reasons why black women with lupus enrolled and finish the trial. We found that older women those who are disabled or unemployed, and those with few children in their households, were the most likely to enroll and stay in the trial. In fact, for each additional child in a woman’s household, our odds of staying in the study reduced by 22%. So remember, I mentioned that lupus affects women of reproductive age, or women of childbearing age, life which children can be very busy and schedules of parents may not permit the addition of a clinical trial. I’ve been there. Trials need to improve participation among those with children by making provision for childcare, either on site or through reimbursements with child care services.
Zoe Rothblatt 10:10
From what I’m hearing from you, there are so many stakeholders involved. You started by outlining solutions in the doctor’s office, what physicians can do, then talking about how patients can get involved, then things like post market surveillance, which is a whole other group involved in that. And you know, not only are all the stakeholders, but like you just mentioned, we need to look at the patient as a whole. You can’t just say, okay, here’s a lupus patient, put them in the trial, there are things going on. You mentioned school, work, if there’s a family, and I think that’s so important, because when you live with a chronic disease, that’s just one part of your life. And it may be a really big part, but there’s all these other pieces that you need to advocate for yourself in order to be well, there’s so much more to your health than just the one piece. I’d like to switch gears a little bit and talk about your research on chronic pain. Can you tell us about the study that you worked on and why the findings are important for patients?
Dr. Lola Falassinu 11:04
So people with autoimmune rheumatic diseases such as lupus and rheumatoid arthritis and psoriatic arthritis face many health challenges. This includes unpredictable disease flares and organ damage. Chronic pain often compounds these challenges and often takes many forms including arthritis, headaches and abdominal pain for example. Scientists and clinicians do not fully understand the mechanisms that cause pain and autoimmune rheumatic diseases but we know that pain is one of the most under-addressed complaints in patients with rheumatic diseases. Pain researchers identified about 11 conditions that they named chronic overlapping conditions. These include fibromyalgia, irritable bowel syndrome and chronic low back pain. In the general population, as the number of chronic overlapping pain conditions increases in a patient so does the a likelihood of disability and psychological problems. Chronic overlapping pain conditions are also associated with fatigue, mood, and sleep disturbances. So in this study, our goal was to estimate the burden of chronic overlapping pain conditions in patients with autoimmune rheumatic diseases. So this knowledge can be foundational in developing more effective management options for chronic pain in patients with autoimmune rheumatic diseases and improve their quality of life and function. So we looked at electronic health records of 6,000 patients with five autoimmune rheumatic diseases: psoriatic arthritis, rheumatoid arthritis, lupus, sjogrens syndrome and systemic sclerosis. So between 36 to 62% of patients in the study had chronic overlapping pain condition diagnosis. The most common chronic overlapping pain condition was chronic low back pain followed by migraine and also fibromyalgia. We found higher prevalence among black patients and those using public insurance and also found that patients with one or more chronic overlapping pain condition were more likely to report depression and anxiety and they also had more frequent emergency department visits, surgeries and hospitalizations. So this finding suggests that chronic overlapping pain conditions are strikingly common among patients with rheumatic disease and are associated with lower quality of life and greater health care needs. So what does this mean? We need better chronic pain treatment options. We also urgently need guidelines for the management of chronic pain in these conditions to address the individual needs of the patients from a biopsychosocial perspective, which is where the physical and emotional well being of the patients are prioritized. So this requires an interdisciplinary approach where multiple specialties work in concert with rheumatologists to address the complex needs of patients with chronic pain conditions.
Zoe Rothblatt 13:28
A common thread that I’m seeing in your research is just, you know, looking at the patient as a whole, involving all stakeholders, like it really isn’t on one person to figure this out. As a patient, you’re not alone. There’s other people in your care and I so appreciate that your research is looking at the physical, the mental, the lifestyle, there’s not a lot of research out there that patients can point to and say: “that’s me”, especially when you say that there’s a lack of diversity in clinical trials and just research in general and the fact that you’re paying attention to black voices, so that people can see that research and identify with it is so important. So thank you so much for all that you do. Okay, the last question I want to ask you is what does health and patient advocacy mean to you?
Dr. Lola Falassinu 14:10
So this is such a good question, and it strikes at the heart of the issue of reflexivity. And in research, reflexivity means examining one’s own beliefs, judgments and practices during the research process and how these may influence the research. So I’m a black woman doing research in rheumatology. As I mentioned before, my experience with friends and family living with lupus tends to intentionally or unintentionally show up in the research questions that I pursue. So first, we cannot talk about lupus without talking about sex and the biological significance of sex. However, much less of the conversation is focused on the issue of gender as a constructing risk, morbidity and mortality in lupus and actually in any chronic disease. For example, lupus is an unrecognized leading cause of death in young women in the United States. It is a top five cause of death in 15 to 24 year old Black and Hispanic women. But we do not talk about the psychosocial burden of these young women contemplating their mortality at such a young age. They are often dying of diseases that most people die of at much older age groups. Then there’s the issue of life interruptions. Imagine being a young woman diagnosed with lupus in the middle of say, getting a degree. It’s usually a crescendo of symptoms, and then they finally get a diagnosis. So let’s remember that most people are sickest around the time of diagnosis. So what happens to their dreams of having a partner or children, holding down a job, the achievements that we often take for granted are often out of reach for many lupus patients and this is the same in many chronic diseases, too. And then there’s the issue of social isolation. There are gender disparities in the rate of partner abandonment in chronic disease. For example, in multiple sclerosis, there’s a six fold increase in the risk of divorce after diagnosis when a female spouse is afflicted with multiple sclerosis to when if their spouse is afflicted with multiple sclerosis. So we need longitudinal assessments of social transitions in lupus patients. So how are individual social trajectories unfolding in response to chronic disease to lupus burden for example. So we need interventions to improve resilience coping and medication adherence in patients with lupus. So these are usually like the questions that guide my research priorities.
Zoe Rothblatt 16:25
Well, thank you so much for all you do and for sharing with us today. We really appreciate your time.
Dr. Lola Falassinu 16:31
Thank you for having me.
Steven Newmark 16:33
Yeah, thank you, Dr. Falasinnu and thank you, Zoe. That was a great interview.
Zoe Rothblatt 16:37
Thanks, Steven. I’m so glad you enjoyed it. And may I ask what did you learn today?
Steven Newmark 16:41
Well, you know, I learned… I thought it was fascinating to hear from somebody who has the disciplines of pain management and epidemiology and the interplay between the two. So it was great to hear that interview with Dr. Falasinnu.
Zoe Rothblatt 16:52
Agreed. It was so important to hear from her about, you know, the patient experience and really highlighting that minority groups in order to provide the right care.
Steven Newmark 17:03
Yeah, we hope that you learned something too. And before we go, we definitely want to give a shout out to our colleague Joe Coe who hosts Talking Head Pain where he speaks with people living with migraine and headache about their journey. You can check out all of our podcasts at ghlf.org/listen.
Zoe Rothblatt 17:18
Well, everyone thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, please give us a rating and write a positive review on Apple Podcasts. Subscribe and check us out on YouTube. I’m Zoe Rothblatt.
Steven Newmark 17:34
I’m Steven Newmark. We’ll see you next time.
Narrator 17:39
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
S5, Ep 14- RSV, Flu, and COVID: A Look at Today’s “Tripledemic”
As we start the new year with a “tripledemic” from the combined threat of RSV, flu, and COVID-19, there’s both a sense of hope and concern. There’s hope that flu and RSV surges are now declining after a peak earlier in the season and there’s concern among the immunocompromised community that the general public has moved on and are no longer taking COVID-19 safety precautions.
“It’s January. January is a time when viruses tend to promulgate. We’re certainly in the midst of another wave when it comes to COVID, and if you want to stay safe, you’re going to have to keep a mask on. A nice, good, tight-fitting mask, whenever you’re in public,” says Steven Newmark, Director of Policy at GHLF. “And, unfortunately, there aren’t too many other ways to mitigate [risk] in our society.”
RSV, Flu, and COVID: A Look at Today's “Tripledemic”
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:06
“It’s January. January is a time when viruses tend to promulgate. We’re certainly in the midst of another wave when it comes to COVID, and if you want to stay safe, you’re going to have to keep a mask on. A nice, good, tight-fitting mask, whenever you’re in public. And unfortunately, there aren’t too many other ways to mitigate in our society.
Steven Newmark 00:30
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:39
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:44
Our goal is to help you understand what’s happening in the health care world to help you make informed decisions to live your best life. Today, we will talk about the state of the pandemic and other respiratory diseases going around as well as what to expect for Health Policy in 2023.
Zoe Rothblatt 00:59
2023, that’s right! Happy New Year Steven!
Steven Newmark 01:02
Happy New Year! We hope all of our listeners had a restful holiday. How was your holiday Zoe?
Zoe Rothblatt 01:07
You know, it was really great. In the beginning, I went on a mini road trip. So I saw a bunch of southern cities. It was so fun. Unfortunately, on that road trip, I did catch COVID…
Steven Newmark 01:18
Who invited that guest along for the trip, man?
Zoe Rothblatt 01:21
I know it was a nasty guest. It was pretty rough. As our listeners know, I live with two chronic diseases. So you know, it definitely flared those up. I was in contact with my doctor. But I think you can hear my voice now I’m doing a lot better. So I’m glad to be here recording with you and able to just, you know, focus on my health and good things for the new year.
Steven Newmark 01:41
Well, that’s good to hear. It’s not totally surprising that you caught COVID because it’s still with us, and it’s still with us in a pretty robust fashion. And today we’re going to talk about the latest on what’s happening with COVID-19, the flu, and RSV in the United States, otherwise known as the “tripledemic”, or the “tri-demic”, or the “triple pandemic”.
Zoe Rothblatt 02:01
Don’t threaten me with that, Steven. I don’t think our emotional health can handle a “tripledemic”.
Steven Newmark 02:06
Well, I don’t know what to tell you, welcome to 2023.
Zoe Rothblatt 02:09
Right. It’s not a fun winter. So you know, let’s dive in. What is going on with all these respiratory conditions?
Steven Newmark 02:16
Yeah, well, sorry to say, it is looking a little rough out there. There’s a high number of influenza like illnesses, sometimes shorthand for that is IOI. Those are illnesses that deal with fever, cough and/or sore throat, that are reported at doctors offices, are looking high as of January 2023.
Zoe Rothblatt 02:33
And we know that respiratory season started early. And you know, a lot of that is due because we’ve all been quarantined. And the flu hasn’t been around as much as the past two years because we were taking all the COVID precautions and now as society moves on and the mask comes off and you know, people are just going about their everyday life without distancing and protections. We’re seeing the rising cases. But you know, it’s also on the descent, there is some hope although it’s too early to celebrate because we may see humps as we did in you know, pre pandemic years. And like we see with COVID there’s different waves of it, but it seems like this high wave is on the descent.
Steven Newmark 03:10
Yeah, so you know, let’s break it down disease specific from the “tripledemic”, if you will.
Zoe Rothblatt 03:14
Yeah. Shall we start with RSV, Steven? You’re a parent so I know that this has probably been top of mind for you especially.
Steven Newmark 03:22
Yeah, that’s true. I mean, luckily I don’t have children under the age of five, which is where you really start to look for RSV. RSV, by the way stands for respiratory syncytial virus infection, very difficult to say and also not fun when you have it. But the good news for those following RSV is that cases are actually coming down pretty heavily. So this is good news for older adults as well as parents of children under the age of five.
Zoe Rothblatt 03:45
That’s really good news. You know, we’d never want anyone to get sick, but it’s especially scary when it’s young children. So it’s really good to hear that the hospitalizations are going down and the peak is going down.
Steven Newmark 03:56
Yeah, the peak really was really mid-November of 2022. Hospitalizations, they just blew through the pre pandemic years, you know, and they reached an all time high of 70 kids hospitalized per 100,000 infections. Historically, peaks have been from anywhere between 26 and 52 kids per 100,000 infections. So it was much higher than that. But thankfully, the numbers are really starting to come down
Zoe Rothblatt 04:18
And what’s going on with the flu. I mean, we’ve been hearing a lot about the flu this year.
Steven Newmark 04:22
Yeah, similar to RSV, the flu came on early this year and it appears to have peaked early as well though we won’t know until of course the end of the season to see if it makes a comeback, but trends are going down, not as quickly as RSV but by all metrics, testing positivity rate positive numbers in nursing homes, hospitalizations, are all showing movement in the good direction.
Zoe Rothblatt 04:45
That’s good to hear. Especially you know the difference I think with COVID I know we’re gonna get on a little bit but we have the at home test but for flu I don’t think there’s an at home test. So these numbers should be pretty accurate because it’s people going in to get tested.
Steven Newmark 04:59
Correct. So like I said, the numbers overall are going down. Another thing that’s somewhat positive, the severity of the flu this year is not particularly high. They are on track for a mediocre season when it comes to hospitalizations. So that’s a good thing as well, of course, and not to minimize what is happening out there. We’ve already lost 13,000 Americans to the flu this season. 61 of those were children. So I don’t want to minimize what’s going on with the flu. But just to be positive, we are moving in a positive direction.
Zoe Rothblatt 05:30
I was about to say that, yeah, it’s helpful to hear these numbers. But of course, we can’t minimize the suffering, especially for our community with chronic disease. Sometimes it hits a little bit harder. And, you know, as someone who was just sick, I’m like, we can’t minimize this at all. So stay safe out there friends. Definitely.
Steven Newmark 05:50
Yeah. And I should mention that in the Southern Hemisphere, we saw during the strain of flu, we saw two waves. So there’s a high possibility, if you will, that a second strain could be coming our way.
Zoe Rothblatt 06:02
Because we in the U.S. currently have that influenza A strain, right? And then the other one was B, so we could be seeing that.
Steven Newmark 06:10
Correct. So maybe breathe a half a sigh of relief, not a full sigh of relief, if you will?
Zoe Rothblatt 06:14
Yeah, well, it’s important to know about this. And we’re lucky enough that we get that information from the southern hemisphere and have a little bit of advantage. So you know, the scientists, epidemiologists can be planning and we get the right public health messages out. I do think that so much of advocating for yourself as looking at this information and being well informed so you can make the right decisions to stay healthy throughout this season. Because as we’re talking about, there’s a bunch of stuff going around that we need to be on the lookout for.
Steven Newmark 06:43
Definitely. Well, and then there’s the big one: COVID.
Zoe Rothblatt 06:48
Yeah, it’s hard to believe this is what the third year, the fourth year, I can’t even keep track anymore. It’s still very much in our everyday lives going into 2023.
Steven Newmark 06:59
Yeah, as we enter 2023, I guess, technically the fourth calendar year, if you will, of us dealing with COVID. For some good news, we did get through all 2022 an entire year without a new variant of concern. In other words, Omicron continue to mutate without a variant coming from out of left field. So that’s good.
Zoe Rothblatt 07:17
Oh, right. Because before we are seeing, you know, Delta then Omicron, now these are all just in the Omicron family. And we do have that bivalent booster focused on the Omicron family. So that is good news. But I know it’s good news, always comes bad news. What do you have for us next, Steven?
Steven Newmark 07:35
Well, well, the bad news is that the Omicron subvariants are doing plenty of damage on their own. This is especially the case when coupled with the holidays, you know, the changing behaviors and a lot of socialization without masks. So we’re starting to see an uptick. And the current viral culprit right now is known as the subvariant XBB.1.5.
Zoe Rothblatt 07:57
That sounds threatening.
Steven Newmark 07:58
Yeah, it’s pretty bad. Pretty, “pretty badass”, if you will. It’s definitely like something cool in a science fiction movie, I suppose. The World Health Organization is currently conducting a risk assessment. So hopefully that will come out in a short period of time. But it definitely has a viral advantage here to the United States. It started in the northeast, but it’s now quickly spreading to the south and will dominate pretty much the entire country very shortly with the peak expected sometime in February.
Zoe Rothblatt 08:23
I caught it in the south. So it’s definitely there. Granted I don’t know what variant I had.
Steven Newmark 08:29
Right. Of course.
Zoe Rothblatt 08:30
I’m assuming it’s one of the newer ones, because it’s accounting for a lot of the cases. But it’s definitely moving through the country, which is, you know, like you said, we had the holiday travel we saw after Thanksgiving that cases spiked. And now it’s been a week or whatever, since Christmas, New Year’s, Hanukkah, whatever you celebrated. So…
Steven Newmark 08:50
Yeah.
Zoe Rothblatt 08:50
We are seeing those peaks. And we’re you, just said, we’re expecting another peak in February. So we really do have to stay vigilant this time of year and I became a little more relaxed with my restrictions. I’ll be totally honest. And it was rough. And I’m definitely going to be more careful moving forward.
Steven Newmark 09:08
No, absolutely. I mean, look, I think the key takeaway is, it’s January, January is a time when viruses tend to propagate, we’re certainly in the midst of another wave on when it comes to COVID. And if you want to stay safe, you’re going to have to keep a mask on a nice, good, tight fitting mask whenever you’re in public. And unfortunately, there aren’t too many other ways to mitigate in our society.
Zoe Rothblatt 09:31
Also, unfortunately, a lot of people have moved on and it sort of feels like every man for himself at this point. I know our chronic disease community like really is there for each other and it’s amazing to have that support, but it’s not as strong with the general public. So you know, as we’re in this new year, and people continue to get over COVID I just want to say that you know, we’re here for you and we understand you and we’re going to keep talking about and providing you know, tips and health advocacy for you know, fighting this virus together?
Steven Newmark 10:01
No, absolutely, yeah. That’s what I was referring to when I said there aren’t too many ways of mitigating in our society generally other than wearing the mask yourself. So, you know, each person for themselves out there. But we should talk about some positives. You know, I think it’s important to note that hospitalizations are very different today than they used to be, you know, indications of severe hospitalization, like the number of patients in the ICU are not increasing. This is a very good sign that the severity of Omicron and these mutations may not have changed or may not be changing for the worse. So it’s early, but that’s good. And the second thing, as we say all the time, vaccines work. People that were vaccinated with the bivalent booster have, according to a latest study an 18.6 times lower risk of dying from COVID, than unvaccinated people. The risk of infection is also three times lower when folks are vaccinated. This is even the case for folks with weaker immune systems, like those of us who are chronically ill, and those who are over 80 years old. So the vaccines work, the vaccines help, and we have a bivalent booster that’s specifically targeted for the Omicron variant.
Zoe Rothblatt 11:01
Yes, although I mean, it’s great, we have the vaccines, I don’t want to diminish that, it’s just one thing top of mind for our community is that with the newer subvariants that, you know, the monoclonal antibodies, including Evusheld doesn’t work as well. So you know, it’s still something is better than nothing, it’s what physicians and experts are saying, it just may not be as effective as it once was. Although we do have the treatment Paxlovid which still works. You know, talk to your doctor about what’s right for you. But I would say the best thing is, after just having had COVID, I had been in contact with my doctor before about you know what would happen if I do get it and I had a plan, which made me feel the best about the situation I was in, so I would say that’s my top piece of advice when you hear about these things like Evusheld and Paxlovid and the vaccines, definitely talk to your doctor now, before anything, so you guys can plan together.
Steven Newmark 11:53
Absolutely. I think what you said just to tease it out, is make a plan with your doctor. Be ready.
Zoe Rothblatt 11:58
For sure. So okay, so what’s the bottom line? RSV and Flu trends are showing welcoming signs. But you know, COVID is now taking over the impact of this new subvariant and the height of the COVID winter wave is unknown, but vulnerable people are in a tough spot as they have been, as we have been.
Steven Newmark 12:18
Look, there are a lot of people out there getting sick, and there are still plenty of winter season left. But you know, as a listener of this podcast, you know what to do, make a plan with your doctor, make a plan with your family, make a plan for yourself and be ready.
Zoe Rothblatt 12:31
So Steven, switching gears really quick, I wanted to ask about what we could expect for Health Policy in 2023. We have a new Congress. I know we talked a lot about the election when that was going on. And I wanted to hear your thoughts on this new Congress.
Steven Newmark 12:46
Sure. So as you said, we do have a new Congress. The Senate is somewhat unchanged, there’s a one more democratic seat than there was in the previous Senate, so it’s still controlled by Democrats. However, over on the House side, the Republicans have taken over. And in fact, they even have a speaker of the house, which last week, we weren’t so sure that would happen, but it has happened. So things are up and functioning such as they are over in the house. However, with a divided government, and particularly a divided Congress, it’s going to be very difficult to get things done.
Zoe Rothblatt 13:15
So you know, let’s focus on some areas relevant to our community, we might have talked about them in the past, but going into 2023, we’re still going to be focused on the Safe Step Act, which is a federal piece of legislation that helps protect patients from step therapy, the insurance practice that requires you to try and fail medications before you can get the one prescribed by your doctor. So you know, we’re just continuing to advocate for this and hope for passage. What do you think is the likelihood of something like this passing this year?
Steven Newmark 13:45
Yeah, that’s a great question. I would think of it less in terms of this year or more in terms of this Congress, which is a two year project. And I’ll just say, you know, first and foremost, the odds of any grand legislation in healthcare, or really any area is essentially unlikely because it’s a divided Congress. So the odds of coming together to get something that both Republicans and Democrats are behind, that is somewhat radical, it’s going to be very rare. Now, in our world, you mentioned the safe step act. This has been introduced in the prior three congresses. So for the past six years, it’s been part of the legislative process. And each time it gets introduced, we get more and more sponsors more and more senators on the Senate side, and Congress members on the House side signing on to it. It’s bipartisan. It’s got bipartisan support. And like I said, it continues to grow in support. So at some point, you know, we’re hoping that it will reach the tipping point and knock on wood, fingers crossed, whatever you might want to do. We are hopeful that this will be the Congress where it happens. Congress, I seem to think of it in terms of two years, but really, it’s more like a year and a few months because once we get into mid 2024, it becomes presidential election season. So that’s another time period when very little is likely to get accomplished. But yeah, Safe Step Act is a top priority for GHLF and other patient groups as well. So we hope to work with our coalition partners and with members like you to help push for the passage.
Zoe Rothblatt 15:08
Definitely, um, you know, just thinking about some other top line items. What about COVID? We talked about this, the election would affect COVID funding. What are you thinking now, given the new Congress?
Steven Newmark 15:19
You know, I would say Republicans, particularly Republicans in the House are less than enthusiastic about continuing funding for COVID policies generally, for continuing any policies that relate to protection measures when dealing with COVID. So I think it’s very unlikely they will see more funding more funding from the federal government to trickle down to state and local governments to assist with COVID. That being said, the Biden administration did just authorize, through existing funds, for more free tests per household. So that’s something you should definitely take advantage of, you can get that through usps.gov, or through vaccines.gov. So you know, that’s some minor good news for now. But it’s unlikely that some of the funding will continue. And when I say funding, I’m talking about the ability to get vaccines for free, the ability to obtain some free PCR tests and things of that nature.
Zoe Rothblatt 16:12
You know, it’s interesting, you brought up the free COVID test, I had a mental note to say it. So thank you for the reminder. I took advantage of that, and mine came within a week. So definitely a really great option.
Steven Newmark 16:22
And look, they’re still extremely helpful. I had a family gathering this past weekend. And it’s very comforting to know that we all have plenty of tests, so we can each test without worrying about diminishing our supply, and then we’re able to gather and feel comfortable about it. So it’s great.
Zoe Rothblatt 16:37
And then around the states, we have a bunch of stuff going on. And I wanted to encourage our listeners to get involved with us, you could go to 50statenetwork.org or email us at [email protected]. You know, we have copay accumulator legislation, which helps patients count their money that they paid for their prescriptions, and you know, coupon codes they use or assistance that counts towards the medication and their deductible. And, okay… this is a little bit of a list so bear with me, I just want our our friends in all states to hear where we’re focused. There is Florida, Texas, Pennsylvania, Colorado, Massachusetts, Michigan, Ohio, South Carolina, Utah, and Wisconsin. And I say that with such joy, because it is amazing that, you know, we have so many states focused on this type of legislation to help our patients get affordable access to treatment.
Steven Newmark 17:30
Yeah, no, it’s great working through the states. It’s where a lot of the legislation can be found, particularly with some of the gridlock in Washington that we’re likely to see. So we at GHLF have always been focused on the states through our 50-state network. And we will be hyper focused on the states that you mentioned and particular legislation that you had just brought up.
Zoe Rothblatt 17:49
And then Steven, you know, we’re focused on a few more issues around the states. The first one is non-medical switching, which helps give patients protections to get their medication for the full year and avoid being unnecessarily switched. And we’ll focus there in Texas and Pennsylvania, as well as in Washington, some pharmacy benefit manager reform bills to help increase transparency there. So lots of exciting stuff. And I really encourage our listeners get involved, whether or not you’ve been affected by this issues, if you’re someone living with chronic disease, you can speak to you know how staying on your medication has helped you feel good. I certainly have shared my story just generally, and it really helps when legislators can hear the personal stories of the community.
Steven Newmark 18:33
Yeah, no, absolutely. And as I mentioned, we at GHLF look forward to getting active in the states in 2023.
Zoe Rothblatt 18:42
Okay, Steven, I think that brings us to the close of our show. What did you learn today?
Steven Newmark 18:46
Well, I learned from your unfortunate personal experience that you know, no matter how vigilant you are, COVID can still break through. So you know, it’s unfortunate, but as we spoke about, always be prepared, be ready, be ready with a plan.
Zoe Rothblatt 18:59
And I was comforted by you to hear about, you know, the numbers and hospitalizations going down, especially for RSV. And it’s just really helpful to, you know, put some facts to the worry.
Steven Newmark 19:12
Well, we hope that you learn something too. And before we go, we definitely want to give a shout-out to our colleague, Daniel Hernandez, who’s got a great program called Let’s Get Personal, and it’s focused on rheumatoid arthritis patient journey, so please check it out.
Zoe Rothblatt 19:25
Yeah, that’s a great listen. I highly recommend checking out Let’s Get Personal and you can listen to all of our podcasts at ghlf.org/listen. Well everyone thanks for listening to The Health Advocates a podcast that breaks down major health news of the week to help you make sense of it all. If you like this episode, give us a rating and write a review on Apple Podcasts and hit that subscribe button wherever you listen. Also, don’t forget to check us out on YouTube. I’m Zoe Rothblatt.
Steven Newmark 19:52
I’m Steven Newmark. We’ll see you next time.
Narrator 19:58
Be inspired, supported and empowered, this is the Global Healthy Living Foundation Podcast Network
S5, Ep 13- Health Policy and Advocacy Impact: A Look Back at 2022 and What’s Coming in 2023
As 2022 comes to an end, our hosts reflect on yet another eventful year for health policy and advocacy work. Seven bills that GHLF advocated for were passed at the state level, including copay accumulator bills, step therapy bills, and a non-medical switching bill. Patients also received protections against surprise billing.
Our hosts discuss their advocacy work as well as the advancements for patients and issues covered this year on The Health Advocates. “We talked a lot about COVID this year and also other infectious diseases such as Mpox, polio…. We talked about vaccine hesitancy and how it is affecting this pandemic as well as winter flu season and how we’ve said many times throughout 2022: It’s too soon to be totally over with COVID,” says Steven Newmark, Director of Policy at GHLF. The Health Advocates also offer their thoughts on what’s to come for health policy and advocacy in 2023.
“Because they’ve been sort of bottled up for so long, COVID is on the verge of exploding in China. They are already reporting very high numbers, nearly 40,000 new infections per day,” says Steven Newmark, Director of Policy at GHLF.
Health Policy and Advocacy Impact: A Look Back at 2022 and What’s Coming in 2023
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
“We talked a lot about COVID this year and also other infectious diseases such as mpox, polio… We talked about how the mRNA technology helps bring about new treatments for care. We talked about vaccine hesitancy and how it is affecting this pandemic as well as winter flu season and how we’ve said many, many times throughout 2022, it’s too soon to be totally over with COVID.”
Steven Newmark 00:33
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:42
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:47
Our goal is to help you understand what’s happening in the health care world to help you make informed decisions to live your best life. But before we get started, we want to be sure that everyone takes a listen to all of GHLF’s great podcasts. We have so many to choose from.
Zoe Rothblatt 01:00
We sure do. As a reminder to our listeners, you can check all of our podcasts out at ghlf.org/listen. This week, we’ll give a shout-out to Talking Head Pain hosted by Joe Coe. If you live with headaches and migraine or know someone who does this podcast covers a wide range of experiences when it comes to living with this neurological disorder.
Steven Newmark 01:22
Definitely. It’s a great show and I definitely recommend it.
Zoe Rothblatt 01:25
Okay, let’s start with a listener comment. Ready?
Steven Newmark 01:27
I’m ready.
Zoe Rothblatt 01:27
This one is from Nathan P. who wrote: “Thanks for putting on such a great podcast.”
Steven Newmark 01:32
Well, thank you Nathan for listening to such a great podcast.
Zoe Rothblatt 01:35
Yeah, thanks, Nathan.
Steven Newmark 01:37
Today we’ll be talking about all the advancements in advocacy and policy we saw in 2022. And some top pieces of news from the year.
Zoe Rothblatt 01:44
This is our last episode of the year, kind of bittersweet.
Steven Newmark 01:48
So sad.
Zoe Rothblatt 01:49
You know, we’ll be back in the new year to keep providing content to you all. And I just want to say we’re so grateful to all of our listeners.
Steven Newmark 01:56
Absolutely. 2020 sucked, 2021 sort of sucked, 2022 big improvement!
Zoe Rothblatt 02:02
Well, speaking about improvement, we had seven bills around the states passed that we advocated for.
Steven Newmark 02:08
Yes!
Zoe Rothblatt 02:08
That’s pretty big, especially in an election year.
Steven Newmark 02:11
Absolutely. We had four copay accumulator bills in New York, Washington, Delaware, Maine that passed, why don’t you explain what these bills do actually?
Zoe Rothblatt 02:20
Yeah so, briefly explained, you know, we can go on and on about these bills but just, you know, a quick one sentence if you know, you want to tell your friends and family what’s going on. So these bills give protections so that any payment made on your behalf for a medication, like let’s say you use a copay card to pay for your copay, that money will count towards your deductible.
Steven Newmark 02:40
We also had a nice non medical switching bill that passed in New York, why don’t you explain what that means Zoe?
Zoe Rothblatt 02:45
So this law will prohibit health insurance from switching stable patients off their current medications to another medication. You know the scenario would be here: you’re just going about taking your medication, refilling it as usual and all of a sudden, one day in the middle of the plan year you get a notice saying: “Hey, we actually think you should take this medication instead.” You’re obviously upset because you’re doing well. You want to take what your doctor prescribed, and you’re worried that the other one won’t be effective. So this law ultimately stops that process.
Steven Newmark 03:14
Great. We also had 2 step therapy bills that passed in California and Massachusetts. Why don’t you explain what those do Zoe?
Zoe Rothblatt 03:22
I could have bet on that question. So great news about the two step therapy bills, especially in California, because California actually had a step therapy bill passed a long time ago, so this helped bring in some of the newer protections that advocates have been fighting for, so it strengthened the old bill. So step therapy bills, what it does is it provides protections against the insurance practice of requiring you to try and fail on a different medication before you could have the one originally prescribed. So basically, your doctor says I want you to take ‘x’ medication, insurance says no, you have to take ‘y’ and prove that it’s not effective before you could take ‘x’ and this law provides an exemptions process so you don’t have to do that.
Steven Newmark 04:02
Excellent work. We also got a few protections for surprise billing.
Zoe Rothblatt 04:06
Oh Yeah, this happened in the new year. I almost forgot about that.
Steven Newmark 04:10
If you go back way back when to episode two of season three from our show, we discussed that surprise billing is now illegal under the No Surprises Act.
Zoe Rothblatt 04:19
And surprise billing is literally what the name suggests. It’s just an unexpected bill but it’s usually for a substantial amount of money because, like you accidentally got care from a provider out of network, and the insurance company doesn’t cover services from that provider. Like, I’ve heard stories about: “Oh, the anesthesiologist wasn’t in the plan, and I got this huge bill.” So this is protections against that happening.
Steven Newmark 04:43
Yeah, so some great pieces of legislation around the country, and I would say a big thank you to our patients who helped us get these pieces of legislation passed.
Zoe Rothblatt 04:53
Yeah, we cannot do this without patient stories. Legislators can look at numbers in the bill all day, but hearing the voice from the person impacted ultimately really helps sway legislators to have these discussions with their peers and get stuff passed.
Steven Newmark 05:10
Absolutely. Some other highlights of 2022. We talked a lot about COVID this year, and also other infectious diseases such as mpox, polio… We talked about the idea of getting free tests from the government, and now the elimination of those free tests. What it means to live during an endemic and a pandemic. How the mRNA technology helps bring about new treatments for care. We talked about vaccine hesitancy and how it is affecting this pandemic, as well as winter flu season, and how we’ve said many, many times throughout 2022: it’s too soon to be totally over with COVID.
Zoe Rothblatt 05:45
Agreed. You know, it’s interesting when you parse out these different topics we’ve discussed because COVID can often become a blur and feel like we’re having the same conversation over and over again. But what stood out to me there, you just talked about the mRNA technology that is huge that that can help, you know, bring about new treatments for patients. Also free tests. I hope maybe that program gets mimicked in other health areas. I think there’s a lot to learn from what’s been going on.
Steven Newmark 06:12
Yeah, absolutely. We also met with many patient advocates on the air. I had some great discussions. I’m not going to go through all of them. I will just give a quick shout-out… oh, gosh, too many to name, but I thought it was really exciting to talk to Kellie Cusack who uses her background and interest in fashion to be a disability advocate. I found that to be a great conversation. Any conversations that stuck out for you in 2022?
Zoe Rothblatt 06:35
Yeah, you know, what really stands out was over the summer, we talked a lot about methotrexate access. When patients around the country were having trouble getting their prescriptions filled, or ultimately just worried about losing access to their medication. And we spoke to one of my friends Cheryl Crow, Arthritis Life Cheryl. She’s an occupational therapist, and rheumatoid arthritis patient, and she was following closely what was happening on social media. So it was cool to hear from her. And we also spoke to Dr. Donald Miller, who was a pharmacist, and we got to hear from his perspective about this access issue and what role pharmacists play in helping patients get medications.
Steven Newmark 07:13
Yeah, that was fascinating. We also had the good fortune to attend and report back on many conferences as well as advocacy days that we participated in.
Zoe Rothblatt 07:23
So yeah, what’s like one takeaway from each of these?
Steven Newmark 07:27
Yeah, so I had the good fortune of being able to attend the EULAR conference. That’s the European League Against Rheumatism conference. And one takeaway from that was that chronic pain was being called its own disease.
Zoe Rothblatt 07:40
Oh, yeah, that was really cool, and so important. So many people live with chronic pain and undiagnosed chronic pain so to hear it being recognized as its own could really lead to some advancements.
Steven Newmark 07:51
Yeah.
Zoe Rothblatt 07:51
You know, the next one, which just happened recently, ACR, the American College of Rheumatology, I attended both as GHLF staff, but also as a patient presenter and my main takeaway is just how important it is to insert the patient voice into these conversations that are just outside the doctor’s office and give doctors and patients the ability to communicate with each other.
Steven Newmark 08:14
Yeah, and we also did a bunch of advocacy on days virtually. And I think that the main takeaway from those various advocacy days around the states and in Washington DC, is that advocacy can happen over zoom and be effective. So it was great that we were able to do that this year.
Zoe Rothblatt 08:30
Totally agreed. And I’ve been a part of a few zoom meetings, and whether you’re with a legislator or their staff, I really feel like you do have that one-on-one time with them. Sometimes in person it can be a little chaotic and hard to feel that closeness, but I’ve actually really felt it translated well on Zoom. And then the other thing I’d say is, from the Advocacy Days, we’ve learned that we really need more representation and advocacy. It’s often the same group of people showing up and we need more diverse voices. And you know, we’re definitely trying to find those diverse voices and help them come along, because it’s really important to hear the stories of people.
Steven Newmark 09:10
So true… so true. So we did a lot in 2022 We’ve had some good successes. And of course, there’s still more to do. So let’s give a little preview of what’s on the horizon in 2023.
Zoe Rothblatt 09:21
Well, the COVID emergency is expected to renew so I’m sure we’ll keep talking about it and you know, regardless of its emergency status, so long as it’s affecting our community who lives with chronic disease, we’ll definitely keep talking about it.
Steven Newmark 09:37
Yeah, we will continue to advocate of course to get more bills passed and ensure patients have access to care and medications without obstacles.
Zoe Rothblatt 09:44
So key and just so frustrating that year after year, this has to be a priority, like I wish we could just get it all done and patients could have access and we could live in a perfect world but alas here we are. Keep advocating. And you know, ultimately also more coverage of our conferences and Advocacy Days and of course, bringing along wonderful guests.
Steven Newmark 10:05
Yeah. Well, before we close, I just want to say to you Zoe how great it’s been to do this podcast week after week with you. It’s been a real pleasure in 2022. I’m looking forward to continuing in 2023. And I hope that you will have some restful time as we get to the end of this year and celebrate the holidays with your family and to all of our listeners, Merry Christmas, happy Hanukkah, happy Kwanzaa, whatever it is that you celebrate, Happy New Year. If you celebrate nothing else, at least celebrate yourself!
Zoe Rothblatt 10:31
That’s a great message. Thank you so much, Steven. I’ve enjoyed doing this with you as well. And I’m just so grateful for our listeners that you know, they’re here tuning into us and we’re able to have this time and put a show on for everyone. And yes, Happy Celebrations everyone! We hope you have a relaxing time off. We’ll see you in the new year.
Zoe Rothblatt 10:51
Well, everyone thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you like this episode, please give us a rating and write a review on Apple podcasts and check us out on YouTube. I’m Zoe Rothblatt.
Narrator 11:05
I’m Steven Newmark. We’ll see you next year. Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
EXTRA Part 2- Non-Radiographic Axial Spondyloarthritis: A Conversation with Policy Expert Amanda Ledford and Patient Advocate Ricky White
In the second part of a two-part episode dedicated to non-radiographic axial spondyloarthritis (non-rad AxSpA), our hosts are joined by Amanda Ledford, Director of Policy at UCB, and patient advocate Ricky White, who lives with non-rad AxSpA. Amanda and Ricky discuss the advocacy efforts around helping patients receive a diagnosis and how policy and advocacy play a role in helping patients access affordable treatments.
“We’re really working to remove barriers to the providers’ ability to prescribe the most appropriate therapy to their patients. We feel strongly that decisions about the most appropriate treatment should be made by the health care provider and the patient rather than the insurance company,” says Amanda.
EXTRA Part 2- Non-Radiographic Axial Spondyloarthritis: A Conversation with Policy Expert Amanda Ledford and Patient Advocate Ricky White
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Amanda Ledford 00:06
“We’re really working to remove barriers to the providers’ ability to prescribe the most appropriate therapy to their patients. We feel strongly that decisions about the most appropriate treatment should be made by the health care provider and the patient rather than the insurance company.”
Steven Newmark 00:25
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:34
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:39
Our goal is to help you understand what’s happening in the health care world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:45
So Steven, we’re conducting part two of our episodes on non-radiographic axial spondyloarthritis. You know, what it is, how we’re dealing with it and what medical professionals are doing to help.
Steven Newmark 00:57
In our first episode, we talked to Ricky White about the struggles he’s gone through to get a diagnosis and feel better. We learned from Ricky how community is key in the non-rad axSpA journey as community brings support and information.
Zoe Rothblatt 01:09
We also heard from Dr. Jeff Stark who talked about the advancements in non-rad axSpA. I found it really interesting when Dr. Stark mentioned how non-rad axspa has traditionally been under recognized and undertreated but that there’s many efforts going on to improve diagnosis.
Steven Newmark 01:25
Yeah, and to learn even more today we will hear from Ricky and we’re also joined by Amanda Ledford, Director of Policy at UCB on how policy and advocacy play a role in helping patients and some of the challenges and advocacy around helping get patients diagnosed.
Zoe Rothblatt 01:41
So let’s introduce our guests. We’re joined today by Ricky White and Amanda Ledford. You all remember Ricky from our first episode on non-rad axSpA and he joins us again for part two. Amanda Ledford also joins us from UCB where she is Director of Policy. Amanda leads a host of public policy initiatives and strategies focused on improving access and removing barriers to care for patients, especially for those living with chronic and severe diseases. UCB and GHLF have worked together on several policy issues so we’re really excited to have Amanda here today. Welcome again, Ricky and welcome Amanda.
Ricky White 02:17
Thanks for having me.
Amanda Ledford 02:18
Thank you for having me today. I’m really excited to be here and join you and Ricky.
Zoe Rothblatt 02:22
Great. So let’s get started. Amanda, I’ll direct the first question to you. Let’s start talking about diagnosis codes called ICD-10 codes. I know there was a big effort in order to get a code for non-rad axSpA. Can you talk to us about that process? And then I’ll turn it over to Ricky after, to hear his thoughts.
Amanda Ledford 02:41
Thanks, Zoe. I’m happy to talk about ICD-10 codes. As you heard from my colleague Dr. Stark in the previous episode, the UCB team began hearing from patient and provider groups that there’s a need for an ICD-10 or diagnosis code for nr-axSpA. For medical professionals, these codes are common and they’re an important way that rheumatologists can identify patients as accurately as possible – separating nr-axSpA patients from other disease states. There may be differences in the way those patients respond to medications and knowing what to expect and choosing the proper therapy for a patient is critical. Having an ICD-10 code to reinforce the characteristics of a disease really helps to ensure that patients are diagnosed and treated accurately. However, administrative advancements always seem to lag behind regulatory and certainly scientific advancements. So even though the FDA had approved multiple therapies to treat nr-axSpA, and this was a big step and legitimizing the disease, there is still no ICD-10 code to help recognize nr-axSpA. So UCB worked with a wide range of stakeholders to submit an application to the Centers for Disease Control and Prevention or the CDC to obtain an ICD-10 code for nr-axSpA. The path to obtaining this code was a journey in and of itself and this committee accepts requests for coding changes only twice a year. Prior to October of 2020 there was no approved code of any kind for nr-axSpA. Patients were diagnosed using the spectrum of codes providers have available for ankylosing spondylitis. In 2018, UCB submitted an application for a new ICD-10 code. And then in October of 2020, we saw the first step in the right direction. The Coding Committee indexed an existing code to include nr-axSpA. This was progress but still it wasn’t a specific ICD-10 code for nr-axSpA, which is what we ultimately wanted. So with continuing advocacy from UCB, patient groups, professional societies, a new and specific code for nr-axSpA became effective October 2021. So we were very excited about that, because getting a specific code for the condition brings attention to the condition and legitimizes the disease. I know this is something that Ricky and Dr. Stark mentioned in the first episode particularly with respect to Ricky’s own journey.
Zoe Rothblatt 05:01
Yeah, Ricky, if you want to pick up there. Thanks Amanda for talking about that journey of, you know, how many years it took to get a code and then get a more specific code. It’s amazing to think about how many patients were left hanging. And Ricky, you are one of those patients. You told us in the first episode how you had to get diagnosed with ankylosing spondylitis, even though today, you would be categorized as non-rad axSpA. What does all of this bring up for you? Is there anything that stood out to you from what Amanda said?
Ricky White 05:31
Yeah, quite a bit. I mean, it’s great that this is now happening. It’s a shame, it wasn’t the case in 2010, when I was diagnosed. And like we discussed last time, yeah, I had to get a diagnosis of ankylosing spondylitis just to even get any treatment at all. And even with that, I was still refused treatment. So even with a diagnosis for ankylosing spondylitis, I still struggled to get treatment because although I had it on paper my clinical symptoms didn’t match up. And the NHS, which is what I was under, at the time back in England, they knew that my clinical symptoms didn’t match up to the diagnosis so they refused to fund the treatment. And I’ve heard very similar stories here in the U.S. You may have recalled, you know, I moved to the U.S. in 2014 so I’ve had the benefit of being in both health care systems and seeing how they work differently but for all the differences, there’s still a lot of similarity and getting disease codes like this is key for people to get the accurate diagnosis and then get treatment. I still hear today, people get misdiagnosed all the time and with a degenerative disease, it’s critical that we can get diagnosis and treatment done earlier because we can prevent so much damage and so much pain and problems in the long term if we can do that. And so this is just the first step of many to do that.
Zoe Rothblatt 06:42
I want to pick up on something you said talking about access issues and how the diagnosis is just one piece to like starting to get answers, but it ultimately can lead to some more obstacles along the way. Like you mentioned, you didn’t have the right criteria to get certain medications. Can you talk to us about the kind of access issues that you had and if you’ve heard from other patients about having them and what was going through your mind at the time?
Ricky White 07:09
Yeah, it’s something I hear a lot from other people. I’ve been more fortunate than some in my journey in regards to access. It helps to have a well-paying job and good health insurance and all of those kinds of things but not everyone has that privilege. So it’s really difficult, potentially, in somewhere as advanced as even the U.S. that there’s such a difference in availability across 50 states, and I hear everything from I can’t get any coverage at all, because of their disease and the requirements of their disease to: “Yeah, I get everything I want and it costs me very little”, and there is such a broad spectrum for many people. Again, I’m now in a place of privilege, where I have good health insurance and my costs are affordable to me, but not everyone’s the same. I mean, a lot of the anti-TNF injections that people take for non-rad axSpA and ankylosing spondylitis. If you look at the sticker price of those before the insurance, some people pay that out-of-pocket, and it’s, you know, upwards of $1,500-$1,600 a week and that’s not affordable for a lot of people. And so barriers like that certainly cause a lot of problems for patients. And so by having now this new diagnosis code, and then what will come with it is better guidance around treatment availability for those and then it’d be less of a kind of zip code lottery and more of a guidelines and standards approach, right? If you’re diagnosed with this, then these are the treatment options available to you based on clinical studies. That’s the place we want to get to. Getting the code is the first step.
Zoe Rothblatt 08:37
So Amanda, talk to us about how we get to that place that Ricky’s talking about where patients can have access to medications at an affordable and equitable place. What kind of work are you involved in at UCB to help move this along?
Amanda Ledford 08:52
Thanks Zoe, that’s a fantastic question. UCB is committed to promoting affordable and equitable access to care for all patients. And Ricky alluded to this. Ideally, we would like to see all patients have access to a range of affordable, high quality health insurance options that meet their needs, but also have transparent, reliable, formularies and affordable out-of-pocket costs. As far as specifics, we’re really working to remove barriers to the provider’s ability to prescribe the most appropriate therapy to their patients, we feel strongly that decisions about the most appropriate treatment should be made by the health care provider and the patient rather than the insurance company. One example is step edits, or the practice of forcing patients to try and fail on one or sometimes more drugs before getting access to the originally prescribed medication. Also restrictive formularies make it more difficult for patients to access the best treatment for their individual circumstances. UCB is working with a coalition of patient groups, including GHLF, so thank you for your continuing work and your leadership on this issue. We’re working with that coalition to advocate for step therapy override legislation at both the state and the federal level. Step therapy override legislation would create a process whereby a physician can override step therapy protocols under certain circumstances. For example, if the patient has already tried and failed on a particular medicine. And this creates a clear path to get the patient on the most medically appropriate treatment. These bills don’t prevent or prohibit step edits, but they do provide a clear pathway for providers to override health insurance plans’ step therapy requirements. To date we have seen a good bit of success at the state level, over 30 states have enacted step therapy override legislation and we are actively working to promote the Safe Step Act at the federal level when the new Congress arrives in January.
Zoe Rothblatt 10:48
Thank you, Amanda, all such important work. I know so many in our community deal with step therapy and you know, we always say that patients should have access to the right med at the right time and the one they originally agreed upon with their doctor. So let’s say that scenario is true and the patient does get the medication their doctor prescribed, there are often a lot of challenges around paying for treatment. Amanda, can you talk to us about this affordability and the concept of copay accumulator adjusters and what those are?
Amanda Ledford 11:20
Absolutely. Thank you for raising the issue. At UCB we want to preserve manufacturer’s ability to provide financial assistance to patients who aren’t able to afford the medications they need. We’re working to advocate for policies that would prohibit or at least curb the insurer practice of penalizing patients for accepting manufacturer assistance to help with out-of-pocket costs. Specifically, we’re working to advance legislation at both the federal and the state level that would prohibit or at least put some parameters around the use of so called copay accumulator programs. Accumulators are utilized by insurance companies so that they do not have to count manufacturer assistance towards a patient’s out-of-pocket maximum or their deductible. So as a result, individual patients can struggle to afford and adhere to their medications. But the insurers and the pharmacy benefit managers are the middlemen, they really shift more cost-sharing responsibility to the patients and siphon some benefit from the manufacturer assistant themselves. We are also working with several organizations to advocate for closing a loophole in the Essential Health Benefits requirements, which would no longer allow plans to employ so-called copay maximizer programs. These programs are a little less problematic for patients than an accumulator program because patients don’t see that huge mid-year “cliff” or high out-of-pocket payment. The maximizers still take part of the value of the manufacturer assistance from the patient to the benefit of the insurers. And those manufacturer assistance amounts don’t count towards the patient’s out-of-pocket maximum or their deductible amount. 16 states and Puerto Rico have already passed some form of copay accumulator legislation at the state level, and in Congress copay accumulators and maximizers continue to be a major priority for UCB. In 2023, we plan to work with our advocacy partners, including GHLF on commonsense reforms to help bring down costs for patients.
Zoe Rothblatt 13:24
Thank you, Amanda. It’s amazing to hear about the progress. To hear that 16 states and Puerto Rico have passed legislation to protect patients and help them get access to affordable medication is really huge. And like you mentioned, we’re hoping we can see action on the federal level. Ricky turning it over to you, what were you thinking about as Amanda discussed these maximizer programs where the payment made on behalf of a patient isn’t counted towards their deductible? Have you ever encountered something like this? Or do you hear from other patients about difficulty using their copay cards?
Ricky White 13:59
I’ve definitely heard about other people having difficulty for sure. It’s not something I’ve personally dealt with. But yeah, absolutely. And so the more things we can do… I think everyone would agree, the more things we can do to help make these medications and the correct medications more affordable for patients is a good thing. So I mean, my question would then be: how can I as an individual, or maybe as a local patient organization, what can we do to help pass these legislation at the state level? What can we do to get involved?
Amanda Ledford 14:25
Ricky, that is a fantastic question. And I know that at UCB these are issues that we believe strongly in, but we also recognize that patients are the best face and the best voice to take these issues to policymakers. So we do everything we can to support patients and their advocacy.
Zoe Rothblatt 14:42
I totally second everything Amanda just said. I think at the end of the day, policymakers can read the bill and look at the numbers, but you know, hearing a personal patient story can really sway the decisionmakers into understanding the real life impact that these policies have on people, to individual lives at stake. It’s… you know, their well being, it’s their ability to afford other things in their life and not just have everything about health so I think that including the patient’s story and all that you do to advocate is so important. And in thinking about how you Ricky or other patients can get involved, GHLF has a 50-State Network where we’re active in all 50 states and Puerto Rico and we always encourage advocates to join us and advocate with us whether it’s testifying, submitting comment letters, writing an op-ed about your experience. I think that the way you want to get involved in advocacy is really up to you and how you want to raise your voice. I’ll open it up, if either of you have any closing thoughts on today’s discussion, you know, whether it’s about the advancements in diagnosis, or helping patients get access to treatment. Ricky and then Amanda, either of your closing thoughts.
Ricky White 15:50
So it’s great to hear about all these new changes and the new ICD code. And this is only going to have trickle down effects, and so something I’ve been involved with is talking to patients on an individual level through our organization Walk AS One, and what we found is, because people have traditionally been diagnosed with other conditions or forms of ankylosing spondylitis, that’s the term they Google when they get home from the doctor. They don’t Google non-rad axSpA. And so by having that now recognized, it’s going to have a trickle down effect. So when they get home from the doctor, and they want more information or more support, they can now make sure they’re looking in the right places for that support. And then, you know, organizations like ourselves, and people like UCB, and you guys over there can make sure that the resources are there for them when they do do that Google search.
Zoe Rothblatt 16:38
Yeah, thank you Ricky. I think it’s so important that people can find information that they can relate to and not feel like they’re trying to squeeze themselves into somebody else’s diagnosis. And Amanda, I’ll turn it over to you, any closing thoughts on today’s discussion?
Amanda Ledford 16:53
Thank you, Zoe. First of all, thank you and Ricky for having me today and letting me be part of this conversation. It was fantastic to talk about the ICD-10 code for nr-axSpA and really excited and proud of our part in getting that for this patient community. It was also great to talk about the progress that’s been made towards increasing patient affordability and access to necessary medicines but as we all know, there’s still a lot of work left to do in this space. So I’m very thankful to have partners like you and like Ricky to work with us on these important issues.
Zoe Rothblatt 17:31
Well, Ricky and Amanda thank you so much for joining us today. It was really valuable to hear the insights from you about, you know, the policy changes and improving the lives of people with non-rad axSpA.
Steven Newmark 17:42
Yeah, that was great. It’s always fascinating to hear from a patient directly and of course, from someone like Amanda who gives the insight on policy and advocacy. This episode, as well as our first episode on this topic was made possible with support from UCB, sponsor of the Global Healthy Living Foundation. We’d love to hear from you about your experience with non-radiographic axial spondyloarthritis so send your email to [email protected].
Zoe Rothblatt 18:08
And who knows whatever you share, maybe included in our listener feedback portion of future episodes.
Steven Newmark 18:13
Also email us if you want to subscribe to our weekly newsletter, where we share the top health news of the week.
Zoe Rothblatt 18:18
Well, everyone thanks for listening to The Health Advocates a podcast that breaks down major health news of the week to help you make sense of it all. If you like this episode, give us a rating and write a review on Apple Podcasts and check us out on YouTube. I’m Zoe Rothblatt.
Steven Newmark 18:32
I’m Steven Newmark. We’ll see you next time.
Narrator 18:38
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
S5, Ep 12- China Eases “Zero-COVID” Policy: Insight on the Implications
In this episode, our hosts discuss China’s decision to roll back some of its “Zero COVID” policy by reducing testing and quarantine restrictions.
While easing these restrictions is in line with what has happened in the U.S., we can’t help but wonder – is China prepared to do so with low booster rates and no variant-specific vaccine? Our hosts also discuss what implications this has for the immunocompromised community.
“Because they’ve been sort of bottled up for so long, COVID is on the verge of exploding in China. They are already reporting very high numbers, nearly 40,000 new infections per day,” says Steven Newmark, Director of Policy at GHLF.
China Eases “Zero-COVID” Policy: Insight on the Implications
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
“Because they’ve been sort of bottled up for so long, COVID is on the verge of exploding in China. They are already reporting very high numbers, nearly 40,000 new infections per day.” Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:30
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:35
Our goal is to help you understand what’s happening in the health care world to help you make informed decisions to live your best life. Before we get started, we want to be sure that everyone takes listen to all of GHLF’s great podcasts. We have so many to choose from.
Zoe Rothblatt 00:48
We sure do and as a reminder, you can check them all out at ghlf.org/listen. This week, we’ll give a shout-out to Let’s Get Personal, a podcast hosted by Dr. Daniel Hernandez. And it’s focused on the rheumatoid arthritis patient journey. So definitely take a listen.
Steven Newmark 01:05
Excellent. I look forward to that.
Zoe Rothblatt 01:06
All right, let’s start with the listener comment. Are you ready Steven?
Steven Newmark 01:10
I am ready.
Zoe Rothblatt 01:11
This one came from Stephanie W., who wrote: “Informative podcast for those who are chronically ill.”
Steven Newmark 01:16
Great, that’s what we try to do is to inform and we try to do it through the lens of the chronically ill community.
Zoe Rothblatt 01:22
Which is you know, if I could just have a little moment here, it’s so important because we’re often left out of the major news. So we just really want to insert the voices of our community back into the news.
Steven Newmark 01:33
Well, let’s get started! Today, we will talk about China, what’s happening with COVID over there, and ultimately what it means for our community. But first, we have a few news updates.
Zoe Rothblatt 01:42
We sure do. And the first bit of news: I saw 44 states are reporting high or very high flu activity.
Steven Newmark 01:50
Yeah, over the past two years masking and other pandemic precautions has kept the flu at lower rates and has left us for lack of a better term immunologically naive.
Zoe Rothblatt 01:59
Right, because you know, I haven’t gotten the flu since the pandemic started. So I definitely fall into that category. Although I have a vaccine so I do have some protection but none of that acquired immunity I think it’s called. Okay, so here are some numbers. The CDC estimates that so far this season, there have been at least 8.7 million illnesses, 78,000 hospitalizations, and 4,500 deaths all due to the flu.
Steven Newmark 02:27
Yeah, these numbers spiked after Thanksgiving, which is no surprise. And that’s a good reminder to try and stay safe for the upcoming holidays. You know, I’ve said this before I wear a mask, probably in larger part these days for the flu and other viruses than even for COVID in some respects.
Zoe Rothblatt 02:43
Yeah. And I know you always talk about how you and your family are always masking the week leading up to a gathering. And you know, it’s just a good idea.
Steven Newmark 02:50
I’m masked all the time, but that’s different. I know, I know. I’m in the minority. I get it.
Zoe Rothblatt 02:54
Yeah, well, extra cautious. And we’ve seen this year over year and the data shows that when we have gatherings these infectious diseases spread and the numbers spike. So it’s just a really good reminder that you know, we have the tools to stay safe. So as we go into the rest of the holiday season, you’ll consider what you can do to avoid getting illness as best you can.
Steven Newmark 03:17
Absolutely. In other news, the U.S. is going to formally end the Mpox emergency declaration.
Zoe Rothblatt 03:23
Yeah, and Mpox is the new term for monkey pox. And I saw that the Biden Administration recently announced that it doesn’t expect to extend the declaration of public health emergency for Mpox. And this declaration expires at the end of January.
Steven Newmark 03:38
Yes, the administration cited the low number of new virus cases as they announced these upcoming plans.
Zoe Rothblatt 03:44
And of course you know that doesn’t mean that there’s going to be no effort and no consideration of Mpox. It’ll still be monitored, and the case trends will be looked at closely. It’s just not in that emergency state.
Steven Newmark 03:56
Exactly. Just because something’s not officially an emergency doesn’t mean we stopped looking at it. In other news, you told me before we got on the air that you’ve got some new COVID-19 Patient Support Program polls to share.
Zoe Rothblatt 04:07
Oh, yeah, so these are always really fun because we get to learn what our community is thinking about and experiencing. So this time, we polled our support program on long COVID to learn more about if they’ve been diagnosed with it, and what symptoms they had. And you know, if they haven’t been diagnosed, ultimately what symptoms concern them.
Steven Newmark 04:26
Right.
Zoe Rothblatt 04:26
So are you ready to hear the results?
Steven Newmark 04:28
I’m ready.
Zoe Rothblatt 04:29
65% said they’ve been diagnosed or tested positive for COVID. And of that, 44% of those said they’ve been diagnosed with long COVID.
Steven Newmark 04:38
Wow. Interesting. What were some of the diagnoses that they reported?
Zoe Rothblatt 04:42
So yeah, it’s a great question. The most common symptoms they had were chronic fatigue, brain fog and shortness of breath. And what was also really cool was this lined up with the top symptoms people reported being worried about. I mean, I don’t know if that’s cool, because what people are worried about is actually what people are experiencing. But it was interesting to note that those lined up really well.
Steven Newmark 05:04
Interesting. Well, hopefully those folks with long COVID are taking the care that they need and will get better soon. And hopefully all of us will be in a better state as we enter 2023.
Zoe Rothblatt 05:14
For sure. I’m definitely hoping for continued research on long COVID Because we still have so many questions, but little polls like these help us learn a bit more and add to that.
Steven Newmark 05:24
Yeah, so in big news in our main discussion for today, we’re going to talk a little bit about what’s going on in China. As many of you are aware, China has this “zero-COVID” policy, which can be quite draconian in the way it treats its residents, but they’ve begun lifting some of its COVID restrictions, even though the government “zero-COVID” policy officially still remains.
Zoe Rothblatt 05:44
Okay, Steven, how come now China decided to lift the “zero-COVID” policy?
Steven Newmark 05:49
Well, there were essentially nationwide protests that began in late November after the communist government decided to stick with “zero-COVID” policies. And as you know, protesting in China is not a common occurrence. It’s not like the United States. And so the idea that protests were capable of even breaking out I think, really affected some of the Chinese leadership.
Zoe Rothblatt 06:07
So Steven, talk to me, what were the results of this? You know, where and how are they reducing the “zero-COVID” policy?
Steven Newmark 06:16
Well, more than 20 cities, including major cities, like Beijing, got rid of the requirements for negative COVID tests just to enter public transportation and other public venues and some residential compounds now allow infected residents with special needs to quarantine at home instead of be sent to a centralized quarantine.
Zoe Rothblatt 06:33
All seem very fair to me. I can’t imagine being sick with COVID and having to quarantine in a centralized facility and not in the comfort of your home as someone that’s chronically ill we rely so much on like the safety of our home and you know, just having loved ones around. Now obviously, if you have COVID you can’t necessarily have loved ones around but just having the things that you need.
Steven Newmark 06:54
Yeah. Well, your loved inanimate objects, if I can, my iPad.
Zoe Rothblatt 06:59
Exactly. Your cozy blankets, anything you need…
Steven Newmark 07:03
My books!
Zoe Rothblatt 07:03
I can’t imagine having to go somewhere else. It’s pretty scary. So I am glad to see some of these. I don’t even know if you could call them precautions.
Steven Newmark 07:12
Well, just the idea. Imagine having to show a negative test every time you ride public transportation. I mean, how would you get around?
Zoe Rothblatt 07:18
I mean, I would never go anywhere. Yeah.
Steven Newmark 07:21
You can’t get around. You’d have to take a test, like every three hours. It’s Looney Tunes.
Zoe Rothblatt 07:25
Yeah. And like if you think about even just like having to go to the doctor like just like basic things that you need to do. It’s like an extra step. It’s already hard enough, let’s say to get to the doctor, because you need insurance approval, you need to get an appointment. There’s all these wait times, and now you have to get a test. Like it just doesn’t stop.
Steven Newmark 07:42
Yeah, well, here’s the downside. Because they’ve been sort of bottled up for so long. COVID is on the verge of exploding in China. They are already reporting and this is from China. So we don’t even… we can’t even verify how accurate this is. But they’re already reporting very high numbers, nearly 40,000 new infections per day.
Zoe Rothblatt 07:59
So let’s talk about what factors are at play here because China does have a highly vaccinated population. About 90% are vaccinated with the primary series, which just for context, in the US, we have about 68% that are fully vaccinated.
Steven Newmark 08:17
Yeah, but they’re not using the same vaccines as us they refuse to use our American vaccines. Their vaccines are called Sinovac and Sinopharm. These are inactivated vaccines that are just not quite as effective. These are vaccines that were developed, of course, early on in the pandemic, they’re refusing to accept our boosters, which are more Omicron specific and do a better job, not to mention on top of that boosters generally lag. While you mentioned 90% of folks have been vaccinated for the primary series, the number of folks who have gotten boosters is well below that. In fact, one number I did see is that only 30% of 80 plus year olds have had a booster shot in China
Zoe Rothblatt 08:57
Well, and we know how important the boosters are because your immunity wanes. We have these new variants that require more targeted vaccines. So it’s one thing to say you have a highly vaccinated population. But then when you look deeper, and you say, okay we’re not as highly vaccinated as we thought because we’re lacking in the quality.
Steven Newmark 09:15
Right. And don’t forget, they’ve had a lot less folks who’ve been infected. So their infection induced immunities is very low.
Zoe Rothblatt 09:22
That’s true, you know, with “zero-COVID”, people haven’t been getting infected, so they don’t have that immunity.
Steven Newmark 09:28
Epidemiologists are warning that the country is not prepared for wave of deadly COVID infections that it may face from Omicron very soon.
Zoe Rothblatt 09:36
And while we know that Omicron is less deadly than Delta, because we’ve seen that with data here, we’ve still seen how it can be deadly for people with no vaccine protection and vulnerable groups. So it’s just really important to remember that aspect of it.
Steven Newmark 09:51
Absolutely. And you know, if we’ve learned anything from this pandemic is that what happens in China affects everyone around the globe, everyone, right?
Zoe Rothblatt 10:00
Right! Yeah, I was about to ask, you know, what does this mean for us in our community?
Steven Newmark 10:04
Yeah.
Zoe Rothblatt 10:05
Of course, you know, we’re a global society. New mutations can arise that can come our way. Right. You know, we’re not in this COVID fight alone.
Steven Newmark 10:14
Yeah, exactly. So as we know, the virus began in China… began with, you know, one case, a handful of cases, whatever it was, and it became what it became. And you could have said two, three years ago at this point, oh gosh, I’m losing track of time, you would have said: it’s only a few cases in China. But look what happened. So now you have a situation where, again, in China is over a billion people. And as we mentioned, the population just doesn’t have the protections that we have here. The Chinese government is refusing to accept the boosters that are Omicron specific, even though that’s the dominant strain. Now, they’re not taking proactive measures to get folks boosting at all in the way that other countries around the globe have. And you have a population that just has a much lower rate of infection induced immunity. So it’s a little bit of a powder keg, and we’ll cross our fingers and hope for the best.
Zoe Rothblatt 11:01
And a population that’s over it. You know, they’re in the streets protesting because they don’t want the “zero-COVID” policy. I can’t speak for the Chinese population but it must be really disheartening to know that there are vaccines across the world that are working to protect and you have to be so isolated and following all these strict rules.
Steven Newmark 11:22
Yeah, no, absolutely. Many political commentators suggest that the ruling party in China has instituted these rules less for public health measures and more as the ability to design a more authoritarian regime. Because certainly, it’s not working to help in the public health interest. At some point, China is going to open it as we mentioned, it’s starting to open now, and they’re going to be in a more vulnerable state as a result.
Zoe Rothblatt 11:45
And you know, that just makes my heart go out to our immunocompromised friends in China. We know people here are feeling alone and isolated. I imagine that’s just so much more heightened over there.
Steven Newmark 11:56
Definitely. Well, like I said, I wish we could do something better than just cross our fingers. But for now, we’ll have to hope for the best.
Zoe Rothblatt 12:03
Yeah, we’ll keep having these discussions. You know, I think that’s also important just to talk about it.
Steven Newmark 12:08
Absolutely.
Zoe Rothblatt 12:10
Okay, Steven, that brings us to the close of our show. What did you learn today?
Steven Newmark 12:14
I thought it was interesting that of those in our patient support program who responded to the poll 44% have said they’d be diagnosed with long COVID, you know, suggesting the interplay between Long COVID and chronic illness.
Zoe Rothblatt 12:27
And you know, I learned from you about what’s going on in China with the reduction of the “zero-COVID” policy.
Steven Newmark 12:35
Well, we hope that you learn something too. We’d love to hear from you about your advocacy stories. Send your email to [email protected] Or better yet, include a short video or audio clip.
Zoe Rothblatt 12:45
And who knows whatever you share may be included in our listener feedback portion of future episodes.
Steven Newmark 12:51
Also email us you want to subscribe for our weekly newsletter, where we share the top health news of the week.
Zoe Rothblatt 12:56
Well, everyone thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you like this episode, please give us a rating and write a review on Apple Podcasts and check us out on YouTube. I’m Zoe Rothblatt.
Steven Newmark 13:10
I’m Steven Newmark. We’ll see you next time.
Narrator 13:16
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
S5, Ep 11- Building a more just and equitable medicines system for all – with Priti Krishtel from I-MAK
Millions of lives are at risk worldwide because of unjust systems that prevent those who are most vulnerable from getting the medicines they need. Even in the U.S., structural inequities exist and remain prevalent, despite appeals for their elimination.
In this episode, Priti Krishtel, a health justice lawyer and Co-Founder and Co-Executive Director of the non-profit organization I-MAK, shares how her organization advances solutions to address structural inequity in the medicines system through research, education, and policy.
“I think in the U.S. we have a real problem now. And that’s why so many people are speaking out to say prescription drugs should not be priced this high,” says Priti Krishtel.
Building a more just and equitable medicines system for all – with Priti Krishtel from I-MAK
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Priti Krishtel 00:06
“We were working in the Global South like India or Brazil, countries that had the ability to produce medicines themselves, and there we saw a lot of wins. You know, we were able to reform patent law to have more safeguards for health. But I think in the U.S. we have a real problem now. And that’s why so many people are speaking out to say prescription drugs should not be priced this high. We’ve got to have a way to rein in these costs!”
Steven Newmark 00:36
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:46
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:51
Our goal is to help you understand what’s happening in the health care world to help you make informed decisions to live your best life. Before we get started, we want to be sure that everyone takes a listen to all of GHLF’s great podcasts, we have so many to choose from.
Zoe Rothblatt 01:04
We sure do and as a reminder, you can check all of our podcasts out at ghlf.org/listen. This week, we’ll give a shout-out to Talking Head Pain. Joe, the host of the show recently attended the American Headache Society Conference and just has some really great conversations with experts there. My personal favorite was a quick episode on the link between migraine and COVID. So definitely check it out.
Steven Newmark 01:28
Yeah, I had the good fortune to join Joe at the American Headache Society Conference and it seems like he was interviewing anyone and everyone and all the most interesting conversations he had are now being posted. So I look forward to listening.
Zoe Rothblatt 01:40
Awesome. Well, we have a listener comment. Are you ready, Steven?
Steven Newmark 01:43
I am ready.
Zoe Rothblatt 01:44
This one is from Diana W. who wrote: “Thanks for the Thanksgiving talking points. It really sparked great conversation.”
Steven Newmark 01:50
Oh, well, thank you, Diana. Hopefully the conversation was civil, to say the least. And we hope you and all of our listeners had a great Thanksgiving.
Zoe Rothblatt 01:58
Yeah, amen to that. I had a really nice Thanksgiving. How about you Steven?
Steven Newmark 02:01
It was good. It was good. I unfortunately over ate, I guess that happens. Yeah. But you know, what can you do? You got to atone the week after I guess.
Zoe Rothblatt 02:09
Me too! Well, today I’m really excited for you to hear the interview I had with Priti Krishtel, a health justice lawyer and co-founder and co-executive director of I-MAK, which is a non-profit building a more just and equitable medicines system. And I spoke with her about patient access to medication and the importance of bringing patient voices into the decision making process. So I’m just excited for you and our listeners to hear it.
Steven Newmark 02:35
Great. I’m excited to listen. But first we have some news updates. A first thing you should know is that Twitter has stopped enforcing COVID misinformation policy.
Zoe Rothblatt 02:44
Yeah, this put a pit in my stomach when I saw that. You know, it could have really serious consequences and just lead to even more false claims about COVID and the vaccine than we’ve already seen.
Steven Newmark 02:55
Definitely. There’s a lot of dealings and goings happening over in Twitter land. So you know, COVID seems to be a part of that. And certainly COVID misinformation. Elon Musk introduced his policy recently, and it counters a policy that Twitter introduced in January of 2020.
Zoe Rothblatt 03:10
I saw that when they first enacted that, more than 11,000 accounts were suspended for violating the rules, and nearly 100,000 pieces of content were removed from Twitter. So that means I guess all that could be back now which is scary.
Steven Newmark 03:26
Oh, absolutely. The problem is, it’s larger than one platform. Elon Musk likes to call Twitter, the virtual town square, where people come together to exchange ideas. And he’s into protecting free speech and all this kind of stuff, which is great but you know, the analogy doesn’t fully hold. A town square in the golden days was a place where a handful of people or a dozen people or several dozen people got together. But misinformation that spreads on the internet, particularly a place like Twitter, can reach millions of people in a matter of seconds, let alone minutes and days. And influential people who have influence over others, people who are respected and looked up to start to spread this misinformation as well. And it starts to get into people’s brains.
Zoe Rothblatt 04:08
And like you said, it’s not just Twitter, it’s all of social media. It’s really a problem. We’ve been working hard the whole pandemic to counter that misinformation with things like our COVID Support Program, which is still ongoing, and people can sign up for it. And you know, we really try to look to experts, specialists, you know, doctors and patients to say: “Here is actually informed and evidence-based information that we can give out.”
Steven Newmark 04:34
Right. And again, one of the problems with Twitter and other social media is they have these algorithms where you’re only seeing certain select feeds based on your individual user algorithm. So you may only be getting the misinformation. But you know, the only thing I could say is the best way to combat this is by promulgating more truthful statements and the more that we can get our truthful statements out there regarding, not just COVID-19, but you know just the idea of what it’s like to live with a chronic condition. It’s the best way to combat it and hopefully break through to some of these algorithms to some of the folks that you may know.
Zoe Rothblatt 05:08
Well, in other COVID news a big topic is Evusheld. Evusheld is the preventative COVID treatment for people immunocompromised, and I saw in a recent statement by the National Institutes of Health, the NIH, said that, you know, the new subvariants are likely resistant to Evusheld.
Steven Newmark 05:25
Yeah, Evusheld as a reminder, as you mentioned, is the preventive COVID treatment for people who are immunocompromised, and it’s disheartening to hear that the new subvariants are likely resistant to Evusheld but what can you do? Well, you know, advocate for yourself, as we always say, talk to your doctor and make a plan for if you do get COVID.
Zoe Rothblatt 05:43
Yeah, and you know, you still get some protection from Evusheld, and some protections is of course better than none, right? It’s not saying it’s totally ineffective, it’s just waning in effectiveness. But you know, still talk to your doctor about getting that. But also, in that case, the bivalent booster is becoming even more important to make sure you have all the layers of protection you could possibly have.
Steven Newmark 06:04
Right, absolutely. Moving on, December 1 through December 7 marks Crohn’s and Colitis Awareness Week.
Zoe Rothblatt 06:11
Yeah, this runs every year during the first week of December, and it’s really a good time to just spread awareness and raise the voices of people living with Inflammatory Bowel Disease (IBD), which is the umbrella term for Crohn’s and colitis. So okay, Steven, here’s some fast facts about IBD. Are you ready?
Steven Newmark 06:29
I’m ready.
Zoe Rothblatt 06:29
So according to the CDC, around 3.1 million adults in the U.S. have been diagnosed with IBD, and around 7 million people worldwide have IBD.
Steven Newmark 06:40
Wow. Well, I’m no stranger to IBD myself so that’s not too surprising. It’s unfortunate, but not too surprising, I would say. I also know that the main symptoms of IBD are abdominal pain, chronic diarrhea, rectal bleeding, weight loss and fatigue.
Zoe Rothblatt 06:54
And you know, you said it, there are chronic, there is no cure. It’s a chronic disease. And there are great advancements and medications and you know, in serious cases, you might need surgery that that can help you reach remission. So although there’s no cure, you know, there’s a lot of stuff going on that can help patients live healthy and meaningful lives with IBD.
Steven Newmark 07:13
Absolutely. So this is a great week to raise awareness for patients with Crohn’s and Colitis.
Zoe Rothblatt 07:20
So like I mentioned, we have a special guest here with us, Priti Krishtel, a health justice lawyer and co-founder and co-executive director of I-MAK, a non-profit building a more just and equitable medicines system. She has spent nearly two decades exposing structural inequities affecting access to medicines and vaccines across the Global South and in the United States. That includes advocating for equitable access to COVID-19 vaccines across the globe to ensuring that the Biden-Harris administration is prioritizing equity in the Patent and Trademark Office. Well, Priti welcome to The Health Advocates.
Priti Krishtel 07:54
Thank you. Thanks for having me.
Zoe Rothblatt 07:56
Awesome. We’re so glad to have you here. Why don’t you start off by telling us a bit about your organization and its mission and how you got started in this work?
Priti Krishtel 08:04
Sure. So we started working on this issue at the peak of the HIV epidemic. So early 2000s, where drugs had come to market for HIV, but weren’t reaching people worldwide who needed them. And that’s where me and my co-founder Tahir first met. We had both gone to India, purely by chance, he was a private sector lawyer who represented big companies on their intellectual property or their patents. And I was a health justice lawyer working with clients who lived under the poverty line who couldn’t afford their medication. And when we met, we realized that a lot of the reasons drugs were coming to market, but then not reaching patients who needed them was because of the way the patent system was being misused. Many of the biggest drug companies were saying that they couldn’t allow for competition, they couldn’t allow prices to come down, and that there was no way to do it. And at the time it was generic companies in India and all over the world who said: “Actually, that’s not true.” This is a worldwide health epidemic, and we can make sure it happens. So we started I-MAK then, and we’ve been working together with our team ever since. And, yeah, we’re coming on almost 20 years of doing that work now.
Zoe Rothblatt 09:17
That’s awesome. Congratulations on almost 20 years! And as you say that it makes me think what change have you seen in the last 20 years? Have there been advancements in getting patients the medications that they need, like you’re talking about?
Priti Krishtel 09:31
Yeah, you know, it’s really interesting, because we were working in the Global South, like in really, usually middle income countries that have really huge populations living in poverty, you know, India or Brazil, other countries, and countries that had the ability to produce medicines themselves. And there, we saw a lot of wins, you know, we were able to reform patent law to have more safeguards for health. We were able to bring cases alongside people living with diseases who are directly affected, to be able to say: “Hey, you know, patents are supposed to be a reward for when somebody invents something.” But when the system starts to get misused, they start to basically build these patent walls, and they start to extend their monopolies longer than they should have them and prices go up and patients don’t get access. So we were able to win legal cases, reform laws, start to change the public conversation. But then in about 2015, we started getting calls from the United States, because you know prescription drugs spending, I think, has increased about 60% over the last 10 years in the U.S. Like it’s at $400 billion today, which is much higher than it used to be. And we started to get calls saying: “Can you come see whether we have a patent problem here in the US too?” Like: is this system not working as intended? And so through all of our research here, we started to realize that yes, actually, like drug makers here, the biggest drug makers, on the most profitable drugs are actually like filing for and getting hundreds of patents on the top selling drugs. And so, you know, your question like: “Is it getting better?” Well, in some cases, it got better globally. But I think in the US, we have a real problem now. And that’s why so many people are speaking out to say prescription drugs should not be priced this high. They shouldn’t cost the country, you know, public payers like Medicare this much. We’ve got to have a way to rein in these costs.
Zoe Rothblatt 11:27
Yeah, especially for the community that our organization serves with chronic disease. It’s like a lifelong condition that you keep having to pay these high prices. It’s really, really challenging when you’re already managing your health to also be strapped with financial decisions like that. And I wanted to ask about your Participatory Change-Making tool and how that fits into this discussion around patents and hopefully changes.
Priti Krishtel 11:53
Yeah, so you know, we spend a lot of time as I was saying, like, using our research to expose the problem, making sure that the press and policymakers and the public knew that this gaming of the patent system was really happening and eroding and diluting its original intent. What happened next is we started to observe the way that law reform usually happens in the U.S. is that it’s those with the deepest pockets who are able to lobby Congress. And so we built Participatory Change-Making to really make sure that people who are being affected would have a seat at the table with policymaking around medicines. We focus first on patents because it’s, you know, kind of the core of our work and usually with patent policymaking, it’s only major corporation who have a seat at the table. So for example, the patent the Public Advisory Committee to the Director of the Patent and Trademark Office, you know, it doesn’t have patient groups or affected communities. So we’ve been making a big push with the agency that that needs to change, but Participatory Change-Making, or PCM, that’s our program, we convene different stakeholders together. And so we make sure that Patent Office officials for example are at the table with people living with cancer, or arthritis, or diabetes, or other conditions, so that they can hear directly from communities who are affected. But in the spirit, also of making sure that our democracy survives in this moment, like, because America is so polarized, because we’ve lost our way on… in general, being able to have difficult conversations across difference… What we do is we bring together a pretty broad-ranging set of stakeholders. So you might have lawyers for the pharmaceutical industry at the table or investors, or patent judges, or academics. And really, by having that very big table with a lot of diverse viewpoints represented, not just like ideological or political differences but also just people who have a different lens on the system, the idea is that people’s understanding of the system would be deepened, and then better policy would come out of it. So policy development could happen in a really informed way.
Zoe Rothblatt 14:05
Yeah, that’s amazing. Thank you for all that you do to make it an inclusive conversation and bring in so many voices. I want to quickly ask what’s it like bringing all those groups together, and if there’s, you know, a memorable moment from a patient interaction that you remember?
Priti Krishtel 14:20
Yeah, in our last convening, we had different government agencies represented, different types of sectors, even because the patent system affects not only pharma, but also tech and, you know, other stakeholders. And so it’s a very diverse room in terms of viewpoints. And we asked some of the people living with cancer or diabetes to open up to us and just make sure that they grounded us in the stories of the impact of the cost of medicines on the real lives. And we got to hear, you know, just that, and I think it sort of anchored us in the policy conversation and that perspective. And then a very rich conversation ensued, where we were talking about the wonkiness of policies about the intersection of the patent office and the FDA. And then at one point, we were really, you know, a bunch of us or lawyers or policy people were getting into it, and I remember somebody from T1International, which is a diabetes advocacy organization, spoke up and said: “Can I just ask, does this actually have anything to do with my life?” And we looked at the policy we were discussing again, and we realized that actually it wouldn’t have an impact, you know, down the line in terms of the cost of medication, you know, to an individual patient or family. And so it really was such an important and powerful course correction that I realized, like we have to keep going, we have to keep pushing government to engage in this type of participatory policymaking, because right now, it’s happening in a very top-down way, and it’s not going to have an impact on people’s lives unless we keep building that bigger table.
Zoe Rothblatt 15:51
That is such a good point! Always remembering that at the end of the day it’s, you know, the patient at the center of these conversations, and that’s, you know, whose life is really at stake here. My final question for you is, you know, what advice do you have for someone looking to get into this type of advocacy? Maybe a patient wants to get involved and raise their voice. What, what would you like to impart to them?
Priti Krishtel 16:14
Yeah, I mean, I’m told as a lawyer regularly that these are technical conversations that you need the facts and the evidence. And that you need to be an expert to have your voice heard. That’s the message that comes from those who want to uphold the status quo. Because it’s the status quo that makes people… you know, there’s billions of dollars on the table, people have a vested interest in maintaining it. And I really urge everyone to see through that and to know that it’s not true, and that if it’s so complicated, we as the public can’t understand it, then it’s actually the wrong system for us. One direct way to get involved is there’s an organization called Patients For Affordable Drugs that we work with quite closely, that spans different disease areas. And so I always encourage everybody to look at their website, or sign up for their newsletter, because they put out regular briefings on the different issues coming out of DC that people may want to get involved with. And if you’re interested in learning about what’s happening with patent reform specifically, you can sign up for our newsletter as well, you can go to our website, I-MAK.org. And then you can click on the thing that says ‘join us’, and then you’ll get our newsletter every month at that point.
Zoe Rothblatt 17:24
Excellent. We’ll be sure to include that in our show notes. Well Priti, thank you so much for joining us today on The Health Advocates and sharing about all the amazing work you and your organization do. We appreciate you.
Priti Krishtel 17:34
Yeah definitely. Thank you so much for everything you all do as well.
Steven Newmark 17:39
Wow. Yeah, that was fantastic. It was really great hearing from Priti about all that she does on behalf of patients, and particularly as a lawyer myself, I was fascinated to hear about how to use the legal system. In fact, I’m going to preempt you by saying that was my learning today.
Zoe Rothblatt 17:54
Oh, yeah. I was about to ask, you know, it’s the close of our show, what did you learn, so I will share that I was reminded by Priti about the importance of bringing the patient voice into conversations especially among decision makers.
Steven Newmark 18:07
Well, we hope that you learn something too. We’d love to hear from you about your advocacy stories. Send us an email at [email protected]. We hope to hear from you soon.
Zoe Rothblatt 18:18
And who knows whatever you share may be included in our listener feedback portion of future episodes.
Steven Newmark 18:23
Also email us if you want to subscribe to our weekly newsletter, where we share the top health news of the week.
Zoe Rothblatt 18:28
Well, everyone thanks for listening to The Health Advocates a podcast that breaks down major health news of the week to help you make sense of it all. If you liked this episode, give us a rating and write a review on Apple Podcasts. And also check us out on YouTube. I’m Zoe Rothblatt.
Steven Newmark 18:43
I’m Steven Newmark. We’ll see you next time.
Narrator 18:49
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
S5, Ep 10- Talking Turkey Day and COVID
While COVID-19 vaccines and medications are largely available, this year’s celebrations will not be without risks, especially for the chronic disease community.
Our hosts discuss their plans for Thanksgiving and share their tips to stay healthy and to help advocate for communities that are at higher risks from COVID. “If you have loved ones or you’re surrounded by folks who may not be as sympathetic or as understanding to getting the vaccine or wearing masks, the best way to listen is to listen with empathy. It may be difficult to listen if you hear loved ones repeating false claims about the vaccine, masking or COVID, but if you immediately shut down their concerns, they may not listen to you in return,” says Steven Newmark, Director of Policy at GHLF.
Talking Turkey Day and COVID
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Steven Newmark 00:08
“If you have loved ones or you’re surrounded by folks who may not be as sympathetic or as understanding to getting the vaccine or wearing masks, you know, the best way to listen is to listen with empathy. It may be difficult to listen if you hear loved ones repeating false claims about the vaccine, masking or COVID but if you immediately shut down their concerns, they may not listen to you in return.”
Steven Newmark 00:30
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense if at all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:41
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:45
Hey Zoe, it’s Thanksgiving time, my favorite time of the year.
Zoe Rothblatt 00:48
Me too. I love it so much.
Steven Newmark 00:51
I do too. I like to overeat. I accept that it’s okay. Moderation is great, but only in moderation, as they say. So Thanksgiving is a good day to break from that moderation though, right?
Zoe Rothblatt 01:00
Yeah, you have to indulge a little bit. You know, the crispy marshmallows at the top of the sweet potato, something that you would probably never serve any other day of the year but it’s totally acceptable to have dessert on the table at Thanksgiving.
Steven Newmark 01:14
Umm marshmallows. That is true. I always say, 364 days a year, I cannot recall ever eating a whole turkey in my life, ever.
Zoe Rothblatt 01:23
It’s so fun. I love the indulgence.
Steven Newmark 01:25
Totally. And it’s so American.
Zoe Rothblatt 01:27
Yeah. Well, this year is my first southern Thanksgiving. I’m staying in Nashville. So we’ll see how that goes.
Steven Newmark 01:33
Excellent. So you’ll see a different part of the country. That’s very exciting. Well, today, on today’s special episode, we’re going to talk about Thanksgiving. And we’re going to do our annual Turkey Day talking points and how to talk to some of your relatives about what you’re dealing with as you go through your daily day with a chronic illness or as an advocate for folks with chronic disease.
Zoe Rothblatt 01:52
You know, the dinner table and like that fun environment we were just talking about is such a great time to educate loved ones about living with a chronic condition, the advocacy you do, it feels like pretty low stakes because you know, everyone’s just sitting around anyways. It’s not like you’ve called this big meeting.
Steven Newmark 02:09
Right?
Zoe Rothblatt 02:09
And people are in a good mood and having fun. And yeah, it’s just a great time to talk about these concerns that you have.
Steven Newmark 02:15
Yeah, and whether you’re with friends or family or neighbors, you know, hopefully there’s a celebration of love in the room, and it will be an easy time to talk with folks. Yeah. And you know, of course, we’re not ignoring that COVID is still very real. We know that many will be celebrating over zoom or with smaller groups. And that’s actually exactly what we want to talk about. We’ve said it once, we’ll say it again, you know, it feels like a lot of the general public is back in ‘normal life’, quote, unquote. Mass mandates have been lifted, work-from-home employees returned to offices, and many have just resumed pre-pandemic ways generally. And I’ll say it, you know, things aren’t cut and dry for those of us living with chronic illness. Yeah. And it’s a great idea whether you’re over Zoom or in person to start a conversation about your health and why it is important to stay safe from infectious diseases like COVID-19, and the flu.
Zoe Rothblatt 03:06
So Steven, you know, sometimes these conversations can be really hard to have, especially like everyone these days thinks they’re a public health expert.
Steven Newmark 03:13
Right?
Zoe Rothblatt 03:14
And sometimes it can feel really combative. So what are a few good ways to get going and even start having a conversation like this?
Steven Newmark 03:22
Yeah, I mean, even just starting the conversation is probably the most difficult part. But you can begin by explaining why you got involved with GHLF and the 50-State Network. You can share your personal story to the extent you’re comfortable doing that. You’re likely used to explaining your chronic illness and how it impacts your life so you can go into these conversations knowing that you’ve done this clearly, firmly and successfully before. You can explain your diagnosis and how it may put you at higher risk of severe COVID-19.
Zoe Rothblatt 03:49
Yeah, that’s a really good point. Just start out by making it about you and you know, like the focus on why you advocate, why you’re at severe risk maybe, and your chronic condition and just really making it about: “Hey, guys, I want to talk about these things that are important to me.”
Steven Newmark 04:05
Absolutely. And then you can easily transition into why wearing a mask helps protect the chronic disease community. Some folks are still questioning the use of masks but you could explain that people who are immunocompromised because they take immunosuppressive medication may still be vulnerable to COVID-19 after being vaccinated since we don’t have enough data yet on how well the COVID-19 vaccine protects these individuals. For now, many experts recommend that immunocompromised patients continue to follow standard mitigation efforts like wearing a mask even after they’re fully vaccinated.
Zoe Rothblatt 04:35
Yeah, that’s a really good point. Like it’s not coming out of nowhere, doctors and experts are saying that you should still wear masks and that they are protective. And it definitely helps. I feel more comfortable when I see someone wearing a mask. I know we’ve talked about this. It’s like you’ll get a little smile like: “Oh, that’s my companion out in the wild.”
Steven Newmark 04:52
Yeah, I feel that for sure!
Zoe Rothblatt 04:54
So what about the vaccine? This conversation can get really tricky and uncomfortable. How would you broach that topic with friends and family?
Steven Newmark 05:03
Yeah, again, I will explain that getting vaccinated helps protect the chronic disease community. It protects you, of course, but it also protects the broader community. Public health experts, medical organizations, doctors and specialists have stated that the COVID vaccine is safe and recommends that patients should get vaccinated unless they have a specific contraindication like an allergy to a vaccine ingredient, but concerns remain about whether the vaccine may be somewhat less effective in these patient groups compared to the general population, which makes it all the more important for the loved ones of immunocompromised individuals to get vaccinated too.
Zoe Rothblatt 05:38
Yeah, I’ve been on like a mini campaign these past few weeks to get my loved ones the flu shot and the bivalent booster and it’s going well so far but you know, sometimes it takes a little push to get your loved ones vaccinated.
Steven Newmark 05:51
Yeah, and if you have loved ones, or you’re surrounded by folks who may not be as sympathetic or as understanding to getting the vaccine or wearing masks, you know, the best way to listen is to listen with empathy. It may be difficult to listen if you hear loved ones repeating false claims about the vaccine, masking, or COVID but if you immediately shut down their concerns, they may not listen to you in return. So in this situation, it can be helpful to focus on sharing ideas and having facts ready. Instead of telling others they are wrong, you can explain why you feel otherwise and how staying safe is important to your health.
Zoe Rothblatt 06:24
Yeah, I think that’s a really good point, listening with empathy and also making it about you. Sometimes the news is just so general, and you know, this is good, this is bad, must do, can’t do… And when you bring it down to the personal level about, you know, why you need to stay safe and effective and what your loved ones caring for you means, I think it helps shut down a lot of those concerns.
Steven Newmark 06:47
Absolutely. And when you do have a sympathetic ear, definitely mention the 50-State Network, you can encourage your family and friends to become advocates and join our 50-State Network.
Zoe Rothblatt 06:56
Yeah, we have advocates all over the country and all 50 states and Puerto Rico and you know, we do trainings, and we have some really exciting stuff coming up for 2023. So definitely encourage those around you to get active.
Steven Newmark 07:08
Well, I’m very excited for tomorrow. It’s gonna be a great feast. What are your plans Zoe for Thanksgiving?
Zoe Rothblatt 07:13
So it’s my first Southern Thanksgiving. I’m staying down here in Nashville.
Steven Newmark 07:17
Excellent.
Zoe Rothblatt 07:18
My mom is coming down. So you know, I’ll show her around. We’ll have lots of fun. I’m excited. You know, just to switch up the Thanksgiving traditions this year. Yeah. And, you know, just see how it’s done down South. It’s really exciting. How about you, Steven?
Steven Newmark 07:32
I will be at my wife’s family in Pennsylvania. And I absolutely just love it. It’s a few days of just vegging out. I turn my phone off. I don’t open up a laptop. I try to just veg out. I’m also extra excited this year because the World Cup is going to coincide with Thanksgiving holidays. So I get to watch that as well as American football on Thanksgiving itself. So my brain is gonna be nice and shut off.
Zoe Rothblatt 07:55
Well I’ll be tuning into the Thanksgiving Parade. The Macy’s Parade is a crowd favorite in my family.
Steven Newmark 08:01
Yes! Let me tell you two quick things. The first is when I was a little kid I grew up right outside of New York City. Every year, I would watch the Macy’s Thanksgiving parade, every year I would ask to go see it and every year my parents said maybe next year. And I never got to go and I’m so upset. And I really want to take my kids. Now they live in New York City but of course every year we go to Pennsylvania so I’m never in town.
Zoe Rothblatt 08:22
Well, something cool is also seeing the balloons blow up like the day or so before. Totally. But you risk getting stuck in all the traffic if you hang around in the city too long. Well, sounds like it’s gonna be a fun one this year. You know, I’m definitely feeling good going into Thanksgiving with the bivalent shots. You know, we still have the rapid COVID tests. I feel like we know how to stay safe or you know how to try to stay safe and we can implement those as best we can. But ultimately I’m feeling a bit hopeful to have some in-person fun this year.
Steven Newmark 08:55
Yeah, me too. My family, we tried to time it as best as possible. We got most of our flu and COVID boosters roughly at the three week mark before and we’re all in N95 masks like crazy the week before for the last week. So you know we’re gonna test and we’ll see and I’m pretty hopeful though.
Zoe Rothblatt 09:12
I’m hopeful to! Well, Steven, I hope you have a happy Thanksgiving and to our listeners as well enjoy the holidays. We hope you have time to just relax and take it easy. Well, happy holidays everyone and thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you like this episode, give us a rating and write a review on Apple Podcasts and hit that subscribe button wherever you listen. It’ll help more people like you find us. I’m Zoe Rothblatt.
Steven Newmark 09:42
I’m Steven Newmark. Happy Thanksgiving everyone!
Zoe Rothblatt 09:44
Happy Thanksgiving!
Narrator 09:49
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
S5, Ep 9- ACR Convergence: Key Takeaways from the World’s Premier Rheumatology Conference
The Health Advocates share several takeaways from attending the 2022 American College of Rheumatology Convergence (ACR), a meeting where rheumatology health professionals from around the world gather to share best clinical practices and cutting edge-research.
A highlight of the conference was the patient perspective posters, and our hosts got to speak with a few of the patient presenters about their experiences. Stephanie Aleite, a Mental/Behavioral Health Fellow and patient advocate, created “Engaging with the Spoon Theory” to help her patient peers prioritize how they expend energy. “My hope is that by using this, patients feel empowered to make more meaningful decisions about engaging with their support system and really prioritize events that can give the biggest emotional payoff.”
ACR Convergence: Key Takeaways from the World’s Premier Rheumatology Conference
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Stephanie Aleite 00:08
“So my hope is that by using this, patients really feel less of the emotional strain that comes from living with arthritis and that they feel empowered to make more meaningful decisions about engaging with their support system and really prioritize events that can give the biggest emotional payoff.”
Steven Newmark 00:30
Welcome to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:39
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:44
Our goal is to help you understand what’s happening in the health care world to help you make informed decisions to live your best life. But before we get started, we want to be sure that everyone takes a listen to all of GHLF’s great podcasts. We have so many to choose from.
Zoe Rothblatt 00:57
We sure do, Steven. And as a reminder to our listeners, you can check all of our podcasts out at ghlf.org/listen. This week, we’ll give a shoutout to Talking Head Pain hosted by Joe Coe. Season 3 has dropped and Joe is just talking to migraine and headache advocates about their journeys. It’s really great.
Steven Newmark 01:15
Excellent.
Zoe Rothblatt 01:16
So let’s start with a listener comment. Ready?
Steven Newmark 01:19
Yes, yes.
Zoe Rothblatt 01:20
This one came in from Grace K. who wrote: “Great podcast, really informative!”
Steven Newmark 01:24
Thanks, Grace. That’s what we aim to do.
Zoe Rothblatt 01:28
Alright, Steven, that brings us into today’s discussion where we’ll talk about the recent conference, we both attended: the American College of Rheumatology 2022 Convergence, or as people commonly call it: ACR.
Steven Newmark 01:40
Yes, I was there in person and you were there virtually?
Zoe Rothblatt 01:44
Yeah. Once again, I’m so grateful for the virtual option, the hybrid option, for those of us who aren’t ready to go in person or you know, the travel’s a little more expensive. For you it’s a train, for me it’s a flight. I’m just grateful to have that virtual option.
Steven Newmark 01:59
Absolutely. And for me, being there in person, I was grateful that it wasn’t as crowded as it might have been, because it was offered virtually.
Zoe Rothblatt 02:06
Oh, yeah, that’s a good point. So let’s dive in. What is ACR and why does it matter?
Steven Newmark 02:12
Sure. Well, every fall, rheumatology and health professionals from around the world gather to share best clinical practices and cutting edge research at the American College of Rheumatology Convergence. The goal of the meeting is to educate providers about the latest rheumatology science in order to provide better care for their patients.
Zoe Rothblatt 02:28
And you know, from what you’re saying, it’s geared towards providers, and obviously, we’re a patient organization. So I think, you know, the next question is like, what does it mean for patients? And from our perspective, you know, the meeting serves as a really important goal for educating patients about the latest rheumatology science so that you know, our listeners and our community can learn more about their conditions and be more engaged with their providers.
Steven Newmark 02:53
Absolutely. And I saw a lot of patients while I was there, and I know that you Zoe were connecting to a lot of patients online to get important information.
Zoe Rothblatt 03:01
Oh, yes. Spoiler alert. We’ll hear from a few patients in this episode.
Steven Newmark 03:05
Great.
Zoe Rothblatt 03:05
So you know, what are some key takeaways that you learned from the conference? There was a lot of information going around. You know, what either surprised you or was a common theme that you were hearing about?
Steven Newmark 03:16
Well, I think some of what we learned is that there was a lot of discussion about a shortage of rheumatologists.
Zoe Rothblatt 03:23
Yeah, that was a big one.
Steven Newmark 03:24
Yeah, shortage of doctors specializing in rheumatology.
Zoe Rothblatt 03:28
Steven, I saw that they said that in Barbados, there was only one rheumatologist, that was really shocking to me.
Steven Newmark 03:35
Wow, it seems as though less and less MDs are selected as their specialty while at the same time some of the older doctors are retiring. So there’s not that infill that generally takes place in the profession, unfortunately.
Zoe Rothblatt 03:48
Yeah. Okay. What else did you learn?
Steven Newmark 03:50
There was a lot of talk about the need to humanize health care to make medication more accessible and the idea of working together to find better solutions. And working together that means doctors working with other doctors, patients talking to other patients, and of course patients and doctors talking together along with public health professionals.
Zoe Rothblatt 04:07
Yeah, I saw a lot of talk about the… you know, collaboration between the doctor and patient and it’s cool that you felt that in person and I felt that virtually the messages were getting through to us. I also saw some stuff about telemedicine and by some stuff, I mean, a bunch of stuff. You know, one of the speakers mentioned: “Telemedicine is here to stay! Go virtual or go home.” So that was really exciting to hear.
Steven Newmark 04:31
Yeah, for sure. Look, we all know, we’ve spoken about the benefits of telemedicine and to hear it said in blunt terms that this is here and it’s not going away, from the doctors, is good news I think because I think we all appreciate if nothing else, the option of telemedicine.
Zoe Rothblatt 04:46
Yeah, I definitely do. I love telemedicine. Especially for kind of routine check-ins to go over lab work or something like that. It’s really helpful. And you know, lastly, I would say my last big takeaway was that we’re still very much fighting COVID and it was comforting to hear that talked about in a large conference. Because you know, Steven, we always talk about how the public is kind of ignoring COVID. And it sometimes feels like just our community is shouting out. I know this was sort of a community event where it’s like a gathering of rheumatologists. But it was helpful for me to see that there’s still research being done and discussions being had. And critical discussions like: we don’t know the future but what do we know right now?
Steven Newmark 05:25
Absolutely, there was a lot of discussion about that. And, again, it’s… I think a lot of that is the patient’s voice that’s amplifying that. So it was good that we were there. And it was good that you were there as well, most importantly, to get the information into the hands of patients around the country and around the globe.
Zoe Rothblatt 05:40
Well, speaking of patients, you know, patients are invited to submit a poster about an intervention that helped them improve their health. And you know, these patient perspectives are a really important part of a conference that’s geared towards doctors.
Steven Newmark 05:54
Absolutely.
Zoe Rothblatt 05:55
Many of the speakers are just health professionals. It’s really important to have the patient perspective in there, I think, because, you know, there’s really no one-size-fits-all approach when it comes to medicine, and getting that patient voice and patient perspective helps doctors personalize their care.
Steven Newmark 06:11
Yeah, no, absolutely. You know, it’s really important, again, for doctors to see patients at a conference like this. It’s a very different way of seeing patients than doctors normally get. You know, you’re limited to your six minutes, if you’re lucky one on one with individual patients. But here’s an opportunity to see patients coming together. And speaking in a louder voice. Doctors are able to really take a breath, they’re not in a medical setting per se, and trying to provide medical care.
Zoe Rothblatt 06:35
There is a more equal power balance in a conference versus the doctor’s office.
Steven Newmark 06:41
That’s a good way of putting it, yeah. A more equal power balance. The doctor is not trying to rush you out, because they have another patient to see there. They’re settled in for the weekend. And if they could take a little bit more time to look over some of these patient posters to talk with some of these patients and to see what they’re talking about. It’s really important.
Zoe Rothblatt 06:58
For sure, and actually, I was one of those patients. I submitted a poster with Cheryl Crow who is an occupational therapist and she lives with rheumatoid arthritis. You may know her as Arthritis Life’s Cheryl, she’s so awesome. And we wrote about how social media can be used for good and help us on our healthcare journeys. But you know, GHLF also worked with 8 patients on posters, I guess 8 including me, so seven others, and I sat down and spoke to a few of them about their poster and what it was like So Steven, shall we have a listen?
Steven Newmark 07:29
Definitely.
Zoe Rothblatt 07:29
Okay, let’s start with Stephanie Aleite. Hi, Stephanie. Welcome to The Health Advocates. We’re so excited to have you here today to talk about your poster at the ACR Convergence. Why don’t you start off by introducing yourself to our listeners?
Stephanie Aleite 07:44
Hi Zoe, thanks so much for having me. Yes. So I live with rheumatoid arthritis. I was diagnosed 26 years ago and for the last 10 years, I’ve been a patient advocate. I am also a behavioral health fellow and a clinical social worker.
Zoe Rothblatt 08:02
Great, so what brings us here today is to talk about your poster. Why don’t you dive in and tell us about what you uncovered in your poster.
Stephanie Aleite 08:09
So the abstract that I submitted is called engaging with the Spoon Theory. And it features the intervention that I created, which is called: “Spoon Theory Economics”. It’s a cost-benefit analysis that I created to kind of help patients increase the connection they have with their support system. As an RA patient, I really know firsthand just how isolating living with arthritis can be. And as a social worker, I know that isolation can have a really significant impact on, not just mental wellbeing, but physical wellbeing too. And social support is actually something that has been really, really well documented in clinical research. Especially its relationship with positive health outcomes. So we know The Spoon Theory framework, right. And individuals with chronic health conditions have a reduced number of spoons or units of energy that they have to use every day strategically to complete daily tasks. So my proposed intervention, I won’t go into really definite details, but I’ll give a little overview. Spoon Theory Economics engages The Spoon Theory framework by asking patients to do a very simple mathematical calculation when they’re making decisions about social events. Don’t worry, this isn’t calculus. It’s just a subtraction.
Zoe Rothblatt 09:35
Okay, let’s hear it.
Stephanie Aleite 09:36
Okay. So if you can count to 20, and you know how to use the minus sign, you’re good. All we’re doing is calculating the difference between the importance of an event and the amount of energy or spoons required to do it. Both are rated on a scale of zero to 20. So essentially, the total value, the higher it is, it means the greater emotional gain. I’ll give you an example. If you are rating the importance of an event as 15 out of 20 points, but it costs you 10 spoons to do that, then you’re only getting a five out of 20 total value. So you know, you have some decisions to make. The variables I like to consider when determining the importance of an event are the guestlist, the rarity of the event, the fun factor, and the value to my career.
Zoe Rothblatt 10:29
And what sparked you to come up with this, and you know, submit a poster to ACR?
Stephanie Aleite 10:35
Oh, yeah, well, honestly, it’s a huge honor. It’s something I’ve wanted to do for a very long time. So I was so grateful to get the opportunity to do so. But I came up with a theory because honestly, I was so tired of just the emotional and physical burnout of FOMO, like the fear of missing out, you know. I was so tired of pushing myself so hard to attend things, and then paying for it later, because I was scared that if I stopped attending social events, that people would just stop inviting me. So to be honest with you, I did get to a point where I just gave up participating because the resentment and the burnout was just so real to me. And that’s why I created this intervention. I wanted to figure out an easy way to either help me make decisions about events, meaning which events I’m going to say yes or no to, or at a minimum just helped me be more aware of the cost so I can prepare and plan ahead. Like, for example, if I want to go somewhere, and I know it’s going to cost me a lot of spoons, I might ask a friend to drive me or help me in some other way. So my hope is that by using this, patients really feel less of the emotional strain that comes from living with arthritis, and that they feel empowered to make more meaningful decisions about engaging with their support system, and that they do so in ways that bring about like maximum fulfillment and joy, and really prioritize events that can give the biggest emotional payoff, hopefully free of the consequences that come from overspending spoons.
Zoe Rothblatt 12:21
I love that so much. You know, you mentioned you’ve been an advocate for 10 years. And I love the use that you’re putting your advocacy to in creating this tool that other patients can use to help them advocate for themselves, just like you have for yourself. So thank you for all that you do, Stephanie.
Stephanie Aleite 12:36
No, thank you so much. Honestly, this method has really just helped me in more ways than ever before. And I really hope the same is true for others.
Zoe Rothblatt 12:45
Thanks, Stephanie. Ashley had a few things to say about her poster as well. Why don’t you start off by introducing yourself to our listeners.
Ashley Krivohlavek 12:54
So my name is Ashley Krivohlavek. I am in the Tulsa Oklahoma area, and I have been living with psoriatic arthritis for about, I think we’re coming up on my ninth year now. So quite a while. The title of my poster is: “Please Hear Me: How Effective Provider-Patient Communication Improved My Psoriatic Arthritis”. And my objective with this poster was to absolutely give patients the ability to communicate more effectively with their provider. A lot of times I think that patients are like, well, they should just understand that I’m… when I say I’m fatigued… and just go from there. And a lot of times providers think: “Oh, well, they should know that I need to know how many days out of the week, I need to know that you’re fatigued and how it’s, you know, affecting your daily routines” and stuff like that. So what I really wanted to do was kind of bridge that communication gap and prepare patients going into those office visits with the best, most effective information that they can so that they can talk about different treatment options, or you know, what other lifestyle modifications that may be. So that was sort of the goal with us. And I have employed that advice myself many times, but particularly while changing rheumatology provider during the pandemic. But we came out on the other side and it’s actually for the first time in 8… 9 years it’s being well managed. So very grateful for that.
Zoe Rothblatt 14:41
Yeah, well, congratulations! That is such a big accomplishment to, you know, feel your disease is well managed and in control, and it’s really inspiring that you got to that point because of your self-advocacy, and now you’re sharing it with other patients.
Ashley Krivohlavek 14:55
Yeah, thank you. Every day I kind of just pinch myself and I’m like: “Oh my gosh. I can’t believe that I moved at this point with my chronic illness.” When I first started… I always tell the story… But when I first started my sort of journey into this, I would go by the infusion room. And I would always go past the infusion room and think: “Please, I don’t want my disease to progress to that level where I have to have infusions or other medical interventions.” And like about a year into the diagnosis, I was begging to be in infusion room because I was like, I need it. So it was such a short turnaround. But I am really grateful to be where I’m at today!
Zoe Rothblatt 15:41
And speaking of where you’re at today, what inspired you to submit this as a patient poster at ACR this year?
Ashley Krivohlavek 15:48
So for a variety of reasons. One is that I have been wanting to do more of written and information like just writing and getting things out to people that way. And secondly, the ACR is so amazing, because it puts our writers and people that are working in the rheumatology community in the same building as patients. And so what a unique opportunity that you get to have to talk to providers in sort of an informal setting, you’re not really talking necessarily about yourself, but you’re talking in broad about how to improve, you know, the disease for everybody. And it’s such a collaborative sort of feeling that I’m so excited to be able to do that and be able to communicate and see other patients that are doing the same thing as me and advocating because not everybody likes to advocate or discuss their own journey. And that’s totally fine. But I don’t mind at all. So this was perfect for me.
Zoe Rothblatt 16:57
That’s awesome. Well, thank you for, you know, coming on to The Health Advocates and sharing your advocacy with us and our listeners. We appreciate all that you do Ashley and finally now let’s hear from Eileen. Hi Eileen. Welcome to The Health Advocates. We’re so excited to have you here today to talk about your ACR poster.
Eileen Davidson 17:16
Hi, my name is Eileen Davidson. I’m from Vancouver, BC, Canada and I live with rheumatoid arthritis. I’m also a writer for CreakyJoints, as well as a patient partner with Arthritis Research Canada and several other organizations.
Zoe Rothblatt 17:29
And you will also participate in the Let’s Get Personal podcast, I’ll just give a little shoutout there, where you share your RA journey. So today we’re here to talk about the recent American College of Rheumatology conference where you presented a poster. Tell us about that poster and what you did in there.
Eileen Davidson 17:45
Well, I’ve been partnering with Arthritis Research Canada since 2018. And I’ve learned a lot from doing so particularly the studies that have involved exercise, and it was Arthritis Research that really kind of gave me a deeper understanding of how to live with this disease and pace with it. So when I attended the American College of Rheumatology Conference in Atlanta, in 2019, I saw the patient perspective posters. I instantly knew I wanted to do one. However, I waited a couple of years because I really wanted to do it in person, not virtual. So I knew this year, I was going to be presenting with Dr. Linda Li from Arthritis Research Canada on about a 24 hour day with rheumatoid arthritis. But I also wanted to do a poster and I narrowed it down to two studies that really kind of transformed my life. And I was also to really help out with the research. So they were the studies based off of physical activity, tracking my symptoms and my steps every day, as well as working with a kinesiologist on breaking down the barriers that I face as somebody living with rheumatoid arthritis… And I was able to take my experiences, which helps me write better, exercise better, live better and manage with my condition, but also create useful content for people living with the same condition or similar conditions as me and I kind of just wanted to put it all into one poster.
Zoe Rothblatt 19:08
That’s awesome. And I know you touched on this a little, that you went ACR and saw the posters and want to submit one but you know, what was it about seeing them there that made you say, I want to be part of this conference specifically?
Eileen Davidson 19:21
Well, I wanted to also promote patient engagement and research to other researchers and clinicians. And I think it’s really important for actually clinicians to understand that patients can get involved like this because often medical appointments are infrequent, there’s long waitlists, you won’t necessarily find the answers that you need to, but this is an avenue where you can get information and resources for living with your condition outside of the doctor’s office.
Zoe Rothblatt 19:45
Eileen, that’s so great. And I think it’s really amazing that you’re bringing the patient perspective to these conferences and continue to advocate especially for something like exercise, which I know can be really challenging when you live with arthritis. So thank you for all you do. And thank you for sharing with us today.
Eileen Davidson 20:02
You’re welcome. Thank you so much for the opportunity to do this and the support in being able to learn how to write an abstract, because without CrwakyJoints’ help, I really don’t know if I would have even been accepted.
Zoe Rothblatt 20:13
Well, you did all the hard work. So thank you, Eileen.
Steven Newmark 20:16
Yeah. Wow, that was fantastic. Zoe, it’s so great hearing from the patients one on one, you talking to the patients. You know, having been at the Convergence, it was great seeing the patients, but it felt different than the more intimate conversations you had with Stephanie, Ashley and Eileen. So that was fantastic.
Zoe Rothblatt 20:31
Yeah, agreed. It was really a wonderful opportunity to be able to sit and chat with them. So Steven, that brings us to the close of our show. What did you learn today?
Steven Newmark 20:41
Well, I hope that everyone learned the importance of inserting the patient voice into the medical community. You know it’s not just in the offices when you get that few minutes with your doctor one on one, but also the louder voice when we’re able to amplify it at larger gatherings of doctors.
Zoe Rothblatt 20:55
Well, thank you. And, you know, I learned that it’s really helpful to debrief after these conferences and hear from each other about key takeaways and just the difference between in person-virtual, it’s good to have these conversations together.
Steven Newmark 21:10
Well, we hope that you learn something too. We’d love to hear from you about your advocacy stories, Send your email to [email protected]. Or better yet, include a short video or audio clip.
Zoe Rothblatt 21:21
And who knows, whatever you share, maybe included in our listener feedback portion of future episodes.
Steven Newmark 21:26
Also email us if you want to subscribe to our weekly newsletter, where we share the top health news of the week.
Zoe Rothblatt 21:31
Well, everyone thanks for listening to The Health Advocates, a podcast that breaks down major health news of the week to help you make sense of it all. If you like this episode, give us a rating and write a review on Apple Podcasts and hit that subscribe button wherever you listen, and it will help more people like you find us. I’m Zoe Rothblatt.
Steven Newmark 21:48
I’m Steven Newmark. We’ll see you next time.
Narrator 21:54
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
EXTRA Part 1- Non-Radiographic Axial Spondyloarthritis: A Conversation with Dr. Jeff Stark and Patient Advocate Ricky White
The truth is there are more than 100 types of arthritis, but not all of them receive the public recognition they deserve, especially non-radiographic axial spondyloarthritis (non-rad AxSpA).
In the first of a two-part episode, The Health Advocates are joined by rheumatologist and Head of Immunology Medical at UCB, Dr. Jeff Stark, and patient advocate Ricky White who lives with non-rad AxSpA. Dr. Stark and Ricky discuss the challenges in diagnosis, the advancements in treatment, and the research and advocacy being done to improve the patient journey.
“There are barriers for patients around diagnosis and certainly we want for patients with non-radiographic AxSpA to have appropriate treatments,” says Dr. Stark about the challenges patients face, “but there is so much more that can positively impact the journey that patients with this condition undergo.”
EXTRA Part 1- Non-Radiographic Axial Spondyloarthritis: A Conversation with Dr. Jeff Stark and Patient Advocate Ricky White
Narrator 00:00
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
Dr. Jeff Stark 00:08
I think that there are barriers for patients around diagnosis and certainly we want for patients with non-radiographic AxSpA to have appropriate treatments. But there is so much more that can positively impact the journey that patients with this condition undergo. And one of those is the way that we capture and record this disease or even have the ability to do that in medical records.
Steven Newmark 00:33
Welcome to The Health Advocates. A podcast that breaks down major health news of the week to help you make sense of it all. I’m Steven Newmark, Director of Policy at the Global Healthy Living Foundation.
Zoe Rothblatt 00:42
And I’m Zoe Rothblatt, Associate Director of Community Outreach at GHLF.
Steven Newmark 00:47
Our goal is to help you understand what’s happening in the health care world to help you make informed decisions to live your best life.
Zoe Rothblatt 00:53
Well Steven, today’s episode is a bit different than our usual stuff. We are conducting a two-part episode about non-radiographic axial spondyloarthritis. In these two episodes, we’ll cover what it is, the road to getting a diagnosis, the advancements in treatment, and most of all, how to advocate for yourself when living with a chronic illness like non-rad AxSpA.
Steven Newmark 01:14
In this episode, we will hear from a patient Ricky White on his journey with getting a diagnosis of non-rad AxSpA, how he became an advocate and where he is today.
Zoe Rothblatt 01:23
And we’re also joined by Dr. Jeff Stark to learn about non-radiographic axial spondyloarthritis, the work done to improve diagnosis, and the importance of research in this area. So, you know, let’s dive in. When people think about arthritis, they generally think rheumatoid arthritis. I know that when I bring up my spondyloarthritis, my friends and family often call it RA. Maybe that’s because it’s easier to say than non-radiographic axial spondyloarthritis?
Steven Newmark 01:51
Is that true, RA is easier to say?
Zoe Rothblatt 01:54
I think so.
Steven Newmark 01:55
I guess you’re right.
Zoe Rothblatt 01:56
Well, whatever the reason is, we got to change that!
Steven Newmark 02:00
We sure do, because the truth is that there are over 100 types of arthritis. And today we will be talking specifically about non-radiographic axial spondyloarthritis. Part of being a patient advocate and a health advocate is letting people know about this information so that number one; people who are undiagnosed may hear about it and recognize symptoms and be able to make an appointment and get a diagnosis, and number two; to provide a sense of community for those living with the condition as they hear from us and from others.
Zoe Rothblatt 02:26
That’s very true. That sense of community really, really helps with coping with a chronic illness. So what is non-radiographic axial spondyloarthritis? Let’s start there.
Steven Newmark 02:36
That’s a great question Zoe, and we’re joined here today by Dr. Jeff Stark, the Head of Immunology Medical at UCB. Jeff is also rheumatologist and spends a lot of time and focus on non-rad AxSpA. UCB has invested in years of research and understanding of this chronic disease. Dr. Stark, how do you describe non-radiographic axial spondyloarthritis to patients and what makes it a particularly challenging disease?
Dr. Jeff Stark 02:59
Thanks Steven. And I love your abbreviated form of non-rad AxSpA because it is something of a mouthful. You know, non-radiographic axial spondyloarthritis, or sometimes we call it Nr-axSpA, is a form of arthritis and it belongs to a larger family of diseases that we call axial spondyloarthritis. And these are inflammatory conditions that can affect the spine and the sacroiliac joints. And what that means is that for the majority of patients with this condition, they really experience low back pain as a primary symptom of their disease. However, symptoms aren’t limited to that area, we actually see that pain and stiffness can occur in many other parts of the body as well. The diagnosis of non-radiographic AxSpA can actually be a challenge, but is sometimes helped by finding imaging changes on certain tests like MRI scans. But these patients by definition, have no X-ray changes and that can often lead to a misdiagnosis or their condition improperly being assessed as a mild form of disease even though the symptoms may be severe. So because of these challenges, non-radiographic AxSpA patients even today can experience many years of delay in their diagnosis. The data actually tell us that this delay can be up to eight to 10 years for some patients and unfortunately, during that time, they may receive inappropriate treatments or be treated in inappropriate care settings before they finally land in the office of a rheumatologist where they can receive a proper diagnosis and proper care. This misconception as well that non-radiographic AxSpA is a milder form of disease, and unfortunately, for many patients, that’s just not the case. We see these folks have a substantial burden of disease in fact and these symptoms that they experience of pain and stiffness can really affect their quality of life through changes such as chronic pain and a reduction in their ability to function every day.
Steven Newmark 04:53
Thanks for sharing and providing those insights. Our listeners know how much we talk about time to diagnosis and how important it is to get that diagnosis as timely a manner as possible in order to improve the quality of life. And there’s clearly a lot of room for improvement in the journey to diagnosis with non-rad AxSpA. Can you share a little more on how UCB is working to change this?
Dr. Jeff Stark 05:13
Absolutely. And thanks for asking that question, Steven. You know, I think that there are barriers for patients around diagnosis. And certainly we want for patients with non-radiographic AxSpA to have appropriate treatments. But there is so much more that can positively impact the journey that patients with this condition undergo. And one of those is the way that we capture and record this disease or even have the ability to do that in medical records. So for several years, UCB worked in partnership with professional rheumatology organizations as well as patient advocacy groups in soliciting a group called the ICD-10 Coordination and Maintenance Committee (C&M) and this is a group that oversees the diagnostic codes that are available to physicians and health care providers in the United States. We requested along with those community partners the creation of a new ICD-10 code specific for non-radiographic AxSpA. So prior to that time, there was actually no way to record such a diagnosis in electronic medical records. We’re really happy that as a result of those concerted and collaborative efforts that in October of last year, the committee endorsed the creation of a new subcategory for non-radiographic AxSpA, meaning that now today, physicians and health care providers in the US can actually record a specific diagnosis of non-radiographic AxSpA. And that’s important for many reasons, but perhaps most importantly, because it recognizes and validates non-radiographic AxSpA as a real legitimate and separate condition from other diseases in this larger category. So this has been an exciting update we think for the community, but especially for people who are living with this condition that traditionally has been under-recognized and undertreated. We also think that proper coding will help to improve diagnostics. We think that it will help to reduce the delay to diagnosis. And actually really importantly, now that we can track and identify patients with this condition in a very specific way, it’s going to allow us to study these patients and generate real world data about the journey that they undergo the kinds of treatments, that they receive the burden of their disease, etc. And I know I think in a future episode that you’ll be hearing from one of my colleagues, Amanda Ledford in greater detail on this topic. So excited for that to happen at a point in the near future. The other, you know, sort of activity that UCB has been involved in is creating resources to really support the health care community and lead to an earlier recognition and timely referral and diagnosis for these patients who may have undiagnosed axial spondyloarthritis. Last year, UCB introduced something called the axSpA-ID Query Set, which is actually a tool or a platform that’s designed to be used with electronic health care records. And what this set does is it puts a customizable clinical criteria set in the hands of health care providers that helps them. It’s sort of seamlessly embedded in their electronic record and helps them to identify patients who have a higher likelihood of AxSpA so that they can be referred on to an appropriate care setting for a formal evaluation that we hope leads to an accurate diagnosis and appropriate treatment to follow.
Steven Newmark 08:27
That’s really interesting. In terms of treatment, I’d love to hear more about the importance of clinical research in this area.
Dr. Jeff Stark 08:33
Absolutely. So there have been some significant advances, really in the understanding of what drives the inflammation of AxSpA over the last two decades. But a deeper understanding of these topics, really kind of the immune system dysregulation that’s going on may ultimately hold the key to raising the standard of care and optimizing outcomes for patients essentially, the more we understand what’s going wrong with the immune system, what’s causing this abnormal inflammation to be present, the more opportunity we have to target those abnormalities and improve the symptoms that patients with non-radiographic AxSpA experience. UCB continues to study non-radiographic AxSpA as a distinct condition with separate and dedicated clinical trials, which we really feel helps to distinguish it as a unique condition and give it the attention that it deserves as a separate disease state. Actually coming up in the very near future, just next week, we’ll be at the ACR Convergence 2022 Meetings, sharing data across our portfolio, but including data specifically for non-radiographic axial spondyloarthritis, and also hosting a medical symposium. They’re on both axial spondyloarthritis and a related condition called psoriatic arthritis to help educate the community about advances in these areas. So you know, I think just to sum up, UCB is committed to innovative research and development to help improve the lives of patients who live with this tough condition called non-radiographic AxSpA. UCB has one approved treatment option for non-radiographic AxSpA that we produce today, but we’re actively investigating other future potential solutions and are excited about those possibilities down the road.
Steven Newmark 10:15
Well, thank you Dr. Stark, I think we’re all excited to see what’s next for non-rad AxSpA patient care. As you noted, many people have a long road to getting a diagnosis. And hopefully with the work that you guys are doing and others, we can cut that time down.
Zoe Rothblatt 10:28
Well, that was really wonderful to hear Dr. Stark. And as we continue the conversation, let’s hear from someone who has personal experience. We have with us here today, Ricky White an individual living with non-rad AxSpA.
Steven Newmark 10:41
And he has graciously agreed to come on the podcast to share his story.
Dr. Jeff Stark 10:44
Ricky, it’s really, really great to meet you through the magic of the internet today, and really appreciative that you’re willing to join this conversation and share your story. I think one of the things we heard in the first part of this podcast is the really long journey that many patients with your condition undergo and wonder if you could share with us a little bit about what that journey looks like for you.
Ricky White 11:04
Yeah, thanks. Great to meet you, too. So my journey started… I was officially diagnosed in 2010. And I probably should say this upfront is officially my diagnosis was ankylosing spondylitis not non-rad AxSpA but because that term didn’t exist when I got diagnosed back in 2010. So if I was to be re diagnosed today, I would fall under the category of non-rad AxSpA. So just put that out there in case anyone reads anything about me on the internet it will refer to ankylosing spondylitis. But that’s officially my diagnosis. And so part of the reason it stays my diagnosis, though, is to touch on points you mentioned earlier. There’s not always the treatment options available to patients with non-rad AxSpA because this is relatively new to a lot of rheumatologist and the problem you mentioned with the coding issue is with the higher classification, you know, and we both know that that’s not true, that one’s not necessarily worse than the other. But there are more treatment options available to me so downgrading my diagnosis to non-rad AxSpA actually do me more harm than good. So I think that’s one thing to point out. And you very, you explain that very well earlier. So hopefully that makes sense to everybody why that’s the case. So I was diagnosed officially in 2010, I actually started suffering with symptoms just three and a half years prior. So that’s very short for most patients. And I got very lucky. So I was a registered nurse at the time practicing in England, I used to work on the ICU, and I was getting sciatic pain and lower back pain. So I went to see my doctors over and over again, short courses of anti inflammatory drugs: “Oh, you’re a nurse with back pain. That’s pretty common. It’s almost part of the job description,” right? So it was kind of just passed off as well. You know, make sure you do your proper moving and handling techniques correctly, and you’re doing all the things you should be doing as a nurse to prevent further injury. But it kept persisting. And I noticed that this was happening almost cyclically, like every three or four months. So back in England, we have this team of doctors called occupational health doctors. And so they’re basically doctors and nurses, for doctors and nurses right there on site in the hospital. If you have a work related problem, you go see them and they can check you out. So I went to see one of those and he says: “Oh, you actually you don’t have lower back pain, you have inflammation in your SI joint.” And so then pain relief was pretty much the same. But it was a different cause a couple of years after that I was getting worse and worse to the point where I was really struggling to work. I went to see my GP and at the time, she was less receptive to the idea that it might be something other than lower back pain. But the luck I had was one of the doctors I was working with mentioned to me after I was talking to him in the coffee break room: “Have you been tested for ankylosing spondylitis?” And I said: “No, what’s that?” Right? So I had no idea what it was, even as a nurse. I ended up getting tested for HLA-B27 and it was positive and they referred me to rheumatology. And that’s kind of how it progressed.
Dr. Jeff Stark 13:48
Yeah, that’s so interesting. And I smile a bit to myself when I hear you say three and a half years is a short journey to diagnosis. It is truly compared to the average but still a very long time for somebody to, you know, be wondering about what’s going on and whether they’re getting the right treatment, we sort of hope I think for many patients that they land in a rheumatologist office, because that’s the specialty who really has expertise in these disease states. I wonder, you know, what that looked like for you and when you knew you’d found the right doctor if you have indeed, you know, found the right one today and what do you look for in a rheumatologist? Who, you know, you feel like provides you the right kind of care, the right approach to treating this condition?
Ricky White 14:27
So I think I definitely didn’t have the right rheumatologist when I started my journey. I definitely have the right rheumatologist now. Part of that is because I moved 3,000 miles to a different country in a different health care system. So my very first rheumatologist basically said to me: “Let’s do an MRI scan. If you’ve got ankylosing spondylitis, your joints will fuse together and then you won’t have pain anymore.” And I was just gobsmacked when he said that, my jaw dropped to the floor, right. I was used to being around bad news working in an ICU, I was used to, you know, giving it and I’ve been in those stressful situations, but I wasn’t used to receiving it, right. And that was probably one of the worst things you probably could say to a patient, right? It wasn’t helpful. There was no plan of action, there was nothing. And the next rheumatologist I saw, he said: “You’ve got severe AS let’s start treatment now, we’re gonna give you a steroid shot,” bang, bang, bang, all the treatment, just everything went from snail’s pace to 100 miles an hour in the space of one meeting with him. And so that really is when things changed. And after I moved to the US, I wasn’t insured for the first year when I was here, I was an immigrant, right, so I wasn’t eligible for Medicaid or anything I had to pay out of pocket. Then we got insurance from my wife’s work, and then everything kind of picked up from there. And I’ve seen a few rheumatologists with my current health care provider who have all been great. As for kind of what to look for, I think there’s this misconception that people have that much choice that they can choose the right doctor, that’s not the case for most of the world, right? You don’t have the privilege of going: “Well, this doctor is not right for me, let me go see the other one two miles down the road.” That is not realistic for most people in the world, even in the U.S. So I think there’s that misconception that you can find the right doctor, right. I always look at it as it’s a relationship, because you’re going to be shown very intimate parts of your health. And so you’ve got to be comfortable with that person. Obviously, that is the most important, if you’re not comfortable sharing with that person, then maybe they aren’t the right doctor, you need to try and look elsewhere. But just because they may not feel like the most qualified or the right doctor at the time doesn’t mean they’re not still going to give you the right care. I think most of the problems patients have come down to miscommunication and styles in communication. The doctor doesn’t quite know what the patient’s telling them, or misinterprets that and the patient doesn’t really want to know how the doctor wants to receive information. So I think if you can figure out how you can communicate well together, like any relationship, then I think that really is going to set you off on the path to kind of getting the right treatment, being upfront about what your goals are, because what your goals are and what your doctor’s goals for you are, may not be aligned. And so you really have to communicate that and be upfront about what your goals are as a person. Because once your goals align, then the treatments will get you there.
Zoe Rothblatt 17:02
Ricky, you touched on, you know what you’ve heard from other patients. I’m wondering if you’ve found a community of other people living with AS and non-rad AxSpA, what that means to you?
Ricky White 17:13
Yeah, I mean, community is key, right, to dealing with this because this isn’t just a physical condition, right? You’re in pain constantly. Because a mental health aspect that plays into this, right? One point myself, I was clinically depressed, I didn’t leave my studio apartment for three months, because I physically can’t walk to the bathroom, barely. So you know, community is really what got me over that period of depression and actually got me on the road to good treatment and really learning about the condition and about how it affects me and really helped me be introspective about why I’m doing the things I’m doing and what I need to do to overcome the things that my body is feeling. So I’ve been in several communities and the platform use changes. Now it’s you know… it could be Facebook groups or anyway. There is a lot out there if you’re willing to look for them. So my advice always to people who are newly diagnosed is go find a community. Go search. Where do you like to be? Is it Facebook? Is it in forums? Is it in person? Do you want to do an in-person meeting? Where are you most comfortable, and then I guarantee there’s a community there for it. And so one of the many hats I wear in life is, I’m the president of a nonprofit called Walk AS One. We’re an all volunteer organization that serves people with AS and AxSpA all around the world. And the whole reason we exist is for community right? To give people a place to come and talk to each other.
Steven Newmark 18:24
It’s great that you’ve created this community or have joined in this community. How do you use this community to advocate for yourself and for others?
Ricky White 18:32
I think the days of me advocating for myself are gone. I find I get more benefit from advocating for others than myself. So you know, my disease is well controlled. Now I’ve got good treatment, I’ve now got the doctors around me. More importantly, I now have the knowledge that I have about the condition and how to treat my symptoms on a day-to-day basis because it’s ever changing. So I tend not to advocate for myself, I tend to advocate for others and that gives me more reward. So how I do that is I think information is key. But a lot of people get this diagnosis, but they’re not necessarily given the information they need. I know when I was diagnosed I wasn’t told about NASS, which is the National one at the time… it was the National Ankylosing Spondylitis Society in the UK, they’ve since changed the name to Axial Spondyloarthritis Society. But so I wasn’t given that information. But I went out and I found that community and then I got all the information I needed and the community and the support. So I try and be that person too. When I hear someone who’s newly diagnosed is the first thing I do is, here’s the support groups, you’re going to need them and explain why. And then I try and give them the information in a way they want to receive it. But also at a level they’re willing to receive it as well. Because, you know, as a nurse, I could talk on a similar level to Dr. Stark, but that will go over a lot of people’s heads. So you kind of have to talk at the right level for them and where they’re at in their journey.
Dr. Jeff Stark 19:48
That’s fantastic, Ricky. Really, really exciting to hear about how you’ve leveraged your own experience for the benefit of a larger community. And really great to hear that you’ve come so far in your own journey and that your own condition is well controlled. At this point, I wonder if you have any tips or tricks from your own experience of living with this disease of how you’re managing your axial spondyloarthritis, and how you’re maintaining that good condition that you find yourself in today.
Ricky White 20:14
I think the key for most people is to keep an open mind because your condition is gonna evolve over time, and so much the ways you approach and treat your condition. I found in the early days, I don’t do it now, but in the early days, I used to write things down how I was feeling on a particular day, what my pain was what I did, and did it work. I was very analytical, right, I looked at the data, that’s just how my brain works. I think writing things down is still good, even if you’re not putting numbers to things because it lets you be honest with yourself about how you’re doing. And then you can treat it appropriately. If you’re ignoring a symptom, or you’re pushing, you know, this depression down. Or if you’re ignoring something that’s clearly upsetting you, then you’re not going to treat it and it just blows up in your face later down the road. Right? So being honest with yourself, I think is the most important thing. And always have a plan B. That’s the other tip, always have a plan B, right? Maybe I’m going out for drinks tonight. And you know, I have a flare, I can’t go out for drinks anymore, I’ve got a plan B. Maybe I’ll FaceTime and say hi, or something you know. So always have a plan B and educating other people so they can help you is also important, right? Because there are days when I maybe I’m walking a certain way or act in a certain way, and my wife will turn around to me and tell me: “Hey, I see what you’re doing. You need to go do this,” right, because I’m ignoring it. And then she tells me now, this is what we do. And this has happened. Building that support network around you is definitely a big improvement to help as far as how I manage my own condition. While right now I’m on anti-TNF injections, that helps a lot. And the thing that by far is helping me most is exercise. So I’m a martial artist, and doing that amount of stretching. And the conditioning that I do with the martial arts has helped me immensely because it’s not just about exercise. And it was about building functional strength. So on my bad days, I’m still strong enough to stand up straight and all this kind of stuff. So I mean, a lot of doctors will tell you not to do impact sports, when you have this kind of diagnosis. And I say do what makes you happy. If it’s making you happy, you’ll figure out how to make it work.
Dr. Jeff Stark 22:09
Great. Thanks for sharing.
Zoe Rothblatt 22:10
Yeah, thank you both so much for joining us today. You know, there’s so many learnings to take away and I really appreciate having both sides of the conversation patient and doctor and all of us advocates to coming together. So thank you. Well, Steven, that brings us to the close of our show. What did you learn today?
Steven Newmark 22:27
I learned about you know, the importance of talking to doctors and professionals and scientists who are out there working to try and improve the lives of patients. You know, we spend so much of our time talking with patients and advocating on behalf of patients. It was great to hear from a doctor like Dr. Stark who’s out there and actually trying to work to improve timely diagnosis and improve outcomes for patients. So that was great.
Zoe Rothblatt 22:51
And I learned from Ricky just how much goes into caring for yourself and the different aspects of what you can do to care for yourself and advocate for others as well.
Steven Newmark 23:02
We hope that you learned something too. This episode is made possible with support from UCB sponsor the Global Healthy Living Foundation.
Zoe Rothblatt 23:10
And we hope you’ll join us for part two. In part two of this series we’ll have Amanda Ledford describing some of the access and policy challenges in diagnosing non-rad AxSpA.
Steven Newmark 23:19
Thanks as always for listening and a special thank you to Dr. Jeffrey Stark and Ricky White for joining us today.
Zoe Rothblatt 23:25
Yes, thank you so much. I’m Zoe Rothblatt.
Steven Newmark 23:27
I’m Steven Newmark. We’ll see you next time.
Narrator 23:33
Be inspired, supported and empowered. This is the Global Healthy Living Foundation Podcast Network.
About Our Hosts
Steven Newmark
Steven Newmark, JD, MPA, is Director of Policy and General Counsel. Steven leads global advocacy and policy initiatives. He was most recently Special Counsel to the President of NYC Health + Hospitals in New York City. Before that he served as the Senior Health Policy Adviser to New York City Mayor Bill de Blasio. He also served as General Counsel in Mayor de Blasio’s Public Advocate office, and as a Health Sciences Litigation Associate at Orrick, Herrington & Sutcliffe, LLP in New York City where he was part of the team that successfully defended the Vaccine Act before the Supreme Court in Bruesewitz v. Wyeth.
Additionally, he has taught Public Policy at Columbia University and is an Adjunct Professor in U.S. Health Policy at the City University of New York, Baruch College. He received his Juris Doctor from Fordham University School of Law and his Master of Public Policy and Administration, Advanced Policy and Management from Columbia University School of International and Public Affairs. He received his Bachelor of Arts, Philosophy, Politics and Law from the State University of New York at Binghamton.
Zoe Rothblatt
Zoe Rothblatt, MPH, is a Patient Advocate, Community Outreach Manager and engages in direct patient communications, supporting GHLF’s patient councils and board of governors. Zoe is responsible for understanding patient needs and creating patient-centered resources as well as researching policy initiatives. She earned a Master of Public Health at Columbia University’s Mailman School of Public Health, with a focus on Health Policy and Management. She received a Bachelor of Arts in Health: Science, Society and Policy from Brandeis University. Prior to joining GHLF, Zoe worked at the Community Service Society of New York as a community health advocate providing direct service, advocacy, advice and referrals for patients needing assistance.
Subscribe for weekly patient advocacy news right to your inbox
By subscribing, you agree to receive emails from GHLF. We will never sell your data. See our Privacy Policy.